,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,219913,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,29093,MRPL22,https://ctdbase.org/detail.go?type=gene&acc=29093,,,29093.0,MRPL22,10090.0,Mus musculus (house mouse),"[1,2-dimethylhydrazine co-treated with folic acid] results in decreased expression of MRPL22 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
1,219914,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,6150,MRPL23,https://ctdbase.org/detail.go?type=gene&acc=6150,,,6150.0,MRPL23,10090.0,Mus musculus (house mouse),"[1,2-dimethylhydrazine co-treated with folic acid] results in decreased expression of MRPL23 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
2,219915,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,79590,MRPL24,https://ctdbase.org/detail.go?type=gene&acc=79590,,,79590.0,MRPL24,10090.0,Mus musculus (house mouse),"1,2-dimethylhydrazine results in decreased expression of MRPL24 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
3,219916,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,51264,MRPL27,https://ctdbase.org/detail.go?type=gene&acc=51264,,,51264.0,MRPL27,10090.0,Mus musculus (house mouse),"[1,2-dimethylhydrazine co-treated with folic acid] results in decreased expression of MRPL27 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
4,219917,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,10573,MRPL28,https://ctdbase.org/detail.go?type=gene&acc=10573,,,10573.0,MRPL28,10090.0,Mus musculus (house mouse),"Folic acid inhibits the reaction [1,2-dimethylhydrazine results in increased expression of MRPL28 mrna]|1,2-dimethylhydrazine results in increased expression of MRPL28 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
5,219918,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,11222,MRPL3,https://ctdbase.org/detail.go?type=gene&acc=11222,,,11222.0,MRPL3,10090.0,Mus musculus (house mouse),"1,2-dimethylhydrazine results in decreased expression of MRPL3 mrna|[1,2-dimethylhydrazine co-treated with folic acid] results in decreased expression of MRPL3 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
6,219919,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,64983,MRPL32,https://ctdbase.org/detail.go?type=gene&acc=64983,,,64983.0,MRPL32,10090.0,Mus musculus (house mouse),"Folic acid inhibits the reaction [1,2-dimethylhydrazine results in increased expression of MRPL32 mrna]|1,2-dimethylhydrazine results in increased expression of MRPL32 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
7,219920,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,9553,MRPL33,https://ctdbase.org/detail.go?type=gene&acc=9553,,,9553.0,MRPL33,10090.0,Mus musculus (house mouse),"[1,2-dimethylhydrazine co-treated with folic acid] results in decreased expression of MRPL33 mrna|1,2-dimethylhydrazine results in decreased expression of MRPL33 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
8,219921,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,64981,MRPL34,https://ctdbase.org/detail.go?type=gene&acc=64981,,,64981.0,MRPL34,10090.0,Mus musculus (house mouse),"[1,2-dimethylhydrazine co-treated with folic acid] results in decreased expression of MRPL34 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
9,219922,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,51318,MRPL35,https://ctdbase.org/detail.go?type=gene&acc=51318,,,51318.0,MRPL35,10090.0,Mus musculus (house mouse),"1,2-dimethylhydrazine results in decreased expression of MRPL35 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
10,220628,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,6183,MRPS12,https://ctdbase.org/detail.go?type=gene&acc=6183,,,6183.0,MRPS12,10090.0,Mus musculus (house mouse),"[1,2-dimethylhydrazine co-treated with folic acid] results in decreased expression of MRPS12 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
11,220629,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,63931,MRPS14,https://ctdbase.org/detail.go?type=gene&acc=63931,,,63931.0,MRPS14,10090.0,Mus musculus (house mouse),"1,2-dimethylhydrazine results in decreased expression of MRPS14 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
12,220630,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,64960,MRPS15,https://ctdbase.org/detail.go?type=gene&acc=64960,,,64960.0,MRPS15,10090.0,Mus musculus (house mouse),"[1,2-dimethylhydrazine co-treated with folic acid] results in decreased expression of MRPS15 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
13,220631,1322,Comparative Toxicogenomics Database (CTD),"1,2-Dimethylhydrazine",D019813,"1,2-Dimethylhydrazine",https://ctdbase.org/detail.go?type=chem&acc=D019813,51021,MRPS16,https://ctdbase.org/detail.go?type=gene&acc=51021,,,51021.0,MRPS16,10090.0,Mus musculus (house mouse),"[1,2-dimethylhydrazine co-treated with folic acid] results in decreased expression of MRPS16 mrna|1,2-dimethylhydrazine results in decreased expression of MRPS16 mRNA",,,PMID:22206623,https://www.ncbi.nlm.nih.gov/pubmed/22206623,22206623,,
14,219562,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,10090.0,Mus musculus (house mouse),Fomepizole inhibits the reaction [acetaminophen affects the localization of AIFM1 protein],,,PMID:29739258,https://www.ncbi.nlm.nih.gov/pubmed/29739258,29739258,,
15,219563,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,10090.0,Mus musculus (house mouse),Metformin inhibits the reaction [acetaminophen affects the localization of AIFM1 protein],,,PMID:27562556,https://www.ncbi.nlm.nih.gov/pubmed/27562556,27562556,,
16,219564,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,10090.0,Mus musculus (house mouse),Mitotempo inhibits the reaction [acetaminophen affects the localization of AIFM1 protein],,,PMID:27002509,https://www.ncbi.nlm.nih.gov/pubmed/27002509,27002509,,
17,219565,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,10090.0,Mus musculus (house mouse),Necrostatin-1 inhibits the reaction [acetaminophen affects the localization of AIFM1 protein],,,PMID:24440347,https://www.ncbi.nlm.nih.gov/pubmed/24440347,24440347,,
18,219566,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,10090.0,Mus musculus (house mouse),[NQO1 gene mutant form results in increased susceptibility to acetaminophen] which results in increased expression of AIFM1 protein,,,PMID:25224400,https://www.ncbi.nlm.nih.gov/pubmed/25224400,25224400,,
19,219567,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,10090.0,Mus musculus (house mouse),PDK4 protein affects the reaction [acetaminophen results in increased expression of AIFM1 protein],,,PMID:31809757,https://www.ncbi.nlm.nih.gov/pubmed/31809757,31809757,,
20,219568,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of AIFM1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
21,219569,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84883,AIFM2,https://ctdbase.org/detail.go?type=gene&acc=84883,,,84883.0,AIFM2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of AIFM2 mRNA,,,PMID:25704631|PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/25704631|https://www.ncbi.nlm.nih.gov/pubmed/26690555,25704631|26690555,,
22,219732,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55135,WRAP53,https://ctdbase.org/detail.go?type=gene&acc=55135,,,55135.0,WRAP53,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of WRAP53 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
23,219733,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,56897,WRNIP1,https://ctdbase.org/detail.go?type=gene&acc=56897,,,56897.0,WRNIP1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of WRNIP1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
24,219734,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26118,WSB1,https://ctdbase.org/detail.go?type=gene&acc=26118,,,26118.0,WSB1,9606.0,Homo sapiens (human),Acetaminophen affects the expression of WSB1 mRNA,,,PMID:25458485,https://www.ncbi.nlm.nih.gov/pubmed/25458485,25458485,,
25,219735,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26118,WSB1,https://ctdbase.org/detail.go?type=gene&acc=26118,,,26118.0,WSB1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of WSB1 mRNA,,,PMID:22230336|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/22230336|https://www.ncbi.nlm.nih.gov/pubmed/29067470,22230336|29067470,,
26,220472,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9590,AKAP12,https://ctdbase.org/detail.go?type=gene&acc=9590,,,9590.0,AKAP12,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of AKAP12 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
27,220473,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,11214,AKAP13,https://ctdbase.org/detail.go?type=gene&acc=11214,,,11214.0,AKAP13,9606.0,Homo sapiens (human),Acetaminophen affects the expression of AKAP13 mRNA,,,PMID:25458485,https://www.ncbi.nlm.nih.gov/pubmed/25458485,25458485,,
28,220474,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,11214,AKAP13,https://ctdbase.org/detail.go?type=gene&acc=11214,,,11214.0,AKAP13,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of AKAP13 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
29,220475,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,338351,AKAP17B,https://ctdbase.org/detail.go?type=gene&acc=338351,,,338351.0,Akap17b,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of AKAP17B mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
30,220476,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9495,AKAP5,https://ctdbase.org/detail.go?type=gene&acc=9495,,,9495.0,AKAP5,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of AKAP5 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
31,220477,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9472,AKAP6,https://ctdbase.org/detail.go?type=gene&acc=9472,,,9472.0,AKAP6,10116.0,Rattus norvegicus (Norway rat),Acetaminophen affects the expression of AKAP6 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
32,220478,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9465,AKAP7,https://ctdbase.org/detail.go?type=gene&acc=9465,,,9465.0,AKAP7,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of AKAP7 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
33,220479,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9465,AKAP7,https://ctdbase.org/detail.go?type=gene&acc=9465,,,9465.0,AKAP7,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of AKAP7 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
34,220480,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10270,AKAP8,https://ctdbase.org/detail.go?type=gene&acc=10270,,,10270.0,AKAP8,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of AKAP8 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
35,220720,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,389072,PLEKHM3,https://ctdbase.org/detail.go?type=gene&acc=389072,,,389072.0,PLEKHM3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PLEKHM3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
36,220721,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84069,PLEKHN1,https://ctdbase.org/detail.go?type=gene&acc=84069,,,84069.0,PLEKHN1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PLEKHN1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
37,220722,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51177,PLEKHO1,https://ctdbase.org/detail.go?type=gene&acc=51177,,,51177.0,PLEKHO1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PLEKHO1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
38,220723,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,80301,PLEKHO2,https://ctdbase.org/detail.go?type=gene&acc=80301,,,80301.0,PLEKHO2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PLEKHO2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
39,220724,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,80301,PLEKHO2,https://ctdbase.org/detail.go?type=gene&acc=80301,,,80301.0,PLEKHO2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PLEKHO2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
40,220901,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of AKR1B10 mRNA,,,PMID:21420995|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|29067470,,
41,220902,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016.0,AKR1B10,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of AKR1B10 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
42,220903,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,11997,AKR1B7,https://ctdbase.org/detail.go?type=gene&acc=11997,,,11997.0,Akr1b7,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of AKR1B7 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
43,220904,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,14187,AKR1B8,https://ctdbase.org/detail.go?type=gene&acc=14187,,,14187.0,Akr1b8,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of AKR1B8 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
44,220905,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,14187,AKR1B8,https://ctdbase.org/detail.go?type=gene&acc=14187,,,14187.0,Akr1b8,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of AKR1B8 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
45,220906,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of AKR1C1 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
46,220907,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of AKR1C1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
47,220908,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,622402,AKR1C12,https://ctdbase.org/detail.go?type=gene&acc=622402,,,622402.0,Akr1c12,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of AKR1C12 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
48,220909,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,105387,AKR1C14,https://ctdbase.org/detail.go?type=gene&acc=105387,,,105387.0,Akr1c14,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of AKR1C14 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
49,221423,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10769,PLK2,https://ctdbase.org/detail.go?type=gene&acc=10769,,,10769.0,PLK2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PLK2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
50,221424,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,1263,PLK3,https://ctdbase.org/detail.go?type=gene&acc=1263,,,1263.0,PLK3,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PLK3 mRNA,,,PMID:21420995|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|29067470,,
51,221425,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,1263,PLK3,https://ctdbase.org/detail.go?type=gene&acc=1263,,,1263.0,PLK3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PLK3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
52,221426,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,1263,PLK3,https://ctdbase.org/detail.go?type=gene&acc=1263,,,1263.0,PLK3,10090.0,Mus musculus (house mouse),Acetaminophen results in increased expression of PLK3 mRNA,,,PMID:26056430,https://www.ncbi.nlm.nih.gov/pubmed/26056430,26056430,,
53,221427,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,1263,PLK3,https://ctdbase.org/detail.go?type=gene&acc=1263,,,1263.0,PLK3,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of PLK3 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of PLK3 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
54,221428,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,1263,PLK3,https://ctdbase.org/detail.go?type=gene&acc=1263,,,1263.0,PLK3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PLK3 mRNA,,,PMID:32479839|PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/32479839|https://www.ncbi.nlm.nih.gov/pubmed/33387578,32479839|33387578,,
55,221429,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10733,PLK4,https://ctdbase.org/detail.go?type=gene&acc=10733,,,10733.0,PLK4,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PLK4 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
56,221430,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10733,PLK4,https://ctdbase.org/detail.go?type=gene&acc=10733,,,10733.0,PLK4,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PLK4 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
57,221431,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10733,PLK4,https://ctdbase.org/detail.go?type=gene&acc=10733,,,10733.0,PLK4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PLK4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
58,221505,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7518,XRCC4,https://ctdbase.org/detail.go?type=gene&acc=7518,,,7518.0,XRCC4,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of XRCC4 mRNA,,,PMID:29540258,https://www.ncbi.nlm.nih.gov/pubmed/29540258,29540258,,
59,221506,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7518,XRCC4,https://ctdbase.org/detail.go?type=gene&acc=7518,,,7518.0,XRCC4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of XRCC4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
60,221507,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7520,XRCC5,https://ctdbase.org/detail.go?type=gene&acc=7520,,,7520.0,XRCC5,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of XRCC5 mRNA,,,PMID:21420995|PMID:26497421,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/26497421,21420995|26497421,,
61,221508,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7520,XRCC5,https://ctdbase.org/detail.go?type=gene&acc=7520,,,7520.0,XRCC5,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of XRCC5 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
62,221509,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,2547,XRCC6,https://ctdbase.org/detail.go?type=gene&acc=2547,,,2547.0,XRCC6,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of XRCC6 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
63,221510,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,2547,XRCC6,https://ctdbase.org/detail.go?type=gene&acc=2547,,,2547.0,XRCC6,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of XRCC6 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
64,221511,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54464,XRN1,https://ctdbase.org/detail.go?type=gene&acc=54464,,,54464.0,XRN1,9606.0,Homo sapiens (human),Acetaminophen affects the expression of XRN1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
65,221844,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8985,PLOD3,https://ctdbase.org/detail.go?type=gene&acc=8985,,,8985.0,PLOD3,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of PLOD3 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of PLOD3 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
66,221845,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5354,PLP1,https://ctdbase.org/detail.go?type=gene&acc=5354,,,5354.0,PLP1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PLP1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
67,221846,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,368234,PLP1B,https://ctdbase.org/detail.go?type=gene&acc=368234,,,368234.0,plp1b,7955.0,Danio rerio (zebrafish),Acetaminophen affects the expression of PLP1B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
68,221847,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5355,PLP2,https://ctdbase.org/detail.go?type=gene&acc=5355,,,5355.0,PLP2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PLP2 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
69,221848,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8611,PLPP1,https://ctdbase.org/detail.go?type=gene&acc=8611,,,8611.0,PLPP1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PLPP1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
70,222021,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ALAS1 mRNA,,,PMID:15606129|PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/15606129|https://www.ncbi.nlm.nih.gov/pubmed/17562736,15606129|17562736,,
71,222022,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of ALAS1 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of ALAS1 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
72,222023,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen affects the expression of ALAS1 mRNA,,,PMID:17366322,https://www.ncbi.nlm.nih.gov/pubmed/17366322,17366322,,
73,222024,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,212,ALAS2,https://ctdbase.org/detail.go?type=gene&acc=212,,,212.0,ALAS2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ALAS2 mRNA,,,PMID:15606129|PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/15606129|https://www.ncbi.nlm.nih.gov/pubmed/17562736,15606129|17562736,,
74,222025,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,212,ALAS2,https://ctdbase.org/detail.go?type=gene&acc=212,,,212.0,ALAS2,10090.0,Mus musculus (house mouse),PANX1 gene mutant form inhibits the reaction [acetaminophen results in decreased expression of ALAS2 mrna]|acetaminophen results in decreased expression of ALAS2 mRNA,,,PMID:29246445,https://www.ncbi.nlm.nih.gov/pubmed/29246445,29246445,,
75,222026,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,212,ALAS2,https://ctdbase.org/detail.go?type=gene&acc=212,,,212.0,ALAS2,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of ALAS2 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of ALAS2 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
76,222027,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,212,ALAS2,https://ctdbase.org/detail.go?type=gene&acc=212,,,212.0,ALAS2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ALAS2 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
77,222337,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6781,STC1,https://ctdbase.org/detail.go?type=gene&acc=6781,,,6781.0,STC1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of STC1 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
78,222338,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6781,STC1,https://ctdbase.org/detail.go?type=gene&acc=6781,,,6781.0,STC1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of STC1 mRNA,,,PMID:32479839,https://www.ncbi.nlm.nih.gov/pubmed/32479839,32479839,,
79,222339,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,393511,STC1L,https://ctdbase.org/detail.go?type=gene&acc=393511,,,393511.0,stc1l,7955.0,Danio rerio (zebrafish),Acetaminophen affects the expression of STC1L mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
80,222340,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8614,STC2,https://ctdbase.org/detail.go?type=gene&acc=8614,,,8614.0,STC2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of STC2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
81,222341,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26872,STEAP1,https://ctdbase.org/detail.go?type=gene&acc=26872,,,26872.0,STEAP1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of STEAP1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
82,222342,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26872,STEAP1,https://ctdbase.org/detail.go?type=gene&acc=26872,,,26872.0,STEAP1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of STEAP1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
83,222343,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26872,STEAP1,https://ctdbase.org/detail.go?type=gene&acc=26872,,,26872.0,STEAP1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of STEAP1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
84,222344,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55240,STEAP3,https://ctdbase.org/detail.go?type=gene&acc=55240,,,55240.0,STEAP3,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of STEAP3 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
85,222345,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79689,STEAP4,https://ctdbase.org/detail.go?type=gene&acc=79689,,,79689.0,STEAP4,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of STEAP4 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
86,222346,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79689,STEAP4,https://ctdbase.org/detail.go?type=gene&acc=79689,,,79689.0,STEAP4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of STEAP4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
87,222684,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5362,PLXNA2,https://ctdbase.org/detail.go?type=gene&acc=5362,,,5362.0,PLXNA2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PLXNA2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
88,222685,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5362,PLXNA2,https://ctdbase.org/detail.go?type=gene&acc=5362,,,5362.0,PLXNA2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PLXNA2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
89,222686,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5362,PLXNA2,https://ctdbase.org/detail.go?type=gene&acc=5362,,,5362.0,PLXNA2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PLXNA2 mRNA,,,PMID:32479839,https://www.ncbi.nlm.nih.gov/pubmed/32479839,32479839,,
90,222687,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5362,PLXNA2,https://ctdbase.org/detail.go?type=gene&acc=5362,,,5362.0,PLXNA2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PLXNA2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
91,222688,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55558,PLXNA3,https://ctdbase.org/detail.go?type=gene&acc=55558,,,55558.0,PLXNA3,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PLXNA3 mRNA,,,PMID:22230336|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/22230336|https://www.ncbi.nlm.nih.gov/pubmed/29067470,22230336|29067470,,
92,222689,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,91584,PLXNA4,https://ctdbase.org/detail.go?type=gene&acc=91584,,,91584.0,PLXNA4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PLXNA4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
93,222690,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5364,PLXNB1,https://ctdbase.org/detail.go?type=gene&acc=5364,,,5364.0,PLXNB1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PLXNB1 mRNA,,,PMID:21420995|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|29067470,,
94,222691,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5364,PLXNB1,https://ctdbase.org/detail.go?type=gene&acc=5364,,,5364.0,PLXNB1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PLXNB1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
95,222692,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5364,PLXNB1,https://ctdbase.org/detail.go?type=gene&acc=5364,,,5364.0,PLXNB1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PLXNB1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
96,222693,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23654,PLXNB2,https://ctdbase.org/detail.go?type=gene&acc=23654,,,23654.0,PLXNB2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PLXNB2 mRNA,,,PMID:21420995|PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/26690555,21420995|26690555,,
97,222862,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ALDH1B1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
98,222863,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10840,ALDH1L1,https://ctdbase.org/detail.go?type=gene&acc=10840,,,10840.0,ALDH1L1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ALDH1L1 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
99,222864,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10840,ALDH1L1,https://ctdbase.org/detail.go?type=gene&acc=10840,,,10840.0,ALDH1L1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ALDH1L1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
100,222865,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10840,ALDH1L1,https://ctdbase.org/detail.go?type=gene&acc=10840,,,10840.0,ALDH1L1,10090.0,Mus musculus (house mouse),[CTH gene mutant form results in increased susceptibility to acetaminophen] which results in decreased expression of ALDH1L1 protein,,,PMID:25499718,https://www.ncbi.nlm.nih.gov/pubmed/25499718,25499718,,
101,222866,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ALDH2 mRNA,,,PMID:25704631,https://www.ncbi.nlm.nih.gov/pubmed/25704631,25704631,,
102,222867,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,10090.0,Mus musculus (house mouse),Acetaminophen results in increased expression of ALDH2 protein,,,PMID:21329376,https://www.ncbi.nlm.nih.gov/pubmed/21329376,21329376,,
103,222868,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of ALDH2 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of ALDH2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
104,222869,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen affects the expression of ALDH2 mRNA,,,PMID:15800402,https://www.ncbi.nlm.nih.gov/pubmed/15800402,15800402,,
105,223192,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,282974,STK32C,https://ctdbase.org/detail.go?type=gene&acc=282974,,,282974.0,STK32C,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of STK32C mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
106,223193,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,140901,STK35,https://ctdbase.org/detail.go?type=gene&acc=140901,,,140901.0,STK35,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of STK35 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
107,223194,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,27148,STK36,https://ctdbase.org/detail.go?type=gene&acc=27148,,,27148.0,STK36,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of STK36 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
108,223195,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,11329,STK38,https://ctdbase.org/detail.go?type=gene&acc=11329,,,11329.0,STK38,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of STK38 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
109,223196,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,11329,STK38,https://ctdbase.org/detail.go?type=gene&acc=11329,,,11329.0,STK38,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of STK38 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
110,223197,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,11329,STK38,https://ctdbase.org/detail.go?type=gene&acc=11329,,,11329.0,STK38,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of STK38 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
111,223198,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,11329,STK38,https://ctdbase.org/detail.go?type=gene&acc=11329,,,11329.0,STK38,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of STK38 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
112,223199,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,27347,STK39,https://ctdbase.org/detail.go?type=gene&acc=27347,,,27347.0,STK39,9606.0,Homo sapiens (human),Acetaminophen affects the expression of STK39 mRNA,,,PMID:25458485,https://www.ncbi.nlm.nih.gov/pubmed/25458485,25458485,,
113,223200,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,27347,STK39,https://ctdbase.org/detail.go?type=gene&acc=27347,,,27347.0,STK39,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of STK39 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
114,223532,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26137,ZBTB20,https://ctdbase.org/detail.go?type=gene&acc=26137,,,26137.0,ZBTB20,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZBTB20 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
115,223533,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26137,ZBTB20,https://ctdbase.org/detail.go?type=gene&acc=26137,,,26137.0,ZBTB20,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZBTB20 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
116,223534,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,49854,ZBTB21,https://ctdbase.org/detail.go?type=gene&acc=49854,,,49854.0,ZBTB21,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZBTB21 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
117,223535,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,49854,ZBTB21,https://ctdbase.org/detail.go?type=gene&acc=49854,,,49854.0,ZBTB21,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZBTB21 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
118,223536,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,49854,ZBTB21,https://ctdbase.org/detail.go?type=gene&acc=49854,,,49854.0,ZBTB21,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZBTB21 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
119,223537,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9841,ZBTB24,https://ctdbase.org/detail.go?type=gene&acc=9841,,,9841.0,ZBTB24,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZBTB24 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
120,223538,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7597,ZBTB25,https://ctdbase.org/detail.go?type=gene&acc=7597,,,7597.0,ZBTB25,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZBTB25 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
121,223813,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,4860,PNP,https://ctdbase.org/detail.go?type=gene&acc=4860,,,4860.0,PNP,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PNP mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
122,223814,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,4860,PNP,https://ctdbase.org/detail.go?type=gene&acc=4860,,,4860.0,PNP,10090.0,Mus musculus (house mouse),Dioscin inhibits the reaction [acetaminophen results in decreased expression of PNP protein]|acetaminophen results in decreased expression of PNP protein,,,PMID:22939915,https://www.ncbi.nlm.nih.gov/pubmed/22939915,22939915,,
123,223815,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,50640,PNPLA8,https://ctdbase.org/detail.go?type=gene&acc=50640,,,50640.0,PNPLA8,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PNPLA8 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
124,223816,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,4860,PNP,https://ctdbase.org/detail.go?type=gene&acc=4860,,,4860.0,PNP,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of PNP mrna]|[clofibrate co-treated with acetaminophen] affects the expression of PNP mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
125,223817,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,4860,PNP,https://ctdbase.org/detail.go?type=gene&acc=4860,,,4860.0,PNP,10116.0,Rattus norvegicus (Norway rat),Acetaminophen affects the expression of PNP protein,,,PMID:16099942,https://www.ncbi.nlm.nih.gov/pubmed/16099942,16099942,,
126,223818,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,4860,PNP,https://ctdbase.org/detail.go?type=gene&acc=4860,,,4860.0,PNP,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PNP mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
127,223819,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,402940,PNP4B,https://ctdbase.org/detail.go?type=gene&acc=402940,,,402940.0,pnp4b,7955.0,Danio rerio (zebrafish),Acetaminophen affects the expression of PNP4B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
128,223975,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54890,ALKBH5,https://ctdbase.org/detail.go?type=gene&acc=54890,,,54890.0,ALKBH5,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ALKBH5 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
129,224323,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,201595,STT3B,https://ctdbase.org/detail.go?type=gene&acc=201595,,,201595.0,STT3B,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of STT3B mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
130,224324,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,201595,STT3B,https://ctdbase.org/detail.go?type=gene&acc=201595,,,201595.0,STT3B,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of STT3B mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
131,224325,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10273,STUB1,https://ctdbase.org/detail.go?type=gene&acc=10273,,,10273.0,STUB1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of STUB1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
132,224326,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10273,STUB1,https://ctdbase.org/detail.go?type=gene&acc=10273,,,10273.0,STUB1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of STUB1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
133,224327,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8676,STX11,https://ctdbase.org/detail.go?type=gene&acc=8676,,,8676.0,STX11,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of STX11 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
134,224328,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8676,STX11,https://ctdbase.org/detail.go?type=gene&acc=8676,,,8676.0,STX11,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of STX11 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
135,224329,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8676,STX11,https://ctdbase.org/detail.go?type=gene&acc=8676,,,8676.0,STX11,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of STX11 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
136,224330,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23673,STX12,https://ctdbase.org/detail.go?type=gene&acc=23673,,,23673.0,STX12,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of STX12 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
137,224331,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23673,STX12,https://ctdbase.org/detail.go?type=gene&acc=23673,,,23673.0,STX12,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of STX12 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
138,224395,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,115701,ALPK2,https://ctdbase.org/detail.go?type=gene&acc=115701,,,115701.0,ALPK2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ALPK2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
139,224396,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,115701,ALPK2,https://ctdbase.org/detail.go?type=gene&acc=115701,,,115701.0,ALPK2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ALPK2 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
140,224397,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57538,ALPK3,https://ctdbase.org/detail.go?type=gene&acc=57538,,,57538.0,ALPK3,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ALPK3 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
141,224717,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23126,POGZ,https://ctdbase.org/detail.go?type=gene&acc=23126,,,23126.0,POGZ,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of POGZ mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
142,224718,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5422,POLA1,https://ctdbase.org/detail.go?type=gene&acc=5422,,,5422.0,POLA1,10090.0,Mus musculus (house mouse),Acetaminophen results in decreased expression of POLA1 mRNA,,,PMID:17942131,https://www.ncbi.nlm.nih.gov/pubmed/17942131,17942131,,
143,224719,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5422,POLA1,https://ctdbase.org/detail.go?type=gene&acc=5422,,,5422.0,POLA1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of POLA1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
144,224720,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23649,POLA2,https://ctdbase.org/detail.go?type=gene&acc=23649,,,23649.0,POLA2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of POLA2 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
145,224721,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5423,POLB,https://ctdbase.org/detail.go?type=gene&acc=5423,,,5423.0,POLB,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of POLB mRNA,,,PMID:16751229,https://www.ncbi.nlm.nih.gov/pubmed/16751229,16751229,,
146,224722,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5424,POLD1,https://ctdbase.org/detail.go?type=gene&acc=5424,,,5424.0,POLD1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of POLD1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
147,225020,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51538,ZCCHC17,https://ctdbase.org/detail.go?type=gene&acc=51538,,,51538.0,ZCCHC17,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZCCHC17 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
148,225021,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,644353,ZCCHC18,https://ctdbase.org/detail.go?type=gene&acc=644353,,,644353.0,ZCCHC18,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZCCHC18 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
149,225022,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54877,ZCCHC2,https://ctdbase.org/detail.go?type=gene&acc=54877,,,54877.0,ZCCHC2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZCCHC2 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
150,225023,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54877,ZCCHC2,https://ctdbase.org/detail.go?type=gene&acc=54877,,,54877.0,ZCCHC2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZCCHC2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
151,225024,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,219654,ZCCHC24,https://ctdbase.org/detail.go?type=gene&acc=219654,,,219654.0,ZCCHC24,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZCCHC24 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
152,225025,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,219654,ZCCHC24,https://ctdbase.org/detail.go?type=gene&acc=219654,,,219654.0,ZCCHC24,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZCCHC24 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
153,225026,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,219654,ZCCHC24,https://ctdbase.org/detail.go?type=gene&acc=219654,,,219654.0,ZCCHC24,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZCCHC24 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
154,225027,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,85364,ZCCHC3,https://ctdbase.org/detail.go?type=gene&acc=85364,,,85364.0,ZCCHC3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ZCCHC3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
155,225028,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,29063,ZCCHC4,https://ctdbase.org/detail.go?type=gene&acc=29063,,,29063.0,ZCCHC4,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZCCHC4 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
156,225029,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,29063,ZCCHC4,https://ctdbase.org/detail.go?type=gene&acc=29063,,,29063.0,ZCCHC4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ZCCHC4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
157,225237,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,29800,ZDHHC1,https://ctdbase.org/detail.go?type=gene&acc=29800,,,29800.0,ZDHHC1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZDHHC1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
158,225238,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84885,ZDHHC12,https://ctdbase.org/detail.go?type=gene&acc=84885,,,84885.0,ZDHHC12,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZDHHC12 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
159,225239,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54503,ZDHHC13,https://ctdbase.org/detail.go?type=gene&acc=54503,,,54503.0,ZDHHC13,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZDHHC13 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
160,225240,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79683,ZDHHC14,https://ctdbase.org/detail.go?type=gene&acc=79683,,,79683.0,ZDHHC14,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZDHHC14 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
161,225241,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79683,ZDHHC14,https://ctdbase.org/detail.go?type=gene&acc=79683,,,79683.0,ZDHHC14,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZDHHC14 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
162,225242,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,158866,ZDHHC15,https://ctdbase.org/detail.go?type=gene&acc=158866,,,158866.0,ZDHHC15,10116.0,Rattus norvegicus (Norway rat),Acetaminophen affects the expression of ZDHHC15 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
163,225243,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84287,ZDHHC16,https://ctdbase.org/detail.go?type=gene&acc=84287,,,84287.0,ZDHHC16,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZDHHC16 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
164,225244,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84287,ZDHHC16,https://ctdbase.org/detail.go?type=gene&acc=84287,,,84287.0,ZDHHC16,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZDHHC16 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
165,225404,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51430,SUCO,https://ctdbase.org/detail.go?type=gene&acc=51430,,,51430.0,SUCO,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of SUCO mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
166,225405,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51684,SUFU,https://ctdbase.org/detail.go?type=gene&acc=51684,,,51684.0,SUFU,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of SUFU mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
167,225406,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79783,SUGCT,https://ctdbase.org/detail.go?type=gene&acc=79783,,,79783.0,SUGCT,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of SUGCT mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
168,225407,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79783,SUGCT,https://ctdbase.org/detail.go?type=gene&acc=79783,,,79783.0,SUGCT,10090.0,Mus musculus (house mouse),Acetaminophen results in decreased expression of SUGCT mrna|panx1 gene mutant form inhibits the reaction [acetaminophen results in decreased expression of SUGCT mrna],,,PMID:29246445,https://www.ncbi.nlm.nih.gov/pubmed/29246445,29246445,,
169,225408,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57794,SUGP1,https://ctdbase.org/detail.go?type=gene&acc=57794,,,57794.0,SUGP1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of SUGP1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
170,225409,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10147,SUGP2,https://ctdbase.org/detail.go?type=gene&acc=10147,,,10147.0,SUGP2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of SUGP2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
171,225410,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10910,SUGT1,https://ctdbase.org/detail.go?type=gene&acc=10910,,,10910.0,SUGT1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of SUGT1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
172,225411,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23213,SULF1,https://ctdbase.org/detail.go?type=gene&acc=23213,,,23213.0,SULF1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of SULF1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
173,225412,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55959,SULF2,https://ctdbase.org/detail.go?type=gene&acc=55959,,,55959.0,SULF2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of SULF2 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
174,225413,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,393910,SULF2A,https://ctdbase.org/detail.go?type=gene&acc=393910,,,393910.0,sulf2a,7955.0,Danio rerio (zebrafish),Acetaminophen affects the expression of SULF2A mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
175,225591,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,27434,POLM,https://ctdbase.org/detail.go?type=gene&acc=27434,,,27434.0,POLM,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of POLM mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
176,225592,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10721,POLQ,https://ctdbase.org/detail.go?type=gene&acc=10721,,,10721.0,POLQ,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of POLQ mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
177,225593,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10721,POLQ,https://ctdbase.org/detail.go?type=gene&acc=10721,,,10721.0,POLQ,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of POLQ mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
178,225594,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10721,POLQ,https://ctdbase.org/detail.go?type=gene&acc=10721,,,10721.0,POLQ,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of POLQ mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
179,225595,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,25885,POLR1A,https://ctdbase.org/detail.go?type=gene&acc=25885,,,25885.0,POLR1A,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of POLR1A mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
180,225596,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,25885,POLR1A,https://ctdbase.org/detail.go?type=gene&acc=25885,,,25885.0,POLR1A,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of POLR1A mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
181,225597,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84172,POLR1B,https://ctdbase.org/detail.go?type=gene&acc=84172,,,84172.0,POLR1B,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of POLR1B mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
182,225598,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9533,POLR1C,https://ctdbase.org/detail.go?type=gene&acc=9533,,,9533.0,POLR1C,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of POLR1C mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
183,225599,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9533,POLR1C,https://ctdbase.org/detail.go?type=gene&acc=9533,,,9533.0,POLR1C,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of POLR1C mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
184,225664,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79752,ZFAND1,https://ctdbase.org/detail.go?type=gene&acc=79752,,,79752.0,ZFAND1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZFAND1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
185,225958,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51321,AMZ2,https://ctdbase.org/detail.go?type=gene&acc=51321,,,51321.0,AMZ2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of AMZ2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
186,225959,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,64682,ANAPC1,https://ctdbase.org/detail.go?type=gene&acc=64682,,,64682.0,ANAPC1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ANAPC1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
187,225960,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,64682,ANAPC1,https://ctdbase.org/detail.go?type=gene&acc=64682,,,64682.0,ANAPC1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ANAPC1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
188,226004,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5438,POLR2I,https://ctdbase.org/detail.go?type=gene&acc=5438,,,5438.0,POLR2I,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of POLR2I mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
189,226005,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5438,POLR2I,https://ctdbase.org/detail.go?type=gene&acc=5438,,,5438.0,POLR2I,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of POLR2I mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
190,226006,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5440,POLR2K,https://ctdbase.org/detail.go?type=gene&acc=5440,,,5440.0,POLR2K,10090.0,Mus musculus (house mouse),"Acetaminophen results in increased expression of POLR2K mrna|o(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [acetaminophen results in increased expression of POLR2K mrna]",,,PMID:12540782,https://www.ncbi.nlm.nih.gov/pubmed/12540782,12540782,,
191,226007,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5440,POLR2K,https://ctdbase.org/detail.go?type=gene&acc=5440,,,5440.0,POLR2K,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of POLR2K mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
192,226140,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,93550,ZFAND4,https://ctdbase.org/detail.go?type=gene&acc=93550,,,93550.0,ZFAND4,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZFAND4 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
193,226141,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,93550,ZFAND4,https://ctdbase.org/detail.go?type=gene&acc=93550,,,93550.0,ZFAND4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZFAND4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
194,226142,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7763,ZFAND5,https://ctdbase.org/detail.go?type=gene&acc=7763,,,7763.0,ZFAND5,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZFAND5 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
195,226202,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55703,POLR3B,https://ctdbase.org/detail.go?type=gene&acc=55703,,,55703.0,POLR3B,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of POLR3B mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
196,226203,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55703,POLR3B,https://ctdbase.org/detail.go?type=gene&acc=55703,,,55703.0,POLR3B,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of POLR3B mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
197,226355,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,20402,ZFP106,https://ctdbase.org/detail.go?type=gene&acc=20402,,,20402.0,Zfp106,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZFP106 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
198,226356,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57745,ZFP112,https://ctdbase.org/detail.go?type=gene&acc=57745,,,57745.0,Zfp112,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ZFP112 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
199,226796,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,348094,ANKDD1A,https://ctdbase.org/detail.go?type=gene&acc=348094,,,348094.0,ANKDD1A,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ANKDD1A mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
200,226797,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,63926,ANKEF1,https://ctdbase.org/detail.go?type=gene&acc=63926,,,63926.0,ANKEF1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ANKEF1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
201,226798,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51479,ANKFY1,https://ctdbase.org/detail.go?type=gene&acc=51479,,,51479.0,ANKFY1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ANKFY1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
202,226799,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51479,ANKFY1,https://ctdbase.org/detail.go?type=gene&acc=51479,,,51479.0,ANKFY1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ANKFY1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
203,226800,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,56172,ANKH,https://ctdbase.org/detail.go?type=gene&acc=56172,,,56172.0,ANKH,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ANKH mRNA,,,PMID:21420995|PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/26690555,21420995|26690555,,
204,226982,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,27081,ZFP275,https://ctdbase.org/detail.go?type=gene&acc=27081,,,27081.0,Zfp275,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZFP275 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
205,226983,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57247,ZFP276,https://ctdbase.org/detail.go?type=gene&acc=57247,,,57247.0,Zfp276,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZFP276 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
206,226984,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,246196,ZFP277,https://ctdbase.org/detail.go?type=gene&acc=246196,,,246196.0,Zfp277,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ZFP277 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
207,226985,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,140612,ZFP28,https://ctdbase.org/detail.go?type=gene&acc=140612,,,140612.0,ZFP28,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ZFP28 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
208,227336,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,10090.0,Mus musculus (house mouse),Acetaminophen results in decreased expression of POU5F1 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
209,227337,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of POU5F1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
210,227338,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5463,POU6F1,https://ctdbase.org/detail.go?type=gene&acc=5463,,,5463.0,POU6F1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of POU6F1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
211,227339,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,151649,PP2D1,https://ctdbase.org/detail.go?type=gene&acc=151649,,,151649.0,PP2D1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PP2D1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
212,227340,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5464,PPA1,https://ctdbase.org/detail.go?type=gene&acc=5464,,,5464.0,PPA1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PPA1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
213,227341,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5464,PPA1,https://ctdbase.org/detail.go?type=gene&acc=5464,,,5464.0,PPA1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PPA1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
214,227342,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5464,PPA1,https://ctdbase.org/detail.go?type=gene&acc=5464,,,5464.0,PPA1,10090.0,Mus musculus (house mouse),Acetaminophen results in decreased expression of PPA1 protein,,,PMID:22939915,https://www.ncbi.nlm.nih.gov/pubmed/22939915,22939915,,
215,227343,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5464,PPA1,https://ctdbase.org/detail.go?type=gene&acc=5464,,,5464.0,PPA1,10090.0,Mus musculus (house mouse),[CTH gene mutant form results in increased susceptibility to acetaminophen] which results in decreased expression of PPA1 protein,,,PMID:25499718,https://www.ncbi.nlm.nih.gov/pubmed/25499718,25499718,,
216,227492,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23075,SWAP70,https://ctdbase.org/detail.go?type=gene&acc=23075,,,23075.0,SWAP70,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of SWAP70 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
217,227493,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23075,SWAP70,https://ctdbase.org/detail.go?type=gene&acc=23075,,,23075.0,SWAP70,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of SWAP70 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
218,227494,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,375757,SWI5,https://ctdbase.org/detail.go?type=gene&acc=375757,,,375757.0,SWI5,9606.0,Homo sapiens (human),SWI5 gene polymorphism affects the susceptibility to acetaminophen,,,PMID:26104854,https://www.ncbi.nlm.nih.gov/pubmed/26104854,26104854,,
219,227495,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,94056,SYAP1,https://ctdbase.org/detail.go?type=gene&acc=94056,,,94056.0,SYAP1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of SYAP1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
220,227496,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,94056,SYAP1,https://ctdbase.org/detail.go?type=gene&acc=94056,,,94056.0,SYAP1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of SYAP1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
221,227497,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,256126,SYCE2,https://ctdbase.org/detail.go?type=gene&acc=256126,,,256126.0,SYCE2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of SYCE2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
222,227688,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,22852,ANKRD26,https://ctdbase.org/detail.go?type=gene&acc=22852,,,22852.0,ANKRD26,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ANKRD26 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
223,227689,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,22852,ANKRD26,https://ctdbase.org/detail.go?type=gene&acc=22852,,,22852.0,ANKRD26,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ANKRD26 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
224,228665,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5480,PPIC,https://ctdbase.org/detail.go?type=gene&acc=5480,,,5480.0,PPIC,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PPIC mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
225,228666,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5480,PPIC,https://ctdbase.org/detail.go?type=gene&acc=5480,,,5480.0,PPIC,10090.0,Mus musculus (house mouse),Acetaminophen results in increased secretion of PPIC protein,,,PMID:24038040,https://www.ncbi.nlm.nih.gov/pubmed/24038040,24038040,,
226,228667,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5480,PPIC,https://ctdbase.org/detail.go?type=gene&acc=5480,,,5480.0,PPIC,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PPIC mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
227,228668,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5481,PPID,https://ctdbase.org/detail.go?type=gene&acc=5481,,,5481.0,PPID,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PPID mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
228,228669,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5481,PPID,https://ctdbase.org/detail.go?type=gene&acc=5481,,,5481.0,PPID,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PPID mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
229,228670,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5481,PPID,https://ctdbase.org/detail.go?type=gene&acc=5481,,,5481.0,PPID,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PPID mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
230,229429,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307.0,ANXA4,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ANXA4 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
231,229430,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307.0,ANXA4,10090.0,Mus musculus (house mouse),PANX1 gene mutant form inhibits the reaction [acetaminophen results in increased expression of ANXA4 mrna]|acetaminophen results in increased expression of ANXA4 mRNA,,,PMID:29246445,https://www.ncbi.nlm.nih.gov/pubmed/29246445,29246445,,
232,229431,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,307,ANXA4,https://ctdbase.org/detail.go?type=gene&acc=307,,,307.0,ANXA4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ANXA4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
233,229432,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6863,TAC1,https://ctdbase.org/detail.go?type=gene&acc=6863,,,6863.0,TAC1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen inhibits the reaction [[KNG1 protein co-treated with F2 protein co-treated with EDN1 protein co-treated with potassium chloride] results in increased expression of TAC1 mrna],,,PMID:21811393,https://www.ncbi.nlm.nih.gov/pubmed/21811393,21811393,,
234,229433,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,21334,TAC2,https://ctdbase.org/detail.go?type=gene&acc=21334,,,21334.0,Tac2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TAC2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
235,229434,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,255061,TAC4,https://ctdbase.org/detail.go?type=gene&acc=255061,,,255061.0,TAC4,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TAC4 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
236,229435,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6867,TACC1,https://ctdbase.org/detail.go?type=gene&acc=6867,,,6867.0,TACC1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TACC1 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
237,229436,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10579,TACC2,https://ctdbase.org/detail.go?type=gene&acc=10579,,,10579.0,TACC2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TACC2 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
238,229437,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10579,TACC2,https://ctdbase.org/detail.go?type=gene&acc=10579,,,10579.0,TACC2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TACC2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
239,229438,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10579,TACC2,https://ctdbase.org/detail.go?type=gene&acc=10579,,,10579.0,TACC2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TACC2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
240,230048,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8907,AP1M1,https://ctdbase.org/detail.go?type=gene&acc=8907,,,8907.0,AP1M1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of AP1M1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
241,230049,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8907,AP1M1,https://ctdbase.org/detail.go?type=gene&acc=8907,,,8907.0,AP1M1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of AP1M1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
242,230050,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8907,AP1M1,https://ctdbase.org/detail.go?type=gene&acc=8907,,,8907.0,AP1M1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of AP1M1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
243,230051,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10053,AP1M2,https://ctdbase.org/detail.go?type=gene&acc=10053,,,10053.0,AP1M2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of AP1M2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
244,230191,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5504,PPP1R2,https://ctdbase.org/detail.go?type=gene&acc=5504,,,5504.0,PPP1R2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PPP1R2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
245,230192,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,129285,PPP1R21,https://ctdbase.org/detail.go?type=gene&acc=129285,,,129285.0,PPP1R21,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PPP1R21 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
246,230193,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,75871,ZFP821,https://ctdbase.org/detail.go?type=gene&acc=75871,,,75871.0,Zfp821,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZFP821 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
247,230194,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,622675,ZFP827,https://ctdbase.org/detail.go?type=gene&acc=622675,,,622675.0,Zfp827,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ZFP827 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
248,230195,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,72805,ZFP839,https://ctdbase.org/detail.go?type=gene&acc=72805,,,72805.0,Zfp839,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ZFP839 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
249,230196,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,74352,ZFP84,https://ctdbase.org/detail.go?type=gene&acc=74352,,,74352.0,Zfp84,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZFP84 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
250,230197,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,237775,ZFP867,https://ctdbase.org/detail.go?type=gene&acc=237775,,,237775.0,Zfp867,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZFP867 mRNA,,,PMID:32479839,https://www.ncbi.nlm.nih.gov/pubmed/32479839,32479839,,
251,230198,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,234362,ZFP868,https://ctdbase.org/detail.go?type=gene&acc=234362,,,234362.0,Zfp868,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZFP868 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
252,230199,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,619310,ZFP872,https://ctdbase.org/detail.go?type=gene&acc=619310,,,619310.0,Zfp872,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZFP872 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
253,230200,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,214779,ZFP879,https://ctdbase.org/detail.go?type=gene&acc=214779,,,214779.0,Zfp879,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZFP879 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
254,230766,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10239,AP3S2,https://ctdbase.org/detail.go?type=gene&acc=10239,,,10239.0,AP3S2,7955.0,Danio rerio (zebrafish),Acetaminophen affects the expression of AP3S2 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
255,230767,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10717,AP4B1,https://ctdbase.org/detail.go?type=gene&acc=10717,,,10717.0,AP4B1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of AP4B1 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
256,230768,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23431,AP4E1,https://ctdbase.org/detail.go?type=gene&acc=23431,,,23431.0,AP4E1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of AP4E1 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
257,230769,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,11154,AP4S1,https://ctdbase.org/detail.go?type=gene&acc=11154,,,11154.0,AP4S1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of AP4S1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
258,230770,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55745,AP5M1,https://ctdbase.org/detail.go?type=gene&acc=55745,,,55745.0,AP5M1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of AP5M1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
259,230771,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55317,AP5S1,https://ctdbase.org/detail.go?type=gene&acc=55317,,,55317.0,AP5S1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of AP5S1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
260,230772,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9907,AP5Z1,https://ctdbase.org/detail.go?type=gene&acc=9907,,,9907.0,AP5Z1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of AP5Z1 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
261,230773,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of APAF1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
262,230774,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of APAF1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
263,230862,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5518,PPP2R1A,https://ctdbase.org/detail.go?type=gene&acc=5518,,,5518.0,PPP2R1A,9606.0,Homo sapiens (human),[chlorogenic acid co-treated with acetaminophen] results in decreased expression of PPP2R1A protein,,,PMID:29136249,https://www.ncbi.nlm.nih.gov/pubmed/29136249,29136249,,
264,230863,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5518,PPP2R1A,https://ctdbase.org/detail.go?type=gene&acc=5518,,,5518.0,PPP2R1A,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PPP2R1A mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
265,230864,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5520,PPP2R2A,https://ctdbase.org/detail.go?type=gene&acc=5520,,,5520.0,PPP2R2A,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PPP2R2A mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
266,230865,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5520,PPP2R2A,https://ctdbase.org/detail.go?type=gene&acc=5520,,,5520.0,PPP2R2A,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of PPP2R2A mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of PPP2R2A mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
267,230866,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5522,PPP2R2C,https://ctdbase.org/detail.go?type=gene&acc=5522,,,5522.0,PPP2R2C,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PPP2R2C mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
268,230867,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55844,PPP2R2D,https://ctdbase.org/detail.go?type=gene&acc=55844,,,55844.0,PPP2R2D,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PPP2R2D mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
269,230868,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5523,PPP2R3A,https://ctdbase.org/detail.go?type=gene&acc=5523,,,5523.0,PPP2R3A,9606.0,Homo sapiens (human),PPP2R3A gene polymorphism affects the susceptibility to acetaminophen,,,PMID:26104854,https://www.ncbi.nlm.nih.gov/pubmed/26104854,26104854,,
270,230869,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7543,ZFX,https://ctdbase.org/detail.go?type=gene&acc=7543,,,7543.0,ZFX,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ZFX mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
271,230870,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,22767,ZFY1,https://ctdbase.org/detail.go?type=gene&acc=22767,,,22767.0,Zfy1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZFY1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
272,230871,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,53349,ZFYVE1,https://ctdbase.org/detail.go?type=gene&acc=53349,,,53349.0,ZFYVE1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZFYVE1 mRNA,,,PMID:21420995|PMID:22230336|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/22230336|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|22230336|29067470,,
273,231068,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5525,PPP2R5A,https://ctdbase.org/detail.go?type=gene&acc=5525,,,5525.0,PPP2R5A,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PPP2R5A mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
274,231069,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5526,PPP2R5B,https://ctdbase.org/detail.go?type=gene&acc=5526,,,5526.0,PPP2R5B,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PPP2R5B mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
275,231070,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5526,PPP2R5B,https://ctdbase.org/detail.go?type=gene&acc=5526,,,5526.0,PPP2R5B,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PPP2R5B mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
276,231071,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51347,TAOK3,https://ctdbase.org/detail.go?type=gene&acc=51347,,,51347.0,TAOK3,10090.0,Mus musculus (house mouse),Acetaminophen results in increased expression of TAOK3 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
277,231072,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51347,TAOK3,https://ctdbase.org/detail.go?type=gene&acc=51347,,,51347.0,TAOK3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TAOK3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
278,231073,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6890,TAP1,https://ctdbase.org/detail.go?type=gene&acc=6890,,,6890.0,TAP1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TAP1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
279,231074,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6890,TAP1,https://ctdbase.org/detail.go?type=gene&acc=6890,,,6890.0,TAP1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TAP1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
280,231075,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6891,TAP2,https://ctdbase.org/detail.go?type=gene&acc=6891,,,6891.0,TAP2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TAP2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
281,231076,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6891,TAP2,https://ctdbase.org/detail.go?type=gene&acc=6891,,,6891.0,TAP2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TAP2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
282,231077,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6892,TAPBP,https://ctdbase.org/detail.go?type=gene&acc=6892,,,6892.0,TAPBP,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TAPBP mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
283,231226,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,164284,APCDD1L,https://ctdbase.org/detail.go?type=gene&acc=164284,,,164284.0,APCDD1L,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of APCDD1L mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
284,231227,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,325,APCS,https://ctdbase.org/detail.go?type=gene&acc=325,,,325.0,APCS,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of APCS mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
285,231228,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,325,APCS,https://ctdbase.org/detail.go?type=gene&acc=325,,,325.0,APCS,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of APCS mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
286,231229,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,325,APCS,https://ctdbase.org/detail.go?type=gene&acc=325,,,325.0,APCS,10090.0,Mus musculus (house mouse),Acetaminophen results in increased expression of APCS mrna|panx1 gene mutant form inhibits the reaction [acetaminophen results in increased expression of APCS mrna],,,PMID:29246445,https://www.ncbi.nlm.nih.gov/pubmed/29246445,29246445,,
287,231230,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,325,APCS,https://ctdbase.org/detail.go?type=gene&acc=325,,,325.0,APCS,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of APCS mrna]|[clofibrate co-treated with acetaminophen] affects the expression of APCS mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
288,231231,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23051,ZHX3,https://ctdbase.org/detail.go?type=gene&acc=23051,,,23051.0,ZHX3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZHX3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
289,231232,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7546,ZIC2,https://ctdbase.org/detail.go?type=gene&acc=7546,,,7546.0,ZIC2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZIC2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
290,231233,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7547,ZIC3,https://ctdbase.org/detail.go?type=gene&acc=7547,,,7547.0,ZIC3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZIC3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
291,231234,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84107,ZIC4,https://ctdbase.org/detail.go?type=gene&acc=84107,,,84107.0,ZIC4,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZIC4 mRNA,,,PMID:26690555|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/26690555|https://www.ncbi.nlm.nih.gov/pubmed/29067470,26690555|29067470,,
292,231235,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,85416,ZIC5,https://ctdbase.org/detail.go?type=gene&acc=85416,,,85416.0,ZIC5,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZIC5 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
293,231261,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5526,PPP2R5B,https://ctdbase.org/detail.go?type=gene&acc=5526,,,5526.0,PPP2R5B,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PPP2R5B mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
294,231262,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5527,PPP2R5C,https://ctdbase.org/detail.go?type=gene&acc=5527,,,5527.0,PPP2R5C,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PPP2R5C mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
295,231263,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5528,PPP2R5D,https://ctdbase.org/detail.go?type=gene&acc=5528,,,5528.0,PPP2R5D,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PPP2R5D mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
296,231264,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5529,PPP2R5E,https://ctdbase.org/detail.go?type=gene&acc=5529,,,5529.0,PPP2R5E,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PPP2R5E mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
297,231265,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5530,PPP3CA,https://ctdbase.org/detail.go?type=gene&acc=5530,,,5530.0,PPP3CA,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PPP3CA mRNA,,,PMID:21420995|PMID:25704631,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/25704631,21420995|25704631,,
298,231266,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5530,PPP3CA,https://ctdbase.org/detail.go?type=gene&acc=5530,,,5530.0,PPP3CA,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PPP3CA mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
299,231566,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,83940,TATDN1,https://ctdbase.org/detail.go?type=gene&acc=83940,,,83940.0,TATDN1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TATDN1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
300,231567,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9797,TATDN2,https://ctdbase.org/detail.go?type=gene&acc=9797,,,9797.0,TATDN2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TATDN2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
301,231888,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84225,ZMYND15,https://ctdbase.org/detail.go?type=gene&acc=84225,,,84225.0,ZMYND15,10116.0,Rattus norvegicus (Norway rat),Acetaminophen affects the expression of ZMYND15 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
302,231889,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,116225,ZMYND19,https://ctdbase.org/detail.go?type=gene&acc=116225,,,116225.0,ZMYND19,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZMYND19 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
303,231890,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,116225,ZMYND19,https://ctdbase.org/detail.go?type=gene&acc=116225,,,116225.0,ZMYND19,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZMYND19 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
304,231891,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,116225,ZMYND19,https://ctdbase.org/detail.go?type=gene&acc=116225,,,116225.0,ZMYND19,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZMYND19 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
305,231909,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9055,PRC1,https://ctdbase.org/detail.go?type=gene&acc=9055,,,9055.0,PRC1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PRC1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
306,231910,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9055,PRC1,https://ctdbase.org/detail.go?type=gene&acc=9055,,,9055.0,PRC1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PRC1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
307,231911,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5546,PRCC,https://ctdbase.org/detail.go?type=gene&acc=5546,,,5546.0,PRCC,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of PRCC mrna]|[clofibrate co-treated with acetaminophen] affects the expression of PRCC mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
308,231912,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,768206,PRCD,https://ctdbase.org/detail.go?type=gene&acc=768206,,,768206.0,PRCD,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PRCD mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
309,232079,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of APOB mRNA,,,PMID:21420995|PMID:26497421|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/26497421|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|26497421|29067470,,
310,232080,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,339,APOBEC1,https://ctdbase.org/detail.go?type=gene&acc=339,,,339.0,APOBEC1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of APOBEC1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
311,232081,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,339,APOBEC1,https://ctdbase.org/detail.go?type=gene&acc=339,,,339.0,APOBEC1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of APOBEC1 mRNA,,,PMID:17202762,https://www.ncbi.nlm.nih.gov/pubmed/17202762,17202762,,
312,232082,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,339,APOBEC1,https://ctdbase.org/detail.go?type=gene&acc=339,,,339.0,APOBEC1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of APOBEC1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
313,232083,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,80287,APOBEC3,https://ctdbase.org/detail.go?type=gene&acc=80287,,,80287.0,Apobec3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of APOBEC3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
314,232084,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,200315,APOBEC3A,https://ctdbase.org/detail.go?type=gene&acc=200315,,,200315.0,APOBEC3A,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of APOBEC3A mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
315,232085,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,200315,APOBEC3A,https://ctdbase.org/detail.go?type=gene&acc=200315,,,200315.0,APOBEC3A,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of APOBEC3A mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
316,232086,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9582,APOBEC3B,https://ctdbase.org/detail.go?type=gene&acc=9582,,,9582.0,APOBEC3B,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of APOBEC3B mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
317,232087,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9582,APOBEC3B,https://ctdbase.org/detail.go?type=gene&acc=9582,,,9582.0,APOBEC3B,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of APOBEC3B mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
318,232191,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,63976,PRDM16,https://ctdbase.org/detail.go?type=gene&acc=63976,,,63976.0,PRDM16,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PRDM16 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
319,232361,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,27350,APOBEC3C,https://ctdbase.org/detail.go?type=gene&acc=27350,,,27350.0,APOBEC3C,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of APOBEC3C mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
320,232362,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,27350,APOBEC3C,https://ctdbase.org/detail.go?type=gene&acc=27350,,,27350.0,APOBEC3C,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of APOBEC3C mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
321,232363,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,60489,APOBEC3G,https://ctdbase.org/detail.go?type=gene&acc=60489,,,60489.0,APOBEC3G,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of APOBEC3G mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
322,232364,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,164668,APOBEC3H,https://ctdbase.org/detail.go?type=gene&acc=164668,,,164668.0,APOBEC3H,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of APOBEC3H mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
323,232583,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8187,ZNF239,https://ctdbase.org/detail.go?type=gene&acc=8187,,,8187.0,ZNF239,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZNF239 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
324,232584,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7572,ZNF24,https://ctdbase.org/detail.go?type=gene&acc=7572,,,7572.0,ZNF24,9606.0,Homo sapiens (human),ZNF24 gene polymorphism affects the susceptibility to acetaminophen,,,PMID:26104854,https://www.ncbi.nlm.nih.gov/pubmed/26104854,26104854,,
325,232585,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10781,ZNF266,https://ctdbase.org/detail.go?type=gene&acc=10781,,,10781.0,ZNF266,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZNF266 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
326,232586,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10308,ZNF267,https://ctdbase.org/detail.go?type=gene&acc=10308,,,10308.0,ZNF267,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZNF267 mRNA,,,PMID:21420995|PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/22230336,21420995|22230336,,
327,232587,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10793,ZNF273,https://ctdbase.org/detail.go?type=gene&acc=10793,,,10793.0,ZNF273,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZNF273 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
328,232588,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,11179,ZNF277,https://ctdbase.org/detail.go?type=gene&acc=11179,,,11179.0,ZNF277,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZNF277 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
329,232771,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,626615,APOL11A,https://ctdbase.org/detail.go?type=gene&acc=626615,,,626615.0,Apol11a,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of APOL11A mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
330,232772,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23780,APOL2,https://ctdbase.org/detail.go?type=gene&acc=23780,,,23780.0,APOL2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of APOL2 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
331,232773,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,80833,APOL3,https://ctdbase.org/detail.go?type=gene&acc=80833,,,80833.0,APOL3,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of APOL3 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
332,232774,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,80833,APOL3,https://ctdbase.org/detail.go?type=gene&acc=80833,,,80833.0,APOL3,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of APOL3 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
333,232775,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,80833,APOL3,https://ctdbase.org/detail.go?type=gene&acc=80833,,,80833.0,APOL3,10090.0,Mus musculus (house mouse),Acetaminophen results in decreased expression of APOL3 mRNA,,,PMID:17942131,https://www.ncbi.nlm.nih.gov/pubmed/17942131,17942131,,
334,232776,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,80833,APOL3,https://ctdbase.org/detail.go?type=gene&acc=80833,,,80833.0,APOL3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of APOL3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
335,232777,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,80830,APOL6,https://ctdbase.org/detail.go?type=gene&acc=80830,,,80830.0,APOL6,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of APOL6 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
336,232778,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,75761,APOL7A,https://ctdbase.org/detail.go?type=gene&acc=75761,,,75761.0,Apol7a,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of APOL7A mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
337,232779,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,108956,APOL7C,https://ctdbase.org/detail.go?type=gene&acc=108956,,,108956.0,Apol7c,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of APOL7C mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
338,233290,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5549,PRELP,https://ctdbase.org/detail.go?type=gene&acc=5549,,,5549.0,PRELP,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PRELP mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
339,233291,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5550,PREP,https://ctdbase.org/detail.go?type=gene&acc=5550,,,5550.0,PREP,9606.0,Homo sapiens (human),PREP gene polymorphism affects the susceptibility to acetaminophen,,,PMID:26104854,https://www.ncbi.nlm.nih.gov/pubmed/26104854,26104854,,
340,233292,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9581,PREPL,https://ctdbase.org/detail.go?type=gene&acc=9581,,,9581.0,PREPL,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PREPL mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
341,233293,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57580,PREX1,https://ctdbase.org/detail.go?type=gene&acc=57580,,,57580.0,PREX1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PREX1 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
342,233294,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57580,PREX1,https://ctdbase.org/detail.go?type=gene&acc=57580,,,57580.0,PREX1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PREX1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
343,233295,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,80243,PREX2,https://ctdbase.org/detail.go?type=gene&acc=80243,,,80243.0,PREX2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PREX2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
344,233296,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5553,PRG2,https://ctdbase.org/detail.go?type=gene&acc=5553,,,5553.0,PRG2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRG2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
345,233297,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5553,PRG2,https://ctdbase.org/detail.go?type=gene&acc=5553,,,5553.0,PRG2,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of PRG2 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of PRG2 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
346,233298,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10216,PRG4,https://ctdbase.org/detail.go?type=gene&acc=10216,,,10216.0,PRG4,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PRG4 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
347,233299,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10216,PRG4,https://ctdbase.org/detail.go?type=gene&acc=10216,,,10216.0,PRG4,10090.0,Mus musculus (house mouse),PANX1 gene mutant form inhibits the reaction [acetaminophen results in increased expression of PRG4 mrna]|acetaminophen results in increased expression of PRG4 mRNA,,,PMID:29246445,https://www.ncbi.nlm.nih.gov/pubmed/29246445,29246445,,
348,233524,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,30009,TBX21,https://ctdbase.org/detail.go?type=gene&acc=30009,,,30009.0,TBX21,10090.0,Mus musculus (house mouse),Acetaminophen results in decreased expression of TBX21 mRNA,,,PMID:18544908,https://www.ncbi.nlm.nih.gov/pubmed/18544908,18544908,,
349,233525,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6926,TBX3,https://ctdbase.org/detail.go?type=gene&acc=6926,,,6926.0,TBX3,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TBX3 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
350,233526,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6926,TBX3,https://ctdbase.org/detail.go?type=gene&acc=6926,,,6926.0,TBX3,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TBX3 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
351,233527,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6926,TBX3,https://ctdbase.org/detail.go?type=gene&acc=6926,,,6926.0,TBX3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TBX3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
352,233528,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6915,TBXA2R,https://ctdbase.org/detail.go?type=gene&acc=6915,,,6915.0,TBXA2R,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TBXA2R mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
353,233529,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6915,TBXA2R,https://ctdbase.org/detail.go?type=gene&acc=6915,,,6915.0,TBXA2R,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TBXA2R mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
354,233664,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,366,AQP9,https://ctdbase.org/detail.go?type=gene&acc=366,,,366.0,AQP9,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of AQP9 mRNA,,,PMID:21420995|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|29067470,,
355,233665,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9716,AQR,https://ctdbase.org/detail.go?type=gene&acc=9716,,,9716.0,AQR,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of AQR mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
356,233899,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51276,ZNF571,https://ctdbase.org/detail.go?type=gene&acc=51276,,,51276.0,ZNF571,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZNF571 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
357,233900,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,126231,ZNF573,https://ctdbase.org/detail.go?type=gene&acc=126231,,,126231.0,ZNF573,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZNF573 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
358,233901,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,126231,ZNF573,https://ctdbase.org/detail.go?type=gene&acc=126231,,,126231.0,ZNF573,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZNF573 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
359,233902,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,147948,ZNF582,https://ctdbase.org/detail.go?type=gene&acc=147948,,,147948.0,ZNF582,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZNF582 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
360,234049,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,90843,TCEAL8,https://ctdbase.org/detail.go?type=gene&acc=90843,,,90843.0,TCEAL8,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TCEAL8 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
361,234050,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51186,TCEAL9,https://ctdbase.org/detail.go?type=gene&acc=51186,,,51186.0,TCEAL9,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TCEAL9 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
362,234051,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51186,TCEAL9,https://ctdbase.org/detail.go?type=gene&acc=51186,,,51186.0,TCEAL9,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of TCEAL9 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of TCEAL9 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
363,234052,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,378,ARF4,https://ctdbase.org/detail.go?type=gene&acc=378,,,378.0,ARF4,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ARF4 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
364,234053,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,378,ARF4,https://ctdbase.org/detail.go?type=gene&acc=378,,,378.0,ARF4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ARF4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
365,234054,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,382,ARF6,https://ctdbase.org/detail.go?type=gene&acc=382,,,382.0,ARF6,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ARF6 mRNA,,,PMID:27761495,https://www.ncbi.nlm.nih.gov/pubmed/27761495,27761495,,
366,234055,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,382,ARF6,https://ctdbase.org/detail.go?type=gene&acc=382,,,382.0,ARF6,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ARF6 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
367,234056,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55738,ARFGAP1,https://ctdbase.org/detail.go?type=gene&acc=55738,,,55738.0,ARFGAP1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ARFGAP1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
368,234057,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55738,ARFGAP1,https://ctdbase.org/detail.go?type=gene&acc=55738,,,55738.0,ARFGAP1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ARFGAP1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
369,234058,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26286,ARFGAP3,https://ctdbase.org/detail.go?type=gene&acc=26286,,,26286.0,ARFGAP3,10090.0,Mus musculus (house mouse),PANX1 gene mutant form inhibits the reaction [acetaminophen results in increased expression of ARFGAP3 mrna]|acetaminophen results in increased expression of ARFGAP3 mRNA,,,PMID:29246445,https://www.ncbi.nlm.nih.gov/pubmed/29246445,29246445,,
370,234144,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PRKCB mRNA,,,PMID:15120968,https://www.ncbi.nlm.nih.gov/pubmed/15120968,15120968,,
371,234145,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRKCD mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
372,234311,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,170082,TCEANC,https://ctdbase.org/detail.go?type=gene&acc=170082,,,170082.0,TCEANC,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TCEANC mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
373,234312,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,127428,TCEANC2,https://ctdbase.org/detail.go?type=gene&acc=127428,,,127428.0,TCEANC2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TCEANC2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
374,234313,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,127428,TCEANC2,https://ctdbase.org/detail.go?type=gene&acc=127428,,,127428.0,TCEANC2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TCEANC2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
375,234314,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10915,TCERG1,https://ctdbase.org/detail.go?type=gene&acc=10915,,,10915.0,TCERG1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TCERG1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
376,234315,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6938,TCF12,https://ctdbase.org/detail.go?type=gene&acc=6938,,,6938.0,TCF12,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TCF12 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
377,234316,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6938,TCF12,https://ctdbase.org/detail.go?type=gene&acc=6938,,,6938.0,TCF12,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TCF12 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
378,234376,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5583,PRKCH,https://ctdbase.org/detail.go?type=gene&acc=5583,,,5583.0,PRKCH,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRKCH mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
379,234377,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5583,PRKCH,https://ctdbase.org/detail.go?type=gene&acc=5583,,,5583.0,PRKCH,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PRKCH mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
380,234378,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5584,PRKCI,https://ctdbase.org/detail.go?type=gene&acc=5584,,,5584.0,PRKCI,9606.0,Homo sapiens (human),PRKCI gene polymorphism affects the susceptibility to acetaminophen,,,PMID:26104854,https://www.ncbi.nlm.nih.gov/pubmed/26104854,26104854,,
381,234379,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5588,PRKCQ,https://ctdbase.org/detail.go?type=gene&acc=5588,,,5588.0,PRKCQ,9606.0,Homo sapiens (human),[dietary carbohydrates co-treated with acetaminophen] results in decreased expression of PRKCQ mRNA,,,PMID:17093179,https://www.ncbi.nlm.nih.gov/pubmed/17093179,17093179,,
382,234380,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5589,PRKCSH,https://ctdbase.org/detail.go?type=gene&acc=5589,,,5589.0,PRKCSH,7955.0,Danio rerio (zebrafish),Acetaminophen affects the expression of PRKCSH mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
383,234381,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5589,PRKCSH,https://ctdbase.org/detail.go?type=gene&acc=5589,,,5589.0,PRKCSH,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PRKCSH mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
384,234382,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5589,PRKCSH,https://ctdbase.org/detail.go?type=gene&acc=5589,,,5589.0,PRKCSH,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRKCSH mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
385,234383,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5589,PRKCSH,https://ctdbase.org/detail.go?type=gene&acc=5589,,,5589.0,PRKCSH,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of PRKCSH mrna]|[clofibrate co-treated with acetaminophen] affects the expression of PRKCSH mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
386,234384,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,90874,ZNF697,https://ctdbase.org/detail.go?type=gene&acc=90874,,,90874.0,ZNF697,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZNF697 mRNA,,,PMID:21420995|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|29067470,,
387,234385,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7621,ZNF70,https://ctdbase.org/detail.go?type=gene&acc=7621,,,7621.0,ZNF70,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZNF70 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
388,234538,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6929,TCF3,https://ctdbase.org/detail.go?type=gene&acc=6929,,,6929.0,TCF3,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TCF3 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
389,234539,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6925,TCF4,https://ctdbase.org/detail.go?type=gene&acc=6925,,,6925.0,TCF4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TCF4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
390,234540,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6932,TCF7,https://ctdbase.org/detail.go?type=gene&acc=6932,,,6932.0,TCF7,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TCF7 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
391,234541,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6932,TCF7,https://ctdbase.org/detail.go?type=gene&acc=6932,,,6932.0,TCF7,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TCF7 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
392,234542,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,83439,TCF7L1,https://ctdbase.org/detail.go?type=gene&acc=83439,,,83439.0,TCF7L1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TCF7L1 mRNA,,,PMID:22230336|PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/22230336|https://www.ncbi.nlm.nih.gov/pubmed/26690555,22230336|26690555,,
393,234945,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,255394,TCP11L2,https://ctdbase.org/detail.go?type=gene&acc=255394,,,255394.0,TCP11L2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TCP11L2 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
394,234946,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,255394,TCP11L2,https://ctdbase.org/detail.go?type=gene&acc=255394,,,255394.0,TCP11L2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TCP11L2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
395,234947,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,255394,TCP11L2,https://ctdbase.org/detail.go?type=gene&acc=255394,,,255394.0,TCP11L2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TCP11L2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
396,234948,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,407629,TCRA-V54,https://ctdbase.org/detail.go?type=gene&acc=407629,,,407629.0,tcra-v54,7955.0,Danio rerio (zebrafish),Acetaminophen affects the expression of TCRA-V54 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
397,234949,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,21580,TCRB-J,https://ctdbase.org/detail.go?type=gene&acc=21580,,,21580.0,Tcrb-J,10090.0,Mus musculus (house mouse),Acetaminophen results in decreased expression of TCRB-J mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
398,234950,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,236219,TCSTV3,https://ctdbase.org/detail.go?type=gene&acc=236219,,,236219.0,Tcstv3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TCSTV3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
399,234951,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,380878,TCSTV7A,https://ctdbase.org/detail.go?type=gene&acc=380878,,,380878.0,Tcstv7a,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TCSTV7A mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
400,234952,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6988,TCTA,https://ctdbase.org/detail.go?type=gene&acc=6988,,,6988.0,TCTA,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TCTA mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
401,234953,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6988,TCTA,https://ctdbase.org/detail.go?type=gene&acc=6988,,,6988.0,TCTA,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TCTA mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
402,234954,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,6988,TCTA,https://ctdbase.org/detail.go?type=gene&acc=6988,,,6988.0,TCTA,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of TCTA mrna]|[clofibrate co-treated with acetaminophen] affects the expression of TCTA mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
403,235087,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7784,ZP3,https://ctdbase.org/detail.go?type=gene&acc=7784,,,7784.0,ZP3,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZP3 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
404,235088,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7784,ZP3,https://ctdbase.org/detail.go?type=gene&acc=7784,,,7784.0,ZP3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZP3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
405,235089,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7784,ZP3,https://ctdbase.org/detail.go?type=gene&acc=7784,,,7784.0,ZP3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ZP3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
406,235090,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57829,ZP4,https://ctdbase.org/detail.go?type=gene&acc=57829,,,57829.0,ZP4,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZP4 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
407,235091,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,124626,ZPBP2,https://ctdbase.org/detail.go?type=gene&acc=124626,,,124626.0,ZPBP2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZPBP2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
408,235092,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,124626,ZPBP2,https://ctdbase.org/detail.go?type=gene&acc=124626,,,124626.0,ZPBP2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZPBP2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
409,235093,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54764,ZRANB1,https://ctdbase.org/detail.go?type=gene&acc=54764,,,54764.0,ZRANB1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZRANB1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
410,235280,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,3276,PRMT1,https://ctdbase.org/detail.go?type=gene&acc=3276,,,3276.0,PRMT1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PRMT1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
411,235281,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,3275,PRMT2,https://ctdbase.org/detail.go?type=gene&acc=3275,,,3275.0,PRMT2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PRMT2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
412,235282,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,3275,PRMT2,https://ctdbase.org/detail.go?type=gene&acc=3275,,,3275.0,PRMT2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRMT2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
413,235283,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10196,PRMT3,https://ctdbase.org/detail.go?type=gene&acc=10196,,,10196.0,PRMT3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRMT3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
414,235284,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10196,PRMT3,https://ctdbase.org/detail.go?type=gene&acc=10196,,,10196.0,PRMT3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PRMT3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
415,235285,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10419,PRMT5,https://ctdbase.org/detail.go?type=gene&acc=10419,,,10419.0,PRMT5,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PRMT5 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
416,235286,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55170,PRMT6,https://ctdbase.org/detail.go?type=gene&acc=55170,,,55170.0,PRMT6,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRMT6 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
417,235287,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55170,PRMT6,https://ctdbase.org/detail.go?type=gene&acc=55170,,,55170.0,PRMT6,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PRMT6 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
418,235288,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9406,ZRANB2,https://ctdbase.org/detail.go?type=gene&acc=9406,,,9406.0,ZRANB2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ZRANB2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
419,235289,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84083,ZRANB3,https://ctdbase.org/detail.go?type=gene&acc=84083,,,84083.0,ZRANB3,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZRANB3 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
420,235493,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,147011,PROCA1,https://ctdbase.org/detail.go?type=gene&acc=147011,,,147011.0,PROCA1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PROCA1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
421,235494,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544.0,PROCR,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PROCR mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
422,235495,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544.0,PROCR,10090.0,Mus musculus (house mouse),Acetaminophen results in increased expression of PROCR mRNA,,,PMID:11264010,https://www.ncbi.nlm.nih.gov/pubmed/11264010,11264010,,
423,235496,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544.0,PROCR,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PROCR mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
424,235497,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5625,PRODH,https://ctdbase.org/detail.go?type=gene&acc=5625,,,5625.0,PRODH,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PRODH mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
425,235498,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,60675,PROK2,https://ctdbase.org/detail.go?type=gene&acc=60675,,,60675.0,PROK2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PROK2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
426,235499,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,140831,ZSWIM3,https://ctdbase.org/detail.go?type=gene&acc=140831,,,140831.0,ZSWIM3,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ZSWIM3 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
427,235500,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,140831,ZSWIM3,https://ctdbase.org/detail.go?type=gene&acc=140831,,,140831.0,ZSWIM3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ZSWIM3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
428,235501,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,65249,ZSWIM4,https://ctdbase.org/detail.go?type=gene&acc=65249,,,65249.0,ZSWIM4,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ZSWIM4 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
429,236191,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,19134,PRPF4B,https://ctdbase.org/detail.go?type=gene&acc=19134,,,19134.0,Prpf4b,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRPF4B mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
430,236192,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10594,PRPF8,https://ctdbase.org/detail.go?type=gene&acc=10594,,,10594.0,PRPF8,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PRPF8 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
431,236193,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5961,PRPH2,https://ctdbase.org/detail.go?type=gene&acc=5961,,,5961.0,PRPH2,10090.0,Mus musculus (house mouse),Acetaminophen results in decreased expression of PRPH2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
432,236194,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PRPS1 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
433,236195,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5631,PRPS1,https://ctdbase.org/detail.go?type=gene&acc=5631,,,5631.0,PRPS1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRPS1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
434,236196,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,560827,PRPS1B,https://ctdbase.org/detail.go?type=gene&acc=560827,,,560827.0,prps1b,7955.0,Danio rerio (zebrafish),Acetaminophen affects the expression of PRPS1B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
435,236197,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,221823,PRPS1L1,https://ctdbase.org/detail.go?type=gene&acc=221823,,,221823.0,PRPS1L1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRPS1L1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
436,236198,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5635,PRPSAP1,https://ctdbase.org/detail.go?type=gene&acc=5635,,,5635.0,PRPSAP1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PRPSAP1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
437,236199,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5635,PRPSAP1,https://ctdbase.org/detail.go?type=gene&acc=5635,,,5635.0,PRPSAP1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRPSAP1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
438,236200,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5635,PRPSAP1,https://ctdbase.org/detail.go?type=gene&acc=5635,,,5635.0,PRPSAP1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PRPSAP1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
439,236360,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7011,TEP1,https://ctdbase.org/detail.go?type=gene&acc=7011,,,7011.0,TEP1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TEP1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
440,236361,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7011,TEP1,https://ctdbase.org/detail.go?type=gene&acc=7011,,,7011.0,TEP1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TEP1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
441,236362,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7011,TEP1,https://ctdbase.org/detail.go?type=gene&acc=7011,,,7011.0,TEP1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TEP1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
442,236363,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54386,TERF2IP,https://ctdbase.org/detail.go?type=gene&acc=54386,,,54386.0,TERF2IP,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TERF2IP mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
443,236364,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54386,TERF2IP,https://ctdbase.org/detail.go?type=gene&acc=54386,,,54386.0,TERF2IP,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TERF2IP mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
444,236365,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26136,TES,https://ctdbase.org/detail.go?type=gene&acc=26136,,,26136.0,TES,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TES mRNA,,,PMID:21420995|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|29067470,,
445,236366,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26136,TES,https://ctdbase.org/detail.go?type=gene&acc=26136,,,26136.0,TES,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TES mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
446,236367,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54997,TESC,https://ctdbase.org/detail.go?type=gene&acc=54997,,,54997.0,TESC,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TESC mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
447,236377,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,1820,ARID3A,https://ctdbase.org/detail.go?type=gene&acc=1820,,,1820.0,ARID3A,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ARID3A mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
448,236378,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10620,ARID3B,https://ctdbase.org/detail.go?type=gene&acc=10620,,,10620.0,ARID3B,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ARID3B mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
449,236379,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10620,ARID3B,https://ctdbase.org/detail.go?type=gene&acc=10620,,,10620.0,ARID3B,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ARID3B mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
450,236380,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10620,ARID3B,https://ctdbase.org/detail.go?type=gene&acc=10620,,,10620.0,ARID3B,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ARID3B mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
451,236381,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,138715,ARID3C,https://ctdbase.org/detail.go?type=gene&acc=138715,,,138715.0,ARID3C,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ARID3C mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
452,237229,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,379,ARL4D,https://ctdbase.org/detail.go?type=gene&acc=379,,,379.0,ARL4D,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ARL4D mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
453,237230,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,379,ARL4D,https://ctdbase.org/detail.go?type=gene&acc=379,,,379.0,ARL4D,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ARL4D mRNA,,,PMID:30723492|PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/30723492|https://www.ncbi.nlm.nih.gov/pubmed/33387578,30723492|33387578,,
454,237231,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26225,ARL5A,https://ctdbase.org/detail.go?type=gene&acc=26225,,,26225.0,ARL5A,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ARL5A mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
455,237232,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26225,ARL5A,https://ctdbase.org/detail.go?type=gene&acc=26225,,,26225.0,ARL5A,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ARL5A mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
456,237233,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,221079,ARL5B,https://ctdbase.org/detail.go?type=gene&acc=221079,,,221079.0,ARL5B,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ARL5B mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
457,237260,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,58497,PRUNE1,https://ctdbase.org/detail.go?type=gene&acc=58497,,,58497.0,PRUNE1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PRUNE1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
458,237261,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,58497,PRUNE1,https://ctdbase.org/detail.go?type=gene&acc=58497,,,58497.0,PRUNE1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PRUNE1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
459,237262,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,158471,PRUNE2,https://ctdbase.org/detail.go?type=gene&acc=158471,,,158471.0,PRUNE2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PRUNE2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
460,237263,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57716,PRX,https://ctdbase.org/detail.go?type=gene&acc=57716,,,57716.0,PRX,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PRX mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
461,237264,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,57716,PRX,https://ctdbase.org/detail.go?type=gene&acc=57716,,,57716.0,PRX,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PRX mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
462,237265,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84293,PRXL2A,https://ctdbase.org/detail.go?type=gene&acc=84293,,,84293.0,PRXL2A,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PRXL2A mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
463,237420,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7024,TFCP2,https://ctdbase.org/detail.go?type=gene&acc=7024,,,7024.0,TFCP2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TFCP2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
464,237421,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7024,TFCP2,https://ctdbase.org/detail.go?type=gene&acc=7024,,,7024.0,TFCP2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TFCP2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
465,237422,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,29842,TFCP2L1,https://ctdbase.org/detail.go?type=gene&acc=29842,,,29842.0,TFCP2L1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TFCP2L1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
466,237423,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,29842,TFCP2L1,https://ctdbase.org/detail.go?type=gene&acc=29842,,,29842.0,TFCP2L1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TFCP2L1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
467,237424,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7027,TFDP1,https://ctdbase.org/detail.go?type=gene&acc=7027,,,7027.0,TFDP1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TFDP1 mRNA,,,PMID:11793227|PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/11793227|https://www.ncbi.nlm.nih.gov/pubmed/21420995,11793227|21420995,,
468,237425,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7027,TFDP1,https://ctdbase.org/detail.go?type=gene&acc=7027,,,7027.0,TFDP1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TFDP1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
469,237426,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7030,TFE3,https://ctdbase.org/detail.go?type=gene&acc=7030,,,7030.0,TFE3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TFE3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
470,237427,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7030,TFE3,https://ctdbase.org/detail.go?type=gene&acc=7030,,,7030.0,TFE3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TFE3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
471,237428,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7942,TFEB,https://ctdbase.org/detail.go?type=gene&acc=7942,,,7942.0,TFEB,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TFEB mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
472,237429,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,22797,TFEC,https://ctdbase.org/detail.go?type=gene&acc=22797,,,22797.0,TFEC,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TFEC mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
473,237430,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7033,TFF3,https://ctdbase.org/detail.go?type=gene&acc=7033,,,7033.0,TFF3,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TFF3 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
474,237746,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,29968,PSAT1,https://ctdbase.org/detail.go?type=gene&acc=29968,,,29968.0,PSAT1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PSAT1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
475,237747,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,29968,PSAT1,https://ctdbase.org/detail.go?type=gene&acc=29968,,,29968.0,PSAT1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PSAT1 mRNA,,,PMID:18246545,https://www.ncbi.nlm.nih.gov/pubmed/18246545,18246545,,
476,237748,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,29968,PSAT1,https://ctdbase.org/detail.go?type=gene&acc=29968,,,29968.0,PSAT1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PSAT1 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
477,237749,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8000,PSCA,https://ctdbase.org/detail.go?type=gene&acc=8000,,,8000.0,PSCA,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PSCA mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
478,237750,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5662,PSD,https://ctdbase.org/detail.go?type=gene&acc=5662,,,5662.0,PSD,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PSD mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
479,237751,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5662,PSD,https://ctdbase.org/detail.go?type=gene&acc=5662,,,5662.0,PSD,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PSD mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
480,237752,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84249,PSD2,https://ctdbase.org/detail.go?type=gene&acc=84249,,,84249.0,PSD2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PSD2 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
481,237753,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23362,PSD3,https://ctdbase.org/detail.go?type=gene&acc=23362,,,23362.0,PSD3,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PSD3 mRNA,,,PMID:21420995|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|29067470,,
482,237754,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23362,PSD3,https://ctdbase.org/detail.go?type=gene&acc=23362,,,23362.0,PSD3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PSD3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
483,237755,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23550,PSD4,https://ctdbase.org/detail.go?type=gene&acc=23550,,,23550.0,PSD4,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PSD4 mRNA,,,PMID:21420995|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|29067470,,
484,237756,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23550,PSD4,https://ctdbase.org/detail.go?type=gene&acc=23550,,,23550.0,PSD4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PSD4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
485,237913,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,84071,ARMC2,https://ctdbase.org/detail.go?type=gene&acc=84071,,,84071.0,ARMC2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ARMC2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
486,237914,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79798,ARMC5,https://ctdbase.org/detail.go?type=gene&acc=79798,,,79798.0,ARMC5,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ARMC5 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
487,237915,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51309,ARMCX1,https://ctdbase.org/detail.go?type=gene&acc=51309,,,51309.0,ARMCX1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ARMCX1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
488,237916,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51309,ARMCX1,https://ctdbase.org/detail.go?type=gene&acc=51309,,,51309.0,ARMCX1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ARMCX1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
489,237917,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9823,ARMCX2,https://ctdbase.org/detail.go?type=gene&acc=9823,,,9823.0,ARMCX2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ARMCX2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
490,237918,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51566,ARMCX3,https://ctdbase.org/detail.go?type=gene&acc=51566,,,51566.0,ARMCX3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ARMCX3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
491,237919,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,100131755,ARMCX4,https://ctdbase.org/detail.go?type=gene&acc=100131755,,,100131755.0,ARMCX4,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ARMCX4 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
492,237920,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,100131755,ARMCX4,https://ctdbase.org/detail.go?type=gene&acc=100131755,,,100131755.0,ARMCX4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ARMCX4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
493,237921,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,64860,ARMCX5,https://ctdbase.org/detail.go?type=gene&acc=64860,,,64860.0,ARMCX5,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ARMCX5 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
494,237922,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,64860,ARMCX5,https://ctdbase.org/detail.go?type=gene&acc=64860,,,64860.0,ARMCX5,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ARMCX5 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
495,237923,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79591,ARMH3,https://ctdbase.org/detail.go?type=gene&acc=79591,,,79591.0,ARMH3,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of ARMH3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
496,237924,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7980,TFPI2,https://ctdbase.org/detail.go?type=gene&acc=7980,,,7980.0,TFPI2,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of TFPI2 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of TFPI2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
497,237925,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7036,TFR2,https://ctdbase.org/detail.go?type=gene&acc=7036,,,7036.0,TFR2,7955.0,Danio rerio (zebrafish),Acetaminophen affects the expression of TFR2 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
498,237926,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7036,TFR2,https://ctdbase.org/detail.go?type=gene&acc=7036,,,7036.0,TFR2,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of TFR2 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of TFR2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
499,238375,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7042,TGFB2,https://ctdbase.org/detail.go?type=gene&acc=7042,,,7042.0,TGFB2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TGFB2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
500,238376,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7042,TGFB2,https://ctdbase.org/detail.go?type=gene&acc=7042,,,7042.0,TGFB2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen affects the expression of TGFB2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
501,238377,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7043,TGFB3,https://ctdbase.org/detail.go?type=gene&acc=7043,,,7043.0,TGFB3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TGFB3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
502,238378,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7045,TGFBI,https://ctdbase.org/detail.go?type=gene&acc=7045,,,7045.0,TGFBI,9606.0,Homo sapiens (human),Acetaminophen affects the expression of TGFBI mRNA,,,PMID:25458485,https://www.ncbi.nlm.nih.gov/pubmed/25458485,25458485,,
503,238379,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7045,TGFBI,https://ctdbase.org/detail.go?type=gene&acc=7045,,,7045.0,TGFBI,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TGFBI mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
504,238380,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7045,TGFBI,https://ctdbase.org/detail.go?type=gene&acc=7045,,,7045.0,TGFBI,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TGFBI mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
505,238381,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7045,TGFBI,https://ctdbase.org/detail.go?type=gene&acc=7045,,,7045.0,TGFBI,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TGFBI mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
506,238382,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7046,TGFBR1,https://ctdbase.org/detail.go?type=gene&acc=7046,,,7046.0,TGFBR1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TGFBR1 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
507,238383,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7046,TGFBR1,https://ctdbase.org/detail.go?type=gene&acc=7046,,,7046.0,TGFBR1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TGFBR1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
508,238395,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5686,PSMA5,https://ctdbase.org/detail.go?type=gene&acc=5686,,,5686.0,PSMA5,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PSMA5 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
509,238396,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5686,PSMA5,https://ctdbase.org/detail.go?type=gene&acc=5686,,,5686.0,PSMA5,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PSMA5 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
510,238397,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5686,PSMA5,https://ctdbase.org/detail.go?type=gene&acc=5686,,,5686.0,PSMA5,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PSMA5 mrna|acetaminophen results in increased expression of PSMA5 protein,,,PMID:15800402,https://www.ncbi.nlm.nih.gov/pubmed/15800402,15800402,,
511,238398,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5687,PSMA6,https://ctdbase.org/detail.go?type=gene&acc=5687,,,5687.0,PSMA6,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PSMA6 mRNA,,,PMID:25704631,https://www.ncbi.nlm.nih.gov/pubmed/25704631,25704631,,
512,238399,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5687,PSMA6,https://ctdbase.org/detail.go?type=gene&acc=5687,,,5687.0,PSMA6,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PSMA6 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
513,238400,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,143471,PSMA8,https://ctdbase.org/detail.go?type=gene&acc=143471,,,143471.0,PSMA8,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PSMA8 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
514,238401,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5689,PSMB1,https://ctdbase.org/detail.go?type=gene&acc=5689,,,5689.0,PSMB1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PSMB1 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
515,238402,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PSMB10 mRNA,,,PMID:21420995|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|29067470,,
516,238403,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PSMB10 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
517,238404,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,9606.0,Homo sapiens (human),PSMB10 gene polymorphism affects the susceptibility to acetaminophen,,,PMID:26104854,https://www.ncbi.nlm.nih.gov/pubmed/26104854,26104854,,
518,238588,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7050,TGIF1,https://ctdbase.org/detail.go?type=gene&acc=7050,,,7050.0,TGIF1,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of TGIF1 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of TGIF1 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
519,238589,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7050,TGIF1,https://ctdbase.org/detail.go?type=gene&acc=7050,,,7050.0,TGIF1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TGIF1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
520,238590,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,60436,TGIF2,https://ctdbase.org/detail.go?type=gene&acc=60436,,,60436.0,TGIF2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TGIF2 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
521,238591,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,60436,TGIF2,https://ctdbase.org/detail.go?type=gene&acc=60436,,,60436.0,TGIF2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TGIF2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
522,238602,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PSMB10 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
523,238603,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,10090.0,Mus musculus (house mouse),Acetaminophen results in decreased expression of PSMB10 mRNA,,,PMID:18544908,https://www.ncbi.nlm.nih.gov/pubmed/18544908,18544908,,
524,238604,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PSMB10 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
525,238605,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5690,PSMB2,https://ctdbase.org/detail.go?type=gene&acc=5690,,,5690.0,PSMB2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PSMB2 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
526,238606,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,296169,PSMB3L2,https://ctdbase.org/detail.go?type=gene&acc=296169,,,296169.0,Psmb3l2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PSMB3L2 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
527,238607,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5692,PSMB4,https://ctdbase.org/detail.go?type=gene&acc=5692,,,5692.0,PSMB4,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PSMB4 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
528,238608,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5692,PSMB4,https://ctdbase.org/detail.go?type=gene&acc=5692,,,5692.0,PSMB4,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of PSMB4 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of PSMB4 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
529,238609,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5693,PSMB5,https://ctdbase.org/detail.go?type=gene&acc=5693,,,5693.0,PSMB5,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of PSMB5 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of PSMB5 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
530,238610,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5694,PSMB6,https://ctdbase.org/detail.go?type=gene&acc=5694,,,5694.0,PSMB6,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of PSMB6 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
531,238611,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5695,PSMB7,https://ctdbase.org/detail.go?type=gene&acc=5695,,,5695.0,PSMB7,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PSMB7 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
532,238892,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5696,PSMB8,https://ctdbase.org/detail.go?type=gene&acc=5696,,,5696.0,PSMB8,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of PSMB8 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
533,238893,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5696,PSMB8,https://ctdbase.org/detail.go?type=gene&acc=5696,,,5696.0,PSMB8,9606.0,Homo sapiens (human),PSMB8 gene polymorphism affects the susceptibility to acetaminophen,,,PMID:26104854,https://www.ncbi.nlm.nih.gov/pubmed/26104854,26104854,,
534,238894,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5696,PSMB8,https://ctdbase.org/detail.go?type=gene&acc=5696,,,5696.0,PSMB8,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PSMB8 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
535,238895,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5698,PSMB9,https://ctdbase.org/detail.go?type=gene&acc=5698,,,5698.0,PSMB9,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PSMB9 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
536,238896,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5698,PSMB9,https://ctdbase.org/detail.go?type=gene&acc=5698,,,5698.0,PSMB9,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of PSMB9 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
537,238897,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5698,PSMB9,https://ctdbase.org/detail.go?type=gene&acc=5698,,,5698.0,PSMB9,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of PSMB9 mRNA,,,PMID:17202759,https://www.ncbi.nlm.nih.gov/pubmed/17202759,17202759,,
538,238898,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,5701,PSMC2,https://ctdbase.org/detail.go?type=gene&acc=5701,,,5701.0,PSMC2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of PSMC2 mRNA,,,PMID:21420995|PMID:26497421,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/26497421,21420995|26497421,,
539,239501,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7060,THBS4,https://ctdbase.org/detail.go?type=gene&acc=7060,,,7060.0,THBS4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of THBS4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
540,239502,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,117145,THEM4,https://ctdbase.org/detail.go?type=gene&acc=117145,,,117145.0,THEM4,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of THEM4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
541,239503,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,284486,THEM5,https://ctdbase.org/detail.go?type=gene&acc=284486,,,284486.0,THEM5,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of THEM5 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
542,239504,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,284486,THEM5,https://ctdbase.org/detail.go?type=gene&acc=284486,,,284486.0,THEM5,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of THEM5 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
543,239505,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,9473,THEMIS2,https://ctdbase.org/detail.go?type=gene&acc=9473,,,9473.0,THEMIS2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of THEMIS2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
544,239506,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54974,THG1L,https://ctdbase.org/detail.go?type=gene&acc=54974,,,54974.0,THG1L,9606.0,Homo sapiens (human),Acetaminophen affects the expression of THG1L mRNA,,,PMID:25704631,https://www.ncbi.nlm.nih.gov/pubmed/25704631,25704631,,
545,239507,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79896,THNSL1,https://ctdbase.org/detail.go?type=gene&acc=79896,,,79896.0,THNSL1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of THNSL1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
546,239508,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79896,THNSL1,https://ctdbase.org/detail.go?type=gene&acc=79896,,,79896.0,THNSL1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of THNSL1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
547,239509,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,79896,THNSL1,https://ctdbase.org/detail.go?type=gene&acc=79896,,,79896.0,THNSL1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of THNSL1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
548,239510,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55258,THNSL2,https://ctdbase.org/detail.go?type=gene&acc=55258,,,55258.0,THNSL2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of THNSL2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
549,239999,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,433,ASGR2,https://ctdbase.org/detail.go?type=gene&acc=433,,,433.0,ASGR2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ASGR2 mRNA,,,PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/29067470,29067470,,
550,240000,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,433,ASGR2,https://ctdbase.org/detail.go?type=gene&acc=433,,,433.0,ASGR2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ASGR2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
551,240001,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,433,ASGR2,https://ctdbase.org/detail.go?type=gene&acc=433,,,433.0,ASGR2,10090.0,Mus musculus (house mouse),Acetaminophen results in decreased expression of ASGR2 mrna|panx1 gene mutant form inhibits the reaction [acetaminophen results in decreased expression of ASGR2 mrna],,,PMID:29246445,https://www.ncbi.nlm.nih.gov/pubmed/29246445,29246445,,
552,240002,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,54529,ASNSD1,https://ctdbase.org/detail.go?type=gene&acc=54529,,,54529.0,ASNSD1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ASNSD1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
553,240003,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,433,ASGR2,https://ctdbase.org/detail.go?type=gene&acc=433,,,433.0,ASGR2,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of ASGR2 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of ASGR2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
554,240004,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55870,ASH1L,https://ctdbase.org/detail.go?type=gene&acc=55870,,,55870.0,ASH1L,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ASH1L mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
555,240005,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55870,ASH1L,https://ctdbase.org/detail.go?type=gene&acc=55870,,,55870.0,ASH1L,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ASH1L mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
556,240221,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,25917,THUMPD3,https://ctdbase.org/detail.go?type=gene&acc=25917,,,25917.0,THUMPD3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of THUMPD3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
557,240421,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7073,TIAL1,https://ctdbase.org/detail.go?type=gene&acc=7073,,,7073.0,TIAL1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TIAL1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
558,240422,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7074,TIAM1,https://ctdbase.org/detail.go?type=gene&acc=7074,,,7074.0,TIAM1,9606.0,Homo sapiens (human),Acetaminophen affects the expression of TIAM1 mRNA,,,PMID:25458485,https://www.ncbi.nlm.nih.gov/pubmed/25458485,25458485,,
559,240423,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7074,TIAM1,https://ctdbase.org/detail.go?type=gene&acc=7074,,,7074.0,TIAM1,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of TIAM1 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of TIAM1 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
560,240424,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7074,TIAM1,https://ctdbase.org/detail.go?type=gene&acc=7074,,,7074.0,TIAM1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TIAM1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
561,240425,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26230,TIAM2,https://ctdbase.org/detail.go?type=gene&acc=26230,,,26230.0,TIAM2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TIAM2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
562,240426,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26230,TIAM2,https://ctdbase.org/detail.go?type=gene&acc=26230,,,26230.0,TIAM2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TIAM2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
563,240427,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,90381,TICRR,https://ctdbase.org/detail.go?type=gene&acc=90381,,,90381.0,TICRR,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TICRR mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
564,240428,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,90381,TICRR,https://ctdbase.org/detail.go?type=gene&acc=90381,,,90381.0,TICRR,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TICRR mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
565,240429,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7075,TIE1,https://ctdbase.org/detail.go?type=gene&acc=7075,,,7075.0,TIE1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TIE1 mRNA,,,PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/26690555,26690555,,
566,240903,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,23245,ASTN2,https://ctdbase.org/detail.go?type=gene&acc=23245,,,23245.0,ASTN2,10090.0,Mus musculus (house mouse),MAP3K5 protein affects the reaction [acetaminophen results in increased expression of ASTN2 mrna],,,PMID:18700144,https://www.ncbi.nlm.nih.gov/pubmed/18700144,18700144,,
567,240904,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,171023,ASXL1,https://ctdbase.org/detail.go?type=gene&acc=171023,,,171023.0,ASXL1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ASXL1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
568,240905,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,171023,ASXL1,https://ctdbase.org/detail.go?type=gene&acc=171023,,,171023.0,ASXL1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ASXL1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
569,240906,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,171023,ASXL1,https://ctdbase.org/detail.go?type=gene&acc=171023,,,171023.0,ASXL1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ASXL1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
570,240907,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55252,ASXL2,https://ctdbase.org/detail.go?type=gene&acc=55252,,,55252.0,ASXL2,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ASXL2 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
571,240908,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,80816,ASXL3,https://ctdbase.org/detail.go?type=gene&acc=80816,,,80816.0,ASXL3,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of ASXL3 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
572,240909,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8914,TIMELESS,https://ctdbase.org/detail.go?type=gene&acc=8914,,,8914.0,TIMELESS,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TIMELESS mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
573,240910,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,8914,TIMELESS,https://ctdbase.org/detail.go?type=gene&acc=8914,,,8914.0,TIMELESS,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TIMELESS mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
574,240911,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26519,TIMM10,https://ctdbase.org/detail.go?type=gene&acc=26519,,,26519.0,TIMM10,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TIMM10 mRNA,,,PMID:25704631|PMID:26690555,https://www.ncbi.nlm.nih.gov/pubmed/25704631|https://www.ncbi.nlm.nih.gov/pubmed/26690555,25704631|26690555,,
575,240912,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26519,TIMM10,https://ctdbase.org/detail.go?type=gene&acc=26519,,,26519.0,TIMM10,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in decreased expression of TIMM10 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
576,240913,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26515,TIMM10B,https://ctdbase.org/detail.go?type=gene&acc=26515,,,26515.0,TIMM10B,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TIMM10B mRNA,,,PMID:25704631,https://www.ncbi.nlm.nih.gov/pubmed/25704631,25704631,,
577,240914,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26515,TIMM10B,https://ctdbase.org/detail.go?type=gene&acc=26515,,,26515.0,TIMM10B,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TIMM10B mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
578,240915,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26515,TIMM10B,https://ctdbase.org/detail.go?type=gene&acc=26515,,,26515.0,TIMM10B,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of TIMM10B mrna]|[clofibrate co-treated with acetaminophen] affects the expression of TIMM10B mrna|acetaminophen results in decreased expression of TIMM10B mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
579,240916,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26517,TIMM13,https://ctdbase.org/detail.go?type=gene&acc=26517,,,26517.0,TIMM13,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TIMM13 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
580,240917,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10440,TIMM17A,https://ctdbase.org/detail.go?type=gene&acc=10440,,,10440.0,TIMM17A,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TIMM17A mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
581,240918,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,10245,TIMM17B,https://ctdbase.org/detail.go?type=gene&acc=10245,,,10245.0,TIMM17B,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TIMM17B mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
582,241102,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,29028,ATAD2,https://ctdbase.org/detail.go?type=gene&acc=29028,,,29028.0,ATAD2,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ATAD2 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
583,241103,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,29028,ATAD2,https://ctdbase.org/detail.go?type=gene&acc=29028,,,29028.0,ATAD2,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of ATAD2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
584,241104,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,55210,ATAD3A,https://ctdbase.org/detail.go?type=gene&acc=55210,,,55210.0,ATAD3A,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of ATAD3A mrna]|[clofibrate co-treated with acetaminophen] affects the expression of ATAD3A mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
585,241116,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,92609,TIMM50,https://ctdbase.org/detail.go?type=gene&acc=92609,,,92609.0,TIMM50,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TIMM50 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
586,241117,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,1678,TIMM8A,https://ctdbase.org/detail.go?type=gene&acc=1678,,,1678.0,TIMM8A,9606.0,Homo sapiens (human),Acetaminophen affects the expression of TIMM8A mRNA,,,PMID:25704631,https://www.ncbi.nlm.nih.gov/pubmed/25704631,25704631,,
587,241118,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,30058,TIMM8A1,https://ctdbase.org/detail.go?type=gene&acc=30058,,,30058.0,Timm8a1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TIMM8A1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
588,241119,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26520,TIMM9,https://ctdbase.org/detail.go?type=gene&acc=26520,,,26520.0,TIMM9,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TIMM9 mRNA,,,PMID:25704631,https://www.ncbi.nlm.nih.gov/pubmed/25704631,25704631,,
589,241120,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26520,TIMM9,https://ctdbase.org/detail.go?type=gene&acc=26520,,,26520.0,TIMM9,9606.0,Homo sapiens (human),TIMM9 gene polymorphism affects the susceptibility to acetaminophen,,,PMID:26104854,https://www.ncbi.nlm.nih.gov/pubmed/26104854,26104854,,
590,241121,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26520,TIMM9,https://ctdbase.org/detail.go?type=gene&acc=26520,,,26520.0,TIMM9,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TIMM9 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
591,241122,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,26520,TIMM9,https://ctdbase.org/detail.go?type=gene&acc=26520,,,26520.0,TIMM9,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased expression of TIMM9 mRNA,,,PMID:32479839,https://www.ncbi.nlm.nih.gov/pubmed/32479839,32479839,,
592,241123,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,51300,TIMMDC1,https://ctdbase.org/detail.go?type=gene&acc=51300,,,51300.0,TIMMDC1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TIMMDC1 mRNA,,,PMID:25704631|PMID:31059760,https://www.ncbi.nlm.nih.gov/pubmed/25704631|https://www.ncbi.nlm.nih.gov/pubmed/31059760,25704631|31059760,,
593,241304,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,466,ATF1,https://ctdbase.org/detail.go?type=gene&acc=466,,,466.0,ATF1,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of ATF1 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
594,241305,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,7955.0,Danio rerio (zebrafish),Acetaminophen affects the expression of ATF3 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
595,241306,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of ATF3 mRNA,,,PMID:21420995|PMID:29067470,https://www.ncbi.nlm.nih.gov/pubmed/21420995|https://www.ncbi.nlm.nih.gov/pubmed/29067470,21420995|29067470,,
596,241789,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7083,TK1,https://ctdbase.org/detail.go?type=gene&acc=7083,,,7083.0,TK1,9606.0,Homo sapiens (human),Acetaminophen results in increased expression of TK1 mRNA,,,PMID:22230336,https://www.ncbi.nlm.nih.gov/pubmed/22230336,22230336,,
597,241790,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7083,TK1,https://ctdbase.org/detail.go?type=gene&acc=7083,,,7083.0,TK1,10090.0,Mus musculus (house mouse),Acetaminophen affects the expression of TK1 mRNA,,,PMID:17562736,https://www.ncbi.nlm.nih.gov/pubmed/17562736,17562736,,
598,241791,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7083,TK1,https://ctdbase.org/detail.go?type=gene&acc=7083,,,7083.0,TK1,10116.0,Rattus norvegicus (Norway rat),Acetaminophen results in increased activity of TK1 protein,,,PMID:17431590,https://www.ncbi.nlm.nih.gov/pubmed/17431590,17431590,,
599,241792,1983,Comparative Toxicogenomics Database (CTD),Acetaminophen,D000082,Acetaminophen,https://ctdbase.org/detail.go?type=chem&acc=D000082,7084,TK2,https://ctdbase.org/detail.go?type=gene&acc=7084,,,7084.0,TK2,9606.0,Homo sapiens (human),Acetaminophen results in decreased expression of TK2 mRNA,,,PMID:21420995,https://www.ncbi.nlm.nih.gov/pubmed/21420995,21420995,,
600,237070,1986,BindingDB,Acetazolamide,10880,AZA,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10880,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),8.88,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
601,237071,1986,BindingDB,Acetazolamide,10880,AZA,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10880,1247,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1247,P22748,Carbonic anhydrase 4,762.0,CA4,9606.0,Homo sapiens (human),,IC50 (nM),17.5,PMID:10882008|DOI:10.1016/s0968-0896(00)00026-2,https://www.ncbi.nlm.nih.gov/pubmed/10882008|https://doi.org/10.1016/s0968-0896(00)00026-2,10882008,10.1016/s0968-0896(00)00026-2,
602,240450,1986,BindingDB,Acetazolamide,10880,AZA,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10880,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),12,PMID:18640037|DOI:10.1016/j.bmcl.2008.06.105,https://www.ncbi.nlm.nih.gov/pubmed/18640037|https://doi.org/10.1016/j.bmcl.2008.06.105,18640037,10.1016/j.bmcl.2008.06.105,
603,240451,1986,BindingDB,Acetazolamide,10880,AZA,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10880,2920,Carbonic anhydrase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2920,P07451,Carbonic anhydrase 3,761.0,CA3,9606.0,Homo sapiens (human),,Ki (nM),200000,PMID:18640037|DOI:10.1016/j.bmcl.2008.06.105,https://www.ncbi.nlm.nih.gov/pubmed/18640037|https://doi.org/10.1016/j.bmcl.2008.06.105,18640037,10.1016/j.bmcl.2008.06.105,
604,240735,1986,BindingDB,Acetazolamide,10880,AZA,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10880,4928,Serum paraoxonase/arylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4928,P27169,Serum paraoxonase/arylesterase 1,5444.0,PON1,9606.0,Homo sapiens (human),,Ki (nM),743000,PMID:21040495|DOI:10.1111/j.1747-0285.2010.01036.x,https://www.ncbi.nlm.nih.gov/pubmed/21040495|https://doi.org/10.1111/j.1747-0285.2010.01036.x,21040495,10.1111/j.1747-0285.2010.01036.x,
605,240736,1986,BindingDB,Acetazolamide,10880,AZA,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10880,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),3700,PMID:20486938|DOI:10.1111/j.1747-0285.2010.00965.x,https://www.ncbi.nlm.nih.gov/pubmed/20486938|https://doi.org/10.1111/j.1747-0285.2010.00965.x,20486938,10.1111/j.1747-0285.2010.00965.x,
606,243325,1986,Comparative Toxicogenomics Database (CTD),Acetazolamide,D000086,Acetazolamide,https://ctdbase.org/detail.go?type=chem&acc=D000086,11238,CA5B,https://ctdbase.org/detail.go?type=gene&acc=11238,,,11238.0,CA5B,9606.0,Homo sapiens (human),Acetazolamide binds to and results in decreased activity of CA5B protein,,,PMID:28251759,https://www.ncbi.nlm.nih.gov/pubmed/28251759,28251759,,
607,243326,1986,Comparative Toxicogenomics Database (CTD),Acetazolamide,D000086,Acetazolamide,https://ctdbase.org/detail.go?type=chem&acc=D000086,765,CA6,https://ctdbase.org/detail.go?type=gene&acc=765,,,765.0,CA6,9606.0,Homo sapiens (human),Acetazolamide binds to and results in decreased activity of CA6 protein,,,PMID:28251759,https://www.ncbi.nlm.nih.gov/pubmed/28251759,28251759,,
608,243327,1986,Comparative Toxicogenomics Database (CTD),Acetazolamide,D000086,Acetazolamide,https://ctdbase.org/detail.go?type=chem&acc=D000086,766,CA7,https://ctdbase.org/detail.go?type=gene&acc=766,,,766.0,CA7,9606.0,Homo sapiens (human),Acetazolamide binds to and results in decreased activity of CA7 protein,,,PMID:28251759,https://www.ncbi.nlm.nih.gov/pubmed/28251759,28251759,,
609,237072,1988,Drug Gene Interaction database (DGIdb),Acetochlor,,ACETOCHLOR,https://www.dgidb.org/drugs/chembl:CHEMBL1517425,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
610,245390,1988,Comparative Toxicogenomics Database (CTD),Acetochlor,C043377,acetochlor,https://ctdbase.org/detail.go?type=chem&acc=C043377,317733,ESR2B,https://ctdbase.org/detail.go?type=gene&acc=317733,,,317733.0,esr2b,7955.0,Danio rerio (zebrafish),Acetochlor binds to and results in increased activity of ESR2B protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
611,245391,1988,Comparative Toxicogenomics Database (CTD),Acetochlor,C043377,acetochlor,https://ctdbase.org/detail.go?type=chem&acc=C043377,100174814,ESR2.L,https://ctdbase.org/detail.go?type=gene&acc=100174814,,,100174814.0,esr2.L,8355.0,Xenopus laevis (African clawed frog),Acetochlor binds to and results in increased activity of ESR2.L protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
612,245392,1988,Comparative Toxicogenomics Database (CTD),Acetochlor,C043377,acetochlor,https://ctdbase.org/detail.go?type=chem&acc=C043377,2160,F11,https://ctdbase.org/detail.go?type=gene&acc=2160,,,2160.0,F11,8260.0,Platichthys flesus (European flounder),"[herbicides co-treated with 1-aminomethylphosphonic acid co-treated with mecoprop co-treated with acetochlor co-treated with 2,4-dichlorophenoxyacetic acid] results in decreased expression of F11 mRNA",,,PMID:20566314,https://www.ncbi.nlm.nih.gov/pubmed/20566314,20566314,,
613,245393,1988,Comparative Toxicogenomics Database (CTD),Acetochlor,C043377,acetochlor,https://ctdbase.org/detail.go?type=chem&acc=C043377,2147,F2,https://ctdbase.org/detail.go?type=gene&acc=2147,,,2147.0,F2,8260.0,Platichthys flesus (European flounder),"[herbicides co-treated with 1-aminomethylphosphonic acid co-treated with mecoprop co-treated with acetochlor co-treated with 2,4-dichlorophenoxyacetic acid] results in decreased expression of F2 mRNA",,,PMID:20566314,https://www.ncbi.nlm.nih.gov/pubmed/20566314,20566314,,
614,246088,1988,Comparative Toxicogenomics Database (CTD),Acetochlor,C043377,acetochlor,https://ctdbase.org/detail.go?type=chem&acc=C043377,55586,MIOX,https://ctdbase.org/detail.go?type=gene&acc=55586,,,55586.0,MIOX,8260.0,Platichthys flesus (European flounder),"[herbicides co-treated with 1-aminomethylphosphonic acid co-treated with mecoprop co-treated with acetochlor co-treated with 2,4-dichlorophenoxyacetic acid] results in increased expression of MIOX mRNA",,,PMID:20566314,https://www.ncbi.nlm.nih.gov/pubmed/20566314,20566314,,
615,246089,1988,Comparative Toxicogenomics Database (CTD),Acetochlor,C043377,acetochlor,https://ctdbase.org/detail.go?type=chem&acc=C043377,339287,MSL1,https://ctdbase.org/detail.go?type=gene&acc=339287,,,339287.0,MSL1,9606.0,Homo sapiens (human),[herbicides results in increased abundance of acetochlor] which affects the methylation of MSL1 gene,,,PMID:34516295,https://www.ncbi.nlm.nih.gov/pubmed/34516295,34516295,,
616,246090,1988,Comparative Toxicogenomics Database (CTD),Acetochlor,C043377,acetochlor,https://ctdbase.org/detail.go?type=chem&acc=C043377,30696,NKX2.5,https://ctdbase.org/detail.go?type=gene&acc=30696,,,30696.0,nkx2.5,7955.0,Danio rerio (zebrafish),Acetochlor results in decreased expression of NKX2.5 mRNA,,,PMID:28472748,https://www.ncbi.nlm.nih.gov/pubmed/28472748,28472748,,
617,246091,1988,Comparative Toxicogenomics Database (CTD),Acetochlor,C043377,acetochlor,https://ctdbase.org/detail.go?type=chem&acc=C043377,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),Acetochlor binds to and results in increased activity of NR1I2 protein,,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
618,246092,1988,Comparative Toxicogenomics Database (CTD),Acetochlor,C043377,acetochlor,https://ctdbase.org/detail.go?type=chem&acc=C043377,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Acetochlor results in increased cleavage of PARP1 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [acetochlor results in increased cleavage of PARP1 protein],,,PMID:25291404,https://www.ncbi.nlm.nih.gov/pubmed/25291404,25291404,,
619,237073,1990,DrugBank,Acetohydroxamic Acid,DB00551,Acetohydroxamic acid,https://www.drugbank.ca/drugs/DB00551,BE0000334,Urease subunit alpha,https://www.drugbank.ca/bio_entities/BE0000334,P18314,Urease subunit alpha,,,548.0,Klebsiella aerogenes,Inhibitor,,,PMID:17139284|PMID:17016423|PMID:11101668|PMID:11752352,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/11101668|https://www.ncbi.nlm.nih.gov/pubmed/11752352,17139284|17016423|11101668|11752352,,
620,237266,1990,DrugBank,Acetohydroxamic Acid,DB00551,Acetohydroxamic acid,https://www.drugbank.ca/drugs/DB00551,BE0001198,Macrophage metalloelastase,https://www.drugbank.ca/bio_entities/BE0001198,P39900,Macrophage metalloelastase,4321.0,MMP12,9606.0,Homo sapiens (human),Inhibitor,,,PMID:16899369|PMID:15809432|PMID:17269766|PMID:16959356,https://www.ncbi.nlm.nih.gov/pubmed/16899369|https://www.ncbi.nlm.nih.gov/pubmed/15809432|https://www.ncbi.nlm.nih.gov/pubmed/17269766|https://www.ncbi.nlm.nih.gov/pubmed/16959356,16899369|15809432|17269766|16959356,,
621,237267,2048,Comparative Toxicogenomics Database (CTD),"6,7-Dimethyl-2-phenylquinoxaline",C407689,"6,7-dimethoxy-2-phenylquinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C407689,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),"6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]",,,PMID:25896968,https://www.ncbi.nlm.nih.gov/pubmed/25896968,25896968,,
622,237268,2048,Comparative Toxicogenomics Database (CTD),"6,7-Dimethyl-2-phenylquinoxaline",C407689,"6,7-dimethoxy-2-phenylquinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C407689,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),"6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]",,,PMID:25896968,https://www.ncbi.nlm.nih.gov/pubmed/25896968,25896968,,
623,237269,2048,Comparative Toxicogenomics Database (CTD),"6,7-Dimethyl-2-phenylquinoxaline",C407689,"6,7-dimethoxy-2-phenylquinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C407689,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),"6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]",,,PMID:25896968,https://www.ncbi.nlm.nih.gov/pubmed/25896968,25896968,,
624,237270,2048,Comparative Toxicogenomics Database (CTD),"6,7-Dimethyl-2-phenylquinoxaline",C407689,"6,7-dimethoxy-2-phenylquinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C407689,5155,PDGFB,https://ctdbase.org/detail.go?type=gene&acc=5155,,,5155.0,PDGFB,9606.0,Homo sapiens (human),"6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [nicotine results in increased secretion of PDGFB protein]|6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [nicotine results in increased expression of PDGFB mrna]",,,PMID:16149045,https://www.ncbi.nlm.nih.gov/pubmed/16149045,16149045,,
625,237271,2048,Comparative Toxicogenomics Database (CTD),"6,7-Dimethyl-2-phenylquinoxaline",C407689,"6,7-dimethoxy-2-phenylquinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C407689,5155,PDGFB,https://ctdbase.org/detail.go?type=gene&acc=5155,,,5155.0,PDGFB,9606.0,Homo sapiens (human),"6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]|6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]|6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]|6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]",,,PMID:25896968,https://www.ncbi.nlm.nih.gov/pubmed/25896968,25896968,,
626,237272,2048,Comparative Toxicogenomics Database (CTD),"6,7-Dimethyl-2-phenylquinoxaline",C407689,"6,7-dimethoxy-2-phenylquinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C407689,5155,PDGFB,https://ctdbase.org/detail.go?type=gene&acc=5155,,,5155.0,PDGFB,9606.0,Homo sapiens (human),"6,7-dimethoxy-2-phenylquinoxaline results in decreased susceptibility to [PDGFB protein binds to PDGFB protein]",,,PMID:23457620,https://www.ncbi.nlm.nih.gov/pubmed/23457620,23457620,,
627,237273,2048,Comparative Toxicogenomics Database (CTD),"6,7-Dimethyl-2-phenylquinoxaline",C407689,"6,7-dimethoxy-2-phenylquinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C407689,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,9606.0,Homo sapiens (human),"6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [nicotine results in increased expression of PDGFRB protein]",,,PMID:16149045,https://www.ncbi.nlm.nih.gov/pubmed/16149045,16149045,,
628,237274,2048,Comparative Toxicogenomics Database (CTD),"6,7-Dimethyl-2-phenylquinoxaline",C407689,"6,7-dimethoxy-2-phenylquinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C407689,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,9606.0,Homo sapiens (human),"6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]",,,PMID:25896968,https://www.ncbi.nlm.nih.gov/pubmed/25896968,25896968,,
629,237757,2049,Comparative Toxicogenomics Database (CTD),"6,7-Dimethoxy-2-phenylquinoxaline",C106250,"6,7-dimethoxy-3-phenylquinoxaline",https://ctdbase.org/detail.go?type=chem&acc=C106250,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),"6,7-dimethoxy-3-phenylquinoxaline results in decreased phosphorylation of AKT1 protein",,,PMID:16236484,https://www.ncbi.nlm.nih.gov/pubmed/16236484,16236484,,
630,237758,2061,Drug Gene Interaction database (DGIdb),Tyrphostin A25,,TYRPHOSTIN 25,https://www.dgidb.org/drugs/chembl:CHEMBL310798,,POLH,https://www.dgidb.org/genes/hgnc:9181,,,5429.0,POLH,9606.0,Homo sapiens (human),,,,,,,,
631,237759,2061,Drug Gene Interaction database (DGIdb),Tyrphostin A25,,TYRPHOSTIN 25,https://www.dgidb.org/drugs/chembl:CHEMBL310798,,VDR,https://www.dgidb.org/genes/hgnc:12679,,,7421.0,VDR,9606.0,Homo sapiens (human),,,,,,,,
632,237760,2061,Drug Gene Interaction database (DGIdb),Tyrphostin A25,,TYRPHOSTIN 25,https://www.dgidb.org/drugs/chembl:CHEMBL310798,,MPHOSPH8,https://www.dgidb.org/genes/hgnc:29810,,,54737.0,MPHOSPH8,9606.0,Homo sapiens (human),,,,,,,,
633,237761,2071,Comparative Toxicogenomics Database (CTD),Aida,C095756,"1-aminoindan-1,5-dicarboxylic acid",https://ctdbase.org/detail.go?type=chem&acc=C095756,2911,GRM1,https://ctdbase.org/detail.go?type=gene&acc=2911,,,2911.0,GRM1,9606.0,Homo sapiens (human),"1-aminoindan-1,5-dicarboxylic acid binds to and results in decreased activity of GRM1 protein",,,PMID:12373537|PMID:16564428,https://www.ncbi.nlm.nih.gov/pubmed/12373537|https://www.ncbi.nlm.nih.gov/pubmed/16564428,12373537|16564428,,
634,241632,2086,Comparative Toxicogenomics Database (CTD),Temik,D000448,Aldicarb,https://ctdbase.org/detail.go?type=chem&acc=D000448,172156,NPP-6,https://ctdbase.org/detail.go?type=gene&acc=172156,,,172156.0,npp-6,6239.0,Caenorhabditis elegans,NPP-6 protein affects the susceptibility to aldicarb,,,PMID:16049479,https://www.ncbi.nlm.nih.gov/pubmed/16049479,16049479,,
635,241633,2086,Comparative Toxicogenomics Database (CTD),Temik,D000448,Aldicarb,https://ctdbase.org/detail.go?type=chem&acc=D000448,175131,NPR-34,https://ctdbase.org/detail.go?type=gene&acc=175131,,,175131.0,npr-34,6239.0,Caenorhabditis elegans,Aldicarb results in decreased expression of NPR-34 mRNA,,,PMID:21253838,https://www.ncbi.nlm.nih.gov/pubmed/21253838,21253838,,
636,241634,2086,Comparative Toxicogenomics Database (CTD),Temik,D000448,Aldicarb,https://ctdbase.org/detail.go?type=chem&acc=D000448,177736,NRFL-1,https://ctdbase.org/detail.go?type=gene&acc=177736,,,177736.0,nrfl-1,6239.0,Caenorhabditis elegans,NRFL-1 protein affects the reaction [DGK-1 gene mutant form results in increased susceptibility to aldicarb],,,PMID:16049479,https://www.ncbi.nlm.nih.gov/pubmed/16049479,16049479,,
637,241635,2086,Comparative Toxicogenomics Database (CTD),Temik,D000448,Aldicarb,https://ctdbase.org/detail.go?type=chem&acc=D000448,42646,NRX-1,https://ctdbase.org/detail.go?type=gene&acc=42646,,,42646.0,Nrx-1,6239.0,Caenorhabditis elegans,NRXN1 protein affects the reaction [NRX-1 results in decreased susceptibility to aldicarb]|nrx-1 results in decreased susceptibility to aldicarb,,,PMID:23638761,https://www.ncbi.nlm.nih.gov/pubmed/23638761,23638761,,
638,241636,2086,Comparative Toxicogenomics Database (CTD),Temik,D000448,Aldicarb,https://ctdbase.org/detail.go?type=chem&acc=D000448,9378,NRXN1,https://ctdbase.org/detail.go?type=gene&acc=9378,,,9378.0,NRXN1,9606.0,Homo sapiens (human),NRXN1 protein affects the reaction [NRX-1 results in decreased susceptibility to aldicarb]|nrxn1 protein affects the reaction [NLG-1 results in increased susceptibility to aldicarb],,,PMID:23638761,https://www.ncbi.nlm.nih.gov/pubmed/23638761,23638761,,
639,243145,2086,Comparative Toxicogenomics Database (CTD),Temik,D000448,Aldicarb,https://ctdbase.org/detail.go?type=chem&acc=D000448,174009,R12C12.9,https://ctdbase.org/detail.go?type=gene&acc=174009,,,174009.0,R12C12.9,6239.0,Caenorhabditis elegans,R12C12.9 protein affects the reaction [DGK-1 gene mutant form results in increased susceptibility to aldicarb],,,PMID:16049479,https://www.ncbi.nlm.nih.gov/pubmed/16049479,16049479,,
640,243146,2086,Comparative Toxicogenomics Database (CTD),Temik,D000448,Aldicarb,https://ctdbase.org/detail.go?type=chem&acc=D000448,187842,R12E2.6,https://ctdbase.org/detail.go?type=gene&acc=187842,,,187842.0,R12E2.6,6239.0,Caenorhabditis elegans,Aldicarb results in increased expression of R12E2.6 mRNA,,,PMID:21253838,https://www.ncbi.nlm.nih.gov/pubmed/21253838,21253838,,
641,243147,2086,Comparative Toxicogenomics Database (CTD),Temik,D000448,Aldicarb,https://ctdbase.org/detail.go?type=chem&acc=D000448,187912,R160.3,https://ctdbase.org/detail.go?type=gene&acc=187912,,,187912.0,R160.3,6239.0,Caenorhabditis elegans,Aldicarb results in increased expression of R160.3 mRNA,,,PMID:21253838,https://www.ncbi.nlm.nih.gov/pubmed/21253838,21253838,,
642,245257,2086,Comparative Toxicogenomics Database (CTD),Temik,D000448,Aldicarb,https://ctdbase.org/detail.go?type=chem&acc=D000448,188045,SRU-20,https://ctdbase.org/detail.go?type=gene&acc=188045,,,188045.0,sru-20,6239.0,Caenorhabditis elegans,Aldicarb results in decreased expression of SRU-20 mRNA,,,PMID:21253838,https://www.ncbi.nlm.nih.gov/pubmed/21253838,21253838,,
643,245258,2086,Comparative Toxicogenomics Database (CTD),Temik,D000448,Aldicarb,https://ctdbase.org/detail.go?type=chem&acc=D000448,187824,SRW-108,https://ctdbase.org/detail.go?type=gene&acc=187824,,,187824.0,srw-108,6239.0,Caenorhabditis elegans,Aldicarb results in increased expression of SRW-108 mRNA,,,PMID:21253838,https://www.ncbi.nlm.nih.gov/pubmed/21253838,21253838,,
644,248261,2187,Drug Gene Interaction database (DGIdb),Anastrozole,,ANASTROZOLE,https://www.dgidb.org/drugs/rxcui:84857,,ESR1,https://www.dgidb.org/genes/hgnc:3467,,,2099.0,ESR1,9606.0,Homo sapiens (human),,,,,,,,
645,248262,2187,DrugBank,Anastrozole,DB01217,Anastrozole,https://www.drugbank.ca/drugs/DB01217,BE0002090,Aromatase,https://www.drugbank.ca/bio_entities/BE0002090,P11511,Aromatase,1588.0,CYP19A1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:12404296|PMID:14513432|PMID:20923259,https://www.ncbi.nlm.nih.gov/pubmed/12404296|https://www.ncbi.nlm.nih.gov/pubmed/14513432|https://www.ncbi.nlm.nih.gov/pubmed/20923259,12404296|14513432|20923259,,
646,248263,2187,DrugBank,Anastrozole,DB01217,Anastrozole,https://www.drugbank.ca/drugs/DB01217,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:21175441|PMID:9152599,https://www.ncbi.nlm.nih.gov/pubmed/21175441|https://www.ncbi.nlm.nih.gov/pubmed/9152599,21175441|9152599,,
647,248264,2187,DrugBank,Anastrozole,DB01217,Anastrozole,https://www.drugbank.ca/drugs/DB01217,BE0002362,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),Substrate,,,PMID:21175441,https://www.ncbi.nlm.nih.gov/pubmed/21175441,21175441,,
648,248265,2187,DrugBank,Anastrozole,DB01217,Anastrozole,https://www.drugbank.ca/drugs/DB01217,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:21175441,https://www.ncbi.nlm.nih.gov/pubmed/21175441,21175441,,
649,248266,2187,DrugBank,Anastrozole,DB01217,Anastrozole,https://www.drugbank.ca/drugs/DB01217,BE0003544,UDP-glucuronosyltransferase 1-4,https://www.drugbank.ca/bio_entities/BE0003544,P22310,UDP-glucuronosyltransferase 1A4,54657.0,UGT1A4,9606.0,Homo sapiens (human),Substrate,,,PMID:21175441,https://www.ncbi.nlm.nih.gov/pubmed/21175441,21175441,,
650,248267,2187,DrugBank,Anastrozole,DB01217,Anastrozole,https://www.drugbank.ca/drugs/DB01217,BE0003677,UDP-glucuronosyltransferase 1-3,https://www.drugbank.ca/bio_entities/BE0003677,P35503,UDP-glucuronosyltransferase 1A3,54659.0,UGT1A3,9606.0,Homo sapiens (human),Substrate,,,PMID:21175441,https://www.ncbi.nlm.nih.gov/pubmed/21175441,21175441,,
651,248268,2187,DrugBank,Anastrozole,DB01217,Anastrozole,https://www.drugbank.ca/drugs/DB01217,BE0003679,UDP-glucuronosyltransferase 2B7,https://www.drugbank.ca/bio_entities/BE0003679,P16662,UDP-glucuronosyltransferase 2B7,7364.0,UGT2B7,9606.0,Homo sapiens (human),Substrate,,,PMID:21175441,https://www.ncbi.nlm.nih.gov/pubmed/21175441,21175441,,
652,248269,2187,DrugBank,Anastrozole,DB01217,Anastrozole,https://www.drugbank.ca/drugs/DB01217,BE0002433,Cytochrome P450 1A2,https://www.drugbank.ca/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:9152599,https://www.ncbi.nlm.nih.gov/pubmed/9152599,9152599,,
653,249940,2214,Comparative Toxicogenomics Database (CTD),Acetovanillone,C056165,acetovanillone,https://ctdbase.org/detail.go?type=chem&acc=C056165,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,9606.0,Homo sapiens (human),Acetovanillone inhibits the reaction [glucose results in increased expression of and results in increased activity of CYBB protein],,,PMID:19878672,https://www.ncbi.nlm.nih.gov/pubmed/19878672,19878672,,
654,249941,2214,Comparative Toxicogenomics Database (CTD),Acetovanillone,C056165,acetovanillone,https://ctdbase.org/detail.go?type=chem&acc=C056165,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,9606.0,Homo sapiens (human),Acetovanillone inhibits the reaction [[paraquat co-treated with maneb] results in increased expression of CYBB mrna],,,PMID:30797899,https://www.ncbi.nlm.nih.gov/pubmed/30797899,30797899,,
655,249942,2214,Comparative Toxicogenomics Database (CTD),Acetovanillone,C056165,acetovanillone,https://ctdbase.org/detail.go?type=chem&acc=C056165,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,10116.0,Rattus norvegicus (Norway rat),Acetovanillone inhibits the reaction [hydrogen peroxide results in increased expression of CYBB mrna]|acetovanillone inhibits the reaction [hydrogen peroxide results in increased expression of CYBB protein],,,PMID:23270704,https://www.ncbi.nlm.nih.gov/pubmed/23270704,23270704,,
656,249943,2214,Comparative Toxicogenomics Database (CTD),Acetovanillone,C056165,acetovanillone,https://ctdbase.org/detail.go?type=chem&acc=C056165,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,10116.0,Rattus norvegicus (Norway rat),Acetovanillone inhibits the reaction [palmitic acid results in increased expression of CYBB mrna],,,PMID:24080574,https://www.ncbi.nlm.nih.gov/pubmed/24080574,24080574,,
657,239327,2236,Toxin and Toxin Target Database (T3DB),Aristolochic acid,T3D4113,Aristolochic acid,http://www.t3db.ca/toxins/T3D4113,BE0001072,Cyclin-dependent kinase 2,http://www.t3db.ca/biodb/bio_entities/BE0001072,P24941,Cyclin-dependent kinase 2,1017.0,CDK2,9606.0,Homo sapiens (human),,,,PMID:20097066,https://www.ncbi.nlm.nih.gov/pubmed/20097066,20097066,,
658,239328,2244,Drug Gene Interaction database (DGIdb),Aspirin,,ASPIRIN,https://www.dgidb.org/drugs/rxcui:1191,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606.0,Homo sapiens (human),,,,,,,,
659,239329,2244,Drug Gene Interaction database (DGIdb),Aspirin,,ASPIRIN,https://www.dgidb.org/drugs/rxcui:1191,,CYP2C9,https://www.dgidb.org/genes/hgnc:2623,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),,,,,,,,
660,239330,2244,Drug Gene Interaction database (DGIdb),Aspirin,,ASPIRIN,https://www.dgidb.org/drugs/rxcui:1191,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
661,239331,2244,Drug Gene Interaction database (DGIdb),Aspirin,,ASPIRIN,https://www.dgidb.org/drugs/rxcui:1191,,HMGCR,https://www.dgidb.org/genes/hgnc:5006,,,3156.0,HMGCR,9606.0,Homo sapiens (human),,,,,,,,
662,239332,2244,Drug Gene Interaction database (DGIdb),Aspirin,,ASPIRIN,https://www.dgidb.org/drugs/rxcui:1191,,COX8A,https://www.dgidb.org/genes/hgnc:2294,,,1351.0,COX8A,9606.0,Homo sapiens (human),,,,,,,,
663,239333,2244,Drug Gene Interaction database (DGIdb),Aspirin,,ASPIRIN,https://www.dgidb.org/drugs/rxcui:1191,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
664,239334,2244,BindingDB,Aspirin,22360,2-(acetyloxy)benzoate,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22360,7018,Prostaglandin G/H synthase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7018,P05979,Prostaglandin G/H synthase 1,443551.0,PTGS1,9940.0,Ovis aries (sheep),,IC50 (nM),350,PMID:16509583|DOI:10.1021/jm0510474,https://www.ncbi.nlm.nih.gov/pubmed/16509583|https://doi.org/10.1021/jm0510474,16509583,10.1021/jm0510474,
665,239335,2244,BindingDB,Aspirin,22360,2-(acetyloxy)benzoate,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22360,2262,Prostaglandin G/H synthase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2262,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606.0,Homo sapiens (human),,IC50 (nM),2400,PMID:16509583|DOI:10.1021/jm0510474,https://www.ncbi.nlm.nih.gov/pubmed/16509583|https://doi.org/10.1021/jm0510474,16509583,10.1021/jm0510474,
666,294399,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Aspirin results in increased activity of MAPK1 protein,,,PMID:21617849,https://www.ncbi.nlm.nih.gov/pubmed/21617849,21617849,,
667,294400,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),Aspirin results in decreased phosphorylation of and results in decreased activity of MAPK1 protein,,,PMID:10993886,https://www.ncbi.nlm.nih.gov/pubmed/10993886,10993886,,
668,295081,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4314,MMP3,https://ctdbase.org/detail.go?type=gene&acc=4314,,,4314.0,MMP3,10116.0,Rattus norvegicus (Norway rat),Aspirin inhibits the reaction [azoxymethane results in increased expression of MMP3 mrna],,,PMID:20043115,https://www.ncbi.nlm.nih.gov/pubmed/20043115,20043115,,
669,295082,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4316,MMP7,https://ctdbase.org/detail.go?type=gene&acc=4316,,,4316.0,MMP7,10116.0,Rattus norvegicus (Norway rat),Aspirin inhibits the reaction [azoxymethane results in increased expression of MMP7 mrna],,,PMID:20043115,https://www.ncbi.nlm.nih.gov/pubmed/20043115,20043115,,
670,295083,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4316,MMP7,https://ctdbase.org/detail.go?type=gene&acc=4316,,,4316.0,MMP7,10116.0,Rattus norvegicus (Norway rat),Aspirin results in decreased expression of MMP7 mRNA,,,PMID:12800193,https://www.ncbi.nlm.nih.gov/pubmed/12800193,12800193,,
671,295084,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [HGF results in increased expression of MMP9],,,PMID:11981761,https://www.ncbi.nlm.nih.gov/pubmed/11981761,11981761,,
672,295085,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Aspirin results in decreased activity of MMP9 protein,,,PMID:20137092,https://www.ncbi.nlm.nih.gov/pubmed/20137092,20137092,,
673,296272,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Aspirin results in increased degradation of NFKBIA protein,,,PMID:15188000|PMID:15770215,https://www.ncbi.nlm.nih.gov/pubmed/15188000|https://www.ncbi.nlm.nih.gov/pubmed/15770215,15188000|15770215,,
674,296273,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10116.0,Rattus norvegicus (Norway rat),Aspirin results in decreased degradation of NFKBIA protein,,,PMID:16310244,https://www.ncbi.nlm.nih.gov/pubmed/16310244,16310244,,
675,296274,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [TNF protein results in decreased expression of NFKBIA protein],,,PMID:10480951,https://www.ncbi.nlm.nih.gov/pubmed/10480951,10480951,,
676,296275,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4793,NFKBIB,https://ctdbase.org/detail.go?type=gene&acc=4793,,,4793.0,NFKBIB,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [hydrogen peroxide results in increased phosphorylation of and results in increased degradation of NFKBIB protein],,,PMID:14753751,https://www.ncbi.nlm.nih.gov/pubmed/14753751,14753751,,
677,296276,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4793,NFKBIB,https://ctdbase.org/detail.go?type=gene&acc=4793,,,4793.0,NFKBIB,9606.0,Homo sapiens (human),Aspirin inhibits the reaction [TNF results in increased phosphorylation of NFKBIB protein],,,PMID:15036249,https://www.ncbi.nlm.nih.gov/pubmed/15036249,15036249,,
678,296277,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,64332,NFKBIZ,https://ctdbase.org/detail.go?type=gene&acc=64332,,,64332.0,NFKBIZ,9606.0,Homo sapiens (human),Aspirin results in increased expression of NFKBIZ mRNA,,,PMID:15928584,https://www.ncbi.nlm.nih.gov/pubmed/15928584,15928584,,
679,296278,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4804,NGFR,https://ctdbase.org/detail.go?type=gene&acc=4804,,,4804.0,NGFR,9606.0,Homo sapiens (human),Aspirin analog results in increased expression of NGFR protein,,,PMID:17447067,https://www.ncbi.nlm.nih.gov/pubmed/17447067,17447067,,
680,296279,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4814,NINJ1,https://ctdbase.org/detail.go?type=gene&acc=4814,,,4814.0,NINJ1,9606.0,Homo sapiens (human),Aspirin results in decreased expression of NINJ1 mRNA,,,PMID:15928584,https://www.ncbi.nlm.nih.gov/pubmed/15928584,15928584,,
681,296280,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4818,NKG7,https://ctdbase.org/detail.go?type=gene&acc=4818,,,4818.0,NKG7,9606.0,Homo sapiens (human),Aspirin results in decreased expression of NKG7 mRNA,,,PMID:15928584,https://www.ncbi.nlm.nih.gov/pubmed/15928584,15928584,,
682,296763,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,9520,NPEPPS,https://ctdbase.org/detail.go?type=gene&acc=9520,,,9520.0,NPEPPS,9606.0,Homo sapiens (human),Aspirin results in decreased expression of NPEPPS mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
683,296764,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4881,NPR1,https://ctdbase.org/detail.go?type=gene&acc=4881,,,4881.0,NPR1,9606.0,Homo sapiens (human),Aspirin results in decreased expression of NPR1 mRNA,,,PMID:11906190,https://www.ncbi.nlm.nih.gov/pubmed/11906190,11906190,,
684,296765,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),Aspirin analog results in increased activity of NQO1 protein|acetylcysteine inhibits the reaction [aspirin analog results in increased activity of NQO1 protein],,,PMID:23035985,https://www.ncbi.nlm.nih.gov/pubmed/23035985,23035985,,
685,296766,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,8013,NR4A3,https://ctdbase.org/detail.go?type=gene&acc=8013,,,8013.0,NR4A3,9606.0,Homo sapiens (human),Aspirin results in increased expression of NR4A3 mRNA,,,PMID:15928584,https://www.ncbi.nlm.nih.gov/pubmed/15928584,15928584,,
686,296767,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4897,NRCAM,https://ctdbase.org/detail.go?type=gene&acc=4897,,,4897.0,NRCAM,9606.0,Homo sapiens (human),Aspirin results in decreased expression of NRCAM mRNA,,,PMID:15456535,https://www.ncbi.nlm.nih.gov/pubmed/15456535,15456535,,
687,296768,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,10090.0,Mus musculus (house mouse),Aspirin inhibits the reaction [cisplatin results in decreased expression of NRF1 protein],,,PMID:37179038,https://www.ncbi.nlm.nih.gov/pubmed/37179038,37179038,,
688,296769,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,10101,NUBP2,https://ctdbase.org/detail.go?type=gene&acc=10101,,,10101.0,NUBP2,9606.0,Homo sapiens (human),Aspirin results in decreased expression of NUBP2 mRNA,,,PMID:15456535|PMID:15928584,https://www.ncbi.nlm.nih.gov/pubmed/15456535|https://www.ncbi.nlm.nih.gov/pubmed/15928584,15456535|15928584,,
689,296770,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,4938,OAS1,https://ctdbase.org/detail.go?type=gene&acc=4938,,,4938.0,OAS1,9606.0,Homo sapiens (human),Aspirin results in increased expression of OAS1 mRNA,,,PMID:14976132,https://www.ncbi.nlm.nih.gov/pubmed/14976132,14976132,,
690,298573,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,5718,PSMD12,https://ctdbase.org/detail.go?type=gene&acc=5718,,,5718.0,PSMD12,9606.0,Homo sapiens (human),Aspirin results in increased expression of PSMD12 mRNA,,,PMID:15928584,https://www.ncbi.nlm.nih.gov/pubmed/15928584,15928584,,
691,298574,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,11251,PTGDR2,https://ctdbase.org/detail.go?type=gene&acc=11251,,,11251.0,PTGDR2,9606.0,Homo sapiens (human),PTGDR2 gene SNP affects the susceptibility to aspirin,,,PMID:20485159,https://www.ncbi.nlm.nih.gov/pubmed/20485159,20485159,,
692,303849,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7130,TNFAIP6,https://ctdbase.org/detail.go?type=gene&acc=7130,,,7130.0,TNFAIP6,9606.0,Homo sapiens (human),Aspirin results in decreased expression of TNFAIP6 mRNA,,,PMID:32816093,https://www.ncbi.nlm.nih.gov/pubmed/32816093,32816093,,
693,303850,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7130,TNFAIP6,https://ctdbase.org/detail.go?type=gene&acc=7130,,,7130.0,TNFAIP6,9606.0,Homo sapiens (human),Aspirin results in increased expression of TNFAIP6 mRNA,,,PMID:15928584,https://www.ncbi.nlm.nih.gov/pubmed/15928584,15928584,,
694,303851,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606.0,Homo sapiens (human),Aspirin results in increased expression of TNFRSF10B mRNA,,,PMID:20457246,https://www.ncbi.nlm.nih.gov/pubmed/20457246,20457246,,
695,303852,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606.0,Homo sapiens (human),TNFRSF10B protein results in decreased susceptibility to aspirin,,,PMID:18483385,https://www.ncbi.nlm.nih.gov/pubmed/18483385,18483385,,
696,303853,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,10116.0,Rattus norvegicus (Norway rat),Aspirin inhibits the reaction [azoxymethane results in increased expression of TNFRSF10B mrna],,,PMID:20043115,https://www.ncbi.nlm.nih.gov/pubmed/20043115,20043115,,
697,303854,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,7132,TNFRSF1A,https://ctdbase.org/detail.go?type=gene&acc=7132,,,7132.0,TNFRSF1A,9606.0,Homo sapiens (human),Aspirin results in increased expression of TNFRSF1A mRNA,,,PMID:20457246,https://www.ncbi.nlm.nih.gov/pubmed/20457246,20457246,,
698,304344,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,6434,TRA2B,https://ctdbase.org/detail.go?type=gene&acc=6434,,,6434.0,TRA2B,9606.0,Homo sapiens (human),Aspirin results in increased expression of TRA2B mRNA,,,PMID:15928584,https://www.ncbi.nlm.nih.gov/pubmed/15928584,15928584,,
699,304345,2244,Comparative Toxicogenomics Database (CTD),Aspirin,D001241,Aspirin,https://ctdbase.org/detail.go?type=chem&acc=D001241,6434,TRA2B,https://ctdbase.org/detail.go?type=gene&acc=6434,,,6434.0,TRA2B,10116.0,Rattus norvegicus (Norway rat),Aspirin results in decreased expression of TRA2B mRNA,,,PMID:12800193,https://www.ncbi.nlm.nih.gov/pubmed/12800193,12800193,,
700,306013,2244,Toxin and Toxin Target Database (T3DB),Aspirin,T3D2936,Aspirin,http://www.t3db.ca/toxins/T3D2936,BE0000521,Endothelin-1 receptor,http://www.t3db.ca/biodb/bio_entities/BE0000521,P25101,Endothelin-1 receptor,1909.0,EDNRA,9606.0,Homo sapiens (human),,,,PMID:10727528,https://www.ncbi.nlm.nih.gov/pubmed/10727528,10727528,,
701,306014,2244,Toxin and Toxin Target Database (T3DB),Aspirin,T3D2936,Aspirin,http://www.t3db.ca/toxins/T3D2936,BE0000889,Gamma-glutamyltranspeptidase 1,http://www.t3db.ca/biodb/bio_entities/BE0000889,P19440,Glutathione hydrolase 1 proenzyme,2678.0,GGT1,9606.0,Homo sapiens (human),,,,PMID:18400337,https://www.ncbi.nlm.nih.gov/pubmed/18400337,18400337,,
702,306015,2244,Toxin and Toxin Target Database (T3DB),Aspirin,T3D2936,Aspirin,http://www.t3db.ca/toxins/T3D2936,BE0001154,Inhibitor of nuclear factor kappa-B kinase subunit beta,http://www.t3db.ca/biodb/bio_entities/BE0001154,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,3551.0,IKBKB,9606.0,Homo sapiens (human),,,,PMID:9817203,https://www.ncbi.nlm.nih.gov/pubmed/9817203,9817203,,
703,306016,2244,Toxin and Toxin Target Database (T3DB),Aspirin,T3D2936,Aspirin,http://www.t3db.ca/toxins/T3D2936,BE0000439,Integrin alpha-IIb,http://www.t3db.ca/biodb/bio_entities/BE0000439,P08514,Integrin alpha-IIb,3674.0,ITGA2B,9606.0,Homo sapiens (human),,,,PMID:7837237,https://www.ncbi.nlm.nih.gov/pubmed/7837237,7837237,,
704,306017,2244,Toxin and Toxin Target Database (T3DB),Aspirin,T3D2936,Aspirin,http://www.t3db.ca/toxins/T3D2936,BE0003469,NF-kappa-B inhibitor alpha,http://www.t3db.ca/biodb/bio_entities/BE0003469,P25963,NF-kappa-B inhibitor alpha,4792.0,NFKBIA,9606.0,Homo sapiens (human),,,,PMID:10553090,https://www.ncbi.nlm.nih.gov/pubmed/10553090,10553090,,
705,306018,2244,Toxin and Toxin Target Database (T3DB),Aspirin,T3D2936,Aspirin,http://www.t3db.ca/toxins/T3D2936,BE0004903,Nuclear factor NF-kappa-B,http://www.t3db.ca/biodb/bio_entities/BE0004903,Q00653,Nuclear factor NF-kappa-B p100 subunit ,4791.0,NFKB2,9606.0,Homo sapiens (human),,,,PMID:8052854,https://www.ncbi.nlm.nih.gov/pubmed/8052854,8052854,,
706,306019,2244,Toxin and Toxin Target Database (T3DB),Aspirin,T3D2936,Aspirin,http://www.t3db.ca/toxins/T3D2936,BE0004903,Nuclear factor NF-kappa-B,http://www.t3db.ca/biodb/bio_entities/BE0004903,P19838,Nuclear factor NF-kappa-B p105 subunit,4790.0,NFKB1,9606.0,Homo sapiens (human),,,,PMID:8052854,https://www.ncbi.nlm.nih.gov/pubmed/8052854,8052854,,
707,306020,2244,Toxin and Toxin Target Database (T3DB),Aspirin,T3D2936,Aspirin,http://www.t3db.ca/toxins/T3D2936,BE0004876,Ribosomal protein S6 kinase alpha-3,http://www.t3db.ca/biodb/bio_entities/BE0004876,P51812,Ribosomal protein S6 kinase alpha-3,6197.0,RPS6KA3,9606.0,Homo sapiens (human),,,,PMID:10553090,https://www.ncbi.nlm.nih.gov/pubmed/10553090,10553090,,
708,239336,2249,Drug Gene Interaction database (DGIdb),Atenolol,,ATENOLOL,https://www.dgidb.org/drugs/rxcui:1202,,PROX1,https://www.dgidb.org/genes/hgnc:9459,,,5629.0,PROX1,9606.0,Homo sapiens (human),,,,,,,,
709,220398,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,1982,EIF4G2,https://ctdbase.org/detail.go?type=gene&acc=1982,,,1982.0,EIF4G2,7955.0,Danio rerio (zebrafish),Atrazine results in decreased expression of EIF4G2 mRNA,,,PMID:25929836,https://www.ncbi.nlm.nih.gov/pubmed/25929836,25929836,,
710,221596,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,10592,SMC2,https://ctdbase.org/detail.go?type=gene&acc=10592,,,10592.0,SMC2,7962.0,Cyprinus carpio (common carp),Atrazine results in increased expression of SMC2 mRNA,,,PMID:31315571,https://www.ncbi.nlm.nih.gov/pubmed/31315571,31315571,,
711,221597,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,10051,SMC4,https://ctdbase.org/detail.go?type=gene&acc=10051,,,10051.0,SMC4,7962.0,Cyprinus carpio (common carp),Atrazine results in increased expression of SMC4 mRNA,,,PMID:31315571,https://www.ncbi.nlm.nih.gov/pubmed/31315571,31315571,,
712,221782,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,23137,SMC5,https://ctdbase.org/detail.go?type=gene&acc=23137,,,23137.0,SMC5,7955.0,Danio rerio (zebrafish),Atrazine results in increased expression of SMC5 mRNA,,,PMID:25929836,https://www.ncbi.nlm.nih.gov/pubmed/25929836,25929836,,
713,221783,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,23347,SMCHD1,https://ctdbase.org/detail.go?type=gene&acc=23347,,,23347.0,SMCHD1,7962.0,Cyprinus carpio (common carp),Atrazine results in decreased expression of SMCHD1 mRNA,,,PMID:31315571,https://www.ncbi.nlm.nih.gov/pubmed/31315571,31315571,,
714,221784,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,23347,SMCHD1,https://ctdbase.org/detail.go?type=gene&acc=23347,,,23347.0,SMCHD1,7955.0,Danio rerio (zebrafish),Atrazine results in increased expression of SMCHD1 mRNA,,,PMID:25929836,https://www.ncbi.nlm.nih.gov/pubmed/25929836,25929836,,
715,221785,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,4184,SMCP,https://ctdbase.org/detail.go?type=gene&acc=4184,,,4184.0,SMCP,9606.0,Homo sapiens (human),Atrazine results in increased expression of SMCP mRNA,,,PMID:22378314,https://www.ncbi.nlm.nih.gov/pubmed/22378314,22378314,,
716,221786,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,140775,SMCR8,https://ctdbase.org/detail.go?type=gene&acc=140775,,,140775.0,SMCR8,7955.0,Danio rerio (zebrafish),Atrazine results in increased expression of SMCR8 mRNA,,,PMID:25929836,https://www.ncbi.nlm.nih.gov/pubmed/25929836,25929836,,
717,221787,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,91689,SMDT1,https://ctdbase.org/detail.go?type=gene&acc=91689,,,91689.0,SMDT1,7962.0,Cyprinus carpio (common carp),Atrazine results in increased expression of SMDT1 mRNA,,,PMID:31315571,https://www.ncbi.nlm.nih.gov/pubmed/31315571,31315571,,
718,223722,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,6651,SON,https://ctdbase.org/detail.go?type=gene&acc=6651,,,6651.0,SON,9606.0,Homo sapiens (human),Atrazine results in increased expression of SON mRNA,,,PMID:22378314,https://www.ncbi.nlm.nih.gov/pubmed/22378314,22378314,,
719,223723,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,6651,SON,https://ctdbase.org/detail.go?type=gene&acc=6651,,,6651.0,SON,10116.0,Rattus norvegicus (Norway rat),Atrazine affects the methylation of SON gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
720,223724,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,10580,SORBS1,https://ctdbase.org/detail.go?type=gene&acc=10580,,,10580.0,SORBS1,7955.0,Danio rerio (zebrafish),Atrazine results in decreased expression of SORBS1 mRNA,,,PMID:25929836,https://www.ncbi.nlm.nih.gov/pubmed/25929836,25929836,,
721,223725,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,10580,SORBS1,https://ctdbase.org/detail.go?type=gene&acc=10580,,,10580.0,SORBS1,10116.0,Rattus norvegicus (Norway rat),Atrazine results in decreased expression of SORBS1 mRNA,,,PMID:36841081,https://www.ncbi.nlm.nih.gov/pubmed/36841081,36841081,,
722,223726,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,8470,SORBS2,https://ctdbase.org/detail.go?type=gene&acc=8470,,,8470.0,SORBS2,7955.0,Danio rerio (zebrafish),Atrazine results in decreased expression of SORBS2 mRNA,,,PMID:25929836,https://www.ncbi.nlm.nih.gov/pubmed/25929836,25929836,,
723,224479,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,7955.0,Danio rerio (zebrafish),Atrazine results in increased expression of SPARC mRNA,,,PMID:25929836,https://www.ncbi.nlm.nih.gov/pubmed/25929836,25929836,,
724,224480,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,10116.0,Rattus norvegicus (Norway rat),Atrazine results in decreased expression of SPARC mRNA,,,PMID:36841081,https://www.ncbi.nlm.nih.gov/pubmed/36841081,36841081,,
725,224481,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,128153,SPATA17,https://ctdbase.org/detail.go?type=gene&acc=128153,,,128153.0,SPATA17,10116.0,Rattus norvegicus (Norway rat),Atrazine affects the methylation of SPATA17 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
726,224482,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,9825,SPATA2,https://ctdbase.org/detail.go?type=gene&acc=9825,,,9825.0,SPATA2,9606.0,Homo sapiens (human),Atrazine results in decreased expression of SPATA2 mRNA,,,PMID:22378314,https://www.ncbi.nlm.nih.gov/pubmed/22378314,22378314,,
727,224483,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,64847,SPATA20,https://ctdbase.org/detail.go?type=gene&acc=64847,,,64847.0,SPATA20,9606.0,Homo sapiens (human),Atrazine results in increased expression of SPATA20 mRNA,,,PMID:22378314,https://www.ncbi.nlm.nih.gov/pubmed/22378314,22378314,,
728,224484,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,202051,SPATA24,https://ctdbase.org/detail.go?type=gene&acc=202051,,,202051.0,SPATA24,10116.0,Rattus norvegicus (Norway rat),Atrazine results in decreased expression of SPATA24 mRNA,,,PMID:36841081,https://www.ncbi.nlm.nih.gov/pubmed/36841081,36841081,,
729,224485,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,54558,SPATA6,https://ctdbase.org/detail.go?type=gene&acc=54558,,,54558.0,SPATA6,7955.0,Danio rerio (zebrafish),Atrazine results in decreased expression of SPATA6 mRNA,,,PMID:25929836,https://www.ncbi.nlm.nih.gov/pubmed/25929836,25929836,,
730,224486,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,55064,SPATA6L,https://ctdbase.org/detail.go?type=gene&acc=55064,,,55064.0,SPATA6L,7962.0,Cyprinus carpio (common carp),Atrazine results in decreased expression of SPATA6L mRNA,,,PMID:31315571,https://www.ncbi.nlm.nih.gov/pubmed/31315571,31315571,,
731,224487,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,83890,SPATA9,https://ctdbase.org/detail.go?type=gene&acc=83890,,,83890.0,SPATA9,10116.0,Rattus norvegicus (Norway rat),Atrazine affects the methylation of SPATA9 gene,,,PMID:28931070,https://www.ncbi.nlm.nih.gov/pubmed/28931070,28931070,,
732,224488,2256,Comparative Toxicogenomics Database (CTD),Atrazine,D001280,Atrazine,https://ctdbase.org/detail.go?type=chem&acc=D001280,65244,SPATS2,https://ctdbase.org/detail.go?type=gene&acc=65244,,,65244.0,SPATS2,7962.0,Cyprinus carpio (common carp),Atrazine results in increased expression of SPATS2 mRNA,,,PMID:31315571,https://www.ncbi.nlm.nih.gov/pubmed/31315571,31315571,,
733,239627,2259,Drug Gene Interaction database (DGIdb),Aurintricarboxylic acid,,AURINTRICARBOXYLIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL275938,,FEN1,https://www.dgidb.org/genes/hgnc:3650,,,2237.0,FEN1,9606.0,Homo sapiens (human),,,,,,,,
734,239628,2259,Drug Gene Interaction database (DGIdb),Aurintricarboxylic acid,,AURINTRICARBOXYLIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL275938,,PIN1,https://www.dgidb.org/genes/hgnc:8988,,,5300.0,PIN1,9606.0,Homo sapiens (human),,,,,,,,
735,239629,2259,Drug Gene Interaction database (DGIdb),Aurintricarboxylic acid,,AURINTRICARBOXYLIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL275938,,USP2,https://www.dgidb.org/genes/hgnc:12618,,,9099.0,USP2,9606.0,Homo sapiens (human),,,,,,,,
736,239630,2259,Drug Gene Interaction database (DGIdb),Aurintricarboxylic acid,,AURINTRICARBOXYLIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL275938,,ALOX15B,https://www.dgidb.org/genes/hgnc:434,,,247.0,ALOX15B,9606.0,Homo sapiens (human),,,,,,,,
737,239631,2259,Drug Gene Interaction database (DGIdb),Aurintricarboxylic acid,,AURINTRICARBOXYLIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL275938,,BRCA1,https://www.dgidb.org/genes/hgnc:1100,,,672.0,BRCA1,9606.0,Homo sapiens (human),,,,,,,,
738,239632,2259,Drug Gene Interaction database (DGIdb),Aurintricarboxylic acid,,AURINTRICARBOXYLIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL275938,,POLK,https://www.dgidb.org/genes/hgnc:9183,,,51426.0,POLK,9606.0,Homo sapiens (human),,,,,,,,
739,239633,2259,Drug Gene Interaction database (DGIdb),Aurintricarboxylic acid,,AURINTRICARBOXYLIC ACID,https://www.dgidb.org/drugs/chembl:CHEMBL275938,,MPHOSPH8,https://www.dgidb.org/genes/hgnc:29810,,,54737.0,MPHOSPH8,9606.0,Homo sapiens (human),,,,,,,,
740,221003,2265,DrugBank,Azathioprine,DB00993,Azathioprine,https://www.drugbank.ca/drugs/DB00993,BE0002433,Cytochrome P450 1A2,https://www.drugbank.ca/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606.0,Homo sapiens (human),Substrate,,,PMID:10837004,https://www.ncbi.nlm.nih.gov/pubmed/10837004,10837004,,
741,221004,2265,DrugBank,Azathioprine,DB00993,Azathioprine,https://www.drugbank.ca/drugs/DB00993,BE0004706,Equilibrative nucleoside transporter 2,https://www.drugbank.ca/bio_entities/BE0004706,Q14542,Equilibrative nucleoside transporter 2,3177.0,SLC29A2,9606.0,Homo sapiens (human),Substrate,,,PMID:22257476,https://www.ncbi.nlm.nih.gov/pubmed/22257476,22257476,,
742,221005,2265,DrugBank,Azathioprine,DB00993,Azathioprine,https://www.drugbank.ca/drugs/DB00993,BE0001109,Ras-related C3 botulinum toxin substrate 1,https://www.drugbank.ca/bio_entities/BE0001109,P63000,Ras-related C3 botulinum toxin substrate 1,5879.0,RAC1,9606.0,Homo sapiens (human),Modulator,,,PMID:12697733,https://www.ncbi.nlm.nih.gov/pubmed/12697733,12697733,,
743,224661,2265,Therapeutic Target Database (TTD),Azathioprine,D07QCE,Azathioprine,https://idrblab.net/ttd/data/drug/details/D07QCE,T97713,Amidophosphoribosyltransferase (PPAT),https://idrblab.net/ttd/data/target/details/T97713,Q06203,Amidophosphoribosyltransferase,5471.0,PPAT,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
744,224662,2266,Therapeutic Target Database (TTD),Azelaic Acid,D0E4WR,Azelaic Acid,https://idrblab.net/ttd/data/drug/details/D0E4WR,T27265,Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A),https://idrblab.net/ttd/data/target/details/T27265,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,6715.0,SRD5A1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
745,224663,2266,Therapeutic Target Database (TTD),Azelaic Acid,D0E4WR,Azelaic Acid,https://idrblab.net/ttd/data/drug/details/D0E4WR,T27265,Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A),https://idrblab.net/ttd/data/target/details/T27265,P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,6716.0,SRD5A2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
746,224664,2266,Therapeutic Target Database (TTD),Azelaic Acid,D0E4WR,Azelaic Acid,https://idrblab.net/ttd/data/drug/details/D0E4WR,T27265,Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A),https://idrblab.net/ttd/data/target/details/T27265,Q9H8P0,Polyprenol reductase,79644.0,SRD5A3,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
747,224665,2267,Therapeutic Target Database (TTD),Azelastine,D00JVR,Azelastine,https://idrblab.net/ttd/data/drug/details/D00JVR,T77913,Histamine H1 receptor (H1R),https://idrblab.net/ttd/data/target/details/T77913,P35367,Histamine H1 receptor,3269.0,HRH1,9606.0,Homo sapiens (human),Antagonist,,,,,,,
748,221778,2314,Toxin and Toxin Target Database (T3DB),Bendiocarb,T3D0926,Bendiocarb,http://www.t3db.ca/toxins/T3D0926,BE0000717,Urokinase plasminogen activator surface receptor,http://www.t3db.ca/biodb/bio_entities/BE0000717,Q03405,Urokinase plasminogen activator surface receptor,5329.0,PLAUR,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
749,221779,2314,Toxin and Toxin Target Database (T3DB),Bendiocarb,T3D0926,Bendiocarb,http://www.t3db.ca/toxins/T3D0926,BE0003549,Cytochrome P450 2B6,http://www.t3db.ca/biodb/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
750,224844,2315,Therapeutic Target Database (TTD),Bendroflumethiazide,D02PAH,Bendroflumethiazide,https://idrblab.net/ttd/data/drug/details/D02PAH,T84886,Solute carrier family 12 member 3 (SLC12A3),https://idrblab.net/ttd/data/target/details/T84886,P55017,Solute carrier family 12 member 3,6559.0,SLC12A3,9606.0,Homo sapiens (human),Blocker,,,,,,,
751,224845,2315,Therapeutic Target Database (TTD),Bendroflumethiazide,D02PAH,Bendroflumethiazide,https://idrblab.net/ttd/data/drug/details/D02PAH,T93878,Solute carrier family 12 member 1 (SLC12A1),https://idrblab.net/ttd/data/target/details/T93878,Q13621,Solute carrier family 12 member 1,6557.0,SLC12A1,9606.0,Homo sapiens (human),Blocker,,,,,,,
752,220311,2320,Comparative Toxicogenomics Database (CTD),Benfotiamine,C013835,benphothiamine,https://ctdbase.org/detail.go?type=chem&acc=C013835,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),[benphothiamine co-treated with MAPT protein] results in decreased expression of TNF protein,,,PMID:29860433,https://www.ncbi.nlm.nih.gov/pubmed/29860433,29860433,,
753,220312,2320,Comparative Toxicogenomics Database (CTD),Benfotiamine,C013835,benphothiamine,https://ctdbase.org/detail.go?type=chem&acc=C013835,7295,TXN,https://ctdbase.org/detail.go?type=gene&acc=7295,,,7295.0,TXN,10090.0,Mus musculus (house mouse),[benphothiamine co-treated with MAPT protein] results in increased expression of TXN mRNA,,,PMID:29860433,https://www.ncbi.nlm.nih.gov/pubmed/29860433,29860433,,
754,220313,2327,Comparative Toxicogenomics Database (CTD),Benserazide,D001545,Benserazide,https://ctdbase.org/detail.go?type=chem&acc=D001545,1312,COMT,https://ctdbase.org/detail.go?type=gene&acc=1312,,,1312.0,COMT,9606.0,Homo sapiens (human),COMT protein results in increased methylation of benserazide,,,PMID:11160877,https://www.ncbi.nlm.nih.gov/pubmed/11160877,11160877,,
755,220314,2327,Comparative Toxicogenomics Database (CTD),Benserazide,D001545,Benserazide,https://ctdbase.org/detail.go?type=chem&acc=D001545,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,9606.0,Homo sapiens (human),Benserazide binds to and results in decreased activity of DDC protein,,,PMID:35151785,https://www.ncbi.nlm.nih.gov/pubmed/35151785,35151785,,
756,220315,2327,Comparative Toxicogenomics Database (CTD),Benserazide,D001545,Benserazide,https://ctdbase.org/detail.go?type=chem&acc=D001545,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,9606.0,Homo sapiens (human),Benserazide results in decreased activity of DDC protein,,,PMID:1255483|PMID:17920284|PMID:20542064|PMID:4098046|PMID:4147189,https://www.ncbi.nlm.nih.gov/pubmed/1255483|https://www.ncbi.nlm.nih.gov/pubmed/17920284|https://www.ncbi.nlm.nih.gov/pubmed/20542064|https://www.ncbi.nlm.nih.gov/pubmed/4098046|https://www.ncbi.nlm.nih.gov/pubmed/4147189,1255483|17920284|20542064|4098046|4147189,,
757,220316,2327,Comparative Toxicogenomics Database (CTD),Benserazide,D001545,Benserazide,https://ctdbase.org/detail.go?type=chem&acc=D001545,1812,DRD1,https://ctdbase.org/detail.go?type=gene&acc=1812,,,1812.0,DRD1,10116.0,Rattus norvegicus (Norway rat),[oxidopamine co-treated with levodopa methyl ester] promotes the reaction [benserazide results in increased expression of DRD1 protein],,,PMID:19399396,https://www.ncbi.nlm.nih.gov/pubmed/19399396,19399396,,
758,221780,2327,ChEMBL,Benserazide,CHEMBL1096979,BENSERAZIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1096979/,CHEMBL1843,DOPA decarboxylase,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL1843/,P20711,Aromatic-L-amino-acid decarboxylase,1644.0,DDC,9606.0,Homo sapiens (human),DOPA decarboxylase inhibitor,,,PMID:9241095|PMID:2119841|PMID:12703659|PMID:23617953,https://www.ncbi.nlm.nih.gov/pubmed/9241095|https://www.ncbi.nlm.nih.gov/pubmed/2119841|https://www.ncbi.nlm.nih.gov/pubmed/12703659|https://www.ncbi.nlm.nih.gov/pubmed/23617953,9241095|2119841|12703659|23617953,,
759,240748,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,6356,CCL11,https://ctdbase.org/detail.go?type=gene&acc=6356,,,6356.0,CCL11,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in increased expression of CCL11 protein,,,PMID:30517752,https://www.ncbi.nlm.nih.gov/pubmed/30517752,30517752,,
760,240749,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Benzalkonium compounds results in increased expression of CCL2 mrna|benzalkonium compounds results in increased secretion of CCL2 protein,,,PMID:31707104,https://www.ncbi.nlm.nih.gov/pubmed/31707104,31707104,,
761,240750,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in increased expression of CCL2 mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
762,240751,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in increased expression of CCL2 protein,,,PMID:30517752,https://www.ncbi.nlm.nih.gov/pubmed/30517752,30517752,,
763,240752,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,6364,CCL20,https://ctdbase.org/detail.go?type=gene&acc=6364,,,6364.0,CCL20,9606.0,Homo sapiens (human),Benzalkonium compounds results in increased expression of CCL20 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
764,240753,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,6369,CCL24,https://ctdbase.org/detail.go?type=gene&acc=6369,,,6369.0,CCL24,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in decreased expression of CCL24 mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
765,240754,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,6348,CCL3,https://ctdbase.org/detail.go?type=gene&acc=6348,,,6348.0,CCL3,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in increased expression of CCL3 protein,,,PMID:30517752,https://www.ncbi.nlm.nih.gov/pubmed/30517752,30517752,,
766,241447,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in increased expression of CXCL2 mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
767,242122,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,1843,DUSP1,https://ctdbase.org/detail.go?type=gene&acc=1843,,,1843.0,DUSP1,9606.0,Homo sapiens (human),Benzalkonium compounds results in increased expression of DUSP1 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
768,242123,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,10682,EBP,https://ctdbase.org/detail.go?type=gene&acc=10682,,,10682.0,EBP,9606.0,Homo sapiens (human),Benzalkonium compounds results in increased expression of EBP mRNA,,,PMID:26919959,https://www.ncbi.nlm.nih.gov/pubmed/26919959,26919959,,
769,242124,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in decreased expression of EGF mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
770,242125,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,9606.0,Homo sapiens (human),Benzalkonium compounds results in increased expression of EGR1 mRNA,,,PMID:25377654,https://www.ncbi.nlm.nih.gov/pubmed/25377654,25377654,,
771,242126,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,1999,ELF3,https://ctdbase.org/detail.go?type=gene&acc=1999,,,1999.0,ELF3,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in increased expression of ELF3 mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
772,242328,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,2023,ENO1,https://ctdbase.org/detail.go?type=gene&acc=2023,,,2023.0,ENO1,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in decreased expression of ENO1 mRNA,,,PMID:31199489,https://www.ncbi.nlm.nih.gov/pubmed/31199489,31199489,,
773,242329,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,55500,ETNK1,https://ctdbase.org/detail.go?type=gene&acc=55500,,,55500.0,ETNK1,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in increased expression of ETNK1 mRNA,,,PMID:31199489,https://www.ncbi.nlm.nih.gov/pubmed/31199489,31199489,,
774,242330,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,9156,EXO1,https://ctdbase.org/detail.go?type=gene&acc=9156,,,9156.0,EXO1,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in increased expression of EXO1 mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
775,242331,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,7430,EZR,https://ctdbase.org/detail.go?type=gene&acc=7430,,,7430.0,EZR,9606.0,Homo sapiens (human),Benzalkonium compounds results in increased expression of EZR mrna|benzalkonium compounds results in increased expression of EZR protein,,,PMID:29893927,https://www.ncbi.nlm.nih.gov/pubmed/29893927,29893927,,
776,242332,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,84985,FAM83A,https://ctdbase.org/detail.go?type=gene&acc=84985,,,84985.0,FAM83A,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in increased expression of FAM83A mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
777,242333,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247.0,FGF2,9606.0,Homo sapiens (human),FGF2 SNP affects the susceptibility to benzalkonium compounds,,,PMID:27206134,https://www.ncbi.nlm.nih.gov/pubmed/27206134,27206134,,
778,242334,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,2268,FGR,https://ctdbase.org/detail.go?type=gene&acc=2268,,,2268.0,FGR,10090.0,Mus musculus (house mouse),Benzalkonium compounds results in increased expression of FGR mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
779,245903,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9606.0,Homo sapiens (human),Benzalkonium compounds results in increased expression of PTGS2 mRNA,,,PMID:30806763,https://www.ncbi.nlm.nih.gov/pubmed/30806763,30806763,,
780,245904,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,5806,PTX3,https://ctdbase.org/detail.go?type=gene&acc=5806,,,5806.0,PTX3,10090.0,Mus musculus (house mouse),[IL6 protein affects the susceptibility to benzalkonium compounds] which affects the expression of PTX3 mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
781,245905,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,19692,REG1,https://ctdbase.org/detail.go?type=gene&acc=19692,,,19692.0,Reg1,10090.0,Mus musculus (house mouse),[IL6 protein affects the susceptibility to benzalkonium compounds] which affects the expression of REG1 mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
782,245906,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,130120,REG3G,https://ctdbase.org/detail.go?type=gene&acc=130120,,,130120.0,REG3G,10090.0,Mus musculus (house mouse),[IL6 protein affects the susceptibility to benzalkonium compounds] which affects the expression of REG3G mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
783,245907,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,5863,RGL2,https://ctdbase.org/detail.go?type=gene&acc=5863,,,5863.0,RGL2,9606.0,Homo sapiens (human),RGL2 SNP affects the susceptibility to benzalkonium compounds,,,PMID:27258892,https://www.ncbi.nlm.nih.gov/pubmed/27258892,27258892,,
784,245908,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,6222,RPS18,https://ctdbase.org/detail.go?type=gene&acc=6222,,,6222.0,RPS18,9606.0,Homo sapiens (human),RPS18 SNP affects the susceptibility to benzalkonium compounds,,,PMID:27258892,https://www.ncbi.nlm.nih.gov/pubmed/27258892,27258892,,
785,245909,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,6261,RYR1,https://ctdbase.org/detail.go?type=gene&acc=6261,,,6261.0,RYR1,10090.0,Mus musculus (house mouse),[IL6 protein affects the susceptibility to benzalkonium compounds] which affects the expression of RYR1 mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
786,245910,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,20210,SAA3,https://ctdbase.org/detail.go?type=gene&acc=20210,,,20210.0,Saa3,10090.0,Mus musculus (house mouse),[IL6 protein affects the susceptibility to benzalkonium compounds] which affects the expression of SAA3 mRNA,,,PMID:30171875,https://www.ncbi.nlm.nih.gov/pubmed/30171875,30171875,,
787,245911,2330,Comparative Toxicogenomics Database (CTD),Benzyl-dimethyl-tridecylazanium,D001548,Benzalkonium Compounds,https://ctdbase.org/detail.go?type=chem&acc=D001548,6319,SCD,https://ctdbase.org/detail.go?type=gene&acc=6319,,,6319.0,SCD,9606.0,Homo sapiens (human),Benzalkonium compounds results in increased expression of SCD mRNA,,,PMID:29155129,https://www.ncbi.nlm.nih.gov/pubmed/29155129,29155129,,
788,248074,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,3290,HSD11B1,https://ctdbase.org/detail.go?type=gene&acc=3290,,,3290.0,HSD11B1,9606.0,Homo sapiens (human),Benzamide analog results in decreased activity of HSD11B1 protein,,,PMID:18553955|PMID:19217779|PMID:19564108,https://www.ncbi.nlm.nih.gov/pubmed/18553955|https://www.ncbi.nlm.nih.gov/pubmed/19217779|https://www.ncbi.nlm.nih.gov/pubmed/19564108,18553955|19217779|19564108,,
789,248075,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,3290,HSD11B1,https://ctdbase.org/detail.go?type=gene&acc=3290,,,3290.0,HSD11B1,9541.0,Macaca fascicularis (crab-eating macaque),Benzamide analog results in decreased activity of HSD11B1 protein,,,PMID:18553955,https://www.ncbi.nlm.nih.gov/pubmed/18553955,18553955,,
790,248076,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10116.0,Rattus norvegicus (Norway rat),Benzamide results in decreased expression of IFNG mrna|benzamide inhibits the reaction [[ionomycin co-treated with tetradecanoylphorbol acetate] results in increased expression of IFNG mrna],,,PMID:12411406,https://www.ncbi.nlm.nih.gov/pubmed/12411406,12411406,,
791,248077,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Benzamide results in decreased expression of IL1B mRNA,,,PMID:12411406,https://www.ncbi.nlm.nih.gov/pubmed/12411406,12411406,,
792,248078,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,10116.0,Rattus norvegicus (Norway rat),Benzamide inhibits the reaction [[ionomycin co-treated with tetradecanoylphorbol acetate] results in increased expression of IL2 mrna]|benzamide results in decreased expression of IL2 mRNA,,,PMID:12411406,https://www.ncbi.nlm.nih.gov/pubmed/12411406,12411406,,
793,248079,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10090.0,Mus musculus (house mouse),Benzamide promotes the reaction [[INS1 protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased activity of GPD1 protein]|tetradecanoylphorbol acetate inhibits the reaction [[INS1 protein co-treated with benzamide] results in increased activity of GPD1 protein]|[ins1 protein co-treated with benzamide] results in increased activity of GPD1 protein,,,PMID:2523799,https://www.ncbi.nlm.nih.gov/pubmed/2523799,2523799,,
794,248080,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,4067,LYN,https://ctdbase.org/detail.go?type=gene&acc=4067,,,4067.0,LYN,9606.0,Homo sapiens (human),Benzamide analog results in decreased activity of LYN protein,,,PMID:17376680,https://www.ncbi.nlm.nih.gov/pubmed/17376680,17376680,,
795,248081,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),Benzamide analog inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of MAPK1 protein modified form],,,PMID:29935282,https://www.ncbi.nlm.nih.gov/pubmed/29935282,29935282,,
796,248082,2331,Comparative Toxicogenomics Database (CTD),Benzamide,C037689,benzamide,https://ctdbase.org/detail.go?type=chem&acc=C037689,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),Benzamide analog inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of MAPK3 protein modified form],,,PMID:29935282,https://www.ncbi.nlm.nih.gov/pubmed/29935282,29935282,,
797,221781,2333,ChEMBL,Benzbromarone,CHEMBL388590,BENZBROMARONE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL388590/,CHEMBL6120,Solute carrier family 22 member 12,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL6120/,Q96S37,Solute carrier family 22 member 12,116085.0,SLC22A12,9606.0,Homo sapiens (human),Solute carrier family 22 member 12 inhibitor,,,PMID:26106235|PMID:24077632|PMID:25757933|PMID:24594849|PMID:26907620|PMID:18636784,https://www.ncbi.nlm.nih.gov/pubmed/26106235|https://www.ncbi.nlm.nih.gov/pubmed/24077632|https://www.ncbi.nlm.nih.gov/pubmed/25757933|https://www.ncbi.nlm.nih.gov/pubmed/24594849|https://www.ncbi.nlm.nih.gov/pubmed/26907620|https://www.ncbi.nlm.nih.gov/pubmed/18636784,26106235|24077632|25757933|24594849|26907620|18636784,,
798,224846,2333,Therapeutic Target Database (TTD),Benzbromarone,D0Z3DY,Benzbromarone,https://idrblab.net/ttd/data/drug/details/D0Z3DY,T11288,Multidrug resistance-associated protein 1 (ABCC1),https://idrblab.net/ttd/data/target/details/T11288,P33527,Multidrug resistance-associated protein 1 ,4363.0,ABCC1,9606.0,Homo sapiens (human),Stimulator,,,,,,,
799,219570,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8973,CHRNA6,https://ctdbase.org/detail.go?type=gene&acc=8973,,,8973.0,CHRNA6,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CHRNA6 mRNA,,,PMID:15034205,https://www.ncbi.nlm.nih.gov/pubmed/15034205,15034205,,
800,219736,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25849,PARM1,https://ctdbase.org/detail.go?type=gene&acc=25849,,,25849.0,PARM1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PARM1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
801,219737,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25849,PARM1,https://ctdbase.org/detail.go?type=gene&acc=25849,,,25849.0,PARM1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PARM1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
802,219738,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25849,PARM1,https://ctdbase.org/detail.go?type=gene&acc=25849,,,25849.0,PARM1,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PARM1 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
803,219739,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25849,PARM1,https://ctdbase.org/detail.go?type=gene&acc=25849,,,25849.0,PARM1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PARM1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
804,219740,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5073,PARN,https://ctdbase.org/detail.go?type=gene&acc=5073,,,5073.0,PARN,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PARN intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
805,220066,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4863,NPAT,https://ctdbase.org/detail.go?type=gene&acc=4863,,,4863.0,NPAT,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of NPAT mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
806,220067,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,256933,NPB,https://ctdbase.org/detail.go?type=gene&acc=256933,,,256933.0,NPB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NPB promoter|benzo(a)pyrene results in increased methylation of NPB exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
807,220068,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,256933,NPB,https://ctdbase.org/detail.go?type=gene&acc=256933,,,256933.0,NPB,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NPB mRNA,,,PMID:19770486|PMID:21964900,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21964900,19770486|21964900,,
808,220069,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2831,NPBWR1,https://ctdbase.org/detail.go?type=gene&acc=2831,,,2831.0,NPBWR1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NPBWR1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
809,220070,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2832,NPBWR2,https://ctdbase.org/detail.go?type=gene&acc=2832,,,2832.0,NPBWR2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NPBWR2 promoter|benzo(a)pyrene results in decreased methylation of NPBWR2 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
810,220481,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8620,NPFF,https://ctdbase.org/detail.go?type=gene&acc=8620,,,8620.0,NPFF,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NPFF promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
811,220549,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4166,CHST6,https://ctdbase.org/detail.go?type=gene&acc=4166,,,4166.0,CHST6,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CHST6 3' utr|benzo(a)pyrene results in increased methylation of CHST6 promoter|benzo(a)pyrene affects the methylation of CHST6 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
812,220550,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4166,CHST6,https://ctdbase.org/detail.go?type=gene&acc=4166,,,4166.0,CHST6,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CHST6 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
813,220551,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4166,CHST6,https://ctdbase.org/detail.go?type=gene&acc=4166,,,4166.0,CHST6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of CHST6 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
814,220552,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,56548,CHST7,https://ctdbase.org/detail.go?type=gene&acc=56548,,,56548.0,CHST7,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CHST7 exon|benzo(a)pyrene affects the methylation of CHST7 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
815,220553,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,56548,CHST7,https://ctdbase.org/detail.go?type=gene&acc=56548,,,56548.0,CHST7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CHST7 mRNA,,,PMID:21569818|PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/27195522,21569818|27195522,,
816,220554,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,56548,CHST7,https://ctdbase.org/detail.go?type=gene&acc=56548,,,56548.0,CHST7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CHST7 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
817,220555,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64377,CHST8,https://ctdbase.org/detail.go?type=gene&acc=64377,,,64377.0,CHST8,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CHST8 5' utr|benzo(a)pyrene results in increased methylation of CHST8 exon|benzo(a)pyrene results in increased methylation of CHST8 intron|benzo(a)pyrene affects the methylation of CHST8 promoter|benzo(a)pyrene affects the methylation of CHST8 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
818,220632,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2348,FOLR1,https://ctdbase.org/detail.go?type=gene&acc=2348,,,2348.0,FOLR1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of FOLR1 mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
819,220633,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2350,FOLR2,https://ctdbase.org/detail.go?type=gene&acc=2350,,,2350.0,FOLR2,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of FOLR2 mrna]|benzo(a)pyrene results in decreased expression of FOLR2 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
820,220634,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2350,FOLR2,https://ctdbase.org/detail.go?type=gene&acc=2350,,,2350.0,FOLR2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to FOLR2 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
821,220635,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2352,FOLR3,https://ctdbase.org/detail.go?type=gene&acc=2352,,,2352.0,FOLR3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of FOLR3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
822,220636,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of FOS mrna|[benzo(a)pyrene co-treated with fluoranthene] results in decreased expression of FOS mrna|ahr2 affects the reaction [[benzo(a)pyrene co-treated with fluoranthene] results in decreased expression of FOS mrna],,,PMID:25412620,https://www.ncbi.nlm.nih.gov/pubmed/25412620,25412620,,
823,220637,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased methylation of FOS promoter,,,PMID:28329817,https://www.ncbi.nlm.nih.gov/pubmed/28329817,28329817,,
824,220725,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,163782,KANK4,https://ctdbase.org/detail.go?type=gene&acc=163782,,,163782.0,KANK4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KANK4 mRNA,,,PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22610609,22610609,,
825,220726,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,151050,KANSL1L,https://ctdbase.org/detail.go?type=gene&acc=151050,,,151050.0,KANSL1L,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of KANSL1L promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
826,220727,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54934,KANSL2,https://ctdbase.org/detail.go?type=gene&acc=54934,,,54934.0,KANSL2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of KANSL2 exon|benzo(a)pyrene results in increased methylation of KANSL2 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
827,220728,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55683,KANSL3,https://ctdbase.org/detail.go?type=gene&acc=55683,,,55683.0,KANSL3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KANSL3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
828,220729,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100419560,KARS1P2,https://ctdbase.org/detail.go?type=gene&acc=100419560,,,100419560.0,KARS1P2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KARS1P2 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
829,220807,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,399968,PATE4,https://ctdbase.org/detail.go?type=gene&acc=399968,,,399968.0,PATE4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PATE4 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
830,220808,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10207,PATJ,https://ctdbase.org/detail.go?type=gene&acc=10207,,,10207.0,PATJ,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PATJ promoter|benzo(a)pyrene affects the methylation of PATJ 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
831,220809,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10207,PATJ,https://ctdbase.org/detail.go?type=gene&acc=10207,,,10207.0,PATJ,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PATJ exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
832,220810,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10207,PATJ,https://ctdbase.org/detail.go?type=gene&acc=10207,,,10207.0,PATJ,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PATJ mRNA,,,PMID:20106945|PMID:21632981|PMID:22316170|PMID:31255691|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/31255691|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20106945|21632981|22316170|31255691|32234424,,
833,220811,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10207,PATJ,https://ctdbase.org/detail.go?type=gene&acc=10207,,,10207.0,PATJ,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PATJ mRNA,,,PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/21715664,21715664,,
834,220812,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,219988,PATL1,https://ctdbase.org/detail.go?type=gene&acc=219988,,,219988.0,PATL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PATL1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
835,220813,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,197135,PATL2,https://ctdbase.org/detail.go?type=gene&acc=197135,,,197135.0,PATL2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PATL2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
836,220814,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,197135,PATL2,https://ctdbase.org/detail.go?type=gene&acc=197135,,,197135.0,PATL2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PATL2 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
837,220815,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,197135,PATL2,https://ctdbase.org/detail.go?type=gene&acc=197135,,,197135.0,PATL2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of PATL2 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
838,220910,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10361,NPM2,https://ctdbase.org/detail.go?type=gene&acc=10361,,,10361.0,NPM2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to NPM2 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
839,221006,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23598,PATZ1,https://ctdbase.org/detail.go?type=gene&acc=23598,,,23598.0,PATZ1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PATZ1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
840,221007,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5074,PAWR,https://ctdbase.org/detail.go?type=gene&acc=5074,,,5074.0,PAWR,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PAWR intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
841,221008,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5074,PAWR,https://ctdbase.org/detail.go?type=gene&acc=5074,,,5074.0,PAWR,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PAWR mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
842,221009,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5074,PAWR,https://ctdbase.org/detail.go?type=gene&acc=5074,,,5074.0,PAWR,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PAWR mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
843,221010,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5075,PAX1,https://ctdbase.org/detail.go?type=gene&acc=5075,,,5075.0,PAX1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PAX1 promoter|benzo(a)pyrene results in decreased methylation of PAX1 3' utr|benzo(a)pyrene affects the methylation of PAX1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
844,221011,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5076,PAX2,https://ctdbase.org/detail.go?type=gene&acc=5076,,,5076.0,PAX2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PAX2 3' utr|benzo(a)pyrene affects the methylation of PAX2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
845,221012,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5076,PAX2,https://ctdbase.org/detail.go?type=gene&acc=5076,,,5076.0,PAX2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PAX2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
846,221266,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3171,FOXA3,https://ctdbase.org/detail.go?type=gene&acc=3171,,,3171.0,FOXA3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of FOXA3 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
847,221267,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3171,FOXA3,https://ctdbase.org/detail.go?type=gene&acc=3171,,,3171.0,FOXA3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of FOXA3 promoter|benzo(a)pyrene results in decreased methylation of FOXA3 exon|benzo(a)pyrene results in increased methylation of FOXA3 exon|benzo(a)pyrene results in increased methylation of FOXA3 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
848,221268,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27023,FOXB1,https://ctdbase.org/detail.go?type=gene&acc=27023,,,27023.0,FOXB1,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of FOXB1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
849,221340,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,130106,CIB4,https://ctdbase.org/detail.go?type=gene&acc=130106,,,130106.0,CIB4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CIB4 3' utr|benzo(a)pyrene affects the methylation of CIB4 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
850,221341,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,130106,CIB4,https://ctdbase.org/detail.go?type=gene&acc=130106,,,130106.0,CIB4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CIB4 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
851,221342,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,130106,CIB4,https://ctdbase.org/detail.go?type=gene&acc=130106,,,130106.0,CIB4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CIB4 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
852,221343,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,137392,CIBAR1,https://ctdbase.org/detail.go?type=gene&acc=137392,,,137392.0,CIBAR1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of CIBAR1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
853,221344,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,339145,CIBAR2,https://ctdbase.org/detail.go?type=gene&acc=339145,,,339145.0,CIBAR2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CIBAR2 5' utr|benzo(a)pyrene results in increased methylation of CIBAR2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
854,221345,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23152,CIC,https://ctdbase.org/detail.go?type=gene&acc=23152,,,23152.0,CIC,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CIC 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
855,221346,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23152,CIC,https://ctdbase.org/detail.go?type=gene&acc=23152,,,23152.0,CIC,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CIC mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
856,221347,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1149,CIDEA,https://ctdbase.org/detail.go?type=gene&acc=1149,,,1149.0,CIDEA,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CIDEA mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
857,221348,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1149,CIDEA,https://ctdbase.org/detail.go?type=gene&acc=1149,,,1149.0,CIDEA,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of CIDEA promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
858,221349,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1149,CIDEA,https://ctdbase.org/detail.go?type=gene&acc=1149,,,1149.0,CIDEA,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CIDEA mRNA,,,PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22610609,22610609,,
859,221680,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2306,FOXD2,https://ctdbase.org/detail.go?type=gene&acc=2306,,,2306.0,FOXD2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of FOXD2 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
860,221839,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3738,KCNA3,https://ctdbase.org/detail.go?type=gene&acc=3738,,,3738.0,KCNA3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KCNA3 exon|benzo(a)pyrene affects the methylation of KCNA3 3' utr|benzo(a)pyrene affects the methylation of KCNA3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
861,221840,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3739,KCNA4,https://ctdbase.org/detail.go?type=gene&acc=3739,,,3739.0,KCNA4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KCNA4 promoter|benzo(a)pyrene affects the methylation of KCNA4 exon|benzo(a)pyrene affects the methylation of KCNA4 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
862,221841,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3741,KCNA5,https://ctdbase.org/detail.go?type=gene&acc=3741,,,3741.0,KCNA5,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KCNA5 exon|benzo(a)pyrene results in decreased methylation of KCNA5 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
863,221842,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3742,KCNA6,https://ctdbase.org/detail.go?type=gene&acc=3742,,,3742.0,KCNA6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of KCNA6 3' utr|benzo(a)pyrene results in increased methylation of KCNA6 5' utr|benzo(a)pyrene results in increased methylation of KCNA6 exon|benzo(a)pyrene affects the methylation of KCNA6 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
864,221843,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3743,KCNA7,https://ctdbase.org/detail.go?type=gene&acc=3743,,,3743.0,KCNA7,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KCNA7 promoter|benzo(a)pyrene results in increased methylation of KCNA7 exon|benzo(a)pyrene results in increased methylation of KCNA7 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
865,221970,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,400960,PCBP1-AS1,https://ctdbase.org/detail.go?type=gene&acc=400960,,,400960.0,PCBP1-AS1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PCBP1-AS1 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
866,221971,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,369,ARAF,https://ctdbase.org/detail.go?type=gene&acc=369,,,369.0,ARAF,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ARAF mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
867,221972,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,369,ARAF,https://ctdbase.org/detail.go?type=gene&acc=369,,,369.0,ARAF,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ARAF mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
868,221973,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116985,ARAP1,https://ctdbase.org/detail.go?type=gene&acc=116985,,,116985.0,ARAP1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ARAP1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
869,221974,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116985,ARAP1,https://ctdbase.org/detail.go?type=gene&acc=116985,,,116985.0,ARAP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ARAP1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
870,221975,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116984,ARAP2,https://ctdbase.org/detail.go?type=gene&acc=116984,,,116984.0,ARAP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ARAP2 intron|benzo(a)pyrene results in decreased methylation of ARAP2 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
871,221976,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116984,ARAP2,https://ctdbase.org/detail.go?type=gene&acc=116984,,,116984.0,ARAP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of ARAP2 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
872,221977,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116984,ARAP2,https://ctdbase.org/detail.go?type=gene&acc=116984,,,116984.0,ARAP2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ARAP2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
873,221978,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64411,ARAP3,https://ctdbase.org/detail.go?type=gene&acc=64411,,,64411.0,ARAP3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of ARAP3 mRNA,,,PMID:21871943,https://www.ncbi.nlm.nih.gov/pubmed/21871943,21871943,,
874,221979,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83989,ARB2A,https://ctdbase.org/detail.go?type=gene&acc=83989,,,83989.0,ARB2A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ARB2A mRNA,,,PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291,20064835|20106945|21632981|22316170|26238291,,
875,222028,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64111,NPVF,https://ctdbase.org/detail.go?type=gene&acc=64111,,,64111.0,NPVF,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of NPVF mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
876,222029,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,283869,NPW,https://ctdbase.org/detail.go?type=gene&acc=283869,,,283869.0,NPW,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of NPW exon|benzo(a)pyrene results in decreased methylation of NPW 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
877,222030,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4852,NPY,https://ctdbase.org/detail.go?type=gene&acc=4852,,,4852.0,NPY,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NPY promoter|benzo(a)pyrene results in increased methylation of NPY 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
878,222128,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5094,PCBP2,https://ctdbase.org/detail.go?type=gene&acc=5094,,,5094.0,PCBP2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PCBP2 mRNA,,,PMID:20504355|PMID:22228805|PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/20504355|https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/27195522,20504355|22228805|27195522,,
879,222129,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54039,PCBP3,https://ctdbase.org/detail.go?type=gene&acc=54039,,,54039.0,PCBP3,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of PCBP3 mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
880,222130,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54039,PCBP3,https://ctdbase.org/detail.go?type=gene&acc=54039,,,54039.0,PCBP3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PCBP3 3' utr|benzo(a)pyrene affects the methylation of PCBP3 5' utr|benzo(a)pyrene affects the methylation of PCBP3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
881,222131,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54039,PCBP3,https://ctdbase.org/detail.go?type=gene&acc=54039,,,54039.0,PCBP3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PCBP3 protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
882,222132,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54039,PCBP3,https://ctdbase.org/detail.go?type=gene&acc=54039,,,54039.0,PCBP3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PCBP3 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
883,222133,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57060,PCBP4,https://ctdbase.org/detail.go?type=gene&acc=57060,,,57060.0,PCBP4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PCBP4 5' utr|benzo(a)pyrene results in increased methylation of PCBP4 exon|benzo(a)pyrene results in decreased methylation of PCBP4 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
884,222134,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57060,PCBP4,https://ctdbase.org/detail.go?type=gene&acc=57060,,,57060.0,PCBP4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PCBP4 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
885,222135,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57060,PCBP4,https://ctdbase.org/detail.go?type=gene&acc=57060,,,57060.0,PCBP4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PCBP4 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
886,222136,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83989,ARB2A,https://ctdbase.org/detail.go?type=gene&acc=83989,,,83989.0,ARB2A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ARB2A mRNA,,,PMID:19770486|PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21715664,19770486|21715664,,
887,222137,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23237,ARC,https://ctdbase.org/detail.go?type=gene&acc=23237,,,23237.0,ARC,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ARC 5' utr|benzo(a)pyrene results in increased methylation of ARC exon|benzo(a)pyrene affects the methylation of ARC promoter|benzo(a)pyrene results in decreased methylation of ARC 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
888,222287,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,284106,CISD3,https://ctdbase.org/detail.go?type=gene&acc=284106,,,284106.0,CISD3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of CISD3 protein,,,PMID:32717239,https://www.ncbi.nlm.nih.gov/pubmed/32717239,32717239,,
889,222288,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1154,CISH,https://ctdbase.org/detail.go?type=gene&acc=1154,,,1154.0,CISH,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of CISH promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
890,222289,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1154,CISH,https://ctdbase.org/detail.go?type=gene&acc=1154,,,1154.0,CISH,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CISH mRNA,,,PMID:19770486|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/32417428,19770486|32417428,,
891,222290,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1154,CISH,https://ctdbase.org/detail.go?type=gene&acc=1154,,,1154.0,CISH,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CISH mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
892,222291,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11113,CIT,https://ctdbase.org/detail.go?type=gene&acc=11113,,,11113.0,CIT,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of CIT mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
893,222292,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11113,CIT,https://ctdbase.org/detail.go?type=gene&acc=11113,,,11113.0,CIT,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CIT mRNA,,,PMID:20064835|PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20064835|20106945|21632981,,
894,222293,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11113,CIT,https://ctdbase.org/detail.go?type=gene&acc=11113,,,11113.0,CIT,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CIT mRNA,,,PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/20504355,20504355,,
895,222294,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4435,CITED1,https://ctdbase.org/detail.go?type=gene&acc=4435,,,4435.0,CITED1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CITED1 promoter|benzo(a)pyrene affects the methylation of CITED1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
896,222511,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83259,PCDH11Y,https://ctdbase.org/detail.go?type=gene&acc=83259,,,83259.0,PCDH11Y,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PCDH11Y promoter|benzo(a)pyrene results in decreased methylation of PCDH11Y 3' utr|benzo(a)pyrene affects the methylation of PCDH11Y 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
897,222512,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83259,PCDH11Y,https://ctdbase.org/detail.go?type=gene&acc=83259,,,83259.0,PCDH11Y,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PCDH11Y mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
898,222513,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51294,PCDH12,https://ctdbase.org/detail.go?type=gene&acc=51294,,,51294.0,PCDH12,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PCDH12 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
899,222514,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51294,PCDH12,https://ctdbase.org/detail.go?type=gene&acc=51294,,,51294.0,PCDH12,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PCDH12 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
900,222515,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65217,PCDH15,https://ctdbase.org/detail.go?type=gene&acc=65217,,,65217.0,PCDH15,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PCDH15 promoter|benzo(a)pyrene results in increased methylation of PCDH15 3' utr|benzo(a)pyrene results in increased methylation of PCDH15 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
901,222516,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27253,PCDH17,https://ctdbase.org/detail.go?type=gene&acc=27253,,,27253.0,PCDH17,7955.0,Danio rerio (zebrafish),[benzo(a)pyrene co-treated with fluoranthene] results in increased expression of PCDH17 mRNA,,,PMID:25412620,https://www.ncbi.nlm.nih.gov/pubmed/25412620,25412620,,
902,222517,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27253,PCDH17,https://ctdbase.org/detail.go?type=gene&acc=27253,,,27253.0,PCDH17,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PCDH17 promoter|benzo(a)pyrene results in increased methylation of PCDH17 5' utr|benzo(a)pyrene results in decreased methylation of PCDH17 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
903,222518,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27253,PCDH17,https://ctdbase.org/detail.go?type=gene&acc=27253,,,27253.0,PCDH17,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
904,222519,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27253,PCDH17,https://ctdbase.org/detail.go?type=gene&acc=27253,,,27253.0,PCDH17,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PCDH17 mRNA,,,PMID:21569818|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/22228805,21569818|22228805,,
905,222520,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27253,PCDH17,https://ctdbase.org/detail.go?type=gene&acc=27253,,,27253.0,PCDH17,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PCDH17 mRNA,,,PMID:21964900|PMID:22610609|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/21964900|https://www.ncbi.nlm.nih.gov/pubmed/22610609|https://www.ncbi.nlm.nih.gov/pubmed/32417428,21964900|22610609|32417428,,
906,223112,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55843,ARHGAP15,https://ctdbase.org/detail.go?type=gene&acc=55843,,,55843.0,ARHGAP15,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ARHGAP15 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
907,223113,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55114,ARHGAP17,https://ctdbase.org/detail.go?type=gene&acc=55114,,,55114.0,ARHGAP17,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ARHGAP17 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
908,223114,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55114,ARHGAP17,https://ctdbase.org/detail.go?type=gene&acc=55114,,,55114.0,ARHGAP17,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ARHGAP17 mRNA,,,PMID:25908611,https://www.ncbi.nlm.nih.gov/pubmed/25908611,25908611,,
909,223115,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55114,ARHGAP17,https://ctdbase.org/detail.go?type=gene&acc=55114,,,55114.0,ARHGAP17,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of ARHGAP17 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
910,223116,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,93663,ARHGAP18,https://ctdbase.org/detail.go?type=gene&acc=93663,,,93663.0,ARHGAP18,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ARHGAP18 mRNA,,,PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291,20064835|20106945|21632981|22316170|26238291,,
911,223117,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84986,ARHGAP19,https://ctdbase.org/detail.go?type=gene&acc=84986,,,84986.0,ARHGAP19,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ARHGAP19 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
912,223308,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,58504,ARHGAP22,https://ctdbase.org/detail.go?type=gene&acc=58504,,,58504.0,ARHGAP22,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ARHGAP22 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
913,223309,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,58504,ARHGAP22,https://ctdbase.org/detail.go?type=gene&acc=58504,,,58504.0,ARHGAP22,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ARHGAP22 3' utr|benzo(a)pyrene results in increased methylation of ARHGAP22 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
914,223310,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,58504,ARHGAP22,https://ctdbase.org/detail.go?type=gene&acc=58504,,,58504.0,ARHGAP22,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ARHGAP22 mRNA,,,PMID:20713471|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/20713471|https://www.ncbi.nlm.nih.gov/pubmed/22228805,20713471|22228805,,
915,223311,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57636,ARHGAP23,https://ctdbase.org/detail.go?type=gene&acc=57636,,,57636.0,ARHGAP23,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ARHGAP23 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
916,223359,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9572,NR1D1,https://ctdbase.org/detail.go?type=gene&acc=9572,,,9572.0,NR1D1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NR1D1 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
917,223360,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9572,NR1D1,https://ctdbase.org/detail.go?type=gene&acc=9572,,,9572.0,NR1D1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NR1D1 mRNA,,,PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22610609,22610609,,
918,223361,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9975,NR1D2,https://ctdbase.org/detail.go?type=gene&acc=9975,,,9975.0,NR1D2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NR1D2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
919,223362,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9975,NR1D2,https://ctdbase.org/detail.go?type=gene&acc=9975,,,9975.0,NR1D2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NR1D2 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
920,223363,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9975,NR1D2,https://ctdbase.org/detail.go?type=gene&acc=9975,,,9975.0,NR1D2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NR1D2 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
921,223364,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,90134,KCNH7,https://ctdbase.org/detail.go?type=gene&acc=90134,,,90134.0,KCNH7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KCNH7 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
922,223365,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,90134,KCNH7,https://ctdbase.org/detail.go?type=gene&acc=90134,,,90134.0,KCNH7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KCNH7 promoter|benzo(a)pyrene results in increased methylation of KCNH7 3' utr|benzo(a)pyrene results in increased methylation of KCNH7 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
923,223366,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,90134,KCNH7,https://ctdbase.org/detail.go?type=gene&acc=90134,,,90134.0,KCNH7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of KCNH7 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
924,223367,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,131096,KCNH8,https://ctdbase.org/detail.go?type=gene&acc=131096,,,131096.0,KCNH8,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KCNH8 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
925,223368,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,30820,KCNIP1,https://ctdbase.org/detail.go?type=gene&acc=30820,,,30820.0,KCNIP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KCNIP1 exon|benzo(a)pyrene affects the methylation of KCNIP1 promoter|benzo(a)pyrene affects the methylation of KCNIP1 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
926,223487,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,29930,PCDHB1,https://ctdbase.org/detail.go?type=gene&acc=29930,,,29930.0,PCDHB1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PCDHB1 promoter|benzo(a)pyrene results in increased methylation of PCDHB1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
927,223488,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,29930,PCDHB1,https://ctdbase.org/detail.go?type=gene&acc=29930,,,29930.0,PCDHB1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of PCDHB1 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
928,223671,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1184,CLCN5,https://ctdbase.org/detail.go?type=gene&acc=1184,,,1184.0,CLCN5,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CLCN5 promoter|benzo(a)pyrene results in increased methylation of CLCN5 intron|benzo(a)pyrene results in increased methylation of CLCN5 5' utr|benzo(a)pyrene results in increased methylation of CLCN5 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
929,223672,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1184,CLCN5,https://ctdbase.org/detail.go?type=gene&acc=1184,,,1184.0,CLCN5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of CLCN5 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
930,223673,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1184,CLCN5,https://ctdbase.org/detail.go?type=gene&acc=1184,,,1184.0,CLCN5,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CLCN5 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
931,223674,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1185,CLCN6,https://ctdbase.org/detail.go?type=gene&acc=1185,,,1185.0,CLCN6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CLCN6 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
932,223675,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1185,CLCN6,https://ctdbase.org/detail.go?type=gene&acc=1185,,,1185.0,CLCN6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of CLCN6 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
933,223881,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9076,CLDN1,https://ctdbase.org/detail.go?type=gene&acc=9076,,,9076.0,CLDN1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CLDN1 mRNA,,,PMID:20106945|PMID:21632981|PMID:31255691|PMID:35870112,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/31255691|https://www.ncbi.nlm.nih.gov/pubmed/35870112,20106945|21632981|31255691|35870112,,
934,223882,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9076,CLDN1,https://ctdbase.org/detail.go?type=gene&acc=9076,,,9076.0,CLDN1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of CLDN1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
935,224047,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57255,CLDN13,https://ctdbase.org/detail.go?type=gene&acc=57255,,,57255.0,Cldn13,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CLDN13 mRNA,,,PMID:17942131,https://www.ncbi.nlm.nih.gov/pubmed/17942131,17942131,,
936,224048,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23562,CLDN14,https://ctdbase.org/detail.go?type=gene&acc=23562,,,23562.0,CLDN14,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CLDN14 5' utr|benzo(a)pyrene results in increased methylation of CLDN14 exon|benzo(a)pyrene affects the methylation of CLDN14 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
937,224049,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23562,CLDN14,https://ctdbase.org/detail.go?type=gene&acc=23562,,,23562.0,CLDN14,9606.0,Homo sapiens (human),Benzo(a)pyrene metabolite results in decreased expression of CLDN14 mRNA,,,PMID:26314263,https://www.ncbi.nlm.nih.gov/pubmed/26314263,26314263,,
938,224050,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23562,CLDN14,https://ctdbase.org/detail.go?type=gene&acc=23562,,,23562.0,CLDN14,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CLDN14 mRNA,,,PMID:22316170|PMID:26238291|PMID:32234424|PMID:35690182,https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424|https://www.ncbi.nlm.nih.gov/pubmed/35690182,22316170|26238291|32234424|35690182,,
939,224051,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23562,CLDN14,https://ctdbase.org/detail.go?type=gene&acc=23562,,,23562.0,CLDN14,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CLDN14 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
940,224052,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,24146,CLDN15,https://ctdbase.org/detail.go?type=gene&acc=24146,,,24146.0,CLDN15,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CLDN15 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
941,224053,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,24146,CLDN15,https://ctdbase.org/detail.go?type=gene&acc=24146,,,24146.0,CLDN15,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CLDN15 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of CLDN15 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
942,224054,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,81591,CLDN15LA,https://ctdbase.org/detail.go?type=gene&acc=81591,,,81591.0,cldn15la,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in increased expression of CLDN15LA mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
943,224055,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,436719,CLDN15LB,https://ctdbase.org/detail.go?type=gene&acc=436719,,,436719.0,cldn15lb,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in increased expression of CLDN15LB mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
944,224056,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,56113,PCDHGA2,https://ctdbase.org/detail.go?type=gene&acc=56113,,,56113.0,PCDHGA2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PCDHGA2 5' utr|benzo(a)pyrene results in increased methylation of PCDHGA2 intron|benzo(a)pyrene affects the methylation of PCDHGA2 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
945,224216,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10002,NR2E3,https://ctdbase.org/detail.go?type=gene&acc=10002,,,10002.0,NR2E3,9606.0,Homo sapiens (human),S-ethyl glutathione inhibits the reaction [benzo(a)pyrene results in decreased expression of NR2E3 protein]|benzo(a)pyrene inhibits the reaction [NR2E3 protein binds to NR2E3 protein]|acetylcysteine inhibits the reaction [benzo(a)pyrene results in decreased expression of NR2E3 protein]|benzo(a)pyrene results in decreased expression of NR2E3 mrna|benzo(a)pyrene inhibits the reaction [NR2E3 protein binds to ESR1 promoter]|benzo(a)pyrene results in decreased expression of NR2E3 protein,,,PMID:26149760,https://www.ncbi.nlm.nih.gov/pubmed/26149760,26149760,,
946,224217,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10002,NR2E3,https://ctdbase.org/detail.go?type=gene&acc=10002,,,10002.0,NR2E3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NR2E3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
947,224218,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7025,NR2F1,https://ctdbase.org/detail.go?type=gene&acc=7025,,,7025.0,NR2F1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NR2F1 promoter|benzo(a)pyrene results in decreased methylation of NR2F1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
948,224219,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7025,NR2F1,https://ctdbase.org/detail.go?type=gene&acc=7025,,,7025.0,NR2F1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene affects the reaction [AHR protein binds to NR2F1 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
949,224220,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3760,KCNJ3,https://ctdbase.org/detail.go?type=gene&acc=3760,,,3760.0,KCNJ3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KCNJ3 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
950,224221,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3760,KCNJ3,https://ctdbase.org/detail.go?type=gene&acc=3760,,,3760.0,KCNJ3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KCNJ3 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
951,224222,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3760,KCNJ3,https://ctdbase.org/detail.go?type=gene&acc=3760,,,3760.0,KCNJ3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KCNJ3 mRNA,,,PMID:20127859|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/20127859|https://www.ncbi.nlm.nih.gov/pubmed/22228805,20127859|22228805,,
952,224223,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3761,KCNJ4,https://ctdbase.org/detail.go?type=gene&acc=3761,,,3761.0,KCNJ4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of KCNJ4 exon|benzo(a)pyrene results in decreased methylation of KCNJ4 5' utr|benzo(a)pyrene results in decreased methylation of KCNJ4 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
953,224224,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3761,KCNJ4,https://ctdbase.org/detail.go?type=gene&acc=3761,,,3761.0,KCNJ4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KCNJ4 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
954,224225,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3762,KCNJ5,https://ctdbase.org/detail.go?type=gene&acc=3762,,,3762.0,KCNJ5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KCNJ5 3' utr|benzo(a)pyrene results in increased methylation of KCNJ5 promoter|benzo(a)pyrene affects the methylation of KCNJ5 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
955,224657,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7122,CLDN5,https://ctdbase.org/detail.go?type=gene&acc=7122,,,7122.0,CLDN5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of CLDN5 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
956,224658,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7122,CLDN5,https://ctdbase.org/detail.go?type=gene&acc=7122,,,7122.0,CLDN5,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CLDN5 mRNA,,,PMID:19770486|PMID:21715664|PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21715664|https://www.ncbi.nlm.nih.gov/pubmed/27195522,19770486|21715664|27195522,,
957,224659,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9074,CLDN6,https://ctdbase.org/detail.go?type=gene&acc=9074,,,9074.0,CLDN6,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CLDN6 5' utr|benzo(a)pyrene affects the methylation of CLDN6 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
958,224660,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9074,CLDN6,https://ctdbase.org/detail.go?type=gene&acc=9074,,,9074.0,CLDN6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of CLDN6 mRNA,,,PMID:35870112,https://www.ncbi.nlm.nih.gov/pubmed/35870112,35870112,,
959,224723,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25782,RAB3GAP2,https://ctdbase.org/detail.go?type=gene&acc=25782,,,25782.0,RAB3GAP2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of RAB3GAP2 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
960,224724,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5866,RAB3IL1,https://ctdbase.org/detail.go?type=gene&acc=5866,,,5866.0,RAB3IL1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RAB3IL1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
961,224725,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5866,RAB3IL1,https://ctdbase.org/detail.go?type=gene&acc=5866,,,5866.0,RAB3IL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RAB3IL1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
962,224726,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5866,RAB3IL1,https://ctdbase.org/detail.go?type=gene&acc=5866,,,5866.0,RAB3IL1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RAB3IL1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
963,224905,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8013,NR4A3,https://ctdbase.org/detail.go?type=gene&acc=8013,,,8013.0,NR4A3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of NR4A3 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
964,224906,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8013,NR4A3,https://ctdbase.org/detail.go?type=gene&acc=8013,,,8013.0,NR4A3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NR4A3 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
965,224907,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8013,NR4A3,https://ctdbase.org/detail.go?type=gene&acc=8013,,,8013.0,NR4A3,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of NR4A3 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
966,224908,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2516,NR5A1,https://ctdbase.org/detail.go?type=gene&acc=2516,,,2516.0,NR5A1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NR5A1 mRNA,,,PMID:17520059,https://www.ncbi.nlm.nih.gov/pubmed/17520059,17520059,,
967,224909,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3776,KCNK2,https://ctdbase.org/detail.go?type=gene&acc=3776,,,3776.0,KCNK2,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of KCNK2 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
968,224910,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3777,KCNK3,https://ctdbase.org/detail.go?type=gene&acc=3777,,,3777.0,KCNK3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KCNK3 promoter|benzo(a)pyrene results in increased methylation of KCNK3 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
969,224911,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,50801,KCNK4,https://ctdbase.org/detail.go?type=gene&acc=50801,,,50801.0,KCNK4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of KCNK4 promoter|benzo(a)pyrene affects the methylation of KCNK4 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
970,224912,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,50801,KCNK4,https://ctdbase.org/detail.go?type=gene&acc=50801,,,50801.0,KCNK4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KCNK4 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
971,224913,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,50801,KCNK4,https://ctdbase.org/detail.go?type=gene&acc=50801,,,50801.0,KCNK4,34765.0,Oikopleura dioica,Benzo(a)pyrene results in decreased expression of KCNK4 mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
972,224914,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8645,KCNK5,https://ctdbase.org/detail.go?type=gene&acc=8645,,,8645.0,KCNK5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KCNK5 mRNA,,,PMID:20106945|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20106945|32234424,,
973,225182,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,53916,RAB4B,https://ctdbase.org/detail.go?type=gene&acc=53916,,,53916.0,RAB4B,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RAB4B mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
974,225183,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5868,RAB5A,https://ctdbase.org/detail.go?type=gene&acc=5868,,,5868.0,RAB5A,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RAB5A promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
975,225184,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5869,RAB5B,https://ctdbase.org/detail.go?type=gene&acc=5869,,,5869.0,RAB5B,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RAB5B mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
976,225185,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5878,RAB5C,https://ctdbase.org/detail.go?type=gene&acc=5878,,,5878.0,RAB5C,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RAB5C promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
977,225245,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6320,CLEC11A,https://ctdbase.org/detail.go?type=gene&acc=6320,,,6320.0,CLEC11A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of CLEC11A 3' utr|benzo(a)pyrene results in decreased methylation of CLEC11A promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
978,225246,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6320,CLEC11A,https://ctdbase.org/detail.go?type=gene&acc=6320,,,6320.0,CLEC11A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CLEC11A mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
979,225590,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3784,KCNQ1,https://ctdbase.org/detail.go?type=gene&acc=3784,,,3784.0,KCNQ1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KCNQ1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
980,225665,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51267,CLEC1A,https://ctdbase.org/detail.go?type=gene&acc=51267,,,51267.0,CLEC1A,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLEC1A mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
981,225666,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51267,CLEC1A,https://ctdbase.org/detail.go?type=gene&acc=51267,,,51267.0,CLEC1A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CLEC1A mRNA,,,PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22610609,22610609,,
982,225667,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,186582,CLEC-206,https://ctdbase.org/detail.go?type=gene&acc=186582,,,186582.0,clec-206,6239.0,Caenorhabditis elegans,Benzo(a)pyrene results in increased expression of CLEC-206 mRNA,,,PMID:33420596,https://www.ncbi.nlm.nih.gov/pubmed/33420596,33420596,,
983,225668,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,178716,CLEC-209,https://ctdbase.org/detail.go?type=gene&acc=178716,,,178716.0,clec-209,6239.0,Caenorhabditis elegans,Benzo(a)pyrene results in increased expression of CLEC-209 mRNA,,,PMID:33420596,https://www.ncbi.nlm.nih.gov/pubmed/33420596,33420596,,
984,225669,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,387836,CLEC2A,https://ctdbase.org/detail.go?type=gene&acc=387836,,,387836.0,CLEC2A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of CLEC2A 3' utr|benzo(a)pyrene affects the methylation of CLEC2A promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
985,225670,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,387836,CLEC2A,https://ctdbase.org/detail.go?type=gene&acc=387836,,,387836.0,CLEC2A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of CLEC2A gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
986,225671,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9976,CLEC2B,https://ctdbase.org/detail.go?type=gene&acc=9976,,,9976.0,CLEC2B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CLEC2B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
987,225672,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,29121,CLEC2D,https://ctdbase.org/detail.go?type=gene&acc=29121,,,29121.0,CLEC2D,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of CLEC2D mRNA,,,PMID:17879257,https://www.ncbi.nlm.nih.gov/pubmed/17879257,17879257,,
988,225673,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,29121,CLEC2D,https://ctdbase.org/detail.go?type=gene&acc=29121,,,29121.0,CLEC2D,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of CLEC2D 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
989,225777,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of NRF1 3' utr|benzo(a)pyrene results in decreased methylation of NRF1 exon|benzo(a)pyrene affects the methylation of NRF1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
990,225778,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NRF1 mRNA,,,PMID:22865514,https://www.ncbi.nlm.nih.gov/pubmed/22865514,22865514,,
991,225779,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NRF1 protein,,,PMID:21401886|PMID:22865514,https://www.ncbi.nlm.nih.gov/pubmed/21401886|https://www.ncbi.nlm.nih.gov/pubmed/22865514,21401886|22865514,,
992,225780,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,9606.0,Homo sapiens (human),NRF1 mutant form inhibits the reaction [benzo(a)pyrene results in decreased expression of TFAM protein]|nrf1 mutant form promotes the reaction [benzo(a)pyrene results in increased abundance of reactive oxygen species],,,PMID:21401886,https://www.ncbi.nlm.nih.gov/pubmed/21401886,21401886,,
993,225781,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to NRF1 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
994,225782,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [NRF1 protein binds to GSTA1 gene],,,PMID:11961136,https://www.ncbi.nlm.nih.gov/pubmed/11961136,11961136,,
995,225783,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NRF1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
996,225784,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene affects the expression of NRF1 mrna|benzo(a)pyrene affects the expression of NRF1 protein|resveratrol affects the reaction [benzo(a)pyrene affects the expression of NRF1 protein]|resveratrol affects the reaction [benzo(a)pyrene affects the expression of NRF1 mrna],,,PMID:32619457,https://www.ncbi.nlm.nih.gov/pubmed/32619457,32619457,,
997,226008,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5877,RABIF,https://ctdbase.org/detail.go?type=gene&acc=5877,,,5877.0,RABIF,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RABIF promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
998,226009,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5877,RABIF,https://ctdbase.org/detail.go?type=gene&acc=5877,,,5877.0,RABIF,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to RABIF promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
999,226010,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11159,RABL2A,https://ctdbase.org/detail.go?type=gene&acc=11159,,,11159.0,RABL2A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RABL2A mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1000,226011,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,285282,RABL3,https://ctdbase.org/detail.go?type=gene&acc=285282,,,285282.0,RABL3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RABL3 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1001,226012,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,285282,RABL3,https://ctdbase.org/detail.go?type=gene&acc=285282,,,285282.0,RABL3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of RABL3 3' utr|benzo(a)pyrene results in increased methylation of RABL3 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1002,226013,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RAC1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1003,226195,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57582,KCNT1,https://ctdbase.org/detail.go?type=gene&acc=57582,,,57582.0,KCNT1,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of KCNT1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1004,226196,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57582,KCNT1,https://ctdbase.org/detail.go?type=gene&acc=57582,,,57582.0,KCNT1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KCNT1 3' utr|benzo(a)pyrene results in increased methylation of KCNT1 intron|benzo(a)pyrene results in increased methylation of KCNT1 exon|benzo(a)pyrene results in increased methylation of KCNT1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1005,226197,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57582,KCNT1,https://ctdbase.org/detail.go?type=gene&acc=57582,,,57582.0,KCNT1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KCNT1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1006,226198,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57582,KCNT1,https://ctdbase.org/detail.go?type=gene&acc=57582,,,57582.0,KCNT1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to KCNT1 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1007,226199,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57582,KCNT1,https://ctdbase.org/detail.go?type=gene&acc=57582,,,57582.0,KCNT1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KCNT1 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1008,226200,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57582,KCNT1,https://ctdbase.org/detail.go?type=gene&acc=57582,,,57582.0,KCNT1,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of KCNT1 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1009,226201,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,343450,KCNT2,https://ctdbase.org/detail.go?type=gene&acc=343450,,,343450.0,KCNT2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KCNT2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1010,226672,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80820,EEPD1,https://ctdbase.org/detail.go?type=gene&acc=80820,,,80820.0,EEPD1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EEPD1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1011,226673,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80820,EEPD1,https://ctdbase.org/detail.go?type=gene&acc=80820,,,80820.0,EEPD1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EEPD1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1012,226674,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80820,EEPD1,https://ctdbase.org/detail.go?type=gene&acc=80820,,,80820.0,EEPD1,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of EEPD1 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1013,226675,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100003999,EEVS,https://ctdbase.org/detail.go?type=gene&acc=100003999,,,100003999.0,eevs,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in increased expression of EEVS mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
1014,226676,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100130771,EFCAB10,https://ctdbase.org/detail.go?type=gene&acc=100130771,,,100130771.0,EFCAB10,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EFCAB10 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1015,226831,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,53405,CLIC5,https://ctdbase.org/detail.go?type=gene&acc=53405,,,53405.0,CLIC5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of CLIC5 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1016,226832,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,53405,CLIC5,https://ctdbase.org/detail.go?type=gene&acc=53405,,,53405.0,CLIC5,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CLIC5 mRNA,,,PMID:21964900,https://www.ncbi.nlm.nih.gov/pubmed/21964900,21964900,,
1017,226833,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54102,CLIC6,https://ctdbase.org/detail.go?type=gene&acc=54102,,,54102.0,CLIC6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of CLIC6 exon|benzo(a)pyrene affects the methylation of CLIC6 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1018,226834,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54102,CLIC6,https://ctdbase.org/detail.go?type=gene&acc=54102,,,54102.0,CLIC6,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CLIC6 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1019,226835,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54102,CLIC6,https://ctdbase.org/detail.go?type=gene&acc=54102,,,54102.0,CLIC6,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CLIC6 mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
1020,227108,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8438,RAD54L,https://ctdbase.org/detail.go?type=gene&acc=8438,,,8438.0,RAD54L,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RAD54L mRNA,,,PMID:20064835|PMID:21802500,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/21802500,20064835|21802500,,
1021,227109,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8438,RAD54L,https://ctdbase.org/detail.go?type=gene&acc=8438,,,8438.0,RAD54L,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RAD54L mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1022,227110,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8438,RAD54L,https://ctdbase.org/detail.go?type=gene&acc=8438,,,8438.0,RAD54L,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RAD54L promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1023,227159,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54904,NSD3,https://ctdbase.org/detail.go?type=gene&acc=54904,,,54904.0,NSD3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NSD3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1024,227160,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54904,NSD3,https://ctdbase.org/detail.go?type=gene&acc=54904,,,54904.0,NSD3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of NSD3 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1025,227161,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,50814,NSDHL,https://ctdbase.org/detail.go?type=gene&acc=50814,,,50814.0,NSDHL,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of NSDHL mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1026,227275,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2202,EFEMP1,https://ctdbase.org/detail.go?type=gene&acc=2202,,,2202.0,EFEMP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EFEMP1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1027,227276,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2202,EFEMP1,https://ctdbase.org/detail.go?type=gene&acc=2202,,,2202.0,EFEMP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EFEMP1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1028,227277,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2202,EFEMP1,https://ctdbase.org/detail.go?type=gene&acc=2202,,,2202.0,EFEMP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EFEMP1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1029,227278,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,30008,EFEMP2,https://ctdbase.org/detail.go?type=gene&acc=30008,,,30008.0,EFEMP2,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of EFEMP2 mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
1030,227279,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,30008,EFEMP2,https://ctdbase.org/detail.go?type=gene&acc=30008,,,30008.0,EFEMP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of EFEMP2 exon|benzo(a)pyrene affects the methylation of EFEMP2 5' utr|benzo(a)pyrene results in decreased methylation of EFEMP2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1031,227280,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,30008,EFEMP2,https://ctdbase.org/detail.go?type=gene&acc=30008,,,30008.0,EFEMP2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EFEMP2 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1032,227281,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,114327,EFHC1,https://ctdbase.org/detail.go?type=gene&acc=114327,,,114327.0,EFHC1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EFHC1 promoter|benzo(a)pyrene results in increased methylation of EFHC1 exon|benzo(a)pyrene results in increased methylation of EFHC1 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1033,227334,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11014,KDELR2,https://ctdbase.org/detail.go?type=gene&acc=11014,,,11014.0,KDELR2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of KDELR2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1034,227335,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11015,KDELR3,https://ctdbase.org/detail.go?type=gene&acc=11015,,,11015.0,KDELR3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KDELR3 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1035,227452,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5144,PDE4D,https://ctdbase.org/detail.go?type=gene&acc=5144,,,5144.0,PDE4D,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PDE4D mRNA,,,PMID:22316170|PMID:35870112,https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/35870112,22316170|35870112,,
1036,227453,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9659,PDE4DIP,https://ctdbase.org/detail.go?type=gene&acc=9659,,,9659.0,PDE4DIP,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PDE4DIP exon|benzo(a)pyrene results in decreased methylation of PDE4DIP promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1037,227454,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9659,PDE4DIP,https://ctdbase.org/detail.go?type=gene&acc=9659,,,9659.0,PDE4DIP,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of PDE4DIP mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1038,227455,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9659,PDE4DIP,https://ctdbase.org/detail.go?type=gene&acc=9659,,,9659.0,PDE4DIP,10090.0,Mus musculus (house mouse),Benzo(a)pyrene metabolite results in decreased expression of PDE4DIP mRNA,,,PMID:32553695,https://www.ncbi.nlm.nih.gov/pubmed/32553695,32553695,,
1039,227456,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,728920,PDE4DIPP1,https://ctdbase.org/detail.go?type=gene&acc=728920,,,728920.0,PDE4DIPP1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDE4DIPP1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1040,227457,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8654,PDE5A,https://ctdbase.org/detail.go?type=gene&acc=8654,,,8654.0,PDE5A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PDE5A promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1041,227458,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8654,PDE5A,https://ctdbase.org/detail.go?type=gene&acc=8654,,,8654.0,PDE5A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PDE5A mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1042,227488,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79180,EFHD2,https://ctdbase.org/detail.go?type=gene&acc=79180,,,79180.0,EFHD2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EFHD2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1043,227489,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79631,EFL1,https://ctdbase.org/detail.go?type=gene&acc=79631,,,79631.0,EFL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of EFL1 intron|benzo(a)pyrene results in decreased methylation of EFL1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1044,227490,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79631,EFL1,https://ctdbase.org/detail.go?type=gene&acc=79631,,,79631.0,EFL1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EFL1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1045,227491,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1942,EFNA1,https://ctdbase.org/detail.go?type=gene&acc=1942,,,1942.0,EFNA1,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of EFNA1 mrna|[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of EFNA1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1046,227647,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5147,PDE6D,https://ctdbase.org/detail.go?type=gene&acc=5147,,,5147.0,PDE6D,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PDE6D 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1047,227648,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5147,PDE6D,https://ctdbase.org/detail.go?type=gene&acc=5147,,,5147.0,PDE6D,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PDE6D mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1048,227649,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5148,PDE6G,https://ctdbase.org/detail.go?type=gene&acc=5148,,,5148.0,PDE6G,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDE6G promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1049,227650,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,553708,PDE6GA,https://ctdbase.org/detail.go?type=gene&acc=553708,,,553708.0,pde6ga,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in decreased expression of PDE6GA mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
1050,227651,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5149,PDE6H,https://ctdbase.org/detail.go?type=gene&acc=5149,,,5149.0,PDE6H,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in increased expression of PDE6H mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
1051,227680,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1942,EFNA1,https://ctdbase.org/detail.go?type=gene&acc=1942,,,1942.0,EFNA1,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with dextran sulfate] results in decreased expression of EFNA1 mRNA,,,PMID:26271895,https://www.ncbi.nlm.nih.gov/pubmed/26271895,26271895,,
1052,227681,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1942,EFNA1,https://ctdbase.org/detail.go?type=gene&acc=1942,,,1942.0,EFNA1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EFNA1 mRNA,,,PMID:19770486|PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21569818,19770486|21569818,,
1053,227682,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1942,EFNA1,https://ctdbase.org/detail.go?type=gene&acc=1942,,,1942.0,EFNA1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EFNA1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1054,227683,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1943,EFNA2,https://ctdbase.org/detail.go?type=gene&acc=1943,,,1943.0,EFNA2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EFNA2 promoter|benzo(a)pyrene results in increased methylation of EFNA2 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1055,227684,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1944,EFNA3,https://ctdbase.org/detail.go?type=gene&acc=1944,,,1944.0,EFNA3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EFNA3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1056,227685,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1944,EFNA3,https://ctdbase.org/detail.go?type=gene&acc=1944,,,1944.0,EFNA3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EFNA3 mRNA,,,PMID:19770486|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/32417428,19770486|32417428,,
1057,227686,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1945,EFNA4,https://ctdbase.org/detail.go?type=gene&acc=1945,,,1945.0,EFNA4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EFNA4 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1058,227687,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1946,EFNA5,https://ctdbase.org/detail.go?type=gene&acc=1946,,,1946.0,EFNA5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EFNA5 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1059,227814,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,645104,CLRN2,https://ctdbase.org/detail.go?type=gene&acc=645104,,,645104.0,CLRN2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of CLRN2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1060,227815,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,119467,CLRN3,https://ctdbase.org/detail.go?type=gene&acc=119467,,,119467.0,CLRN3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of CLRN3 3' utr|benzo(a)pyrene affects the methylation of CLRN3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1061,227816,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,119467,CLRN3,https://ctdbase.org/detail.go?type=gene&acc=119467,,,119467.0,CLRN3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CLRN3 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1062,227817,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,63967,CLSPN,https://ctdbase.org/detail.go?type=gene&acc=63967,,,63967.0,CLSPN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of CLSPN mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1063,227818,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,63967,CLSPN,https://ctdbase.org/detail.go?type=gene&acc=63967,,,63967.0,CLSPN,9606.0,Homo sapiens (human),CLSPN mRNA affects the reaction [benzo(a)pyrene results in decreased phosphorylation of CDC25A protein]|clspn mRNA affects the reaction [benzo(a)pyrene results in increased phosphorylation of CHEK1 protein]|benzo(a)pyrene results in increased expression of CLSPN protein|clspn mRNA affects the susceptibility to benzo(a)pyrene,,,PMID:19464357,https://www.ncbi.nlm.nih.gov/pubmed/19464357,19464357,,
1064,227819,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27115,PDE7B,https://ctdbase.org/detail.go?type=gene&acc=27115,,,27115.0,PDE7B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDE7B promoter|benzo(a)pyrene results in decreased methylation of PDE7B intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1065,227820,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27115,PDE7B,https://ctdbase.org/detail.go?type=gene&acc=27115,,,27115.0,PDE7B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PDE7B mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1066,227821,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27115,PDE7B,https://ctdbase.org/detail.go?type=gene&acc=27115,,,27115.0,PDE7B,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PDE7B mRNA,,,PMID:15034205,https://www.ncbi.nlm.nih.gov/pubmed/15034205,15034205,,
1067,227822,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5151,PDE8A,https://ctdbase.org/detail.go?type=gene&acc=5151,,,5151.0,PDE8A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PDE8A mRNA,,,PMID:19770486|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/22228805,19770486|22228805,,
1068,227823,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8622,PDE8B,https://ctdbase.org/detail.go?type=gene&acc=8622,,,8622.0,PDE8B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PDE8B exon|benzo(a)pyrene results in increased methylation of PDE8B intron|benzo(a)pyrene affects the methylation of PDE8B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1069,227846,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606.0,Homo sapiens (human),Benzo(a)pyrene promotes the reaction [ARNT protein binds to NFE2L2 promoter]|brca1 protein affects the reaction [benzo(a)pyrene promotes the reaction [ARNT protein binds to UGT1A1 promoter]]|benzo(a)pyrene promotes the reaction [ARNT protein binds to UGT1A1 promoter]|arnt protein affects the reaction [BRCA1 protein affects the susceptibility to benzo(a)pyrene]|brca1 protein affects the reaction [benzo(a)pyrene promotes the reaction [ARNT protein binds to NFE2L2 promoter]]|benzo(a)pyrene promotes the reaction [ARNT protein binds to UGT1A9 promoter]|brca1 protein affects the reaction [benzo(a)pyrene promotes the reaction [ARNT protein binds to UGT1A9 promoter]],,,PMID:21507987,https://www.ncbi.nlm.nih.gov/pubmed/21507987,21507987,,
1070,227847,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the localization of ARNT protein,,,PMID:26350169,https://www.ncbi.nlm.nih.gov/pubmed/26350169,26350169,,
1071,227848,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ARNT intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1072,227849,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1947,EFNB1,https://ctdbase.org/detail.go?type=gene&acc=1947,,,1947.0,EFNB1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EFNB1 5' utr|benzo(a)pyrene results in decreased methylation of EFNB1 3' utr|benzo(a)pyrene affects the methylation of EFNB1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1073,227850,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1947,EFNB1,https://ctdbase.org/detail.go?type=gene&acc=1947,,,1947.0,EFNB1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EFNB1 mRNA,,,PMID:22316170|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/32234424,22316170|32234424,,
1074,227851,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1947,EFNB1,https://ctdbase.org/detail.go?type=gene&acc=1947,,,1947.0,EFNB1,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EFNB1 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1075,227852,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1948,EFNB2,https://ctdbase.org/detail.go?type=gene&acc=1948,,,1948.0,EFNB2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EFNB2 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1076,227853,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1948,EFNB2,https://ctdbase.org/detail.go?type=gene&acc=1948,,,1948.0,EFNB2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EFNB2 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1077,227854,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1948,EFNB2,https://ctdbase.org/detail.go?type=gene&acc=1948,,,1948.0,EFNB2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EFNB2 mRNA,,,PMID:19770486|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/32417428,19770486|32417428,,
1078,227855,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1948,EFNB2,https://ctdbase.org/detail.go?type=gene&acc=1948,,,1948.0,EFNB2,34765.0,Oikopleura dioica,Benzo(a)pyrene results in decreased expression of EFNB2 mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
1079,227983,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,63967,CLSPN,https://ctdbase.org/detail.go?type=gene&acc=63967,,,63967.0,CLSPN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of CLSPN gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1080,227984,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,63967,CLSPN,https://ctdbase.org/detail.go?type=gene&acc=63967,,,63967.0,CLSPN,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CLSPN mRNA,,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
1081,227985,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22883,CLSTN1,https://ctdbase.org/detail.go?type=gene&acc=22883,,,22883.0,CLSTN1,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of CLSTN1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1082,227986,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22883,CLSTN1,https://ctdbase.org/detail.go?type=gene&acc=22883,,,22883.0,CLSTN1,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of CLSTN1 mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
1083,227987,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22883,CLSTN1,https://ctdbase.org/detail.go?type=gene&acc=22883,,,22883.0,CLSTN1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CLSTN1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1084,227988,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22883,CLSTN1,https://ctdbase.org/detail.go?type=gene&acc=22883,,,22883.0,CLSTN1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CLSTN1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1085,227989,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64084,CLSTN2,https://ctdbase.org/detail.go?type=gene&acc=64084,,,64084.0,CLSTN2,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of CLSTN2 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1086,227990,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64084,CLSTN2,https://ctdbase.org/detail.go?type=gene&acc=64084,,,64084.0,CLSTN2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of CLSTN2 promoter|benzo(a)pyrene results in increased methylation of CLSTN2 intron|benzo(a)pyrene results in increased methylation of CLSTN2 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1087,227991,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64084,CLSTN2,https://ctdbase.org/detail.go?type=gene&acc=64084,,,64084.0,CLSTN2,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CLSTN2 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1088,227992,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64084,CLSTN2,https://ctdbase.org/detail.go?type=gene&acc=64084,,,64084.0,CLSTN2,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of CLSTN2 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1089,228024,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606.0,Homo sapiens (human),Benzo(a)pyrene inhibits the reaction [cobaltous chloride promotes the reaction [HIF1A protein binds to ARNT protein]],,,PMID:20228066,https://www.ncbi.nlm.nih.gov/pubmed/20228066,20228066,,
1090,228025,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606.0,Homo sapiens (human),Benzo(a)pyrene promotes the reaction [[AHR protein binds to ARNT protein] which results in increased expression of CYP1A1 mrna],,,PMID:11768231,https://www.ncbi.nlm.nih.gov/pubmed/11768231,11768231,,
1091,228026,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606.0,Homo sapiens (human),Benzo(a)pyrene promotes the reaction [[AHR protein co-treated with ARNT protein] results in increased expression of SLC13A5 mrna],,,PMID:26303333,https://www.ncbi.nlm.nih.gov/pubmed/26303333,26303333,,
1092,228128,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10928,RALBP1,https://ctdbase.org/detail.go?type=gene&acc=10928,,,10928.0,RALBP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RALBP1 promoter|benzo(a)pyrene affects the methylation of RALBP1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1093,228129,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,253959,RALGAPA1,https://ctdbase.org/detail.go?type=gene&acc=253959,,,253959.0,RALGAPA1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RALGAPA1 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1094,228130,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,253959,RALGAPA1,https://ctdbase.org/detail.go?type=gene&acc=253959,,,253959.0,RALGAPA1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RALGAPA1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1095,228131,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57186,RALGAPA2,https://ctdbase.org/detail.go?type=gene&acc=57186,,,57186.0,RALGAPA2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RALGAPA2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1096,228132,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57186,RALGAPA2,https://ctdbase.org/detail.go?type=gene&acc=57186,,,57186.0,RALGAPA2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RALGAPA2 exon|benzo(a)pyrene results in increased methylation of RALGAPA2 intron|benzo(a)pyrene results in decreased methylation of RALGAPA2 3' utr|benzo(a)pyrene affects the methylation of RALGAPA2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1097,228133,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57186,RALGAPA2,https://ctdbase.org/detail.go?type=gene&acc=57186,,,57186.0,RALGAPA2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RALGAPA2 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1098,228134,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57186,RALGAPA2,https://ctdbase.org/detail.go?type=gene&acc=57186,,,57186.0,RALGAPA2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RALGAPA2 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
1099,228135,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57148,RALGAPB,https://ctdbase.org/detail.go?type=gene&acc=57148,,,57148.0,RALGAPB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RALGAPB mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1100,228136,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57148,RALGAPB,https://ctdbase.org/detail.go?type=gene&acc=57148,,,57148.0,RALGAPB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RALGAPB promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1101,228137,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5900,RALGDS,https://ctdbase.org/detail.go?type=gene&acc=5900,,,5900.0,RALGDS,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RALGDS intron|benzo(a)pyrene affects the methylation of RALGDS exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1102,228345,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5900,RALGDS,https://ctdbase.org/detail.go?type=gene&acc=5900,,,5900.0,RALGDS,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RALGDS mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1103,228346,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5900,RALGDS,https://ctdbase.org/detail.go?type=gene&acc=5900,,,5900.0,RALGDS,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RALGDS mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1104,228347,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9649,RALGPS1,https://ctdbase.org/detail.go?type=gene&acc=9649,,,9649.0,RALGPS1,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of RALGPS1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1105,228348,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9649,RALGPS1,https://ctdbase.org/detail.go?type=gene&acc=9649,,,9649.0,RALGPS1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RALGPS1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1106,228448,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of KEAP1 protein,,,PMID:36736873,https://www.ncbi.nlm.nih.gov/pubmed/36736873,36736873,,
1107,228449,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64697,KEG1,https://ctdbase.org/detail.go?type=gene&acc=64697,,,64697.0,Keg1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KEG1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1108,228450,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3792,KEL,https://ctdbase.org/detail.go?type=gene&acc=3792,,,3792.0,KEL,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KEL 3' utr|benzo(a)pyrene results in increased methylation of KEL promoter|benzo(a)pyrene results in increased methylation of KEL exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1109,228451,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11081,KERA,https://ctdbase.org/detail.go?type=gene&acc=11081,,,11081.0,KERA,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in decreased expression of KERA mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
1110,228452,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11081,KERA,https://ctdbase.org/detail.go?type=gene&acc=11081,,,11081.0,KERA,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KERA 3' utr|benzo(a)pyrene results in decreased methylation of KERA promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1111,228481,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,56953,NT5M,https://ctdbase.org/detail.go?type=gene&acc=56953,,,56953.0,NT5M,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NT5M mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1112,228482,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,123803,NTAN1,https://ctdbase.org/detail.go?type=gene&acc=123803,,,123803.0,NTAN1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NTAN1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1113,228483,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,123803,NTAN1,https://ctdbase.org/detail.go?type=gene&acc=123803,,,123803.0,NTAN1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NTAN1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1114,228484,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,123803,NTAN1,https://ctdbase.org/detail.go?type=gene&acc=123803,,,123803.0,NTAN1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NTAN1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1115,228485,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55093,NTAQ1,https://ctdbase.org/detail.go?type=gene&acc=55093,,,55093.0,NTAQ1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of NTAQ1 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1116,228486,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4908,NTF3,https://ctdbase.org/detail.go?type=gene&acc=4908,,,4908.0,NTF3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NTF3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1117,228487,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4908,NTF3,https://ctdbase.org/detail.go?type=gene&acc=4908,,,4908.0,NTF3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NTF3 promoter|benzo(a)pyrene results in increased methylation of NTF3 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1118,228488,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4908,NTF3,https://ctdbase.org/detail.go?type=gene&acc=4908,,,4908.0,NTF3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NTF3 mRNA,,,PMID:22228805|PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/27195522,22228805|27195522,,
1119,228625,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EGFR mRNA,,,PMID:19770486|PMID:21803694,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21803694,19770486|21803694,,
1120,228626,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54583,EGLN1,https://ctdbase.org/detail.go?type=gene&acc=54583,,,54583.0,EGLN1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EGLN1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1121,228661,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3795,KHK,https://ctdbase.org/detail.go?type=gene&acc=3795,,,3795.0,KHK,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KHK mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1122,228662,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23351,KHNYN,https://ctdbase.org/detail.go?type=gene&acc=23351,,,23351.0,KHNYN,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KHNYN promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1123,228663,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23351,KHNYN,https://ctdbase.org/detail.go?type=gene&acc=23351,,,23351.0,KHNYN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KHNYN mRNA,,,PMID:22316170|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291,22316170|26238291,,
1124,228664,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8570,KHSRP,https://ctdbase.org/detail.go?type=gene&acc=8570,,,8570.0,KHSRP,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KHSRP protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
1125,228779,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1215,CMA1,https://ctdbase.org/detail.go?type=gene&acc=1215,,,1215.0,CMA1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CMA1 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1126,228780,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1215,CMA1,https://ctdbase.org/detail.go?type=gene&acc=1215,,,1215.0,CMA1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CMA1 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of CMA1 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1127,228781,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,12763,CMAH,https://ctdbase.org/detail.go?type=gene&acc=12763,,,12763.0,Cmah,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CMAH mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1128,229002,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,410,ARSA,https://ctdbase.org/detail.go?type=gene&acc=410,,,410.0,ARSA,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ARSA exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1129,229003,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,410,ARSA,https://ctdbase.org/detail.go?type=gene&acc=410,,,410.0,ARSA,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of ARSA gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1130,229004,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,410,ARSA,https://ctdbase.org/detail.go?type=gene&acc=410,,,410.0,ARSA,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ARSA mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
1131,229005,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,410,ARSA,https://ctdbase.org/detail.go?type=gene&acc=410,,,410.0,ARSA,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ARSA mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1132,229006,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57610,RANBP10,https://ctdbase.org/detail.go?type=gene&acc=57610,,,57610.0,RANBP10,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RANBP10 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1133,229007,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64901,RANBP17,https://ctdbase.org/detail.go?type=gene&acc=64901,,,64901.0,RANBP17,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RANBP17 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1134,229008,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64901,RANBP17,https://ctdbase.org/detail.go?type=gene&acc=64901,,,64901.0,RANBP17,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RANBP17 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1135,229009,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5903,RANBP2,https://ctdbase.org/detail.go?type=gene&acc=5903,,,5903.0,RANBP2,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of RANBP2 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1136,229010,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5903,RANBP2,https://ctdbase.org/detail.go?type=gene&acc=5903,,,5903.0,RANBP2,10090.0,Mus musculus (house mouse),AHR protein inhibits the reaction [benzo(a)pyrene results in increased expression of RANBP2 mrna],,,PMID:15034205,https://www.ncbi.nlm.nih.gov/pubmed/15034205,15034205,,
1137,229011,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5903,RANBP2,https://ctdbase.org/detail.go?type=gene&acc=5903,,,5903.0,RANBP2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RANBP2 mRNA,,,PMID:15034205|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/15034205|https://www.ncbi.nlm.nih.gov/pubmed/22228805,15034205|22228805,,
1138,229168,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,129607,CMPK2,https://ctdbase.org/detail.go?type=gene&acc=129607,,,129607.0,CMPK2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CMPK2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1139,229169,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,410,ARSA,https://ctdbase.org/detail.go?type=gene&acc=410,,,410.0,ARSA,34765.0,Oikopleura dioica,Benzo(a)pyrene results in decreased expression of ARSA mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
1140,229170,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,411,ARSB,https://ctdbase.org/detail.go?type=gene&acc=411,,,411.0,ARSB,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ARSB intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1141,229171,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,411,ARSB,https://ctdbase.org/detail.go?type=gene&acc=411,,,411.0,ARSB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ARSB exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1142,229172,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,411,ARSB,https://ctdbase.org/detail.go?type=gene&acc=411,,,411.0,ARSB,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ARSB mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1143,229173,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,411,ARSB,https://ctdbase.org/detail.go?type=gene&acc=411,,,411.0,ARSB,34765.0,Oikopleura dioica,Benzo(a)pyrene results in decreased expression of ARSB mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
1144,229174,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,414,ARSD,https://ctdbase.org/detail.go?type=gene&acc=414,,,414.0,ARSD,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ARSD mRNA,,,PMID:22316170|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/32234424,22316170|32234424,,
1145,229175,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,414,ARSD,https://ctdbase.org/detail.go?type=gene&acc=414,,,414.0,ARSD,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ARSD exon|benzo(a)pyrene results in increased methylation of ARSD 3' utr|benzo(a)pyrene results in increased methylation of ARSD promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1146,229176,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,416,ARSF,https://ctdbase.org/detail.go?type=gene&acc=416,,,416.0,ARSF,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ARSF promoter|benzo(a)pyrene results in decreased methylation of ARSF 3' utr|benzo(a)pyrene affects the methylation of ARSF 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1147,229177,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22901,ARSG,https://ctdbase.org/detail.go?type=gene&acc=22901,,,22901.0,ARSG,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of ARSG mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1148,229210,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23301,EHBP1,https://ctdbase.org/detail.go?type=gene&acc=23301,,,23301.0,EHBP1,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of EHBP1 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1149,229211,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,254102,EHBP1L1,https://ctdbase.org/detail.go?type=gene&acc=254102,,,254102.0,EHBP1L1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EHBP1L1 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1150,229212,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,254102,EHBP1L1,https://ctdbase.org/detail.go?type=gene&acc=254102,,,254102.0,EHBP1L1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EHBP1L1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1151,229213,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10938,EHD1,https://ctdbase.org/detail.go?type=gene&acc=10938,,,10938.0,EHD1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EHD1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1152,229214,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10938,EHD1,https://ctdbase.org/detail.go?type=gene&acc=10938,,,10938.0,EHD1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EHD1 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1153,229215,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10938,EHD1,https://ctdbase.org/detail.go?type=gene&acc=10938,,,10938.0,EHD1,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EHD1 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1154,229216,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10938,EHD1,https://ctdbase.org/detail.go?type=gene&acc=10938,,,10938.0,EHD1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EHD1 mRNA,,,PMID:19770486|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/22228805,19770486|22228805,,
1155,229217,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,30846,EHD2,https://ctdbase.org/detail.go?type=gene&acc=30846,,,30846.0,EHD2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EHD2 promoter|benzo(a)pyrene results in decreased methylation of EHD2 5' utr|benzo(a)pyrene affects the methylation of EHD2 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1156,229535,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79642,ARSJ,https://ctdbase.org/detail.go?type=gene&acc=79642,,,79642.0,ARSJ,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the expression of ARSJ mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1157,229536,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79642,ARSJ,https://ctdbase.org/detail.go?type=gene&acc=79642,,,79642.0,ARSJ,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ARSJ exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1158,229537,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79642,ARSJ,https://ctdbase.org/detail.go?type=gene&acc=79642,,,79642.0,ARSJ,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ARSJ mRNA,,,PMID:21569818|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/22228805,21569818|22228805,,
1159,229538,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,415,ARSL,https://ctdbase.org/detail.go?type=gene&acc=415,,,415.0,ARSL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ARSL mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1160,229539,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,415,ARSL,https://ctdbase.org/detail.go?type=gene&acc=415,,,415.0,ARSL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ARSL 3' utr|benzo(a)pyrene results in decreased methylation of ARSL 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1161,229540,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,415,ARSL,https://ctdbase.org/detail.go?type=gene&acc=415,,,415.0,ARSL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of ARSL gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1162,229541,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,417,ART1,https://ctdbase.org/detail.go?type=gene&acc=417,,,417.0,ART1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ART1 promoter|benzo(a)pyrene results in increased methylation of ART1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1163,229542,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,417,ART1,https://ctdbase.org/detail.go?type=gene&acc=417,,,417.0,ART1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ART1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1164,229543,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,419,ART3,https://ctdbase.org/detail.go?type=gene&acc=419,,,419.0,ART3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ART3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1165,229544,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,419,ART3,https://ctdbase.org/detail.go?type=gene&acc=419,,,419.0,ART3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ART3 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1166,229667,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57826,RAP2C,https://ctdbase.org/detail.go?type=gene&acc=57826,,,57826.0,RAP2C,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RAP2C promoter|benzo(a)pyrene results in increased methylation of RAP2C 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1167,229720,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,420,ART4,https://ctdbase.org/detail.go?type=gene&acc=420,,,420.0,ART4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ART4 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1168,229721,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116969,ART5,https://ctdbase.org/detail.go?type=gene&acc=116969,,,116969.0,ART5,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ART5 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1169,229722,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116969,ART5,https://ctdbase.org/detail.go?type=gene&acc=116969,,,116969.0,ART5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ART5 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1170,229723,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116969,ART5,https://ctdbase.org/detail.go?type=gene&acc=116969,,,116969.0,ART5,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ART5 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1171,229724,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9048,ARTN,https://ctdbase.org/detail.go?type=gene&acc=9048,,,9048.0,ARTN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ARTN exon|benzo(a)pyrene results in decreased methylation of ARTN 3' utr|benzo(a)pyrene affects the methylation of ARTN 5' utr|benzo(a)pyrene affects the methylation of ARTN promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1172,229750,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,202333,CMYA5,https://ctdbase.org/detail.go?type=gene&acc=202333,,,202333.0,CMYA5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of CMYA5 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1173,229751,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,168975,CNBD1,https://ctdbase.org/detail.go?type=gene&acc=168975,,,168975.0,CNBD1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CNBD1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1174,229752,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,140894,CNBD2,https://ctdbase.org/detail.go?type=gene&acc=140894,,,140894.0,CNBD2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CNBD2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1175,229753,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,140894,CNBD2,https://ctdbase.org/detail.go?type=gene&acc=140894,,,140894.0,CNBD2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of CNBD2 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1176,229754,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7555,CNBP,https://ctdbase.org/detail.go?type=gene&acc=7555,,,7555.0,CNBP,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CNBP mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
1177,229755,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7555,CNBP,https://ctdbase.org/detail.go?type=gene&acc=7555,,,7555.0,CNBP,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CNBP protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
1178,229756,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7555,CNBP,https://ctdbase.org/detail.go?type=gene&acc=7555,,,7555.0,CNBP,34765.0,Oikopleura dioica,Benzo(a)pyrene results in increased expression of CNBP mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
1179,229894,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,146909,KIF18B,https://ctdbase.org/detail.go?type=gene&acc=146909,,,146909.0,KIF18B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KIF18B promoter|benzo(a)pyrene results in decreased methylation of KIF18B 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1180,229895,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,146909,KIF18B,https://ctdbase.org/detail.go?type=gene&acc=146909,,,146909.0,KIF18B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KIF18B mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1181,229896,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,146909,KIF18B,https://ctdbase.org/detail.go?type=gene&acc=146909,,,146909.0,KIF18B,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KIF18B mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1182,229897,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,146909,KIF18B,https://ctdbase.org/detail.go?type=gene&acc=146909,,,146909.0,KIF18B,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KIF18B mRNA,,,PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/32417428,32417428,,
1183,229898,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,124602,KIF19,https://ctdbase.org/detail.go?type=gene&acc=124602,,,124602.0,KIF19,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KIF19 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1184,229899,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57546,PDP2,https://ctdbase.org/detail.go?type=gene&acc=57546,,,57546.0,PDP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PDP2 mRNA,,,PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20106945|21632981,,
1185,229900,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5170,PDPK1,https://ctdbase.org/detail.go?type=gene&acc=5170,,,5170.0,PDPK1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PDPK1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1186,229901,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5170,PDPK1,https://ctdbase.org/detail.go?type=gene&acc=5170,,,5170.0,PDPK1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PDPK1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1187,229902,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10630,PDPN,https://ctdbase.org/detail.go?type=gene&acc=10630,,,10630.0,PDPN,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDPN promoter|benzo(a)pyrene results in decreased methylation of PDPN 3' utr|benzo(a)pyrene results in decreased methylation of PDPN 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1188,229903,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10630,PDPN,https://ctdbase.org/detail.go?type=gene&acc=10630,,,10630.0,PDPN,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of PDPN mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1189,229904,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10630,PDPN,https://ctdbase.org/detail.go?type=gene&acc=10630,,,10630.0,PDPN,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PDPN mRNA,,,PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/21715664,21715664,,
1190,229940,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,170302,ARX,https://ctdbase.org/detail.go?type=gene&acc=170302,,,170302.0,ARX,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ARX promoter|benzo(a)pyrene affects the methylation of ARX exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1191,229941,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,76976,ARXES2,https://ctdbase.org/detail.go?type=gene&acc=76976,,,76976.0,Arxes2,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ARXES2 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1192,229942,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57412,AS3MT,https://ctdbase.org/detail.go?type=gene&acc=57412,,,57412.0,AS3MT,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of AS3MT promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1193,229943,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57412,AS3MT,https://ctdbase.org/detail.go?type=gene&acc=57412,,,57412.0,AS3MT,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of AS3MT mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1194,229944,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,427,ASAH1,https://ctdbase.org/detail.go?type=gene&acc=427,,,427.0,ASAH1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ASAH1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1195,230052,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,81572,PDRG1,https://ctdbase.org/detail.go?type=gene&acc=81572,,,81572.0,PDRG1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PDRG1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1196,230053,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23047,PDS5B,https://ctdbase.org/detail.go?type=gene&acc=23047,,,23047.0,PDS5B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PDS5B mRNA,,,PMID:20064835|PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945,20064835|20106945,,
1197,230054,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23047,PDS5B,https://ctdbase.org/detail.go?type=gene&acc=23047,,,23047.0,PDS5B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PDS5B mRNA,,,PMID:17879257,https://www.ncbi.nlm.nih.gov/pubmed/17879257,17879257,,
1198,230055,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23590,PDSS1,https://ctdbase.org/detail.go?type=gene&acc=23590,,,23590.0,PDSS1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PDSS1 mrna|[arsenite co-treated with benzo(a)pyrene] results in decreased expression of PDSS1 mRNA,,,PMID:15894712,https://www.ncbi.nlm.nih.gov/pubmed/15894712,15894712,,
1199,230056,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57107,PDSS2,https://ctdbase.org/detail.go?type=gene&acc=57107,,,57107.0,PDSS2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PDSS2 mRNA,,,PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20064835|20106945|21632981|22316170|26238291|32234424,,
1200,230057,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57107,PDSS2,https://ctdbase.org/detail.go?type=gene&acc=57107,,,57107.0,PDSS2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PDSS2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1201,230173,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5610,EIF2AK2,https://ctdbase.org/detail.go?type=gene&acc=5610,,,5610.0,EIF2AK2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EIF2AK2 mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
1202,230174,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9451,EIF2AK3,https://ctdbase.org/detail.go?type=gene&acc=9451,,,9451.0,EIF2AK3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of EIF2AK3 exon|benzo(a)pyrene results in increased methylation of EIF2AK3 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1203,230175,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,440275,EIF2AK4,https://ctdbase.org/detail.go?type=gene&acc=440275,,,440275.0,EIF2AK4,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of EIF2AK4 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1204,230176,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,440275,EIF2AK4,https://ctdbase.org/detail.go?type=gene&acc=440275,,,440275.0,EIF2AK4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EIF2AK4 mRNA,,,PMID:20106945|PMID:21632981|PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170,20106945|21632981|22316170,,
1205,230177,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,440275,EIF2AK4,https://ctdbase.org/detail.go?type=gene&acc=440275,,,440275.0,EIF2AK4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of EIF2AK4 intron|benzo(a)pyrene results in increased methylation of EIF2AK4 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1206,230178,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8891,EIF2B3,https://ctdbase.org/detail.go?type=gene&acc=8891,,,8891.0,EIF2B3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EIF2B3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1207,230179,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8891,EIF2B3,https://ctdbase.org/detail.go?type=gene&acc=8891,,,8891.0,EIF2B3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of EIF2B3 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1208,230180,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8891,EIF2B3,https://ctdbase.org/detail.go?type=gene&acc=8891,,,8891.0,EIF2B3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EIF2B3 mRNA,,,PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/21715664,21715664,,
1209,230378,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8661,EIF3A,https://ctdbase.org/detail.go?type=gene&acc=8661,,,8661.0,EIF3A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EIF3A mRNA,,,PMID:17275222|PMID:17681673|PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/17275222|https://www.ncbi.nlm.nih.gov/pubmed/17681673|https://www.ncbi.nlm.nih.gov/pubmed/20504355,17275222|17681673|20504355,,
1210,230379,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8661,EIF3A,https://ctdbase.org/detail.go?type=gene&acc=8661,,,8661.0,EIF3A,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of EIF3A mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1211,230380,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8662,EIF3B,https://ctdbase.org/detail.go?type=gene&acc=8662,,,8662.0,EIF3B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of EIF3B gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1212,230381,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51248,PDZD11,https://ctdbase.org/detail.go?type=gene&acc=51248,,,51248.0,PDZD11,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PDZD11 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1213,230382,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23037,PDZD2,https://ctdbase.org/detail.go?type=gene&acc=23037,,,23037.0,PDZD2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDZD2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1214,230383,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23037,PDZD2,https://ctdbase.org/detail.go?type=gene&acc=23037,,,23037.0,PDZD2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDZD2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1215,230384,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23037,PDZD2,https://ctdbase.org/detail.go?type=gene&acc=23037,,,23037.0,PDZD2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PDZD2 mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
1216,230385,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57595,PDZD4,https://ctdbase.org/detail.go?type=gene&acc=57595,,,57595.0,PDZD4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDZD4 promoter|benzo(a)pyrene affects the methylation of PDZD4 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1217,230386,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,118987,PDZD8,https://ctdbase.org/detail.go?type=gene&acc=118987,,,118987.0,PDZD8,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDZD8 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1218,230387,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,118987,PDZD8,https://ctdbase.org/detail.go?type=gene&acc=118987,,,118987.0,PDZD8,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PDZD8 mRNA,,,PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20106945|21632981,,
1219,230388,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,255762,PDZD9,https://ctdbase.org/detail.go?type=gene&acc=255762,,,255762.0,PDZD9,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDZD9 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1220,230389,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5174,PDZK1,https://ctdbase.org/detail.go?type=gene&acc=5174,,,5174.0,PDZK1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PDZK1 mRNA,,,PMID:18061397|PMID:22316170|PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/18061397|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,18061397|22316170|26238291|32234424,,
1221,230390,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5174,PDZK1,https://ctdbase.org/detail.go?type=gene&acc=5174,,,5174.0,PDZK1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PDZK1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1222,230391,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10749,KIF1C,https://ctdbase.org/detail.go?type=gene&acc=10749,,,10749.0,KIF1C,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KIF1C 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1223,230392,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10112,KIF20A,https://ctdbase.org/detail.go?type=gene&acc=10112,,,10112.0,KIF20A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KIF20A mRNA,,,PMID:20064835|PMID:21632981|PMID:22316170|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291,20064835|21632981|22316170|26238291,,
1224,230393,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10112,KIF20A,https://ctdbase.org/detail.go?type=gene&acc=10112,,,10112.0,KIF20A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KIF20A mRNA,,,PMID:17942131|PMID:19770486|PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/17942131|https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21569818,17942131|19770486|21569818,,
1225,230394,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10112,KIF20A,https://ctdbase.org/detail.go?type=gene&acc=10112,,,10112.0,KIF20A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KIF20A mRNA,,,PMID:20504355|PMID:20713471|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/20504355|https://www.ncbi.nlm.nih.gov/pubmed/20713471|https://www.ncbi.nlm.nih.gov/pubmed/32417428,20504355|20713471|32417428,,
1226,230395,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9585,KIF20B,https://ctdbase.org/detail.go?type=gene&acc=9585,,,9585.0,KIF20B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KIF20B mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1227,230396,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55605,KIF21A,https://ctdbase.org/detail.go?type=gene&acc=55605,,,55605.0,KIF21A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KIF21A promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1228,230397,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55605,KIF21A,https://ctdbase.org/detail.go?type=gene&acc=55605,,,55605.0,KIF21A,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of KIF21A mrna]|benzo(a)pyrene results in decreased expression of KIF21A mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1229,230554,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5174,PDZK1,https://ctdbase.org/detail.go?type=gene&acc=5174,,,5174.0,PDZK1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PDZK1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1230,230555,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5174,PDZK1,https://ctdbase.org/detail.go?type=gene&acc=5174,,,5174.0,PDZK1,34765.0,Oikopleura dioica,Benzo(a)pyrene results in increased expression of PDZK1 mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
1231,230556,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10158,PDZK1IP1,https://ctdbase.org/detail.go?type=gene&acc=10158,,,10158.0,PDZK1IP1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PDZK1IP1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1232,230557,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10158,PDZK1IP1,https://ctdbase.org/detail.go?type=gene&acc=10158,,,10158.0,PDZK1IP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PDZK1IP1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1233,230558,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10158,PDZK1IP1,https://ctdbase.org/detail.go?type=gene&acc=10158,,,10158.0,PDZK1IP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PDZK1IP1 mRNA,,,PMID:21964900,https://www.ncbi.nlm.nih.gov/pubmed/21964900,21964900,,
1234,230559,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23024,PDZRN3,https://ctdbase.org/detail.go?type=gene&acc=23024,,,23024.0,PDZRN3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PDZRN3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1235,230560,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23024,PDZRN3,https://ctdbase.org/detail.go?type=gene&acc=23024,,,23024.0,PDZRN3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PDZRN3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1236,230561,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23024,PDZRN3,https://ctdbase.org/detail.go?type=gene&acc=23024,,,23024.0,PDZRN3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PDZRN3 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1237,230562,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,29951,PDZRN4,https://ctdbase.org/detail.go?type=gene&acc=29951,,,29951.0,PDZRN4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PDZRN4 intron|benzo(a)pyrene results in increased methylation of PDZRN4 exon|benzo(a)pyrene results in increased methylation of PDZRN4 5' utr|benzo(a)pyrene affects the methylation of PDZRN4 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1238,230563,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8682,PEA15,https://ctdbase.org/detail.go?type=gene&acc=8682,,,8682.0,PEA15,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PEA15 mRNA,,,PMID:20106945|PMID:21632981|PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20106945|21632981|26238291|32234424,,
1239,230564,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RARB intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1240,230565,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of RARB mrna]|benzo(a)pyrene results in increased expression of RARB mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1241,230566,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RARB mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1242,230567,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,9669.0,Mustela putorius furo (domestic ferret),Benzo(a)pyrene results in decreased expression of RARB protein,,,PMID:17651958,https://www.ncbi.nlm.nih.gov/pubmed/17651958,17651958,,
1243,230568,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5915,RARB,https://ctdbase.org/detail.go?type=gene&acc=5915,,,5915.0,RARB,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of RARB protein,,,PMID:21467743,https://www.ncbi.nlm.nih.gov/pubmed/21467743,21467743,,
1244,230569,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5916,RARG,https://ctdbase.org/detail.go?type=gene&acc=5916,,,5916.0,RARG,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RARG mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
1245,230570,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5916,RARG,https://ctdbase.org/detail.go?type=gene&acc=5916,,,5916.0,RARG,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RARG mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1246,230571,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5918,RARRES1,https://ctdbase.org/detail.go?type=gene&acc=5918,,,5918.0,RARRES1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RARRES1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1247,230572,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5918,RARRES1,https://ctdbase.org/detail.go?type=gene&acc=5918,,,5918.0,RARRES1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RARRES1 promoter|benzo(a)pyrene results in decreased methylation of RARRES1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1248,230726,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79834,PEAK1,https://ctdbase.org/detail.go?type=gene&acc=79834,,,79834.0,PEAK1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PEAK1 5' utr|benzo(a)pyrene affects the methylation of PEAK1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1249,230727,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,374872,PEAK3,https://ctdbase.org/detail.go?type=gene&acc=374872,,,374872.0,PEAK3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PEAK3 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1250,230728,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,375033,PEAR1,https://ctdbase.org/detail.go?type=gene&acc=375033,,,375033.0,PEAR1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PEAR1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1251,230729,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,375033,PEAR1,https://ctdbase.org/detail.go?type=gene&acc=375033,,,375033.0,PEAR1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PEAR1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1252,230730,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,375033,PEAR1,https://ctdbase.org/detail.go?type=gene&acc=375033,,,375033.0,PEAR1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PEAR1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1253,230731,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,375033,PEAR1,https://ctdbase.org/detail.go?type=gene&acc=375033,,,375033.0,PEAR1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of PEAR1 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1254,230732,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,375033,PEAR1,https://ctdbase.org/detail.go?type=gene&acc=375033,,,375033.0,PEAR1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PEAR1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1255,230733,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5037,PEBP1,https://ctdbase.org/detail.go?type=gene&acc=5037,,,5037.0,PEBP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PEBP1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1256,230734,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5037,PEBP1,https://ctdbase.org/detail.go?type=gene&acc=5037,,,5037.0,PEBP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PEBP1 promoter|benzo(a)pyrene results in increased methylation of PEBP1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1257,230735,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5037,PEBP1,https://ctdbase.org/detail.go?type=gene&acc=5037,,,5037.0,PEBP1,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PEBP1 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1258,230882,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,283927,NUDT7,https://ctdbase.org/detail.go?type=gene&acc=283927,,,283927.0,NUDT7,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of NUDT7 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1259,230883,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,283927,NUDT7,https://ctdbase.org/detail.go?type=gene&acc=283927,,,283927.0,NUDT7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NUDT7 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1260,230884,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,283927,NUDT7,https://ctdbase.org/detail.go?type=gene&acc=283927,,,283927.0,NUDT7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NUDT7 mRNA,,,PMID:19770486|PMID:20127859,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/20127859,19770486|20127859,,
1261,230885,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,254552,NUDT8,https://ctdbase.org/detail.go?type=gene&acc=254552,,,254552.0,NUDT8,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NUDT8 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1262,230886,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,254552,NUDT8,https://ctdbase.org/detail.go?type=gene&acc=254552,,,254552.0,NUDT8,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NUDT8 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1263,230887,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,119369,NUDT9P1,https://ctdbase.org/detail.go?type=gene&acc=119369,,,119369.0,NUDT9P1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NUDT9P1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1264,230888,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83540,NUF2,https://ctdbase.org/detail.go?type=gene&acc=83540,,,83540.0,NUF2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NUF2 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1265,230889,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83540,NUF2,https://ctdbase.org/detail.go?type=gene&acc=83540,,,83540.0,NUF2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NUF2 mRNA,,,PMID:20504355|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/20504355|https://www.ncbi.nlm.nih.gov/pubmed/32417428,20504355|32417428,,
1266,230922,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1975,EIF4B,https://ctdbase.org/detail.go?type=gene&acc=1975,,,1975.0,EIF4B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EIF4B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1267,230923,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1975,EIF4B,https://ctdbase.org/detail.go?type=gene&acc=1975,,,1975.0,EIF4B,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EIF4B mRNA,,,PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/20504355,20504355,,
1268,230924,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased methylation of EIF4E exon|benzo(a)pyrene results in decreased methylation of EIF4E intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1269,230925,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EIF4E mRNA,,,PMID:20127859|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/20127859|https://www.ncbi.nlm.nih.gov/pubmed/22228805,20127859|22228805,,
1270,230926,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,34765.0,Oikopleura dioica,Benzo(a)pyrene results in increased expression of EIF4E mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
1271,230927,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,253314,EIF4E1B,https://ctdbase.org/detail.go?type=gene&acc=253314,,,253314.0,EIF4E1B,7955.0,Danio rerio (zebrafish),[benzo(a)pyrene co-treated with fluoranthene] affects the expression of EIF4E1B mRNA,,,PMID:25412620,https://www.ncbi.nlm.nih.gov/pubmed/25412620,25412620,,
1272,230928,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,253314,EIF4E1B,https://ctdbase.org/detail.go?type=gene&acc=253314,,,253314.0,EIF4E1B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EIF4E1B 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1273,230929,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9470,EIF4E2,https://ctdbase.org/detail.go?type=gene&acc=9470,,,9470.0,EIF4E2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EIF4E2 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1274,230930,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9470,EIF4E2,https://ctdbase.org/detail.go?type=gene&acc=9470,,,9470.0,EIF4E2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EIF4E2 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
1275,230931,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5037,PEBP1,https://ctdbase.org/detail.go?type=gene&acc=5037,,,5037.0,PEBP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PEBP1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1276,231040,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55582,KIF27,https://ctdbase.org/detail.go?type=gene&acc=55582,,,55582.0,KIF27,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KIF27 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1277,231041,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55582,KIF27,https://ctdbase.org/detail.go?type=gene&acc=55582,,,55582.0,KIF27,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KIF27 mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
1278,231042,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3796,KIF2A,https://ctdbase.org/detail.go?type=gene&acc=3796,,,3796.0,KIF2A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KIF2A promoter|benzo(a)pyrene results in decreased methylation of KIF2A 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1279,231043,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3796,KIF2A,https://ctdbase.org/detail.go?type=gene&acc=3796,,,3796.0,KIF2A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KIF2A mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1280,231044,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84643,KIF2B,https://ctdbase.org/detail.go?type=gene&acc=84643,,,84643.0,KIF2B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KIF2B exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1281,231045,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84643,KIF2B,https://ctdbase.org/detail.go?type=gene&acc=84643,,,84643.0,KIF2B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KIF2B 5' utr|benzo(a)pyrene results in decreased methylation of KIF2B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1282,231046,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11004,KIF2C,https://ctdbase.org/detail.go?type=gene&acc=11004,,,11004.0,KIF2C,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KIF2C mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1283,231047,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11004,KIF2C,https://ctdbase.org/detail.go?type=gene&acc=11004,,,11004.0,KIF2C,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KIF2C mRNA,,,PMID:19770486|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/22228805,19770486|22228805,,
1284,231048,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11004,KIF2C,https://ctdbase.org/detail.go?type=gene&acc=11004,,,11004.0,KIF2C,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased methylation of KIF2C exon|benzo(a)pyrene results in decreased methylation of KIF2C intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1285,231102,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55825,PECR,https://ctdbase.org/detail.go?type=gene&acc=55825,,,55825.0,PECR,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PECR mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1286,231103,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,387521,PEDS1,https://ctdbase.org/detail.go?type=gene&acc=387521,,,387521.0,PEDS1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PEDS1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1287,231104,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23089,PEG10,https://ctdbase.org/detail.go?type=gene&acc=23089,,,23089.0,PEG10,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PEG10 3' utr|benzo(a)pyrene affects the methylation of PEG10 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1288,231105,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23089,PEG10,https://ctdbase.org/detail.go?type=gene&acc=23089,,,23089.0,PEG10,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PEG10 mRNA,,,PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291,20106945|21632981|22316170|26238291,,
1289,231106,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23089,PEG10,https://ctdbase.org/detail.go?type=gene&acc=23089,,,23089.0,PEG10,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PEG10 protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
1290,231107,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5178,PEG3,https://ctdbase.org/detail.go?type=gene&acc=5178,,,5178.0,PEG3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PEG3 promoter|benzo(a)pyrene results in decreased methylation of PEG3 3' utr|benzo(a)pyrene results in increased methylation of PEG3 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1291,231108,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5178,PEG3,https://ctdbase.org/detail.go?type=gene&acc=5178,,,5178.0,PEG3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PEG3 mRNA,,,PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20106945|21632981,,
1292,231109,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57162,PELI1,https://ctdbase.org/detail.go?type=gene&acc=57162,,,57162.0,PELI1,9606.0,Homo sapiens (human),Benzo(a)pyrene metabolite results in decreased expression of PELI1 mRNA,,,PMID:24356939,https://www.ncbi.nlm.nih.gov/pubmed/24356939,24356939,,
1293,231211,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9462,RASAL2,https://ctdbase.org/detail.go?type=gene&acc=9462,,,9462.0,RASAL2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RASAL2 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1294,231212,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64926,RASAL3,https://ctdbase.org/detail.go?type=gene&acc=64926,,,64926.0,RASAL3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RASAL3 promoter|benzo(a)pyrene affects the methylation of RASAL3 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1295,231213,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64926,RASAL3,https://ctdbase.org/detail.go?type=gene&acc=64926,,,64926.0,RASAL3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RASAL3 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1296,231214,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51655,RASD1,https://ctdbase.org/detail.go?type=gene&acc=51655,,,51655.0,RASD1,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of RASD1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1297,231215,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51655,RASD1,https://ctdbase.org/detail.go?type=gene&acc=51655,,,51655.0,RASD1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RASD1 3' utr|benzo(a)pyrene results in decreased methylation of RASD1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1298,231216,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51655,RASD1,https://ctdbase.org/detail.go?type=gene&acc=51655,,,51655.0,RASD1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RASD1 mRNA,,,PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/21871943|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20106945|21632981|21871943|22316170|26238291|32234424,,
1299,231363,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9253,NUMBL,https://ctdbase.org/detail.go?type=gene&acc=9253,,,9253.0,NUMBL,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in increased methylation of NUMBL promoter,,,PMID:28329817,https://www.ncbi.nlm.nih.gov/pubmed/28329817,28329817,,
1300,231364,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9253,NUMBL,https://ctdbase.org/detail.go?type=gene&acc=9253,,,9253.0,NUMBL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of NUMBL 3' utr|benzo(a)pyrene results in increased methylation of NUMBL promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1301,231365,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9253,NUMBL,https://ctdbase.org/detail.go?type=gene&acc=9253,,,9253.0,NUMBL,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NUMBL mrna|[potassium dichromate co-treated with potassium chromate(vi)] inhibits the reaction [benzo(a)pyrene results in increased expression of NUMBL mrna],,,PMID:14625279,https://www.ncbi.nlm.nih.gov/pubmed/14625279,14625279,,
1302,231366,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55746,NUP133,https://ctdbase.org/detail.go?type=gene&acc=55746,,,55746.0,NUP133,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NUP133 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1303,231367,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9972,NUP153,https://ctdbase.org/detail.go?type=gene&acc=9972,,,9972.0,NUP153,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NUP153 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1304,231368,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9631,NUP155,https://ctdbase.org/detail.go?type=gene&acc=9631,,,9631.0,NUP155,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of NUP155 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1305,231369,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9631,NUP155,https://ctdbase.org/detail.go?type=gene&acc=9631,,,9631.0,NUP155,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NUP155 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1306,231370,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23279,NUP160,https://ctdbase.org/detail.go?type=gene&acc=23279,,,23279.0,NUP160,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NUP160 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1307,231371,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23511,NUP188,https://ctdbase.org/detail.go?type=gene&acc=23511,,,23511.0,NUP188,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NUP188 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1308,231372,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23511,NUP188,https://ctdbase.org/detail.go?type=gene&acc=23511,,,23511.0,NUP188,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NUP188 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1309,231422,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5179,PENK,https://ctdbase.org/detail.go?type=gene&acc=5179,,,5179.0,PENK,10090.0,Mus musculus (house mouse),Benzo(a)pyrene affects the expression of PENK mRNA,,,PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22610609,22610609,,
1310,231547,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,24137,KIF4A,https://ctdbase.org/detail.go?type=gene&acc=24137,,,24137.0,KIF4A,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KIF4A intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1311,231548,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,24137,KIF4A,https://ctdbase.org/detail.go?type=gene&acc=24137,,,24137.0,KIF4A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KIF4A mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1312,231549,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,24137,KIF4A,https://ctdbase.org/detail.go?type=gene&acc=24137,,,24137.0,KIF4A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KIF4A 5' utr|benzo(a)pyrene results in increased methylation of KIF4A promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1313,231550,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,285643,KIF4B,https://ctdbase.org/detail.go?type=gene&acc=285643,,,285643.0,KIF4B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of KIF4B exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1314,231551,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3798,KIF5A,https://ctdbase.org/detail.go?type=gene&acc=3798,,,3798.0,KIF5A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KIF5A exon|benzo(a)pyrene affects the methylation of KIF5A promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1315,231552,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3798,KIF5A,https://ctdbase.org/detail.go?type=gene&acc=3798,,,3798.0,KIF5A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KIF5A mRNA,,,PMID:21871943,https://www.ncbi.nlm.nih.gov/pubmed/21871943,21871943,,
1316,231553,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3799,KIF5B,https://ctdbase.org/detail.go?type=gene&acc=3799,,,3799.0,KIF5B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KIF5B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1317,231554,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3800,KIF5C,https://ctdbase.org/detail.go?type=gene&acc=3800,,,3800.0,KIF5C,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KIF5C 3' utr|benzo(a)pyrene results in increased methylation of KIF5C exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1318,231568,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23165,NUP205,https://ctdbase.org/detail.go?type=gene&acc=23165,,,23165.0,NUP205,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NUP205 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1319,231569,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23225,NUP210,https://ctdbase.org/detail.go?type=gene&acc=23225,,,23225.0,NUP210,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NUP210 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1320,231570,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23225,NUP210,https://ctdbase.org/detail.go?type=gene&acc=23225,,,23225.0,NUP210,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NUP210 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1321,231571,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23225,NUP210,https://ctdbase.org/detail.go?type=gene&acc=23225,,,23225.0,NUP210,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NUP210 mRNA,,,PMID:19770486|PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21569818,19770486|21569818,,
1322,231572,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,91181,NUP210L,https://ctdbase.org/detail.go?type=gene&acc=91181,,,91181.0,NUP210L,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NUP210L exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1323,231573,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,91181,NUP210L,https://ctdbase.org/detail.go?type=gene&acc=91181,,,91181.0,NUP210L,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NUP210L intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1324,231574,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,91181,NUP210L,https://ctdbase.org/detail.go?type=gene&acc=91181,,,91181.0,NUP210L,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of NUP210L gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1325,231575,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8021,NUP214,https://ctdbase.org/detail.go?type=gene&acc=8021,,,8021.0,NUP214,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NUP214 3' UTR,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1326,231715,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6016,RIT1,https://ctdbase.org/detail.go?type=gene&acc=6016,,,6016.0,RIT1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RIT1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1327,231716,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6014,RIT2,https://ctdbase.org/detail.go?type=gene&acc=6014,,,6014.0,RIT2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RIT2 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1328,231717,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6017,RLBP1,https://ctdbase.org/detail.go?type=gene&acc=6017,,,6017.0,RLBP1,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of RLBP1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1329,231718,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6017,RLBP1,https://ctdbase.org/detail.go?type=gene&acc=6017,,,6017.0,RLBP1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RLBP1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1330,231892,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57535,ELAPOR1,https://ctdbase.org/detail.go?type=gene&acc=57535,,,57535.0,ELAPOR1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of ELAPOR1 mRNA,,,PMID:22316170|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/32234424,22316170|32234424,,
1331,231893,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,222223,ELAPOR2,https://ctdbase.org/detail.go?type=gene&acc=222223,,,222223.0,ELAPOR2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of ELAPOR2 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1332,231894,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1994,ELAVL1,https://ctdbase.org/detail.go?type=gene&acc=1994,,,1994.0,ELAVL1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ELAVL1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1333,231895,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1994,ELAVL1,https://ctdbase.org/detail.go?type=gene&acc=1994,,,1994.0,ELAVL1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ELAVL1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1334,231896,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1993,ELAVL2,https://ctdbase.org/detail.go?type=gene&acc=1993,,,1993.0,ELAVL2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ELAVL2 5' utr|benzo(a)pyrene results in increased methylation of ELAVL2 promoter|benzo(a)pyrene results in decreased methylation of ELAVL2 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1335,231897,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1993,ELAVL2,https://ctdbase.org/detail.go?type=gene&acc=1993,,,1993.0,ELAVL2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ELAVL2 mRNA,,,PMID:21964900|PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/21964900|https://www.ncbi.nlm.nih.gov/pubmed/27195522,21964900|27195522,,
1336,232068,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54922,RASIP1,https://ctdbase.org/detail.go?type=gene&acc=54922,,,54922.0,RASIP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RASIP1 mRNA,,,PMID:21964900|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/21964900|https://www.ncbi.nlm.nih.gov/pubmed/32417428,21964900|32417428,,
1337,232088,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1996,ELAVL4,https://ctdbase.org/detail.go?type=gene&acc=1996,,,1996.0,ELAVL4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ELAVL4 promoter|benzo(a)pyrene results in increased methylation of ELAVL4 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1338,232270,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65997,RASL11B,https://ctdbase.org/detail.go?type=gene&acc=65997,,,65997.0,RASL11B,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of RASL11B mrna|[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of RASL11B mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1339,232271,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65997,RASL11B,https://ctdbase.org/detail.go?type=gene&acc=65997,,,65997.0,RASL11B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RASL11B exon|benzo(a)pyrene affects the methylation of RASL11B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1340,232272,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65997,RASL11B,https://ctdbase.org/detail.go?type=gene&acc=65997,,,65997.0,RASL11B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RASL11B mRNA,,,PMID:20064835|PMID:35870112,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/35870112,20064835|35870112,,
1341,232283,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2001,ELF5,https://ctdbase.org/detail.go?type=gene&acc=2001,,,2001.0,ELF5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ELF5 promoter|benzo(a)pyrene affects the methylation of ELF5 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1342,232284,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,392617,ELFN1,https://ctdbase.org/detail.go?type=gene&acc=392617,,,392617.0,ELFN1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ELFN1 promoter|benzo(a)pyrene affects the methylation of ELFN1 3' utr|benzo(a)pyrene affects the methylation of ELFN1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1343,232285,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,392617,ELFN1,https://ctdbase.org/detail.go?type=gene&acc=392617,,,392617.0,ELFN1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ELFN1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1344,232286,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,392617,ELFN1,https://ctdbase.org/detail.go?type=gene&acc=392617,,,392617.0,ELFN1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ELFN1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1345,232287,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,392617,ELFN1,https://ctdbase.org/detail.go?type=gene&acc=392617,,,392617.0,ELFN1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to ELFN1 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1346,232288,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,114794,ELFN2,https://ctdbase.org/detail.go?type=gene&acc=114794,,,114794.0,ELFN2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ELFN2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1347,232289,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,114794,ELFN2,https://ctdbase.org/detail.go?type=gene&acc=114794,,,114794.0,ELFN2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ELFN2 5' utr|benzo(a)pyrene results in increased methylation of ELFN2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1348,232290,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,338879,RNASE10,https://ctdbase.org/detail.go?type=gene&acc=338879,,,338879.0,RNASE10,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RNASE10 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1349,232291,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,122651,RNASE11,https://ctdbase.org/detail.go?type=gene&acc=122651,,,122651.0,RNASE11,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RNASE11 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1350,232292,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,493901,RNASE12,https://ctdbase.org/detail.go?type=gene&acc=493901,,,493901.0,RNASE12,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RNASE12 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1351,232413,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3814,KISS1,https://ctdbase.org/detail.go?type=gene&acc=3814,,,3814.0,KISS1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KISS1 5' utr|benzo(a)pyrene affects the methylation of KISS1 promoter|benzo(a)pyrene affects the methylation of KISS1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1352,232414,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84634,KISS1R,https://ctdbase.org/detail.go?type=gene&acc=84634,,,84634.0,KISS1R,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KISS1R 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1353,232415,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3815,KIT,https://ctdbase.org/detail.go?type=gene&acc=3815,,,3815.0,KIT,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of KIT mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1354,232438,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51203,NUSAP1,https://ctdbase.org/detail.go?type=gene&acc=51203,,,51203.0,NUSAP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene metabolite results in increased expression of NUSAP1 mRNA,,,PMID:32553695,https://www.ncbi.nlm.nih.gov/pubmed/32553695,32553695,,
1355,232439,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51203,NUSAP1,https://ctdbase.org/detail.go?type=gene&acc=51203,,,51203.0,NUSAP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NUSAP1 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1356,232440,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51203,NUSAP1,https://ctdbase.org/detail.go?type=gene&acc=51203,,,51203.0,NUSAP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NUSAP1 mRNA,,,PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/32417428,32417428,,
1357,232441,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,728190,NUTM2A-AS1,https://ctdbase.org/detail.go?type=gene&acc=728190,,,728190.0,NUTM2A-AS1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NUTM2A-AS1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1358,232442,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,284434,NWD1,https://ctdbase.org/detail.go?type=gene&acc=284434,,,284434.0,NWD1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NWD1 promoter|benzo(a)pyrene results in decreased methylation of NWD1 5' utr|benzo(a)pyrene results in decreased methylation of NWD1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1359,232443,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2002,ELK1,https://ctdbase.org/detail.go?type=gene&acc=2002,,,2002.0,ELK1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ELK1 promoter|benzo(a)pyrene results in decreased methylation of ELK1 3' utr|benzo(a)pyrene affects the methylation of ELK1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1360,232444,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2002,ELK1,https://ctdbase.org/detail.go?type=gene&acc=2002,,,2002.0,ELK1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ELK1 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1361,232445,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2002,ELK1,https://ctdbase.org/detail.go?type=gene&acc=2002,,,2002.0,ELK1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of ELK1 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1362,232446,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2003,ELK2AP,https://ctdbase.org/detail.go?type=gene&acc=2003,,,2003.0,ELK2AP,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ELK2AP promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1363,232447,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2004,ELK3,https://ctdbase.org/detail.go?type=gene&acc=2004,,,2004.0,ELK3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ELK3 promoter|benzo(a)pyrene affects the methylation of ELK3 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1364,232531,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,445,ASS1,https://ctdbase.org/detail.go?type=gene&acc=445,,,445.0,ASS1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene metabolite results in increased expression of ASS1 mRNA,,,PMID:32553695,https://www.ncbi.nlm.nih.gov/pubmed/32553695,32553695,,
1365,232532,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,445,ASS1,https://ctdbase.org/detail.go?type=gene&acc=445,,,445.0,ASS1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ASS1 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1366,232533,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,28990,ASTE1,https://ctdbase.org/detail.go?type=gene&acc=28990,,,28990.0,ASTE1,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of ASTE1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1367,232534,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,28990,ASTE1,https://ctdbase.org/detail.go?type=gene&acc=28990,,,28990.0,ASTE1,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of ASTE1 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1368,232535,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,431705,ASTL,https://ctdbase.org/detail.go?type=gene&acc=431705,,,431705.0,ASTL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ASTL promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1369,232536,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,431705,ASTL,https://ctdbase.org/detail.go?type=gene&acc=431705,,,431705.0,ASTL,34765.0,Oikopleura dioica,Benzo(a)pyrene results in decreased expression of ASTL mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
1370,232619,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4254,KITLG,https://ctdbase.org/detail.go?type=gene&acc=4254,,,4254.0,KITLG,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KITLG mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1371,232620,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4254,KITLG,https://ctdbase.org/detail.go?type=gene&acc=4254,,,4254.0,KITLG,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KITLG mRNA,,,PMID:20106945|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20106945|32234424,,
1372,232621,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55857,KIZ,https://ctdbase.org/detail.go?type=gene&acc=55857,,,55857.0,KIZ,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KIZ mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1373,232622,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55857,KIZ,https://ctdbase.org/detail.go?type=gene&acc=55857,,,55857.0,KIZ,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KIZ promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1374,232623,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9365,KL,https://ctdbase.org/detail.go?type=gene&acc=9365,,,9365.0,KL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KL mrna|chlorophyllin inhibits the reaction [benzo(a)pyrene results in increased expression of KL mrna],,,PMID:19152381,https://www.ncbi.nlm.nih.gov/pubmed/19152381,19152381,,
1375,232624,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9365,KL,https://ctdbase.org/detail.go?type=gene&acc=9365,,,9365.0,KL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KL promoter|benzo(a)pyrene results in increased methylation of KL exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1376,232690,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23078,VWA8,https://ctdbase.org/detail.go?type=gene&acc=23078,,,23078.0,VWA8,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of VWA8 mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
1377,232691,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23078,VWA8,https://ctdbase.org/detail.go?type=gene&acc=23078,,,23078.0,VWA8,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased methylation of VWA8 intron|benzo(a)pyrene results in decreased methylation of VWA8 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1378,232692,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,375567,VWC2,https://ctdbase.org/detail.go?type=gene&acc=375567,,,375567.0,VWC2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of VWC2 5' utr|benzo(a)pyrene affects the methylation of VWC2 promoter|benzo(a)pyrene results in increased methylation of VWC2 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1379,232693,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,375567,VWC2,https://ctdbase.org/detail.go?type=gene&acc=375567,,,375567.0,VWC2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of VWC2 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1380,232694,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,375567,VWC2,https://ctdbase.org/detail.go?type=gene&acc=375567,,,375567.0,VWC2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of VWC2 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1381,232695,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,402117,VWC2L,https://ctdbase.org/detail.go?type=gene&acc=402117,,,402117.0,VWC2L,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of VWC2L promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1382,232696,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,220001,VWCE,https://ctdbase.org/detail.go?type=gene&acc=220001,,,220001.0,VWCE,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of VWCE mRNA,,,PMID:20064835|PMID:20106945|PMID:32234424|PMID:35870112,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/32234424|https://www.ncbi.nlm.nih.gov/pubmed/35870112,20064835|20106945|32234424|35870112,,
1383,232697,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,220001,VWCE,https://ctdbase.org/detail.go?type=gene&acc=220001,,,220001.0,VWCE,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of VWCE promoter|benzo(a)pyrene results in increased methylation of VWCE 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1384,232698,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,221806,VWDE,https://ctdbase.org/detail.go?type=gene&acc=221806,,,221806.0,VWDE,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of VWDE promoter|benzo(a)pyrene results in decreased methylation of VWDE 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1385,232770,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,166824,RASSF6,https://ctdbase.org/detail.go?type=gene&acc=166824,,,166824.0,RASSF6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RASSF6 promoter|benzo(a)pyrene results in decreased methylation of RASSF6 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1386,232862,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7450,VWF,https://ctdbase.org/detail.go?type=gene&acc=7450,,,7450.0,VWF,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of VWF intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1387,232863,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7450,VWF,https://ctdbase.org/detail.go?type=gene&acc=7450,,,7450.0,VWF,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of VWF promoter|benzo(a)pyrene results in increased methylation of VWF 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1388,232864,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7450,VWF,https://ctdbase.org/detail.go?type=gene&acc=7450,,,7450.0,VWF,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of VWF mRNA,,,PMID:20064835|PMID:21802500,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/21802500,20064835|21802500,,
1389,232903,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,152831,KLB,https://ctdbase.org/detail.go?type=gene&acc=152831,,,152831.0,KLB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KLB mRNA,,,PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,26238291|32234424,,
1390,232904,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,152831,KLB,https://ctdbase.org/detail.go?type=gene&acc=152831,,,152831.0,KLB,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KLB mRNA,,,PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/21715664,21715664,,
1391,232905,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3831,KLC1,https://ctdbase.org/detail.go?type=gene&acc=3831,,,3831.0,KLC1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KLC1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1392,233022,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7732,RNF112,https://ctdbase.org/detail.go?type=gene&acc=7732,,,7732.0,RNF112,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RNF112 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1393,233023,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7737,RNF113A,https://ctdbase.org/detail.go?type=gene&acc=7737,,,7737.0,RNF113A,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RNF113A promoter|benzo(a)pyrene results in increased methylation of RNF113A 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1394,233024,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2006,ELN,https://ctdbase.org/detail.go?type=gene&acc=2006,,,2006.0,ELN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ELN 3' utr|benzo(a)pyrene results in increased methylation of ELN 5' utr|benzo(a)pyrene affects the methylation of ELN promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1395,233025,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,558461,ELNB,https://ctdbase.org/detail.go?type=gene&acc=558461,,,558461.0,elnb,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of ELNB mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
1396,233026,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6924,ELOA,https://ctdbase.org/detail.go?type=gene&acc=6924,,,6924.0,ELOA,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ELOA mRNA,,,PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/21715664,21715664,,
1397,233027,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51224,ELOA2,https://ctdbase.org/detail.go?type=gene&acc=51224,,,51224.0,ELOA2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ELOA2 exon|benzo(a)pyrene results in increased methylation of ELOA2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1398,233028,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,728929,ELOA3BP,https://ctdbase.org/detail.go?type=gene&acc=728929,,,728929.0,ELOA3BP,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ELOA3BP promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1399,233029,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,162699,ELOA3P,https://ctdbase.org/detail.go?type=gene&acc=162699,,,162699.0,ELOA3P,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ELOA3P mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1400,233030,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,162699,ELOA3P,https://ctdbase.org/detail.go?type=gene&acc=162699,,,162699.0,ELOA3P,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ELOA3P promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1401,233031,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100506963,ELOA-AS1,https://ctdbase.org/detail.go?type=gene&acc=100506963,,,100506963.0,ELOA-AS1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ELOA-AS1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1402,233105,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,89953,KLC4,https://ctdbase.org/detail.go?type=gene&acc=89953,,,89953.0,KLC4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KLC4 3' utr|benzo(a)pyrene results in decreased methylation of KLC4 promoter|benzo(a)pyrene results in decreased methylation of KLC4 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1403,233106,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10661,KLF1,https://ctdbase.org/detail.go?type=gene&acc=10661,,,10661.0,KLF1,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of KLF1 mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
1404,233107,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10661,KLF1,https://ctdbase.org/detail.go?type=gene&acc=10661,,,10661.0,KLF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KLF1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1405,233108,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10661,KLF1,https://ctdbase.org/detail.go?type=gene&acc=10661,,,10661.0,KLF1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KLF1 mRNA,,,PMID:17942131,https://www.ncbi.nlm.nih.gov/pubmed/17942131,17942131,,
1406,233109,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7071,KLF10,https://ctdbase.org/detail.go?type=gene&acc=7071,,,7071.0,KLF10,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KLF10 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1407,233110,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7071,KLF10,https://ctdbase.org/detail.go?type=gene&acc=7071,,,7071.0,KLF10,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KLF10 mRNA,,,PMID:19770486|PMID:21715664|PMID:22228805|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21715664|https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/32417428,19770486|21715664|22228805|32417428,,
1408,233111,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8462,KLF11,https://ctdbase.org/detail.go?type=gene&acc=8462,,,8462.0,KLF11,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KLF11 mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
1409,233112,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8462,KLF11,https://ctdbase.org/detail.go?type=gene&acc=8462,,,8462.0,KLF11,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KLF11 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1410,233218,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54898,ELOVL2,https://ctdbase.org/detail.go?type=gene&acc=54898,,,54898.0,ELOVL2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ELOVL2 5' utr|benzo(a)pyrene affects the methylation of ELOVL2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1411,233433,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54838,WBP1L,https://ctdbase.org/detail.go?type=gene&acc=54838,,,54838.0,WBP1L,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of WBP1L 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1412,233434,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54838,WBP1L,https://ctdbase.org/detail.go?type=gene&acc=54838,,,54838.0,WBP1L,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of WBP1L mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1413,233435,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23558,WBP2,https://ctdbase.org/detail.go?type=gene&acc=23558,,,23558.0,WBP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of WBP2 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1414,233457,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ATF4 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1415,233458,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ATF4 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1416,233459,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ATF4 mRNA,,,PMID:21569818|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/22228805,21569818|22228805,,
1417,233460,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,9823.0,Sus scrofa (pig),4-phenylbutyric acid inhibits the reaction [benzo(a)pyrene results in increased expression of ATF4 protein]|benzo(a)pyrene results in increased expression of ATF4 protein,,,PMID:36754226,https://www.ncbi.nlm.nih.gov/pubmed/36754226,36754226,,
1418,233461,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22809,ATF5,https://ctdbase.org/detail.go?type=gene&acc=22809,,,22809.0,ATF5,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of ATF5 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1419,233462,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22809,ATF5,https://ctdbase.org/detail.go?type=gene&acc=22809,,,22809.0,ATF5,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ATF5 mRNA,,,PMID:19770486|PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21715664,19770486|21715664,,
1420,233520,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10365,KLF2,https://ctdbase.org/detail.go?type=gene&acc=10365,,,10365.0,KLF2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KLF2 mRNA,,,PMID:20713471|PMID:21569818|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/20713471|https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/32417428,20713471|21569818|32417428,,
1421,233521,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,117508,KLF2A,https://ctdbase.org/detail.go?type=gene&acc=117508,,,117508.0,klf2a,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in increased expression of KLF2A mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
1422,233522,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51274,KLF3,https://ctdbase.org/detail.go?type=gene&acc=51274,,,51274.0,KLF3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KLF3 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1423,233523,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314.0,KLF4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KLF4 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1424,233654,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ATF6 promoter|benzo(a)pyrene affects the methylation of ATF6 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1425,233655,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ATF6 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1426,233656,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of ATF6 protein,,,PMID:36736873,https://www.ncbi.nlm.nih.gov/pubmed/36736873,36736873,,
1427,233657,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,9823.0,Sus scrofa (pig),Benzo(a)pyrene results in increased expression of ATF6 protein|4-phenylbutyric acid inhibits the reaction [benzo(a)pyrene results in increased expression of ATF6 protein],,,PMID:36754226,https://www.ncbi.nlm.nih.gov/pubmed/36754226,36754226,,
1428,233658,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1388,ATF6B,https://ctdbase.org/detail.go?type=gene&acc=1388,,,1388.0,ATF6B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ATF6B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1429,233659,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1388,ATF6B,https://ctdbase.org/detail.go?type=gene&acc=1388,,,1388.0,ATF6B,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ATF6B mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1430,233660,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1388,ATF6B,https://ctdbase.org/detail.go?type=gene&acc=1388,,,1388.0,ATF6B,34765.0,Oikopleura dioica,Benzo(a)pyrene results in increased expression of ATF6B mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
1431,233661,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11016,ATF7,https://ctdbase.org/detail.go?type=gene&acc=11016,,,11016.0,ATF7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ATF7 5' utr|benzo(a)pyrene affects the methylation of ATF7 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1432,233662,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55729,ATF7IP,https://ctdbase.org/detail.go?type=gene&acc=55729,,,55729.0,ATF7IP,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ATF7IP 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1433,233663,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80063,ATF7IP2,https://ctdbase.org/detail.go?type=gene&acc=80063,,,80063.0,ATF7IP2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ATF7IP2 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1434,233790,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55717,WDR11,https://ctdbase.org/detail.go?type=gene&acc=55717,,,55717.0,WDR11,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of WDR11 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1435,233791,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64743,WDR13,https://ctdbase.org/detail.go?type=gene&acc=64743,,,64743.0,WDR13,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WDR13 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1436,233792,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64743,WDR13,https://ctdbase.org/detail.go?type=gene&acc=64743,,,64743.0,WDR13,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of WDR13 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1437,233793,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116966,WDR17,https://ctdbase.org/detail.go?type=gene&acc=116966,,,116966.0,WDR17,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WDR17 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1438,233794,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116966,WDR17,https://ctdbase.org/detail.go?type=gene&acc=116966,,,116966.0,WDR17,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of WDR17 exon|benzo(a)pyrene results in increased methylation of WDR17 5' utr|benzo(a)pyrene affects the methylation of WDR17 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1439,233795,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116966,WDR17,https://ctdbase.org/detail.go?type=gene&acc=116966,,,116966.0,WDR17,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WDR17 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1440,233796,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116966,WDR17,https://ctdbase.org/detail.go?type=gene&acc=116966,,,116966.0,WDR17,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of WDR17 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1441,233811,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,81847,RNF146,https://ctdbase.org/detail.go?type=gene&acc=81847,,,81847.0,RNF146,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RNF146 mRNA,,,PMID:20498004,https://www.ncbi.nlm.nih.gov/pubmed/20498004,20498004,,
1442,233812,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,284996,RNF149,https://ctdbase.org/detail.go?type=gene&acc=284996,,,284996.0,RNF149,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RNF149 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1443,233813,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57484,RNF150,https://ctdbase.org/detail.go?type=gene&acc=57484,,,57484.0,RNF150,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RNF150 3' utr|benzo(a)pyrene results in increased methylation of RNF150 promoter|benzo(a)pyrene results in increased methylation of RNF150 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1444,233814,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,220441,RNF152,https://ctdbase.org/detail.go?type=gene&acc=220441,,,220441.0,RNF152,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RNF152 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1445,233815,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,220441,RNF152,https://ctdbase.org/detail.go?type=gene&acc=220441,,,220441.0,RNF152,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RNF152 promoter|benzo(a)pyrene results in increased methylation of RNF152 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1446,233816,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,220441,RNF152,https://ctdbase.org/detail.go?type=gene&acc=220441,,,220441.0,RNF152,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RNF152 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1447,233817,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8518,ELP1,https://ctdbase.org/detail.go?type=gene&acc=8518,,,8518.0,ELP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of ELP1 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1448,233818,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8518,ELP1,https://ctdbase.org/detail.go?type=gene&acc=8518,,,8518.0,ELP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ELP1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1449,233819,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55250,ELP2,https://ctdbase.org/detail.go?type=gene&acc=55250,,,55250.0,ELP2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ELP2 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1450,233820,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55250,ELP2,https://ctdbase.org/detail.go?type=gene&acc=55250,,,55250.0,ELP2,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of ELP2 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1451,233967,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55831,EMC3,https://ctdbase.org/detail.go?type=gene&acc=55831,,,55831.0,EMC3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EMC3 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1452,233968,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55831,EMC3,https://ctdbase.org/detail.go?type=gene&acc=55831,,,55831.0,EMC3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EMC3 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1453,234146,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,442075,EMC3-AS1,https://ctdbase.org/detail.go?type=gene&acc=442075,,,442075.0,EMC3-AS1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EMC3-AS1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1454,234147,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,442075,EMC3-AS1,https://ctdbase.org/detail.go?type=gene&acc=442075,,,442075.0,EMC3-AS1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EMC3-AS1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1455,234148,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51234,EMC4,https://ctdbase.org/detail.go?type=gene&acc=51234,,,51234.0,EMC4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EMC4 mRNA,,,PMID:19770486|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/22228805,19770486|22228805,,
1456,234149,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83460,EMC6,https://ctdbase.org/detail.go?type=gene&acc=83460,,,83460.0,EMC6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EMC6 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1457,234150,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51016,EMC9,https://ctdbase.org/detail.go?type=gene&acc=51016,,,51016.0,EMC9,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EMC9 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1458,234151,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51705,EMCN,https://ctdbase.org/detail.go?type=gene&acc=51705,,,51705.0,EMCN,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EMCN 5' utr|benzo(a)pyrene affects the methylation of EMCN promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1459,234152,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51705,EMCN,https://ctdbase.org/detail.go?type=gene&acc=51705,,,51705.0,EMCN,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EMCN mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1460,234153,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51705,EMCN,https://ctdbase.org/detail.go?type=gene&acc=51705,,,51705.0,EMCN,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EMCN mRNA,,,PMID:21569818|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/32417428,21569818|32417428,,
1461,234154,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2010,EMD,https://ctdbase.org/detail.go?type=gene&acc=2010,,,2010.0,EMD,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EMD exon|benzo(a)pyrene results in increased methylation of EMD promoter|benzo(a)pyrene results in increased methylation of EMD 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1462,234155,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,146956,EME1,https://ctdbase.org/detail.go?type=gene&acc=146956,,,146956.0,EME1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EME1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1463,234218,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10533,ATG7,https://ctdbase.org/detail.go?type=gene&acc=10533,,,10533.0,ATG7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ATG7 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1464,234219,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10533,ATG7,https://ctdbase.org/detail.go?type=gene&acc=10533,,,10533.0,ATG7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of ATG7 exon|benzo(a)pyrene results in increased methylation of ATG7 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1465,234220,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79065,ATG9A,https://ctdbase.org/detail.go?type=gene&acc=79065,,,79065.0,ATG9A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of ATG9A protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
1466,234221,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,285973,ATG9B,https://ctdbase.org/detail.go?type=gene&acc=285973,,,285973.0,ATG9B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ATG9B 3' utr|benzo(a)pyrene results in decreased methylation of ATG9B exon|benzo(a)pyrene results in decreased methylation of ATG9B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1467,234222,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,285973,ATG9B,https://ctdbase.org/detail.go?type=gene&acc=285973,,,285973.0,ATG9B,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ATG9B mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of ATG9B mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1468,234223,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51062,ATL1,https://ctdbase.org/detail.go?type=gene&acc=51062,,,51062.0,ATL1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ATL1 5' utr|benzo(a)pyrene results in decreased methylation of ATL1 exon|benzo(a)pyrene results in decreased methylation of ATL1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1469,234224,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51062,ATL1,https://ctdbase.org/detail.go?type=gene&acc=51062,,,51062.0,ATL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ATL1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1470,234297,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25897,RNF19A,https://ctdbase.org/detail.go?type=gene&acc=25897,,,25897.0,RNF19A,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RNF19A intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1471,234298,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25897,RNF19A,https://ctdbase.org/detail.go?type=gene&acc=25897,,,25897.0,RNF19A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RNF19A mRNA,,,PMID:20064835|PMID:22178795,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/22178795,20064835|22178795,,
1472,234299,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25897,RNF19A,https://ctdbase.org/detail.go?type=gene&acc=25897,,,25897.0,RNF19A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RNF19A mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1473,234300,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,146956,EME1,https://ctdbase.org/detail.go?type=gene&acc=146956,,,146956.0,EME1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EME1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1474,234301,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,146956,EME1,https://ctdbase.org/detail.go?type=gene&acc=146956,,,146956.0,EME1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EME1 mRNA,,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
1475,234302,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10436,EMG1,https://ctdbase.org/detail.go?type=gene&acc=10436,,,10436.0,EMG1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EMG1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1476,234303,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,129080,EMID1,https://ctdbase.org/detail.go?type=gene&acc=129080,,,129080.0,EMID1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EMID1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1477,234304,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,129080,EMID1,https://ctdbase.org/detail.go?type=gene&acc=129080,,,129080.0,EMID1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EMID1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1478,234305,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,129080,EMID1,https://ctdbase.org/detail.go?type=gene&acc=129080,,,129080.0,EMID1,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of EMID1 mrna]|benzo(a)pyrene results in increased expression of EMID1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1479,234306,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11117,EMILIN1,https://ctdbase.org/detail.go?type=gene&acc=11117,,,11117.0,EMILIN1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EMILIN1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1480,234307,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11117,EMILIN1,https://ctdbase.org/detail.go?type=gene&acc=11117,,,11117.0,EMILIN1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of EMILIN1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1481,234308,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11117,EMILIN1,https://ctdbase.org/detail.go?type=gene&acc=11117,,,11117.0,EMILIN1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EMILIN1 mRNA,,,PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/32417428,32417428,,
1482,234309,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,751598,EMILIN1B,https://ctdbase.org/detail.go?type=gene&acc=751598,,,751598.0,emilin1b,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of EMILIN1B mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
1483,234310,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84034,EMILIN2,https://ctdbase.org/detail.go?type=gene&acc=84034,,,84034.0,EMILIN2,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of EMILIN2 mrna|[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of EMILIN2 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1484,234533,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4948,OCA2,https://ctdbase.org/detail.go?type=gene&acc=4948,,,4948.0,OCA2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of OCA2 exon|benzo(a)pyrene affects the methylation of OCA2 promoter|benzo(a)pyrene affects the methylation of OCA2 5' utr|benzo(a)pyrene affects the methylation of OCA2 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1485,234534,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4948,OCA2,https://ctdbase.org/detail.go?type=gene&acc=4948,,,4948.0,OCA2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of OCA2 mRNA,,,PMID:21871943|PMID:31555880|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/21871943|https://www.ncbi.nlm.nih.gov/pubmed/31555880|https://www.ncbi.nlm.nih.gov/pubmed/32234424,21871943|31555880|32234424,,
1486,234535,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4948,OCA2,https://ctdbase.org/detail.go?type=gene&acc=4948,,,4948.0,OCA2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of OCA2 gene,,,PMID:31555880,https://www.ncbi.nlm.nih.gov/pubmed/31555880,31555880,,
1487,234536,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79629,OCEL1,https://ctdbase.org/detail.go?type=gene&acc=79629,,,79629.0,OCEL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of OCEL1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1488,234537,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79629,OCEL1,https://ctdbase.org/detail.go?type=gene&acc=79629,,,79629.0,OCEL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of OCEL1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1489,234616,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54853,WDR55,https://ctdbase.org/detail.go?type=gene&acc=54853,,,54853.0,WDR55,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of WDR55 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1490,234617,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79726,WDR59,https://ctdbase.org/detail.go?type=gene&acc=79726,,,79726.0,WDR59,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of WDR59 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1491,234618,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11180,WDR6,https://ctdbase.org/detail.go?type=gene&acc=11180,,,11180.0,WDR6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WDR6 mRNA,,,PMID:20498004,https://www.ncbi.nlm.nih.gov/pubmed/20498004,20498004,,
1492,234619,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,284403,WDR62,https://ctdbase.org/detail.go?type=gene&acc=284403,,,284403.0,WDR62,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of WDR62 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1493,234620,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,128025,WDR64,https://ctdbase.org/detail.go?type=gene&acc=128025,,,128025.0,WDR64,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of WDR64 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1494,234621,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,105267486,WDR67,https://ctdbase.org/detail.go?type=gene&acc=105267486,,,105267486.0,,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of WDR67 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1495,234622,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ATM mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1496,234623,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ATM mRNA,,,PMID:20713471|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/20713471|https://www.ncbi.nlm.nih.gov/pubmed/22228805,20713471|22228805,,
1497,234624,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23300,ATMIN,https://ctdbase.org/detail.go?type=gene&acc=23300,,,23300.0,ATMIN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of ATMIN mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
1498,234625,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1822,ATN1,https://ctdbase.org/detail.go?type=gene&acc=1822,,,1822.0,ATN1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ATN1 promoter|benzo(a)pyrene affects the methylation of ATN1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1499,234626,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1822,ATN1,https://ctdbase.org/detail.go?type=gene&acc=1822,,,1822.0,ATN1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ATN1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1500,234627,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,474,ATOH1,https://ctdbase.org/detail.go?type=gene&acc=474,,,474.0,ATOH1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ATOH1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1501,234628,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,220202,ATOH7,https://ctdbase.org/detail.go?type=gene&acc=220202,,,220202.0,ATOH7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ATOH7 promoter|benzo(a)pyrene results in increased methylation of ATOH7 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1502,234629,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,220202,ATOH7,https://ctdbase.org/detail.go?type=gene&acc=220202,,,220202.0,ATOH7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ATOH7 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1503,234630,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84913,ATOH8,https://ctdbase.org/detail.go?type=gene&acc=84913,,,84913.0,ATOH8,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of ATOH8 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1504,234631,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84913,ATOH8,https://ctdbase.org/detail.go?type=gene&acc=84913,,,84913.0,ATOH8,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ATOH8 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1505,234672,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57674,RNF213,https://ctdbase.org/detail.go?type=gene&acc=57674,,,57674.0,RNF213,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RNF213 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1506,234673,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57674,RNF213,https://ctdbase.org/detail.go?type=gene&acc=57674,,,57674.0,RNF213,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RNF213 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1507,234674,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57674,RNF213,https://ctdbase.org/detail.go?type=gene&acc=57674,,,57674.0,RNF213,10090.0,Mus musculus (house mouse),Benzo(a)pyrene metabolite results in decreased expression of RNF213 mRNA,,,PMID:32553695,https://www.ncbi.nlm.nih.gov/pubmed/32553695,32553695,,
1508,234675,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57674,RNF213,https://ctdbase.org/detail.go?type=gene&acc=57674,,,57674.0,RNF213,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RNF213 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1509,234676,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,200312,RNF215,https://ctdbase.org/detail.go?type=gene&acc=200312,,,200312.0,RNF215,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RNF215 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1510,234677,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54476,RNF216,https://ctdbase.org/detail.go?type=gene&acc=54476,,,54476.0,RNF216,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RNF216 promoter|benzo(a)pyrene results in increased methylation of RNF216 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1511,234678,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54476,RNF216,https://ctdbase.org/detail.go?type=gene&acc=54476,,,54476.0,RNF216,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RNF216 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of RNF216 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1512,234679,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100874342,RNF216-IT1,https://ctdbase.org/detail.go?type=gene&acc=100874342,,,100874342.0,RNF216-IT1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RNF216-IT1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1513,234680,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57626,KLHL1,https://ctdbase.org/detail.go?type=gene&acc=57626,,,57626.0,KLHL1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KLHL1 promoter|benzo(a)pyrene affects the methylation of KLHL1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1514,234681,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57626,KLHL1,https://ctdbase.org/detail.go?type=gene&acc=57626,,,57626.0,KLHL1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KLHL1 mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
1515,234793,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23335,WDR7,https://ctdbase.org/detail.go?type=gene&acc=23335,,,23335.0,WDR7,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WDR7 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1516,234794,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23335,WDR7,https://ctdbase.org/detail.go?type=gene&acc=23335,,,23335.0,WDR7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WDR7 mRNA,,,PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291,20064835|20106945|21632981|22316170|26238291,,
1517,234795,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55100,WDR70,https://ctdbase.org/detail.go?type=gene&acc=55100,,,55100.0,WDR70,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WDR70 mRNA,,,PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291,20064835|20106945|21632981|22316170|26238291,,
1518,234796,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55100,WDR70,https://ctdbase.org/detail.go?type=gene&acc=55100,,,55100.0,WDR70,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of WDR70 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1519,234797,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,256764,WDR72,https://ctdbase.org/detail.go?type=gene&acc=256764,,,256764.0,WDR72,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WDR72 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1520,234798,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,256764,WDR72,https://ctdbase.org/detail.go?type=gene&acc=256764,,,256764.0,WDR72,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WDR72 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1521,234799,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,256764,WDR72,https://ctdbase.org/detail.go?type=gene&acc=256764,,,256764.0,WDR72,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WDR72 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1522,234800,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,256764,WDR72,https://ctdbase.org/detail.go?type=gene&acc=256764,,,256764.0,WDR72,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of WDR72 mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
1523,234823,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23120,ATP10B,https://ctdbase.org/detail.go?type=gene&acc=23120,,,23120.0,ATP10B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ATP10B 5' utr|benzo(a)pyrene results in increased methylation of ATP10B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1524,234824,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2013,EMP2,https://ctdbase.org/detail.go?type=gene&acc=2013,,,2013.0,EMP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EMP2 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1525,234825,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2013,EMP2,https://ctdbase.org/detail.go?type=gene&acc=2013,,,2013.0,EMP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of EMP2 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1526,234826,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2014,EMP3,https://ctdbase.org/detail.go?type=gene&acc=2014,,,2014.0,EMP3,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of EMP3 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1527,234827,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2014,EMP3,https://ctdbase.org/detail.go?type=gene&acc=2014,,,2014.0,EMP3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of EMP3 3' utr|benzo(a)pyrene affects the methylation of EMP3 promoter|benzo(a)pyrene results in increased methylation of EMP3 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1528,234828,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2014,EMP3,https://ctdbase.org/detail.go?type=gene&acc=2014,,,2014.0,EMP3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EMP3 mRNA,,,PMID:21632981|PMID:21871943|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/21871943|https://www.ncbi.nlm.nih.gov/pubmed/32234424,21632981|21871943|32234424,,
1529,234829,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2014,EMP3,https://ctdbase.org/detail.go?type=gene&acc=2014,,,2014.0,EMP3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EMP3 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1530,234830,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100026387,EMR3,https://ctdbase.org/detail.go?type=gene&acc=100026387,,,100026387.0,,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EMR3 promoter|benzo(a)pyrene results in increased methylation of EMR3 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1531,234831,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,611665,EMR4,https://ctdbase.org/detail.go?type=gene&acc=611665,,,611665.0,,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased methylation of EMR4 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1532,234990,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79968,WDR76,https://ctdbase.org/detail.go?type=gene&acc=79968,,,79968.0,WDR76,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WDR76 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1533,234991,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79968,WDR76,https://ctdbase.org/detail.go?type=gene&acc=79968,,,79968.0,WDR76,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of WDR76 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1534,234992,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79968,WDR76,https://ctdbase.org/detail.go?type=gene&acc=79968,,,79968.0,WDR76,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of WDR76 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1535,234993,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79084,WDR77,https://ctdbase.org/detail.go?type=gene&acc=79084,,,79084.0,WDR77,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of WDR77 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1536,235094,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,151230,KLHL23,https://ctdbase.org/detail.go?type=gene&acc=151230,,,151230.0,KLHL23,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KLHL23 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1537,235095,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54800,KLHL24,https://ctdbase.org/detail.go?type=gene&acc=54800,,,54800.0,KLHL24,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KLHL24 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1538,235096,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54800,KLHL24,https://ctdbase.org/detail.go?type=gene&acc=54800,,,54800.0,KLHL24,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KLHL24 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1539,235161,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4953,ODC1,https://ctdbase.org/detail.go?type=gene&acc=4953,,,4953.0,ODC1,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of ODC1 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1540,235162,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4956,ODF1,https://ctdbase.org/detail.go?type=gene&acc=4956,,,4956.0,ODF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ODF1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1541,235301,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,114818,KLHL29,https://ctdbase.org/detail.go?type=gene&acc=114818,,,114818.0,KLHL29,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KLHL29 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1542,235302,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,26249,KLHL3,https://ctdbase.org/detail.go?type=gene&acc=26249,,,26249.0,KLHL3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KLHL3 promoter|benzo(a)pyrene affects the methylation of KLHL3 3' utr|benzo(a)pyrene affects the methylation of KLHL3 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1543,235303,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,377007,KLHL30,https://ctdbase.org/detail.go?type=gene&acc=377007,,,377007.0,KLHL30,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of KLHL30 mrna|[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of KLHL30 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1544,235304,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,377007,KLHL30,https://ctdbase.org/detail.go?type=gene&acc=377007,,,377007.0,KLHL30,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of KLHL30 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1545,235305,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,401265,KLHL31,https://ctdbase.org/detail.go?type=gene&acc=401265,,,401265.0,KLHL31,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KLHL31 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1546,235306,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,114792,KLHL32,https://ctdbase.org/detail.go?type=gene&acc=114792,,,114792.0,KLHL32,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KLHL32 promoter|benzo(a)pyrene affects the methylation of KLHL32 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1547,235307,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,114792,KLHL32,https://ctdbase.org/detail.go?type=gene&acc=114792,,,114792.0,KLHL32,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of KLHL32 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1548,235308,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,114792,KLHL32,https://ctdbase.org/detail.go?type=gene&acc=114792,,,114792.0,KLHL32,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of KLHL32 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1549,235478,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54502,RBM47,https://ctdbase.org/detail.go?type=gene&acc=54502,,,54502.0,RBM47,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RBM47 mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
1550,235479,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83759,RBM4B,https://ctdbase.org/detail.go?type=gene&acc=83759,,,83759.0,RBM4B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RBM4B mRNA,,,PMID:21632981|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/26238291,21632981|26238291,,
1551,235480,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83759,RBM4B,https://ctdbase.org/detail.go?type=gene&acc=83759,,,83759.0,RBM4B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RBM4B 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1552,235481,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10181,RBM5,https://ctdbase.org/detail.go?type=gene&acc=10181,,,10181.0,RBM5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RBM5 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1553,235684,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27303,RBMS3,https://ctdbase.org/detail.go?type=gene&acc=27303,,,27303.0,RBMS3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RBMS3 mRNA,,,PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/20713471,20713471,,
1554,235685,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27316,RBMX,https://ctdbase.org/detail.go?type=gene&acc=27316,,,27316.0,RBMX,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RBMX promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1555,235686,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27316,RBMX,https://ctdbase.org/detail.go?type=gene&acc=27316,,,27316.0,RBMX,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RBMX mrna|ahr protein inhibits the reaction [benzo(a)pyrene results in increased expression of RBMX mrna],,,PMID:15034205,https://www.ncbi.nlm.nih.gov/pubmed/15034205,15034205,,
1556,235687,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27316,RBMX,https://ctdbase.org/detail.go?type=gene&acc=27316,,,27316.0,RBMX,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RBMX mRNA,,,PMID:20713471|PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/20713471|https://www.ncbi.nlm.nih.gov/pubmed/21715664,20713471|21715664,,
1557,235688,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51634,RBMX2,https://ctdbase.org/detail.go?type=gene&acc=51634,,,51634.0,RBMX2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RBMX2 3' utr|benzo(a)pyrene affects the methylation of RBMX2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1558,235843,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8473,OGT,https://ctdbase.org/detail.go?type=gene&acc=8473,,,8473.0,OGT,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of OGT mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1559,235844,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11339,OIP5,https://ctdbase.org/detail.go?type=gene&acc=11339,,,11339.0,OIP5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of OIP5 mRNA,,,PMID:20064835|PMID:21802500,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/21802500,20064835|21802500,,
1560,235845,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,729082,OIP5-AS1,https://ctdbase.org/detail.go?type=gene&acc=729082,,,729082.0,OIP5-AS1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of OIP5-AS1 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
1561,235846,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,170392,OIT3,https://ctdbase.org/detail.go?type=gene&acc=170392,,,170392.0,OIT3,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of OIT3 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1562,235847,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,170392,OIT3,https://ctdbase.org/detail.go?type=gene&acc=170392,,,170392.0,OIT3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of OIT3 3' utr|benzo(a)pyrene results in increased methylation of OIT3 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1563,235848,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,170392,OIT3,https://ctdbase.org/detail.go?type=gene&acc=170392,,,170392.0,OIT3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of OIT3 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1564,235849,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,29789,OLA1,https://ctdbase.org/detail.go?type=gene&acc=29789,,,29789.0,OLA1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of OLA1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1565,235850,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55301,OLAH,https://ctdbase.org/detail.go?type=gene&acc=55301,,,55301.0,OLAH,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of OLAH 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1566,235880,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,124857,WFIKKN2,https://ctdbase.org/detail.go?type=gene&acc=124857,,,124857.0,WFIKKN2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of WFIKKN2 mRNA,,,PMID:21871943,https://www.ncbi.nlm.nih.gov/pubmed/21871943,21871943,,
1567,236041,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,105264016,WHSC2,https://ctdbase.org/detail.go?type=gene&acc=105264016,,,105264016.0,,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of WHSC2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1568,236042,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,692986,WIBG,https://ctdbase.org/detail.go?type=gene&acc=692986,,,692986.0,wibg,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WIBG mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
1569,236043,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11197,WIF1,https://ctdbase.org/detail.go?type=gene&acc=11197,,,11197.0,WIF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of WIF1 5' utr|benzo(a)pyrene results in increased methylation of WIF1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1570,236044,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11197,WIF1,https://ctdbase.org/detail.go?type=gene&acc=11197,,,11197.0,WIF1,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with dextran sulfate] results in increased expression of WIF1 mrna|[benzo(a)pyrene co-treated with dextran sulfate] results in increased expression of WIF1 protein,,,PMID:26271895,https://www.ncbi.nlm.nih.gov/pubmed/26271895,26271895,,
1571,236045,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7456,WIPF1,https://ctdbase.org/detail.go?type=gene&acc=7456,,,7456.0,WIPF1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WIPF1 5' utr|benzo(a)pyrene results in increased methylation of WIPF1 3' utr|benzo(a)pyrene affects the methylation of WIPF1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1572,236230,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,644150,WIPF3,https://ctdbase.org/detail.go?type=gene&acc=644150,,,644150.0,WIPF3,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of WIPF3 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1573,236358,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,56944,OLFML3,https://ctdbase.org/detail.go?type=gene&acc=56944,,,56944.0,OLFML3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of OLFML3 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1574,236359,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,404309,OLFR192,https://ctdbase.org/detail.go?type=gene&acc=404309,,,404309.0,Olfr192,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of OLFR192 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1575,236397,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83758,RBP5,https://ctdbase.org/detail.go?type=gene&acc=83758,,,83758.0,RBP5,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of RBP5 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1576,236398,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83758,RBP5,https://ctdbase.org/detail.go?type=gene&acc=83758,,,83758.0,RBP5,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in increased expression of RBP5 mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
1577,236399,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83758,RBP5,https://ctdbase.org/detail.go?type=gene&acc=83758,,,83758.0,RBP5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RBP5 mRNA,,,PMID:20106945|PMID:22316170|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20106945|22316170|32234424,,
1578,236400,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116362,RBP7,https://ctdbase.org/detail.go?type=gene&acc=116362,,,116362.0,RBP7,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RBP7 promoter|benzo(a)pyrene affects the methylation of RBP7 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1579,236401,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116362,RBP7,https://ctdbase.org/detail.go?type=gene&acc=116362,,,116362.0,RBP7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RBP7 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1580,236402,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116362,RBP7,https://ctdbase.org/detail.go?type=gene&acc=116362,,,116362.0,RBP7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RBP7 mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
1581,236403,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3516,RBPJ,https://ctdbase.org/detail.go?type=gene&acc=3516,,,3516.0,RBPJ,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RBPJ 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1582,236404,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3516,RBPJ,https://ctdbase.org/detail.go?type=gene&acc=3516,,,3516.0,RBPJ,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate promotes the reaction [benzo(a)pyrene results in increased expression of RBPJ mrna]|dibutyl phthalate promotes the reaction [benzo(a)pyrene results in increased expression of RBPJ protein]|benzo(a)pyrene results in increased expression of RBPJ mrna|benzo(a)pyrene results in increased expression of RBPJ protein|benzo(a)pyrene promotes the reaction [dibutyl phthalate results in increased expression of RBPJ protein]|benzo(a)pyrene promotes the reaction [dibutyl phthalate results in increased expression of RBPJ mrna],,,PMID:35378083,https://www.ncbi.nlm.nih.gov/pubmed/35378083,35378083,,
1583,236540,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,93974,ATP5IF1,https://ctdbase.org/detail.go?type=gene&acc=93974,,,93974.0,ATP5IF1,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of ATP5IF1 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1584,236541,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,93974,ATP5IF1,https://ctdbase.org/detail.go?type=gene&acc=93974,,,93974.0,ATP5IF1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ATP5IF1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1585,236542,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100037369,ATP5IF1A,https://ctdbase.org/detail.go?type=gene&acc=100037369,,,100037369.0,atp5if1a,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in decreased expression of ATP5IF1A mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
1586,236553,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2029,ENSA,https://ctdbase.org/detail.go?type=gene&acc=2029,,,2029.0,ENSA,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ENSA promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1587,236554,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2029,ENSA,https://ctdbase.org/detail.go?type=gene&acc=2029,,,2029.0,ENSA,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ENSA mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1588,236555,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,150350,ENTHD1,https://ctdbase.org/detail.go?type=gene&acc=150350,,,150350.0,ENTHD1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ENTHD1 promoter|benzo(a)pyrene results in increased methylation of ENTHD1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1589,236556,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,953,ENTPD1,https://ctdbase.org/detail.go?type=gene&acc=953,,,953.0,ENTPD1,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of ENTPD1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1590,236557,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,953,ENTPD1,https://ctdbase.org/detail.go?type=gene&acc=953,,,953.0,ENTPD1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ENTPD1 promoter|benzo(a)pyrene results in increased methylation of ENTPD1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1591,236558,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,728558,ENTPD1-AS1,https://ctdbase.org/detail.go?type=gene&acc=728558,,,728558.0,ENTPD1-AS1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of ENTPD1-AS1 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
1592,236559,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,954,ENTPD2,https://ctdbase.org/detail.go?type=gene&acc=954,,,954.0,ENTPD2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ENTPD2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1593,236573,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65267,WNK3,https://ctdbase.org/detail.go?type=gene&acc=65267,,,65267.0,WNK3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of WNK3 5' utr|benzo(a)pyrene affects the methylation of WNK3 promoter|benzo(a)pyrene results in increased methylation of WNK3 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1594,236574,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65267,WNK3,https://ctdbase.org/detail.go?type=gene&acc=65267,,,65267.0,WNK3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WNK3 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1595,236575,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65266,WNK4,https://ctdbase.org/detail.go?type=gene&acc=65266,,,65266.0,WNK4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of WNK4 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1596,236576,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7471,WNT1,https://ctdbase.org/detail.go?type=gene&acc=7471,,,7471.0,WNT1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WNT1 promoter|benzo(a)pyrene affects the methylation of WNT1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1597,236577,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7471,WNT1,https://ctdbase.org/detail.go?type=gene&acc=7471,,,7471.0,WNT1,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of WNT1 protein,,,PMID:21467743,https://www.ncbi.nlm.nih.gov/pubmed/21467743,21467743,,
1598,236578,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80326,WNT10A,https://ctdbase.org/detail.go?type=gene&acc=80326,,,80326.0,WNT10A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of WNT10A exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1599,236579,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80326,WNT10A,https://ctdbase.org/detail.go?type=gene&acc=80326,,,80326.0,WNT10A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to WNT10A promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1600,236705,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6096,RORB,https://ctdbase.org/detail.go?type=gene&acc=6096,,,6096.0,RORB,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RORB intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1601,236706,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6096,RORB,https://ctdbase.org/detail.go?type=gene&acc=6096,,,6096.0,RORB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RORB exon|benzo(a)pyrene results in increased methylation of RORB promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1602,236707,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6097,RORC,https://ctdbase.org/detail.go?type=gene&acc=6097,,,6097.0,RORC,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RORC promoter|benzo(a)pyrene results in decreased methylation of RORC exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1603,236708,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6097,RORC,https://ctdbase.org/detail.go?type=gene&acc=6097,,,6097.0,RORC,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RORC mRNA,,,PMID:20106945|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20106945|32234424,,
1604,236709,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6097,RORC,https://ctdbase.org/detail.go?type=gene&acc=6097,,,6097.0,RORC,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RORC mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1605,236710,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6097,RORC,https://ctdbase.org/detail.go?type=gene&acc=6097,,,6097.0,RORC,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RORC mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1606,236711,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,559245,RORCA,https://ctdbase.org/detail.go?type=gene&acc=559245,,,559245.0,rorca,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in increased expression of RORCA mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
1607,236712,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6098,ROS1,https://ctdbase.org/detail.go?type=gene&acc=6098,,,6098.0,ROS1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ROS1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1608,236713,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6098,ROS1,https://ctdbase.org/detail.go?type=gene&acc=6098,,,6098.0,ROS1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ROS1 mRNA,,,PMID:20106945|PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/22316170,20106945|22316170,,
1609,236760,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7472,WNT2,https://ctdbase.org/detail.go?type=gene&acc=7472,,,7472.0,WNT2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WNT2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1610,236761,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7472,WNT2,https://ctdbase.org/detail.go?type=gene&acc=7472,,,7472.0,WNT2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of WNT2 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1611,236762,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7472,WNT2,https://ctdbase.org/detail.go?type=gene&acc=7472,,,7472.0,WNT2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to WNT2 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1612,236763,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7472,WNT2,https://ctdbase.org/detail.go?type=gene&acc=7472,,,7472.0,WNT2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of WNT2 mRNA,,,PMID:22228805|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/32417428,22228805|32417428,,
1613,236764,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7482,WNT2B,https://ctdbase.org/detail.go?type=gene&acc=7482,,,7482.0,WNT2B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WNT2B mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1614,236765,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7473,WNT3,https://ctdbase.org/detail.go?type=gene&acc=7473,,,7473.0,WNT3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WNT3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1615,236766,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7473,WNT3,https://ctdbase.org/detail.go?type=gene&acc=7473,,,7473.0,WNT3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of WNT3 exon|benzo(a)pyrene affects the methylation of WNT3 promoter|benzo(a)pyrene results in increased methylation of WNT3 3' utr|benzo(a)pyrene results in increased methylation of WNT3 5' utr|benzo(a)pyrene results in increased methylation of WNT3 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1616,236875,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,16627,KLRA1,https://ctdbase.org/detail.go?type=gene&acc=16627,,,16627.0,Klra1,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KLRA1 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1617,236876,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27423,KLRA15,https://ctdbase.org/detail.go?type=gene&acc=27423,,,27423.0,Klra15,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KLRA15 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1618,236887,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6101,RP1,https://ctdbase.org/detail.go?type=gene&acc=6101,,,6101.0,RP1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RP1 promoter|benzo(a)pyrene results in increased methylation of RP1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1619,236888,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,94137,RP1L1,https://ctdbase.org/detail.go?type=gene&acc=94137,,,94137.0,RP1L1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RP1L1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1620,236889,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6102,RP2,https://ctdbase.org/detail.go?type=gene&acc=6102,,,6102.0,RP2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RP2 promoter|benzo(a)pyrene results in increased methylation of RP2 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1621,236890,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6102,RP2,https://ctdbase.org/detail.go?type=gene&acc=6102,,,6102.0,RP2,34765.0,Oikopleura dioica,Benzo(a)pyrene results in increased expression of RP2 mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
1622,236891,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,441212,RP9P,https://ctdbase.org/detail.go?type=gene&acc=441212,,,441212.0,RP9P,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RP9P promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1623,236892,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6117,RPA1,https://ctdbase.org/detail.go?type=gene&acc=6117,,,6117.0,RPA1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RPA1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1624,236893,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6117,RPA1,https://ctdbase.org/detail.go?type=gene&acc=6117,,,6117.0,RPA1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPA1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1625,236894,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6117,RPA1,https://ctdbase.org/detail.go?type=gene&acc=6117,,,6117.0,RPA1,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of RPA1 protein,,,PMID:21467743,https://www.ncbi.nlm.nih.gov/pubmed/21467743,21467743,,
1626,237074,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27423,KLRA15,https://ctdbase.org/detail.go?type=gene&acc=27423,,,27423.0,Klra15,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KLRA15 mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
1627,237075,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27424,KLRA16,https://ctdbase.org/detail.go?type=gene&acc=27424,,,27424.0,Klra16,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KLRA16 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1628,237076,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27424,KLRA16,https://ctdbase.org/detail.go?type=gene&acc=27424,,,27424.0,Klra16,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KLRA16 mrna|benzo(a)pyrene results in decreased expression of KLRA16 mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
1629,237077,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,93968,KLRA21,https://ctdbase.org/detail.go?type=gene&acc=93968,,,93968.0,Klra21,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KLRA21 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1630,237078,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,93969,KLRA22,https://ctdbase.org/detail.go?type=gene&acc=93969,,,93969.0,Klra22,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KLRA22 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1631,237079,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,93969,KLRA22,https://ctdbase.org/detail.go?type=gene&acc=93969,,,93969.0,Klra22,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KLRA22 mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
1632,237080,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,16635,KLRA4,https://ctdbase.org/detail.go?type=gene&acc=16635,,,16635.0,Klra4,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KLRA4 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1633,237081,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,16635,KLRA4,https://ctdbase.org/detail.go?type=gene&acc=16635,,,16635.0,Klra4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KLRA4 mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
1634,237082,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,16638,KLRA7,https://ctdbase.org/detail.go?type=gene&acc=16638,,,16638.0,Klra7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of KLRA7 mRNA,,,PMID:21569818|PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/22610609,21569818|22610609,,
1635,237083,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,16639,KLRA8,https://ctdbase.org/detail.go?type=gene&acc=16639,,,16639.0,Klra8,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of KLRA8 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1636,237104,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,92270,ATP6AP1L,https://ctdbase.org/detail.go?type=gene&acc=92270,,,92270.0,ATP6AP1L,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of ATP6AP1L mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1637,237105,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10159,ATP6AP2,https://ctdbase.org/detail.go?type=gene&acc=10159,,,10159.0,ATP6AP2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ATP6AP2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1638,237106,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10159,ATP6AP2,https://ctdbase.org/detail.go?type=gene&acc=10159,,,10159.0,ATP6AP2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene affects the expression of ATP6AP2 mRNA,,,PMID:22342234,https://www.ncbi.nlm.nih.gov/pubmed/22342234,22342234,,
1639,237107,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,535,ATP6V0A1,https://ctdbase.org/detail.go?type=gene&acc=535,,,535.0,ATP6V0A1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ATP6V0A1 5' utr|benzo(a)pyrene results in decreased methylation of ATP6V0A1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1640,237108,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23545,ATP6V0A2,https://ctdbase.org/detail.go?type=gene&acc=23545,,,23545.0,ATP6V0A2,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of ATP6V0A2 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1641,237109,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23545,ATP6V0A2,https://ctdbase.org/detail.go?type=gene&acc=23545,,,23545.0,ATP6V0A2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ATP6V0A2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1642,237411,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,94233,OPN4,https://ctdbase.org/detail.go?type=gene&acc=94233,,,94233.0,OPN4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of OPN4 3' utr|benzo(a)pyrene results in increased methylation of OPN4 promoter|benzo(a)pyrene results in increased methylation of OPN4 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1643,237412,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,94233,OPN4,https://ctdbase.org/detail.go?type=gene&acc=94233,,,94233.0,OPN4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to OPN4 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1644,237413,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,352918,OPN4.1,https://ctdbase.org/detail.go?type=gene&acc=352918,,,352918.0,opn4.1,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in increased expression of OPN4.1 mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
1645,237414,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,221391,OPN5,https://ctdbase.org/detail.go?type=gene&acc=221391,,,221391.0,OPN5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of OPN5 5' utr|benzo(a)pyrene results in increased methylation of OPN5 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1646,237415,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,557053,OPN6B,https://ctdbase.org/detail.go?type=gene&acc=557053,,,557053.0,opn6b,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in increased expression of OPN6B mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
1647,237416,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4985,OPRD1,https://ctdbase.org/detail.go?type=gene&acc=4985,,,4985.0,OPRD1,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of OPRD1 mrna|[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of OPRD1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1648,237417,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4985,OPRD1,https://ctdbase.org/detail.go?type=gene&acc=4985,,,4985.0,OPRD1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of OPRD1 promoter|benzo(a)pyrene affects the methylation of OPRD1 exon|benzo(a)pyrene results in increased methylation of OPRD1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1649,237418,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4985,OPRD1,https://ctdbase.org/detail.go?type=gene&acc=4985,,,4985.0,OPRD1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of OPRD1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1650,237419,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4985,OPRD1,https://ctdbase.org/detail.go?type=gene&acc=4985,,,4985.0,OPRD1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene affects the expression of OPRD1 mRNA,,,PMID:20127859,https://www.ncbi.nlm.nih.gov/pubmed/20127859,20127859,,
1651,237537,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64097,EPB41L4A,https://ctdbase.org/detail.go?type=gene&acc=64097,,,64097.0,EPB41L4A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of EPB41L4A intron|benzo(a)pyrene results in decreased methylation of EPB41L4A promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1652,237538,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64097,EPB41L4A,https://ctdbase.org/detail.go?type=gene&acc=64097,,,64097.0,EPB41L4A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EPB41L4A mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1653,237539,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54566,EPB41L4B,https://ctdbase.org/detail.go?type=gene&acc=54566,,,54566.0,EPB41L4B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of EPB41L4B mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1654,237540,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54566,EPB41L4B,https://ctdbase.org/detail.go?type=gene&acc=54566,,,54566.0,EPB41L4B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EPB41L4B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1655,237541,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54566,EPB41L4B,https://ctdbase.org/detail.go?type=gene&acc=54566,,,54566.0,EPB41L4B,10090.0,Mus musculus (house mouse),Benzo(a)pyrene metabolite results in decreased expression of EPB41L4B mRNA,,,PMID:32553695,https://www.ncbi.nlm.nih.gov/pubmed/32553695,32553695,,
1656,237542,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55135,WRAP53,https://ctdbase.org/detail.go?type=gene&acc=55135,,,55135.0,WRAP53,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of WRAP53 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1657,237543,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,49856,WRAP73,https://ctdbase.org/detail.go?type=gene&acc=49856,,,49856.0,WRAP73,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of WRAP73 intron|benzo(a)pyrene affects the methylation of WRAP73 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1658,237544,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,49856,WRAP73,https://ctdbase.org/detail.go?type=gene&acc=49856,,,49856.0,WRAP73,10090.0,Mus musculus (house mouse),Benzo(a)pyrene affects the expression of WRAP73 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1659,237545,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,770415,WRB,https://ctdbase.org/detail.go?type=gene&acc=770415,,,770415.0,WRB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of WRB 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1660,237546,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7486,WRN,https://ctdbase.org/detail.go?type=gene&acc=7486,,,7486.0,WRN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of WRN promoter|benzo(a)pyrene results in increased methylation of WRN intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1661,237715,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57669,EPB41L5,https://ctdbase.org/detail.go?type=gene&acc=57669,,,57669.0,EPB41L5,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of EPB41L5 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1662,237716,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57669,EPB41L5,https://ctdbase.org/detail.go?type=gene&acc=57669,,,57669.0,EPB41L5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of EPB41L5 mRNA,,,PMID:20106945|PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20106945|26238291|32234424,,
1663,237717,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57669,EPB41L5,https://ctdbase.org/detail.go?type=gene&acc=57669,,,57669.0,EPB41L5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EPB41L5 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1664,237718,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57669,EPB41L5,https://ctdbase.org/detail.go?type=gene&acc=57669,,,57669.0,EPB41L5,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of EPB41L5 mrna]|benzo(a)pyrene results in increased expression of EPB41L5 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1665,237719,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57669,EPB41L5,https://ctdbase.org/detail.go?type=gene&acc=57669,,,57669.0,EPB41L5,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of EPB41L5 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1666,237720,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2038,EPB42,https://ctdbase.org/detail.go?type=gene&acc=2038,,,2038.0,EPB42,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of EPB42 intron|benzo(a)pyrene results in increased methylation of EPB42 promoter|benzo(a)pyrene results in decreased methylation of EPB42 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1667,237721,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80314,EPC1,https://ctdbase.org/detail.go?type=gene&acc=80314,,,80314.0,EPC1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EPC1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1668,237742,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,157506,RDH10,https://ctdbase.org/detail.go?type=gene&acc=157506,,,157506.0,RDH10,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RDH10 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1669,237743,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,157506,RDH10,https://ctdbase.org/detail.go?type=gene&acc=157506,,,157506.0,RDH10,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RDH10 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1670,237744,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51109,RDH11,https://ctdbase.org/detail.go?type=gene&acc=51109,,,51109.0,RDH11,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RDH11 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1671,237745,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51109,RDH11,https://ctdbase.org/detail.go?type=gene&acc=51109,,,51109.0,RDH11,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RDH11 mRNA,,,PMID:21964900,https://www.ncbi.nlm.nih.gov/pubmed/21964900,21964900,,
1672,237882,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,126374,WTIP,https://ctdbase.org/detail.go?type=gene&acc=126374,,,126374.0,WTIP,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of WTIP mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1673,237883,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,126374,WTIP,https://ctdbase.org/detail.go?type=gene&acc=126374,,,126374.0,WTIP,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of WTIP mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1674,237884,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23286,WWC1,https://ctdbase.org/detail.go?type=gene&acc=23286,,,23286.0,WWC1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WWC1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1675,237885,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23286,WWC1,https://ctdbase.org/detail.go?type=gene&acc=23286,,,23286.0,WWC1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WWC1 mRNA,,,PMID:21632981|PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170,21632981|22316170,,
1676,237886,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23286,WWC1,https://ctdbase.org/detail.go?type=gene&acc=23286,,,23286.0,WWC1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of WWC1 mRNA,,,PMID:19770486|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/22228805,19770486|22228805,,
1677,237887,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80014,WWC2,https://ctdbase.org/detail.go?type=gene&acc=80014,,,80014.0,WWC2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WWC2 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1678,237907,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54749,EPDR1,https://ctdbase.org/detail.go?type=gene&acc=54749,,,54749.0,EPDR1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EPDR1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1679,237908,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54749,EPDR1,https://ctdbase.org/detail.go?type=gene&acc=54749,,,54749.0,EPDR1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EPDR1 protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
1680,237909,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54749,EPDR1,https://ctdbase.org/detail.go?type=gene&acc=54749,,,54749.0,EPDR1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EPDR1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1681,237910,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54749,EPDR1,https://ctdbase.org/detail.go?type=gene&acc=54749,,,54749.0,EPDR1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EPDR1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1682,237911,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57724,EPG5,https://ctdbase.org/detail.go?type=gene&acc=57724,,,57724.0,EPG5,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EPG5 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1683,237912,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57724,EPG5,https://ctdbase.org/detail.go?type=gene&acc=57724,,,57724.0,EPG5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EPG5 exon|benzo(a)pyrene affects the methylation of EPG5 promoter|benzo(a)pyrene results in increased methylation of EPG5 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1684,238047,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,200916,RPL22L1,https://ctdbase.org/detail.go?type=gene&acc=200916,,,200916.0,RPL22L1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPL22L1 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of RPL22L1 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1685,238048,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,200916,RPL22L1,https://ctdbase.org/detail.go?type=gene&acc=200916,,,200916.0,RPL22L1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RPL22L1 mRNA,,,PMID:19770486|PMID:22610609|PMID:25908611,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/22610609|https://www.ncbi.nlm.nih.gov/pubmed/25908611,19770486|22610609|25908611,,
1686,238049,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9349,RPL23,https://ctdbase.org/detail.go?type=gene&acc=9349,,,9349.0,RPL23,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of RPL23 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1687,238050,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9349,RPL23,https://ctdbase.org/detail.go?type=gene&acc=9349,,,9349.0,RPL23,10090.0,Mus musculus (house mouse),AHR protein inhibits the reaction [benzo(a)pyrene results in increased expression of RPL23 mrna],,,PMID:15034205,https://www.ncbi.nlm.nih.gov/pubmed/15034205,15034205,,
1688,238067,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51741,WWOX,https://ctdbase.org/detail.go?type=gene&acc=51741,,,51741.0,WWOX,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of WWOX mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1689,238068,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51741,WWOX,https://ctdbase.org/detail.go?type=gene&acc=51741,,,51741.0,WWOX,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of WWOX intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1690,238069,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51741,WWOX,https://ctdbase.org/detail.go?type=gene&acc=51741,,,51741.0,WWOX,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WWOX mRNA,,,PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:26238291|PMID:31555880|PMID:32234424|PMID:35690182,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/21871943|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/31555880|https://www.ncbi.nlm.nih.gov/pubmed/32234424|https://www.ncbi.nlm.nih.gov/pubmed/35690182,20106945|21632981|21871943|22316170|26238291|31555880|32234424|35690182,,
1691,238070,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51741,WWOX,https://ctdbase.org/detail.go?type=gene&acc=51741,,,51741.0,WWOX,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of WWOX mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1692,238071,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51741,WWOX,https://ctdbase.org/detail.go?type=gene&acc=51741,,,51741.0,WWOX,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of WWOX mRNA,,,PMID:19770486|PMID:20713471,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/20713471,19770486|20713471,,
1693,238072,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51741,WWOX,https://ctdbase.org/detail.go?type=gene&acc=51741,,,51741.0,WWOX,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of WWOX intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1694,238073,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11059,WWP1,https://ctdbase.org/detail.go?type=gene&acc=11059,,,11059.0,WWP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased methylation of WWP1 exon|benzo(a)pyrene results in decreased methylation of WWP1 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1695,238074,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11060,WWP2,https://ctdbase.org/detail.go?type=gene&acc=11060,,,11060.0,WWP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of WWP2 mRNA,,,PMID:20106945|PMID:21632981|PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170,20106945|21632981|22316170,,
1696,238075,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11060,WWP2,https://ctdbase.org/detail.go?type=gene&acc=11060,,,11060.0,WWP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of WWP2 3' utr|benzo(a)pyrene results in increased methylation of WWP2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1697,238076,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11060,WWP2,https://ctdbase.org/detail.go?type=gene&acc=11060,,,11060.0,WWP2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of WWP2 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1698,238221,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6152,RPL24,https://ctdbase.org/detail.go?type=gene&acc=6152,,,6152.0,RPL24,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPL24 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1699,238222,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6152,RPL24,https://ctdbase.org/detail.go?type=gene&acc=6152,,,6152.0,RPL24,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RPL24 mrna|benzo(a)pyrene results in increased expression of RPL24 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of RPL24 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1700,238223,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6154,RPL26,https://ctdbase.org/detail.go?type=gene&acc=6154,,,6154.0,RPL26,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPL26 mRNA,,,PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/20504355,20504355,,
1701,238224,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51121,RPL26L1,https://ctdbase.org/detail.go?type=gene&acc=51121,,,51121.0,RPL26L1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RPL26L1 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1702,238225,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6155,RPL27,https://ctdbase.org/detail.go?type=gene&acc=6155,,,6155.0,RPL27,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPL27 mRNA,,,PMID:15034205|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/15034205|https://www.ncbi.nlm.nih.gov/pubmed/22228805,15034205|22228805,,
1703,238226,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6157,RPL27A,https://ctdbase.org/detail.go?type=gene&acc=6157,,,6157.0,RPL27A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RPL27A mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1704,238227,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6157,RPL27A,https://ctdbase.org/detail.go?type=gene&acc=6157,,,6157.0,RPL27A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RPL27A mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1705,238228,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6157,RPL27A,https://ctdbase.org/detail.go?type=gene&acc=6157,,,6157.0,RPL27A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPL27A mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1706,238229,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6158,RPL28,https://ctdbase.org/detail.go?type=gene&acc=6158,,,6158.0,RPL28,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RPL28 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1707,238241,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9735,KNTC1,https://ctdbase.org/detail.go?type=gene&acc=9735,,,9735.0,KNTC1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KNTC1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1708,238252,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1969,EPHA2,https://ctdbase.org/detail.go?type=gene&acc=1969,,,1969.0,EPHA2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EPHA2 mRNA,,,PMID:21569818|PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/22610609,21569818|22610609,,
1709,238253,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2042,EPHA3,https://ctdbase.org/detail.go?type=gene&acc=2042,,,2042.0,EPHA3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of EPHA3 mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
1710,238254,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2043,EPHA4,https://ctdbase.org/detail.go?type=gene&acc=2043,,,2043.0,EPHA4,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of EPHA4 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1711,238255,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2043,EPHA4,https://ctdbase.org/detail.go?type=gene&acc=2043,,,2043.0,EPHA4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EPHA4 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1712,238256,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2043,EPHA4,https://ctdbase.org/detail.go?type=gene&acc=2043,,,2043.0,EPHA4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EPHA4 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
1713,238257,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2043,EPHA4,https://ctdbase.org/detail.go?type=gene&acc=2043,,,2043.0,EPHA4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EPHA4 mRNA,,,PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22610609,22610609,,
1714,238258,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64270,EPHA4B,https://ctdbase.org/detail.go?type=gene&acc=64270,,,64270.0,epha4b,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of EPHA4B mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
1715,238259,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2044,EPHA5,https://ctdbase.org/detail.go?type=gene&acc=2044,,,2044.0,EPHA5,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EPHA5 promoter|benzo(a)pyrene results in increased methylation of EPHA5 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1716,238260,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,285220,EPHA6,https://ctdbase.org/detail.go?type=gene&acc=285220,,,285220.0,EPHA6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of EPHA6 promoter|benzo(a)pyrene results in increased methylation of EPHA6 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1717,238384,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5962,RDX,https://ctdbase.org/detail.go?type=gene&acc=5962,,,5962.0,RDX,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RDX 5' utr|benzo(a)pyrene affects the methylation of RDX promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1718,238405,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6158,RPL28,https://ctdbase.org/detail.go?type=gene&acc=6158,,,6158.0,RPL28,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RPL28 mRNA,,,PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/20504355,20504355,,
1719,238406,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6159,RPL29,https://ctdbase.org/detail.go?type=gene&acc=6159,,,6159.0,RPL29,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of RPL29 mrna]|benzo(a)pyrene results in increased expression of RPL29 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1720,238407,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,118432,RPL29P2,https://ctdbase.org/detail.go?type=gene&acc=118432,,,118432.0,RPL29P2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPL29P2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1721,238408,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6122,RPL3,https://ctdbase.org/detail.go?type=gene&acc=6122,,,6122.0,RPL3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RPL3 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1722,238409,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6122,RPL3,https://ctdbase.org/detail.go?type=gene&acc=6122,,,6122.0,RPL3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPL3 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of RPL3 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1723,238410,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6122,RPL3,https://ctdbase.org/detail.go?type=gene&acc=6122,,,6122.0,RPL3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RPL3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1724,238411,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6156,RPL30,https://ctdbase.org/detail.go?type=gene&acc=6156,,,6156.0,RPL30,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RPL30 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1725,238412,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6156,RPL30,https://ctdbase.org/detail.go?type=gene&acc=6156,,,6156.0,RPL30,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of RPL30 mrna]|benzo(a)pyrene results in increased expression of RPL30 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1726,238413,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6160,RPL31,https://ctdbase.org/detail.go?type=gene&acc=6160,,,6160.0,RPL31,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPL31 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1727,238592,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65055,REEP1,https://ctdbase.org/detail.go?type=gene&acc=65055,,,65055.0,REEP1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of REEP1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1728,238593,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65055,REEP1,https://ctdbase.org/detail.go?type=gene&acc=65055,,,65055.0,REEP1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of REEP1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1729,238594,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65055,REEP1,https://ctdbase.org/detail.go?type=gene&acc=65055,,,65055.0,REEP1,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1730,238595,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65055,REEP1,https://ctdbase.org/detail.go?type=gene&acc=65055,,,65055.0,REEP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of REEP1 mRNA,,,PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22610609,22610609,,
1731,238596,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51308,REEP2,https://ctdbase.org/detail.go?type=gene&acc=51308,,,51308.0,REEP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of REEP2 mRNA,,,PMID:20106945|PMID:21632981|PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20106945|21632981|26238291|32234424,,
1732,238597,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51308,REEP2,https://ctdbase.org/detail.go?type=gene&acc=51308,,,51308.0,REEP2,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP2 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1733,238598,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,221035,REEP3,https://ctdbase.org/detail.go?type=gene&acc=221035,,,221035.0,REEP3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of REEP3 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
1734,238599,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,221035,REEP3,https://ctdbase.org/detail.go?type=gene&acc=221035,,,221035.0,REEP3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to REEP3 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1735,238600,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,221035,REEP3,https://ctdbase.org/detail.go?type=gene&acc=221035,,,221035.0,REEP3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of REEP3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1736,238601,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80346,REEP4,https://ctdbase.org/detail.go?type=gene&acc=80346,,,80346.0,REEP4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of REEP4 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1737,238612,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,641311,RPL31P11,https://ctdbase.org/detail.go?type=gene&acc=641311,,,641311.0,RPL31P11,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RPL31P11 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1738,238613,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,132241,RPL32P3,https://ctdbase.org/detail.go?type=gene&acc=132241,,,132241.0,RPL32P3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RPL32P3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1739,238614,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,619547,RPL34-PS1,https://ctdbase.org/detail.go?type=gene&acc=619547,,,619547.0,Rpl34-ps1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPL34-PS1 mRNA,,,PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/32417428,32417428,,
1740,238615,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25873,RPL36,https://ctdbase.org/detail.go?type=gene&acc=25873,,,25873.0,RPL36,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPL36 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1741,238616,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25873,RPL36,https://ctdbase.org/detail.go?type=gene&acc=25873,,,25873.0,RPL36,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to RPL36 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1742,238617,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25873,RPL36,https://ctdbase.org/detail.go?type=gene&acc=25873,,,25873.0,RPL36,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RPL36 mRNA,,,PMID:20504355|PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/20504355|https://www.ncbi.nlm.nih.gov/pubmed/27195522,20504355|27195522,,
1743,238741,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,440153,OR11H12,https://ctdbase.org/detail.go?type=gene&acc=440153,,,440153.0,OR11H12,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of OR11H12 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1744,238742,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,258113,OR11H23,https://ctdbase.org/detail.go?type=gene&acc=258113,,,258113.0,Or11h23,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of OR11H23 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1745,238743,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,390442,OR11H4,https://ctdbase.org/detail.go?type=gene&acc=390442,,,390442.0,OR11H4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of OR11H4 exon|benzo(a)pyrene results in decreased methylation of OR11H4 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1746,238744,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,122748,OR11H6,https://ctdbase.org/detail.go?type=gene&acc=122748,,,122748.0,OR11H6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of OR11H6 promoter|benzo(a)pyrene results in decreased methylation of OR11H6 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1747,238804,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,130120,REG3G,https://ctdbase.org/detail.go?type=gene&acc=130120,,,130120.0,REG3G,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of REG3G promoter|benzo(a)pyrene results in increased methylation of REG3G 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1748,238805,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,130120,REG3G,https://ctdbase.org/detail.go?type=gene&acc=130120,,,130120.0,REG3G,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of REG3G mRNA,,,PMID:20127859|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/20127859|https://www.ncbi.nlm.nih.gov/pubmed/22228805,20127859|22228805,,
1749,238806,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83998,REG4,https://ctdbase.org/detail.go?type=gene&acc=83998,,,83998.0,REG4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of REG4 promoter|benzo(a)pyrene results in increased methylation of REG4 3' utr|benzo(a)pyrene results in increased methylation of REG4 5' utr|benzo(a)pyrene results in increased methylation of REG4 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1750,238807,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5966,REL,https://ctdbase.org/detail.go?type=gene&acc=5966,,,5966.0,REL,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of REL mrna|benzo(a)pyrene results in increased expression of REL mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1751,238808,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6170,RPL39,https://ctdbase.org/detail.go?type=gene&acc=6170,,,6170.0,RPL39,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPL39 exon|benzo(a)pyrene affects the methylation of RPL39 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1752,238809,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6170,RPL39,https://ctdbase.org/detail.go?type=gene&acc=6170,,,6170.0,RPL39,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPL39 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1753,238810,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,116832,RPL39L,https://ctdbase.org/detail.go?type=gene&acc=116832,,,116832.0,RPL39L,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPL39L 5' utr|benzo(a)pyrene results in increased methylation of RPL39L promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1754,238811,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100271531,RPL39P40,https://ctdbase.org/detail.go?type=gene&acc=100271531,,,100271531.0,RPL39P40,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RPL39P40 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1755,238812,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6123,RPL3L,https://ctdbase.org/detail.go?type=gene&acc=6123,,,6123.0,RPL3L,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RPL3L mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1756,238813,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6171,RPL41,https://ctdbase.org/detail.go?type=gene&acc=6171,,,6171.0,RPL41,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to RPL41 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1757,238981,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6129,RPL7,https://ctdbase.org/detail.go?type=gene&acc=6129,,,6129.0,RPL7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPL7 mRNA,,,PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/20504355,20504355,,
1758,238982,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6130,RPL7A,https://ctdbase.org/detail.go?type=gene&acc=6130,,,6130.0,RPL7A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RPL7A mRNA,,,PMID:18247414,https://www.ncbi.nlm.nih.gov/pubmed/18247414,18247414,,
1759,238983,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6130,RPL7A,https://ctdbase.org/detail.go?type=gene&acc=6130,,,6130.0,RPL7A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPL7A mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1760,239066,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,26053,AUTS2,https://ctdbase.org/detail.go?type=gene&acc=26053,,,26053.0,AUTS2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of AUTS2 mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
1761,239067,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57099,AVEN,https://ctdbase.org/detail.go?type=gene&acc=57099,,,57099.0,AVEN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of AVEN 3' utr|benzo(a)pyrene affects the methylation of AVEN promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1762,239068,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57099,AVEN,https://ctdbase.org/detail.go?type=gene&acc=57099,,,57099.0,AVEN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of AVEN mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1763,239069,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57099,AVEN,https://ctdbase.org/detail.go?type=gene&acc=57099,,,57099.0,AVEN,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of AVEN mRNA,,,PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/21715664,21715664,,
1764,239070,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,10677,AVIL,https://ctdbase.org/detail.go?type=gene&acc=10677,,,10677.0,AVIL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of AVIL exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1765,239071,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23080,AVL9,https://ctdbase.org/detail.go?type=gene&acc=23080,,,23080.0,AVL9,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of AVL9 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1766,239072,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23080,AVL9,https://ctdbase.org/detail.go?type=gene&acc=23080,,,23080.0,AVL9,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of AVL9 protein,,,PMID:32717239,https://www.ncbi.nlm.nih.gov/pubmed/32717239,32717239,,
1767,239073,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,551,AVP,https://ctdbase.org/detail.go?type=gene&acc=551,,,551.0,AVP,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of AVP promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1768,239074,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,551,AVP,https://ctdbase.org/detail.go?type=gene&acc=551,,,551.0,AVP,10090.0,Mus musculus (house mouse),Benzo(a)pyrene affects the reaction [AHR protein binds to AVP promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1769,239075,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,551,AVP,https://ctdbase.org/detail.go?type=gene&acc=551,,,551.0,AVP,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of AVP mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1770,239139,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83999,KREMEN1,https://ctdbase.org/detail.go?type=gene&acc=83999,,,83999.0,KREMEN1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of KREMEN1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1771,239140,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,889,KRIT1,https://ctdbase.org/detail.go?type=gene&acc=889,,,889.0,KRIT1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KRIT1 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of KRIT1 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1772,239141,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11103,KRR1,https://ctdbase.org/detail.go?type=gene&acc=11103,,,11103.0,KRR1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KRR1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1773,239142,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3848,KRT1,https://ctdbase.org/detail.go?type=gene&acc=3848,,,3848.0,KRT1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KRT1 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1774,239143,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3848,KRT1,https://ctdbase.org/detail.go?type=gene&acc=3848,,,3848.0,KRT1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KRT1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1775,239144,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3848,KRT1,https://ctdbase.org/detail.go?type=gene&acc=3848,,,3848.0,KRT1,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of KRT1 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1776,239145,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3858,KRT10,https://ctdbase.org/detail.go?type=gene&acc=3858,,,3858.0,KRT10,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KRT10 exon|benzo(a)pyrene results in increased methylation of KRT10 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1777,239146,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3858,KRT10,https://ctdbase.org/detail.go?type=gene&acc=3858,,,3858.0,KRT10,9606.0,Homo sapiens (human),[soot co-treated with benzo(a)pyrene] results in decreased expression of KRT10 protein modified form,,,PMID:24464499,https://www.ncbi.nlm.nih.gov/pubmed/24464499,24464499,,
1778,239158,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,26188,OR1C1,https://ctdbase.org/detail.go?type=gene&acc=26188,,,26188.0,OR1C1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of OR1C1 promoter|benzo(a)pyrene results in decreased methylation of OR1C1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1779,239159,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,642740,RPL9P11,https://ctdbase.org/detail.go?type=gene&acc=642740,,,642740.0,RPL9P11,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RPL9P11 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1780,239160,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6175,RPLP0,https://ctdbase.org/detail.go?type=gene&acc=6175,,,6175.0,RPLP0,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of RPLP0 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1781,239161,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,113157,RPLP0P2,https://ctdbase.org/detail.go?type=gene&acc=113157,,,113157.0,RPLP0P2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPLP0P2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1782,239162,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6176,RPLP1,https://ctdbase.org/detail.go?type=gene&acc=6176,,,6176.0,RPLP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RPLP1 mRNA,,,PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/20504355,20504355,,
1783,239163,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6181,RPLP2,https://ctdbase.org/detail.go?type=gene&acc=6181,,,6181.0,RPLP2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPLP2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1784,239164,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6184,RPN1,https://ctdbase.org/detail.go?type=gene&acc=6184,,,6184.0,RPN1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPN1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1785,239165,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6185,RPN2,https://ctdbase.org/detail.go?type=gene&acc=6185,,,6185.0,RPN2,35525.0,Daphnia magna,[benzo(a)pyrene co-treated with sodium bichromate] results in decreased expression of RPN2 mRNA,,,PMID:21632023,https://www.ncbi.nlm.nih.gov/pubmed/21632023,21632023,,
1786,239166,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6185,RPN2,https://ctdbase.org/detail.go?type=gene&acc=6185,,,6185.0,RPN2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RPN2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1787,239167,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6185,RPN2,https://ctdbase.org/detail.go?type=gene&acc=6185,,,6185.0,RPN2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPN2 mRNA,,,PMID:20127859,https://www.ncbi.nlm.nih.gov/pubmed/20127859,20127859,,
1788,239256,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,552,AVPR1A,https://ctdbase.org/detail.go?type=gene&acc=552,,,552.0,AVPR1A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of AVPR1A mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1789,239257,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,552,AVPR1A,https://ctdbase.org/detail.go?type=gene&acc=552,,,552.0,AVPR1A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of AVPR1A mRNA,,,PMID:19770486|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/22228805,19770486|22228805,,
1790,239258,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,553,AVPR1B,https://ctdbase.org/detail.go?type=gene&acc=553,,,553.0,AVPR1B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of AVPR1B 3' UTR,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1791,239259,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,553,AVPR1B,https://ctdbase.org/detail.go?type=gene&acc=553,,,553.0,AVPR1B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of AVPR1B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1792,239260,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,554,AVPR2,https://ctdbase.org/detail.go?type=gene&acc=554,,,554.0,AVPR2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of AVPR2 promoter|benzo(a)pyrene results in decreased methylation of AVPR2 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1793,239261,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,158833,AWAT1,https://ctdbase.org/detail.go?type=gene&acc=158833,,,158833.0,AWAT1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of AWAT1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1794,239262,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,158835,AWAT2,https://ctdbase.org/detail.go?type=gene&acc=158835,,,158835.0,AWAT2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of AWAT2 promoter|benzo(a)pyrene results in decreased methylation of AWAT2 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1795,239296,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),Hesperetin inhibits the reaction [benzo(a)pyrene results in increased expression of RELA protein],,,PMID:26546711,https://www.ncbi.nlm.nih.gov/pubmed/26546711,26546711,,
1796,239297,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),Plant extracts inhibits the reaction [benzo(a)pyrene results in increased expression of RELA protein],,,PMID:28032951,https://www.ncbi.nlm.nih.gov/pubmed/28032951,28032951,,
1797,239298,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene affects the localization of RELA protein,,,PMID:22051199|PMID:26358852,https://www.ncbi.nlm.nih.gov/pubmed/22051199|https://www.ncbi.nlm.nih.gov/pubmed/26358852,22051199|26358852,,
1798,239299,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [benzo(a)pyrene results in increased expression of RELA protein]|benzo(a)pyrene results in increased expression of RELA protein,,,PMID:27206700,https://www.ncbi.nlm.nih.gov/pubmed/27206700,27206700,,
1799,239300,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Glycyrrhizic acid inhibits the reaction [benzo(a)pyrene affects the localization of RELA protein],,,PMID:22051199,https://www.ncbi.nlm.nih.gov/pubmed/22051199,22051199,,
1800,239301,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5971,RELB,https://ctdbase.org/detail.go?type=gene&acc=5971,,,5971.0,RELB,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RELB promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1801,239302,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5971,RELB,https://ctdbase.org/detail.go?type=gene&acc=5971,,,5971.0,RELB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RELB mRNA,,,PMID:21871943|PMID:22316170|PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/21871943|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,21871943|22316170|26238291|32234424,,
1802,239303,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5971,RELB,https://ctdbase.org/detail.go?type=gene&acc=5971,,,5971.0,RELB,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RELB mRNA,,,PMID:17275222|PMID:17681673|PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/17275222|https://www.ncbi.nlm.nih.gov/pubmed/17681673|https://www.ncbi.nlm.nih.gov/pubmed/19770486,17275222|17681673|19770486,,
1803,239304,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5971,RELB,https://ctdbase.org/detail.go?type=gene&acc=5971,,,5971.0,RELB,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RELB mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1804,239429,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3859,KRT12,https://ctdbase.org/detail.go?type=gene&acc=3859,,,3859.0,KRT12,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KRT12 exon|benzo(a)pyrene results in increased methylation of KRT12 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1805,239430,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3859,KRT12,https://ctdbase.org/detail.go?type=gene&acc=3859,,,3859.0,KRT12,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KRT12 mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
1806,239431,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3860,KRT13,https://ctdbase.org/detail.go?type=gene&acc=3860,,,3860.0,KRT13,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of KRT13 promoter|benzo(a)pyrene results in increased methylation of KRT13 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1807,239432,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3861,KRT14,https://ctdbase.org/detail.go?type=gene&acc=3861,,,3861.0,KRT14,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KRT14 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1808,239433,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3861,KRT14,https://ctdbase.org/detail.go?type=gene&acc=3861,,,3861.0,KRT14,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KRT14 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1809,239434,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3861,KRT14,https://ctdbase.org/detail.go?type=gene&acc=3861,,,3861.0,KRT14,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of KRT14 protein,,,PMID:16456883,https://www.ncbi.nlm.nih.gov/pubmed/16456883,16456883,,
1810,239435,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3866,KRT15,https://ctdbase.org/detail.go?type=gene&acc=3866,,,3866.0,KRT15,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of KRT15 mRNA,,,PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/26001963,26001963,,
1811,239436,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3866,KRT15,https://ctdbase.org/detail.go?type=gene&acc=3866,,,3866.0,KRT15,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KRT15 5' utr|benzo(a)pyrene results in decreased methylation of KRT15 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1812,239603,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2060,EPS15,https://ctdbase.org/detail.go?type=gene&acc=2060,,,2060.0,EPS15,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EPS15 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1813,239604,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2060,EPS15,https://ctdbase.org/detail.go?type=gene&acc=2060,,,2060.0,EPS15,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EPS15 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1814,239605,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,58513,EPS15L1,https://ctdbase.org/detail.go?type=gene&acc=58513,,,58513.0,EPS15L1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EPS15L1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1815,239606,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,558,AXL,https://ctdbase.org/detail.go?type=gene&acc=558,,,558.0,AXL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of AXL mRNA,,,PMID:21632981|PMID:21871943|PMID:22316170|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/21871943|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/32234424,21632981|21871943|22316170|32234424,,
1816,239607,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,558,AXL,https://ctdbase.org/detail.go?type=gene&acc=558,,,558.0,AXL,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to AXL promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1817,239608,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,563,AZGP1,https://ctdbase.org/detail.go?type=gene&acc=563,,,563.0,AZGP1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of AZGP1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1818,239609,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,563,AZGP1,https://ctdbase.org/detail.go?type=gene&acc=563,,,563.0,AZGP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of AZGP1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1819,239610,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,563,AZGP1,https://ctdbase.org/detail.go?type=gene&acc=563,,,563.0,AZGP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of AZGP1 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1820,239611,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,646282,AZGP1P1,https://ctdbase.org/detail.go?type=gene&acc=646282,,,646282.0,AZGP1P1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of AZGP1P1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1821,239612,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,401393,AZGP1P2,https://ctdbase.org/detail.go?type=gene&acc=401393,,,401393.0,AZGP1P2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of AZGP1P2 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1822,239666,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,135941,OR2A14,https://ctdbase.org/detail.go?type=gene&acc=135941,,,135941.0,OR2A14,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of OR2A14 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1823,239667,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,442361,OR2A2,https://ctdbase.org/detail.go?type=gene&acc=442361,,,442361.0,OR2A2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of OR2A2 promoter|benzo(a)pyrene results in decreased methylation of OR2A2 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1824,239668,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79541,OR2A4,https://ctdbase.org/detail.go?type=gene&acc=79541,,,79541.0,OR2A4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of OR2A4 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1825,239669,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,393046,OR2A5,https://ctdbase.org/detail.go?type=gene&acc=393046,,,393046.0,OR2A5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of OR2A5 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1826,239670,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,401427,OR2A7,https://ctdbase.org/detail.go?type=gene&acc=401427,,,401427.0,OR2A7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of OR2A7 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1827,239671,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,441295,OR2A9P,https://ctdbase.org/detail.go?type=gene&acc=441295,,,441295.0,OR2A9P,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of OR2A9P mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1828,239672,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,81392,OR2AE1,https://ctdbase.org/detail.go?type=gene&acc=81392,,,81392.0,OR2AE1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of OR2AE1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1829,239673,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,144125,OR2AG1,https://ctdbase.org/detail.go?type=gene&acc=144125,,,144125.0,OR2AG1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of OR2AG1 promoter|benzo(a)pyrene affects the methylation of OR2AG1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1830,239780,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2059,EPS8,https://ctdbase.org/detail.go?type=gene&acc=2059,,,2059.0,EPS8,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EPS8 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1831,239781,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54869,EPS8L1,https://ctdbase.org/detail.go?type=gene&acc=54869,,,54869.0,EPS8L1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EPS8L1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1832,239782,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64787,EPS8L2,https://ctdbase.org/detail.go?type=gene&acc=64787,,,64787.0,EPS8L2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of EPS8L2 promoter|benzo(a)pyrene affects the methylation of EPS8L2 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1833,239783,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64787,EPS8L2,https://ctdbase.org/detail.go?type=gene&acc=64787,,,64787.0,EPS8L2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EPS8L2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1834,239784,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64787,EPS8L2,https://ctdbase.org/detail.go?type=gene&acc=64787,,,64787.0,EPS8L2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EPS8L2 mRNA,,,PMID:21632981|PMID:22316170|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291,21632981|22316170|26238291,,
1835,239785,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64787,EPS8L2,https://ctdbase.org/detail.go?type=gene&acc=64787,,,64787.0,EPS8L2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EPS8L2 protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
1836,239786,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64787,EPS8L2,https://ctdbase.org/detail.go?type=gene&acc=64787,,,64787.0,EPS8L2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of EPS8L2 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1837,239925,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6230,RPS25,https://ctdbase.org/detail.go?type=gene&acc=6230,,,6230.0,RPS25,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPS25 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1838,239926,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6231,RPS26,https://ctdbase.org/detail.go?type=gene&acc=6231,,,6231.0,RPS26,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RPS26 protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
1839,239958,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64787,EPS8L2,https://ctdbase.org/detail.go?type=gene&acc=64787,,,64787.0,EPS8L2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of EPS8L2 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1840,239959,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79574,EPS8L3,https://ctdbase.org/detail.go?type=gene&acc=79574,,,79574.0,EPS8L3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EPS8L3 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1841,239960,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79574,EPS8L3,https://ctdbase.org/detail.go?type=gene&acc=79574,,,79574.0,EPS8L3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EPS8L3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1842,239961,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79574,EPS8L3,https://ctdbase.org/detail.go?type=gene&acc=79574,,,79574.0,EPS8L3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of EPS8L3 mRNA,,,PMID:21632981|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/32234424,21632981|32234424,,
1843,239962,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,393332,EPS8L3B,https://ctdbase.org/detail.go?type=gene&acc=393332,,,393332.0,eps8l3b,7955.0,Danio rerio (zebrafish),[ethanol co-treated with benzo(a)pyrene] results in increased expression of EPS8L3B mRNA,,,PMID:35412187,https://www.ncbi.nlm.nih.gov/pubmed/35412187,35412187,,
1844,239963,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,94240,EPSTI1,https://ctdbase.org/detail.go?type=gene&acc=94240,,,94240.0,EPSTI1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of EPSTI1 5' utr|benzo(a)pyrene affects the methylation of EPSTI1 promoter|benzo(a)pyrene results in decreased methylation of EPSTI1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1845,239964,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,94240,EPSTI1,https://ctdbase.org/detail.go?type=gene&acc=94240,,,94240.0,EPSTI1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of EPSTI1 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of EPSTI1 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1846,240118,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51065,RPS27L,https://ctdbase.org/detail.go?type=gene&acc=51065,,,51065.0,RPS27L,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPS27L mRNA,,,PMID:19770486|PMID:21964900|PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21964900|https://www.ncbi.nlm.nih.gov/pubmed/22610609,19770486|21964900|22610609,,
1847,240119,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6234,RPS28,https://ctdbase.org/detail.go?type=gene&acc=6234,,,6234.0,RPS28,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RPS28 protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
1848,240120,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6235,RPS29,https://ctdbase.org/detail.go?type=gene&acc=6235,,,6235.0,RPS29,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPS29 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1849,240121,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,256355,RPS2P32,https://ctdbase.org/detail.go?type=gene&acc=256355,,,256355.0,RPS2P32,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPS2P32 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1850,240122,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,390206,RPS2P37,https://ctdbase.org/detail.go?type=gene&acc=390206,,,390206.0,RPS2P37,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RPS2P37 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1851,240123,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7518,XRCC4,https://ctdbase.org/detail.go?type=gene&acc=7518,,,7518.0,XRCC4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of XRCC4 mRNA,,,PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:25690898|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/25690898|https://www.ncbi.nlm.nih.gov/pubmed/26238291,20064835|20106945|21632981|22316170|25690898|26238291,,
1852,240124,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7518,XRCC4,https://ctdbase.org/detail.go?type=gene&acc=7518,,,7518.0,XRCC4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of XRCC4 mRNA,,,PMID:19770486|PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21715664,19770486|21715664,,
1853,240125,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7518,XRCC4,https://ctdbase.org/detail.go?type=gene&acc=7518,,,7518.0,XRCC4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of XRCC4 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1854,240126,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7520,XRCC5,https://ctdbase.org/detail.go?type=gene&acc=7520,,,7520.0,XRCC5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of XRCC5 3' utr|benzo(a)pyrene results in decreased methylation of XRCC5 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1855,240127,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7520,XRCC5,https://ctdbase.org/detail.go?type=gene&acc=7520,,,7520.0,XRCC5,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of XRCC5 mRNA,,,PMID:28461126,https://www.ncbi.nlm.nih.gov/pubmed/28461126,28461126,,
1856,240128,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7520,XRCC5,https://ctdbase.org/detail.go?type=gene&acc=7520,,,7520.0,XRCC5,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of XRCC5 mRNA,,,PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/20504355,20504355,,
1857,240129,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2547,XRCC6,https://ctdbase.org/detail.go?type=gene&acc=2547,,,2547.0,XRCC6,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of XRCC6 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1858,240130,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100167901,XRCC6BP1,https://ctdbase.org/detail.go?type=gene&acc=100167901,,,100167901.0,,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of XRCC6BP1 intron|benzo(a)pyrene results in increased methylation of XRCC6BP1 3' utr|benzo(a)pyrene results in increased methylation of XRCC6BP1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1859,240131,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,442459,XRCC6P5,https://ctdbase.org/detail.go?type=gene&acc=442459,,,442459.0,XRCC6P5,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of XRCC6P5 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1860,240132,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54464,XRN1,https://ctdbase.org/detail.go?type=gene&acc=54464,,,54464.0,XRN1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of XRN1 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1861,240287,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6188,RPS3,https://ctdbase.org/detail.go?type=gene&acc=6188,,,6188.0,RPS3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPS3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1862,240288,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6188,RPS3,https://ctdbase.org/detail.go?type=gene&acc=6188,,,6188.0,RPS3,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of RPS3 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1863,240289,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6188,RPS3,https://ctdbase.org/detail.go?type=gene&acc=6188,,,6188.0,RPS3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPS3 mRNA,,,PMID:20504355|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/20504355|https://www.ncbi.nlm.nih.gov/pubmed/22228805,20504355|22228805,,
1864,240290,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6189,RPS3A,https://ctdbase.org/detail.go?type=gene&acc=6189,,,6189.0,RPS3A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RPS3A promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1865,240291,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6189,RPS3A,https://ctdbase.org/detail.go?type=gene&acc=6189,,,6189.0,RPS3A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RPS3A mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1866,240292,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6191,RPS4X,https://ctdbase.org/detail.go?type=gene&acc=6191,,,6191.0,RPS4X,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RPS4X promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1867,240293,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6192,RPS4Y1,https://ctdbase.org/detail.go?type=gene&acc=6192,,,6192.0,RPS4Y1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RPS4Y1 promoter|benzo(a)pyrene results in increased methylation of RPS4Y1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1868,240294,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,140032,RPS4Y2,https://ctdbase.org/detail.go?type=gene&acc=140032,,,140032.0,RPS4Y2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RPS4Y2 exon|benzo(a)pyrene affects the methylation of RPS4Y2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1869,240430,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5979,RET,https://ctdbase.org/detail.go?type=gene&acc=5979,,,5979.0,RET,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RET mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1870,240507,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2067,ERCC1,https://ctdbase.org/detail.go?type=gene&acc=2067,,,2067.0,ERCC1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the expression of ERCC1 mRNA,,,PMID:20624995,https://www.ncbi.nlm.nih.gov/pubmed/20624995,20624995,,
1871,240508,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2067,ERCC1,https://ctdbase.org/detail.go?type=gene&acc=2067,,,2067.0,ERCC1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ERCC1 mrna|folic acid inhibits the reaction [benzo(a)pyrene results in decreased expression of ERCC1 protein]|[folic acid co-treated with benzo(a)pyrene] results in increased expression of ERCC1 mrna|folic acid inhibits the reaction [benzo(a)pyrene results in decreased expression of ERCC1 mrna]|benzo(a)pyrene results in decreased expression of ERCC1 protein,,,PMID:30020114,https://www.ncbi.nlm.nih.gov/pubmed/30020114,30020114,,
1872,240509,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2067,ERCC1,https://ctdbase.org/detail.go?type=gene&acc=2067,,,2067.0,ERCC1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of ERCC1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1873,240835,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,26750,RPS6KC1,https://ctdbase.org/detail.go?type=gene&acc=26750,,,26750.0,RPS6KC1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RPS6KC1 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1874,240836,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,26750,RPS6KC1,https://ctdbase.org/detail.go?type=gene&acc=26750,,,26750.0,RPS6KC1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RPS6KC1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1875,240837,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83694,RPS6KL1,https://ctdbase.org/detail.go?type=gene&acc=83694,,,83694.0,RPS6KL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RPS6KL1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1876,240838,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8089,YEATS4,https://ctdbase.org/detail.go?type=gene&acc=8089,,,8089.0,YEATS4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of YEATS4 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1877,240839,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8089,YEATS4,https://ctdbase.org/detail.go?type=gene&acc=8089,,,8089.0,YEATS4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of YEATS4 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1878,240840,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7525,YES1,https://ctdbase.org/detail.go?type=gene&acc=7525,,,7525.0,YES1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of YES1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1879,240841,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,7525,YES1,https://ctdbase.org/detail.go?type=gene&acc=7525,,,7525.0,YES1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of YES1 mRNA,,,PMID:31255691,https://www.ncbi.nlm.nih.gov/pubmed/31255691,31255691,,
1880,240842,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54432,YIPF1,https://ctdbase.org/detail.go?type=gene&acc=54432,,,54432.0,YIPF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of YIPF1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1881,240843,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54432,YIPF1,https://ctdbase.org/detail.go?type=gene&acc=54432,,,54432.0,YIPF1,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of YIPF1 mrna]|benzo(a)pyrene results in increased expression of YIPF1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1882,240844,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,78992,YIPF2,https://ctdbase.org/detail.go?type=gene&acc=78992,,,78992.0,YIPF2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of YIPF2 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1883,240919,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55049,REX1BD,https://ctdbase.org/detail.go?type=gene&acc=55049,,,55049.0,REX1BD,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of REX1BD promoter,,,PMID:27901495|PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/27901495|https://www.ncbi.nlm.nih.gov/pubmed/30157460,27901495|30157460,,
1884,240920,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55049,REX1BD,https://ctdbase.org/detail.go?type=gene&acc=55049,,,55049.0,REX1BD,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of REX1BD mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1885,240921,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100288527,REXO1L2P,https://ctdbase.org/detail.go?type=gene&acc=100288527,,,100288527.0,REXO1L2P,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of REXO1L2P promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1886,240922,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25996,REXO2,https://ctdbase.org/detail.go?type=gene&acc=25996,,,25996.0,REXO2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of REXO2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1887,241124,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5983,RFC3,https://ctdbase.org/detail.go?type=gene&acc=5983,,,5983.0,RFC3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RFC3 mRNA,,,PMID:21802500,https://www.ncbi.nlm.nih.gov/pubmed/21802500,21802500,,
1888,241125,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5983,RFC3,https://ctdbase.org/detail.go?type=gene&acc=5983,,,5983.0,RFC3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RFC3 mRNA,,,PMID:32234424|PMID:33411230,https://www.ncbi.nlm.nih.gov/pubmed/32234424|https://www.ncbi.nlm.nih.gov/pubmed/33411230,32234424|33411230,,
1889,241256,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3853,KRT6A,https://ctdbase.org/detail.go?type=gene&acc=3853,,,3853.0,KRT6A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of KRT6A mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1890,241257,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3853,KRT6A,https://ctdbase.org/detail.go?type=gene&acc=3853,,,3853.0,KRT6A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KRT6A mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
1891,241258,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3854,KRT6B,https://ctdbase.org/detail.go?type=gene&acc=3854,,,3854.0,KRT6B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of KRT6B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1892,241259,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3854,KRT6B,https://ctdbase.org/detail.go?type=gene&acc=3854,,,3854.0,KRT6B,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of KRT6B mRNA,,,PMID:20127859|PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/20127859|https://www.ncbi.nlm.nih.gov/pubmed/23735875,20127859|23735875,,
1893,241260,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,286887,KRT6C,https://ctdbase.org/detail.go?type=gene&acc=286887,,,286887.0,KRT6C,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of KRT6C promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1894,241261,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3855,KRT7,https://ctdbase.org/detail.go?type=gene&acc=3855,,,3855.0,KRT7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of KRT7 exon|benzo(a)pyrene affects the methylation of KRT7 5' utr|benzo(a)pyrene results in decreased methylation of KRT7 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1895,241262,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3855,KRT7,https://ctdbase.org/detail.go?type=gene&acc=3855,,,3855.0,KRT7,9606.0,Homo sapiens (human),[soot co-treated with benzo(a)pyrene] results in increased expression of KRT7 protein modified form,,,PMID:24464499,https://www.ncbi.nlm.nih.gov/pubmed/24464499,24464499,,
1896,241263,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,3855,KRT7,https://ctdbase.org/detail.go?type=gene&acc=3855,,,3855.0,KRT7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to KRT7 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1897,241264,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,258676,OR4D10B,https://ctdbase.org/detail.go?type=gene&acc=258676,,,258676.0,Or4d10b,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of OR4D10B mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1898,241265,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,219986,OR4D11,https://ctdbase.org/detail.go?type=gene&acc=219986,,,219986.0,OR4D11,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of OR4D11 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1899,241793,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6240,RRM1,https://ctdbase.org/detail.go?type=gene&acc=6240,,,6240.0,RRM1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RRM1 mRNA,,,PMID:15034205|PMID:17942131,https://www.ncbi.nlm.nih.gov/pubmed/15034205|https://www.ncbi.nlm.nih.gov/pubmed/17942131,15034205|17942131,,
1900,241794,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6240,RRM1,https://ctdbase.org/detail.go?type=gene&acc=6240,,,6240.0,RRM1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RRM1 mRNA,,,PMID:20504355|PMID:22228805|PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/20504355|https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/22610609,20504355|22228805|22610609,,
1901,241795,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RRM2 promoter|benzo(a)pyrene affects the methylation of RRM2 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1902,241796,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RRM2 mRNA,,,PMID:20064835|PMID:20106945|PMID:21802500|PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21802500|https://www.ncbi.nlm.nih.gov/pubmed/22316170,20064835|20106945|21802500|22316170,,
1903,241797,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1904,241798,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RRM2 mRNA,,,PMID:17942131|PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/17942131|https://www.ncbi.nlm.nih.gov/pubmed/19770486,17942131|19770486,,
1905,241971,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,50484,RRM2B,https://ctdbase.org/detail.go?type=gene&acc=50484,,,50484.0,RRM2B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RRM2B mRNA,,,PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:30453624|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/30453624|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20064835|20106945|21632981|22316170|30453624|32234424,,
1906,241972,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54700,RRN3,https://ctdbase.org/detail.go?type=gene&acc=54700,,,54700.0,RRN3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RRN3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1907,241973,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54700,RRN3,https://ctdbase.org/detail.go?type=gene&acc=54700,,,54700.0,RRN3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RRN3 mRNA,,,PMID:19770486|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/22228805,19770486|22228805,,
1908,241974,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,730092,RRN3P1,https://ctdbase.org/detail.go?type=gene&acc=730092,,,730092.0,RRN3P1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RRN3P1 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
1909,241975,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,730092,RRN3P1,https://ctdbase.org/detail.go?type=gene&acc=730092,,,730092.0,RRN3P1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RRN3P1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1910,241976,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8568,RRP1,https://ctdbase.org/detail.go?type=gene&acc=8568,,,8568.0,RRP1,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RRP1 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1911,241977,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23223,RRP12,https://ctdbase.org/detail.go?type=gene&acc=23223,,,23223.0,RRP12,7955.0,Danio rerio (zebrafish),[benzo(a)pyrene co-treated with fluoranthene] affects the expression of RRP12 mRNA,,,PMID:25412620,https://www.ncbi.nlm.nih.gov/pubmed/25412620,25412620,,
1912,242487,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23179,RGL1,https://ctdbase.org/detail.go?type=gene&acc=23179,,,23179.0,RGL1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene affects the expression of RGL1 mRNA,,,PMID:22342234,https://www.ncbi.nlm.nih.gov/pubmed/22342234,22342234,,
1913,242488,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23179,RGL1,https://ctdbase.org/detail.go?type=gene&acc=23179,,,23179.0,RGL1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RGL1 mRNA,,,PMID:20713471|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/20713471|https://www.ncbi.nlm.nih.gov/pubmed/22228805,20713471|22228805,,
1914,242489,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57139,RGL3,https://ctdbase.org/detail.go?type=gene&acc=57139,,,57139.0,RGL3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RGL3 polya tail,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1915,242490,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57139,RGL3,https://ctdbase.org/detail.go?type=gene&acc=57139,,,57139.0,RGL3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RGL3 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1916,242491,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57139,RGL3,https://ctdbase.org/detail.go?type=gene&acc=57139,,,57139.0,RGL3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RGL3 exon|benzo(a)pyrene results in decreased methylation of RGL3 promoter|benzo(a)pyrene results in increased methylation of RGL3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1917,243138,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6002,RGS12,https://ctdbase.org/detail.go?type=gene&acc=6002,,,6002.0,RGS12,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RGS12 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1918,243139,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6002,RGS12,https://ctdbase.org/detail.go?type=gene&acc=6002,,,6002.0,RGS12,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RGS12 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1919,243140,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6002,RGS12,https://ctdbase.org/detail.go?type=gene&acc=6002,,,6002.0,RGS12,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RGS12 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1920,243141,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6002,RGS12,https://ctdbase.org/detail.go?type=gene&acc=6002,,,6002.0,RGS12,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RGS12 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1921,243142,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6002,RGS12,https://ctdbase.org/detail.go?type=gene&acc=6002,,,6002.0,RGS12,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RGS12 mRNA,,,PMID:21569818|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/22228805,21569818|22228805,,
1922,243143,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6002,RGS12,https://ctdbase.org/detail.go?type=gene&acc=6002,,,6002.0,RGS12,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RGS12 mRNA,,,PMID:22610609|PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/22610609|https://www.ncbi.nlm.nih.gov/pubmed/23735875,22610609|23735875,,
1923,243144,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6003,RGS13,https://ctdbase.org/detail.go?type=gene&acc=6003,,,6003.0,RGS13,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of RGS13 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1924,243328,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,309622,RT1-BB,https://ctdbase.org/detail.go?type=gene&acc=309622,,,309622.0,RT1-Bb,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of RT1-BB mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1925,243329,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83546,RTBDN,https://ctdbase.org/detail.go?type=gene&acc=83546,,,83546.0,RTBDN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RTBDN 3' utr|benzo(a)pyrene affects the methylation of RTBDN promoter|benzo(a)pyrene affects the methylation of RTBDN exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1926,243330,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8634,RTCA,https://ctdbase.org/detail.go?type=gene&acc=8634,,,8634.0,RTCA,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased methylation of RTCA intron|benzo(a)pyrene results in decreased methylation of RTCA exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1927,243331,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51493,RTCB,https://ctdbase.org/detail.go?type=gene&acc=51493,,,51493.0,RTCB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RTCB promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1928,243332,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51493,RTCB,https://ctdbase.org/detail.go?type=gene&acc=51493,,,51493.0,RTCB,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RTCB mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1929,243333,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51750,RTEL1,https://ctdbase.org/detail.go?type=gene&acc=51750,,,51750.0,RTEL1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RTEL1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1930,243334,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51750,RTEL1,https://ctdbase.org/detail.go?type=gene&acc=51750,,,51750.0,RTEL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RTEL1 promoter|benzo(a)pyrene results in increased methylation of RTEL1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1931,243553,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2101,ESRRA,https://ctdbase.org/detail.go?type=gene&acc=2101,,,2101.0,ESRRA,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ESRRA 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1932,243554,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2101,ESRRA,https://ctdbase.org/detail.go?type=gene&acc=2101,,,2101.0,ESRRA,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ESRRA mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1933,243708,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,153918,ZC2HC1B,https://ctdbase.org/detail.go?type=gene&acc=153918,,,153918.0,ZC2HC1B,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ZC2HC1B 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1934,243709,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9877,ZC3H11A,https://ctdbase.org/detail.go?type=gene&acc=9877,,,9877.0,ZC3H11A,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ZC3H11A 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1935,243710,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80149,ZC3H12A,https://ctdbase.org/detail.go?type=gene&acc=80149,,,80149.0,ZC3H12A,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] affects the expression of ZC3H12A mrna|benzo(a)pyrene results in increased expression of ZC3H12A mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1936,243711,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80149,ZC3H12A,https://ctdbase.org/detail.go?type=gene&acc=80149,,,80149.0,ZC3H12A,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ZC3H12A promoter|benzo(a)pyrene results in increased methylation of ZC3H12A 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1937,243712,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80149,ZC3H12A,https://ctdbase.org/detail.go?type=gene&acc=80149,,,80149.0,ZC3H12A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to ZC3H12A promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1938,243713,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,80149,ZC3H12A,https://ctdbase.org/detail.go?type=gene&acc=80149,,,80149.0,ZC3H12A,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ZC3H12A mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1939,243714,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,340554,ZC3H12B,https://ctdbase.org/detail.go?type=gene&acc=340554,,,340554.0,ZC3H12B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ZC3H12B promoter|benzo(a)pyrene affects the methylation of ZC3H12B 3' utr|benzo(a)pyrene results in decreased methylation of ZC3H12B exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1940,243715,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,340152,ZC3H12D,https://ctdbase.org/detail.go?type=gene&acc=340152,,,340152.0,ZC3H12D,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ZC3H12D promoter|benzo(a)pyrene results in increased methylation of ZC3H12D 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1941,243895,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,79882,ZC3H14,https://ctdbase.org/detail.go?type=gene&acc=79882,,,79882.0,ZC3H14,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ZC3H14 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1942,243896,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55854,ZC3H15,https://ctdbase.org/detail.go?type=gene&acc=55854,,,55854.0,ZC3H15,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ZC3H15 mrna|ahr protein promotes the reaction [benzo(a)pyrene results in decreased expression of ZC3H15 mrna],,,PMID:15034205,https://www.ncbi.nlm.nih.gov/pubmed/15034205,15034205,,
1943,243897,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55854,ZC3H15,https://ctdbase.org/detail.go?type=gene&acc=55854,,,55854.0,ZC3H15,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZC3H15 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1944,243898,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,124245,ZC3H18,https://ctdbase.org/detail.go?type=gene&acc=124245,,,124245.0,ZC3H18,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ZC3H18 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1945,243899,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,124245,ZC3H18,https://ctdbase.org/detail.go?type=gene&acc=124245,,,124245.0,ZC3H18,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZC3H18 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1946,244087,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57142,RTN4,https://ctdbase.org/detail.go?type=gene&acc=57142,,,57142.0,RTN4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RTN4 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1947,244088,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,57142,RTN4,https://ctdbase.org/detail.go?type=gene&acc=57142,,,57142.0,RTN4,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of RTN4 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
1948,244089,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84816,RTN4IP1,https://ctdbase.org/detail.go?type=gene&acc=84816,,,84816.0,RTN4IP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RTN4IP1 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
1949,244090,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,65078,RTN4R,https://ctdbase.org/detail.go?type=gene&acc=65078,,,65078.0,RTN4R,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RTN4R intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1950,244091,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,146760,RTN4RL1,https://ctdbase.org/detail.go?type=gene&acc=146760,,,146760.0,RTN4RL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RTN4RL1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1951,244092,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,146760,RTN4RL1,https://ctdbase.org/detail.go?type=gene&acc=146760,,,146760.0,RTN4RL1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RTN4RL1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
1952,244093,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,349667,RTN4RL2,https://ctdbase.org/detail.go?type=gene&acc=349667,,,349667.0,RTN4RL2,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of RTN4RL2 mrna|[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of RTN4RL2 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1953,244094,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,349667,RTN4RL2,https://ctdbase.org/detail.go?type=gene&acc=349667,,,349667.0,RTN4RL2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RTN4RL2 mRNA,,,PMID:19770486|PMID:21715664|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21715664|https://www.ncbi.nlm.nih.gov/pubmed/32417428,19770486|21715664|32417428,,
1954,244095,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,132112,RTP1,https://ctdbase.org/detail.go?type=gene&acc=132112,,,132112.0,RTP1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RTP1 promoter|benzo(a)pyrene affects the methylation of RTP1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1955,244096,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,132112,RTP1,https://ctdbase.org/detail.go?type=gene&acc=132112,,,132112.0,RTP1,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of RTP1 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1956,244239,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,389874,ZCCHC13,https://ctdbase.org/detail.go?type=gene&acc=389874,,,389874.0,ZCCHC13,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ZCCHC13 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1957,244240,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23174,ZCCHC14,https://ctdbase.org/detail.go?type=gene&acc=23174,,,23174.0,ZCCHC14,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ZCCHC14 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
1958,244241,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23174,ZCCHC14,https://ctdbase.org/detail.go?type=gene&acc=23174,,,23174.0,ZCCHC14,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ZCCHC14 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1959,244242,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83597,RTP3,https://ctdbase.org/detail.go?type=gene&acc=83597,,,83597.0,RTP3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RTP3 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1960,244243,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83597,RTP3,https://ctdbase.org/detail.go?type=gene&acc=83597,,,83597.0,RTP3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RTP3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1961,244244,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83597,RTP3,https://ctdbase.org/detail.go?type=gene&acc=83597,,,83597.0,RTP3,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RTP3 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
1962,244245,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64108,RTP4,https://ctdbase.org/detail.go?type=gene&acc=64108,,,64108.0,RTP4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RTP4 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1963,244246,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64108,RTP4,https://ctdbase.org/detail.go?type=gene&acc=64108,,,64108.0,RTP4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RTP4 gene|benzo(a)pyrene results in decreased expression of RTP4 mRNA,,,PMID:31555880,https://www.ncbi.nlm.nih.gov/pubmed/31555880,31555880,,
1964,244247,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64108,RTP4,https://ctdbase.org/detail.go?type=gene&acc=64108,,,64108.0,RTP4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RTP4 mRNA,,,PMID:19770486|PMID:20713471|PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/20713471|https://www.ncbi.nlm.nih.gov/pubmed/21569818,19770486|20713471|21569818,,
1965,244248,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64108,RTP4,https://ctdbase.org/detail.go?type=gene&acc=64108,,,64108.0,RTP4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RTP4 mRNA,,,PMID:22228805|PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/23735875,22228805|23735875,,
1966,244399,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,219654,ZCCHC24,https://ctdbase.org/detail.go?type=gene&acc=219654,,,219654.0,ZCCHC24,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of ZCCHC24 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1967,244400,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,219654,ZCCHC24,https://ctdbase.org/detail.go?type=gene&acc=219654,,,219654.0,ZCCHC24,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ZCCHC24 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1968,244401,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,219654,ZCCHC24,https://ctdbase.org/detail.go?type=gene&acc=219654,,,219654.0,ZCCHC24,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ZCCHC24 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1969,244402,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,219654,ZCCHC24,https://ctdbase.org/detail.go?type=gene&acc=219654,,,219654.0,ZCCHC24,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ZCCHC24 3' utr|benzo(a)pyrene results in increased methylation of ZCCHC24 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1970,244403,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,85364,ZCCHC3,https://ctdbase.org/detail.go?type=gene&acc=85364,,,85364.0,ZCCHC3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ZCCHC3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1971,244404,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5269,SERPINB6,https://ctdbase.org/detail.go?type=gene&acc=5269,,,5269.0,SERPINB6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of SERPINB6 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1972,244582,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,85364,ZCCHC3,https://ctdbase.org/detail.go?type=gene&acc=85364,,,85364.0,ZCCHC3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZCCHC3 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of ZCCHC3 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1973,244583,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100857368,ZCCHC6,https://ctdbase.org/detail.go?type=gene&acc=100857368,,,100857368.0,ZCCHC6,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ZCCHC6 promoter|benzo(a)pyrene results in increased methylation of ZCCHC6 exon|benzo(a)pyrene results in increased methylation of ZCCHC6 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1974,244584,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84186,ZCCHC7,https://ctdbase.org/detail.go?type=gene&acc=84186,,,84186.0,ZCCHC7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ZCCHC7 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
1975,244585,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84186,ZCCHC7,https://ctdbase.org/detail.go?type=gene&acc=84186,,,84186.0,ZCCHC7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZCCHC7 mRNA,,,PMID:21964900,https://www.ncbi.nlm.nih.gov/pubmed/21964900,21964900,,
1976,244586,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55596,ZCCHC8,https://ctdbase.org/detail.go?type=gene&acc=55596,,,55596.0,ZCCHC8,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ZCCHC8 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1977,244587,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84240,ZCCHC9,https://ctdbase.org/detail.go?type=gene&acc=84240,,,84240.0,ZCCHC9,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ZCCHC9 mrna|benzo(a)pyrene results in increased expression of ZCCHC9 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1978,244588,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55063,ZCWPW1,https://ctdbase.org/detail.go?type=gene&acc=55063,,,55063.0,ZCWPW1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ZCWPW1 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
1979,244589,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55063,ZCWPW1,https://ctdbase.org/detail.go?type=gene&acc=55063,,,55063.0,ZCWPW1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ZCWPW1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1980,244924,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51201,ZDHHC2,https://ctdbase.org/detail.go?type=gene&acc=51201,,,51201.0,ZDHHC2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of ZDHHC2 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1981,244925,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,253832,ZDHHC20,https://ctdbase.org/detail.go?type=gene&acc=253832,,,253832.0,ZDHHC20,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of ZDHHC20 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
1982,245249,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6009,RHEB,https://ctdbase.org/detail.go?type=gene&acc=6009,,,6009.0,RHEB,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RHEB promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1983,245250,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,121268,RHEBL1,https://ctdbase.org/detail.go?type=gene&acc=121268,,,121268.0,RHEBL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RHEBL1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1984,245251,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,121268,RHEBL1,https://ctdbase.org/detail.go?type=gene&acc=121268,,,121268.0,RHEBL1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RHEBL1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1985,245252,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,440712,RHEX,https://ctdbase.org/detail.go?type=gene&acc=440712,,,440712.0,RHEX,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RHEX 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1986,245253,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,440712,RHEX,https://ctdbase.org/detail.go?type=gene&acc=440712,,,440712.0,RHEX,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RHEX mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1987,245254,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,440712,RHEX,https://ctdbase.org/detail.go?type=gene&acc=440712,,,440712.0,RHEX,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of RHEX gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
1988,245255,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83695,RHNO1,https://ctdbase.org/detail.go?type=gene&acc=83695,,,83695.0,RHNO1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of RHNO1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
1989,245256,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6010,RHO,https://ctdbase.org/detail.go?type=gene&acc=6010,,,6010.0,RHO,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RHO 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1990,245394,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51289,RXFP3,https://ctdbase.org/detail.go?type=gene&acc=51289,,,51289.0,RXFP3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to RXFP3 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
1991,245395,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,339403,RXFP4,https://ctdbase.org/detail.go?type=gene&acc=339403,,,339403.0,RXFP4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RXFP4 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1992,245396,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RXRA intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
1993,245397,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Benzo(a)pyrene inhibits the reaction [calcitriol promotes the reaction [RXRA protein binds to CYP24A1 promoter]],,,PMID:19244278,https://www.ncbi.nlm.nih.gov/pubmed/19244278,19244278,,
1994,245398,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of RXRA mRNA,,,PMID:20064835|PMID:22316170|PMID:26238291|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/32234424,20064835|22316170|26238291|32234424,,
1995,245399,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RXRA 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1996,245912,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,29984,RHOD,https://ctdbase.org/detail.go?type=gene&acc=29984,,,29984.0,RHOD,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RHOD promoter|benzo(a)pyrene results in decreased methylation of RHOD exon|benzo(a)pyrene results in increased methylation of RHOD 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
1997,246406,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,27081,ZFP275,https://ctdbase.org/detail.go?type=gene&acc=27081,,,27081.0,Zfp275,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP275 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1998,246407,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,246196,ZFP277,https://ctdbase.org/detail.go?type=gene&acc=246196,,,246196.0,Zfp277,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ZFP277 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of ZFP277 mrna]|benzo(a)pyrene results in increased expression of ZFP277 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
1999,246769,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23586,RIGI,https://ctdbase.org/detail.go?type=gene&acc=23586,,,23586.0,RIGI,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RIGI mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2000,246770,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,284485,RIIAD1,https://ctdbase.org/detail.go?type=gene&acc=284485,,,284485.0,RIIAD1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RIIAD1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2001,246771,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,284485,RIIAD1,https://ctdbase.org/detail.go?type=gene&acc=284485,,,284485.0,RIIAD1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of RIIAD1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2002,246772,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83547,RILP,https://ctdbase.org/detail.go?type=gene&acc=83547,,,83547.0,RILP,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of RILP mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
2003,246773,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83547,RILP,https://ctdbase.org/detail.go?type=gene&acc=83547,,,83547.0,RILP,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of RILP promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2004,246774,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,83547,RILP,https://ctdbase.org/detail.go?type=gene&acc=83547,,,83547.0,RILP,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of RILP mRNA,,,PMID:27195522,https://www.ncbi.nlm.nih.gov/pubmed/27195522,27195522,,
2005,246775,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,353116,RILPL1,https://ctdbase.org/detail.go?type=gene&acc=353116,,,353116.0,RILPL1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RILPL1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2006,246776,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,353116,RILPL1,https://ctdbase.org/detail.go?type=gene&acc=353116,,,353116.0,RILPL1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of RILPL1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2007,246777,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,196383,RILPL2,https://ctdbase.org/detail.go?type=gene&acc=196383,,,196383.0,RILPL2,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in increased expression of RILPL2 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
2008,246778,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23504,RIMBP2,https://ctdbase.org/detail.go?type=gene&acc=23504,,,23504.0,RIMBP2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of RIMBP2 5' utr|benzo(a)pyrene affects the methylation of RIMBP2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2009,247076,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,346007,EYS,https://ctdbase.org/detail.go?type=gene&acc=346007,,,346007.0,EYS,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of EYS intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2010,247077,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,346007,EYS,https://ctdbase.org/detail.go?type=gene&acc=346007,,,346007.0,EYS,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of EYS 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2011,247234,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11331,PHB2,https://ctdbase.org/detail.go?type=gene&acc=11331,,,11331.0,PHB2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PHB2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2012,247235,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11331,PHB2,https://ctdbase.org/detail.go?type=gene&acc=11331,,,11331.0,PHB2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of PHB2 protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
2013,247236,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,11331,PHB2,https://ctdbase.org/detail.go?type=gene&acc=11331,,,11331.0,PHB2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to PHB2 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
2014,247237,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1911,PHC1,https://ctdbase.org/detail.go?type=gene&acc=1911,,,1911.0,PHC1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PHC1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2015,247238,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1911,PHC1,https://ctdbase.org/detail.go?type=gene&acc=1911,,,1911.0,PHC1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PHC1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2016,247239,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,328801,ZFP414,https://ctdbase.org/detail.go?type=gene&acc=328801,,,328801.0,Zfp414,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP414 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2017,247240,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,232854,ZFP418,https://ctdbase.org/detail.go?type=gene&acc=232854,,,232854.0,Zfp418,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP418 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2018,247241,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,132625,ZFP42,https://ctdbase.org/detail.go?type=gene&acc=132625,,,132625.0,ZFP42,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of ZFP42 5' utr|benzo(a)pyrene results in increased methylation of ZFP42 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2019,247242,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,132625,ZFP42,https://ctdbase.org/detail.go?type=gene&acc=132625,,,132625.0,ZFP42,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of ZFP42 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
2020,247243,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,232969,ZFP428,https://ctdbase.org/detail.go?type=gene&acc=232969,,,232969.0,Zfp428,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ZFP428 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2021,247420,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5251,PHEX,https://ctdbase.org/detail.go?type=gene&acc=5251,,,5251.0,PHEX,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PHEX mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2022,247421,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5251,PHEX,https://ctdbase.org/detail.go?type=gene&acc=5251,,,5251.0,PHEX,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PHEX mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2023,247422,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5252,PHF1,https://ctdbase.org/detail.go?type=gene&acc=5252,,,5252.0,PHF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PHF1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2024,247423,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5252,PHF1,https://ctdbase.org/detail.go?type=gene&acc=5252,,,5252.0,PHF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PHF1 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
2025,247424,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5252,PHF1,https://ctdbase.org/detail.go?type=gene&acc=5252,,,5252.0,PHF1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PHF1 mRNA,,,PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/21715664,21715664,,
2026,247425,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55274,PHF10,https://ctdbase.org/detail.go?type=gene&acc=55274,,,55274.0,PHF10,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PHF10 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2027,247426,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,224691,ZFP472,https://ctdbase.org/detail.go?type=gene&acc=224691,,,224691.0,Zfp472,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP472 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2028,247427,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,243963,ZFP473,https://ctdbase.org/detail.go?type=gene&acc=243963,,,243963.0,Zfp473,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ZFP473 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2029,247428,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,69752,ZFP511,https://ctdbase.org/detail.go?type=gene&acc=69752,,,69752.0,Zfp511,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP511 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2030,247429,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22710,ZFP52,https://ctdbase.org/detail.go?type=gene&acc=22710,,,22710.0,Zfp52,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP52 mRNA,,,PMID:19770486|PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21569818,19770486|21569818,,
2031,248405,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,644844,PHGR1,https://ctdbase.org/detail.go?type=gene&acc=644844,,,644844.0,PHGR1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PHGR1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2032,248406,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55023,PHIP,https://ctdbase.org/detail.go?type=gene&acc=55023,,,55023.0,PHIP,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PHIP mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2033,248407,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55023,PHIP,https://ctdbase.org/detail.go?type=gene&acc=55023,,,55023.0,PHIP,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of PHIP mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
2034,248408,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5255,PHKA1,https://ctdbase.org/detail.go?type=gene&acc=5255,,,5255.0,PHKA1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PHKA1 promoter|benzo(a)pyrene results in increased methylation of PHKA1 5' utr|benzo(a)pyrene affects the methylation of PHKA1 3' utr|benzo(a)pyrene results in increased methylation of PHKA1 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2035,248409,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5255,PHKA1,https://ctdbase.org/detail.go?type=gene&acc=5255,,,5255.0,PHKA1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PHKA1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2036,248410,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5256,PHKA2,https://ctdbase.org/detail.go?type=gene&acc=5256,,,5256.0,PHKA2,44932.0,Boreogadus saida,Benzo(a)pyrene results in decreased expression of PHKA2 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
2037,248411,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5256,PHKA2,https://ctdbase.org/detail.go?type=gene&acc=5256,,,5256.0,PHKA2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PHKA2 promoter|benzo(a)pyrene affects the methylation of PHKA2 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2038,248412,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100132163,PHKA2-AS1,https://ctdbase.org/detail.go?type=gene&acc=100132163,,,100132163.0,PHKA2-AS1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PHKA2-AS1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2039,248413,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5257,PHKB,https://ctdbase.org/detail.go?type=gene&acc=5257,,,5257.0,PHKB,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PHKB intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2040,248890,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,67109,ZFP787,https://ctdbase.org/detail.go?type=gene&acc=67109,,,67109.0,Zfp787,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP787 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2041,248891,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,233056,ZFP790,https://ctdbase.org/detail.go?type=gene&acc=233056,,,233056.0,Zfp790,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of ZFP790 exon|benzo(a)pyrene results in increased methylation of ZFP790 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2042,248892,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,240064,ZFP799,https://ctdbase.org/detail.go?type=gene&acc=240064,,,240064.0,Zfp799,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP799 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2043,248893,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,241514,ZFP804A,https://ctdbase.org/detail.go?type=gene&acc=241514,,,241514.0,Zfp804a,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of ZFP804A exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2044,248894,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,235047,ZFP809,https://ctdbase.org/detail.go?type=gene&acc=235047,,,235047.0,Zfp809,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP809 mRNA,,,PMID:21569818|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/21569818|https://www.ncbi.nlm.nih.gov/pubmed/22228805,21569818|22228805,,
2045,248895,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,284406,ZFP82,https://ctdbase.org/detail.go?type=gene&acc=284406,,,284406.0,ZFP82,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of ZFP82 5' utr|benzo(a)pyrene affects the methylation of ZFP82 promoter|benzo(a)pyrene results in decreased methylation of ZFP82 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2046,248896,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,235956,ZFP825,https://ctdbase.org/detail.go?type=gene&acc=235956,,,235956.0,Zfp825,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP825 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2047,248897,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,622675,ZFP827,https://ctdbase.org/detail.go?type=gene&acc=622675,,,622675.0,Zfp827,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of ZFP827 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
2048,248898,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,66983,ZFP830,https://ctdbase.org/detail.go?type=gene&acc=66983,,,66983.0,Zfp830,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to ZFP830 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
2049,248899,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22746,ZFP85,https://ctdbase.org/detail.go?type=gene&acc=22746,,,22746.0,Zfp85,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFP85 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2050,249052,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,93594,TBC1D31,https://ctdbase.org/detail.go?type=gene&acc=93594,,,93594.0,TBC1D31,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of TBC1D31 mRNA,,,PMID:20064835,https://www.ncbi.nlm.nih.gov/pubmed/20064835,20064835,,
2051,249053,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,221322,TBC1D32,https://ctdbase.org/detail.go?type=gene&acc=221322,,,221322.0,TBC1D32,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of TBC1D32 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2052,249054,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,102723859,TBC1D3E,https://ctdbase.org/detail.go?type=gene&acc=102723859,,,102723859.0,TBC1D3E,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of TBC1D3E promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2053,249055,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84218,TBC1D3F,https://ctdbase.org/detail.go?type=gene&acc=84218,,,84218.0,TBC1D3F,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of TBC1D3F mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
2054,249056,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,729877,TBC1D3H,https://ctdbase.org/detail.go?type=gene&acc=729877,,,729877.0,TBC1D3H,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of TBC1D3H promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2055,249057,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,653645,TBC1D3P1-DHX40P1,https://ctdbase.org/detail.go?type=gene&acc=653645,,,653645.0,TBC1D3P1-DHX40P1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of TBC1D3P1-DHX40P1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2056,249058,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9882,TBC1D4,https://ctdbase.org/detail.go?type=gene&acc=9882,,,9882.0,TBC1D4,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of TBC1D4 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
2057,249059,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9882,TBC1D4,https://ctdbase.org/detail.go?type=gene&acc=9882,,,9882.0,TBC1D4,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of TBC1D4 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2058,249615,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,254295,PHYHD1,https://ctdbase.org/detail.go?type=gene&acc=254295,,,254295.0,PHYHD1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of PHYHD1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2059,249616,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,254295,PHYHD1,https://ctdbase.org/detail.go?type=gene&acc=254295,,,254295.0,PHYHD1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of PHYHD1 mRNA,,,PMID:19770486|PMID:21715664,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21715664,19770486|21715664,,
2060,249617,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,254295,PHYHD1,https://ctdbase.org/detail.go?type=gene&acc=254295,,,254295.0,PHYHD1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of PHYHD1 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
2061,249618,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9796,PHYHIP,https://ctdbase.org/detail.go?type=gene&acc=9796,,,9796.0,PHYHIP,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of PHYHIP 5' utr|benzo(a)pyrene results in increased methylation of PHYHIP promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2062,249619,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9796,PHYHIP,https://ctdbase.org/detail.go?type=gene&acc=9796,,,9796.0,PHYHIP,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of PHYHIP mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2063,249620,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84457,PHYHIPL,https://ctdbase.org/detail.go?type=gene&acc=84457,,,84457.0,PHYHIPL,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of PHYHIPL 5' utr|benzo(a)pyrene results in increased methylation of PHYHIPL 3' utr|benzo(a)pyrene results in decreased methylation of PHYHIPL promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2064,249788,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23503,ZFYVE26,https://ctdbase.org/detail.go?type=gene&acc=23503,,,23503.0,ZFYVE26,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ZFYVE26 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2065,249789,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23503,ZFYVE26,https://ctdbase.org/detail.go?type=gene&acc=23503,,,23503.0,ZFYVE26,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of ZFYVE26 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2066,249790,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,118813,ZFYVE27,https://ctdbase.org/detail.go?type=gene&acc=118813,,,118813.0,ZFYVE27,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of ZFYVE27 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2067,250130,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,81846,SBF2,https://ctdbase.org/detail.go?type=gene&acc=81846,,,81846.0,SBF2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased methylation of SBF2 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2068,250131,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,388228,SBK1,https://ctdbase.org/detail.go?type=gene&acc=388228,,,388228.0,SBK1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of SBK1 5' utr|benzo(a)pyrene results in increased methylation of SBK1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2069,250132,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,388228,SBK1,https://ctdbase.org/detail.go?type=gene&acc=388228,,,388228.0,SBK1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of SBK1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2070,250133,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,646643,SBK2,https://ctdbase.org/detail.go?type=gene&acc=646643,,,646643.0,SBK2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of SBK2 exon|benzo(a)pyrene results in increased methylation of SBK2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2071,250134,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55206,SBNO1,https://ctdbase.org/detail.go?type=gene&acc=55206,,,55206.0,SBNO1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of SBNO1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2072,250135,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22904,SBNO2,https://ctdbase.org/detail.go?type=gene&acc=22904,,,22904.0,SBNO2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of SBNO2 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2073,250136,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,22904,SBNO2,https://ctdbase.org/detail.go?type=gene&acc=22904,,,22904.0,SBNO2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of SBNO2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2074,250336,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9522,SCAMP1,https://ctdbase.org/detail.go?type=gene&acc=9522,,,9522.0,SCAMP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of SCAMP1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2075,250337,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9522,SCAMP1,https://ctdbase.org/detail.go?type=gene&acc=9522,,,9522.0,SCAMP1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of SCAMP1 exon|benzo(a)pyrene results in increased methylation of SCAMP1 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2076,294915,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2934,GSN,https://ctdbase.org/detail.go?type=gene&acc=2934,,,2934.0,GSN,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of GSN mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
2077,294916,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2934,GSN,https://ctdbase.org/detail.go?type=gene&acc=2934,,,2934.0,GSN,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of GSN mRNA,,,PMID:19770486|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/22228805,19770486|22228805,,
2078,294917,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2935,GSPT1,https://ctdbase.org/detail.go?type=gene&acc=2935,,,2935.0,GSPT1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of GSPT1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2079,296592,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),[benzo(a)pyrene co-treated with vehicle emissions] results in decreased expression of CYP1B1 protein,,,PMID:20435083,https://www.ncbi.nlm.nih.gov/pubmed/20435083,20435083,,
2080,296593,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Benzo(a)pyrene promotes the reaction [estradiol results in increased expression of CYP1B1 mrna],,,PMID:19619570,https://www.ncbi.nlm.nih.gov/pubmed/19619570,19619570,,
2081,296594,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased activity of CYP1B1 protein,,,PMID:15905203|PMID:16484233|PMID:33411230,https://www.ncbi.nlm.nih.gov/pubmed/15905203|https://www.ncbi.nlm.nih.gov/pubmed/16484233|https://www.ncbi.nlm.nih.gov/pubmed/33411230,15905203|16484233|33411230,,
2082,296595,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,13101,CYP2D10,https://ctdbase.org/detail.go?type=gene&acc=13101,,,13101.0,Cyp2d10,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CYP2D10 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2083,296596,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of CYP1B1 mRNA,,,PMID:11854143|PMID:12107646|PMID:15041469|PMID:15297370|PMID:15566942|PMID:15713371|PMID:15735009|PMID:15808406|PMID:15808407|PMID:15905203|PMID:16120219|PMID:16258175|PMID:16381670|PMID:16484233|PMID:16530937|PMID:17253728|PMID:18061397|PMID:18174961|PMID:18214805|PMID:19152381|PMID:19244278|PMID:19358281|PMID:19365803|PMID:19576839|PMID:19835593|PMID:19879285|PMID:19879933|PMID:19919601|PMID:20064835|PMID:20106945|PMID:20163913|PMID:20228066|PMID:20553787|PMID:20702593|PMID:20951464|PMID:21256203|PMID:21256954|PMID:21632981|PMID:21669939|PMID:21714911|PMID:21873647|PMID:21887816|PMID:22167199|PMID:22178795|PMID:22316170|PMID:22581694|PMID:24114850|PMID:24472612|PMID:25233930|PMID:26438400|PMID:27196671|PMID:27830268|PMID:28238931|PMID:28351761|PMID:28461126|PMID:30248327|PMID:30439556|PMID:30453624|PMID:31087746|PMID:31111189|PMID:31255691|PMID:31515600|PMID:31830554|PMID:32234424|PMID:32890658|PMID:33411230|PMID:33421718|PMID:35870112,https://www.ncbi.nlm.nih.gov/pubmed/11854143|https://www.ncbi.nlm.nih.gov/pubmed/12107646|https://www.ncbi.nlm.nih.gov/pubmed/15041469|https://www.ncbi.nlm.nih.gov/pubmed/15297370|https://www.ncbi.nlm.nih.gov/pubmed/15566942|https://www.ncbi.nlm.nih.gov/pubmed/15713371|https://www.ncbi.nlm.nih.gov/pubmed/15735009|https://www.ncbi.nlm.nih.gov/pubmed/15808406|https://www.ncbi.nlm.nih.gov/pubmed/15808407|https://www.ncbi.nlm.nih.gov/pubmed/15905203|https://www.ncbi.nlm.nih.gov/pubmed/16120219|https://www.ncbi.nlm.nih.gov/pubmed/16258175|https://www.ncbi.nlm.nih.gov/pubmed/16381670|https://www.ncbi.nlm.nih.gov/pubmed/16484233|https://www.ncbi.nlm.nih.gov/pubmed/16530937|https://www.ncbi.nlm.nih.gov/pubmed/17253728|https://www.ncbi.nlm.nih.gov/pubmed/18061397|https://www.ncbi.nlm.nih.gov/pubmed/18174961|https://www.ncbi.nlm.nih.gov/pubmed/18214805|https://www.ncbi.nlm.nih.gov/pubmed/19152381|https://www.ncbi.nlm.nih.gov/pubmed/19244278|https://www.ncbi.nlm.nih.gov/pubmed/19358281|https://www.ncbi.nlm.nih.gov/pubmed/19365803|https://www.ncbi.nlm.nih.gov/pubmed/19576839|https://www.ncbi.nlm.nih.gov/pubmed/19835593|https://www.ncbi.nlm.nih.gov/pubmed/19879285|https://www.ncbi.nlm.nih.gov/pubmed/19879933|https://www.ncbi.nlm.nih.gov/pubmed/19919601|https://www.ncbi.nlm.nih.gov/pubmed/20064835|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/20163913|https://www.ncbi.nlm.nih.gov/pubmed/20228066|https://www.ncbi.nlm.nih.gov/pubmed/20553787|https://www.ncbi.nlm.nih.gov/pubmed/20702593|https://www.ncbi.nlm.nih.gov/pubmed/20951464|https://www.ncbi.nlm.nih.gov/pubmed/21256203|https://www.ncbi.nlm.nih.gov/pubmed/21256954|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/21669939|https://www.ncbi.nlm.nih.gov/pubmed/21714911|https://www.ncbi.nlm.nih.gov/pubmed/21873647|https://www.ncbi.nlm.nih.gov/pubmed/21887816|https://www.ncbi.nlm.nih.gov/pubmed/22167199|https://www.ncbi.nlm.nih.gov/pubmed/22178795|https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/22581694|https://www.ncbi.nlm.nih.gov/pubmed/24114850|https://www.ncbi.nlm.nih.gov/pubmed/24472612|https://www.ncbi.nlm.nih.gov/pubmed/25233930|https://www.ncbi.nlm.nih.gov/pubmed/26438400|https://www.ncbi.nlm.nih.gov/pubmed/27196671|https://www.ncbi.nlm.nih.gov/pubmed/27830268|https://www.ncbi.nlm.nih.gov/pubmed/28238931|https://www.ncbi.nlm.nih.gov/pubmed/28351761|https://www.ncbi.nlm.nih.gov/pubmed/28461126|https://www.ncbi.nlm.nih.gov/pubmed/30248327|https://www.ncbi.nlm.nih.gov/pubmed/30439556|https://www.ncbi.nlm.nih.gov/pubmed/30453624|https://www.ncbi.nlm.nih.gov/pubmed/31087746|https://www.ncbi.nlm.nih.gov/pubmed/31111189|https://www.ncbi.nlm.nih.gov/pubmed/31255691|https://www.ncbi.nlm.nih.gov/pubmed/31515600|https://www.ncbi.nlm.nih.gov/pubmed/31830554|https://www.ncbi.nlm.nih.gov/pubmed/32234424|https://www.ncbi.nlm.nih.gov/pubmed/32890658|https://www.ncbi.nlm.nih.gov/pubmed/33411230|https://www.ncbi.nlm.nih.gov/pubmed/33421718|https://www.ncbi.nlm.nih.gov/pubmed/35870112,11854143|12107646|15041469|15297370|15566942|15713371|15735009|15808406|15808407|15905203|16120219|16258175|16381670|16484233|16530937|17253728|18061397|18174961|18214805|19152381|19244278|19358281|19365803|19576839|19835593|19879285|19879933|19919601|20064835|20106945|20163913|20228066|20553787|20702593|20951464|21256203|21256954|21632981|21669939|21714911|21873647|21887816|22167199|22178795|22316170|22581694|24114850|24472612|25233930|26438400|27196671|27830268|28238931|28351761|28461126|30248327|30439556|30453624|31087746|31111189|31255691|31515600|31830554|32234424|32890658|33411230|33421718|35870112,,
2084,296597,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,373156,GSTK1,https://ctdbase.org/detail.go?type=gene&acc=373156,,,373156.0,GSTK1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene affects the expression of GSTK1 mRNA,,,PMID:20127859,https://www.ncbi.nlm.nih.gov/pubmed/20127859,20127859,,
2085,296761,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),CXCL8 protein promotes the reaction [benzo(a)pyrene results in increased expression of CYP1B1 mrna],,,PMID:28238931,https://www.ncbi.nlm.nih.gov/pubmed/28238931,28238931,,
2086,296762,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),CYP1B1 mutant form inhibits the reaction [benzo(a)pyrene results in increased expression of CASP3 mrna]|cyp1b1 mutant form inhibits the reaction [benzo(a)pyrene results in increased expression of CASP7 mrna],,,PMID:24239969,https://www.ncbi.nlm.nih.gov/pubmed/24239969,24239969,,
2087,298246,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10116.0,Rattus norvegicus (Norway rat),TNF protein promotes the reaction [benzo(a)pyrene results in increased expression of CYP1B1 mrna]|tnf protein promotes the reaction [benzo(a)pyrene results in increased expression of CYP1B1 protein],,,PMID:21745554,https://www.ncbi.nlm.nih.gov/pubmed/21745554,21745554,,
2088,298247,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,553637,CYP1C1,https://ctdbase.org/detail.go?type=gene&acc=553637,,,553637.0,cyp1c1,7955.0,Danio rerio (zebrafish),Alpha-naphthoflavone inhibits the reaction [benzo(a)pyrene results in increased expression of CYP1C1 mrna]|resveratrol affects the reaction [benzo(a)pyrene results in increased expression of CYP1C1 mrna],,,PMID:20615557,https://www.ncbi.nlm.nih.gov/pubmed/20615557,20615557,,
2089,298248,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,553637,CYP1C1,https://ctdbase.org/detail.go?type=gene&acc=553637,,,553637.0,cyp1c1,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in increased expression of CYP1C1 mRNA,,,PMID:19403181|PMID:22209252|PMID:25612249|PMID:26001963,https://www.ncbi.nlm.nih.gov/pubmed/19403181|https://www.ncbi.nlm.nih.gov/pubmed/22209252|https://www.ncbi.nlm.nih.gov/pubmed/25612249|https://www.ncbi.nlm.nih.gov/pubmed/26001963,19403181|22209252|25612249|26001963,,
2090,298249,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,553637,CYP1C1,https://ctdbase.org/detail.go?type=gene&acc=553637,,,553637.0,cyp1c1,7955.0,Danio rerio (zebrafish),CYP1C1 protein affects the metabolism of benzo(a)pyrene,,,PMID:20599672,https://www.ncbi.nlm.nih.gov/pubmed/20599672,20599672,,
2091,298250,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,553637,CYP1C1,https://ctdbase.org/detail.go?type=gene&acc=553637,,,553637.0,cyp1c1,8078.0,Fundulus heteroclitus (mummichog),Benzo(a)pyrene results in increased expression of CYP1C1 mRNA,,,PMID:20471113,https://www.ncbi.nlm.nih.gov/pubmed/20471113,20471113,,
2092,298251,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,553637,CYP1C1,https://ctdbase.org/detail.go?type=gene&acc=553637,,,553637.0,cyp1c1,8128.0,Oreochromis niloticus (Nile tilapia),Benzo(a)pyrene results in increased expression of CYP1C1 mRNA,,,PMID:22204985,https://www.ncbi.nlm.nih.gov/pubmed/22204985,22204985,,
2093,298252,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100137725,CYP1C2,https://ctdbase.org/detail.go?type=gene&acc=100137725,,,100137725.0,cyp1c2,7955.0,Danio rerio (zebrafish),[benzo(a)pyrene co-treated with alpha-naphthoflavone] results in decreased expression of CYP1C2 mRNA,,,PMID:20615557,https://www.ncbi.nlm.nih.gov/pubmed/20615557,20615557,,
2094,299393,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,14910,GT(ROSA)26SOR,https://ctdbase.org/detail.go?type=gene&acc=14910,,,14910.0,Gt(ROSA)26Sor,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of GT(ROSA)26SOR mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2095,299394,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51512,GTSE1,https://ctdbase.org/detail.go?type=gene&acc=51512,,,51512.0,GTSE1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of GTSE1 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
2096,299395,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51512,GTSE1,https://ctdbase.org/detail.go?type=gene&acc=51512,,,51512.0,GTSE1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene metabolite results in increased expression of GTSE1 mRNA,,,PMID:32553695,https://www.ncbi.nlm.nih.gov/pubmed/32553695,32553695,,
2097,299396,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51512,GTSE1,https://ctdbase.org/detail.go?type=gene&acc=51512,,,51512.0,GTSE1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of GTSE1 mRNA,,,PMID:19770486|PMID:20713471|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/20713471|https://www.ncbi.nlm.nih.gov/pubmed/32417428,19770486|20713471|32417428,,
2098,299397,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,121355,GTSF1,https://ctdbase.org/detail.go?type=gene&acc=121355,,,121355.0,GTSF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of GTSF1 3' utr|benzo(a)pyrene affects the methylation of GTSF1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2099,299398,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,149699,GTSF1L,https://ctdbase.org/detail.go?type=gene&acc=149699,,,149699.0,GTSF1L,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of GTSF1L promoter|benzo(a)pyrene affects the methylation of GTSF1L exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2100,300086,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2986,GUCY2F,https://ctdbase.org/detail.go?type=gene&acc=2986,,,2986.0,GUCY2F,7955.0,Danio rerio (zebrafish),Benzo(a)pyrene results in decreased expression of GUCY2F mrna|benzo(a)pyrene results in increased methylation of GUCY2F promoter,,,PMID:28329817,https://www.ncbi.nlm.nih.gov/pubmed/28329817,28329817,,
2101,300087,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2986,GUCY2F,https://ctdbase.org/detail.go?type=gene&acc=2986,,,2986.0,GUCY2F,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of GUCY2F 3' utr|benzo(a)pyrene results in increased methylation of GUCY2F promoter|benzo(a)pyrene results in increased methylation of GUCY2F exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2102,300088,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,73707,GUCY2G,https://ctdbase.org/detail.go?type=gene&acc=73707,,,73707.0,Gucy2g,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of GUCY2G promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2103,300089,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,60558,GUF1,https://ctdbase.org/detail.go?type=gene&acc=60558,,,60558.0,GUF1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of GUF1 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
2104,300770,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,74558,GVIN1,https://ctdbase.org/detail.go?type=gene&acc=74558,,,74558.0,Gvin1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of GVIN1 mRNA,,,PMID:22228805|PMID:22610609|PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/22610609|https://www.ncbi.nlm.nih.gov/pubmed/23735875,22228805|22610609|23735875,,
2105,300771,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,283464,GXYLT1,https://ctdbase.org/detail.go?type=gene&acc=283464,,,283464.0,GXYLT1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of GXYLT1 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
2106,300772,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,283464,GXYLT1,https://ctdbase.org/detail.go?type=gene&acc=283464,,,283464.0,GXYLT1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of GXYLT1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2107,300773,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,727936,GXYLT2,https://ctdbase.org/detail.go?type=gene&acc=727936,,,727936.0,GXYLT2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of GXYLT2 mRNA,,,PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20106945|21632981,,
2108,300774,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2992,GYG1,https://ctdbase.org/detail.go?type=gene&acc=2992,,,2992.0,GYG1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of GYG1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2109,300775,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2992,GYG1,https://ctdbase.org/detail.go?type=gene&acc=2992,,,2992.0,GYG1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of GYG1 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
2110,300776,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,2992,GYG1,https://ctdbase.org/detail.go?type=gene&acc=2992,,,2992.0,GYG1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of GYG1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2111,300777,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8908,GYG2,https://ctdbase.org/detail.go?type=gene&acc=8908,,,8908.0,GYG2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of GYG2 promoter|benzo(a)pyrene results in decreased methylation of GYG2 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2112,300778,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8908,GYG2,https://ctdbase.org/detail.go?type=gene&acc=8908,,,8908.0,GYG2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of GYG2 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2113,301811,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,50708,H1F2,https://ctdbase.org/detail.go?type=gene&acc=50708,,,50708.0,H1f2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of H1F2 mRNA,,,PMID:15034205|PMID:19770486|PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/15034205|https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/22610609,15034205|19770486|22610609,,
2114,301812,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,50709,H1F4,https://ctdbase.org/detail.go?type=gene&acc=50709,,,50709.0,H1f4,10090.0,Mus musculus (house mouse),[arsenite co-treated with benzo(a)pyrene] results in increased expression of H1F4 mRNA,,,PMID:15894712,https://www.ncbi.nlm.nih.gov/pubmed/15894712,15894712,,
2115,301813,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,50709,H1F4,https://ctdbase.org/detail.go?type=gene&acc=50709,,,50709.0,H1f4,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of H1F4 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
2116,301814,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,50709,H1F4,https://ctdbase.org/detail.go?type=gene&acc=50709,,,50709.0,H1f4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of H1F4 mRNA,,,PMID:15894712|PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/15894712|https://www.ncbi.nlm.nih.gov/pubmed/20504355,15894712|20504355,,
2117,301815,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,54388,H1F9,https://ctdbase.org/detail.go?type=gene&acc=54388,,,54388.0,H1f9,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of H1F9 mRNA,,,PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/20504355,20504355,,
2118,301816,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,14960,H2-AA,https://ctdbase.org/detail.go?type=gene&acc=14960,,,14960.0,H2-Aa,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of H2-AA mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2119,301817,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,14960,H2-AA,https://ctdbase.org/detail.go?type=gene&acc=14960,,,14960.0,H2-Aa,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of H2-AA mRNA,,,PMID:22228805|PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/23735875,22228805|23735875,,
2120,301818,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,14961,H2-AB1,https://ctdbase.org/detail.go?type=gene&acc=14961,,,14961.0,H2-Ab1,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of H2-AB1 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2121,301819,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,14961,H2-AB1,https://ctdbase.org/detail.go?type=gene&acc=14961,,,14961.0,H2-Ab1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of H2-AB1 mRNA,,,PMID:19770486|PMID:20127859,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/20127859,19770486|20127859,,
2122,302293,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,723790,H2AC19,https://ctdbase.org/detail.go?type=gene&acc=723790,,,723790.0,H2AC19,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of H2AC19 mRNA,,,PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/20504355,20504355,,
2123,302294,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8338,H2AC20,https://ctdbase.org/detail.go?type=gene&acc=8338,,,8338.0,H2AC20,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of H2AC20 mRNA,,,PMID:22316170|PMID:26238291|PMID:35870112,https://www.ncbi.nlm.nih.gov/pubmed/22316170|https://www.ncbi.nlm.nih.gov/pubmed/26238291|https://www.ncbi.nlm.nih.gov/pubmed/35870112,22316170|26238291|35870112,,
2124,302295,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8338,H2AC20,https://ctdbase.org/detail.go?type=gene&acc=8338,,,8338.0,H2AC20,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of H2AC20 protein,,,PMID:33044785,https://www.ncbi.nlm.nih.gov/pubmed/33044785,33044785,,
2125,302296,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,317772,H2AC21,https://ctdbase.org/detail.go?type=gene&acc=317772,,,317772.0,H2AC21,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of H2AC21 mrna|benzo(a)pyrene results in increased expression of H2AC21 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
2126,302297,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,665433,H2AC23,https://ctdbase.org/detail.go?type=gene&acc=665433,,,665433.0,H2ac23,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of H2AC23 mRNA,,,PMID:21569818,https://www.ncbi.nlm.nih.gov/pubmed/21569818,21569818,,
2127,302298,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,92815,H2AC25,https://ctdbase.org/detail.go?type=gene&acc=92815,,,92815.0,H2AC25,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of H2AC25 mRNA,,,PMID:19770486|PMID:20504355,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/20504355,19770486|20504355,,
2128,302299,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8335,H2AC4,https://ctdbase.org/detail.go?type=gene&acc=8335,,,8335.0,H2AC4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of H2AC4 mRNA,,,PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/22316170,22316170,,
2129,302476,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10090.0,Mus musculus (house mouse),Benzo(a)pyrene promotes the reaction [AHR protein binds to CYP4A14 promoter],,,PMID:19654925,https://www.ncbi.nlm.nih.gov/pubmed/19654925,19654925,,
2130,302477,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CYP4A14 mRNA,,,PMID:19770486|PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/32417428,19770486|32417428,,
2131,302478,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of CYP4A14 protein,,,PMID:34472326,https://www.ncbi.nlm.nih.gov/pubmed/34472326,34472326,,
2132,302479,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,284541,CYP4A22,https://ctdbase.org/detail.go?type=gene&acc=284541,,,284541.0,CYP4A22,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CYP4A22 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2133,302480,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,284541,CYP4A22,https://ctdbase.org/detail.go?type=gene&acc=284541,,,284541.0,CYP4A22,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of CYP4A22 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2134,302481,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1580,CYP4B1,https://ctdbase.org/detail.go?type=gene&acc=1580,,,1580.0,CYP4B1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of CYP4B1 promoter|benzo(a)pyrene results in increased methylation of CYP4B1 exon|benzo(a)pyrene affects the methylation of CYP4B1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2135,302482,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1580,CYP4B1,https://ctdbase.org/detail.go?type=gene&acc=1580,,,1580.0,CYP4B1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of CYP4B1 mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2136,302483,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1580,CYP4B1,https://ctdbase.org/detail.go?type=gene&acc=1580,,,1580.0,CYP4B1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of CYP4B1 mRNA,,,PMID:22228805|PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/22228805|https://www.ncbi.nlm.nih.gov/pubmed/23735875,22228805|23735875,,
2137,305146,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8358,H3C2,https://ctdbase.org/detail.go?type=gene&acc=8358,,,8358.0,H3C2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of H3C2 mRNA,,,PMID:20127859,https://www.ncbi.nlm.nih.gov/pubmed/20127859,20127859,,
2138,305147,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8352,H3C3,https://ctdbase.org/detail.go?type=gene&acc=8352,,,8352.0,H3C3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of H3C3 exon|benzo(a)pyrene results in decreased methylation of H3C3 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2139,305148,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8351,H3C4,https://ctdbase.org/detail.go?type=gene&acc=8351,,,8351.0,H3C4,9606.0,Homo sapiens (human),[benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of H3C4 mRNA,,,PMID:17690111,https://www.ncbi.nlm.nih.gov/pubmed/17690111,17690111,,
2140,305149,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,8351,H3C4,https://ctdbase.org/detail.go?type=gene&acc=8351,,,8351.0,H3C4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of H3C4 mRNA,,,PMID:16269432|PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/16269432|https://www.ncbi.nlm.nih.gov/pubmed/22316170,16269432|22316170,,
2141,305335,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,168002,DACT2,https://ctdbase.org/detail.go?type=gene&acc=168002,,,168002.0,DACT2,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of DACT2 mrna]|benzo(a)pyrene results in decreased expression of DACT2 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2142,305336,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,147906,DACT3,https://ctdbase.org/detail.go?type=gene&acc=147906,,,147906.0,DACT3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of DACT3 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2143,305337,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1605,DAG1,https://ctdbase.org/detail.go?type=gene&acc=1605,,,1605.0,DAG1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of DAG1 exon|benzo(a)pyrene affects the methylation of DAG1 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2144,305338,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1605,DAG1,https://ctdbase.org/detail.go?type=gene&acc=1605,,,1605.0,DAG1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of DAG1 protein,,,PMID:33278487,https://www.ncbi.nlm.nih.gov/pubmed/33278487,33278487,,
2145,305339,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1605,DAG1,https://ctdbase.org/detail.go?type=gene&acc=1605,,,1605.0,DAG1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of DAG1 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2146,305340,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,1605,DAG1,https://ctdbase.org/detail.go?type=gene&acc=1605,,,1605.0,DAG1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of DAG1 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of DAG1 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2147,305341,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,747,DAGLA,https://ctdbase.org/detail.go?type=gene&acc=747,,,747.0,DAGLA,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of DAGLA 5' utr|benzo(a)pyrene affects the methylation of DAGLA promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2148,305539,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,747,DAGLA,https://ctdbase.org/detail.go?type=gene&acc=747,,,747.0,DAGLA,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of DAGLA mRNA,,,PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/32417428,32417428,,
2149,305540,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,221955,DAGLB,https://ctdbase.org/detail.go?type=gene&acc=221955,,,221955.0,DAGLB,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of DAGLB promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2150,305541,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,221955,DAGLB,https://ctdbase.org/detail.go?type=gene&acc=221955,,,221955.0,DAGLB,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of DAGLB mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2151,305542,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,105264650,DAK,https://ctdbase.org/detail.go?type=gene&acc=105264650,,,105264650.0,,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of DAK 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2152,305543,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,55152,DALRD3,https://ctdbase.org/detail.go?type=gene&acc=55152,,,55152.0,DALRD3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of DALRD3 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2153,341085,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9172,MYOM2,https://ctdbase.org/detail.go?type=gene&acc=9172,,,9172.0,MYOM2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of MYOM2 promoter|benzo(a)pyrene affects the methylation of MYOM2 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2154,341086,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9172,MYOM2,https://ctdbase.org/detail.go?type=gene&acc=9172,,,9172.0,MYOM2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of MYOM2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2155,341087,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9172,MYOM2,https://ctdbase.org/detail.go?type=gene&acc=9172,,,9172.0,MYOM2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of MYOM2 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2156,341088,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9172,MYOM2,https://ctdbase.org/detail.go?type=gene&acc=9172,,,9172.0,MYOM2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of MYOM2 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
2157,341089,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9172,MYOM2,https://ctdbase.org/detail.go?type=gene&acc=9172,,,9172.0,MYOM2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of MYOM2 mRNA,,,PMID:22610609,https://www.ncbi.nlm.nih.gov/pubmed/22610609,22610609,,
2158,341090,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,127294,MYOM3,https://ctdbase.org/detail.go?type=gene&acc=127294,,,127294.0,MYOM3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of MYOM3 promoter|benzo(a)pyrene affects the methylation of MYOM3 exon,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2159,341091,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,127294,MYOM3,https://ctdbase.org/detail.go?type=gene&acc=127294,,,127294.0,MYOM3,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of MYOM3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2160,341787,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,114803,MYSM1,https://ctdbase.org/detail.go?type=gene&acc=114803,,,114803.0,MYSM1,10116.0,Rattus norvegicus (Norway rat),Benzo(a)pyrene results in decreased expression of MYSM1 mRNA,,,PMID:21839799,https://www.ncbi.nlm.nih.gov/pubmed/21839799,21839799,,
2161,341788,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,101448016,MYST2,https://ctdbase.org/detail.go?type=gene&acc=101448016,,,101448016.0,,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of MYST2 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2162,341789,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4661,MYT1,https://ctdbase.org/detail.go?type=gene&acc=4661,,,4661.0,MYT1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of MYT1 5' utr|benzo(a)pyrene affects the methylation of MYT1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2163,341790,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4661,MYT1,https://ctdbase.org/detail.go?type=gene&acc=4661,,,4661.0,MYT1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of MYT1 intron|benzo(a)pyrene affects the methylation of MYT1 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2164,341791,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4661,MYT1,https://ctdbase.org/detail.go?type=gene&acc=4661,,,4661.0,MYT1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of MYT1 mRNA,,,PMID:16120219,https://www.ncbi.nlm.nih.gov/pubmed/16120219,16120219,,
2165,341792,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23040,MYT1L,https://ctdbase.org/detail.go?type=gene&acc=23040,,,23040.0,MYT1L,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of MYT1L promoter|benzo(a)pyrene affects the methylation of MYT1L 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2166,341793,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23040,MYT1L,https://ctdbase.org/detail.go?type=gene&acc=23040,,,23040.0,MYT1L,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of MYT1L mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2167,342725,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,254827,NAALADL2,https://ctdbase.org/detail.go?type=gene&acc=254827,,,254827.0,NAALADL2,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NAALADL2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2168,342726,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,254827,NAALADL2,https://ctdbase.org/detail.go?type=gene&acc=254827,,,254827.0,NAALADL2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NAALADL2 mRNA,,,PMID:32234424|PMID:35690182,https://www.ncbi.nlm.nih.gov/pubmed/32234424|https://www.ncbi.nlm.nih.gov/pubmed/35690182,32234424|35690182,,
2169,342727,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,254827,NAALADL2,https://ctdbase.org/detail.go?type=gene&acc=254827,,,254827.0,NAALADL2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NAALADL2 mRNA,,,PMID:23735875,https://www.ncbi.nlm.nih.gov/pubmed/23735875,23735875,,
2170,342728,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4664,NAB1,https://ctdbase.org/detail.go?type=gene&acc=4664,,,4664.0,NAB1,44932.0,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in increased expression of NAB1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
2171,345153,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9027,NAT8,https://ctdbase.org/detail.go?type=gene&acc=9027,,,9027.0,NAT8,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NAT8 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2172,345154,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9027,NAT8,https://ctdbase.org/detail.go?type=gene&acc=9027,,,9027.0,NAT8,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NAT8 mRNA,,,PMID:20106945|PMID:21632981|PMID:22316170,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/22316170,20106945|21632981|22316170,,
2173,345155,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9027,NAT8,https://ctdbase.org/detail.go?type=gene&acc=9027,,,9027.0,NAT8,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of NAT8 mRNA,,,PMID:27858113,https://www.ncbi.nlm.nih.gov/pubmed/27858113,27858113,,
2174,345156,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9027,NAT8,https://ctdbase.org/detail.go?type=gene&acc=9027,,,9027.0,NAT8,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NAT8 mRNA,,,PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/32417428,32417428,,
2175,345157,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,51471,NAT8B,https://ctdbase.org/detail.go?type=gene&acc=51471,,,51471.0,NAT8B,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NAT8B promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2176,345158,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,66116,NAT8F1,https://ctdbase.org/detail.go?type=gene&acc=66116,,,66116.0,Nat8f1,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NAT8F1 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2177,345159,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,93673,NAT8F2,https://ctdbase.org/detail.go?type=gene&acc=93673,,,93673.0,Nat8f2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NAT8F2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2178,345160,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,93674,NAT8F3,https://ctdbase.org/detail.go?type=gene&acc=93674,,,93674.0,Nat8f3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NAT8F3 mRNA,,,PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/32417428,32417428,,
2179,346120,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,101060226,NBPF19,https://ctdbase.org/detail.go?type=gene&acc=101060226,,,101060226.0,NBPF19,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NBPF19 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2180,346121,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,285622,NBPF22P,https://ctdbase.org/detail.go?type=gene&acc=285622,,,285622.0,NBPF22P,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of NBPF22P promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2181,346122,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84224,NBPF3,https://ctdbase.org/detail.go?type=gene&acc=84224,,,84224.0,NBPF3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased methylation of NBPF3 promoter|benzo(a)pyrene results in decreased methylation of NBPF3 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2182,346123,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,84224,NBPF3,https://ctdbase.org/detail.go?type=gene&acc=84224,,,84224.0,NBPF3,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of NBPF3 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
2183,346124,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,343505,NBPF7P,https://ctdbase.org/detail.go?type=gene&acc=343505,,,343505.0,NBPF7P,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NBPF7P promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2184,346762,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9918,NCAPD2,https://ctdbase.org/detail.go?type=gene&acc=9918,,,9918.0,NCAPD2,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NCAPD2 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2185,346763,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9918,NCAPD2,https://ctdbase.org/detail.go?type=gene&acc=9918,,,9918.0,NCAPD2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NCAPD2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2186,346764,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,9918,NCAPD2,https://ctdbase.org/detail.go?type=gene&acc=9918,,,9918.0,NCAPD2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NCAPD2 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2187,346765,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64151,NCAPG,https://ctdbase.org/detail.go?type=gene&acc=64151,,,64151.0,NCAPG,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NCAPG mRNA,,,PMID:21802500,https://www.ncbi.nlm.nih.gov/pubmed/21802500,21802500,,
2188,346766,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64151,NCAPG,https://ctdbase.org/detail.go?type=gene&acc=64151,,,64151.0,NCAPG,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NCAPG mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2189,346767,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64151,NCAPG,https://ctdbase.org/detail.go?type=gene&acc=64151,,,64151.0,NCAPG,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NCAPG mRNA,,,PMID:17942131|PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/17942131|https://www.ncbi.nlm.nih.gov/pubmed/19770486,17942131|19770486,,
2190,346768,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,64151,NCAPG,https://ctdbase.org/detail.go?type=gene&acc=64151,,,64151.0,NCAPG,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NCAPG mRNA,,,PMID:32417428,https://www.ncbi.nlm.nih.gov/pubmed/32417428,32417428,,
2191,348723,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,100302746,NCRUPAR,https://ctdbase.org/detail.go?type=gene&acc=100302746,,,100302746.0,NCRUPAR,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NCRUPAR promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2192,348724,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23413,NCS1,https://ctdbase.org/detail.go?type=gene&acc=23413,,,23413.0,NCS1,44932.0,Boreogadus saida,Benzo(a)pyrene results in increased expression of NCS1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
2193,348725,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23413,NCS1,https://ctdbase.org/detail.go?type=gene&acc=23413,,,23413.0,NCS1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NCS1 3' utr|benzo(a)pyrene affects the methylation of NCS1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2194,348726,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23413,NCS1,https://ctdbase.org/detail.go?type=gene&acc=23413,,,23413.0,NCS1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NCS1 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
2195,348727,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,23385,NCSTN,https://ctdbase.org/detail.go?type=gene&acc=23385,,,23385.0,NCSTN,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NCSTN mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2196,348728,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4535,ND1,https://ctdbase.org/detail.go?type=gene&acc=4535,,,4535.0,ND1,29158.0,Mytilus galloprovincialis (Mediterranean mussel),Benzo(a)pyrene affects the expression of ND1 mRNA,,,PMID:28651000,https://www.ncbi.nlm.nih.gov/pubmed/28651000,28651000,,
2197,348729,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4536,ND2,https://ctdbase.org/detail.go?type=gene&acc=4536,,,4536.0,ND2,29158.0,Mytilus galloprovincialis (Mediterranean mussel),Benzo(a)pyrene results in increased expression of ND2 mRNA,,,PMID:28651000,https://www.ncbi.nlm.nih.gov/pubmed/28651000,28651000,,
2198,350086,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4700,NDUFA6,https://ctdbase.org/detail.go?type=gene&acc=4700,,,4700.0,NDUFA6,10090.0,Mus musculus (house mouse),AHR protein promotes the reaction [benzo(a)pyrene results in increased expression of NDUFA6 mrna]|benzo(a)pyrene results in increased expression of NDUFA6 mRNA,,,PMID:15034205,https://www.ncbi.nlm.nih.gov/pubmed/15034205,15034205,,
2199,350087,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4701,NDUFA7,https://ctdbase.org/detail.go?type=gene&acc=4701,,,4701.0,NDUFA7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NDUFA7 protein,,,PMID:32717239,https://www.ncbi.nlm.nih.gov/pubmed/32717239,32717239,,
2200,350088,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4702,NDUFA8,https://ctdbase.org/detail.go?type=gene&acc=4702,,,4702.0,NDUFA8,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased methylation of NDUFA8 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2201,350089,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4704,NDUFA9,https://ctdbase.org/detail.go?type=gene&acc=4704,,,4704.0,NDUFA9,10090.0,Mus musculus (house mouse),AHR protein affects the reaction [benzo(a)pyrene affects the expression of NDUFA9 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2202,350785,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4724,NDUFS4,https://ctdbase.org/detail.go?type=gene&acc=4724,,,4724.0,NDUFS4,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in increased expression of NDUFS4 mrna|ahr protein affects the reaction [benzo(a)pyrene affects the expression of NDUFS4 mrna],,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2203,350786,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,4726,NDUFS6,https://ctdbase.org/detail.go?type=gene&acc=4726,,,4726.0,NDUFS6,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NDUFS6 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2204,351423,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,5819,NECTIN2,https://ctdbase.org/detail.go?type=gene&acc=5819,,,5819.0,NECTIN2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NECTIN2 mRNA,,,PMID:19770486|PMID:21715664|PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/19770486|https://www.ncbi.nlm.nih.gov/pubmed/21715664|https://www.ncbi.nlm.nih.gov/pubmed/22228805,19770486|21715664|22228805,,
2205,351424,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,25945,NECTIN3,https://ctdbase.org/detail.go?type=gene&acc=25945,,,25945.0,NECTIN3,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NECTIN3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2206,351425,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,81607,NECTIN4,https://ctdbase.org/detail.go?type=gene&acc=81607,,,81607.0,NECTIN4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NECTIN4 mRNA,,,PMID:31255691,https://www.ncbi.nlm.nih.gov/pubmed/31255691,31255691,,
2207,351426,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,81607,NECTIN4,https://ctdbase.org/detail.go?type=gene&acc=81607,,,81607.0,NECTIN4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NECTIN4 3' utr|benzo(a)pyrene results in decreased methylation of NECTIN4 promoter|benzo(a)pyrene results in decreased methylation of NECTIN4 5' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2208,351427,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,81607,NECTIN4,https://ctdbase.org/detail.go?type=gene&acc=81607,,,81607.0,NECTIN4,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NECTIN4 mRNA,,,PMID:20106945|PMID:21632981|PMID:32234424|PMID:35690182,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/32234424|https://www.ncbi.nlm.nih.gov/pubmed/35690182,20106945|21632981|32234424|35690182,,
2209,351428,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,121441,NEDD1,https://ctdbase.org/detail.go?type=gene&acc=121441,,,121441.0,NEDD1,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NEDD1 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2210,351429,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,121441,NEDD1,https://ctdbase.org/detail.go?type=gene&acc=121441,,,121441.0,NEDD1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NEDD1 mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
2211,351430,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,121441,NEDD1,https://ctdbase.org/detail.go?type=gene&acc=121441,,,121441.0,NEDD1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased expression of NEDD1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
2212,352593,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,140609,NEK7,https://ctdbase.org/detail.go?type=gene&acc=140609,,,140609.0,NEK7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NEK7 3' utr|benzo(a)pyrene affects the methylation of NEK7 5' utr|benzo(a)pyrene results in increased methylation of NEK7 intron,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2213,352594,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,140609,NEK7,https://ctdbase.org/detail.go?type=gene&acc=140609,,,140609.0,NEK7,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased mutagenesis of NEK7 gene,,,PMID:25435355,https://www.ncbi.nlm.nih.gov/pubmed/25435355,25435355,,
2214,352595,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,140609,NEK7,https://ctdbase.org/detail.go?type=gene&acc=140609,,,140609.0,NEK7,10090.0,Mus musculus (house mouse),AHR protein inhibits the reaction [benzo(a)pyrene results in increased expression of NEK7 mrna]|benzo(a)pyrene results in increased expression of NEK7 mRNA,,,PMID:15034205,https://www.ncbi.nlm.nih.gov/pubmed/15034205,15034205,,
2215,352596,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,140609,NEK7,https://ctdbase.org/detail.go?type=gene&acc=140609,,,140609.0,NEK7,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NEK7 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2216,352597,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,284086,NEK8,https://ctdbase.org/detail.go?type=gene&acc=284086,,,284086.0,NEK8,10090.0,Mus musculus (house mouse),Benzo(a)pyrene results in decreased expression of NEK8 mRNA,,,PMID:22228805,https://www.ncbi.nlm.nih.gov/pubmed/22228805,22228805,,
2217,352598,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,91754,NEK9,https://ctdbase.org/detail.go?type=gene&acc=91754,,,91754.0,NEK9,9606.0,Homo sapiens (human),Benzo(a)pyrene affects the methylation of NEK9 promoter,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2218,359730,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,158801,NKAPP1,https://ctdbase.org/detail.go?type=gene&acc=158801,,,158801.0,NKAPP1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NKAPP1 mRNA,,,PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/26238291,26238291,,
2219,359731,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,85407,NKD1,https://ctdbase.org/detail.go?type=gene&acc=85407,,,85407.0,NKD1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in decreased expression of NKD1 mRNA,,,PMID:20106945|PMID:21632981|PMID:26238291,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981|https://www.ncbi.nlm.nih.gov/pubmed/26238291,20106945|21632981|26238291,,
2220,359732,2336,Comparative Toxicogenomics Database (CTD),Benzo[a]pyrene,D001564,Benzo(a)pyrene,https://ctdbase.org/detail.go?type=chem&acc=D001564,85407,NKD1,https://ctdbase.org/detail.go?type=gene&acc=85407,,,85407.0,NKD1,9606.0,Homo sapiens (human),Benzo(a)pyrene results in increased methylation of NKD1 3' UTR,,,PMID:27901495,https://www.ncbi.nlm.nih.gov/pubmed/27901495,27901495,,
2221,220071,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of ARHGDIB protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2222,220072,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of ARHGDIB mRNA,,,PMID:23894361,https://www.ncbi.nlm.nih.gov/pubmed/23894361,23894361,,
2223,220073,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,397,ARHGDIB,https://ctdbase.org/detail.go?type=gene&acc=397,,,397.0,ARHGDIB,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of ARHGDIB mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2224,220074,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,9138,ARHGEF1,https://ctdbase.org/detail.go?type=gene&acc=9138,,,9138.0,ARHGEF1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of ARHGEF1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2225,220075,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,23365,ARHGEF12,https://ctdbase.org/detail.go?type=gene&acc=23365,,,23365.0,ARHGEF12,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of ARHGEF12 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2226,220227,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,55515,ASIC4,https://ctdbase.org/detail.go?type=gene&acc=55515,,,55515.0,ASIC4,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of ASIC4 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2227,220228,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,445,ASS1,https://ctdbase.org/detail.go?type=gene&acc=445,,,445.0,ASS1,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of ASS1 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2228,220229,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,9474,ATG5,https://ctdbase.org/detail.go?type=gene&acc=9474,,,9474.0,ATG5,10090.0,Mus musculus (house mouse),"Alpinetin promotes the reaction [dextran sulfate results in increased expression of ATG5 mrna]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [dextran sulfate results in increased expression of ATG5 mrna]]|leucine inhibits the reaction [alpinetin promotes the reaction [dextran sulfate results in increased expression of ATG5 mrna]]|dextran sulfate results in increased expression of ATG5 mrna|6-formylindolo(3,2-b)carbazole promotes the reaction [dextran sulfate results in increased expression of ATG5 mrna]",,,PMID:31676321,https://www.ncbi.nlm.nih.gov/pubmed/31676321,31676321,,
2229,220230,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,9474,ATG5,https://ctdbase.org/detail.go?type=gene&acc=9474,,,9474.0,ATG5,10090.0,Mus musculus (house mouse),ATG5 protein affects the reaction [HU 308 inhibits the reaction [[dextran sulfate co-treated with lipopolysaccharides] results in increased cleavage of CASP1 protein]]|atg5 protein affects the reaction [HU 308 inhibits the reaction [[dextran sulfate co-treated with lipopolysaccharides] results in increased secretion of IL1B protein]],,,PMID:27611972,https://www.ncbi.nlm.nih.gov/pubmed/27611972,27611972,,
2230,220231,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,9474,ATG5,https://ctdbase.org/detail.go?type=gene&acc=9474,,,9474.0,ATG5,10090.0,Mus musculus (house mouse),Obeticholic acid inhibits the reaction [[dietary fats co-treated with dextran sulfate] results in decreased expression of ATG5 mrna]|[dietary fats co-treated with dextran sulfate] results in decreased expression of ATG5 mRNA,,,PMID:35439472,https://www.ncbi.nlm.nih.gov/pubmed/35439472,35439472,,
2231,221167,2337,DrugBank,Benzocaine,DB01086,Benzocaine,https://www.drugbank.ca/drugs/DB01086,BE0004879,Alpha-1-acid glycoprotein 2,https://www.drugbank.ca/bio_entities/BE0004879,P19652,Alpha-1-acid glycoprotein 2,5005.0,ORM2,9606.0,Homo sapiens (human),Binder,,,PMID:17175824,https://www.ncbi.nlm.nih.gov/pubmed/17175824,17175824,,
2232,221269,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7439,BEST1,https://ctdbase.org/detail.go?type=gene&acc=7439,,,7439.0,BEST1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of BEST1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2233,221270,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,633,BGN,https://ctdbase.org/detail.go?type=gene&acc=633,,,633.0,BGN,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of BGN mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2234,221271,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,51411,BIN2,https://ctdbase.org/detail.go?type=gene&acc=51411,,,51411.0,BIN2,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of BIN2 protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2235,221272,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,10090.0,Mus musculus (house mouse),Plant extracts inhibits the reaction [[azoxymethane co-treated with dextran sulfate] results in increased expression of BIRC5 protein]|[azoxymethane co-treated with dextran sulfate] results in increased expression of BIRC5 protein|aspirin inhibits the reaction [[azoxymethane co-treated with dextran sulfate] results in increased expression of BIRC5 protein]|camptothecin inhibits the reaction [[azoxymethane co-treated with dextran sulfate] results in increased expression of BIRC5 protein],,,PMID:25449198,https://www.ncbi.nlm.nih.gov/pubmed/25449198,25449198,,
2236,221273,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,57448,BIRC6,https://ctdbase.org/detail.go?type=gene&acc=57448,,,57448.0,BIRC6,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of BIRC6 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2237,221274,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,649,BMP1,https://ctdbase.org/detail.go?type=gene&acc=649,,,649.0,BMP1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of BMP1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2238,221275,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,27302,BMP10,https://ctdbase.org/detail.go?type=gene&acc=27302,,,27302.0,BMP10,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of BMP10 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2239,221432,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,51297,BPIFA1,https://ctdbase.org/detail.go?type=gene&acc=51297,,,51297.0,BPIFA1,10090.0,Mus musculus (house mouse),[dextran sulfate co-treated with bisphenol A] results in increased expression of BPIFA1 protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2240,221598,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,50908,C1S1,https://ctdbase.org/detail.go?type=gene&acc=50908,,,50908.0,C1s1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of C1S1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2241,221599,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,317677,C1S2,https://ctdbase.org/detail.go?type=gene&acc=317677,,,317677.0,C1s2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of C1S2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2242,221600,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,718,C3,https://ctdbase.org/detail.go?type=gene&acc=718,,,718.0,C3,10090.0,Mus musculus (house mouse),[dextran sulfate co-treated with bisphenol A] results in increased expression of C3 protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2243,221601,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,718,C3,https://ctdbase.org/detail.go?type=gene&acc=718,,,718.0,C3,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of C3 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2244,221602,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,719,C3AR1,https://ctdbase.org/detail.go?type=gene&acc=719,,,719.0,C3AR1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of C3AR1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2245,221603,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,721,C4B,https://ctdbase.org/detail.go?type=gene&acc=721,,,721.0,C4B,10090.0,Mus musculus (house mouse),Erianin inhibits the reaction [dextran sulfate results in increased expression of C4B protein]|dextran sulfate results in increased expression of C4B protein,,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2246,221604,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,721,C4B,https://ctdbase.org/detail.go?type=gene&acc=721,,,721.0,C4B,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of C4B mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2247,221605,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,12269,C4BP,https://ctdbase.org/detail.go?type=gene&acc=12269,,,12269.0,C4bp,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of C4BP mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2248,222295,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),EIF2AK2 protein affects the reaction [dextran sulfate results in increased activity of CASP3 protein],,,PMID:27920257,https://www.ncbi.nlm.nih.gov/pubmed/27920257,27920257,,
2249,222296,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Sulfasalazine inhibits the reaction [dextran sulfate results in increased activity of CASP3 protein]|gingerol inhibits the reaction [dextran sulfate results in increased activity of CASP3 protein],,,PMID:28421826,https://www.ncbi.nlm.nih.gov/pubmed/28421826,28421826,,
2250,222460,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),[streptozocin co-treated with dextran sulfate] results in decreased expression of CAT protein,,,PMID:34964214,https://www.ncbi.nlm.nih.gov/pubmed/34964214,34964214,,
2251,222461,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,8436,CAVIN2,https://ctdbase.org/detail.go?type=gene&acc=8436,,,8436.0,CAVIN2,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of CAVIN2 protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2252,222462,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,873,CBR1,https://ctdbase.org/detail.go?type=gene&acc=873,,,873.0,CBR1,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of CBR1 protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2253,222463,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,874,CBR3,https://ctdbase.org/detail.go?type=gene&acc=874,,,874.0,CBR3,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CBR3 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2254,222464,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,151903,CCDC12,https://ctdbase.org/detail.go?type=gene&acc=151903,,,151903.0,CCDC12,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CCDC12 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2255,222465,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,115098,CCDC124,https://ctdbase.org/detail.go?type=gene&acc=115098,,,115098.0,CCDC124,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CCDC124 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2256,222466,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,152206,CCDC13,https://ctdbase.org/detail.go?type=gene&acc=152206,,,152206.0,CCDC13,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CCDC13 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2257,222467,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,339965,CCDC158,https://ctdbase.org/detail.go?type=gene&acc=339965,,,339965.0,CCDC158,10090.0,Mus musculus (house mouse),Erianin inhibits the reaction [dextran sulfate results in decreased expression of CCDC158 protein]|dextran sulfate results in decreased expression of CCDC158 protein,,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2258,222468,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,283234,CCDC88B,https://ctdbase.org/detail.go?type=gene&acc=283234,,,283234.0,CCDC88B,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CCDC88B mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2259,222469,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,26093,CCDC9,https://ctdbase.org/detail.go?type=gene&acc=26093,,,26093.0,CCDC9,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CCDC9 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2260,222804,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),DUSP1 protein affects the reaction [butylated hydroxyanisole inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein]]|butylated hydroxyanisole inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein]|nfe2l2 protein affects the reaction [butylated hydroxyanisole inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein]]|nfe2l2 protein affects the reaction [resveratrol inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein]]|dusp1 protein affects the reaction [resveratrol inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein]],,,PMID:30844440,https://www.ncbi.nlm.nih.gov/pubmed/30844440,30844440,,
2261,222805,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Fraxinellone inhibits the reaction [dextran sulfate results in increased expression of PTGS2 mrna]|dexamethasone inhibits the reaction [dextran sulfate results in increased expression of PTGS2 mrna],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
2262,222806,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of PTGS2 mRNA,,,PMID:15652231|PMID:19940103|PMID:20079348|PMID:25448682|PMID:25472953|PMID:26973525|PMID:27920257|PMID:30142311|PMID:32033881,https://www.ncbi.nlm.nih.gov/pubmed/15652231|https://www.ncbi.nlm.nih.gov/pubmed/19940103|https://www.ncbi.nlm.nih.gov/pubmed/20079348|https://www.ncbi.nlm.nih.gov/pubmed/25448682|https://www.ncbi.nlm.nih.gov/pubmed/25472953|https://www.ncbi.nlm.nih.gov/pubmed/26973525|https://www.ncbi.nlm.nih.gov/pubmed/27920257|https://www.ncbi.nlm.nih.gov/pubmed/30142311|https://www.ncbi.nlm.nih.gov/pubmed/32033881,15652231|19940103|20079348|25448682|25472953|26973525|27920257|30142311|32033881,,
2263,222955,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,20305,CCL6,https://ctdbase.org/detail.go?type=gene&acc=20305,,,20305.0,Ccl6,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of CCL6 mRNA,,,PMID:19645018,https://www.ncbi.nlm.nih.gov/pubmed/19645018,19645018,,
2264,222956,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,20305,CCL6,https://ctdbase.org/detail.go?type=gene&acc=20305,,,20305.0,Ccl6,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CCL6 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2265,222957,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6354,CCL7,https://ctdbase.org/detail.go?type=gene&acc=6354,,,6354.0,CCL7,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CCL7 mRNA,,,PMID:19645018|PMID:32033881,https://www.ncbi.nlm.nih.gov/pubmed/19645018|https://www.ncbi.nlm.nih.gov/pubmed/32033881,19645018|32033881,,
2266,222958,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6354,CCL7,https://ctdbase.org/detail.go?type=gene&acc=6354,,,6354.0,CCL7,10090.0,Mus musculus (house mouse),Qingdai compound inhibits the reaction [dextran sulfate results in increased expression of CCL7 mrna],,,PMID:32033881,https://www.ncbi.nlm.nih.gov/pubmed/32033881,32033881,,
2267,222959,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6354,CCL7,https://ctdbase.org/detail.go?type=gene&acc=6354,,,6354.0,CCL7,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CCL7 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2268,222960,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6355,CCL8,https://ctdbase.org/detail.go?type=gene&acc=6355,,,6355.0,CCL8,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CCL8 mRNA,,,PMID:19645018|PMID:23894361,https://www.ncbi.nlm.nih.gov/pubmed/19645018|https://www.ncbi.nlm.nih.gov/pubmed/23894361,19645018|23894361,,
2269,223012,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [dextran sulfate results in increased expression of PTGS2 mrna],,,PMID:19940103,https://www.ncbi.nlm.nih.gov/pubmed/19940103,19940103,,
2270,223013,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Resveratrol inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein],,,PMID:20132809|PMID:30844440,https://www.ncbi.nlm.nih.gov/pubmed/20132809|https://www.ncbi.nlm.nih.gov/pubmed/30844440,20132809|30844440,,
2271,223014,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Rutin inhibits the reaction [dextran sulfate results in increased expression of PTGS2 mrna],,,PMID:15652231,https://www.ncbi.nlm.nih.gov/pubmed/15652231,15652231,,
2272,223015,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of PTGS2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2273,223016,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Tussilagone inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein]|tussilagone inhibits the reaction [dextran sulfate results in increased expression of PTGS2 mrna],,,PMID:30142311,https://www.ncbi.nlm.nih.gov/pubmed/30142311,30142311,,
2274,223017,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein]|dextran sulfate results in increased expression of PTGS2 protein,,,PMID:19228061,https://www.ncbi.nlm.nih.gov/pubmed/19228061,19228061,,
2275,223312,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,4064,CD180,https://ctdbase.org/detail.go?type=gene&acc=4064,,,4064.0,CD180,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CD180 mRNA,,,PMID:23894361,https://www.ncbi.nlm.nih.gov/pubmed/23894361,23894361,,
2276,223313,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,4064,CD180,https://ctdbase.org/detail.go?type=gene&acc=4064,,,4064.0,CD180,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CD180 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2277,223314,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,930,CD19,https://ctdbase.org/detail.go?type=gene&acc=930,,,930.0,CD19,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CD19 mRNA,,,PMID:23894361,https://www.ncbi.nlm.nih.gov/pubmed/23894361,23894361,,
2278,223315,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,4345,CD200,https://ctdbase.org/detail.go?type=gene&acc=4345,,,4345.0,CD200,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CD200 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2279,223316,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,69142,CD209F,https://ctdbase.org/detail.go?type=gene&acc=69142,,,69142.0,Cd209f,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of CD209F mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2280,223317,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,919,CD247,https://ctdbase.org/detail.go?type=gene&acc=919,,,919.0,CD247,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CD247 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2281,223717,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of CDH1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2282,223718,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CDH2 protein|7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [dextran sulfate results in increased expression of CDH2 protein],,,PMID:36543318,https://www.ncbi.nlm.nih.gov/pubmed/36543318,36543318,,
2283,223719,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,10090.0,Mus musculus (house mouse),[azoxymethane co-treated with dextran sulfate] results in increased expression of CDH2 protein,,,PMID:34273909,https://www.ncbi.nlm.nih.gov/pubmed/34273909,34273909,,
2284,223720,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1003,CDH5,https://ctdbase.org/detail.go?type=gene&acc=1003,,,1003.0,CDH5,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CDH5 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2285,223721,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,54825,CDHR2,https://ctdbase.org/detail.go?type=gene&acc=54825,,,54825.0,CDHR2,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of CDHR2 protein|erianin inhibits the reaction [dextran sulfate results in decreased expression of CDHR2 protein],,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2286,224542,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased phosphorylation of and affects the localization of RELA protein,,,PMID:37385329,https://www.ncbi.nlm.nih.gov/pubmed/37385329,37385329,,
2287,224543,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased phosphorylation of RELA protein,,,PMID:24038091|PMID:27920257|PMID:34964214|PMID:36543318,https://www.ncbi.nlm.nih.gov/pubmed/24038091|https://www.ncbi.nlm.nih.gov/pubmed/27920257|https://www.ncbi.nlm.nih.gov/pubmed/34964214|https://www.ncbi.nlm.nih.gov/pubmed/36543318,24038091|27920257|34964214|36543318,,
2288,224544,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),GW 506033X inhibits the reaction [dextran sulfate results in increased phosphorylation of RELA protein]|eif2ak2 protein affects the reaction [dextran sulfate results in increased phosphorylation of RELA protein]|rela protein affects the reaction [dextran sulfate results in increased expression of NOS2 mrna],,,PMID:27920257,https://www.ncbi.nlm.nih.gov/pubmed/27920257,27920257,,
2289,224545,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),[streptozocin co-treated with dextran sulfate] results in increased phosphorylation of RELA protein,,,PMID:34964214,https://www.ncbi.nlm.nih.gov/pubmed/34964214,34964214,,
2290,224546,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),Tussilagone inhibits the reaction [dextran sulfate results in increased expression of RELA protein],,,PMID:30142311,https://www.ncbi.nlm.nih.gov/pubmed/30142311,30142311,,
2291,224547,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5973,RENBP,https://ctdbase.org/detail.go?type=gene&acc=5973,,,5973.0,RENBP,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of RENBP mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2292,224548,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,245195,RETNLG,https://ctdbase.org/detail.go?type=gene&acc=245195,,,245195.0,Retnlg,10090.0,Mus musculus (house mouse),[dextran sulfate co-treated with bisphenol A] results in increased expression of RETNLG protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2293,224549,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,54884,RETSAT,https://ctdbase.org/detail.go?type=gene&acc=54884,,,54884.0,RETSAT,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of RETSAT mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2294,225511,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1291,COL6A1,https://ctdbase.org/detail.go?type=gene&acc=1291,,,1291.0,COL6A1,10090.0,Mus musculus (house mouse),Erianin inhibits the reaction [dextran sulfate results in decreased expression of COL6A1 protein]|dextran sulfate results in decreased expression of COL6A1 protein,,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2295,225512,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1292,COL6A2,https://ctdbase.org/detail.go?type=gene&acc=1292,,,1292.0,COL6A2,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of COL6A2 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2296,225513,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1292,COL6A2,https://ctdbase.org/detail.go?type=gene&acc=1292,,,1292.0,COL6A2,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of COL6A2 protein|erianin inhibits the reaction [dextran sulfate results in decreased expression of COL6A2 protein],,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2297,225514,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,68553,COL6A4,https://ctdbase.org/detail.go?type=gene&acc=68553,,,68553.0,Col6a4,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of COL6A4 protein|erianin inhibits the reaction [dextran sulfate results in decreased expression of COL6A4 protein],,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2298,225515,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1295,COL8A1,https://ctdbase.org/detail.go?type=gene&acc=1295,,,1295.0,COL8A1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of COL8A1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2299,225516,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,11151,CORO1A,https://ctdbase.org/detail.go?type=gene&acc=11151,,,11151.0,CORO1A,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of CORO1A protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2300,225517,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,23603,CORO1C,https://ctdbase.org/detail.go?type=gene&acc=23603,,,23603.0,CORO1C,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of CORO1C protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2301,226323,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CXCL1 mRNA,,,PMID:19645018|PMID:20079348|PMID:31807802|PMID:34998820,https://www.ncbi.nlm.nih.gov/pubmed/19645018|https://www.ncbi.nlm.nih.gov/pubmed/20079348|https://www.ncbi.nlm.nih.gov/pubmed/31807802|https://www.ncbi.nlm.nih.gov/pubmed/34998820,19645018|20079348|31807802|34998820,,
2302,226324,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased secretion of CXCL1 protein|tetrachlorodibenzodioxin inhibits the reaction [dextran sulfate results in increased secretion of CXCL1 protein],,,PMID:21858153,https://www.ncbi.nlm.nih.gov/pubmed/21858153,21858153,,
2303,226479,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CXCL1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2304,226480,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627.0,CXCL10,10090.0,Mus musculus (house mouse),[azoxymethane co-treated with dextran sulfate] results in decreased expression of CXCL10 mrna|isoliquiritigenin inhibits the reaction [[azoxymethane co-treated with dextran sulfate] results in decreased expression of CXCL10 mrna],,,PMID:25026504,https://www.ncbi.nlm.nih.gov/pubmed/25026504,25026504,,
2305,226481,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6387,CXCL12,https://ctdbase.org/detail.go?type=gene&acc=6387,,,6387.0,CXCL12,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of CXCL12 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2306,226482,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,10563,CXCL13,https://ctdbase.org/detail.go?type=gene&acc=10563,,,10563.0,CXCL13,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CXCL13 mRNA,,,PMID:23894361|PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/23894361|https://www.ncbi.nlm.nih.gov/pubmed/35093514,23894361|35093514,,
2307,226483,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,9547,CXCL14,https://ctdbase.org/detail.go?type=gene&acc=9547,,,9547.0,CXCL14,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CXCL14 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2308,226484,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,20309,CXCL15,https://ctdbase.org/detail.go?type=gene&acc=20309,,,20309.0,Cxcl15,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CXCL15 protein,,,PMID:20637373,https://www.ncbi.nlm.nih.gov/pubmed/20637373,20637373,,
2309,226485,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),"Resolvin D2 inhibits the reaction [dextran sulfate results in increased expression of CXCL2 protein]|resolvin D1 inhibits the reaction [dextran sulfate results in increased expression of CXCL2 protein]|dextran sulfate results in increased expression of CXCL2 protein|17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [dextran sulfate results in increased expression of CXCL2 protein]",,,PMID:21724996,https://www.ncbi.nlm.nih.gov/pubmed/21724996,21724996,,
2310,226486,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),AHR gene mutant form promotes the reaction [dextran sulfate results in increased expression of CXCL2 mrna],,,PMID:36519841,https://www.ncbi.nlm.nih.gov/pubmed/36519841,36519841,,
2311,226487,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),Benzo(a)pyrene inhibits the reaction [dextran sulfate results in increased expression of CXCL2 mrna],,,PMID:34998820,https://www.ncbi.nlm.nih.gov/pubmed/34998820,34998820,,
2312,226677,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090.0,Mus musculus (house mouse),Qingdai compound inhibits the reaction [dextran sulfate results in increased expression of CXCL2 mrna],,,PMID:32033881,https://www.ncbi.nlm.nih.gov/pubmed/32033881,32033881,,
2313,226678,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6374,CXCL5,https://ctdbase.org/detail.go?type=gene&acc=6374,,,6374.0,CXCL5,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CXCL5 mRNA,,,PMID:19645018,https://www.ncbi.nlm.nih.gov/pubmed/19645018,19645018,,
2314,226679,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6374,CXCL5,https://ctdbase.org/detail.go?type=gene&acc=6374,,,6374.0,CXCL5,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of CXCL5 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2315,226680,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CXCL8 protein|sulfasalazine inhibits the reaction [dextran sulfate results in increased expression of CXCL8 protein]|erianin inhibits the reaction [dextran sulfate results in increased expression of CXCL8 protein],,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2316,226681,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,4283,CXCL9,https://ctdbase.org/detail.go?type=gene&acc=4283,,,4283.0,CXCL9,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of CXCL9 mRNA,,,PMID:23894361,https://www.ncbi.nlm.nih.gov/pubmed/23894361,23894361,,
2317,226952,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,9376,SLC22A8,https://ctdbase.org/detail.go?type=gene&acc=9376,,,9376.0,SLC22A8,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of SLC22A8 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2318,226953,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1468,SLC25A10,https://ctdbase.org/detail.go?type=gene&acc=1468,,,1468.0,SLC25A10,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of SLC25A10 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2319,227162,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,81894,SLC25A28,https://ctdbase.org/detail.go?type=gene&acc=81894,,,81894.0,SLC25A28,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of SLC25A28 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2320,227163,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,291,SLC25A4,https://ctdbase.org/detail.go?type=gene&acc=291,,,291.0,SLC25A4,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of SLC25A4 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2321,227164,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,10861,SLC26A1,https://ctdbase.org/detail.go?type=gene&acc=10861,,,10861.0,SLC26A1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of SLC26A1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2322,227165,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1836,SLC26A2,https://ctdbase.org/detail.go?type=gene&acc=1836,,,1836.0,SLC26A2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of SLC26A2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2323,227166,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1811,SLC26A3,https://ctdbase.org/detail.go?type=gene&acc=1811,,,1811.0,SLC26A3,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of SLC26A3 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2324,227167,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,115111,SLC26A7,https://ctdbase.org/detail.go?type=gene&acc=115111,,,115111.0,SLC26A7,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of SLC26A7 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2325,227168,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,115019,SLC26A9,https://ctdbase.org/detail.go?type=gene&acc=115019,,,115019.0,SLC26A9,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of SLC26A9 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2326,228167,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1843,DUSP1,https://ctdbase.org/detail.go?type=gene&acc=1843,,,1843.0,DUSP1,10090.0,Mus musculus (house mouse),DUSP1 protein affects the susceptibility to [azoxymethane co-treated with dextran sulfate]|dusp1 protein affects the reaction [butylated hydroxyanisole inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein]]|dusp1 protein affects the reaction [butylated hydroxyanisole affects the reaction [dextran sulfate affects the expression of IL6 protein]]|dusp1 protein affects the reaction [resveratrol affects the reaction [dextran sulfate affects the expression of IL6 protein]]|dusp1 protein affects the reaction [butylated hydroxyanisole affects the reaction [dextran sulfate affects the expression of TNF protein]]|dusp1 protein affects the reaction [resveratrol inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein]]|dusp1 protein affects the reaction [resveratrol affects the reaction [dextran sulfate affects the expression of TNF protein]],,,PMID:30844440,https://www.ncbi.nlm.nih.gov/pubmed/30844440,30844440,,
2327,228443,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,30844,EHD4,https://ctdbase.org/detail.go?type=gene&acc=30844,,,30844.0,EHD4,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of EHD4 protein|[dextran sulfate co-treated with bisphenol A] results in decreased expression of EHD4 protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2328,228444,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,1962,EHHADH,https://ctdbase.org/detail.go?type=gene&acc=1962,,,1962.0,EHHADH,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of EHHADH mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2329,228445,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,10919,EHMT2,https://ctdbase.org/detail.go?type=gene&acc=10919,,,10919.0,EHMT2,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of EHMT2 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2330,228446,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,5610,EIF2AK2,https://ctdbase.org/detail.go?type=gene&acc=5610,,,5610.0,EIF2AK2,10090.0,Mus musculus (house mouse),EIF2AK2 protein affects the reaction [dextran sulfate results in increased phosphorylation of RELA protein]|dextran sulfate results in increased phosphorylation of EIF2AK2 protein|eif2ak2 protein affects the reaction [dextran sulfate results in increased expression of IL6 mrna]|eif2ak2 protein affects the reaction [dextran sulfate results in increased expression of NOS2 mrna]|gw 506033X inhibits the reaction [dextran sulfate results in increased phosphorylation of EIF2AK2 protein]|eif2ak2 protein affects the reaction [dextran sulfate results in increased activity of CASP3 protein],,,PMID:27920257,https://www.ncbi.nlm.nih.gov/pubmed/27920257,27920257,,
2331,228447,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,8661,EIF3A,https://ctdbase.org/detail.go?type=gene&acc=8661,,,8661.0,EIF3A,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with dextran sulfate] results in increased expression of EIF3A mRNA,,,PMID:26271895,https://www.ncbi.nlm.nih.gov/pubmed/26271895,26271895,,
2332,228489,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6549,SLC9A2,https://ctdbase.org/detail.go?type=gene&acc=6549,,,6549.0,SLC9A2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of SLC9A2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2333,228490,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6550,SLC9A3,https://ctdbase.org/detail.go?type=gene&acc=6550,,,6550.0,SLC9A3,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of SLC9A3 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2334,229381,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,283742,FAM98B,https://ctdbase.org/detail.go?type=gene&acc=283742,,,283742.0,FAM98B,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of FAM98B mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2335,229382,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2197,FAU,https://ctdbase.org/detail.go?type=gene&acc=2197,,,2197.0,FAU,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of FAU protein|erianin inhibits the reaction [dextran sulfate results in decreased expression of FAU protein],,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2336,229383,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2199,FBLN2,https://ctdbase.org/detail.go?type=gene&acc=2199,,,2199.0,FBLN2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of FBLN2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2337,229384,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,10516,FBLN5,https://ctdbase.org/detail.go?type=gene&acc=10516,,,10516.0,FBLN5,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of FBLN5 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2338,229385,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,10516,FBLN5,https://ctdbase.org/detail.go?type=gene&acc=10516,,,10516.0,FBLN5,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of FBLN5 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2339,229597,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10090.0,Mus musculus (house mouse),Qingdai compound inhibits the reaction [dextran sulfate results in increased phosphorylation of STAT3 protein],,,PMID:31737179,https://www.ncbi.nlm.nih.gov/pubmed/31737179,31737179,,
2340,229598,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10116.0,Rattus norvegicus (Norway rat),Melatonin inhibits the reaction [[azoxymethane co-treated with dextran sulfate] results in increased expression of STAT3 protein]|[azoxymethane co-treated with dextran sulfate] results in increased expression of STAT3 protein,,,PMID:19028472,https://www.ncbi.nlm.nih.gov/pubmed/19028472,19028472,,
2341,229599,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,26872,STEAP1,https://ctdbase.org/detail.go?type=gene&acc=26872,,,26872.0,STEAP1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of STEAP1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2342,229600,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,261729,STEAP2,https://ctdbase.org/detail.go?type=gene&acc=261729,,,261729.0,STEAP2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of STEAP2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2343,229601,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6786,STIM1,https://ctdbase.org/detail.go?type=gene&acc=6786,,,6786.0,STIM1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of STIM1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2344,229602,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,10963,STIP1,https://ctdbase.org/detail.go?type=gene&acc=10963,,,10963.0,STIP1,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of STIP1 protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2345,229603,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,6789,STK4,https://ctdbase.org/detail.go?type=gene&acc=6789,,,6789.0,STK4,10090.0,Mus musculus (house mouse),[RASSF1 gene mutant form results in increased susceptibility to dextran sulfate] which results in decreased activity of STK4 protein,,,PMID:24146755,https://www.ncbi.nlm.nih.gov/pubmed/24146755,24146755,,
2346,229604,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,346673,STRA8,https://ctdbase.org/detail.go?type=gene&acc=346673,,,346673.0,STRA8,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of STRA8 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2347,229605,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,10923,SUB1,https://ctdbase.org/detail.go?type=gene&acc=10923,,,10923.0,SUB1,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of SUB1 protein|erianin inhibits the reaction [dextran sulfate results in decreased expression of SUB1 protein],,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2348,229606,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,8801,SUCLG2,https://ctdbase.org/detail.go?type=gene&acc=8801,,,8801.0,SUCLG2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of SUCLG2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2349,230171,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,50943,FOXP3,https://ctdbase.org/detail.go?type=gene&acc=50943,,,50943.0,FOXP3,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of FOXP3 mRNA,,,PMID:31807802|PMID:34998820,https://www.ncbi.nlm.nih.gov/pubmed/31807802|https://www.ncbi.nlm.nih.gov/pubmed/34998820,31807802|34998820,,
2350,230172,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,50943,FOXP3,https://ctdbase.org/detail.go?type=gene&acc=50943,,,50943.0,FOXP3,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin inhibits the reaction [dextran sulfate results in increased methylation of FOXP3 gene]|dextran sulfate results in increased methylation of FOXP3 gene,,,PMID:21858153,https://www.ncbi.nlm.nih.gov/pubmed/21858153,21858153,,
2351,230890,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7060,THBS4,https://ctdbase.org/detail.go?type=gene&acc=7060,,,7060.0,THBS4,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of THBS4 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2352,230891,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7070,THY1,https://ctdbase.org/detail.go?type=gene&acc=7070,,,7070.0,THY1,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of THY1 protein|erianin inhibits the reaction [dextran sulfate results in increased expression of THY1 protein],,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2353,231039,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2624,GATA2,https://ctdbase.org/detail.go?type=gene&acc=2624,,,2624.0,GATA2,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with dextran sulfate] results in increased expression of GATA2 mRNA,,,PMID:26271895,https://www.ncbi.nlm.nih.gov/pubmed/26271895,26271895,,
2354,231100,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10090.0,Mus musculus (house mouse),Mesalamine inhibits the reaction [dextran sulfate results in increased expression of TLR4 protein]|7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [dextran sulfate results in increased expression of TLR4 protein],,,PMID:36543318,https://www.ncbi.nlm.nih.gov/pubmed/36543318,36543318,,
2355,231101,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10090.0,Mus musculus (house mouse),TLR4 protein affects the susceptibility to dextran sulfate|dextran sulfate affects the reaction [TLR4 protein affects the expression of TNF protein]|tlr4 protein affects the reaction [dextran sulfate results in increased expression of CSF2 protein]|dextran sulfate affects the reaction [TLR4 protein affects the expression of IL6 protein]|tlr4 protein affects the reaction [dextran sulfate results in increased expression of IL6 protein]|tlr4 protein affects the reaction [dextran sulfate results in increased expression of TNF protein],,,PMID:31442584,https://www.ncbi.nlm.nih.gov/pubmed/31442584,31442584,,
2356,231545,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2788,GNG7,https://ctdbase.org/detail.go?type=gene&acc=2788,,,2788.0,GNG7,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GNG7 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2357,231546,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,94235,GNG8,https://ctdbase.org/detail.go?type=gene&acc=94235,,,94235.0,GNG8,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GNG8 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2358,231586,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),"7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [dextran sulfate results in increased expression of TNF protein]",,,PMID:24038091,https://www.ncbi.nlm.nih.gov/pubmed/24038091,24038091,,
2359,231587,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),ADAM17 protein affects the reaction [dextran sulfate results in increased expression of TNF protein],,,PMID:24548422,https://www.ncbi.nlm.nih.gov/pubmed/24548422,24548422,,
2360,231588,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Coumarins inhibits the reaction [dextran sulfate results in increased expression of TNF protein],,,PMID:25231984,https://www.ncbi.nlm.nih.gov/pubmed/25231984,25231984,,
2361,231741,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,51206,GP6,https://ctdbase.org/detail.go?type=gene&acc=51206,,,51206.0,GP6,10090.0,Mus musculus (house mouse),[dextran sulfate co-treated with bisphenol A] results in decreased expression of GP6 protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2362,231742,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,151306,GPBAR1,https://ctdbase.org/detail.go?type=gene&acc=151306,,,151306.0,GPBAR1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GPBAR1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2363,231743,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,8111,GPR68,https://ctdbase.org/detail.go?type=gene&acc=8111,,,8111.0,GPR68,10090.0,Mus musculus (house mouse),[azoxymethane co-treated with dextran sulfate] results in increased expression of GPR68 mRNA,,,PMID:28174749,https://www.ncbi.nlm.nih.gov/pubmed/28174749,28174749,,
2364,231744,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2239,GPC4,https://ctdbase.org/detail.go?type=gene&acc=2239,,,2239.0,GPC4,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GPC4 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2365,231745,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2821,GPI,https://ctdbase.org/detail.go?type=gene&acc=2821,,,2821.0,GPI,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of GPI protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2366,231945,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,139760,GPR119,https://ctdbase.org/detail.go?type=gene&acc=139760,,,139760.0,GPR119,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] affects the expression of GPR119 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2367,231946,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7107,GPR137B,https://ctdbase.org/detail.go?type=gene&acc=7107,,,7107.0,GPR137B,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GPR137B mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2368,231947,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,664862,GPR137B-PS,https://ctdbase.org/detail.go?type=gene&acc=664862,,,664862.0,Gpr137b-ps,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GPR137B-PS mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2369,231948,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,344758,GPR149,https://ctdbase.org/detail.go?type=gene&acc=344758,,,344758.0,GPR149,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GPR149 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2370,231949,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2838,GPR15,https://ctdbase.org/detail.go?type=gene&acc=2838,,,2838.0,GPR15,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of GPR15 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2371,231950,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,390212,GPR152,https://ctdbase.org/detail.go?type=gene&acc=390212,,,390212.0,GPR152,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of GPR152 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2372,231951,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,76206,GPR165,https://ctdbase.org/detail.go?type=gene&acc=76206,,,76206.0,Gpr165,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of GPR165 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2373,231952,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2840,GPR17,https://ctdbase.org/detail.go?type=gene&acc=2840,,,2840.0,GPR17,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of GPR17 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2374,231953,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,11245,GPR176,https://ctdbase.org/detail.go?type=gene&acc=11245,,,11245.0,GPR176,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GPR176 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2375,232589,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Melatonin inhibits the reaction [dextran sulfate results in increased expression of TNF mrna]|melatonin inhibits the reaction [dextran sulfate results in increased expression of TNF protein],,,PMID:36265525,https://www.ncbi.nlm.nih.gov/pubmed/36265525,36265525,,
2376,232590,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),MIF protein affects the reaction [dextran sulfate results in increased expression of TNF mrna],,,PMID:12105854,https://www.ncbi.nlm.nih.gov/pubmed/12105854,12105854,,
2377,232591,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Minocycline inhibits the reaction [dextran sulfate results in increased expression of TNF mrna],,,PMID:19285099,https://www.ncbi.nlm.nih.gov/pubmed/19285099,19285099,,
2378,232592,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Nicotine inhibits the reaction [dextran sulfate results in increased expression of TNF protein],,,PMID:31926917,https://www.ncbi.nlm.nih.gov/pubmed/31926917,31926917,,
2379,232855,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2981,GUCA2B,https://ctdbase.org/detail.go?type=gene&acc=2981,,,2981.0,GUCA2B,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of GUCA2B protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2380,232856,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2986,GUCY2F,https://ctdbase.org/detail.go?type=gene&acc=2986,,,2986.0,GUCY2F,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GUCY2F mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2381,232857,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,2987,GUK1,https://ctdbase.org/detail.go?type=gene&acc=2987,,,2987.0,GUK1,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of GUK1 protein|erianin inhibits the reaction [dextran sulfate results in decreased expression of GUK1 protein],,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2382,232858,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of GULO mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2383,232859,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3001,GZMA,https://ctdbase.org/detail.go?type=gene&acc=3001,,,3001.0,GZMA,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of GZMA mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2384,232860,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,243529,H1F10,https://ctdbase.org/detail.go?type=gene&acc=243529,,,243529.0,H1f10,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of H1F10 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2385,232861,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,14960,H2-AA,https://ctdbase.org/detail.go?type=gene&acc=14960,,,14960.0,H2-Aa,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of H2-AA mRNA,,,PMID:23894361,https://www.ncbi.nlm.nih.gov/pubmed/23894361,23894361,,
2386,233426,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] affects the expression of HES1 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2387,233427,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of HIF1A protein|resveratrol inhibits the reaction [dextran sulfate results in increased expression of HIF1A protein],,,PMID:26074695,https://www.ncbi.nlm.nih.gov/pubmed/26074695,26074695,,
2388,233428,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,8479,HIRIP3,https://ctdbase.org/detail.go?type=gene&acc=8479,,,8479.0,HIRIP3,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of HIRIP3 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2389,233429,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,303175,HIST3H2BA,https://ctdbase.org/detail.go?type=gene&acc=303175,,,303175.0,Hist3h2ba,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of HIST3H2BA protein|erianin inhibits the reaction [dextran sulfate results in increased expression of HIST3H2BA protein],,,PMID:32272095,https://www.ncbi.nlm.nih.gov/pubmed/32272095,32272095,,
2390,233430,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3098,HK1,https://ctdbase.org/detail.go?type=gene&acc=3098,,,3098.0,HK1,10090.0,Mus musculus (house mouse),Mesalamine inhibits the reaction [dextran sulfate results in increased expression of HK1 protein]|dextran sulfate results in increased expression of HK1 protein|hydroxysafflor yellow A inhibits the reaction [dextran sulfate results in increased expression of HK1 protein],,,PMID:37001609,https://www.ncbi.nlm.nih.gov/pubmed/37001609,37001609,,
2391,233431,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3101,HK3,https://ctdbase.org/detail.go?type=gene&acc=3101,,,3101.0,HK3,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of HK3 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2392,233432,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090.0,Mus musculus (house mouse),MIF protein affects the reaction [dextran sulfate results in increased expression of IFNG mrna],,,PMID:12105854,https://www.ncbi.nlm.nih.gov/pubmed/12105854,12105854,,
2393,233724,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3174,HNF4G,https://ctdbase.org/detail.go?type=gene&acc=3174,,,3174.0,HNF4G,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of HNF4G mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2394,233725,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,10949,HNRNPA0,https://ctdbase.org/detail.go?type=gene&acc=10949,,,10949.0,HNRNPA0,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of HNRNPA0 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2395,233726,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,29911,HOOK2,https://ctdbase.org/detail.go?type=gene&acc=29911,,,29911.0,HOOK2,10090.0,Mus musculus (house mouse),Dextran sulfate results in increased expression of HOOK2 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2396,233727,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3240,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240.0,HP,10090.0,Mus musculus (house mouse),Chlorpyrifos promotes the reaction [dextran sulfate results in increased expression of HP protein]|dextran sulfate results in increased expression of HP protein,,,PMID:31807802,https://www.ncbi.nlm.nih.gov/pubmed/31807802,31807802,,
2397,233728,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3240,HP,https://ctdbase.org/detail.go?type=gene&acc=3240,,,3240.0,HP,10090.0,Mus musculus (house mouse),[dextran sulfate co-treated with bisphenol A] results in increased expression of HP protein,,,PMID:35999755,https://www.ncbi.nlm.nih.gov/pubmed/35999755,35999755,,
2398,233893,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,10090.0,Mus musculus (house mouse),Dextran sulfate results in decreased expression of HSD3B1 mRNA,,,PMID:35093514,https://www.ncbi.nlm.nih.gov/pubmed/35093514,35093514,,
2399,233894,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,15495,HSD3B4,https://ctdbase.org/detail.go?type=gene&acc=15495,,,15495.0,Hsd3b4,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of HSD3B4 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2400,233895,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3320,HSP90AA1,https://ctdbase.org/detail.go?type=gene&acc=3320,,,3320.0,HSP90AA1,10116.0,Rattus norvegicus (Norway rat),Dextran sulfate results in increased expression of HSP90AA1 mrna|celastrol inhibits the reaction [dextran sulfate results in increased expression of HSP90AA1 mrna],,,PMID:32470352,https://www.ncbi.nlm.nih.gov/pubmed/32470352,32470352,,
2401,233896,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3326,HSP90AB1,https://ctdbase.org/detail.go?type=gene&acc=3326,,,3326.0,HSP90AB1,10116.0,Rattus norvegicus (Norway rat),Celastrol inhibits the reaction [dextran sulfate results in increased expression of HSP90AB1 protein]|dextran sulfate results in increased expression of HSP90AB1 protein,,,PMID:32470352,https://www.ncbi.nlm.nih.gov/pubmed/32470352,32470352,,
2402,233897,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3303,HSPA1A,https://ctdbase.org/detail.go?type=gene&acc=3303,,,3303.0,HSPA1A,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with dextran sulfate] results in decreased expression of HSPA1A mRNA,,,PMID:26271895,https://www.ncbi.nlm.nih.gov/pubmed/26271895,26271895,,
2403,233898,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,3304,HSPA1B,https://ctdbase.org/detail.go?type=gene&acc=3304,,,3304.0,HSPA1B,10090.0,Mus musculus (house mouse),[benzo(a)pyrene co-treated with dextran sulfate] results in decreased expression of HSPA1B mRNA,,,PMID:26271895,https://www.ncbi.nlm.nih.gov/pubmed/26271895,26271895,,
2404,235472,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,65266,WNK4,https://ctdbase.org/detail.go?type=gene&acc=65266,,,65266.0,WNK4,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of WNK4 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2405,235473,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,80326,WNT10A,https://ctdbase.org/detail.go?type=gene&acc=80326,,,80326.0,WNT10A,10090.0,Mus musculus (house mouse),[dextran sulfate co-treated with azoxymethane] results in increased expression of WNT10A mrna|celastrol inhibits the reaction [[dextran sulfate co-treated with azoxymethane] results in increased expression of WNT10A mrna],,,PMID:31715269,https://www.ncbi.nlm.nih.gov/pubmed/31715269,31715269,,
2406,235474,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7472,WNT2,https://ctdbase.org/detail.go?type=gene&acc=7472,,,7472.0,WNT2,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of WNT2 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2407,235475,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7482,WNT2B,https://ctdbase.org/detail.go?type=gene&acc=7482,,,7482.0,WNT2B,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of WNT2B mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
2408,235476,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7473,WNT3,https://ctdbase.org/detail.go?type=gene&acc=7473,,,7473.0,WNT3,10090.0,Mus musculus (house mouse),Celastrol inhibits the reaction [[dextran sulfate co-treated with azoxymethane] results in increased expression of WNT3 mrna]|[dextran sulfate co-treated with azoxymethane] results in increased expression of WNT3 mRNA,,,PMID:31715269,https://www.ncbi.nlm.nih.gov/pubmed/31715269,31715269,,
2409,235477,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D016264,Dextran Sulfate,https://ctdbase.org/detail.go?type=chem&acc=D016264,7475,WNT6,https://ctdbase.org/detail.go?type=gene&acc=7475,,,7475.0,WNT6,10090.0,Mus musculus (house mouse),[dextran sulfate co-treated with azoxymethane] results in increased expression of WNT6 mrna|celastrol inhibits the reaction [[dextran sulfate co-treated with azoxymethane] results in increased expression of WNT6 mrna],,,PMID:31715269,https://www.ncbi.nlm.nih.gov/pubmed/31715269,31715269,,
2410,244405,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D001566,Benzocaine,https://ctdbase.org/detail.go?type=chem&acc=D001566,6351,CCL4,https://ctdbase.org/detail.go?type=gene&acc=6351,,,6351.0,CCL4,9606.0,Homo sapiens (human),Benzocaine results in increased expression of CCL4 protein,,,PMID:18353026,https://www.ncbi.nlm.nih.gov/pubmed/18353026,18353026,,
2411,244406,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D001566,Benzocaine,https://ctdbase.org/detail.go?type=chem&acc=D001566,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090.0,Mus musculus (house mouse),[benzocaine co-treated with ionomycin co-treated with tetradecanoylphorbol acetate] results in decreased expression of IFNG protein,,,PMID:15588918,https://www.ncbi.nlm.nih.gov/pubmed/15588918,15588918,,
2412,244407,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D001566,Benzocaine,https://ctdbase.org/detail.go?type=chem&acc=D001566,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10090.0,Mus musculus (house mouse),[benzocaine co-treated with ionomycin co-treated with tetradecanoylphorbol acetate] results in decreased expression of IL10 protein,,,PMID:15588918,https://www.ncbi.nlm.nih.gov/pubmed/15588918,15588918,,
2413,244408,2337,Comparative Toxicogenomics Database (CTD),Benzocaine,D001566,Benzocaine,https://ctdbase.org/detail.go?type=chem&acc=D001566,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,10090.0,Mus musculus (house mouse),Benzocaine results in increased activity of IL18 protein,,,PMID:15840424,https://www.ncbi.nlm.nih.gov/pubmed/15840424,15840424,,
2414,220317,2347,Comparative Toxicogenomics Database (CTD),Benzyl butyl phthalate,C027561,butylbenzyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C027561,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10090.0,Mus musculus (house mouse),[diethylhexyl phthalate co-treated with dibutyl phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA,,,PMID:30802670,https://www.ncbi.nlm.nih.gov/pubmed/30802670,30802670,,
2415,220318,2347,Comparative Toxicogenomics Database (CTD),Benzyl butyl phthalate,C027561,butylbenzyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C027561,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10090.0,Mus musculus (house mouse),[diethylhexyl phthalate co-treated with diethyl phthalate co-treated with dibutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11A1 mRNA,,,PMID:34597818,https://www.ncbi.nlm.nih.gov/pubmed/34597818,34597818,,
2416,220319,2347,Comparative Toxicogenomics Database (CTD),Benzyl butyl phthalate,C027561,butylbenzyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C027561,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,10090.0,Mus musculus (house mouse),"[diethyl phthalate co-treated with dibutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of CYP11A1 mRNA",,,PMID:32518293,https://www.ncbi.nlm.nih.gov/pubmed/32518293,32518293,,
2417,221074,2347,Comparative Toxicogenomics Database (CTD),Benzyl butyl phthalate,C027561,butylbenzyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C027561,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),"AHR mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 mrna]|ahr mutant form inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 protein]|butylbenzyl phthalate results in increased expression of CYP1B1 protein|butylbenzyl phthalate promotes the reaction [AHR protein binds to CYP1B1 promoter]|3',4'-dimethoxyflavone inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 protein]|3',4'-dimethoxyflavone inhibits the reaction [butylbenzyl phthalate results in increased expression of CYP1B1 mrna]|butylbenzyl phthalate results in increased expression of CYP1B1 mRNA",,,PMID:22138065,https://www.ncbi.nlm.nih.gov/pubmed/22138065,22138065,,
2418,222179,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of IGF1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2419,222180,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,3484,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484.0,IGFBP1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of IGFBP1 mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2420,222181,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,3485,IGFBP2,https://ctdbase.org/detail.go?type=gene&acc=3485,,,3485.0,IGFBP2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of IGFBP2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2421,222182,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,3486,IGFBP3,https://ctdbase.org/detail.go?type=gene&acc=3486,,,3486.0,IGFBP3,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of IGFBP3 mRNA,,,PMID:32151702,https://www.ncbi.nlm.nih.gov/pubmed/32151702,32151702,,
2422,222183,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,3490,IGFBP7,https://ctdbase.org/detail.go?type=gene&acc=3490,,,3490.0,IGFBP7,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of IGFBP7 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2423,222184,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,3321,IGSF3,https://ctdbase.org/detail.go?type=gene&acc=3321,,,3321.0,IGSF3,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of IGSF3 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2424,222621,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,50616,IL22,https://ctdbase.org/detail.go?type=gene&acc=50616,,,50616.0,IL22,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of IL22 mRNA,,,PMID:25716673,https://www.ncbi.nlm.nih.gov/pubmed/25716673,25716673,,
2425,222622,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,51561,IL23A,https://ctdbase.org/detail.go?type=gene&acc=51561,,,51561.0,IL23A,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of IL23A mRNA,,,PMID:32151702,https://www.ncbi.nlm.nih.gov/pubmed/32151702,32151702,,
2426,223018,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,83729,INHBE,https://ctdbase.org/detail.go?type=gene&acc=83729,,,83729.0,INHBE,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of INHBE mRNA,,,PMID:17175557,https://www.ncbi.nlm.nih.gov/pubmed/17175557,17175557,,
2427,223019,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,51141,INSIG2,https://ctdbase.org/detail.go?type=gene&acc=51141,,,51141.0,INSIG2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of INSIG2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2428,223020,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,3641,INSL4,https://ctdbase.org/detail.go?type=gene&acc=3641,,,3641.0,INSL4,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of INSL4 mRNA,,,PMID:19737606|PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/19737606|https://www.ncbi.nlm.nih.gov/pubmed/32858204,19737606|32858204,,
2429,223021,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,3656,IRAK2,https://ctdbase.org/detail.go?type=gene&acc=3656,,,3656.0,IRAK2,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of IRAK2 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2430,223872,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,160313,KRT19P2,https://ctdbase.org/detail.go?type=gene&acc=160313,,,160313.0,KRT19P2,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of KRT19P2 mRNA,,,PMID:32151702,https://www.ncbi.nlm.nih.gov/pubmed/32151702,32151702,,
2431,224550,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,56891,LGALS14,https://ctdbase.org/detail.go?type=gene&acc=56891,,,56891.0,LGALS14,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of LGALS14 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2432,225838,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4194,MDM4,https://ctdbase.org/detail.go?type=gene&acc=4194,,,4194.0,MDM4,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of MDM4 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2433,225839,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4199,ME1,https://ctdbase.org/detail.go?type=gene&acc=4199,,,4199.0,ME1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of ME1 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2434,225840,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4204,MECP2,https://ctdbase.org/detail.go?type=gene&acc=4204,,,4204.0,MECP2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of MECP2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2435,225841,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,1954,MEGF8,https://ctdbase.org/detail.go?type=gene&acc=1954,,,1954.0,MEGF8,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of MEGF8 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2436,225842,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4223,MEOX2,https://ctdbase.org/detail.go?type=gene&acc=4223,,,4223.0,MEOX2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of MEOX2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2437,225843,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4232,MEST,https://ctdbase.org/detail.go?type=gene&acc=4232,,,4232.0,MEST,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of MEST mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2438,225844,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4239,MFAP4,https://ctdbase.org/detail.go?type=gene&acc=4239,,,4239.0,MFAP4,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in decreased expression of MFAP4 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2439,225845,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,84879,MFSD2A,https://ctdbase.org/detail.go?type=gene&acc=84879,,,84879.0,MFSD2A,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of MFSD2A mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2440,225846,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4256,MGP,https://ctdbase.org/detail.go?type=gene&acc=4256,,,4256.0,MGP,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of MGP mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2441,225847,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4257,MGST1,https://ctdbase.org/detail.go?type=gene&acc=4257,,,4257.0,MGST1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of MGST1 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2442,226325,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of MMP2 mRNA,,,PMID:18164116|PMID:20045035,https://www.ncbi.nlm.nih.gov/pubmed/18164116|https://www.ncbi.nlm.nih.gov/pubmed/20045035,18164116|20045035,,
2443,226326,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,26561,MMP23,https://ctdbase.org/detail.go?type=gene&acc=26561,,,26561.0,Mmp23,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in decreased expression of MMP23 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2444,226327,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,26561,MMP23,https://ctdbase.org/detail.go?type=gene&acc=26561,,,26561.0,Mmp23,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of MMP23 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2445,226328,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4314,MMP3,https://ctdbase.org/detail.go?type=gene&acc=4314,,,4314.0,MMP3,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of MMP3 mRNA,,,PMID:32151702,https://www.ncbi.nlm.nih.gov/pubmed/32151702,32151702,,
2446,226329,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of MMP9 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2447,226330,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of MMP9 mRNA,,,PMID:32151702,https://www.ncbi.nlm.nih.gov/pubmed/32151702,32151702,,
2448,226331,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,9019,MPZL1,https://ctdbase.org/detail.go?type=gene&acc=9019,,,9019.0,MPZL1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of MPZL1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2449,226332,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,51253,MRPL37,https://ctdbase.org/detail.go?type=gene&acc=51253,,,51253.0,MRPL37,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of MRPL37 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2450,226530,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6307,MSMO1,https://ctdbase.org/detail.go?type=gene&acc=6307,,,6307.0,MSMO1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of MSMO1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2451,226531,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4482,MSRA,https://ctdbase.org/detail.go?type=gene&acc=4482,,,4482.0,MSRA,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of MSRA mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2452,226532,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,17748,MT1,https://ctdbase.org/detail.go?type=gene&acc=17748,,,17748.0,Mt1,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of MT1 mRNA,,,PMID:14998373,https://www.ncbi.nlm.nih.gov/pubmed/14998373,14998373,,
2453,226533,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4489,MT1A,https://ctdbase.org/detail.go?type=gene&acc=4489,,,4489.0,MT1A,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of MT1A mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2454,226534,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4493,MT1E,https://ctdbase.org/detail.go?type=gene&acc=4493,,,4493.0,MT1E,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of MT1E mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2455,226535,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4494,MT1F,https://ctdbase.org/detail.go?type=gene&acc=4494,,,4494.0,MT1F,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of MT1F mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2456,226536,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4494,MT1F,https://ctdbase.org/detail.go?type=gene&acc=4494,,,4494.0,MT1F,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of MT1F mRNA,,,PMID:32151702,https://www.ncbi.nlm.nih.gov/pubmed/32151702,32151702,,
2457,226537,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4495,MT1G,https://ctdbase.org/detail.go?type=gene&acc=4495,,,4495.0,MT1G,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of MT1G mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2458,226538,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4496,MT1H,https://ctdbase.org/detail.go?type=gene&acc=4496,,,4496.0,MT1H,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of MT1H mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2459,226539,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4501,MT1X,https://ctdbase.org/detail.go?type=gene&acc=4501,,,4501.0,MT1X,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of MT1X mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2460,226954,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598.0,MVK,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of MVK mRNA,,,PMID:31225620,https://www.ncbi.nlm.nih.gov/pubmed/31225620,31225620,,
2461,226955,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4608,MYBPH,https://ctdbase.org/detail.go?type=gene&acc=4608,,,4608.0,MYBPH,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of MYBPH mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2462,226956,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,4628,MYH10,https://ctdbase.org/detail.go?type=gene&acc=4628,,,4628.0,MYH10,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of MYH10 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2463,226957,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,26509,MYOF,https://ctdbase.org/detail.go?type=gene&acc=26509,,,26509.0,MYOF,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of MYOF mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2464,226958,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,51778,MYOZ2,https://ctdbase.org/detail.go?type=gene&acc=51778,,,51778.0,MYOZ2,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of MYOZ2 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2465,226959,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,10003,NAALAD2,https://ctdbase.org/detail.go?type=gene&acc=10003,,,10003.0,NAALAD2,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of NAALAD2 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2466,226960,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,337920,NAGLT1,https://ctdbase.org/detail.go?type=gene&acc=337920,,,337920.0,Naglt1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of NAGLT1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2467,226961,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,66116,NAT8F1,https://ctdbase.org/detail.go?type=gene&acc=66116,,,66116.0,Nat8f1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of NAT8F1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2468,227111,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,100132406,NBPF10,https://ctdbase.org/detail.go?type=gene&acc=100132406,,,100132406.0,NBPF10,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of NBPF10 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2469,227112,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,100288142,NBPF20,https://ctdbase.org/detail.go?type=gene&acc=100288142,,,100288142.0,NBPF20,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of NBPF20 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2470,227113,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,653361,NCF1,https://ctdbase.org/detail.go?type=gene&acc=653361,,,653361.0,NCF1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of NCF1 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2471,227114,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,654817,NCF1C,https://ctdbase.org/detail.go?type=gene&acc=654817,,,654817.0,NCF1C,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of NCF1C mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2472,227115,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,64168,NECAB1,https://ctdbase.org/detail.go?type=gene&acc=64168,,,64168.0,NECAB1,10090.0,Mus musculus (house mouse),[andrographolide co-treated with beta-naphthoflavone] results in increased expression of NECAB1 mRNA,,,PMID:19737545,https://www.ncbi.nlm.nih.gov/pubmed/19737545,19737545,,
2473,227116,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,25945,NECTIN3,https://ctdbase.org/detail.go?type=gene&acc=25945,,,25945.0,NECTIN3,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of NECTIN3 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2474,229668,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,5307,PITX1,https://ctdbase.org/detail.go?type=gene&acc=5307,,,5307.0,PITX1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of PITX1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2475,229669,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,5316,PKNOX1,https://ctdbase.org/detail.go?type=gene&acc=5316,,,5316.0,PKNOX1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of PKNOX1 mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2476,229670,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,51365,PLA1A,https://ctdbase.org/detail.go?type=gene&acc=51365,,,51365.0,PLA1A,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of PLA1A mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2477,229671,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,5319,PLA2G1B,https://ctdbase.org/detail.go?type=gene&acc=5319,,,5319.0,PLA2G1B,10116.0,Rattus norvegicus (Norway rat),Beta-naphthoflavone results in decreased expression of PLA2G1B mRNA,,,PMID:12883083,https://www.ncbi.nlm.nih.gov/pubmed/12883083,12883083,,
2478,229672,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,391013,PLA2G2C,https://ctdbase.org/detail.go?type=gene&acc=391013,,,391013.0,PLA2G2C,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of PLA2G2C mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2479,229673,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,5321,PLA2G4A,https://ctdbase.org/detail.go?type=gene&acc=5321,,,5321.0,PLA2G4A,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of PLA2G4A mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2480,230603,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Beta-naphthoflavone inhibits the reaction [triclosan results in increased expression of PPARG protein],,,PMID:33722737,https://www.ncbi.nlm.nih.gov/pubmed/33722737,33722737,,
2481,230604,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,8495,PPFIBP2,https://ctdbase.org/detail.go?type=gene&acc=8495,,,8495.0,PPFIBP2,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of PPFIBP2 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2482,230605,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,23759,PPIL2,https://ctdbase.org/detail.go?type=gene&acc=23759,,,23759.0,PPIL2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of PPIL2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2483,230606,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,9647,PPM1F,https://ctdbase.org/detail.go?type=gene&acc=9647,,,9647.0,PPM1F,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of PPM1F mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2484,230607,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,81706,PPP1R14C,https://ctdbase.org/detail.go?type=gene&acc=81706,,,81706.0,PPP1R14C,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of PPP1R14C mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2485,230608,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,5529,PPP2R5E,https://ctdbase.org/detail.go?type=gene&acc=5529,,,5529.0,PPP2R5E,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of PPP2R5E mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2486,230609,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,9989,PPP4R1,https://ctdbase.org/detail.go?type=gene&acc=9989,,,9989.0,PPP4R1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of PPP4R1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2487,231756,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,83937,RASSF4,https://ctdbase.org/detail.go?type=gene&acc=83937,,,83937.0,RASSF4,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of RASSF4 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2488,231757,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of RB1 mrna|[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of RB1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2489,231758,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,155435,RBM33,https://ctdbase.org/detail.go?type=gene&acc=155435,,,155435.0,RBM33,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of RBM33 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2490,231759,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,5950,RBP4,https://ctdbase.org/detail.go?type=gene&acc=5950,,,5950.0,RBP4,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of RBP4 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2491,231760,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,1827,RCAN1,https://ctdbase.org/detail.go?type=gene&acc=1827,,,1827.0,RCAN1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of RCAN1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2492,232192,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,8601,RGS20,https://ctdbase.org/detail.go?type=gene&acc=8601,,,8601.0,RGS20,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of RGS20 mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2493,232193,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,5999,RGS4,https://ctdbase.org/detail.go?type=gene&acc=5999,,,5999.0,RGS4,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of RGS4 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2494,232194,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,8787,RGS9,https://ctdbase.org/detail.go?type=gene&acc=8787,,,8787.0,RGS9,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of RGS9 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2495,232195,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,57127,RHBG,https://ctdbase.org/detail.go?type=gene&acc=57127,,,57127.0,RHBG,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of RHBG mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2496,232196,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,9886,RHOBTB1,https://ctdbase.org/detail.go?type=gene&acc=9886,,,9886.0,RHOBTB1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of RHOBTB1 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2497,232197,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,18617,RHOX5,https://ctdbase.org/detail.go?type=gene&acc=18617,,,18617.0,Rhox5,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of RHOX5 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2498,232198,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,8767,RIPK2,https://ctdbase.org/detail.go?type=gene&acc=8767,,,8767.0,RIPK2,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of RIPK2 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2499,232199,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6016,RIT1,https://ctdbase.org/detail.go?type=gene&acc=6016,,,6016.0,RIT1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of RIT1 mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2500,232200,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,8635,RNASET2,https://ctdbase.org/detail.go?type=gene&acc=8635,,,8635.0,RNASET2,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of RNASET2 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2501,232406,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6196,RPS6KA2,https://ctdbase.org/detail.go?type=gene&acc=6196,,,6196.0,RPS6KA2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of RPS6KA2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2502,232407,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,9252,RPS6KA5,https://ctdbase.org/detail.go?type=gene&acc=9252,,,9252.0,RPS6KA5,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of RPS6KA5 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2503,232408,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,23076,RRP1B,https://ctdbase.org/detail.go?type=gene&acc=23076,,,23076.0,RRP1B,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of RRP1B mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2504,232409,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,24737,RT1-EC2,https://ctdbase.org/detail.go?type=gene&acc=24737,,,24737.0,RT1-EC2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of RT1-EC2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2505,232410,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6242,RTKN,https://ctdbase.org/detail.go?type=gene&acc=6242,,,6242.0,RTKN,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of RTKN mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2506,232411,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,57142,RTN4,https://ctdbase.org/detail.go?type=gene&acc=57142,,,57142.0,RTN4,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of RTN4 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2507,232412,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,864,RUNX3,https://ctdbase.org/detail.go?type=gene&acc=864,,,864.0,RUNX3,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of RUNX3 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2508,232615,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,1901,S1PR1,https://ctdbase.org/detail.go?type=gene&acc=1901,,,1901.0,S1PR1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of S1PR1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2509,232616,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,220004,SAXO4,https://ctdbase.org/detail.go?type=gene&acc=220004,,,220004.0,SAXO4,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of SAXO4 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2510,232617,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,638345,SBPL,https://ctdbase.org/detail.go?type=gene&acc=638345,,,638345.0,Sbpl,10090.0,Mus musculus (house mouse),[andrographolide co-treated with beta-naphthoflavone] results in decreased expression of SBPL mRNA,,,PMID:19737545,https://www.ncbi.nlm.nih.gov/pubmed/19737545,19737545,,
2511,232618,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,9522,SCAMP1,https://ctdbase.org/detail.go?type=gene&acc=9522,,,9522.0,SCAMP1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SCAMP1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2512,233103,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,66222,SERPINB1A,https://ctdbase.org/detail.go?type=gene&acc=66222,,,66222.0,Serpinb1a,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SERPINB1A mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2513,233104,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of SERPINE1 mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2514,233979,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,123096,SLC25A29,https://ctdbase.org/detail.go?type=gene&acc=123096,,,123096.0,SLC25A29,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SLC25A29 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2515,233980,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,55186,SLC25A36,https://ctdbase.org/detail.go?type=gene&acc=55186,,,55186.0,SLC25A36,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of SLC25A36 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2516,233981,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,11001,SLC27A2,https://ctdbase.org/detail.go?type=gene&acc=11001,,,11001.0,SLC27A2,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of SLC27A2 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2517,233982,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of SLC2A1 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2518,233983,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in decreased expression of SLC2A1 mRNA,,,PMID:29521512,https://www.ncbi.nlm.nih.gov/pubmed/29521512,29521512,,
2519,233984,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SLC2A1 protein,,,PMID:28903497,https://www.ncbi.nlm.nih.gov/pubmed/28903497,28903497,,
2520,233985,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6518,SLC2A5,https://ctdbase.org/detail.go?type=gene&acc=6518,,,6518.0,SLC2A5,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of SLC2A5 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2521,234460,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6533,SLC6A6,https://ctdbase.org/detail.go?type=gene&acc=6533,,,6533.0,SLC6A6,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of SLC6A6 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2522,234461,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6541,SLC7A1,https://ctdbase.org/detail.go?type=gene&acc=6541,,,6541.0,SLC7A1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SLC7A1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2523,234462,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,8140,SLC7A5,https://ctdbase.org/detail.go?type=gene&acc=8140,,,8140.0,SLC7A5,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of SLC7A5 mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2524,234463,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,28250,SLCO1A4,https://ctdbase.org/detail.go?type=gene&acc=28250,,,28250.0,Slco1a4,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of SLCO1A4 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2525,234464,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of SLCO2B1 mRNA,,,PMID:15919853,https://www.ncbi.nlm.nih.gov/pubmed/15919853,15919853,,
2526,234465,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,28232,SLCO3A1,https://ctdbase.org/detail.go?type=gene&acc=28232,,,28232.0,SLCO3A1,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of SLCO3A1 mRNA,,,PMID:15919853,https://www.ncbi.nlm.nih.gov/pubmed/15919853,15919853,,
2527,235108,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of SQLE mrna|ahr protein affects the reaction [beta-naphthoflavone results in decreased expression of SQLE mrna],,,PMID:22234961,https://www.ncbi.nlm.nih.gov/pubmed/22234961,22234961,,
2528,235109,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SQLE mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2529,235110,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of SQSTM1 mRNA,,,PMID:32151702,https://www.ncbi.nlm.nih.gov/pubmed/32151702,32151702,,
2530,235111,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SRC mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2531,235112,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6715,SRD5A1,https://ctdbase.org/detail.go?type=gene&acc=6715,,,6715.0,SRD5A1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of SRD5A1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2532,235113,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in decreased expression of SREBF1 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2533,235327,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6728,SRP19,https://ctdbase.org/detail.go?type=gene&acc=6728,,,6728.0,SRP19,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of SRP19 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2534,235328,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,6734,SRPRA,https://ctdbase.org/detail.go?type=gene&acc=6734,,,6734.0,SRPRA,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of SRPRA mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2535,235329,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,8406,SRPX,https://ctdbase.org/detail.go?type=gene&acc=8406,,,8406.0,SRPX,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of SRPX mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2536,235330,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,8406,SRPX,https://ctdbase.org/detail.go?type=gene&acc=8406,,,8406.0,SRPX,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of SRPX mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2537,235331,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,140809,SRXN1,https://ctdbase.org/detail.go?type=gene&acc=140809,,,140809.0,SRXN1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of SRXN1 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2538,236877,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,389208,TMPRSS11F,https://ctdbase.org/detail.go?type=gene&acc=389208,,,389208.0,TMPRSS11F,10090.0,Mus musculus (house mouse),[andrographolide co-treated with beta-naphthoflavone] results in increased expression of TMPRSS11F mRNA,,,PMID:19737545,https://www.ncbi.nlm.nih.gov/pubmed/19737545,19737545,,
2539,236878,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,286527,TMSB15B,https://ctdbase.org/detail.go?type=gene&acc=286527,,,286527.0,TMSB15B,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of TMSB15B mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2540,236879,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,100034363,TMSB15B2,https://ctdbase.org/detail.go?type=gene&acc=100034363,,,100034363.0,Tmsb15b2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of TMSB15B2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2541,236880,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,3371,TNC,https://ctdbase.org/detail.go?type=gene&acc=3371,,,3371.0,TNC,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of TNC mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2542,236881,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of TNF mRNA,,,PMID:32151702,https://www.ncbi.nlm.nih.gov/pubmed/32151702,32151702,,
2543,236882,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Isoquercitrin inhibits the reaction [[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of TNF mrna]|[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of TNF mRNA,,,PMID:21295105,https://www.ncbi.nlm.nih.gov/pubmed/21295105,21295105,,
2544,236883,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,7127,TNFAIP2,https://ctdbase.org/detail.go?type=gene&acc=7127,,,7127.0,TNFAIP2,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of TNFAIP2 mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2545,236884,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,7130,TNFAIP6,https://ctdbase.org/detail.go?type=gene&acc=7130,,,7130.0,TNFAIP6,9606.0,Homo sapiens (human),Beta-naphthoflavone results in decreased expression of TNFAIP6 mRNA,,,PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/32858204,32858204,,
2546,236885,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,51330,TNFRSF12A,https://ctdbase.org/detail.go?type=gene&acc=51330,,,51330.0,TNFRSF12A,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of TNFRSF12A mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2547,236886,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,51330,TNFRSF12A,https://ctdbase.org/detail.go?type=gene&acc=51330,,,51330.0,TNFRSF12A,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of TNFRSF12A mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2548,237575,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,203068,TUBB,https://ctdbase.org/detail.go?type=gene&acc=203068,,,203068.0,TUBB,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of TUBB mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2549,237576,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,84617,TUBB6,https://ctdbase.org/detail.go?type=gene&acc=84617,,,84617.0,TUBB6,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of TUBB6 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2550,237577,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,9352,TXNL1,https://ctdbase.org/detail.go?type=gene&acc=9352,,,9352.0,TXNL1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of TXNL1 mRNA,,,PMID:19737606,https://www.ncbi.nlm.nih.gov/pubmed/19737606,19737606,,
2551,237578,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,10907,TXNL4A,https://ctdbase.org/detail.go?type=gene&acc=10907,,,10907.0,TXNL4A,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of TXNL4A mRNA,,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
2552,237579,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296.0,TXNRD1,9606.0,Homo sapiens (human),Beta-naphthoflavone results in increased expression of TXNRD1 mRNA,,,PMID:12949356|PMID:19737606|PMID:32858204,https://www.ncbi.nlm.nih.gov/pubmed/12949356|https://www.ncbi.nlm.nih.gov/pubmed/19737606|https://www.ncbi.nlm.nih.gov/pubmed/32858204,12949356|19737606|32858204,,
2553,237580,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,7298,TYMS,https://ctdbase.org/detail.go?type=gene&acc=7298,,,7298.0,TYMS,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of TYMS mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2554,238220,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,54578,UGT1A6,https://ctdbase.org/detail.go?type=gene&acc=54578,,,54578.0,UGT1A6,10090.0,Mus musculus (house mouse),Beta-naphthoflavone results in increased expression of UGT1A6 mRNA,,,PMID:19144771|PMID:19737545,https://www.ncbi.nlm.nih.gov/pubmed/19144771|https://www.ncbi.nlm.nih.gov/pubmed/19737545,19144771|19737545,,
2555,239137,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,56829,ZC3HAV1,https://ctdbase.org/detail.go?type=gene&acc=56829,,,56829.0,ZC3HAV1,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of ZC3HAV1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2556,239138,2361,Comparative Toxicogenomics Database (CTD),beta-Naphthoflavone,D019324,beta-Naphthoflavone,https://ctdbase.org/detail.go?type=chem&acc=D019324,51201,ZDHHC2,https://ctdbase.org/detail.go?type=gene&acc=51201,,,51201.0,ZDHHC2,10116.0,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of ZDHHC2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
2557,247068,2396,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide i,C070515,bisindolylmaleimide I,https://ctdbase.org/detail.go?type=chem&acc=C070515,693162,MIR577,https://ctdbase.org/detail.go?type=gene&acc=693162,,,693162.0,MIR577,9606.0,Homo sapiens (human),Bisindolylmaleimide I results in decreased expression of MIR577,,,PMID:35134991,https://www.ncbi.nlm.nih.gov/pubmed/35134991,35134991,,
2558,247069,2396,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide i,C070515,bisindolylmaleimide I,https://ctdbase.org/detail.go?type=chem&acc=C070515,693186,MIR601,https://ctdbase.org/detail.go?type=gene&acc=693186,,,693186.0,MIR601,9606.0,Homo sapiens (human),Bisindolylmaleimide I results in increased expression of MIR601,,,PMID:35134991,https://www.ncbi.nlm.nih.gov/pubmed/35134991,35134991,,
2559,247070,2396,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide i,C070515,bisindolylmaleimide I,https://ctdbase.org/detail.go?type=chem&acc=C070515,100126309,MIR875,https://ctdbase.org/detail.go?type=gene&acc=100126309,,,100126309.0,MIR875,9606.0,Homo sapiens (human),Bisindolylmaleimide I results in increased expression of MIR875,,,PMID:35134991,https://www.ncbi.nlm.nih.gov/pubmed/35134991,35134991,,
2560,247071,2396,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide i,C070515,bisindolylmaleimide I,https://ctdbase.org/detail.go?type=chem&acc=C070515,407056,MIR99B,https://ctdbase.org/detail.go?type=gene&acc=407056,,,407056.0,MIR99B,9606.0,Homo sapiens (human),Bisindolylmaleimide I results in decreased expression of MIR99B,,,PMID:35134991,https://www.ncbi.nlm.nih.gov/pubmed/35134991,35134991,,
2561,247072,2396,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide i,C070515,bisindolylmaleimide I,https://ctdbase.org/detail.go?type=chem&acc=C070515,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Bisindolylmaleimide I inhibits the reaction [tetradecanoylphorbol acetate results in increased secretion of MMP9 protein]|bisindolylmaleimide I inhibits the reaction [HGF protein results in increased expression of MMP9 mrna]|bisindolylmaleimide I inhibits the reaction [TNF protein results in increased expression of MMP9 mrna],,,PMID:12745093,https://www.ncbi.nlm.nih.gov/pubmed/12745093,12745093,,
2562,247073,2396,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide i,C070515,bisindolylmaleimide I,https://ctdbase.org/detail.go?type=chem&acc=C070515,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Bisindolylmaleimide I inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of MMP9 protein],,,PMID:19447859,https://www.ncbi.nlm.nih.gov/pubmed/19447859,19447859,,
2563,247074,2396,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide i,C070515,bisindolylmaleimide I,https://ctdbase.org/detail.go?type=chem&acc=C070515,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Bisindolylmaleimide I inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of and results in increased activity of MMP9 protein],,,PMID:23288142,https://www.ncbi.nlm.nih.gov/pubmed/23288142,23288142,,
2564,247075,2396,Comparative Toxicogenomics Database (CTD),Bisindolylmaleimide i,C070515,bisindolylmaleimide I,https://ctdbase.org/detail.go?type=chem&acc=C070515,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10090.0,Mus musculus (house mouse),Bisindolylmaleimide I inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of MPO protein],,,PMID:8273558,https://www.ncbi.nlm.nih.gov/pubmed/8273558,8273558,,
2565,236382,2405,Drug Gene Interaction database (DGIdb),Bisoprolol,,BISOPROLOL,https://www.dgidb.org/drugs/rxcui:19484,,ADRB1,https://www.dgidb.org/genes/hgnc:285,,,153.0,ADRB1,9606.0,Homo sapiens (human),,,,,,,,
2566,236383,2406,Drug Gene Interaction database (DGIdb),Bithionol,,BITHIONOL,https://www.dgidb.org/drugs/ncit:C77030,,ADAMTSL4-AS1,https://www.dgidb.org/genes/hgnc:32041,,,574406.0,ADAMTSL4-AS1,9606.0,Homo sapiens (human),,,,,,,,
2567,236384,2406,Drug Gene Interaction database (DGIdb),Bithionol,,BITHIONOL,https://www.dgidb.org/drugs/ncit:C77030,,ESR2,https://www.dgidb.org/genes/hgnc:3468,,,2100.0,ESR2,9606.0,Homo sapiens (human),,,,,,,,
2568,234632,2415,Comparative Toxicogenomics Database (CTD),2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-1-morpholinoethanone,C471852,indomethacin morpholinylamide,https://ctdbase.org/detail.go?type=chem&acc=C471852,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Indomethacin morpholinylamide promotes the reaction [[lipopolysaccharides co-treated with IFNG] results in increased secretion of TNF],,,PMID:12813001,https://www.ncbi.nlm.nih.gov/pubmed/12813001,12813001,,
2569,236385,2419,IUPHAR/BPS Guide to PHARMACOLOGY,"8-(2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl)-8-azaspiro[4.5]decane-7,9-dione",9,BMY-7378,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9,1,5-HT1A receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1,P08908,5-hydroxytryptamine receptor 1A,3350.0,HTR1A,9606.0,Homo sapiens (human),Partial agonist,pIC50,6.8 - 8,PMID:9048968,https://www.ncbi.nlm.nih.gov/pubmed/9048968,9048968,,
2570,236386,2427,Therapeutic Target Database (TTD),Bpiq-i,D0U6WB,BPIQ-I,https://idrblab.net/ttd/data/drug/details/D0U6WB,T59328,Epidermal growth factor receptor (EGFR),https://idrblab.net/ttd/data/target/details/T59328,P00533,Epidermal growth factor receptor,1956.0,EGFR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
2571,234633,2435,Comparative Toxicogenomics Database (CTD),Brimonidine,D000068438,Brimonidine Tartrate,https://ctdbase.org/detail.go?type=chem&acc=D000068438,150,ADRA2A,https://ctdbase.org/detail.go?type=gene&acc=150,,,150.0,ADRA2A,9606.0,Homo sapiens (human),Yohimbine inhibits the reaction [brimonidine tartrate promotes the reaction [phenylephrine binds to and results in increased activity of ADRA2A protein]]|prazosin inhibits the reaction [phenylephrine promotes the reaction [brimonidine tartrate binds to and results in increased activity of ADRA2A protein]]|phenylephrine promotes the reaction [brimonidine tartrate binds to and results in increased activity of ADRA2A protein]|brimonidine tartrate inhibits the reaction [norepinephrine binds to and results in increased activity of ADRA2A protein]|brimonidine tartrate promotes the reaction [phenylephrine binds to and results in increased activity of ADRA2A protein],,,PMID:10742289,https://www.ncbi.nlm.nih.gov/pubmed/10742289,10742289,,
2572,234634,2435,Comparative Toxicogenomics Database (CTD),Brimonidine,D000068438,Brimonidine Tartrate,https://ctdbase.org/detail.go?type=chem&acc=D000068438,150,ADRA2A,https://ctdbase.org/detail.go?type=gene&acc=150,,,150.0,ADRA2A,10090.0,Mus musculus (house mouse),Brimonidine tartrate binds to and results in increased activity of ADRA2A protein,,,PMID:12598592,https://www.ncbi.nlm.nih.gov/pubmed/12598592,12598592,,
2573,234772,2435,Comparative Toxicogenomics Database (CTD),Brimonidine,D000068438,Brimonidine Tartrate,https://ctdbase.org/detail.go?type=chem&acc=D000068438,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10116.0,Rattus norvegicus (Norway rat),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [brimonidine tartrate results in increased phosphorylation of CREB1 protein]|brimonidine tartrate results in increased phosphorylation of CREB1 protein,,,PMID:17680988,https://www.ncbi.nlm.nih.gov/pubmed/17680988,17680988,,
2574,234773,2435,Comparative Toxicogenomics Database (CTD),Brimonidine,D000068438,Brimonidine Tartrate,https://ctdbase.org/detail.go?type=chem&acc=D000068438,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,10116.0,Rattus norvegicus (Norway rat),Nitric oxide deficiency promotes the reaction [brimonidine tartrate affects the localization of PRKCA protein]|brimonidine tartrate affects the localization of PRKCA protein,,,PMID:12388232,https://www.ncbi.nlm.nih.gov/pubmed/12388232,12388232,,
2575,234774,2435,Comparative Toxicogenomics Database (CTD),Brimonidine,D000068438,Brimonidine Tartrate,https://ctdbase.org/detail.go?type=chem&acc=D000068438,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,10116.0,Rattus norvegicus (Norway rat),Brimonidine tartrate affects the localization of PRKCD protein|nitric oxide deficiency inhibits the reaction [brimonidine tartrate affects the localization of PRKCD protein],,,PMID:12388232,https://www.ncbi.nlm.nih.gov/pubmed/12388232,12388232,,
2576,234775,2435,Comparative Toxicogenomics Database (CTD),Brimonidine,D000068438,Brimonidine Tartrate,https://ctdbase.org/detail.go?type=chem&acc=D000068438,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,10116.0,Rattus norvegicus (Norway rat),"Brimonidine tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]|4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [brimonidine tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]|1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [brimonidine tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]|tempol inhibits the reaction [brimonidine tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]|bisindolylmaleimide I inhibits the reaction [brimonidine tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]|diphenyleneiodonium inhibits the reaction [brimonidine tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]",,,PMID:18250367,https://www.ncbi.nlm.nih.gov/pubmed/18250367,18250367,,
2577,234776,2435,Comparative Toxicogenomics Database (CTD),Brimonidine,D000068438,Brimonidine Tartrate,https://ctdbase.org/detail.go?type=chem&acc=D000068438,6582,SLC22A2,https://ctdbase.org/detail.go?type=gene&acc=6582,,,6582.0,SLC22A2,9606.0,Homo sapiens (human),Brimonidine tartrate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium],,,PMID:21599003,https://www.ncbi.nlm.nih.gov/pubmed/21599003,21599003,,
2578,234777,2435,Drug Gene Interaction database (DGIdb),Brimonidine,,BRIMONIDINE,https://www.dgidb.org/drugs/rxcui:134615,,ADRA2C,https://www.dgidb.org/genes/hgnc:283,,,152.0,ADRA2C,9606.0,Homo sapiens (human),,,,,,,,
2579,234778,2435,Drug Gene Interaction database (DGIdb),Brimonidine,,BRIMONIDINE,https://www.dgidb.org/drugs/rxcui:134615,,ADRA2A,https://www.dgidb.org/genes/hgnc:281,,,150.0,ADRA2A,9606.0,Homo sapiens (human),,,,,,,,
2580,234779,2441,Comparative Toxicogenomics Database (CTD),Bromazepam,D001960,Bromazepam,https://ctdbase.org/detail.go?type=chem&acc=D001960,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606.0,Homo sapiens (human),Bromazepam results in decreased activity of AKR1C3 protein,,,PMID:11995921,https://www.ncbi.nlm.nih.gov/pubmed/11995921,11995921,,
2581,237234,2474,Comparative Toxicogenomics Database (CTD),Bupivacaine,D002045,Bupivacaine,https://ctdbase.org/detail.go?type=chem&acc=D002045,7442,TRPV1,https://ctdbase.org/detail.go?type=gene&acc=7442,,,7442.0,TRPV1,10116.0,Rattus norvegicus (Norway rat),Bupivacaine affects the reaction [capsaicin results in increased activity of TRPV1 protein],,,PMID:15854744,https://www.ncbi.nlm.nih.gov/pubmed/15854744,15854744,,
2582,237235,2474,Comparative Toxicogenomics Database (CTD),Bupivacaine,D002045,Bupivacaine,https://ctdbase.org/detail.go?type=chem&acc=D002045,7442,TRPV1,https://ctdbase.org/detail.go?type=gene&acc=7442,,,7442.0,TRPV1,10116.0,Rattus norvegicus (Norway rat),Bupivacaine results in increased activity of TRPV1 protein,,,PMID:18172555,https://www.ncbi.nlm.nih.gov/pubmed/18172555,18172555,,
2583,237236,2474,Comparative Toxicogenomics Database (CTD),Bupivacaine,D002045,Bupivacaine,https://ctdbase.org/detail.go?type=chem&acc=D002045,2547,XRCC6,https://ctdbase.org/detail.go?type=gene&acc=2547,,,2547.0,XRCC6,10090.0,Mus musculus (house mouse),Glucose inhibits the reaction [bupivacaine results in increased expression of XRCC6 protein]|8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one inhibits the reaction [[glucose co-treated with bupivacaine] results in increased expression of XRCC6 protein]|bupivacaine results in increased expression of XRCC6 protein|[glucose co-treated with bupivacaine] results in increased expression of XRCC6 protein,,,PMID:31672611,https://www.ncbi.nlm.nih.gov/pubmed/31672611,31672611,,
2584,234984,2477,Drug Gene Interaction database (DGIdb),Buspirone,,BUSPIRONE,https://www.dgidb.org/drugs/rxcui:1827,,DRD2,https://www.dgidb.org/genes/hgnc:3023,,,1813.0,DRD2,9606.0,Homo sapiens (human),,,,,,,,
2585,237237,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,205,AK4,https://ctdbase.org/detail.go?type=gene&acc=205,,,205.0,AK4,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of AK4 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2586,237238,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,26993,AKAP8L,https://ctdbase.org/detail.go?type=gene&acc=26993,,,26993.0,AKAP8L,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of AKAP8L mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2587,238899,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,51027,BOLA1,https://ctdbase.org/detail.go?type=gene&acc=51027,,,51027.0,BOLA1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of BOLA1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2588,238900,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,669,BPGM,https://ctdbase.org/detail.go?type=gene&acc=669,,,669.0,BPGM,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of BPGM mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2589,238901,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,7832,BTG2,https://ctdbase.org/detail.go?type=gene&acc=7832,,,7832.0,BTG2,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of BTG2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2590,239832,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,56994,CHPT1,https://ctdbase.org/detail.go?type=gene&acc=56994,,,56994.0,CHPT1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of CHPT1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2591,239833,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,91612,CHURC1,https://ctdbase.org/detail.go?type=gene&acc=91612,,,91612.0,CHURC1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of CHURC1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2592,239834,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1164,CKS2,https://ctdbase.org/detail.go?type=gene&acc=1164,,,1164.0,CKS2,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of CKS2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2593,239835,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,165530,CLEC4F,https://ctdbase.org/detail.go?type=gene&acc=165530,,,165530.0,CLEC4F,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of CLEC4F mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2594,239836,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1192,CLIC1,https://ctdbase.org/detail.go?type=gene&acc=1192,,,1192.0,CLIC1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of CLIC1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2595,239837,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,81570,CLPB,https://ctdbase.org/detail.go?type=gene&acc=81570,,,81570.0,CLPB,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of CLPB mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2596,239838,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1212,CLTB,https://ctdbase.org/detail.go?type=gene&acc=1212,,,1212.0,CLTB,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of CLTB mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2597,239839,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,54918,CMTM6,https://ctdbase.org/detail.go?type=gene&acc=54918,,,54918.0,CMTM6,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of CMTM6 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2598,239840,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,27013,CNPPD1,https://ctdbase.org/detail.go?type=gene&acc=27013,,,27013.0,CNPPD1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of CNPPD1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2599,239841,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1268,CNR1,https://ctdbase.org/detail.go?type=gene&acc=1268,,,1268.0,CNR1,10090.0,Mus musculus (house mouse),CNR1 affects the susceptibility to buspirone,,,PMID:15081793,https://www.ncbi.nlm.nih.gov/pubmed/15081793,15081793,,
2600,240737,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,56266,CYP4F1,https://ctdbase.org/detail.go?type=gene&acc=56266,,,56266.0,Cyp4f1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of CYP4F1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2601,240738,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,286904,CYP4F4,https://ctdbase.org/detail.go?type=gene&acc=286904,,,286904.0,Cyp4f4,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of CYP4F4 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2602,240739,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1582,CYP8B1,https://ctdbase.org/detail.go?type=gene&acc=1582,,,1582.0,CYP8B1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of CYP8B1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2603,240740,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,23002,DAAM1,https://ctdbase.org/detail.go?type=gene&acc=23002,,,23002.0,DAAM1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of DAAM1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2604,240741,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1601,DAB2,https://ctdbase.org/detail.go?type=gene&acc=1601,,,1601.0,DAB2,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of DAB2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2605,240742,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1612,DAPK1,https://ctdbase.org/detail.go?type=gene&acc=1612,,,1612.0,DAPK1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of DAPK1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2606,240743,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1622,DBI,https://ctdbase.org/detail.go?type=gene&acc=1622,,,1622.0,DBI,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of DBI mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2607,240744,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of DDC mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2608,240745,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,80821,DDHD1,https://ctdbase.org/detail.go?type=gene&acc=80821,,,80821.0,DDHD1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of DDHD1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2609,240746,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1653,DDX1,https://ctdbase.org/detail.go?type=gene&acc=1653,,,1653.0,DDX1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of DDX1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2610,240747,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,1666,DECR1,https://ctdbase.org/detail.go?type=gene&acc=1666,,,1666.0,DECR1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of DECR1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2611,241637,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,55224,ETNK2,https://ctdbase.org/detail.go?type=gene&acc=55224,,,55224.0,ETNK2,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of ETNK2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2612,241638,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,2130,EWSR1,https://ctdbase.org/detail.go?type=gene&acc=2130,,,2130.0,EWSR1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of EWSR1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2613,241639,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,56915,EXOSC5,https://ctdbase.org/detail.go?type=gene&acc=56915,,,56915.0,EXOSC5,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of EXOSC5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2614,241640,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,2171,FABP5,https://ctdbase.org/detail.go?type=gene&acc=2171,,,2171.0,FABP5,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of FABP5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2615,241641,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,3992,FADS1,https://ctdbase.org/detail.go?type=gene&acc=3992,,,3992.0,FADS1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of FADS1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2616,245729,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,4830,NME1,https://ctdbase.org/detail.go?type=gene&acc=4830,,,4830.0,NME1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of NME1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2617,245730,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,4832,NME3,https://ctdbase.org/detail.go?type=gene&acc=4832,,,4832.0,NME3,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of NME3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2618,245731,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,100194995,NOL5,https://ctdbase.org/detail.go?type=gene&acc=100194995,,,100194995.0,,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of NOL5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2619,245732,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,29997,NOP53,https://ctdbase.org/detail.go?type=gene&acc=29997,,,29997.0,NOP53,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of NOP53 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2620,245733,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,4842,NOS1,https://ctdbase.org/detail.go?type=gene&acc=4842,,,4842.0,NOS1,10116.0,Rattus norvegicus (Norway rat),Buspirone inhibits the reaction [methotrexate results in increased expression of NOS1 mrna],,,PMID:37341015,https://www.ncbi.nlm.nih.gov/pubmed/37341015,37341015,,
2621,245734,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,4853,NOTCH2,https://ctdbase.org/detail.go?type=gene&acc=4853,,,4853.0,NOTCH2,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of NOTCH2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2622,245735,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,9975,NR1D2,https://ctdbase.org/detail.go?type=gene&acc=9975,,,9975.0,NR1D2,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of NR1D2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2623,245736,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of NR1I2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2624,245737,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,340371,NRBP2,https://ctdbase.org/detail.go?type=gene&acc=340371,,,340371.0,NRBP2,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of NRBP2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2625,245738,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,9315,NREP,https://ctdbase.org/detail.go?type=gene&acc=9315,,,9315.0,NREP,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of NREP mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2626,249252,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,9789,SPCS2,https://ctdbase.org/detail.go?type=gene&acc=9789,,,9789.0,SPCS2,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of SPCS2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2627,249253,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,51324,SPG21,https://ctdbase.org/detail.go?type=gene&acc=51324,,,51324.0,SPG21,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of SPG21 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2628,249254,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,6690,SPINK1,https://ctdbase.org/detail.go?type=gene&acc=6690,,,6690.0,SPINK1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of SPINK1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2629,249255,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,83985,SPNS1,https://ctdbase.org/detail.go?type=gene&acc=83985,,,83985.0,SPNS1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of SPNS1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2630,249256,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,171546,SPTSSA,https://ctdbase.org/detail.go?type=gene&acc=171546,,,171546.0,SPTSSA,10116.0,Rattus norvegicus (Norway rat),Buspirone results in increased expression of SPTSSA mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2631,249257,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,10116.0,Rattus norvegicus (Norway rat),Buspirone results in decreased expression of SREBF1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
2632,250496,2477,Comparative Toxicogenomics Database (CTD),Buspirone,D002065,Buspirone,https://ctdbase.org/detail.go?type=chem&acc=D002065,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Buspirone inhibits the reaction [methotrexate results in increased expression of TNF protein],,,PMID:37341015,https://www.ncbi.nlm.nih.gov/pubmed/37341015,37341015,,
2633,234985,2481,Drug Gene Interaction database (DGIdb),Butalbital,,BUTALBITAL,https://www.dgidb.org/drugs/rxcui:19860,,GRIA2,https://www.dgidb.org/genes/hgnc:4572,,,2891.0,GRIA2,9606.0,Homo sapiens (human),,,,,,,,
2634,234986,2481,Drug Gene Interaction database (DGIdb),Butalbital,,BUTALBITAL,https://www.dgidb.org/drugs/rxcui:19860,,GRIA2,https://www.dgidb.org/genes/hgnc:4572,,,2891.0,GRIA2,9606.0,Homo sapiens (human),,,,,,,,
2635,234987,2481,Drug Gene Interaction database (DGIdb),Butalbital,,BUTALBITAL,https://www.dgidb.org/drugs/rxcui:19860,,GABRA6,https://www.dgidb.org/genes/hgnc:4080,,,2559.0,GABRA6,9606.0,Homo sapiens (human),,,,,,,,
2636,234988,2481,Drug Gene Interaction database (DGIdb),Butalbital,,BUTALBITAL,https://www.dgidb.org/drugs/rxcui:19860,,GABRA6,https://www.dgidb.org/genes/hgnc:4080,,,2559.0,GABRA6,9606.0,Homo sapiens (human),,,,,,,,
2637,234989,2499,Therapeutic Target Database (TTD),(2-Acetyloxy-3-hexadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate,D06AUX,enantio PAF C-16,https://idrblab.net/ttd/data/drug/details/D06AUX,T87023,Platelet-activating factor receptor (PTAFR),https://idrblab.net/ttd/data/target/details/T87023,P25105,Platelet-activating factor receptor,5724.0,PTAFR,9606.0,Homo sapiens (human),Agonist,,,,,,,
2638,247890,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495.0,FTH1,10116.0,Rattus norvegicus (Norway rat),Cacodylic acid results in increased expression of FTH1 mRNA,,,PMID:16122865,https://www.ncbi.nlm.nih.gov/pubmed/16122865,16122865,,
2639,247891,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,14325,FTL1,https://ctdbase.org/detail.go?type=gene&acc=14325,,,14325.0,Ftl1,10116.0,Rattus norvegicus (Norway rat),Cacodylic acid results in increased expression of FTL1 mRNA,,,PMID:16122865,https://www.ncbi.nlm.nih.gov/pubmed/16122865,16122865,,
2640,247892,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,2523,FUT1,https://ctdbase.org/detail.go?type=gene&acc=2523,,,2523.0,FUT1,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in decreased expression of FUT1 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
2641,247893,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,170384,FUT11,https://ctdbase.org/detail.go?type=gene&acc=170384,,,170384.0,FUT11,10090.0,Mus musculus (house mouse),Cacodylic acid results in decreased expression of FUT11 mRNA,,,PMID:22246474,https://www.ncbi.nlm.nih.gov/pubmed/22246474,22246474,,
2642,247894,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606.0,Homo sapiens (human),Cacodylic acid analog results in increased expression of GADD45A protein,,,PMID:23994116,https://www.ncbi.nlm.nih.gov/pubmed/23994116,23994116,,
2643,247895,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in decreased expression of GADD45A mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
2644,247896,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,10116.0,Rattus norvegicus (Norway rat),Cacodylic acid results in increased expression of GADD45A mRNA,,,PMID:16122865,https://www.ncbi.nlm.nih.gov/pubmed/16122865,16122865,,
2645,247897,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,2580,GAK,https://ctdbase.org/detail.go?type=gene&acc=2580,,,2580.0,GAK,10116.0,Rattus norvegicus (Norway rat),Cacodylic acid results in increased expression of GAK mRNA,,,PMID:16122865,https://www.ncbi.nlm.nih.gov/pubmed/16122865,16122865,,
2646,247898,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,2621,GAS6,https://ctdbase.org/detail.go?type=gene&acc=2621,,,2621.0,GAS6,10116.0,Rattus norvegicus (Norway rat),Cacodylic acid results in decreased expression of GAS6 mRNA,,,PMID:37567419,https://www.ncbi.nlm.nih.gov/pubmed/37567419,37567419,,
2647,249258,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,14869,GSTP2,https://ctdbase.org/detail.go?type=gene&acc=14869,,,14869.0,Gstp2,10116.0,Rattus norvegicus (Norway rat),Cacodylic acid results in increased expression of GSTP2 mRNA,,,PMID:16122865|PMID:16436460,https://www.ncbi.nlm.nih.gov/pubmed/16122865|https://www.ncbi.nlm.nih.gov/pubmed/16436460,16122865|16436460,,
2648,249259,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,14869,GSTP2,https://ctdbase.org/detail.go?type=gene&acc=14869,,,14869.0,Gstp2,10116.0,Rattus norvegicus (Norway rat),Cacodylic acid results in increased expression of GSTP2 protein,,,PMID:16436460,https://www.ncbi.nlm.nih.gov/pubmed/16436460,16436460,,
2649,249260,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,9606.0,Homo sapiens (human),GSTT1 gene affects the susceptibility to cacodylic acid|gstt1 protein affects the metabolism of cacodylic acid,,,PMID:17431481,https://www.ncbi.nlm.nih.gov/pubmed/17431481,17431481,,
2650,249261,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,9606.0,Homo sapiens (human),[GSTT1 gene polymorphism affects the metabolism of arsenic] which affects the abundance of cacodylic acid,,,PMID:32650499,https://www.ncbi.nlm.nih.gov/pubmed/32650499,32650499,,
2651,250658,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,80216,ALPK1,https://ctdbase.org/detail.go?type=gene&acc=80216,,,80216.0,ALPK1,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in decreased expression of ALPK1 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
2652,250659,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,10218,ANGPTL7,https://ctdbase.org/detail.go?type=gene&acc=10218,,,10218.0,ANGPTL7,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of ANGPTL7 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
2653,250660,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,27063,ANKRD1,https://ctdbase.org/detail.go?type=gene&acc=27063,,,27063.0,ANKRD1,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of ANKRD1 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
2654,250661,2513,Comparative Toxicogenomics Database (CTD),Cacodylic acid,D002101,Cacodylic Acid,https://ctdbase.org/detail.go?type=chem&acc=D002101,55018,ANKRD40CL,https://ctdbase.org/detail.go?type=gene&acc=55018,,,55018.0,ANKRD40CL,10090.0,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of ANKRD40CL mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
2655,220232,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6185,RPN2,https://ctdbase.org/detail.go?type=gene&acc=6185,,,6185.0,RPN2,9606.0,Homo sapiens (human),Caffeine results in increased expression of RPN2 protein,,,PMID:31195006,https://www.ncbi.nlm.nih.gov/pubmed/31195006,31195006,,
2656,220233,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,58490,RPRD1B,https://ctdbase.org/detail.go?type=gene&acc=58490,,,58490.0,RPRD1B,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of RPRD1B protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2657,220234,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23248,RPRD2,https://ctdbase.org/detail.go?type=gene&acc=23248,,,23248.0,RPRD2,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of RPRD2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2658,220235,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6204,RPS10,https://ctdbase.org/detail.go?type=gene&acc=6204,,,6204.0,RPS10,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of RPS10 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2659,220236,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6205,RPS11,https://ctdbase.org/detail.go?type=gene&acc=6205,,,6205.0,RPS11,9606.0,Homo sapiens (human),Caffeine results in increased expression of RPS11 protein,,,PMID:31195006,https://www.ncbi.nlm.nih.gov/pubmed/31195006,31195006,,
2660,220546,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9146,HGS,https://ctdbase.org/detail.go?type=gene&acc=9146,,,9146.0,HGS,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of HGS protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2661,220547,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,79802,HHIPL2,https://ctdbase.org/detail.go?type=gene&acc=79802,,,79802.0,HHIPL2,9606.0,Homo sapiens (human),Caffeine results in decreased expression of HHIPL2 protein,,,PMID:31195006,https://www.ncbi.nlm.nih.gov/pubmed/31195006,31195006,,
2662,220548,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23119,HIC2,https://ctdbase.org/detail.go?type=gene&acc=23119,,,23119.0,HIC2,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of HIC2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2663,220816,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10090.0,Mus musculus (house mouse),[caffeine co-treated with bisphenol A] results in decreased expression of HIF1A mRNA,,,PMID:31756439,https://www.ncbi.nlm.nih.gov/pubmed/31756439,31756439,,
2664,221075,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,51773,RSF1,https://ctdbase.org/detail.go?type=gene&acc=51773,,,51773.0,RSF1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of RSF1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2665,221076,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,26156,RSL1D1,https://ctdbase.org/detail.go?type=gene&acc=26156,,,26156.0,RSL1D1,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of RSL1D1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2666,221077,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,84870,RSPO3,https://ctdbase.org/detail.go?type=gene&acc=84870,,,84870.0,RSPO3,10090.0,Mus musculus (house mouse),"Caffeine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RSPO3 mrna]|[caffeine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of RSPO3 mRNA",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
2667,221078,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,65117,RSRC2,https://ctdbase.org/detail.go?type=gene&acc=65117,,,65117.0,RSRC2,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of RSRC2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2668,221079,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,51750,RTEL1,https://ctdbase.org/detail.go?type=gene&acc=51750,,,51750.0,RTEL1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of RTEL1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2669,221080,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6242,RTKN,https://ctdbase.org/detail.go?type=gene&acc=6242,,,6242.0,RTKN,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of RTKN protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2670,221081,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,57529,RTL9,https://ctdbase.org/detail.go?type=gene&acc=57529,,,57529.0,RTL9,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of RTL9 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2671,221082,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,10313,RTN3,https://ctdbase.org/detail.go?type=gene&acc=10313,,,10313.0,RTN3,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of RTN3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2672,221083,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,57142,RTN4,https://ctdbase.org/detail.go?type=gene&acc=57142,,,57142.0,RTN4,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of RTN4 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2673,221671,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3187,HNRNPH1,https://ctdbase.org/detail.go?type=gene&acc=3187,,,3187.0,HNRNPH1,9606.0,Homo sapiens (human),Caffeine results in decreased expression of HNRNPH1 protein,,,PMID:31195006,https://www.ncbi.nlm.nih.gov/pubmed/31195006,31195006,,
2674,221672,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3187,HNRNPH1,https://ctdbase.org/detail.go?type=gene&acc=3187,,,3187.0,HNRNPH1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of HNRNPH1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2675,221673,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3188,HNRNPH2,https://ctdbase.org/detail.go?type=gene&acc=3188,,,3188.0,HNRNPH2,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of HNRNPH2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2676,221674,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3189,HNRNPH3,https://ctdbase.org/detail.go?type=gene&acc=3189,,,3189.0,HNRNPH3,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of HNRNPH3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2677,221675,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3190,HNRNPK,https://ctdbase.org/detail.go?type=gene&acc=3190,,,3190.0,HNRNPK,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of HNRNPK protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2678,221676,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3190,HNRNPK,https://ctdbase.org/detail.go?type=gene&acc=3190,,,3190.0,HNRNPK,9606.0,Homo sapiens (human),Caffeine results in increased expression of HNRNPK protein,,,PMID:31195006,https://www.ncbi.nlm.nih.gov/pubmed/31195006,31195006,,
2679,221677,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3190,HNRNPK,https://ctdbase.org/detail.go?type=gene&acc=3190,,,3190.0,HNRNPK,10116.0,Rattus norvegicus (Norway rat),Caffeine results in decreased expression of HNRNPK mRNA,,,PMID:25868845,https://www.ncbi.nlm.nih.gov/pubmed/25868845,25868845,,
2680,221678,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3191,HNRNPL,https://ctdbase.org/detail.go?type=gene&acc=3191,,,3191.0,HNRNPL,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of HNRNPL protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2681,221679,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,92906,HNRNPLL,https://ctdbase.org/detail.go?type=gene&acc=92906,,,92906.0,HNRNPLL,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of HNRNPLL protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2682,222185,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,22828,SCAF8,https://ctdbase.org/detail.go?type=gene&acc=22828,,,22828.0,SCAF8,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SCAF8 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2683,222186,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9522,SCAMP1,https://ctdbase.org/detail.go?type=gene&acc=9522,,,9522.0,SCAMP1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of SCAMP1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2684,222187,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,10067,SCAMP3,https://ctdbase.org/detail.go?type=gene&acc=10067,,,10067.0,SCAMP3,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of SCAMP3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2685,222188,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,113178,SCAMP4,https://ctdbase.org/detail.go?type=gene&acc=113178,,,113178.0,SCAMP4,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of SCAMP4 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2686,222623,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23513,SCRIB,https://ctdbase.org/detail.go?type=gene&acc=23513,,,23513.0,SCRIB,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SCRIB protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2687,222624,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6385,SDC4,https://ctdbase.org/detail.go?type=gene&acc=6385,,,6385.0,SDC4,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of SDC4 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2688,222625,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6386,SDCBP,https://ctdbase.org/detail.go?type=gene&acc=6386,,,6386.0,SDCBP,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of SDCBP protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2689,222626,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,27111,SDCBP2,https://ctdbase.org/detail.go?type=gene&acc=27111,,,27111.0,SDCBP2,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of SDCBP2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2690,222627,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6396,SEC13,https://ctdbase.org/detail.go?type=gene&acc=6396,,,6396.0,SEC13,9606.0,Homo sapiens (human),Caffeine results in decreased expression of SEC13 mRNA,,,PMID:11793227,https://www.ncbi.nlm.nih.gov/pubmed/11793227,11793227,,
2691,222628,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6397,SEC14L1,https://ctdbase.org/detail.go?type=gene&acc=6397,,,6397.0,SEC14L1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SEC14L1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2692,222629,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9919,SEC16A,https://ctdbase.org/detail.go?type=gene&acc=9919,,,9919.0,SEC16A,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SEC16A protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2693,222630,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,89866,SEC16B,https://ctdbase.org/detail.go?type=gene&acc=89866,,,89866.0,SEC16B,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SEC16B protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2694,222797,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3329,HSPD1,https://ctdbase.org/detail.go?type=gene&acc=3329,,,3329.0,HSPD1,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of HSPD1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2695,222798,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3336,HSPE1,https://ctdbase.org/detail.go?type=gene&acc=3336,,,3336.0,HSPE1,10090.0,Mus musculus (house mouse),"Caffeine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HSPE1 mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
2696,222799,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3339,HSPG2,https://ctdbase.org/detail.go?type=gene&acc=3339,,,3339.0,HSPG2,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of HSPG2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2697,222800,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,10808,HSPH1,https://ctdbase.org/detail.go?type=gene&acc=10808,,,10808.0,HSPH1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of HSPH1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2698,222801,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,27336,HTATSF1,https://ctdbase.org/detail.go?type=gene&acc=27336,,,27336.0,HTATSF1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of HTATSF1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2699,222802,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3359,HTR3A,https://ctdbase.org/detail.go?type=gene&acc=3359,,,3359.0,HTR3A,9606.0,Homo sapiens (human),Caffeine results in decreased expression of HTR3A mRNA,,,PMID:35940281,https://www.ncbi.nlm.nih.gov/pubmed/35940281,35940281,,
2700,222803,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,3064,HTT,https://ctdbase.org/detail.go?type=gene&acc=3064,,,3064.0,HTT,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of HTT protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2701,223666,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,54557,SGTB,https://ctdbase.org/detail.go?type=gene&acc=54557,,,54557.0,SGTB,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of SGTB protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2702,223667,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,25970,SH2B1,https://ctdbase.org/detail.go?type=gene&acc=25970,,,25970.0,SH2B1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SH2B1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2703,223668,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,10045,SH2D3A,https://ctdbase.org/detail.go?type=gene&acc=10045,,,10045.0,SH2D3A,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SH2D3A protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2704,223669,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,400745,SH2D5,https://ctdbase.org/detail.go?type=gene&acc=400745,,,400745.0,SH2D5,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of SH2D5 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2705,223670,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23616,SH3BP1,https://ctdbase.org/detail.go?type=gene&acc=23616,,,23616.0,SH3BP1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of SH3BP1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2706,224143,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,10280,SIGMAR1,https://ctdbase.org/detail.go?type=gene&acc=10280,,,10280.0,SIGMAR1,10116.0,Rattus norvegicus (Norway rat),Caffeine results in decreased expression of SIGMAR1 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
2707,224144,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,25942,SIN3A,https://ctdbase.org/detail.go?type=gene&acc=25942,,,25942.0,SIN3A,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SIN3A protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2708,224145,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6494,SIPA1,https://ctdbase.org/detail.go?type=gene&acc=6494,,,6494.0,SIPA1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of SIPA1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2709,224146,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,26037,SIPA1L1,https://ctdbase.org/detail.go?type=gene&acc=26037,,,26037.0,SIPA1L1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SIPA1L1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2710,224147,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23094,SIPA1L3,https://ctdbase.org/detail.go?type=gene&acc=23094,,,23094.0,SIPA1L3,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SIPA1L3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2711,228292,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,84926,SPRYD3,https://ctdbase.org/detail.go?type=gene&acc=84926,,,84926.0,SPRYD3,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of SPRYD3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2712,228293,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6709,SPTAN1,https://ctdbase.org/detail.go?type=gene&acc=6709,,,6709.0,SPTAN1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of SPTAN1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2713,228294,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6711,SPTBN1,https://ctdbase.org/detail.go?type=gene&acc=6711,,,6711.0,SPTBN1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SPTBN1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2714,228295,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,9606.0,Homo sapiens (human),Caffeine results in decreased expression of SQLE mRNA,,,PMID:11793227,https://www.ncbi.nlm.nih.gov/pubmed/11793227,11793227,,
2715,228296,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,10116.0,Rattus norvegicus (Norway rat),Caffeine results in decreased expression of SQLE mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
2716,228297,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,10116.0,Rattus norvegicus (Norway rat),Caffeine results in increased expression of SQLE mRNA,,,PMID:25868845,https://www.ncbi.nlm.nih.gov/pubmed/25868845,25868845,,
2717,228298,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of SQSTM1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2718,228299,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606.0,Homo sapiens (human),Caffeine inhibits the reaction [doxorubicin results in increased degradation of SQSTM1 protein],,,PMID:22927544,https://www.ncbi.nlm.nih.gov/pubmed/22927544,22927544,,
2719,228300,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606.0,Homo sapiens (human),Caffeine results in decreased expression of SQSTM1 protein,,,PMID:21081844,https://www.ncbi.nlm.nih.gov/pubmed/21081844,21081844,,
2720,228301,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10116.0,Rattus norvegicus (Norway rat),Caffeine results in increased expression of SQSTM1 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
2721,229821,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6801,STRN,https://ctdbase.org/detail.go?type=gene&acc=6801,,,6801.0,STRN,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of STRN protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2722,230027,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,20909,STX4A,https://ctdbase.org/detail.go?type=gene&acc=20909,,,20909.0,Stx4a,10090.0,Mus musculus (house mouse),"Caffeine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of STX4A mrna]|[caffeine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of STX4A mRNA",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
2723,230028,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,10228,STX6,https://ctdbase.org/detail.go?type=gene&acc=10228,,,10228.0,STX6,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of STX6 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2724,230029,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8417,STX7,https://ctdbase.org/detail.go?type=gene&acc=8417,,,8417.0,STX7,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of STX7 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2725,230030,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9482,STX8,https://ctdbase.org/detail.go?type=gene&acc=9482,,,9482.0,STX8,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of STX8 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2726,230031,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,252983,STXBP4,https://ctdbase.org/detail.go?type=gene&acc=252983,,,252983.0,STXBP4,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of STXBP4 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2727,231382,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,57551,TAOK1,https://ctdbase.org/detail.go?type=gene&acc=57551,,,57551.0,TAOK1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of TAOK1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2728,231383,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9344,TAOK2,https://ctdbase.org/detail.go?type=gene&acc=9344,,,9344.0,TAOK2,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of TAOK2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2729,231384,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,202018,TAPT1,https://ctdbase.org/detail.go?type=gene&acc=202018,,,202018.0,TAPT1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of TAPT1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2730,231385,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6895,TARBP2,https://ctdbase.org/detail.go?type=gene&acc=6895,,,6895.0,TARBP2,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of TARBP2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2731,231386,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23435,TARDBP,https://ctdbase.org/detail.go?type=gene&acc=23435,,,23435.0,TARDBP,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of TARDBP protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2732,231387,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of TARS1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2733,231388,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,54906,TASOR2,https://ctdbase.org/detail.go?type=gene&acc=54906,,,54906.0,TASOR2,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of TASOR2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2734,231389,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9797,TATDN2,https://ctdbase.org/detail.go?type=gene&acc=9797,,,9797.0,TATDN2,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of TATDN2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2735,231390,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,30851,TAX1BP3,https://ctdbase.org/detail.go?type=gene&acc=30851,,,30851.0,TAX1BP3,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of TAX1BP3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2736,231391,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,26000,TBC1D10B,https://ctdbase.org/detail.go?type=gene&acc=26000,,,26000.0,TBC1D10B,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of TBC1D10B protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2737,233145,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9874,TLK1,https://ctdbase.org/detail.go?type=gene&acc=9874,,,9874.0,TLK1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of TLK1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2738,233146,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,11011,TLK2,https://ctdbase.org/detail.go?type=gene&acc=11011,,,11011.0,TLK2,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of TLK2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2739,234924,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Caffeine inhibits the reaction [doxorubicin results in increased expression of TP53 protein],,,PMID:22927544,https://www.ncbi.nlm.nih.gov/pubmed/22927544,22927544,,
2740,236067,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,11078,TRIOBP,https://ctdbase.org/detail.go?type=gene&acc=11078,,,11078.0,TRIOBP,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of TRIOBP protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2741,236068,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9322,TRIP10,https://ctdbase.org/detail.go?type=gene&acc=9322,,,9322.0,TRIP10,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of TRIP10 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2742,236069,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9321,TRIP11,https://ctdbase.org/detail.go?type=gene&acc=9321,,,9321.0,TRIP11,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of TRIP11 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2743,236070,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9320,TRIP12,https://ctdbase.org/detail.go?type=gene&acc=9320,,,9320.0,TRIP12,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of TRIP12 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2744,236071,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,54802,TRIT1,https://ctdbase.org/detail.go?type=gene&acc=54802,,,54802.0,TRIT1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of TRIT1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2745,236072,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,55621,TRMT1,https://ctdbase.org/detail.go?type=gene&acc=55621,,,55621.0,TRMT1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of TRMT1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2746,236073,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,51504,TRMT112,https://ctdbase.org/detail.go?type=gene&acc=51504,,,51504.0,TRMT112,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of TRMT112 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2747,236074,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,81627,TRMT1L,https://ctdbase.org/detail.go?type=gene&acc=81627,,,81627.0,TRMT1L,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of TRMT1L protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2748,237391,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,56893,UBQLN4,https://ctdbase.org/detail.go?type=gene&acc=56893,,,56893.0,UBQLN4,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of UBQLN4 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2749,237392,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,197131,UBR1,https://ctdbase.org/detail.go?type=gene&acc=197131,,,197131.0,UBR1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of UBR1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2750,237393,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23304,UBR2,https://ctdbase.org/detail.go?type=gene&acc=23304,,,23304.0,UBR2,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of UBR2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2751,237394,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23352,UBR4,https://ctdbase.org/detail.go?type=gene&acc=23352,,,23352.0,UBR4,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of UBR4 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2752,237395,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,51366,UBR5,https://ctdbase.org/detail.go?type=gene&acc=51366,,,51366.0,UBR5,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of UBR5 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2753,237396,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,55148,UBR7,https://ctdbase.org/detail.go?type=gene&acc=55148,,,55148.0,UBR7,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of UBR7 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2754,237397,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,137886,UBXN2B,https://ctdbase.org/detail.go?type=gene&acc=137886,,,137886.0,UBXN2B,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of UBXN2B protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2755,237398,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23190,UBXN4,https://ctdbase.org/detail.go?type=gene&acc=23190,,,23190.0,UBXN4,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of UBXN4 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2756,237399,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,80700,UBXN6,https://ctdbase.org/detail.go?type=gene&acc=80700,,,80700.0,UBXN6,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of UBXN6 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2757,237591,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,26043,UBXN7,https://ctdbase.org/detail.go?type=gene&acc=26043,,,26043.0,UBXN7,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of UBXN7 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2758,237592,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,7345,UCHL1,https://ctdbase.org/detail.go?type=gene&acc=7345,,,7345.0,UCHL1,10090.0,Mus musculus (house mouse),"Caffeine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of UCHL1 mrna]|[caffeine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of UCHL1 mRNA",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
2759,237593,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,83549,UCK1,https://ctdbase.org/detail.go?type=gene&acc=83549,,,83549.0,UCK1,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of UCK1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2760,237594,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,54963,UCKL1,https://ctdbase.org/detail.go?type=gene&acc=54963,,,54963.0,UCKL1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of UCKL1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2761,238041,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,7390,UROS,https://ctdbase.org/detail.go?type=gene&acc=7390,,,7390.0,UROS,10090.0,Mus musculus (house mouse),"[caffeine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of UROS mrna|caffeine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of UROS mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
2762,238042,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8615,USO1,https://ctdbase.org/detail.go?type=gene&acc=8615,,,8615.0,USO1,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of USO1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2763,238043,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,7398,USP1,https://ctdbase.org/detail.go?type=gene&acc=7398,,,7398.0,USP1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of USP1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2764,238044,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9100,USP10,https://ctdbase.org/detail.go?type=gene&acc=9100,,,9100.0,USP10,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of USP10 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2765,238045,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8237,USP11,https://ctdbase.org/detail.go?type=gene&acc=8237,,,8237.0,USP11,10116.0,Rattus norvegicus (Norway rat),Caffeine results in increased expression of USP11 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
2766,238046,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9958,USP15,https://ctdbase.org/detail.go?type=gene&acc=9958,,,9958.0,USP15,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of USP15 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2767,238745,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9341,VAMP3,https://ctdbase.org/detail.go?type=gene&acc=9341,,,9341.0,VAMP3,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of VAMP3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2768,238746,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8673,VAMP8,https://ctdbase.org/detail.go?type=gene&acc=8673,,,8673.0,VAMP8,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of VAMP8 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2769,238747,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,81839,VANGL1,https://ctdbase.org/detail.go?type=gene&acc=81839,,,81839.0,VANGL1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of VANGL1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2770,238748,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9218,VAPA,https://ctdbase.org/detail.go?type=gene&acc=9218,,,9218.0,VAPA,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of VAPA protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2771,238749,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,7407,VARS1,https://ctdbase.org/detail.go?type=gene&acc=7407,,,7407.0,VARS1,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of VARS1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2772,238750,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,7408,VASP,https://ctdbase.org/detail.go?type=gene&acc=7408,,,7408.0,VASP,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of VASP protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2773,239674,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,80304,WDCP,https://ctdbase.org/detail.go?type=gene&acc=80304,,,80304.0,WDCP,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of WDCP protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2774,239675,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,57590,WDFY1,https://ctdbase.org/detail.go?type=gene&acc=57590,,,57590.0,WDFY1,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of WDFY1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2775,240587,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,78992,YIPF2,https://ctdbase.org/detail.go?type=gene&acc=78992,,,78992.0,YIPF2,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of YIPF2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2776,240588,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,81576,YJU2B,https://ctdbase.org/detail.go?type=gene&acc=81576,,,81576.0,YJU2B,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of YJU2B protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2777,240589,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,56252,YLPM1,https://ctdbase.org/detail.go?type=gene&acc=56252,,,56252.0,YLPM1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of YLPM1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2778,240590,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,79693,YRDC,https://ctdbase.org/detail.go?type=gene&acc=79693,,,79693.0,YRDC,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of YRDC protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2779,240591,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,91746,YTHDC1,https://ctdbase.org/detail.go?type=gene&acc=91746,,,91746.0,YTHDC1,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of YTHDC1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2780,240592,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,64848,YTHDC2,https://ctdbase.org/detail.go?type=gene&acc=64848,,,64848.0,YTHDC2,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of YTHDC2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2781,242637,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,284695,ZNF326,https://ctdbase.org/detail.go?type=gene&acc=284695,,,284695.0,ZNF326,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of ZNF326 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2782,242638,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,63925,ZNF335,https://ctdbase.org/detail.go?type=gene&acc=63925,,,63925.0,ZNF335,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of ZNF335 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2783,242639,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,26152,ZNF337,https://ctdbase.org/detail.go?type=gene&acc=26152,,,26152.0,ZNF337,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of ZNF337 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2784,242640,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,7581,ZNF33A,https://ctdbase.org/detail.go?type=gene&acc=7581,,,7581.0,ZNF33A,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of ZNF33A protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2785,242641,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,149076,ZNF362,https://ctdbase.org/detail.go?type=gene&acc=149076,,,149076.0,ZNF362,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of ZNF362 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2786,341640,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9371,KIF3B,https://ctdbase.org/detail.go?type=gene&acc=9371,,,9371.0,KIF3B,10090.0,Mus musculus (house mouse),"[caffeine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of KIF3B mrna|caffeine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of KIF3B mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
2787,344279,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,256586,LYSMD2,https://ctdbase.org/detail.go?type=gene&acc=256586,,,256586.0,LYSMD2,10116.0,Rattus norvegicus (Norway rat),Caffeine results in decreased expression of LYSMD2 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
2788,344280,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,116068,LYSMD3,https://ctdbase.org/detail.go?type=gene&acc=116068,,,116068.0,LYSMD3,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of LYSMD3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2789,344281,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,84445,LZTS2,https://ctdbase.org/detail.go?type=gene&acc=84445,,,84445.0,LZTS2,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of LZTS2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2790,344282,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23499,MACF1,https://ctdbase.org/detail.go?type=gene&acc=23499,,,23499.0,MACF1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of MACF1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2791,344283,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,55219,MACO1,https://ctdbase.org/detail.go?type=gene&acc=55219,,,55219.0,MACO1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of MACO1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2792,344284,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9555,MACROH2A1,https://ctdbase.org/detail.go?type=gene&acc=9555,,,9555.0,MACROH2A1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of MACROH2A1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2793,344285,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,84944,MAEL,https://ctdbase.org/detail.go?type=gene&acc=84944,,,84944.0,MAEL,9606.0,Homo sapiens (human),Caffeine results in decreased expression of MAEL protein,,,PMID:31195006,https://www.ncbi.nlm.nih.gov/pubmed/31195006,31195006,,
2794,344286,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,84232,MAF1,https://ctdbase.org/detail.go?type=gene&acc=84232,,,84232.0,MAF1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of MAF1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2795,344287,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23764,MAFF,https://ctdbase.org/detail.go?type=gene&acc=23764,,,23764.0,MAFF,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of MAFF protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2796,344763,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4128,MAOA,https://ctdbase.org/detail.go?type=gene&acc=4128,,,4128.0,MAOA,10090.0,Mus musculus (house mouse),"[caffeine co-treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of MAOA mrna|caffeine inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of MAOA mrna]",,,PMID:20230807,https://www.ncbi.nlm.nih.gov/pubmed/20230807,20230807,,
2797,344764,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4131,MAP1B,https://ctdbase.org/detail.go?type=gene&acc=4131,,,4131.0,MAP1B,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of MAP1B protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2798,346125,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4170,MCL1,https://ctdbase.org/detail.go?type=gene&acc=4170,,,4170.0,MCL1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of MCL1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2799,346126,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,55388,MCM10,https://ctdbase.org/detail.go?type=gene&acc=55388,,,55388.0,MCM10,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of MCM10 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2800,346127,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4171,MCM2,https://ctdbase.org/detail.go?type=gene&acc=4171,,,4171.0,MCM2,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of MCM2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2801,346128,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4172,MCM3,https://ctdbase.org/detail.go?type=gene&acc=4172,,,4172.0,MCM3,10090.0,Mus musculus (house mouse),Caffeine results in increased expression of MCM3 protein,,,PMID:20025956,https://www.ncbi.nlm.nih.gov/pubmed/20025956,20025956,,
2802,346129,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4173,MCM4,https://ctdbase.org/detail.go?type=gene&acc=4173,,,4173.0,MCM4,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of MCM4 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2803,349476,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4597,MVD,https://ctdbase.org/detail.go?type=gene&acc=4597,,,4597.0,MVD,10116.0,Rattus norvegicus (Norway rat),Caffeine results in decreased expression of MVD mRNA,,,PMID:25868845,https://www.ncbi.nlm.nih.gov/pubmed/25868845,25868845,,
2804,349477,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598.0,MVK,10116.0,Rattus norvegicus (Norway rat),Caffeine results in increased expression of MVK mRNA,,,PMID:25868845,https://www.ncbi.nlm.nih.gov/pubmed/25868845,25868845,,
2805,349478,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,439921,MXRA7,https://ctdbase.org/detail.go?type=gene&acc=439921,,,439921.0,MXRA7,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of MXRA7 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2806,349479,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,10514,MYBBP1A,https://ctdbase.org/detail.go?type=gene&acc=10514,,,10514.0,MYBBP1A,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of MYBBP1A protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2807,349480,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4605,MYBL2,https://ctdbase.org/detail.go?type=gene&acc=4605,,,4605.0,MYBL2,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of MYBL2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2808,349481,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4607,MYBPC3,https://ctdbase.org/detail.go?type=gene&acc=4607,,,4607.0,MYBPC3,7955.0,Danio rerio (zebrafish),Caffeine results in decreased expression of MYBPC3 mRNA,,,PMID:23774253,https://www.ncbi.nlm.nih.gov/pubmed/23774253,23774253,,
2809,349482,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of MYC protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2810,349483,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10116.0,Rattus norvegicus (Norway rat),"Caffeine promotes the reaction [[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with dietary fats] results in increased expression of MYC mrna]",,,PMID:18283038,https://www.ncbi.nlm.nih.gov/pubmed/18283038,18283038,,
2811,351258,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,10825,NEU3,https://ctdbase.org/detail.go?type=gene&acc=10825,,,10825.0,NEU3,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of NEU3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2812,351259,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,63973,NEUROG2,https://ctdbase.org/detail.go?type=gene&acc=63973,,,63973.0,NEUROG2,9606.0,Homo sapiens (human),Caffeine results in increased expression of NEUROG2 mRNA,,,PMID:31711903,https://www.ncbi.nlm.nih.gov/pubmed/31711903,31711903,,
2813,351260,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4763,NF1,https://ctdbase.org/detail.go?type=gene&acc=4763,,,4763.0,NF1,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of NF1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2814,351261,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,10725,NFAT5,https://ctdbase.org/detail.go?type=gene&acc=10725,,,10725.0,NFAT5,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of NFAT5 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2815,351262,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4773,NFATC2,https://ctdbase.org/detail.go?type=gene&acc=4773,,,4773.0,NFATC2,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of NFATC2 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2816,351263,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,84901,NFATC2IP,https://ctdbase.org/detail.go?type=gene&acc=84901,,,84901.0,NFATC2IP,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of NFATC2IP protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2817,351264,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4775,NFATC3,https://ctdbase.org/detail.go?type=gene&acc=4775,,,4775.0,NFATC3,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of NFATC3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2818,352599,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,29881,NPC1L1,https://ctdbase.org/detail.go?type=gene&acc=29881,,,29881.0,NPC1L1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of NPC1L1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2819,352600,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,261734,NPHP4,https://ctdbase.org/detail.go?type=gene&acc=261734,,,261734.0,NPHP4,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of NPHP4 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2820,352601,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4868,NPHS1,https://ctdbase.org/detail.go?type=gene&acc=4868,,,4868.0,NPHS1,10116.0,Rattus norvegicus (Norway rat),Caffeine results in decreased expression of NPHS1 mRNA,,,PMID:25986755|PMID:31306741,https://www.ncbi.nlm.nih.gov/pubmed/25986755|https://www.ncbi.nlm.nih.gov/pubmed/31306741,25986755|31306741,,
2821,352602,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4868,NPHS1,https://ctdbase.org/detail.go?type=gene&acc=4868,,,4868.0,NPHS1,10116.0,Rattus norvegicus (Norway rat),Caffeine results in decreased expression of NPHS1 protein,,,PMID:31306741,https://www.ncbi.nlm.nih.gov/pubmed/31306741,31306741,,
2822,353523,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,4926,NUMA1,https://ctdbase.org/detail.go?type=gene&acc=4926,,,4926.0,NUMA1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of NUMA1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2823,353524,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8650,NUMB,https://ctdbase.org/detail.go?type=gene&acc=8650,,,8650.0,NUMB,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of NUMB protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2824,353525,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,55746,NUP133,https://ctdbase.org/detail.go?type=gene&acc=55746,,,55746.0,NUP133,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of NUP133 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2825,353526,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,9972,NUP153,https://ctdbase.org/detail.go?type=gene&acc=9972,,,9972.0,NUP153,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of NUP153 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2826,353527,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23511,NUP188,https://ctdbase.org/detail.go?type=gene&acc=23511,,,23511.0,NUP188,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of NUP188 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2827,353528,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23165,NUP205,https://ctdbase.org/detail.go?type=gene&acc=23165,,,23165.0,NUP205,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of NUP205 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2828,353529,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23225,NUP210,https://ctdbase.org/detail.go?type=gene&acc=23225,,,23225.0,NUP210,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of NUP210 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2829,353530,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8021,NUP214,https://ctdbase.org/detail.go?type=gene&acc=8021,,,8021.0,NUP214,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of NUP214 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2830,353997,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,23594,ORC6,https://ctdbase.org/detail.go?type=gene&acc=23594,,,23594.0,ORC6,9606.0,Homo sapiens (human),Caffeine results in increased phosphorylation of ORC6 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2831,353998,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,5004,ORM1,https://ctdbase.org/detail.go?type=gene&acc=5004,,,5004.0,ORM1,10090.0,Mus musculus (house mouse),Caffeine results in increased expression of ORM1 protein,,,PMID:20025956,https://www.ncbi.nlm.nih.gov/pubmed/20025956,20025956,,
2832,355978,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,50940,PDE11A,https://ctdbase.org/detail.go?type=gene&acc=50940,,,50940.0,PDE11A,10116.0,Rattus norvegicus (Norway rat),Caffeine results in decreased expression of PDE11A mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
2833,355979,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,5140,PDE3B,https://ctdbase.org/detail.go?type=gene&acc=5140,,,5140.0,PDE3B,9606.0,Homo sapiens (human),Caffeine affects the phosphorylation of PDE3B protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2834,355980,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,8654,PDE5A,https://ctdbase.org/detail.go?type=gene&acc=8654,,,8654.0,PDE5A,10116.0,Rattus norvegicus (Norway rat),Caffeine results in decreased expression of PDE5A mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
2835,355981,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,5151,PDE8A,https://ctdbase.org/detail.go?type=gene&acc=5151,,,5151.0,PDE8A,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of PDE8A protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2836,356608,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,267004,PGBD3,https://ctdbase.org/detail.go?type=gene&acc=267004,,,267004.0,PGBD3,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of PGBD3 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2837,356609,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,5228,PGF,https://ctdbase.org/detail.go?type=gene&acc=5228,,,5228.0,PGF,9031.0,Gallus gallus (chicken),Caffeine results in decreased expression of PGF mRNA,,,PMID:26179615,https://www.ncbi.nlm.nih.gov/pubmed/26179615,26179615,,
2838,356610,2519,Comparative Toxicogenomics Database (CTD),Caffeine,D002110,Caffeine,https://ctdbase.org/detail.go?type=chem&acc=D002110,5230,PGK1,https://ctdbase.org/detail.go?type=gene&acc=5230,,,5230.0,PGK1,9606.0,Homo sapiens (human),Caffeine results in decreased phosphorylation of PGK1 protein,,,PMID:35688186,https://www.ncbi.nlm.nih.gov/pubmed/35688186,35688186,,
2839,224398,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [ABCB1 protein results in increased transport of paclitaxel]|verapamil inhibits the reaction [ABCB1 protein results in increased transport of doxorubicin]|verapamil inhibits the reaction [ABCB1 protein results in increased transport of daunorubicin]|verapamil inhibits the reaction [ABCB1 protein results in increased transport of vinblastine],,,PMID:12708479,https://www.ncbi.nlm.nih.gov/pubmed/12708479,12708479,,
2840,224399,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [ABCB1 protein results in increased transport of digoxin],,,PMID:10527640|PMID:11895100|PMID:24380838,https://www.ncbi.nlm.nih.gov/pubmed/10527640|https://www.ncbi.nlm.nih.gov/pubmed/11895100|https://www.ncbi.nlm.nih.gov/pubmed/24380838,10527640|11895100|24380838,,
2841,224400,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [ABCB1 protein results in increased transport of huperzine A],,,PMID:28587984,https://www.ncbi.nlm.nih.gov/pubmed/28587984,28587984,,
2842,224401,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [ABCB1 protein results in increased transport of quinidinium],,,PMID:25268938|PMID:31348918,https://www.ncbi.nlm.nih.gov/pubmed/25268938|https://www.ncbi.nlm.nih.gov/pubmed/31348918,25268938|31348918,,
2843,224402,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [ABCB1 protein results in increased transport of sulpiride],,,PMID:28597291,https://www.ncbi.nlm.nih.gov/pubmed/28597291,28597291,,
2844,224403,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [ABCB1 protein results in increased uptake of digoxin],,,PMID:16904803|PMID:32003934,https://www.ncbi.nlm.nih.gov/pubmed/16904803|https://www.ncbi.nlm.nih.gov/pubmed/32003934,16904803|32003934,,
2845,224404,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [acetaminophen results in increased activity of ABCB1 protein],,,PMID:16930294|PMID:17526808,https://www.ncbi.nlm.nih.gov/pubmed/16930294|https://www.ncbi.nlm.nih.gov/pubmed/17526808,16930294|17526808,,
2846,225081,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Verapamil metabolite binds to ABCB1 protein|verapamil binds to ABCB1 protein,,,PMID:10783826,https://www.ncbi.nlm.nih.gov/pubmed/10783826,10783826,,
2847,225082,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [[ABCB1 protein co-treated with MGMT protein mutant form] results in decreased susceptibility to etoposide],,,PMID:16733832,https://www.ncbi.nlm.nih.gov/pubmed/16733832,16733832,,
2848,225083,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Verapamil results in decreased activity of ABCB1 protein,,,PMID:11724091|PMID:23200901|PMID:23562926|PMID:29187454,https://www.ncbi.nlm.nih.gov/pubmed/11724091|https://www.ncbi.nlm.nih.gov/pubmed/23200901|https://www.ncbi.nlm.nih.gov/pubmed/23562926|https://www.ncbi.nlm.nih.gov/pubmed/29187454,11724091|23200901|23562926|29187454,,
2849,225084,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10090.0,Mus musculus (house mouse),ABCB1A protein affects the susceptibility to verapamil,,,PMID:15502009,https://www.ncbi.nlm.nih.gov/pubmed/15502009,15502009,,
2850,225085,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10090.0,Mus musculus (house mouse),Verapamil promotes the reaction [vanadates results in decreased activity of ABCB1A protein],,,PMID:12670938,https://www.ncbi.nlm.nih.gov/pubmed/12670938,12670938,,
2851,225086,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10090.0,Mus musculus (house mouse),Verapamil results in decreased activity of ABCB1A protein,,,PMID:17134887,https://www.ncbi.nlm.nih.gov/pubmed/17134887,17134887,,
2852,225087,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10116.0,Rattus norvegicus (Norway rat),Verapamil results in decreased activity of ABCB1A protein,,,PMID:12202523,https://www.ncbi.nlm.nih.gov/pubmed/12202523,12202523,,
2853,225088,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10116.0,Rattus norvegicus (Norway rat),Verapamil results in decreased expression of ABCB1A mRNA,,,PMID:17973928|PMID:25625052,https://www.ncbi.nlm.nih.gov/pubmed/17973928|https://www.ncbi.nlm.nih.gov/pubmed/25625052,17973928|25625052,,
2854,225089,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,18669,ABCB1B,https://ctdbase.org/detail.go?type=gene&acc=18669,,,18669.0,Abcb1b,10090.0,Mus musculus (house mouse),ABCB1B protein affects the susceptibility to verapamil,,,PMID:15502009,https://www.ncbi.nlm.nih.gov/pubmed/15502009,15502009,,
2855,225775,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,358,AQP1,https://ctdbase.org/detail.go?type=gene&acc=358,,,358.0,AQP1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [cobaltous chloride results in increased expression of AQP1 protein],,,PMID:22415096,https://www.ncbi.nlm.nih.gov/pubmed/22415096,22415096,,
2856,225776,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Verapamil results in increased expression of BAX protein|temozolomide promotes the reaction [verapamil results in increased expression of BAX protein]|[verapamil co-treated with temozolomide] results in increased expression of BAX mRNA,,,PMID:30003979,https://www.ncbi.nlm.nih.gov/pubmed/30003979,30003979,,
2857,226801,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,10090.0,Mus musculus (house mouse),Verapamil results in decreased activity of CYP2C9 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
2858,226802,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,56448,CYP2D22,https://ctdbase.org/detail.go?type=gene&acc=56448,,,56448.0,Cyp2d22,10090.0,Mus musculus (house mouse),Verapamil results in decreased activity of CYP2D22 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
2859,226803,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,1565,CYP2D6,https://ctdbase.org/detail.go?type=gene&acc=1565,,,1565.0,CYP2D6,10090.0,Mus musculus (house mouse),Verapamil results in decreased activity of CYP2D6 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
2860,226804,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,13112,CYP3A11,https://ctdbase.org/detail.go?type=gene&acc=13112,,,13112.0,Cyp3a11,10090.0,Mus musculus (house mouse),Verapamil results in decreased activity of CYP3A11 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
2861,226805,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,252931,CYP3A18,https://ctdbase.org/detail.go?type=gene&acc=252931,,,252931.0,Cyp3a18,10116.0,Rattus norvegicus (Norway rat),Verapamil results in decreased expression of CYP3A18 mRNA,,,PMID:17973928,https://www.ncbi.nlm.nih.gov/pubmed/17973928,17973928,,
2862,228339,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),Verapamil promotes the reaction [cilostazol inhibits the reaction [thioacetamide results in decreased expression of NQO1 protein]]|verapamil inhibits the reaction [thioacetamide results in decreased expression of NQO1 protein],,,PMID:30295103,https://www.ncbi.nlm.nih.gov/pubmed/30295103,30295103,,
2863,228340,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,190,NR0B1,https://ctdbase.org/detail.go?type=gene&acc=190,,,190.0,NR0B1,10090.0,Mus musculus (house mouse),Verapamil promotes the reaction [cyclic AMP results in decreased expression of NR0B1 mrna]|verapamil results in decreased expression of NR0B1 mRNA,,,PMID:19822634,https://www.ncbi.nlm.nih.gov/pubmed/19822634,19822634,,
2864,228341,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),[verapamil results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mrna|verapamil results in increased activity of NR1I2 protein,,,PMID:25455453,https://www.ncbi.nlm.nih.gov/pubmed/25455453,25455453,,
2865,228342,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,10090.0,Mus musculus (house mouse),Verapamil promotes the reaction [dexamethasone results in increased activity of NR3C1 protein],,,PMID:12871829,https://www.ncbi.nlm.nih.gov/pubmed/12871829,12871829,,
2866,228343,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,5020,OXT,https://ctdbase.org/detail.go?type=gene&acc=5020,,,5020.0,OXT,9606.0,Homo sapiens (human),Verapamil results in decreased susceptibility to OXT protein,,,PMID:2339153|PMID:2806374,https://www.ncbi.nlm.nih.gov/pubmed/2339153|https://www.ncbi.nlm.nih.gov/pubmed/2806374,2339153|2806374,,
2867,228344,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein|acetylcysteine inhibits the reaction [[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein]|benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[verapamil co-treated with gambogic acid] results in increased cleavage of PARP1 protein],,,PMID:24373880,https://www.ncbi.nlm.nih.gov/pubmed/24373880,24373880,,
2868,228959,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244.0,SLC47A1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [SLC47A1 protein results in increased import of tetraethylammonium],,,PMID:27450509,https://www.ncbi.nlm.nih.gov/pubmed/27450509,27450509,,
2869,228960,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244.0,SLC47A1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [SLC47A1 protein results in increased uptake of 1-methyl-4-phenylpyridinium],,,PMID:22419765,https://www.ncbi.nlm.nih.gov/pubmed/22419765,22419765,,
2870,228961,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244.0,SLC47A1,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [SLC47A1 protein results in increased uptake of tetraethylammonium],,,PMID:27989701,https://www.ncbi.nlm.nih.gov/pubmed/27989701,27989701,,
2871,228962,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244.0,SLC47A1,9606.0,Homo sapiens (human),Verapamil results in decreased activity of SLC47A1 protein,,,PMID:31364238,https://www.ncbi.nlm.nih.gov/pubmed/31364238,31364238,,
2872,228963,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,146802,SLC47A2,https://ctdbase.org/detail.go?type=gene&acc=146802,,,146802.0,SLC47A2,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of 1-methyl-4-phenylpyridinium],,,PMID:22419765,https://www.ncbi.nlm.nih.gov/pubmed/22419765,22419765,,
2873,228964,2520,Comparative Toxicogenomics Database (CTD),Verapamil,D014700,Verapamil,https://ctdbase.org/detail.go?type=chem&acc=D014700,146802,SLC47A2,https://ctdbase.org/detail.go?type=gene&acc=146802,,,146802.0,SLC47A2,9606.0,Homo sapiens (human),Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of tetraethylammonium],,,PMID:27989701,https://www.ncbi.nlm.nih.gov/pubmed/27989701,27989701,,
2874,240275,2520,DrugBank,Verapamil,DB00661,Verapamil,https://www.drugbank.ca/drugs/DB00661,BE0004902,Voltage-dependent calcium channel gamma-5 subunit,https://www.drugbank.ca/bio_entities/BE0004902,Q9UF02,Voltage-dependent calcium channel gamma-5 subunit,27091.0,CACNG5,9606.0,Homo sapiens (human),Inhibitor,,,PMID:18091748,https://www.ncbi.nlm.nih.gov/pubmed/18091748,18091748,,
2875,240276,2520,DrugBank,Verapamil,DB00661,Verapamil,https://www.drugbank.ca/drugs/DB00661,BE0004902,Voltage-dependent calcium channel gamma-6 subunit,https://www.drugbank.ca/bio_entities/BE0004902,Q9BXT2,Voltage-dependent calcium channel gamma-6 subunit,59285.0,CACNG6,9606.0,Homo sapiens (human),Inhibitor,,,PMID:18091748,https://www.ncbi.nlm.nih.gov/pubmed/18091748,18091748,,
2876,241448,2520,DrugBank,Verapamil,DB00661,Verapamil,https://www.drugbank.ca/drugs/DB00661,BE0003651,Multidrug resistance-associated protein 7,https://www.drugbank.ca/bio_entities/BE0003651,Q5T3U5,ATP-binding cassette sub-family C member 10,89845.0,ABCC10,9606.0,Homo sapiens (human),Inhibitor,,,PMID:12527806,https://www.ncbi.nlm.nih.gov/pubmed/12527806,12527806,,
2877,241449,2520,DrugBank,Verapamil,DB00661,Verapamil,https://www.drugbank.ca/drugs/DB00661,BE0003657,Multidrug and toxin extrusion protein 1,https://www.drugbank.ca/bio_entities/BE0003657,Q96FL8,Multidrug and toxin extrusion protein 1,55244.0,SLC47A1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:26246409,https://www.ncbi.nlm.nih.gov/pubmed/26246409,26246409,,
2878,241450,2520,DrugBank,Verapamil,DB00661,Verapamil,https://www.drugbank.ca/drugs/DB00661,BE0004752,Multidrug and toxin extrusion protein 2,https://www.drugbank.ca/bio_entities/BE0004752,Q86VL8,Multidrug and toxin extrusion protein 2,146802.0,SLC47A2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:26246409,https://www.ncbi.nlm.nih.gov/pubmed/26246409,26246409,,
2879,241451,2520,DrugBank,Verapamil,DB00661,Verapamil,https://www.drugbank.ca/drugs/DB00661,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Substrate,,,,,,,
2880,241452,2520,DrugBank,Verapamil,DB00661,Verapamil,https://www.drugbank.ca/drugs/DB00661,BE0000925,Alpha-1-acid glycoprotein 1,https://www.drugbank.ca/bio_entities/BE0000925,P02763,Alpha-1-acid glycoprotein 1,5004.0,ORM1,9606.0,Homo sapiens (human),Substrate,,,,,,,
2881,241453,2520,DrugBank,Verapamil,DB00661,Verapamil,https://www.drugbank.ca/drugs/DB00661,BE0000715,Alpha-1D adrenergic receptor,https://www.drugbank.ca/bio_entities/BE0000715,P25100,Alpha-1D adrenergic receptor,146.0,ADRA1D,9606.0,Homo sapiens (human),Antagonist,,,PMID:9570190,https://www.ncbi.nlm.nih.gov/pubmed/9570190,9570190,,
2882,241454,2520,Drug Gene Interaction database (DGIdb),Verapamil,,VERAPAMIL,https://www.dgidb.org/drugs/rxcui:11170,,CACNA1D,https://www.dgidb.org/genes/hgnc:1391,,,776.0,CACNA1D,9606.0,Homo sapiens (human),Blocker,,,,,,,
2883,241455,2520,Drug Gene Interaction database (DGIdb),Verapamil,,VERAPAMIL,https://www.dgidb.org/drugs/rxcui:11170,,CACNA1F,https://www.dgidb.org/genes/hgnc:1393,,,778.0,CACNA1F,9606.0,Homo sapiens (human),Blocker,,,,,,,
2884,241456,2520,Drug Gene Interaction database (DGIdb),Verapamil,,VERAPAMIL,https://www.dgidb.org/drugs/rxcui:11170,,CACNA1C,https://www.dgidb.org/genes/hgnc:1390,,,775.0,CACNA1C,9606.0,Homo sapiens (human),Blocker,,,,,,,
2885,294563,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,11117,EMILIN1,https://ctdbase.org/detail.go?type=gene&acc=11117,,,11117.0,EMILIN1,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of EMILIN1 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2886,294564,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,8507,ENC1,https://ctdbase.org/detail.go?type=gene&acc=8507,,,8507.0,ENC1,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of ENC1 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2887,294565,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5169,ENPP3,https://ctdbase.org/detail.go?type=gene&acc=5169,,,5169.0,ENPP3,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ENPP3 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2888,294566,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,377841,ENTPD8,https://ctdbase.org/detail.go?type=gene&acc=377841,,,377841.0,ENTPD8,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ENTPD8 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2889,294567,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,2035,EPB41,https://ctdbase.org/detail.go?type=gene&acc=2035,,,2035.0,EPB41,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of EPB41 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2890,294568,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,83481,EPPK1,https://ctdbase.org/detail.go?type=gene&acc=83481,,,83481.0,EPPK1,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of EPPK1 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2891,294569,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,64787,EPS8L2,https://ctdbase.org/detail.go?type=gene&acc=64787,,,64787.0,EPS8L2,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of EPS8L2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2892,294570,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,11160,ERLIN2,https://ctdbase.org/detail.go?type=gene&acc=11160,,,11160.0,ERLIN2,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ERLIN2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2893,294571,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,100144434,ETL4,https://ctdbase.org/detail.go?type=gene&acc=100144434,,,100144434.0,ETL4,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ETL4 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2894,294572,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,64850,ETNPPL,https://ctdbase.org/detail.go?type=gene&acc=64850,,,64850.0,ETNPPL,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ETNPPL mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2895,297748,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,4217,MAP3K5,https://ctdbase.org/detail.go?type=gene&acc=4217,,,4217.0,MAP3K5,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of MAP3K5 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2896,297749,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,9064,MAP3K6,https://ctdbase.org/detail.go?type=gene&acc=9064,,,9064.0,MAP3K6,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of MAP3K6 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2897,297750,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,4144,MAT2A,https://ctdbase.org/detail.go?type=gene&acc=4144,,,4144.0,MAT2A,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of MAT2A mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2898,297751,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,4147,MATN2,https://ctdbase.org/detail.go?type=gene&acc=4147,,,4147.0,MATN2,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of MATN2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2899,297752,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,4153,MBL2,https://ctdbase.org/detail.go?type=gene&acc=4153,,,4153.0,MBL2,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of MBL2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2900,297956,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,84879,MFSD2A,https://ctdbase.org/detail.go?type=gene&acc=84879,,,84879.0,MFSD2A,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of MFSD2A mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2901,297957,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,84895,MIGA2,https://ctdbase.org/detail.go?type=gene&acc=84895,,,84895.0,MIGA2,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of MIGA2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2902,298243,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,100039008,MUP10,https://ctdbase.org/detail.go?type=gene&acc=100039008,,,100039008.0,Mup10,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of MUP10 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2903,298244,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,17844,MUP5,https://ctdbase.org/detail.go?type=gene&acc=17844,,,17844.0,Mup5,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of MUP5 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2904,298245,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,4615,MYD88,https://ctdbase.org/detail.go?type=gene&acc=4615,,,4615.0,MYD88,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of MYD88 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2905,299544,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,8396,PIP4K2B,https://ctdbase.org/detail.go?type=gene&acc=8396,,,8396.0,PIP4K2B,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PIP4K2B mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2906,299545,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,55529,PIP4P2,https://ctdbase.org/detail.go?type=gene&acc=55529,,,55529.0,PIP4P2,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PIP4P2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2907,299546,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,66776,PISD-PS3,https://ctdbase.org/detail.go?type=gene&acc=66776,,,66776.0,Pisd-ps3,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PISD-PS3 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2908,299547,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5311,PKD2,https://ctdbase.org/detail.go?type=gene&acc=5311,,,5311.0,PKD2,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PKD2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2909,299548,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,8398,PLA2G6,https://ctdbase.org/detail.go?type=gene&acc=8398,,,8398.0,PLA2G6,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of PLA2G6 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2910,299549,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,51316,PLAC8,https://ctdbase.org/detail.go?type=gene&acc=51316,,,51316.0,PLAC8,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of PLAC8 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2911,299550,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5335,PLCG1,https://ctdbase.org/detail.go?type=gene&acc=5335,,,5335.0,PLCG1,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PLCG1 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2912,300241,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5567,PRKACB,https://ctdbase.org/detail.go?type=gene&acc=5567,,,5567.0,PRKACB,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PRKACB mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2913,300242,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,23683,PRKD3,https://ctdbase.org/detail.go?type=gene&acc=23683,,,23683.0,PRKD3,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PRKD3 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2914,300243,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,8575,PRKRA,https://ctdbase.org/detail.go?type=gene&acc=8575,,,8575.0,PRKRA,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PRKRA mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2915,300244,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5618,PRLR,https://ctdbase.org/detail.go?type=gene&acc=5618,,,5618.0,PRLR,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PRLR mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2916,300245,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5621,PRNP,https://ctdbase.org/detail.go?type=gene&acc=5621,,,5621.0,PRNP,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PRNP mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2917,300246,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5627,PROS1,https://ctdbase.org/detail.go?type=gene&acc=5627,,,5627.0,PROS1,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of PROS1 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2918,300247,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5635,PRPSAP1,https://ctdbase.org/detail.go?type=gene&acc=5635,,,5635.0,PRPSAP1,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PRPSAP1 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2919,300444,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5660,PSAP,https://ctdbase.org/detail.go?type=gene&acc=5660,,,5660.0,PSAP,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of PSAP mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2920,300445,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,5710,PSMD4,https://ctdbase.org/detail.go?type=gene&acc=5710,,,5710.0,PSMD4,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of PSMD4 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2921,300446,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,79810,PTCD2,https://ctdbase.org/detail.go?type=gene&acc=79810,,,79810.0,PTCD2,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of PTCD2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2922,301978,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,256394,SERPINA11,https://ctdbase.org/detail.go?type=gene&acc=256394,,,256394.0,SERPINA11,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of SERPINA11 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2923,303526,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,6907,TBL1X,https://ctdbase.org/detail.go?type=gene&acc=6907,,,6907.0,TBL1X,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of TBL1X mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2924,303527,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,79718,TBL1XR1,https://ctdbase.org/detail.go?type=gene&acc=79718,,,79718.0,TBL1XR1,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of TBL1XR1 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2925,303528,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,6926,TBX3,https://ctdbase.org/detail.go?type=gene&acc=6926,,,6926.0,TBX3,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of TBX3 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2926,303529,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,6988,TCTA,https://ctdbase.org/detail.go?type=gene&acc=6988,,,6988.0,TCTA,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of TCTA mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2927,303530,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,23424,TDRD7,https://ctdbase.org/detail.go?type=gene&acc=23424,,,23424.0,TDRD7,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of TDRD7 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2928,303531,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,7003,TEAD1,https://ctdbase.org/detail.go?type=gene&acc=7003,,,7003.0,TEAD1,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of TEAD1 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2929,303532,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,7015,TERT,https://ctdbase.org/detail.go?type=gene&acc=7015,,,7015.0,TERT,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of TERT mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2930,304831,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,10009,ZBTB33,https://ctdbase.org/detail.go?type=gene&acc=10009,,,10009.0,ZBTB33,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ZBTB33 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2931,304832,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,57659,ZBTB4,https://ctdbase.org/detail.go?type=gene&acc=57659,,,57659.0,ZBTB4,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ZBTB4 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2932,304833,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,434178,ZFP141,https://ctdbase.org/detail.go?type=gene&acc=434178,,,434178.0,Zfp141,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ZFP141 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2933,304834,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,22661,ZFP148,https://ctdbase.org/detail.go?type=gene&acc=22661,,,22661.0,Zfp148,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ZFP148 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2934,304835,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,26466,ZFP260,https://ctdbase.org/detail.go?type=gene&acc=26466,,,26466.0,Zfp260,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ZFP260 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2935,304836,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,67230,ZFP329,https://ctdbase.org/detail.go?type=gene&acc=67230,,,67230.0,Zfp329,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ZFP329 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2936,304837,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,678,ZFP36L2,https://ctdbase.org/detail.go?type=gene&acc=678,,,678.0,ZFP36L2,10090.0,Mus musculus (house mouse),Pantogab results in increased expression of ZFP36L2 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2937,304838,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,22698,ZFP39,https://ctdbase.org/detail.go?type=gene&acc=22698,,,22698.0,Zfp39,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ZFP39 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2938,304839,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,72807,ZFP429,https://ctdbase.org/detail.go?type=gene&acc=72807,,,72807.0,Zfp429,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ZFP429 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2939,304840,2527,Comparative Toxicogenomics Database (CTD),"4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid",C016030,pantogab,https://ctdbase.org/detail.go?type=chem&acc=C016030,68910,ZFP467,https://ctdbase.org/detail.go?type=gene&acc=68910,,,68910.0,Zfp467,10090.0,Mus musculus (house mouse),Pantogab results in decreased expression of ZFP467 mRNA,,,PMID:17379144,https://www.ncbi.nlm.nih.gov/pubmed/17379144,17379144,,
2940,242127,2540,Comparative Toxicogenomics Database (CTD),Candesartan Cilexetil,C077793,candesartan cilexetil,https://ctdbase.org/detail.go?type=chem&acc=C077793,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),Candesartan cilexetil results in increased expression of AGT protein modified form,,,PMID:22120037,https://www.ncbi.nlm.nih.gov/pubmed/22120037,22120037,,
2941,242128,2540,Comparative Toxicogenomics Database (CTD),Candesartan Cilexetil,C077793,candesartan cilexetil,https://ctdbase.org/detail.go?type=chem&acc=C077793,185,AGTR1,https://ctdbase.org/detail.go?type=gene&acc=185,,,185.0,AGTR1,9606.0,Homo sapiens (human),Candesartan cilexetil binds to and results in decreased activity of AGTR1 protein,,,PMID:11086231,https://www.ncbi.nlm.nih.gov/pubmed/11086231,11086231,,
2942,242129,2540,Comparative Toxicogenomics Database (CTD),Candesartan Cilexetil,C077793,candesartan cilexetil,https://ctdbase.org/detail.go?type=chem&acc=C077793,185,AGTR1,https://ctdbase.org/detail.go?type=gene&acc=185,,,185.0,AGTR1,9606.0,Homo sapiens (human),Candesartan cilexetil results in decreased activity of AGTR1 protein,,,PMID:11518847|PMID:9853001,https://www.ncbi.nlm.nih.gov/pubmed/11518847|https://www.ncbi.nlm.nih.gov/pubmed/9853001,11518847|9853001,,
2943,242130,2540,Comparative Toxicogenomics Database (CTD),Candesartan Cilexetil,C077793,candesartan cilexetil,https://ctdbase.org/detail.go?type=chem&acc=C077793,11607,AGTR1A,https://ctdbase.org/detail.go?type=gene&acc=11607,,,11607.0,Agtr1a,10116.0,Rattus norvegicus (Norway rat),Candesartan cilexetil binds to and results in decreased activity of AGTR1A protein,,,PMID:15667801,https://www.ncbi.nlm.nih.gov/pubmed/15667801,15667801,,
2944,242131,2540,Comparative Toxicogenomics Database (CTD),Candesartan Cilexetil,C077793,candesartan cilexetil,https://ctdbase.org/detail.go?type=chem&acc=C077793,186,AGTR2,https://ctdbase.org/detail.go?type=gene&acc=186,,,186.0,AGTR2,10116.0,Rattus norvegicus (Norway rat),Candesartan cilexetil results in increased expression of AGTR2 protein,,,PMID:22120037,https://www.ncbi.nlm.nih.gov/pubmed/22120037,22120037,,
2945,242335,2541,Comparative Toxicogenomics Database (CTD),Candesartan,C081643,candesartan,https://ctdbase.org/detail.go?type=chem&acc=C081643,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9606.0,Homo sapiens (human),Candesartan results in increased expression of ADIPOQ protein|[candesartan co-treated with fenofibrate] results in increased expression of ADIPOQ protein,,,PMID:16443859,https://www.ncbi.nlm.nih.gov/pubmed/16443859,16443859,,
2946,242336,2541,Comparative Toxicogenomics Database (CTD),Candesartan,C081643,candesartan,https://ctdbase.org/detail.go?type=chem&acc=C081643,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9606.0,Homo sapiens (human),Ramipril promotes the reaction [candesartan results in increased expression of adipoq]|candesartan promotes the reaction [ramipril results in increased expression of adipoq]|candesartan results in decreased expression of ADIPOQ,,,PMID:17483542,https://www.ncbi.nlm.nih.gov/pubmed/17483542,17483542,,
2947,235309,2551,BindingDB,Carbamoylcholine,50004656,(2-Carbamoyloxy-ethyl)-trimethyl-ammonium,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50004656,9099,"Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,A177C]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9099,P08483,Muscarinic acetylcholine receptor M3,24260.0,Chrm3,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),4.13e+4,PMID:24133207|DOI:10.1074/jbc.M113.503714,https://www.ncbi.nlm.nih.gov/pubmed/24133207|https://doi.org/10.1074/jbc.M113.503714,24133207,10.1074/jbc.M113.503714,
2948,235310,2551,BindingDB,Carbamoylcholine,50004656,(2-Carbamoyloxy-ethyl)-trimethyl-ammonium,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50004656,9100,"Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,K178C]",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9100,P08483,Muscarinic acetylcholine receptor M3,24260.0,Chrm3,10116.0,Rattus norvegicus (Norway rat),,Ki (nM),2.95e+4,PMID:24133207|DOI:10.1074/jbc.M113.503714,https://www.ncbi.nlm.nih.gov/pubmed/24133207|https://doi.org/10.1074/jbc.M113.503714,24133207,10.1074/jbc.M113.503714,
2949,306872,2554,Toxin and Toxin Target Database (T3DB),Carbamazepine,T3D2826,Carbamazepine,http://www.t3db.ca/toxins/T3D2826,BE0000132,Androgen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000132,P10275,Androgen receptor,367.0,AR,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
2950,306873,2554,Toxin and Toxin Target Database (T3DB),Carbamazepine,T3D2826,Carbamazepine,http://www.t3db.ca/toxins/T3D2826,BE0001777,Bile acid receptor,http://www.t3db.ca/biodb/bio_entities/BE0001777,Q96RI1,Bile acid receptor,9971.0,NR1H4,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
2951,306874,2554,Toxin and Toxin Target Database (T3DB),Carbamazepine,T3D2826,Carbamazepine,http://www.t3db.ca/toxins/T3D2826,BE0004019,Hepatocyte nuclear factor 4-alpha,http://www.t3db.ca/biodb/bio_entities/BE0004019,P41235,Hepatocyte nuclear factor 4-alpha,3172.0,HNF4A,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
2952,306875,2554,Toxin and Toxin Target Database (T3DB),Carbamazepine,T3D2826,Carbamazepine,http://www.t3db.ca/toxins/T3D2826,BE0003554,Nuclear receptor ROR-beta,http://www.t3db.ca/biodb/bio_entities/BE0003554,Q92753,Nuclear receptor ROR-beta,,,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
2953,306876,2554,Toxin and Toxin Target Database (T3DB),Carbamazepine,T3D2826,Carbamazepine,http://www.t3db.ca/toxins/T3D2826,BE0002088,Estrogen-related receptor gamma,http://www.t3db.ca/biodb/bio_entities/BE0002088,P62508,Estrogen-related receptor gamma,2104.0,ESRRG,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
2954,306877,2554,Toxin and Toxin Target Database (T3DB),Carbamazepine,T3D2826,Carbamazepine,http://www.t3db.ca/toxins/T3D2826,BE0000794,Glucocorticoid receptor,http://www.t3db.ca/biodb/bio_entities/BE0000794,P04150,Glucocorticoid receptor,2908.0,NR3C1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
2955,306878,2554,Toxin and Toxin Target Database (T3DB),Carbamazepine,T3D2826,Carbamazepine,http://www.t3db.ca/toxins/T3D2826,BE0005493,Nuclear receptor subfamily 4 group A member 2,http://www.t3db.ca/biodb/bio_entities/BE0005493,P43354,Nuclear receptor subfamily 4 group A member 2,4929.0,NR4A2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
2956,344101,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,97,ACYP1,https://ctdbase.org/detail.go?type=gene&acc=97,,,97.0,ACYP1,9606.0,Homo sapiens (human),Carbamazepine affects the expression of ACYP1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
2957,344102,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,8728,ADAM19,https://ctdbase.org/detail.go?type=gene&acc=8728,,,8728.0,ADAM19,9606.0,Homo sapiens (human),Carbamazepine affects the expression of ADAM19 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
2958,344103,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,10863,ADAM28,https://ctdbase.org/detail.go?type=gene&acc=10863,,,10863.0,ADAM28,9606.0,Homo sapiens (human),Carbamazepine affects the expression of ADAM28 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
2959,347403,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,587,BCAT2,https://ctdbase.org/detail.go?type=gene&acc=587,,,587.0,BCAT2,9606.0,Homo sapiens (human),Carbamazepine affects the expression of BCAT2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
2960,347404,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,593,BCKDHA,https://ctdbase.org/detail.go?type=gene&acc=593,,,593.0,BCKDHA,9606.0,Homo sapiens (human),Carbamazepine affects the expression of BCKDHA mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
2961,347405,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Carbamazepine results in increased expression of BCL2 mrna|carbamazepine results in increased expression of BCL2 protein,,,PMID:18719996,https://www.ncbi.nlm.nih.gov/pubmed/18719996,18719996,,
2962,347406,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),Carbamazepine affects the expression of BCL2L1 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
2963,347407,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,10018,BCL2L11,https://ctdbase.org/detail.go?type=gene&acc=10018,,,10018.0,BCL2L11,9606.0,Homo sapiens (human),Carbamazepine affects the expression of BCL2L11 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
2964,347408,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116.0,Rattus norvegicus (Norway rat),Carbamazepine affects the expression of BDNF mRNA,,,PMID:31324950,https://www.ncbi.nlm.nih.gov/pubmed/31324950,31324950,,
2965,347409,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116.0,Rattus norvegicus (Norway rat),Carbamazepine results in increased expression of BDNF mrna|carbamazepine results in increased expression of BDNF protein,,,PMID:18719996,https://www.ncbi.nlm.nih.gov/pubmed/18719996,18719996,,
2966,347410,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,10116.0,Rattus norvegicus (Norway rat),[[streptozocin co-treated with carbamazepine] affects the susceptibility to dietary fats] which results in decreased expression of BECN1 mRNA,,,PMID:35786680,https://www.ncbi.nlm.nih.gov/pubmed/35786680,35786680,,
2967,347411,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,57673,BEND3,https://ctdbase.org/detail.go?type=gene&acc=57673,,,57673.0,BEND3,9606.0,Homo sapiens (human),Carbamazepine affects the expression of BEND3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
2968,347412,2554,Comparative Toxicogenomics Database (CTD),Carbamazepine,D002220,Carbamazepine,https://ctdbase.org/detail.go?type=chem&acc=D002220,389206,BEND4,https://ctdbase.org/detail.go?type=gene&acc=389206,,,389206.0,BEND4,9606.0,Homo sapiens (human),Carbamazepine affects the expression of BEND4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
2969,306879,2562,Comparative Toxicogenomics Database (CTD),Carbetapentane,C018861,carbetapentane,https://ctdbase.org/detail.go?type=chem&acc=C018861,5244,ABCB4,https://ctdbase.org/detail.go?type=gene&acc=5244,,,5244.0,ABCB4,9606.0,Homo sapiens (human),Carbetapentane results in decreased activity of ABCB4 protein,,,PMID:28437613,https://www.ncbi.nlm.nih.gov/pubmed/28437613,28437613,,
2970,306880,2562,Comparative Toxicogenomics Database (CTD),Carbetapentane,C018861,carbetapentane,https://ctdbase.org/detail.go?type=chem&acc=C018861,654,BMP6,https://ctdbase.org/detail.go?type=gene&acc=654,,,654.0,BMP6,9606.0,Homo sapiens (human),Carbetapentane results in increased expression of BMP6 mRNA,,,PMID:32816093,https://www.ncbi.nlm.nih.gov/pubmed/32816093,32816093,,
2971,245070,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),Carboplatin results in decreased expression of ABCG2 mrna|carboplatin results in decreased expression of ABCG2 protein,,,PMID:27692344,https://www.ncbi.nlm.nih.gov/pubmed/27692344,27692344,,
2972,245071,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,130399,ACVR1C,https://ctdbase.org/detail.go?type=gene&acc=130399,,,130399.0,ACVR1C,9606.0,Homo sapiens (human),ACVR1C results in increased susceptibility to carboplatin,,,PMID:21224400,https://www.ncbi.nlm.nih.gov/pubmed/21224400,21224400,,
2973,245072,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),Carboplatin results in decreased expression of AHR mRNA,,,PMID:36536508,https://www.ncbi.nlm.nih.gov/pubmed/36536508,36536508,,
2974,245073,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,231,AKR1B1,https://ctdbase.org/detail.go?type=gene&acc=231,,,231.0,AKR1B1,10116.0,Rattus norvegicus (Norway rat),Carboplatin results in increased expression of AKR1B1 mRNA,,,PMID:18172885,https://www.ncbi.nlm.nih.gov/pubmed/18172885,18172885,,
2975,246914,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,10456,HAX1,https://ctdbase.org/detail.go?type=gene&acc=10456,,,10456.0,HAX1,10116.0,Rattus norvegicus (Norway rat),Pravastatin inhibits the reaction [carboplatin results in decreased expression of HAX1 protein],,,PMID:18483861,https://www.ncbi.nlm.nih.gov/pubmed/18483861,18483861,,
2976,246915,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,3043,HBB,https://ctdbase.org/detail.go?type=gene&acc=3043,,,3043.0,HBB,10116.0,Rattus norvegicus (Norway rat),Carboplatin results in decreased expression of HBB mRNA,,,PMID:21296123,https://www.ncbi.nlm.nih.gov/pubmed/21296123,21296123,,
2977,246916,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Carboplatin results in increased expression of HMOX1 mRNA,,,PMID:26260164,https://www.ncbi.nlm.nih.gov/pubmed/26260164,26260164,,
2978,246917,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),HMOX1 protein inhibits the reaction [carboplatin results in increased activity of NFATC4],,,PMID:21198546,https://www.ncbi.nlm.nih.gov/pubmed/21198546,21198546,,
2979,246918,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Carboplatin results in decreased expression of HMOX1 mRNA,,,PMID:18172885,https://www.ncbi.nlm.nih.gov/pubmed/18172885,18172885,,
2980,246919,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),HMOX1 protein results in decreased susceptibility to carboplatin,,,PMID:20368269,https://www.ncbi.nlm.nih.gov/pubmed/20368269,20368269,,
2981,246920,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,3295,HSD17B4,https://ctdbase.org/detail.go?type=gene&acc=3295,,,3295.0,HSD17B4,10116.0,Rattus norvegicus (Norway rat),Carboplatin results in decreased expression of HSD17B4 mRNA,,,PMID:18172885,https://www.ncbi.nlm.nih.gov/pubmed/18172885,18172885,,
2982,246921,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,3303,HSPA1A,https://ctdbase.org/detail.go?type=gene&acc=3303,,,3303.0,HSPA1A,10116.0,Rattus norvegicus (Norway rat),Carboplatin results in increased expression of HSPA1A mRNA,,,PMID:18172885,https://www.ncbi.nlm.nih.gov/pubmed/18172885,18172885,,
2983,246922,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,3304,HSPA1B,https://ctdbase.org/detail.go?type=gene&acc=3304,,,3304.0,HSPA1B,10116.0,Rattus norvegicus (Norway rat),Carboplatin results in increased expression of HSPA1B mRNA,,,PMID:18172885,https://www.ncbi.nlm.nih.gov/pubmed/18172885,18172885,,
2984,246923,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,10116.0,Rattus norvegicus (Norway rat),Carboplatin results in decreased expression of HSPA5 mRNA,,,PMID:18172885,https://www.ncbi.nlm.nih.gov/pubmed/18172885,18172885,,
2985,248270,2568,Comparative Toxicogenomics Database (CTD),"1,1-Cyclobutanedicarboxylic acid",D016190,Carboplatin,https://ctdbase.org/detail.go?type=chem&acc=D016190,1317,SLC31A1,https://ctdbase.org/detail.go?type=gene&acc=1317,,,1317.0,SLC31A1,9606.0,Homo sapiens (human),[tetrathiomolybdate results in increased expression of SLC31A1 mrna] which results in increased susceptibility to carboplatin|[trientine results in increased expression of SLC31A1 mrna] which results in increased susceptibility to carboplatin|[penicillamine results in increased expression of SLC31A1 mrna] which results in increased susceptibility to carboplatin,,,PMID:22914438,https://www.ncbi.nlm.nih.gov/pubmed/22914438,22914438,,
2986,235708,2576,DrugBank,Carisoprodol,DB00395,Carisoprodol,https://www.drugbank.ca/drugs/DB00395,BE0002346,Gamma-aminobutyric acid receptor subunit beta-2,https://www.drugbank.ca/bio_entities/BE0002346,P47870,Gamma-aminobutyric acid receptor subunit beta-2,2561.0,GABRB2,9606.0,Homo sapiens (human),Modulator,,,PMID:19244096|PMID:26872987|PMID:20419052,https://www.ncbi.nlm.nih.gov/pubmed/19244096|https://www.ncbi.nlm.nih.gov/pubmed/26872987|https://www.ncbi.nlm.nih.gov/pubmed/20419052,19244096|26872987|20419052,,
2987,235709,2576,DrugBank,Carisoprodol,DB00395,Carisoprodol,https://www.drugbank.ca/drugs/DB00395,BE0003592,Gamma-aminobutyric acid receptor subunit gamma-2,https://www.drugbank.ca/bio_entities/BE0003592,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),,,,PMID:19244096|PMID:20419052|PMID:28642232,https://www.ncbi.nlm.nih.gov/pubmed/19244096|https://www.ncbi.nlm.nih.gov/pubmed/20419052|https://www.ncbi.nlm.nih.gov/pubmed/28642232,19244096|20419052|28642232,,
2988,235710,2576,DrugBank,Carisoprodol,DB00395,Carisoprodol,https://www.drugbank.ca/drugs/DB00395,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,https://www.drugbank.ca/bio_entities/BE0000471,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,2558.0,GABRA5,9606.0,Homo sapiens (human),Modulator,,,PMID:26872987,https://www.ncbi.nlm.nih.gov/pubmed/26872987,26872987,,
2989,235711,2576,DrugBank,Carisoprodol,DB00395,Carisoprodol,https://www.drugbank.ca/drugs/DB00395,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,https://www.drugbank.ca/bio_entities/BE0000523,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606.0,Homo sapiens (human),Modulator,,,PMID:26872987|PMID:28642232,https://www.ncbi.nlm.nih.gov/pubmed/26872987|https://www.ncbi.nlm.nih.gov/pubmed/28642232,26872987|28642232,,
2990,235712,2576,DrugBank,Carisoprodol,DB00395,Carisoprodol,https://www.drugbank.ca/drugs/DB00395,BE0003536,Cytochrome P450 2C19,https://www.drugbank.ca/bio_entities/BE0003536,P33261,Cytochrome P450 2C19,1557.0,CYP2C19,9606.0,Homo sapiens (human),Substrate,,,PMID:12835613|PMID:28520382,https://www.ncbi.nlm.nih.gov/pubmed/12835613|https://www.ncbi.nlm.nih.gov/pubmed/28520382,12835613|28520382,,
2991,235713,2576,Drug Gene Interaction database (DGIdb),Carisoprodol,,CARISOPRODOL,https://www.dgidb.org/drugs/rxcui:2101,,CYP2C19,https://www.dgidb.org/genes/hgnc:2621,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,,,,,
2992,222951,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9913.0,Bos taurus (cattle),Carmustine results in decreased activity of GSR protein,,,PMID:2373173,https://www.ncbi.nlm.nih.gov/pubmed/2373173,2373173,,
2993,222952,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9913.0,Bos taurus (cattle),[carmustine results in decreased activity of GSR protein] promotes the reaction [diamide affects the abundance of calcium],,,PMID:21148766,https://www.ncbi.nlm.nih.gov/pubmed/21148766,21148766,,
2994,222953,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,6279.0,Brugia malayi,Carmustine results in increased activity of GSR protein,,,PMID:12659765,https://www.ncbi.nlm.nih.gov/pubmed/12659765,12659765,,
2995,222954,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),Carmustine results in decreased activity of GSR protein,,,PMID:12632252|PMID:15857610|PMID:18155673|PMID:19401447|PMID:19668867|PMID:19856331,https://www.ncbi.nlm.nih.gov/pubmed/12632252|https://www.ncbi.nlm.nih.gov/pubmed/15857610|https://www.ncbi.nlm.nih.gov/pubmed/18155673|https://www.ncbi.nlm.nih.gov/pubmed/19401447|https://www.ncbi.nlm.nih.gov/pubmed/19668867|https://www.ncbi.nlm.nih.gov/pubmed/19856331,12632252|15857610|18155673|19401447|19668867|19856331,,
2996,223118,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),[carmustine results in decreased activity of GSR protein] which results in increased susceptibility to doxorubicin,,,PMID:16160061,https://www.ncbi.nlm.nih.gov/pubmed/16160061,16160061,,
2997,223119,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),[carmustine results in decreased activity of GSR protein] which results in increased susceptibility to zinc chloride,,,PMID:12632252,https://www.ncbi.nlm.nih.gov/pubmed/12632252,12632252,,
2998,223120,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),Glutathione disulfide inhibits the reaction [carmustine results in decreased activity of GSR protein]|nadp affects the reaction [carmustine results in decreased activity of GSR protein],,,PMID:19668867,https://www.ncbi.nlm.nih.gov/pubmed/19668867,19668867,,
2999,223121,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10090.0,Mus musculus (house mouse),Carmustine results in decreased activity of GSR protein,,,PMID:15857610|PMID:17498860,https://www.ncbi.nlm.nih.gov/pubmed/15857610|https://www.ncbi.nlm.nih.gov/pubmed/17498860,15857610|17498860,,
3000,223479,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,9606.0,Homo sapiens (human),GSTP1 protein results in decreased susceptibility to carmustine,,,PMID:16899598,https://www.ncbi.nlm.nih.gov/pubmed/16899598,16899598,,
3001,223480,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,9606.0,Homo sapiens (human),GSTT1 protein affects the susceptibility to carmustine,,,PMID:16874663,https://www.ncbi.nlm.nih.gov/pubmed/16874663,16874663,,
3002,223481,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,9606.0,Homo sapiens (human),GSTT1 protein results in decreased nitrosation of carmustine,,,PMID:11841793,https://www.ncbi.nlm.nih.gov/pubmed/11841793,11841793,,
3003,223482,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,10090.0,Mus musculus (house mouse),GSTT1 protein affects the metabolism of carmustine,,,PMID:17827337,https://www.ncbi.nlm.nih.gov/pubmed/17827337,17827337,,
3004,223483,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2962,GTF2F1,https://ctdbase.org/detail.go?type=gene&acc=2962,,,2962.0,GTF2F1,9606.0,Homo sapiens (human),Carmustine results in decreased expression of GTF2F1 mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3005,223484,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,2974,GUCY1B2,https://ctdbase.org/detail.go?type=gene&acc=2974,,,2974.0,GUCY1B2,10116.0,Rattus norvegicus (Norway rat),Carmustine results in decreased expression of GUCY1B2 mRNA,,,PMID:16005536,https://www.ncbi.nlm.nih.gov/pubmed/16005536,16005536,,
3006,223485,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),Carmustine results in increased phosphorylation of H2AX protein|mdm4 protein promotes the reaction [carmustine results in increased phosphorylation of H2AX protein]|carmustine affects the localization of H2AX protein|mdm4 protein promotes the reaction [carmustine affects the localization of H2AX protein],,,PMID:20472715,https://www.ncbi.nlm.nih.gov/pubmed/20472715,20472715,,
3007,223486,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),Carmustine results in decreased expression of H2AX mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3008,223810,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,3486,IGFBP3,https://ctdbase.org/detail.go?type=gene&acc=3486,,,3486.0,IGFBP3,10116.0,Rattus norvegicus (Norway rat),Carmustine results in decreased expression of IGFBP3 mRNA,,,PMID:16005536,https://www.ncbi.nlm.nih.gov/pubmed/16005536,16005536,,
3009,223811,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,8517,IKBKG,https://ctdbase.org/detail.go?type=gene&acc=8517,,,8517.0,IKBKG,9606.0,Homo sapiens (human),Carmustine results in decreased expression of IKBKG mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3010,223812,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,3593,IL12B,https://ctdbase.org/detail.go?type=gene&acc=3593,,,3593.0,IL12B,10090.0,Mus musculus (house mouse),Carmustine promotes the reaction [lipopolysaccharides results in increased expression of IL12B protein],,,PMID:12688424,https://www.ncbi.nlm.nih.gov/pubmed/12688424,12688424,,
3011,224847,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4248,MGAT3,https://ctdbase.org/detail.go?type=gene&acc=4248,,,4248.0,MGAT3,9606.0,Homo sapiens (human),Carmustine results in decreased expression of MGAT3 mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3012,224848,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,9615.0,Canis lupus familiaris (dog),MGMT protein mutant form results in decreased susceptibility to carmustine|mgmt protein results in decreased susceptibility to carmustine,,,PMID:15053863,https://www.ncbi.nlm.nih.gov/pubmed/15053863,15053863,,
3013,224849,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,9615.0,Canis lupus familiaris (dog),MGMT protein mutant form results in decreased susceptibility to [carmustine co-treated with O(6)-benzylguanine],,,PMID:14617759,https://www.ncbi.nlm.nih.gov/pubmed/14617759,14617759,,
3014,224850,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,9606.0,Homo sapiens (human),Carmustine results in increased alkylation of MGMT protein,,,PMID:8823159,https://www.ncbi.nlm.nih.gov/pubmed/8823159,8823159,,
3015,224851,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,9606.0,Homo sapiens (human),MGMT gene modified form affects the susceptibility to carmustine,,,PMID:12684420,https://www.ncbi.nlm.nih.gov/pubmed/12684420,12684420,,
3016,224852,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,9606.0,Homo sapiens (human),MGMT mRNA results in decreased susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3017,224853,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,9606.0,Homo sapiens (human),MGMT mutant form results in increased susceptibility to carmustine,,,PMID:26208482,https://www.ncbi.nlm.nih.gov/pubmed/26208482,26208482,,
3018,225176,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,10090.0,Mus musculus (house mouse),Carmustine results in decreased activity of MGMT protein|mgmt protein results in decreased susceptibility to carmustine,,,PMID:16126841,https://www.ncbi.nlm.nih.gov/pubmed/16126841,16126841,,
3019,225177,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,10090.0,Mus musculus (house mouse),[O(6)-benzylguanine results in decreased activity of MGMT protein] which affects the susceptibility to carmustine|mgmt protein affects the susceptibility to carmustine,,,PMID:19844954,https://www.ncbi.nlm.nih.gov/pubmed/19844954,19844954,,
3020,225178,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,10090.0,Mus musculus (house mouse),MGMT protein mutant form results in decreased susceptibility to [carmustine co-treated with O(6)-benzylguanine],,,PMID:14707273,https://www.ncbi.nlm.nih.gov/pubmed/14707273,14707273,,
3021,225179,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,10090.0,Mus musculus (house mouse),MGMT protein results in decreased susceptibility to carmustine,,,PMID:15284838,https://www.ncbi.nlm.nih.gov/pubmed/15284838,15284838,,
3022,225180,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,10116.0,Rattus norvegicus (Norway rat),Carmustine results in decreased expression of MGMT protein,,,PMID:15104113,https://www.ncbi.nlm.nih.gov/pubmed/15104113,15104113,,
3023,225181,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4255,MGMT,https://ctdbase.org/detail.go?type=gene&acc=4255,,,4255.0,MGMT,9606.0,Homo sapiens (human),[MGMT protein mutant form co-treated with ABCC1 protein] results in decreased susceptibility to [carmustine co-treated with O(6)-benzylguanine]|[mgmt protein mutant form co-treated with ABCB1 protein] results in decreased susceptibility to [carmustine co-treated with O(6)-benzylguanine]|mgmt protein mutant form results in decreased susceptibility to [carmustine co-treated with O(6)-benzylguanine],,,PMID:16733832,https://www.ncbi.nlm.nih.gov/pubmed/16733832,16733832,,
3024,225322,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4258,MGST2,https://ctdbase.org/detail.go?type=gene&acc=4258,,,4258.0,MGST2,9606.0,Homo sapiens (human),MGST2 mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3025,225323,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606.0,Homo sapiens (human),MLH1 protein affects the susceptibility to carmustine,,,PMID:18430789,https://www.ncbi.nlm.nih.gov/pubmed/18430789,18430789,,
3026,225324,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,79083,MLPH,https://ctdbase.org/detail.go?type=gene&acc=79083,,,79083.0,MLPH,9606.0,Homo sapiens (human),MLPH mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3027,225325,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4350,MPG,https://ctdbase.org/detail.go?type=gene&acc=4350,,,4350.0,MPG,9606.0,Homo sapiens (human),MPG protein results in decreased susceptibility to carmustine,,,PMID:16288039,https://www.ncbi.nlm.nih.gov/pubmed/16288039,16288039,,
3028,225326,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4357,MPST,https://ctdbase.org/detail.go?type=gene&acc=4357,,,4357.0,MPST,9606.0,Homo sapiens (human),MPST mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3029,225327,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,100270714,MRCL3,https://ctdbase.org/detail.go?type=gene&acc=100270714,,,100270714.0,,9606.0,Homo sapiens (human),MRCL3 mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3030,225328,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,44141,MSF,https://ctdbase.org/detail.go?type=gene&acc=44141,,,44141.0,msf,9606.0,Homo sapiens (human),MSF mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3031,225329,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606.0,Homo sapiens (human),MSH2 protein affects the susceptibility to carmustine,,,PMID:18430789,https://www.ncbi.nlm.nih.gov/pubmed/18430789,18430789,,
3032,226478,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,8654,PDE5A,https://ctdbase.org/detail.go?type=gene&acc=8654,,,8654.0,PDE5A,9606.0,Homo sapiens (human),PDE5A mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3033,227450,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,6096,RORB,https://ctdbase.org/detail.go?type=gene&acc=6096,,,6096.0,RORB,10116.0,Rattus norvegicus (Norway rat),Carmustine affects the expression of RORB mRNA,,,PMID:19174181,https://www.ncbi.nlm.nih.gov/pubmed/19174181,19174181,,
3034,227451,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,1903,S1PR3,https://ctdbase.org/detail.go?type=gene&acc=1903,,,1903.0,S1PR3,9606.0,Homo sapiens (human),S1PR3 mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3035,227643,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,5413,SEPTIN5,https://ctdbase.org/detail.go?type=gene&acc=5413,,,5413.0,SEPTIN5,9606.0,Homo sapiens (human),Carmustine results in decreased expression of SEPTIN5 mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3036,227644,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,1992,SERPINB1,https://ctdbase.org/detail.go?type=gene&acc=1992,,,1992.0,SERPINB1,9606.0,Homo sapiens (human),SERPINB1 mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3037,227645,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,7536,SF1,https://ctdbase.org/detail.go?type=gene&acc=7536,,,7536.0,SF1,9606.0,Homo sapiens (human),SF1 mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3038,227646,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,6421,SFPQ,https://ctdbase.org/detail.go?type=gene&acc=6421,,,6421.0,SFPQ,9606.0,Homo sapiens (human),Carmustine results in decreased expression of SFPQ mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3039,228617,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,171024,SYNPO2,https://ctdbase.org/detail.go?type=gene&acc=171024,,,171024.0,SYNPO2,9606.0,Homo sapiens (human),SYNPO2 mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3040,228618,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,6855,SYP,https://ctdbase.org/detail.go?type=gene&acc=6855,,,6855.0,SYP,10116.0,Rattus norvegicus (Norway rat),Carmustine results in decreased expression of SYP protein|melatonin inhibits the reaction [carmustine results in decreased expression of SYP protein],,,PMID:17572393,https://www.ncbi.nlm.nih.gov/pubmed/17572393,17572393,,
3041,228619,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,6863,TAC1,https://ctdbase.org/detail.go?type=gene&acc=6863,,,6863.0,TAC1,9606.0,Homo sapiens (human),Carmustine results in decreased expression of TAC1 mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3042,228620,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,6876,TAGLN,https://ctdbase.org/detail.go?type=gene&acc=6876,,,6876.0,TAGLN,9606.0,Homo sapiens (human),TAGLN mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3043,228621,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,6926,TBX3,https://ctdbase.org/detail.go?type=gene&acc=6926,,,6926.0,TBX3,9606.0,Homo sapiens (human),TBX3 mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3044,228622,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,6943,TCF21,https://ctdbase.org/detail.go?type=gene&acc=6943,,,6943.0,TCF21,9606.0,Homo sapiens (human),Carmustine results in decreased expression of TCF21 mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3045,228623,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,56892,TCIM,https://ctdbase.org/detail.go?type=gene&acc=56892,,,56892.0,TCIM,9606.0,Homo sapiens (human),TCIM mRNA results in increased susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3046,228624,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,157695,TDRP,https://ctdbase.org/detail.go?type=gene&acc=157695,,,157695.0,TDRP,9606.0,Homo sapiens (human),TDRP mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3047,228820,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,373123,TEGT,https://ctdbase.org/detail.go?type=gene&acc=373123,,,373123.0,tegt,9606.0,Homo sapiens (human),Carmustine results in increased expression of TEGT mrna|carmustine results in decreased expression of TEGT mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3048,228821,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,7015,TERT,https://ctdbase.org/detail.go?type=gene&acc=7015,,,7015.0,TERT,9606.0,Homo sapiens (human),TERT protein mutant form results in decreased susceptibility to carmustine,,,PMID:12488552,https://www.ncbi.nlm.nih.gov/pubmed/12488552,12488552,,
3049,229208,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,7164,TPD52L1,https://ctdbase.org/detail.go?type=gene&acc=7164,,,7164.0,TPD52L1,9606.0,Homo sapiens (human),TPD52L1 mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3050,229209,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,7185,TRAF1,https://ctdbase.org/detail.go?type=gene&acc=7185,,,7185.0,TRAF1,9606.0,Homo sapiens (human),Carmustine results in decreased expression of TRAF1 mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3051,250652,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,977,CD151,https://ctdbase.org/detail.go?type=gene&acc=977,,,977.0,CD151,9606.0,Homo sapiens (human),Carmustine results in decreased expression of CD151 mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3052,250653,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,960,CD44,https://ctdbase.org/detail.go?type=gene&acc=960,,,960.0,CD44,9606.0,Homo sapiens (human),CD44 mRNA affects the susceptibility to carmustine,,,PMID:16365179,https://www.ncbi.nlm.nih.gov/pubmed/16365179,16365179,,
3053,250654,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,968,CD68,https://ctdbase.org/detail.go?type=gene&acc=968,,,968.0,CD68,9606.0,Homo sapiens (human),Carmustine results in decreased expression of CD68 mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3054,250655,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,973,CD79A,https://ctdbase.org/detail.go?type=gene&acc=973,,,973.0,CD79A,9606.0,Homo sapiens (human),Carmustine results in decreased expression of CD79A mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3055,250656,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,941,CD80,https://ctdbase.org/detail.go?type=gene&acc=941,,,941.0,CD80,9606.0,Homo sapiens (human),Carmustine results in increased expression of CD80 mRNA,,,PMID:15980968,https://www.ncbi.nlm.nih.gov/pubmed/15980968,15980968,,
3056,250657,2578,Comparative Toxicogenomics Database (CTD),Carmustine,D002330,Carmustine,https://ctdbase.org/detail.go?type=chem&acc=D002330,994,CDC25B,https://ctdbase.org/detail.go?type=gene&acc=994,,,994.0,CDC25B,10116.0,Rattus norvegicus (Norway rat),Carmustine results in decreased expression of CDC25B mRNA,,,PMID:16005536,https://www.ncbi.nlm.nih.gov/pubmed/16005536,16005536,,
3057,229747,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Valspodar inhibits the reaction [ABCB1 protein results in increased transport of carvedilol]|abcb1 protein results in increased transport of carvedilol,,,PMID:16671962,https://www.ncbi.nlm.nih.gov/pubmed/16671962,16671962,,
3058,229748,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Carvedilol inhibits the reaction [ABCB1 protein results in increased transport of vinblastine]|carvedilol inhibits the reaction [ABCB1 protein results in increased transport of daunorubicin]|carvedilol inhibits the reaction [ABCB1 protein results in increased transport of doxorubicin]|[carvedilol inhibits the reaction [ABCB1 protein results in increased transport of daunorubicin]] which results in decreased susceptibility to daunorubicin|[carvedilol inhibits the reaction [ABCB1 protein results in increased transport of vinblastine]] which results in decreased susceptibility to vinblastine|carvedilol inhibits the reaction [ABCB1 protein results in increased transport of paclitaxel]|[carvedilol inhibits the reaction [ABCB1 protein results in increased transport of doxorubicin]] which results in decreased susceptibility to doxorubicin|[carvedilol inhibits the reaction [ABCB1 protein results in increased transport of paclitaxel]] which results in decreased susceptibility to paclitaxel,,,PMID:12708479,https://www.ncbi.nlm.nih.gov/pubmed/12708479,12708479,,
3059,229749,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Carvedilol inhibits the reaction [ABCB1 protein results in increased transport of digoxin],,,PMID:11895100|PMID:16671962,https://www.ncbi.nlm.nih.gov/pubmed/11895100|https://www.ncbi.nlm.nih.gov/pubmed/16671962,11895100|16671962,,
3060,229935,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,10090.0,Mus musculus (house mouse),Carvedilol results in decreased expression of ABCC4 protein,,,PMID:37632784,https://www.ncbi.nlm.nih.gov/pubmed/37632784,37632784,,
3061,229936,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,9606.0,Homo sapiens (human),Carvedilol inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of ACE mrna],,,PMID:15071347,https://www.ncbi.nlm.nih.gov/pubmed/15071347,15071347,,
3062,229937,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [colchicine results in decreased activity of ACE protein],,,PMID:18992766,https://www.ncbi.nlm.nih.gov/pubmed/18992766,18992766,,
3063,229938,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [carbon tetrachloride results in increased expression of ACTA2 protein],,,PMID:30254303,https://www.ncbi.nlm.nih.gov/pubmed/30254303,30254303,,
3064,229939,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [ethanol results in increased expression of ACTA2 mrna]|carvedilol inhibits the reaction [ethanol results in increased expression of ACTA2 protein],,,PMID:22413959,https://www.ncbi.nlm.nih.gov/pubmed/22413959,22413959,,
3065,230453,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,153,ADRB1,https://ctdbase.org/detail.go?type=gene&acc=153,,,153.0,ADRB1,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in increased expression of ADRB1 mRNA,,,PMID:20668454|PMID:21216836,https://www.ncbi.nlm.nih.gov/pubmed/20668454|https://www.ncbi.nlm.nih.gov/pubmed/21216836,20668454|21216836,,
3066,230454,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,153,ADRB1,https://ctdbase.org/detail.go?type=gene&acc=153,,,153.0,ADRB1,9606.0,Homo sapiens (human),Carvedilol binds to and results in decreased activity of ADRB1 protein,,,PMID:10630826|PMID:11336626|PMID:12904089,https://www.ncbi.nlm.nih.gov/pubmed/10630826|https://www.ncbi.nlm.nih.gov/pubmed/11336626|https://www.ncbi.nlm.nih.gov/pubmed/12904089,10630826|11336626|12904089,,
3067,230455,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,154,ADRB2,https://ctdbase.org/detail.go?type=gene&acc=154,,,154.0,ADRB2,9606.0,Homo sapiens (human),[ADRB1 gene co-treated with ADRB2 gene] affects the susceptibility to carvedilol,,,PMID:21395649,https://www.ncbi.nlm.nih.gov/pubmed/21395649,21395649,,
3068,230456,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,154,ADRB2,https://ctdbase.org/detail.go?type=gene&acc=154,,,154.0,ADRB2,9606.0,Homo sapiens (human),ADRB2 gene SNP affects the susceptibility to carvedilol,,,PMID:20352314,https://www.ncbi.nlm.nih.gov/pubmed/20352314,20352314,,
3069,230457,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,154,ADRB2,https://ctdbase.org/detail.go?type=gene&acc=154,,,154.0,ADRB2,9606.0,Homo sapiens (human),ADRB2 protein polymorphism affects the susceptibility to carvedilol,,,PMID:12835612|PMID:19034036|PMID:19175363|PMID:19422106|PMID:21599570,https://www.ncbi.nlm.nih.gov/pubmed/12835612|https://www.ncbi.nlm.nih.gov/pubmed/19034036|https://www.ncbi.nlm.nih.gov/pubmed/19175363|https://www.ncbi.nlm.nih.gov/pubmed/19422106|https://www.ncbi.nlm.nih.gov/pubmed/21599570,12835612|19034036|19175363|19422106|21599570,,
3070,230458,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,154,ADRB2,https://ctdbase.org/detail.go?type=gene&acc=154,,,154.0,ADRB2,9606.0,Homo sapiens (human),Carvedilol binds to ADRB2 protein,,,PMID:10372227|PMID:15306222,https://www.ncbi.nlm.nih.gov/pubmed/10372227|https://www.ncbi.nlm.nih.gov/pubmed/15306222,10372227|15306222,,
3071,230459,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [isoproterenol results in increased expression of CASP3 protein]|[carvedilol co-treated with aliskiren] inhibits the reaction [isoproterenol results in increased expression of CASP3 protein],,,PMID:26982530,https://www.ncbi.nlm.nih.gov/pubmed/26982530,26982530,,
3072,230460,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,153,ADRB1,https://ctdbase.org/detail.go?type=gene&acc=153,,,153.0,ADRB1,9606.0,Homo sapiens (human),RTKI cpd inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]|hbegf protein inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK1 protein]]|ag 1879 inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK1 protein]]|carvedilol results in increased phosphorylation of ADRB1 protein|arrb1 protein promotes the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK1 protein]]|arrb2 protein promotes the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK1 protein]]|n-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]|[carvedilol results in increased phosphorylation of ADRB1 protein] which results in increased phosphorylation of EGFR protein|carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK1 protein]|rtki cpd inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]|carvedilol promotes the reaction [ADRB1 protein binds to ARRB2 protein]|ag 1879 inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]|carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]|n-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|carvedilol promotes the reaction [ADRB1 protein results in increased phosphorylation of and results in increased uptake of EGFR protein]|hbegf protein inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|n-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK1 protein]]|rtki cpd inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK1 protein]]|carvedilol promotes the reaction [ADRB1 protein binds to ARRB1 protein]|arrb1 protein promotes the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|ag 1879 inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|hbegf protein promotes the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased phosphorylation of EGFR protein]]|arrb2 protein promotes the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|propranolol inhibits the reaction [carvedilol promotes the reaction [ADRB1 protein results in increased uptake of EGFR protein]],,,PMID:18787115,https://www.ncbi.nlm.nih.gov/pubmed/18787115,18787115,,
3073,231257,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,551,AVP,https://ctdbase.org/detail.go?type=gene&acc=551,,,551.0,AVP,9606.0,Homo sapiens (human),Carvedilol results in decreased expression of AVP protein,,,PMID:12523682,https://www.ncbi.nlm.nih.gov/pubmed/12523682,12523682,,
3074,231258,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,551,AVP,https://ctdbase.org/detail.go?type=gene&acc=551,,,551.0,AVP,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [AVP protein results in increased import of and results in increased abundance of calcium],,,PMID:14711191,https://www.ncbi.nlm.nih.gov/pubmed/14711191,14711191,,
3075,231259,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,10116.0,Rattus norvegicus (Norway rat),[[oxygen deficiency co-treated with glucose deficiency] results in increased susceptibility to carvedilol] which results in decreased expression of BAK1 mRNA,,,PMID:29122578,https://www.ncbi.nlm.nih.gov/pubmed/29122578,29122578,,
3076,231260,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Carvedilol inhibits the reaction [cisplatin results in increased expression of BAX protein],,,PMID:24012798,https://www.ncbi.nlm.nih.gov/pubmed/24012798,24012798,,
3077,231413,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [doxorubicin results in increased expression of BAX protein],,,PMID:26036690,https://www.ncbi.nlm.nih.gov/pubmed/26036690,26036690,,
3078,231414,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [potassium dichromate results in increased expression of BAX protein],,,PMID:25245570,https://www.ncbi.nlm.nih.gov/pubmed/25245570,25245570,,
3079,231415,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in decreased expression of BAX,,,PMID:12973927,https://www.ncbi.nlm.nih.gov/pubmed/12973927,12973927,,
3080,231416,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in increased expression of BAX protein,,,PMID:20079142,https://www.ncbi.nlm.nih.gov/pubmed/20079142,20079142,,
3081,231417,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Carvedilol affects the expression of BCL2 protein,,,PMID:22000973,https://www.ncbi.nlm.nih.gov/pubmed/22000973,22000973,,
3082,231418,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [doxorubicin results in decreased expression of BCL2 mrna],,,PMID:15380674,https://www.ncbi.nlm.nih.gov/pubmed/15380674,15380674,,
3083,231419,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [doxorubicin results in decreased expression of BCL2 protein],,,PMID:26036690,https://www.ncbi.nlm.nih.gov/pubmed/26036690,26036690,,
3084,231420,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [potassium dichromate results in decreased expression of BCL2 protein],,,PMID:25245570,https://www.ncbi.nlm.nih.gov/pubmed/25245570,25245570,,
3085,231421,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in increased expression of BCL2 mRNA,,,PMID:16780994|PMID:16909474,https://www.ncbi.nlm.nih.gov/pubmed/16780994|https://www.ncbi.nlm.nih.gov/pubmed/16909474,16780994|16909474,,
3086,231589,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in increased expression of BCL2L1 protein,,,PMID:20079142,https://www.ncbi.nlm.nih.gov/pubmed/20079142,20079142,,
3087,231590,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in increased expression of BECN1 protein,,,PMID:20079142,https://www.ncbi.nlm.nih.gov/pubmed/20079142,20079142,,
3088,231591,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,796,CALCA,https://ctdbase.org/detail.go?type=gene&acc=796,,,796.0,CALCA,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in increased secretion of [CALCA protein co-treated with CALCB protein]|capsazepine inhibits the reaction [carvedilol results in increased secretion of [CALCA protein co-treated with CALCB protein]],,,PMID:14764656,https://www.ncbi.nlm.nih.gov/pubmed/14764656,14764656,,
3089,231592,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,797,CALCB,https://ctdbase.org/detail.go?type=gene&acc=797,,,797.0,CALCB,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in increased secretion of [CALCA protein co-treated with CALCB protein]|capsazepine inhibits the reaction [carvedilol results in increased secretion of [CALCA protein co-treated with CALCB protein]],,,PMID:14764656,https://www.ncbi.nlm.nih.gov/pubmed/14764656,14764656,,
3090,231593,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [doxorubicin results in increased expression of CASP3 protein],,,PMID:26036690,https://www.ncbi.nlm.nih.gov/pubmed/26036690,26036690,,
3091,231594,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [potassium dichromate results in increased cleavage of CASP3 protein],,,PMID:25245570,https://www.ncbi.nlm.nih.gov/pubmed/25245570,25245570,,
3092,231595,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [arginine results in decreased activity of CAT protein],,,PMID:32569593,https://www.ncbi.nlm.nih.gov/pubmed/32569593,32569593,,
3093,231746,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in increased activity of CAT protein,,,PMID:16909474,https://www.ncbi.nlm.nih.gov/pubmed/16909474,16909474,,
3094,231747,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [carbon tetrachloride results in decreased expression of CDH1 protein],,,PMID:30254303,https://www.ncbi.nlm.nih.gov/pubmed/30254303,30254303,,
3095,231748,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1003,CDH5,https://ctdbase.org/detail.go?type=gene&acc=1003,,,1003.0,CDH5,9823.0,Sus scrofa (pig),Carvedilol results in decreased expression of CDH5 mrna|carvedilol results in increased expression of CDH5 protein,,,PMID:16824628,https://www.ncbi.nlm.nih.gov/pubmed/16824628,16824628,,
3096,231749,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1072,CFL1,https://ctdbase.org/detail.go?type=gene&acc=1072,,,1072.0,CFL1,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in decreased expression of CFL1 protein,,,PMID:20403466,https://www.ncbi.nlm.nih.gov/pubmed/20403466,20403466,,
3097,231750,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1152,CKB,https://ctdbase.org/detail.go?type=gene&acc=1152,,,1152.0,CKB,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]],,,PMID:25496245,https://www.ncbi.nlm.nih.gov/pubmed/25496245,25496245,,
3098,231751,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1158,CKM,https://ctdbase.org/detail.go?type=gene&acc=1158,,,1158.0,CKM,10116.0,Rattus norvegicus (Norway rat),[carvedilol co-treated with aliskiren] inhibits the reaction [isoproterenol results in increased expression of and results in increased secretion of CKM protein]|carvedilol inhibits the reaction [isoproterenol results in increased expression of and results in increased secretion of CKM protein],,,PMID:26982530,https://www.ncbi.nlm.nih.gov/pubmed/26982530,26982530,,
3099,231752,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1158,CKM,https://ctdbase.org/detail.go?type=gene&acc=1158,,,1158.0,CKM,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [isoproterenol results in increased expression of and results in increased secretion of [CKM protein binds to CKB protein]],,,PMID:25496245,https://www.ncbi.nlm.nih.gov/pubmed/25496245,25496245,,
3100,231753,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [ethanol results in increased expression of COL1A1 mrna],,,PMID:22413959,https://www.ncbi.nlm.nih.gov/pubmed/22413959,22413959,,
3101,231754,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [norepinephrine results in increased expression of COL1A1 mrna],,,PMID:10722803|PMID:19575289,https://www.ncbi.nlm.nih.gov/pubmed/10722803|https://www.ncbi.nlm.nih.gov/pubmed/19575289,10722803|19575289,,
3102,231755,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10116.0,Rattus norvegicus (Norway rat),"Carvedilol inhibits the reaction [[sodium, dietary co-treated with dietary fats] results in increased expression of COL1A1 mrna]",,,PMID:11682445,https://www.ncbi.nlm.nih.gov/pubmed/11682445,11682445,,
3103,231954,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in decreased expression of COL1A1 mRNA,,,PMID:21216836,https://www.ncbi.nlm.nih.gov/pubmed/21216836,21216836,,
3104,232689,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in decreased expression of FN1 protein,,,PMID:11181017,https://www.ncbi.nlm.nih.gov/pubmed/11181017,11181017,,
3105,233219,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),Carvedilol inhibits the reaction [CSF2 results in increased expression of IL10 protein]|carvedilol results in increased expression of IL10 protein|carvedilol inhibits the reaction [CSF2 results in increased expression of IL10 mrna],,,PMID:12722941,https://www.ncbi.nlm.nih.gov/pubmed/12722941,12722941,,
3106,233220,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in increased expression of IL10 mRNA,,,PMID:18971572,https://www.ncbi.nlm.nih.gov/pubmed/18971572,18971572,,
3107,233221,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10116.0,Rattus norvegicus (Norway rat),Carvedilol results in increased expression of IL10 protein,,,PMID:16310260|PMID:20017808,https://www.ncbi.nlm.nih.gov/pubmed/16310260|https://www.ncbi.nlm.nih.gov/pubmed/20017808,16310260|20017808,,
3108,233222,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,3592,IL12A,https://ctdbase.org/detail.go?type=gene&acc=3592,,,3592.0,IL12A,9606.0,Homo sapiens (human),Carvedilol promotes the reaction [lipopolysaccharides results in increased expression of [IL12A protein binds to IL12B protein]]|carvedilol promotes the reaction [hemagglutinins results in increased expression of [IL12A protein binds to IL12B protein]],,,PMID:15229385,https://www.ncbi.nlm.nih.gov/pubmed/15229385,15229385,,
3109,233223,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,3593,IL12B,https://ctdbase.org/detail.go?type=gene&acc=3593,,,3593.0,IL12B,9606.0,Homo sapiens (human),Carvedilol promotes the reaction [lipopolysaccharides results in increased expression of [IL12A protein binds to IL12B protein]]|carvedilol promotes the reaction [hemagglutinins results in increased expression of [IL12A protein binds to IL12B protein]],,,PMID:15229385,https://www.ncbi.nlm.nih.gov/pubmed/15229385,15229385,,
3110,233224,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Carvedilol inhibits the reaction [lipopolysaccharides results in increased secretion of IL1B protein],,,PMID:14684360,https://www.ncbi.nlm.nih.gov/pubmed/14684360,14684360,,
3111,233225,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Carvedilol results in decreased expression of IL1B mRNA,,,PMID:15921778,https://www.ncbi.nlm.nih.gov/pubmed/15921778,15921778,,
3112,233226,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [arginine results in increased expression of IL1B protein],,,PMID:32569593,https://www.ncbi.nlm.nih.gov/pubmed/32569593,32569593,,
3113,233227,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [norepinephrine results in increased expression of IL1B mrna],,,PMID:10722803,https://www.ncbi.nlm.nih.gov/pubmed/10722803,10722803,,
3114,233719,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10116.0,Rattus norvegicus (Norway rat),Carvedilol affects the expression of MYC protein,,,PMID:22000973,https://www.ncbi.nlm.nih.gov/pubmed/22000973,22000973,,
3115,233720,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),ARRB1 protein promotes the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]|arrb2 protein promotes the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|n-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|ag 1879 inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|carvedilol results in increased phosphorylation of MAPK3 protein|hbegf protein inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|rtki cpd inhibits the reaction [carvedilol promotes the reaction [[ADRB1 protein co-treated with EGFR protein] results in increased phosphorylation of MAPK3 protein]]|erlotinib hydrochloride inhibits the reaction [carvedilol results in increased phosphorylation of MAPK3 protein],,,PMID:18787115,https://www.ncbi.nlm.nih.gov/pubmed/18787115,18787115,,
3116,233721,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Carvedilol results in increased phosphorylation of MAPK3 protein|[carvedilol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein|ici 118551 inhibits the reaction [[carvedilol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein]|arrb2 protein promotes the reaction [carvedilol results in increased phosphorylation of MAPK3 protein],,,PMID:17925438,https://www.ncbi.nlm.nih.gov/pubmed/17925438,17925438,,
3117,233722,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Carvedilol inhibits the reaction [[phenylephrine co-treated with ADRA1A protein] results in increased phosphorylation of MAPK3 protein]|carvedilol inhibits the reaction [[phenylephrine co-treated with ADRA1B protein] results in increased phosphorylation of MAPK3 protein]|carvedilol inhibits the reaction [[phenylephrine co-treated with ADRA1D protein] results in increased phosphorylation of MAPK3 protein],,,PMID:15306222,https://www.ncbi.nlm.nih.gov/pubmed/15306222,15306222,,
3118,233723,2585,Comparative Toxicogenomics Database (CTD),Carvedilol,D000077261,Carvedilol,https://ctdbase.org/detail.go?type=chem&acc=D000077261,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Carvedilol inhibits the reaction [norepinephrine results in increased phosphorylation of MAPK3 protein],,,PMID:11054474,https://www.ncbi.nlm.nih.gov/pubmed/11054474,11054474,,
3119,235873,2603,Toxin and Toxin Target Database (T3DB),(3-Chlorophenyl)hydrazonomalononitrile,T3D1697,Carbonyl cyanide m-chlorophenyl hydrazone,http://www.t3db.ca/toxins/T3D1697,BE0003546,"Alkaline phosphatase, tissue-nonspecific isozyme",http://www.t3db.ca/biodb/bio_entities/BE0003546,P05186,"Alkaline phosphatase, tissue-nonspecific isozyme",249.0,ALPL,9606.0,Homo sapiens (human),Cyanide inhibits alkaline phosphatases. (A73),,,PMID:924371,https://www.ncbi.nlm.nih.gov/pubmed/924371,924371,,
3120,235874,2603,Toxin and Toxin Target Database (T3DB),(3-Chlorophenyl)hydrazonomalononitrile,T3D1697,Carbonyl cyanide m-chlorophenyl hydrazone,http://www.t3db.ca/toxins/T3D1697,BE0001207,Catalase,http://www.t3db.ca/biodb/bio_entities/BE0001207,P04040,Catalase,847.0,CAT,9606.0,Homo sapiens (human),Cyanide inhibits catalase. (A74),,,PMID:16728955,https://www.ncbi.nlm.nih.gov/pubmed/16728955,16728955,,
3121,235875,2603,Toxin and Toxin Target Database (T3DB),(3-Chlorophenyl)hydrazonomalononitrile,T3D1697,Carbonyl cyanide m-chlorophenyl hydrazone,http://www.t3db.ca/toxins/T3D1697,BE0000335,Cytochrome c oxidase subunit 1,http://www.t3db.ca/biodb/bio_entities/BE0000335,P00395,Cytochrome c oxidase subunit 1,4512.0,COX1,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
3122,235876,2603,Toxin and Toxin Target Database (T3DB),(3-Chlorophenyl)hydrazonomalononitrile,T3D1697,Carbonyl cyanide m-chlorophenyl hydrazone,http://www.t3db.ca/toxins/T3D1697,BE0003385,Cytochrome c oxidase subunit 2,http://www.t3db.ca/biodb/bio_entities/BE0003385,P00403,Cytochrome c oxidase subunit 2,4513.0,COX2,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
3123,235877,2603,Toxin and Toxin Target Database (T3DB),(3-Chlorophenyl)hydrazonomalononitrile,T3D1697,Carbonyl cyanide m-chlorophenyl hydrazone,http://www.t3db.ca/toxins/T3D1697,BE0003987,Cytochrome c oxidase subunit 3,http://www.t3db.ca/biodb/bio_entities/BE0003987,P00414,Cytochrome c oxidase subunit 3,4514.0,COX3,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
3124,235878,2603,Toxin and Toxin Target Database (T3DB),(3-Chlorophenyl)hydrazonomalononitrile,T3D1697,Carbonyl cyanide m-chlorophenyl hydrazone,http://www.t3db.ca/toxins/T3D1697,BE0003986,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003986,P13073,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",1327.0,COX4I1,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
3125,235879,2603,Toxin and Toxin Target Database (T3DB),(3-Chlorophenyl)hydrazonomalononitrile,T3D1697,Carbonyl cyanide m-chlorophenyl hydrazone,http://www.t3db.ca/toxins/T3D1697,BE0004980,"Cytochrome c oxidase subunit 4 isoform 2, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0004980,Q96KJ9,"Cytochrome c oxidase subunit 4 isoform 2, mitochondrial",84701.0,COX4I2,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
3126,236055,2603,Toxin and Toxin Target Database (T3DB),(3-Chlorophenyl)hydrazonomalononitrile,T3D1697,Carbonyl cyanide m-chlorophenyl hydrazone,http://www.t3db.ca/toxins/T3D1697,BE0004990,"Cytochrome c oxidase subunit 7B2, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0004990,Q8TF08,"Cytochrome c oxidase subunit 7B2, mitochondrial",170712.0,COX7B2,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
3127,236056,2603,Toxin and Toxin Target Database (T3DB),(3-Chlorophenyl)hydrazonomalononitrile,T3D1697,Carbonyl cyanide m-chlorophenyl hydrazone,http://www.t3db.ca/toxins/T3D1697,BE0003992,"Cytochrome c oxidase subunit 7C, mitochondrial",http://www.t3db.ca/biodb/bio_entities/BE0003992,P15954,"Cytochrome c oxidase subunit 7C, mitochondrial",1350.0,COX7C,9606.0,Homo sapiens (human),"Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). it complexes with the ferric iron atom in this enzyme. the binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. as a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. (L97)",,,,,,,
3128,236767,2703,IUPHAR/BPS Guide to PHARMACOLOGY,Chelerythrine,5953,chelerythrine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5953,1486,protein kinase C epsilon,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1486,Q02156,Protein kinase C epsilon type,5581.0,PRKCE,9606.0,Homo sapiens (human),Inhibition,pIC50,7.62,PMID:18077363,https://www.ncbi.nlm.nih.gov/pubmed/18077363,18077363,,
3129,236768,2707,Comparative Toxicogenomics Database (CTD),Chloral Hydrate,D002697,Chloral Hydrate,https://ctdbase.org/detail.go?type=chem&acc=D002697,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,9606.0,Homo sapiens (human),[chloral hydrate results in decreased activity of ALDH2 protein] which results in decreased metabolism of nitroglycerin,,,PMID:18272654,https://www.ncbi.nlm.nih.gov/pubmed/18272654,18272654,,
3130,236769,2707,Comparative Toxicogenomics Database (CTD),Chloral Hydrate,D002697,Chloral Hydrate,https://ctdbase.org/detail.go?type=chem&acc=D002697,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,10116.0,Rattus norvegicus (Norway rat),[chloral hydrate results in decreased activity of ALDH2 protein] which results in increased susceptibility to glycolaldehyde|[chloral hydrate results in decreased activity of ALDH2 protein] which results in increased susceptibility to glyceraldehyde,,,PMID:21376711,https://www.ncbi.nlm.nih.gov/pubmed/21376711,21376711,,
3131,236935,2707,Comparative Toxicogenomics Database (CTD),Chloral Hydrate,D002697,Chloral Hydrate,https://ctdbase.org/detail.go?type=chem&acc=D002697,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Chloral hydrate results in increased expression of IL1B mRNA,,,PMID:15207037|PMID:15207038,https://www.ncbi.nlm.nih.gov/pubmed/15207037|https://www.ncbi.nlm.nih.gov/pubmed/15207038,15207037|15207038,,
3132,236936,2707,Comparative Toxicogenomics Database (CTD),Chloral Hydrate,D002697,Chloral Hydrate,https://ctdbase.org/detail.go?type=chem&acc=D002697,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Ozone inhibits the reaction [chloral hydrate results in increased expression of IL1B mrna],,,PMID:15207037,https://www.ncbi.nlm.nih.gov/pubmed/15207037,15207037,,
3133,236937,2707,Comparative Toxicogenomics Database (CTD),Chloral Hydrate,D002697,Chloral Hydrate,https://ctdbase.org/detail.go?type=chem&acc=D002697,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Chloral hydrate results in increased expression of IL6 mRNA,,,PMID:15207037|PMID:15207038,https://www.ncbi.nlm.nih.gov/pubmed/15207037|https://www.ncbi.nlm.nih.gov/pubmed/15207038,15207037|15207038,,
3134,237712,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,9606.0,Homo sapiens (human),GSTP1 protein results in decreased susceptibility to chlorambucil|gstp1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to chlorambucil],,,PMID:10900222,https://www.ncbi.nlm.nih.gov/pubmed/10900222,10900222,,
3135,237713,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),Chlorambucil analog results in increased phosphorylation of H2AX protein,,,PMID:16861886,https://www.ncbi.nlm.nih.gov/pubmed/16861886,16861886,,
3136,237714,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606.0,Homo sapiens (human),Chlorambucil results in increased phosphorylation of H2AX protein,,,PMID:32482060,https://www.ncbi.nlm.nih.gov/pubmed/32482060,32482060,,
3137,237878,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,9606.0,Homo sapiens (human),Chlorambucil results in increased expression of MDM2 mRNA,,,PMID:17476690,https://www.ncbi.nlm.nih.gov/pubmed/17476690,17476690,,
3138,237879,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),IL4 protein inhibits the reaction [[theophylline co-treated with chlorambucil] results in increased expression of MYC protein]|[theophylline co-treated with chlorambucil] results in increased expression of MYC protein|chlorambucil affects the expression of MYC mrna|chlorambucil results in increased expression of MYC protein,,,PMID:8822937,https://www.ncbi.nlm.nih.gov/pubmed/8822937,8822937,,
3139,237880,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,4644,MYO5A,https://ctdbase.org/detail.go?type=gene&acc=4644,,,4644.0,MYO5A,10090.0,Mus musculus (house mouse),Chlorambucil results in increased mutagenesis of MYO5A gene,,,PMID:10517996,https://www.ncbi.nlm.nih.gov/pubmed/10517996,10517996,,
3140,237881,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to chlorambucil|buthionine sulfoximine inhibits the reaction [[KEAP1 gene mutant form results in increased activity of NFE2L2] which results in decreased susceptibility to chlorambucil]|nfe2l2 gene mutant form results in increased susceptibility to chlorambucil,,,PMID:19608619,https://www.ncbi.nlm.nih.gov/pubmed/19608619,19608619,,
3141,238061,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,5277,PIGA,https://ctdbase.org/detail.go?type=gene&acc=5277,,,5277.0,PIGA,10116.0,Rattus norvegicus (Norway rat),Chlorambucil results in increased mutagenesis of PIGA,,,PMID:22923490,https://www.ncbi.nlm.nih.gov/pubmed/22923490,22923490,,
3142,238062,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,5888,RAD51,https://ctdbase.org/detail.go?type=gene&acc=5888,,,5888.0,RAD51,9606.0,Homo sapiens (human),Chlorambucil results in increased expression of RAD51 protein,,,PMID:10473103,https://www.ncbi.nlm.nih.gov/pubmed/10473103,10473103,,
3143,238063,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,2810,SFN,https://ctdbase.org/detail.go?type=gene&acc=2810,,,2810.0,SFN,9606.0,Homo sapiens (human),Chlorambucil results in increased expression of SFN mRNA,,,PMID:18092340,https://www.ncbi.nlm.nih.gov/pubmed/18092340,18092340,,
3144,238064,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,8797,TNFRSF10A,https://ctdbase.org/detail.go?type=gene&acc=8797,,,8797.0,TNFRSF10A,9606.0,Homo sapiens (human),Chlorambucil affects the expression of TNFRSF10A mRNA,,,PMID:14614459,https://www.ncbi.nlm.nih.gov/pubmed/14614459,14614459,,
3145,238065,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606.0,Homo sapiens (human),Chlorambucil affects the expression of TNFRSF10B protein,,,PMID:14614459,https://www.ncbi.nlm.nih.gov/pubmed/14614459,14614459,,
3146,238066,2708,Comparative Toxicogenomics Database (CTD),Chlorambucil,D002699,Chlorambucil,https://ctdbase.org/detail.go?type=chem&acc=D002699,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606.0,Homo sapiens (human),Chlorambucil results in increased expression of TNFRSF10B mrna|chlorambucil results in increased expression of TNFRSF10B protein,,,PMID:18092340,https://www.ncbi.nlm.nih.gov/pubmed/18092340,18092340,,
3147,239437,2710,Comparative Toxicogenomics Database (CTD),Chlorcyclizine,C084597,chlorcyclizine,https://ctdbase.org/detail.go?type=chem&acc=C084597,26471,NUPR1,https://ctdbase.org/detail.go?type=gene&acc=26471,,,26471.0,NUPR1,9606.0,Homo sapiens (human),Chlorcyclizine results in increased expression of NUPR1 mRNA,,,PMID:15342952,https://www.ncbi.nlm.nih.gov/pubmed/15342952,15342952,,
3148,239438,2710,Comparative Toxicogenomics Database (CTD),Chlorcyclizine,C084597,chlorcyclizine,https://ctdbase.org/detail.go?type=chem&acc=C084597,4958,OMD,https://ctdbase.org/detail.go?type=gene&acc=4958,,,4958.0,OMD,10116.0,Rattus norvegicus (Norway rat),Chlorcyclizine results in increased expression of OMD mRNA,,,PMID:21058326,https://www.ncbi.nlm.nih.gov/pubmed/21058326,21058326,,
3149,239624,2710,Comparative Toxicogenomics Database (CTD),Chlorcyclizine,C084597,chlorcyclizine,https://ctdbase.org/detail.go?type=chem&acc=C084597,29767,TMOD2,https://ctdbase.org/detail.go?type=gene&acc=29767,,,29767.0,TMOD2,10116.0,Rattus norvegicus (Norway rat),Chlorcyclizine results in decreased expression of TMOD2 mRNA,,,PMID:21058326,https://www.ncbi.nlm.nih.gov/pubmed/21058326,21058326,,
3150,239625,2710,Comparative Toxicogenomics Database (CTD),Chlorcyclizine,C084597,chlorcyclizine,https://ctdbase.org/detail.go?type=chem&acc=C084597,64102,TNMD,https://ctdbase.org/detail.go?type=gene&acc=64102,,,64102.0,TNMD,10116.0,Rattus norvegicus (Norway rat),Chlorcyclizine results in increased expression of TNMD mRNA,,,PMID:21058326,https://www.ncbi.nlm.nih.gov/pubmed/21058326,21058326,,
3151,239626,2710,Comparative Toxicogenomics Database (CTD),Chlorcyclizine,C084597,chlorcyclizine,https://ctdbase.org/detail.go?type=chem&acc=C084597,7103,TSPAN8,https://ctdbase.org/detail.go?type=gene&acc=7103,,,7103.0,TSPAN8,10116.0,Rattus norvegicus (Norway rat),Chlorcyclizine results in increased expression of TSPAN8 mRNA,,,PMID:21058326,https://www.ncbi.nlm.nih.gov/pubmed/21058326,21058326,,
3152,239996,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1787,TRDMT1,https://ctdbase.org/detail.go?type=gene&acc=1787,,,1787.0,TRDMT1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TRDMT1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3153,239997,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,22041,TRF,https://ctdbase.org/detail.go?type=gene&acc=22041,,,22041.0,Trf,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TRF mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3154,239998,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,7200,TRH,https://ctdbase.org/detail.go?type=gene&acc=7200,,,7200.0,TRH,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in increased expression of TRH mrna|[ethylenethiourea co-treated with chlorpyrifos] results in increased expression of TRH mRNA,,,PMID:32738127,https://www.ncbi.nlm.nih.gov/pubmed/32738127,32738127,,
3155,240180,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,7706,TRIM25,https://ctdbase.org/detail.go?type=gene&acc=7706,,,7706.0,TRIM25,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TRIM25 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3156,240181,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,5987,TRIM27,https://ctdbase.org/detail.go?type=gene&acc=5987,,,5987.0,TRIM27,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TRIM27 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3157,240182,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,10155,TRIM28,https://ctdbase.org/detail.go?type=gene&acc=10155,,,10155.0,TRIM28,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TRIM28 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3158,240183,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,23650,TRIM29,https://ctdbase.org/detail.go?type=gene&acc=23650,,,23650.0,TRIM29,7962.0,Cyprinus carpio (common carp),Chlorpyrifos results in decreased expression of TRIM29 mRNA,,,PMID:28648885,https://www.ncbi.nlm.nih.gov/pubmed/28648885,28648885,,
3159,240337,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,23650,TRIM29,https://ctdbase.org/detail.go?type=gene&acc=23650,,,23650.0,TRIM29,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TRIM29 mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3160,240338,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,10612,TRIM3,https://ctdbase.org/detail.go?type=gene&acc=10612,,,10612.0,TRIM3,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TRIM3 mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3161,240339,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,10612,TRIM3,https://ctdbase.org/detail.go?type=gene&acc=10612,,,10612.0,TRIM3,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TRIM3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3162,240340,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,53840,TRIM34,https://ctdbase.org/detail.go?type=gene&acc=53840,,,53840.0,TRIM34,10116.0,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of TRIM34 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
3163,240341,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,94094,TRIM34A,https://ctdbase.org/detail.go?type=gene&acc=94094,,,94094.0,Trim34a,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TRIM34A mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3164,240342,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,4591,TRIM37,https://ctdbase.org/detail.go?type=gene&acc=4591,,,4591.0,TRIM37,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TRIM37 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3165,240343,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,653192,TRIM43B,https://ctdbase.org/detail.go?type=gene&acc=653192,,,653192.0,TRIM43B,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TRIM43B mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3166,240344,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,80128,TRIM46,https://ctdbase.org/detail.go?type=gene&acc=80128,,,80128.0,TRIM46,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TRIM46 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3167,240345,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,91107,TRIM47,https://ctdbase.org/detail.go?type=gene&acc=91107,,,91107.0,TRIM47,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TRIM47 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3168,240346,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,85363,TRIM5,https://ctdbase.org/detail.go?type=gene&acc=85363,,,85363.0,TRIM5,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TRIM5 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3169,241406,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,353223,TSHBA,https://ctdbase.org/detail.go?type=gene&acc=353223,,,353223.0,tshba,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in increased expression of TSHBA mRNA,,,PMID:32738127,https://www.ncbi.nlm.nih.gov/pubmed/32738127,32738127,,
3170,241407,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,7247,TSN,https://ctdbase.org/detail.go?type=gene&acc=7247,,,7247.0,TSN,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TSN mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3171,241408,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,7247,TSN,https://ctdbase.org/detail.go?type=gene&acc=7247,,,7247.0,TSN,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of TSN mRNA,,,PMID:18668222,https://www.ncbi.nlm.nih.gov/pubmed/18668222,18668222,,
3172,241409,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,23555,TSPAN15,https://ctdbase.org/detail.go?type=gene&acc=23555,,,23555.0,TSPAN15,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TSPAN15 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3173,241410,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,10099,TSPAN3,https://ctdbase.org/detail.go?type=gene&acc=10099,,,10099.0,TSPAN3,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TSPAN3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3174,246082,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,51398,WDR83OS,https://ctdbase.org/detail.go?type=gene&acc=51398,,,51398.0,WDR83OS,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of WDR83OS mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3175,246083,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,112840,WDR89,https://ctdbase.org/detail.go?type=gene&acc=112840,,,112840.0,WDR89,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of WDR89 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3176,246084,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,197335,WDR90,https://ctdbase.org/detail.go?type=gene&acc=197335,,,197335.0,WDR90,7955.0,Danio rerio (zebrafish),[copper co-treated with chlorpyrifos] results in decreased expression of WDR90 mRNA,,,PMID:21356183,https://www.ncbi.nlm.nih.gov/pubmed/21356183,21356183,,
3177,246085,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,151525,WDSUB1,https://ctdbase.org/detail.go?type=gene&acc=151525,,,151525.0,WDSUB1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of WDSUB1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3178,246086,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,23038,WDTC1,https://ctdbase.org/detail.go?type=gene&acc=23038,,,23038.0,WDTC1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of WDTC1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3179,246087,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,7465,WEE1,https://ctdbase.org/detail.go?type=gene&acc=7465,,,7465.0,WEE1,10116.0,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of WEE1 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
3180,246250,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,140686,WFDC3,https://ctdbase.org/detail.go?type=gene&acc=140686,,,140686.0,WFDC3,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of WFDC3 mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3181,246251,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,259240,WFDC9,https://ctdbase.org/detail.go?type=gene&acc=259240,,,259240.0,WFDC9,10116.0,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased methylation of WFDC9 gene,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
3182,248404,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,21408,ZFP354A,https://ctdbase.org/detail.go?type=gene&acc=21408,,,21408.0,Zfp354a,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of ZFP354A mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3183,294728,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [chlorpyrifos results in decreased expression of CTNNB1 protein]|[ag 1879 co-treated with fulvestrant] inhibits the reaction [chlorpyrifos results in decreased expression of and affects the localization of CTNNB1 protein]|chlorpyrifos results in decreased expression of and affects the localization of CTNNB1 protein|ag 1879 inhibits the reaction [chlorpyrifos results in decreased expression of and affects the localization of CTNNB1 protein],,,PMID:32956863,https://www.ncbi.nlm.nih.gov/pubmed/32956863,32956863,,
3184,294918,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Chlorpyrifos affects the expression of CTNNB1 protein,,,PMID:33930485|PMID:34424684,https://www.ncbi.nlm.nih.gov/pubmed/33930485|https://www.ncbi.nlm.nih.gov/pubmed/34424684,33930485|34424684,,
3185,294919,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in increased expression of CTNNB1 mRNA,,,PMID:20691718,https://www.ncbi.nlm.nih.gov/pubmed/20691718,20691718,,
3186,294920,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1500,CTNND1,https://ctdbase.org/detail.go?type=gene&acc=1500,,,1500.0,CTNND1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of CTNND1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3187,294921,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1497,CTNS,https://ctdbase.org/detail.go?type=gene&acc=1497,,,1497.0,CTNS,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of CTNS mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3188,294922,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1504,CTRB1,https://ctdbase.org/detail.go?type=gene&acc=1504,,,1504.0,CTRB1,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in increased expression of CTRB1 mRNA,,,PMID:21356183,https://www.ncbi.nlm.nih.gov/pubmed/21356183,21356183,,
3189,294923,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1506,CTRL,https://ctdbase.org/detail.go?type=gene&acc=1506,,,1506.0,CTRL,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of CTRL mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3190,294924,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,117066,CTS3,https://ctdbase.org/detail.go?type=gene&acc=117066,,,117066.0,Cts3,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of CTS3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3191,295229,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3356,HTR2A,https://ctdbase.org/detail.go?type=gene&acc=3356,,,3356.0,HTR2A,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in increased expression of HTR2A mRNA alternative form,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
3192,295230,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3356,HTR2A,https://ctdbase.org/detail.go?type=gene&acc=3356,,,3356.0,HTR2A,10116.0,Rattus norvegicus (Norway rat),Metformin inhibits the reaction [chlorpyrifos results in increased expression of HTR2A mrna],,,PMID:35448458,https://www.ncbi.nlm.nih.gov/pubmed/35448458,35448458,,
3193,295231,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3357,HTR2B,https://ctdbase.org/detail.go?type=gene&acc=3357,,,3357.0,HTR2B,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of HTR2B mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
3194,295232,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3357,HTR2B,https://ctdbase.org/detail.go?type=gene&acc=3357,,,3357.0,HTR2B,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in increased expression of HTR2B mRNA,,,PMID:18835401,https://www.ncbi.nlm.nih.gov/pubmed/18835401,18835401,,
3195,295233,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3358,HTR2C,https://ctdbase.org/detail.go?type=gene&acc=3358,,,3358.0,HTR2C,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of HTR2C mRNA,,,PMID:18668222,https://www.ncbi.nlm.nih.gov/pubmed/18668222,18668222,,
3196,295414,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3358,HTR2C,https://ctdbase.org/detail.go?type=gene&acc=3358,,,3358.0,HTR2C,10116.0,Rattus norvegicus (Norway rat),FMR1 inhibits the reaction [chlorpyrifos results in increased expression of HTR2C mrna],,,PMID:35802248,https://www.ncbi.nlm.nih.gov/pubmed/35802248,35802248,,
3197,295415,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,9177,HTR3B,https://ctdbase.org/detail.go?type=gene&acc=9177,,,9177.0,HTR3B,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of HTR3B mRNA,,,PMID:18835401,https://www.ncbi.nlm.nih.gov/pubmed/18835401,18835401,,
3198,295416,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,9177,HTR3B,https://ctdbase.org/detail.go?type=gene&acc=9177,,,9177.0,HTR3B,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in increased expression of HTR3B mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
3199,295417,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3361,HTR5A,https://ctdbase.org/detail.go?type=gene&acc=3361,,,3361.0,HTR5A,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of HTR5A mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
3200,295418,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3361,HTR5A,https://ctdbase.org/detail.go?type=gene&acc=3361,,,3361.0,HTR5A,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in increased expression of HTR5A mRNA,,,PMID:18835401,https://www.ncbi.nlm.nih.gov/pubmed/18835401,18835401,,
3201,296588,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6535,SLC6A8,https://ctdbase.org/detail.go?type=gene&acc=6535,,,6535.0,SLC6A8,10090.0,Mus musculus (house mouse),Chlorpyrifos promotes the reaction [hemicholinium 3 binds to SLC6A8 protein],,,PMID:33007016,https://www.ncbi.nlm.nih.gov/pubmed/33007016,33007016,,
3202,296589,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6535,SLC6A8,https://ctdbase.org/detail.go?type=gene&acc=6535,,,6535.0,SLC6A8,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of SLC6A8 mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
3203,296590,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6535,SLC6A8,https://ctdbase.org/detail.go?type=gene&acc=6535,,,6535.0,SLC6A8,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in increased expression of SLC6A8 mRNA,,,PMID:18812211,https://www.ncbi.nlm.nih.gov/pubmed/18812211,18812211,,
3204,296591,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6536,SLC6A9,https://ctdbase.org/detail.go?type=gene&acc=6536,,,6536.0,SLC6A9,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SLC6A9 mRNA,,,PMID:34289071,https://www.ncbi.nlm.nih.gov/pubmed/34289071,34289071,,
3205,298104,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,23676,SMPX,https://ctdbase.org/detail.go?type=gene&acc=23676,,,23676.0,SMPX,10116.0,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased methylation of SMPX gene,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
3206,298105,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6525,SMTN,https://ctdbase.org/detail.go?type=gene&acc=6525,,,6525.0,SMTN,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of SMTN mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3207,298106,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6525,SMTN,https://ctdbase.org/detail.go?type=gene&acc=6525,,,6525.0,SMTN,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SMTN mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3208,298107,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,64750,SMURF2,https://ctdbase.org/detail.go?type=gene&acc=64750,,,64750.0,SMURF2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SMURF2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3209,298108,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,10322,SMYD5,https://ctdbase.org/detail.go?type=gene&acc=10322,,,10322.0,SMYD5,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of SMYD5 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3210,298109,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6591,SNAI2,https://ctdbase.org/detail.go?type=gene&acc=6591,,,6591.0,SNAI2,9606.0,Homo sapiens (human),Chlorpyrifos results in increased expression of and affects the localization of SNAI2 protein,,,PMID:32956863,https://www.ncbi.nlm.nih.gov/pubmed/32956863,32956863,,
3211,298110,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,9342,SNAP29,https://ctdbase.org/detail.go?type=gene&acc=9342,,,9342.0,SNAP29,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of SNAP29 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3212,298401,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,26523,AGO1,https://ctdbase.org/detail.go?type=gene&acc=26523,,,26523.0,AGO1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AGO1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3213,298402,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,10554,AGPAT1,https://ctdbase.org/detail.go?type=gene&acc=10554,,,10554.0,AGPAT1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AGPAT1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3214,298403,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,10555,AGPAT2,https://ctdbase.org/detail.go?type=gene&acc=10555,,,10555.0,AGPAT2,9606.0,Homo sapiens (human),[chlorpyrifos co-treated with 2-chloro-5-nitrobenzanilide] affects the expression of AGPAT2 mRNA,,,PMID:34756920,https://www.ncbi.nlm.nih.gov/pubmed/34756920,34756920,,
3215,298404,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,10555,AGPAT2,https://ctdbase.org/detail.go?type=gene&acc=10555,,,10555.0,AGPAT2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AGPAT2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3216,298405,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,55326,AGPAT5,https://ctdbase.org/detail.go?type=gene&acc=55326,,,55326.0,AGPAT5,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AGPAT5 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3217,298575,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8303,SNN,https://ctdbase.org/detail.go?type=gene&acc=8303,,,8303.0,SNN,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SNN mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3218,298576,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,641451,SNORA19,https://ctdbase.org/detail.go?type=gene&acc=641451,,,641451.0,SNORA19,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of SNORA19 mRNA,,,PMID:18668222,https://www.ncbi.nlm.nih.gov/pubmed/18668222,18668222,,
3219,298577,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,389084,SNORC,https://ctdbase.org/detail.go?type=gene&acc=389084,,,389084.0,SNORC,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SNORC mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3220,298578,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,54861,SNRK,https://ctdbase.org/detail.go?type=gene&acc=54861,,,54861.0,SNRK,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SNRK mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3221,298579,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,393806,SNRKB,https://ctdbase.org/detail.go?type=gene&acc=393806,,,393806.0,snrkb,7955.0,Danio rerio (zebrafish),[copper co-treated with chlorpyrifos] results in increased expression of SNRKB mrna|chlorpyrifos results in increased expression of SNRKB mRNA,,,PMID:21356183,https://www.ncbi.nlm.nih.gov/pubmed/21356183,21356183,,
3222,298580,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,23020,SNRNP200,https://ctdbase.org/detail.go?type=gene&acc=23020,,,23020.0,SNRNP200,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of SNRNP200 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3223,298581,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,23020,SNRNP200,https://ctdbase.org/detail.go?type=gene&acc=23020,,,23020.0,SNRNP200,10116.0,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of SNRNP200 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
3224,298582,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6626,SNRPA,https://ctdbase.org/detail.go?type=gene&acc=6626,,,6626.0,SNRPA,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SNRPA mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3225,299224,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of SOD1 protein|ginsenosides inhibits the reaction [chlorpyrifos results in decreased expression of SOD1 protein],,,PMID:36152060,https://www.ncbi.nlm.nih.gov/pubmed/36152060,36152060,,
3226,299225,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SOD1 mRNA,,,PMID:32602772,https://www.ncbi.nlm.nih.gov/pubmed/32602772,32602772,,
3227,299226,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),Plant extracts inhibits the reaction [[cypermethrin co-treated with chlorpyrifos] results in decreased activity of SOD1 protein]|[cypermethrin co-treated with chlorpyrifos] results in decreased activity of SOD1 protein,,,PMID:15991261,https://www.ncbi.nlm.nih.gov/pubmed/15991261,15991261,,
3228,299227,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10114.0,Rattus,Chlorpyrifos results in increased expression of SOD1 protein,,,PMID:36341877,https://www.ncbi.nlm.nih.gov/pubmed/36341877,36341877,,
3229,299228,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6649,SOD3,https://ctdbase.org/detail.go?type=gene&acc=6649,,,6649.0,SOD3,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of SOD3 mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
3230,299399,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8816,DCAF5,https://ctdbase.org/detail.go?type=gene&acc=8816,,,8816.0,DCAF5,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DCAF5 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3231,299400,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,10238,DCAF7,https://ctdbase.org/detail.go?type=gene&acc=10238,,,10238.0,DCAF7,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of DCAF7 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3232,299401,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,18630,DCAF8L,https://ctdbase.org/detail.go?type=gene&acc=18630,,,18630.0,Dcaf8l,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DCAF8L mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3233,299402,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,79877,DCAKD,https://ctdbase.org/detail.go?type=gene&acc=79877,,,79877.0,DCAKD,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DCAKD mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3234,299704,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,59899.0,Clarias batrachus (walking catfish),Chlorpyrifos results in decreased secretion of ALB protein,,,PMID:27810534,https://www.ncbi.nlm.nih.gov/pubmed/27810534,27810534,,
3235,299705,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of ALB mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3236,299878,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,7915,ALDH5A1,https://ctdbase.org/detail.go?type=gene&acc=7915,,,7915.0,ALDH5A1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of ALDH5A1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3237,299879,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,501,ALDH7A1,https://ctdbase.org/detail.go?type=gene&acc=501,,,501.0,ALDH7A1,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of ALDH7A1 mRNA,,,PMID:20691718,https://www.ncbi.nlm.nih.gov/pubmed/20691718,20691718,,
3238,299880,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,501,ALDH7A1,https://ctdbase.org/detail.go?type=gene&acc=501,,,501.0,ALDH7A1,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in increased expression of ALDH7A1 protein,,,PMID:34058248,https://www.ncbi.nlm.nih.gov/pubmed/34058248,34058248,,
3239,299881,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,64577,ALDH8A1,https://ctdbase.org/detail.go?type=gene&acc=64577,,,64577.0,ALDH8A1,9606.0,Homo sapiens (human),Chlorpyrifos results in decreased expression of ALDH8A1 mRNA,,,PMID:25424538,https://www.ncbi.nlm.nih.gov/pubmed/25424538,25424538,,
3240,300090,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1650,DDOST,https://ctdbase.org/detail.go?type=gene&acc=1650,,,1650.0,DDOST,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DDOST mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3241,300091,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,780,DDR1,https://ctdbase.org/detail.go?type=gene&acc=780,,,780.0,DDR1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DDR1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3242,300092,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,4921,DDR2,https://ctdbase.org/detail.go?type=gene&acc=4921,,,4921.0,DDR2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DDR2 mRNA,,,PMID:34289071,https://www.ncbi.nlm.nih.gov/pubmed/34289071,34289071,,
3243,300093,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,65992,DDRGK1,https://ctdbase.org/detail.go?type=gene&acc=65992,,,65992.0,DDRGK1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DDRGK1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3244,300094,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1652,DDT,https://ctdbase.org/detail.go?type=gene&acc=1652,,,1652.0,DDT,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DDT mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3245,300095,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1653,DDX1,https://ctdbase.org/detail.go?type=gene&acc=1653,,,1653.0,DDX1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of DDX1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3246,300238,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,347902,AMIGO2,https://ctdbase.org/detail.go?type=gene&acc=347902,,,347902.0,AMIGO2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of AMIGO2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3247,300239,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,386724,AMIGO3,https://ctdbase.org/detail.go?type=gene&acc=386724,,,386724.0,AMIGO3,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AMIGO3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3248,300240,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,386724,AMIGO3,https://ctdbase.org/detail.go?type=gene&acc=386724,,,386724.0,AMIGO3,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in increased expression of AMIGO3 mRNA,,,PMID:20691718,https://www.ncbi.nlm.nih.gov/pubmed/20691718,20691718,,
3249,300779,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8562,DENR,https://ctdbase.org/detail.go?type=gene&acc=8562,,,8562.0,DENR,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of DENR mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3250,301118,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,311,ANXA11,https://ctdbase.org/detail.go?type=gene&acc=311,,,311.0,ANXA11,10116.0,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of ANXA11 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
3251,301119,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,353358,ANXA1B,https://ctdbase.org/detail.go?type=gene&acc=353358,,,353358.0,anxa1b,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in increased expression of ANXA1B mRNA,,,PMID:28391457,https://www.ncbi.nlm.nih.gov/pubmed/28391457,28391457,,
3252,301120,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,494158,ANXA1C,https://ctdbase.org/detail.go?type=gene&acc=494158,,,494158.0,anxa1c,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in decreased expression of ANXA1C mRNA,,,PMID:21356183,https://www.ncbi.nlm.nih.gov/pubmed/21356183,21356183,,
3253,301121,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,302,ANXA2,https://ctdbase.org/detail.go?type=gene&acc=302,,,302.0,ANXA2,7962.0,Cyprinus carpio (common carp),Chlorpyrifos results in increased expression of ANXA2 mRNA,,,PMID:28648885,https://www.ncbi.nlm.nih.gov/pubmed/28648885,28648885,,
3254,301122,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,302,ANXA2,https://ctdbase.org/detail.go?type=gene&acc=302,,,302.0,ANXA2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of ANXA2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3255,301314,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,316,AOX1,https://ctdbase.org/detail.go?type=gene&acc=316,,,316.0,AOX1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AOX1 mRNA,,,PMID:32955216|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/32955216|https://www.ncbi.nlm.nih.gov/pubmed/37019170,32955216|37019170,,
3256,301315,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,162,AP1B1,https://ctdbase.org/detail.go?type=gene&acc=162,,,162.0,AP1B1,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of AP1B1 mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
3257,301316,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,164,AP1G1,https://ctdbase.org/detail.go?type=gene&acc=164,,,164.0,AP1G1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of AP1G1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3258,301450,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6712,SPTBN2,https://ctdbase.org/detail.go?type=gene&acc=6712,,,6712.0,SPTBN2,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of SPTBN2 protein,,,PMID:34058248,https://www.ncbi.nlm.nih.gov/pubmed/34058248,34058248,,
3259,301451,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,10558,SPTLC1,https://ctdbase.org/detail.go?type=gene&acc=10558,,,10558.0,SPTLC1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of SPTLC1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3260,301452,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,9606.0,Homo sapiens (human),Chlorpyrifos results in increased expression of SQLE mRNA,,,PMID:25424538,https://www.ncbi.nlm.nih.gov/pubmed/25424538,25424538,,
3261,301453,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of SQLE mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3262,301454,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10090.0,Mus musculus (house mouse),Chlorpyrifos affects the expression of SQSTM1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3263,301455,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in increased expression of SQSTM1 protein|stat1 protein affects the reaction [chlorpyrifos results in increased expression of SQSTM1 protein],,,PMID:29859868,https://www.ncbi.nlm.nih.gov/pubmed/29859868,29859868,,
3264,301456,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SRC mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3265,301457,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,80725,SRCIN1,https://ctdbase.org/detail.go?type=gene&acc=80725,,,80725.0,SRCIN1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of SRCIN1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3266,301458,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6716,SRD5A2,https://ctdbase.org/detail.go?type=gene&acc=6716,,,6716.0,SRD5A2,10116.0,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased methylation of SRD5A2 gene,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
3267,303845,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6821,SUOX,https://ctdbase.org/detail.go?type=gene&acc=6821,,,6821.0,SUOX,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SUOX mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3268,303846,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,114741,SUPT16,https://ctdbase.org/detail.go?type=gene&acc=114741,,,114741.0,Supt16,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of SUPT16 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3269,303847,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,56241,SUSD2,https://ctdbase.org/detail.go?type=gene&acc=56241,,,56241.0,SUSD2,10116.0,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of SUSD2 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
3270,303848,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,203328,SUSD3,https://ctdbase.org/detail.go?type=gene&acc=203328,,,203328.0,SUSD3,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of SUSD3 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3271,304038,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,51514,DTL,https://ctdbase.org/detail.go?type=gene&acc=51514,,,51514.0,DTL,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of DTL mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3272,304039,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1837,DTNA,https://ctdbase.org/detail.go?type=gene&acc=1837,,,1837.0,DTNA,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DTNA mRNA,,,PMID:34289071,https://www.ncbi.nlm.nih.gov/pubmed/34289071,34289071,,
3273,304040,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,1838,DTNB,https://ctdbase.org/detail.go?type=gene&acc=1838,,,1838.0,DTNB,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of DTNB mRNA,,,PMID:18668222,https://www.ncbi.nlm.nih.gov/pubmed/18668222,18668222,,
3274,304041,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,113878,DTX2,https://ctdbase.org/detail.go?type=gene&acc=113878,,,113878.0,DTX2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of DTX2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3275,304185,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,7955.0,Danio rerio (zebrafish),Chlorpyrifos results in increased expression of ATF3 mRNA,,,PMID:21356183,https://www.ncbi.nlm.nih.gov/pubmed/21356183,21356183,,
3276,304186,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of ATF3 mRNA,,,PMID:34289071|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34289071|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34289071|37019170,,
3277,304187,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,10090.0,Mus musculus (house mouse),BBC3 gene mutant form promotes the reaction [chlorpyrifos results in increased expression of ATF4 protein],,,PMID:34289071,https://www.ncbi.nlm.nih.gov/pubmed/34289071,34289071,,
3278,304188,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of ATF4 mRNA,,,PMID:34289071|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34289071|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34289071|37019170,,
3279,304189,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,22809,ATF5,https://ctdbase.org/detail.go?type=gene&acc=22809,,,22809.0,ATF5,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of ATF5 mRNA,,,PMID:34289071|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34289071|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34289071|37019170,,
3280,304190,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of ATF6 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3281,305854,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,25771,TBC1D22A,https://ctdbase.org/detail.go?type=gene&acc=25771,,,25771.0,TBC1D22A,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TBC1D22A mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3282,305855,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,55773,TBC1D23,https://ctdbase.org/detail.go?type=gene&acc=55773,,,55773.0,TBC1D23,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TBC1D23 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3283,305856,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,23329,TBC1D30,https://ctdbase.org/detail.go?type=gene&acc=23329,,,23329.0,TBC1D30,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TBC1D30 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3284,305857,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,93594,TBC1D31,https://ctdbase.org/detail.go?type=gene&acc=93594,,,93594.0,TBC1D31,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TBC1D31 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3285,305858,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,221322,TBC1D32,https://ctdbase.org/detail.go?type=gene&acc=221322,,,221322.0,TBC1D32,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of TBC1D32 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3286,305859,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,9882,TBC1D4,https://ctdbase.org/detail.go?type=gene&acc=9882,,,9882.0,TBC1D4,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TBC1D4 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3287,305860,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,51256,TBC1D7,https://ctdbase.org/detail.go?type=gene&acc=51256,,,51256.0,TBC1D7,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TBC1D7 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3288,305861,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,55171,TBCCD1,https://ctdbase.org/detail.go?type=gene&acc=55171,,,55171.0,TBCCD1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of TBCCD1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3289,306177,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Chlorpyrifos results in increased expression of BAX mRNA,,,PMID:30981936,https://www.ncbi.nlm.nih.gov/pubmed/30981936,30981936,,
3290,306178,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),[atrazine co-treated with chlorpyrifos co-treated with endosulfan] results in decreased expression of BAX protein|chlorpyrifos results in decreased expression of BAX protein,,,PMID:22515965,https://www.ncbi.nlm.nih.gov/pubmed/22515965,22515965,,
3291,306179,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Chlorpyrifos affects the expression of BAX protein,,,PMID:30378422,https://www.ncbi.nlm.nih.gov/pubmed/30378422,30378422,,
3292,306180,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of BAX mRNA,,,PMID:27737797|PMID:33349080|PMID:36152060|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/27737797|https://www.ncbi.nlm.nih.gov/pubmed/33349080|https://www.ncbi.nlm.nih.gov/pubmed/36152060|https://www.ncbi.nlm.nih.gov/pubmed/37019170,27737797|33349080|36152060|37019170,,
3293,306181,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of BAX protein,,,PMID:32120800|PMID:36811218,https://www.ncbi.nlm.nih.gov/pubmed/32120800|https://www.ncbi.nlm.nih.gov/pubmed/36811218,32120800|36811218,,
3294,306182,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Ginsenoside rg1 inhibits the reaction [chlorpyrifos results in increased expression of BAX protein],,,PMID:36811218,https://www.ncbi.nlm.nih.gov/pubmed/36811218,36811218,,
3295,306183,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Ginsenosides inhibits the reaction [chlorpyrifos results in increased expression of BAX mrna],,,PMID:36152060,https://www.ncbi.nlm.nih.gov/pubmed/36152060,36152060,,
3296,306184,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Plant extracts inhibits the reaction [chlorpyrifos results in increased expression of BAX protein]|polyphenols inhibits the reaction [chlorpyrifos results in increased expression of BAX protein],,,PMID:32120800,https://www.ncbi.nlm.nih.gov/pubmed/32120800,32120800,,
3297,306185,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),3-(indol-3-yl)propionic acid inhibits the reaction [chlorpyrifos results in increased expression of BAX protein],,,PMID:34678318,https://www.ncbi.nlm.nih.gov/pubmed/34678318,34678318,,
3298,306543,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,9606.0,Homo sapiens (human),[[chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with glyphosate] results in decreased susceptibility to cisplatin] which results in decreased expression of BBC3 mrna|[[chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with glyphosate] results in decreased susceptibility to temozolomide] which results in decreased expression of BBC3 mrna|[[chlorpyrifos co-treated with decamethrin co-treated with polymarcine co-treated with glyphosate] results in decreased susceptibility to fluorouracil] which results in decreased expression of BBC3 mRNA,,,PMID:32800223,https://www.ncbi.nlm.nih.gov/pubmed/32800223,32800223,,
3299,306544,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,10090.0,Mus musculus (house mouse),BBC3 gene mutant form results in decreased susceptibility to chlorpyrifos|chlorpyrifos results in increased expression of BBC3 protein|bbc3 gene mutant form inhibits the reaction [chlorpyrifos results in increased expression of TRP53 mrna]|bbc3 gene mutant form promotes the reaction [chlorpyrifos results in increased expression of ATF4 protein]|bbc3 gene mutant form inhibits the reaction [chlorpyrifos results in increased expression of PMAIP1 mrna]|bbc3 gene mutant form promotes the reaction [chlorpyrifos results in increased expression of DDIT3 mrna]|bbc3 gene mutant form promotes the reaction [chlorpyrifos results in increased expression of DDIT3 protein]|bbc3 gene mutant form inhibits the reaction [chlorpyrifos results in increased phosphorylation of and results in increased expression of MAPT protein]|bbc3 gene mutant form inhibits the reaction [chlorpyrifos results in increased cleavage of CASP3 protein],,,PMID:34289071,https://www.ncbi.nlm.nih.gov/pubmed/34289071,34289071,,
3300,306545,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of BBC3 mRNA,,,PMID:30378422|PMID:34289071|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/30378422|https://www.ncbi.nlm.nih.gov/pubmed/34289071|https://www.ncbi.nlm.nih.gov/pubmed/37019170,30378422|34289071|37019170,,
3301,306546,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8424,BBOX1,https://ctdbase.org/detail.go?type=gene&acc=8424,,,8424.0,BBOX1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of BBOX1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3302,306547,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,582,BBS1,https://ctdbase.org/detail.go?type=gene&acc=582,,,582.0,BBS1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of BBS1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3303,306548,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,79738,BBS10,https://ctdbase.org/detail.go?type=gene&acc=79738,,,79738.0,BBS10,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of BBS10 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3304,306549,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,166379,BBS12,https://ctdbase.org/detail.go?type=gene&acc=166379,,,166379.0,BBS12,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of BBS12 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3305,306550,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,583,BBS2,https://ctdbase.org/detail.go?type=gene&acc=583,,,583.0,BBS2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of BBS2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3306,350616,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Chlorpyrifos results in decreased expression of IL1B mRNA,,,PMID:26948828,https://www.ncbi.nlm.nih.gov/pubmed/26948828,26948828,,
3307,352751,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3654,IRAK1,https://ctdbase.org/detail.go?type=gene&acc=3654,,,3654.0,IRAK1,143606.0,Gobiocypris rarus,Chlorpyrifos results in increased expression of IRAK1 mRNA,,,PMID:29427811,https://www.ncbi.nlm.nih.gov/pubmed/29427811,29427811,,
3308,352752,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,134728,IRAK1BP1,https://ctdbase.org/detail.go?type=gene&acc=134728,,,134728.0,IRAK1BP1,10116.0,Rattus norvegicus (Norway rat),Chlorpyrifos results in decreased expression of IRAK1BP1 mRNA,,,PMID:18668222,https://www.ncbi.nlm.nih.gov/pubmed/18668222,18668222,,
3309,352753,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3656,IRAK2,https://ctdbase.org/detail.go?type=gene&acc=3656,,,3656.0,IRAK2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of IRAK2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3310,352754,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,51135,IRAK4,https://ctdbase.org/detail.go?type=gene&acc=51135,,,51135.0,IRAK4,7962.0,Cyprinus carpio (common carp),Chlorpyrifos results in increased expression of IRAK4 mRNA,,,PMID:31479757,https://www.ncbi.nlm.nih.gov/pubmed/31479757,31479757,,
3311,352755,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3659,IRF1,https://ctdbase.org/detail.go?type=gene&acc=3659,,,3659.0,IRF1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of IRF1 mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3312,352756,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,26145,IRF2BP1,https://ctdbase.org/detail.go?type=gene&acc=26145,,,26145.0,IRF2BP1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of IRF2BP1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3313,352757,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,359948,IRF2BP2,https://ctdbase.org/detail.go?type=gene&acc=359948,,,359948.0,IRF2BP2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of IRF2BP2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3314,352758,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,359948,IRF2BP2,https://ctdbase.org/detail.go?type=gene&acc=359948,,,359948.0,IRF2BP2,10116.0,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of IRF2BP2 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
3315,352759,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,64207,IRF2BPL,https://ctdbase.org/detail.go?type=gene&acc=64207,,,64207.0,IRF2BPL,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of IRF2BPL mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3316,353195,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3673,ITGA2,https://ctdbase.org/detail.go?type=gene&acc=3673,,,3673.0,ITGA2,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of ITGA2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3317,353196,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3678,ITGA5,https://ctdbase.org/detail.go?type=gene&acc=3678,,,3678.0,ITGA5,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of ITGA5 protein|chlorpyrifos results in decreased expression of ITGA5 mRNA,,,PMID:32440878,https://www.ncbi.nlm.nih.gov/pubmed/32440878,32440878,,
3318,353197,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3678,ITGA5,https://ctdbase.org/detail.go?type=gene&acc=3678,,,3678.0,ITGA5,10090.0,Mus musculus (house mouse),Chlorpyrifos results in increased expression of ITGA5 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3319,353198,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,8516,ITGA8,https://ctdbase.org/detail.go?type=gene&acc=8516,,,8516.0,ITGA8,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of ITGA8 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3320,353847,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,150771,ITPRIPL1,https://ctdbase.org/detail.go?type=gene&acc=150771,,,150771.0,ITPRIPL1,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of ITPRIPL1 mRNA,,,PMID:32715474,https://www.ncbi.nlm.nih.gov/pubmed/32715474,32715474,,
3321,353848,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,6453,ITSN1,https://ctdbase.org/detail.go?type=gene&acc=6453,,,6453.0,ITSN1,10090.0,Mus musculus (house mouse),Chlorpyrifos affects the expression of ITSN1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3322,356151,2730,Comparative Toxicogenomics Database (CTD),Chlorpyrifos,D004390,Chlorpyrifos,https://ctdbase.org/detail.go?type=chem&acc=D004390,3799,KIF5B,https://ctdbase.org/detail.go?type=gene&acc=3799,,,3799.0,KIF5B,10090.0,Mus musculus (house mouse),Chlorpyrifos results in decreased expression of KIF5B mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
3323,230553,2758,Comparative Toxicogenomics Database (CTD),Eucalyptol,D000077591,Eucalyptol,https://ctdbase.org/detail.go?type=chem&acc=D000077591,2017,CTTN,https://ctdbase.org/detail.go?type=gene&acc=2017,,,2017.0,CTTN,10090.0,Mus musculus (house mouse),Eucalyptol inhibits the reaction [glucose results in decreased expression of CTTN protein]|eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of CTTN protein],,,PMID:31483951,https://www.ncbi.nlm.nih.gov/pubmed/31483951,31483951,,
3324,231207,2758,Comparative Toxicogenomics Database (CTD),Eucalyptol,D000077591,Eucalyptol,https://ctdbase.org/detail.go?type=chem&acc=D000077591,4586,MUC5AC,https://ctdbase.org/detail.go?type=gene&acc=4586,,,4586.0,MUC5AC,10116.0,Rattus norvegicus (Norway rat),Eucalyptol inhibits the reaction [tobacco smoke pollution results in increased expression of MUC5AC mrna]|eucalyptol inhibits the reaction [tobacco smoke pollution results in increased expression of MUC5AC protein],,,PMID:29215731,https://www.ncbi.nlm.nih.gov/pubmed/29215731,29215731,,
3325,231208,2758,Comparative Toxicogenomics Database (CTD),Eucalyptol,D000077591,Eucalyptol,https://ctdbase.org/detail.go?type=chem&acc=D000077591,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606.0,Homo sapiens (human),Eucalyptol results in decreased expression of MYC mRNA,,,PMID:36331666,https://www.ncbi.nlm.nih.gov/pubmed/36331666,36331666,,
3326,231209,2758,Comparative Toxicogenomics Database (CTD),Eucalyptol,D000077591,Eucalyptol,https://ctdbase.org/detail.go?type=chem&acc=D000077591,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Eucalyptol inhibits the reaction [lipopolysaccharides inhibits the reaction [RELA protein binds to NFKBIA protein]]|eucalyptol inhibits the reaction [lipopolysaccharides affects the expression of NFKBIA protein],,,PMID:23872422,https://www.ncbi.nlm.nih.gov/pubmed/23872422,23872422,,
3327,231210,2758,Comparative Toxicogenomics Database (CTD),Eucalyptol,D000077591,Eucalyptol,https://ctdbase.org/detail.go?type=chem&acc=D000077591,8013,NR4A3,https://ctdbase.org/detail.go?type=gene&acc=8013,,,8013.0,NR4A3,9606.0,Homo sapiens (human),Eucalyptol results in decreased expression of NR4A3 mRNA,,,PMID:36331666,https://www.ncbi.nlm.nih.gov/pubmed/36331666,36331666,,
3328,296428,2767,DrugBank,cis-Diaminedichloroplatinum,DB00515,Cisplatin,https://www.drugbank.ca/drugs/DB00515,BE0003549,Cytochrome P450 2B6,https://www.drugbank.ca/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),Inhibitor,,,PMID:19378397|PMID:17101742,https://www.ncbi.nlm.nih.gov/pubmed/19378397|https://www.ncbi.nlm.nih.gov/pubmed/17101742,19378397|17101742,,
3329,296429,2767,DrugBank,cis-Diaminedichloroplatinum,DB00515,Cisplatin,https://www.drugbank.ca/drugs/DB00515,BE0002180,Cholinesterase,https://www.drugbank.ca/bio_entities/BE0002180,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),Inhibitor,,,PMID:20417682,https://www.ncbi.nlm.nih.gov/pubmed/20417682,20417682,,
3330,296430,2767,DrugBank,cis-Diaminedichloroplatinum,DB00515,Cisplatin,https://www.drugbank.ca/drugs/DB00515,BE0000818,Glutathione S-transferase theta-1,https://www.drugbank.ca/bio_entities/BE0000818,P30711,Glutathione S-transferase theta-1,2952.0,GSTT1,9606.0,Homo sapiens (human),Substrate,,,PMID:11081456,https://www.ncbi.nlm.nih.gov/pubmed/11081456,11081456,,
3331,296431,2767,DrugBank,cis-Diaminedichloroplatinum,DB00515,Cisplatin,https://www.drugbank.ca/drugs/DB00515,BE0004778,Metallothionein-1A,https://www.drugbank.ca/bio_entities/BE0004778,P04731,Metallothionein-1A,4489.0,MT1A,9606.0,Homo sapiens (human),Substrate,,,PMID:10709094,https://www.ncbi.nlm.nih.gov/pubmed/10709094,10709094,,
3332,296432,2767,DrugBank,cis-Diaminedichloroplatinum,DB00515,Cisplatin,https://www.drugbank.ca/drugs/DB00515,BE0004779,Metallothionein-2,https://www.drugbank.ca/bio_entities/BE0004779,P02795,Metallothionein-2,4502.0,MT2A,9606.0,Homo sapiens (human),Substrate,,,PMID:10709094,https://www.ncbi.nlm.nih.gov/pubmed/10709094,10709094,,
3333,296433,2767,DrugBank,cis-Diaminedichloroplatinum,DB00515,Cisplatin,https://www.drugbank.ca/drugs/DB00515,BE0002390,Superoxide dismutase [Cu-Zn],https://www.drugbank.ca/bio_entities/BE0002390,P00441,Superoxide dismutase [Cu-Zn],6647.0,SOD1,9606.0,Homo sapiens (human),Substrate,,,,,,,
3334,296434,2767,DrugBank,cis-Diaminedichloroplatinum,DB00515,Cisplatin,https://www.drugbank.ca/drugs/DB00515,BE0000814,Glutathione S-transferase P,https://www.drugbank.ca/bio_entities/BE0000814,P09211,Glutathione S-transferase P,2950.0,GSTP1,9606.0,Homo sapiens (human),Substrate,,,PMID:11081456,https://www.ncbi.nlm.nih.gov/pubmed/11081456,11081456,,
3335,296915,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,80824,DUSP16,https://ctdbase.org/detail.go?type=gene&acc=80824,,,80824.0,DUSP16,10090.0,Mus musculus (house mouse),PPARA affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of DUSP16 mrna]|[clofibrate co-treated with acetaminophen] affects the expression of DUSP16 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3336,296916,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1892,ECHS1,https://ctdbase.org/detail.go?type=gene&acc=1892,,,1892.0,ECHS1,10116.0,Rattus norvegicus (Norway rat),Clofibrate results in increased expression of ECHS1 protein,,,PMID:16470657,https://www.ncbi.nlm.nih.gov/pubmed/16470657,16470657,,
3337,296917,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1848,DUSP6,https://ctdbase.org/detail.go?type=gene&acc=1848,,,1848.0,DUSP6,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of DUSP6 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of DUSP6 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3338,296918,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1850,DUSP8,https://ctdbase.org/detail.go?type=gene&acc=1850,,,1850.0,DUSP8,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of DUSP8 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of DUSP8 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3339,296919,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,1852,DUSP9,https://ctdbase.org/detail.go?type=gene&acc=1852,,,1852.0,DUSP9,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of DUSP9 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3340,296920,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,140735,DYNLL2,https://ctdbase.org/detail.go?type=gene&acc=140735,,,140735.0,DYNLL2,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of DYNLL2 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
3341,299078,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053.0,EPHX2,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of EPHX2 mrna|clofibrate results in increased expression of EPHX2 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of EPHX2 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3342,299079,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053.0,EPHX2,10090.0,Mus musculus (house mouse),Clofibrate results in increased activity of EPHX2 protein,,,PMID:3621371,https://www.ncbi.nlm.nih.gov/pubmed/3621371,3621371,,
3343,302814,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2584,GALK1,https://ctdbase.org/detail.go?type=gene&acc=2584,,,2584.0,GALK1,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of GALK1 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of GALK1 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3344,302815,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2590,GALNT2,https://ctdbase.org/detail.go?type=gene&acc=2590,,,2590.0,GALNT2,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GALNT2 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3345,302816,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2590,GALNT2,https://ctdbase.org/detail.go?type=gene&acc=2590,,,2590.0,GALNT2,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of GALNT2 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
3346,302817,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,8484,GALR3,https://ctdbase.org/detail.go?type=gene&acc=8484,,,8484.0,GALR3,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GALR3 mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3347,302818,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2593,GAMT,https://ctdbase.org/detail.go?type=gene&acc=2593,,,2593.0,GAMT,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GAMT mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3348,302819,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2593,GAMT,https://ctdbase.org/detail.go?type=gene&acc=2593,,,2593.0,GAMT,10116.0,Rattus norvegicus (Norway rat),Clofibrate affects the expression of GAMT mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
3349,302820,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,10116.0,Rattus norvegicus (Norway rat),Clofibrate affects the expression of GAPDH mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
3350,303006,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2627,GATA6,https://ctdbase.org/detail.go?type=gene&acc=2627,,,2627.0,GATA6,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GATA6 mrna|[clofibrate co-treated with acetaminophen] affects the expression of GATA6 mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of GATA6 mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3351,303007,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,54815,GATAD2A,https://ctdbase.org/detail.go?type=gene&acc=54815,,,54815.0,GATAD2A,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GATAD2A mRNA,,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3352,303008,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2628,GATM,https://ctdbase.org/detail.go?type=gene&acc=2628,,,2628.0,GATM,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of GATM mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of GATM mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3353,303009,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,57704,GBA2,https://ctdbase.org/detail.go?type=gene&acc=57704,,,57704.0,GBA2,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GBA2 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
3354,303010,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2632,GBE1,https://ctdbase.org/detail.go?type=gene&acc=2632,,,2632.0,GBE1,10116.0,Rattus norvegicus (Norway rat),Clofibrate affects the expression of GBE1 mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
3355,303011,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2638,GC,https://ctdbase.org/detail.go?type=gene&acc=2638,,,2638.0,GC,10116.0,Rattus norvegicus (Norway rat),Clofibrate results in decreased expression of GC mRNA,,,PMID:12851107,https://www.ncbi.nlm.nih.gov/pubmed/12851107,12851107,,
3356,303012,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2641,GCG,https://ctdbase.org/detail.go?type=gene&acc=2641,,,2641.0,GCG,9606.0,Homo sapiens (human),Clofibrate affects the secretion of GCG protein,,,PMID:1143089,https://www.ncbi.nlm.nih.gov/pubmed/1143089,1143089,,
3357,303013,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2643,GCH1,https://ctdbase.org/detail.go?type=gene&acc=2643,,,2643.0,GCH1,10090.0,Mus musculus (house mouse),Clofibrate results in decreased expression of GCH1 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
3358,303014,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2644,GCHFR,https://ctdbase.org/detail.go?type=gene&acc=2644,,,2644.0,GCHFR,10116.0,Rattus norvegicus (Norway rat),Clofibrate affects the expression of GCHFR mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
3359,303015,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2645,GCK,https://ctdbase.org/detail.go?type=gene&acc=2645,,,2645.0,GCK,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of GCK mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of GCK mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3360,304666,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2934,GSN,https://ctdbase.org/detail.go?type=gene&acc=2934,,,2934.0,GSN,34765.0,Oikopleura dioica,Clofibrate results in decreased expression of GSN mRNA,,,PMID:22300585,https://www.ncbi.nlm.nih.gov/pubmed/22300585,22300585,,
3361,304667,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,37273.0,Gambusia holbrooki (eastern mosquitofish),Clofibrate results in decreased activity of GSR protein,,,PMID:18243307,https://www.ncbi.nlm.nih.gov/pubmed/18243307,18243307,,
3362,304668,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2937,GSS,https://ctdbase.org/detail.go?type=gene&acc=2937,,,2937.0,GSS,10090.0,Mus musculus (house mouse),[clofibrate co-treated with acetaminophen] affects the expression of GSS mrna|ppara affects the reaction [[clofibrate co-treated with acetaminophen] affects the expression of GSS mrna],,,PMID:17585979,https://www.ncbi.nlm.nih.gov/pubmed/17585979,17585979,,
3363,304669,2796,Comparative Toxicogenomics Database (CTD),Clofibrate,D002994,Clofibrate,https://ctdbase.org/detail.go?type=chem&acc=D002994,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,10090.0,Mus musculus (house mouse),Clofibrate results in increased expression of GSTA1 mrna|ppara protein affects the reaction [clofibrate results in increased expression of GSTA1 mrna],,,PMID:22496397,https://www.ncbi.nlm.nih.gov/pubmed/22496397,22496397,,
3364,297081,2803,DrugBank,Clonidine,DB00575,Clonidine,https://www.drugbank.ca/drugs/DB00575,BE0002433,Cytochrome P450 1A2,https://www.drugbank.ca/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606.0,Homo sapiens (human),Substrate,,,PMID:20570945,https://www.ncbi.nlm.nih.gov/pubmed/20570945,20570945,,
3365,297082,2803,DrugBank,Clonidine,DB00575,Clonidine,https://www.drugbank.ca/drugs/DB00575,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606.0,Homo sapiens (human),Substrate,,,PMID:20570945,https://www.ncbi.nlm.nih.gov/pubmed/20570945,20570945,,
3366,297083,2803,DrugBank,Clonidine,DB00575,Clonidine,https://www.drugbank.ca/drugs/DB00575,BE0003543,Cytochrome P450 1A1,https://www.drugbank.ca/bio_entities/BE0003543,P04798,Cytochrome P450 1A1,1543.0,CYP1A1,9606.0,Homo sapiens (human),Substrate,,,PMID:20570945,https://www.ncbi.nlm.nih.gov/pubmed/20570945,20570945,,
3367,297084,2803,DrugBank,Clonidine,DB00575,Clonidine,https://www.drugbank.ca/drugs/DB00575,BE0002362,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0002362,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606.0,Homo sapiens (human),Substrate,,,PMID:20570945,https://www.ncbi.nlm.nih.gov/pubmed/20570945,20570945,,
3368,297085,2803,DrugBank,Clonidine,DB00575,Clonidine,https://www.drugbank.ca/drugs/DB00575,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606.0,Homo sapiens (human),Substrate,,,PMID:20570945,https://www.ncbi.nlm.nih.gov/pubmed/20570945,20570945,,
3369,297086,2803,DrugBank,Clonidine,DB00575,Clonidine,https://www.drugbank.ca/drugs/DB00575,BE0003650,Solute carrier family 22 member 3,https://www.drugbank.ca/bio_entities/BE0003650,O75751,Solute carrier family 22 member 3,6581.0,SLC22A3,9606.0,Homo sapiens (human),Inhibitor,,,PMID:10966924|PMID:11191835,https://www.ncbi.nlm.nih.gov/pubmed/10966924|https://www.ncbi.nlm.nih.gov/pubmed/11191835,10966924|11191835,,
3370,297087,2803,DrugBank,Clonidine,DB00575,Clonidine,https://www.drugbank.ca/drugs/DB00575,BE0000106,Solute carrier family 22 member 5,https://www.drugbank.ca/bio_entities/BE0000106,O76082,Solute carrier family 22 member 5,6584.0,SLC22A5,9606.0,Homo sapiens (human),Inhibitor,,,PMID:10525100|PMID:10454528,https://www.ncbi.nlm.nih.gov/pubmed/10525100|https://www.ncbi.nlm.nih.gov/pubmed/10454528,10525100|10454528,,
3371,297088,2803,DrugBank,Clonidine,DB00575,Clonidine,https://www.drugbank.ca/drugs/DB00575,BE0000757,Solute carrier family 22 member 4,https://www.drugbank.ca/bio_entities/BE0000757,Q9H015,Solute carrier family 22 member 4,6583.0,SLC22A4,9606.0,Homo sapiens (human),Inhibitor,,,PMID:10215651,https://www.ncbi.nlm.nih.gov/pubmed/10215651,10215651,,
3372,232059,2812,Toxin and Toxin Target Database (T3DB),Clotrimazole,T3D2729,Clotrimazole,http://www.t3db.ca/toxins/T3D2729,BE0002793,Cytochrome P450 2C9,http://www.t3db.ca/biodb/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
3373,232060,2812,Toxin and Toxin Target Database (T3DB),Clotrimazole,T3D2729,Clotrimazole,http://www.t3db.ca/toxins/T3D2729,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
3374,232061,2812,Toxin and Toxin Target Database (T3DB),Clotrimazole,T3D2729,Clotrimazole,http://www.t3db.ca/toxins/T3D2729,BE0003536,Cytochrome P450 2C19,http://www.t3db.ca/biodb/bio_entities/BE0003536,P33261,Cytochrome P450 2C19,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
3375,232062,2812,Toxin and Toxin Target Database (T3DB),Clotrimazole,T3D2729,Clotrimazole,http://www.t3db.ca/toxins/T3D2729,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
3376,232063,2812,Toxin and Toxin Target Database (T3DB),Clotrimazole,T3D2729,Clotrimazole,http://www.t3db.ca/toxins/T3D2729,BE0002363,Cytochrome P450 2D6,http://www.t3db.ca/biodb/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
3377,232064,2812,Toxin and Toxin Target Database (T3DB),Clotrimazole,T3D2729,Clotrimazole,http://www.t3db.ca/toxins/T3D2729,BE0005490,Nuclear factor erythroid 2-related factor 2,http://www.t3db.ca/biodb/bio_entities/BE0005490,Q16236,Nuclear factor erythroid 2-related factor 2,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
3378,232065,2818,BindingDB,,22869,"6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1,3(8),4,6,10,12,14-heptaene",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22869,2289,Histamine H4 receptor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2289,Q9H3N8,Histamine H4 receptor,59340.0,HRH4,9606.0,Homo sapiens (human),,Ki (nM),200,PMID:15947036|DOI:10.1124/jpet.105.087965,https://www.ncbi.nlm.nih.gov/pubmed/15947036|https://doi.org/10.1124/jpet.105.087965,15947036,10.1124/jpet.105.087965,
3379,235519,2876,Comparative Toxicogenomics Database (CTD),"2-((2-Hydroxyethyl)thio)-3-methylnaphthalene-1,4-dione",C446520,"2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone",https://ctdbase.org/detail.go?type=chem&acc=C446520,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),"2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone results in decreased expression of BCL2",,,PMID:16077967,https://www.ncbi.nlm.nih.gov/pubmed/16077967,16077967,,
3380,235520,2876,Comparative Toxicogenomics Database (CTD),"2-((2-Hydroxyethyl)thio)-3-methylnaphthalene-1,4-dione",C446520,"2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone",https://ctdbase.org/detail.go?type=chem&acc=C446520,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),"2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone results in decreased expression of BCL2L1",,,PMID:16077967,https://www.ncbi.nlm.nih.gov/pubmed/16077967,16077967,,
3381,235521,2876,Comparative Toxicogenomics Database (CTD),"2-((2-Hydroxyethyl)thio)-3-methylnaphthalene-1,4-dione",C446520,"2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone",https://ctdbase.org/detail.go?type=chem&acc=C446520,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),"2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone results in increased activity of CASP3 protein",,,PMID:16096431,https://www.ncbi.nlm.nih.gov/pubmed/16096431,16096431,,
3382,232066,2895,Drug Gene Interaction database (DGIdb),Cyclobenzaprine,,CYCLOBENZAPRINE,https://www.dgidb.org/drugs/rxcui:21949,,KCNH2,https://www.dgidb.org/genes/hgnc:6251,,,3757.0,KCNH2,9606.0,Homo sapiens (human),,,,,,,,
3383,235699,2898,ChEMBL,Cyclofenil,CHEMBL141305,CYCLOFENIL,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL141305/,CHEMBL2093866,Estrogen receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2093866/,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),Estrogen receptor modulator,,,PMID:1551955|PMID:23264159|PMID:1736900|PMID:2777926|PMID:16610793|PMID:6411113|PMID:6826112|PMID:6437390,https://www.ncbi.nlm.nih.gov/pubmed/1551955|https://www.ncbi.nlm.nih.gov/pubmed/23264159|https://www.ncbi.nlm.nih.gov/pubmed/1736900|https://www.ncbi.nlm.nih.gov/pubmed/2777926|https://www.ncbi.nlm.nih.gov/pubmed/16610793|https://www.ncbi.nlm.nih.gov/pubmed/6411113|https://www.ncbi.nlm.nih.gov/pubmed/6826112|https://www.ncbi.nlm.nih.gov/pubmed/6437390,1551955|23264159|1736900|2777926|16610793|6411113|6826112|6437390,,
3384,232067,2907,Drug Gene Interaction database (DGIdb),Cyclophosphamide,,CYCLOPHOSPHAMIDE ANHYDROUS,https://www.dgidb.org/drugs/rxcui:1545988,,CYP1A2,https://www.dgidb.org/genes/hgnc:2596,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,,,,,
3385,232263,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,81858,SHARPIN,https://ctdbase.org/detail.go?type=gene&acc=81858,,,81858.0,SHARPIN,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in decreased expression of SHARPIN mRNA,,,PMID:27281708,https://www.ncbi.nlm.nih.gov/pubmed/27281708,27281708,,
3386,232264,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,23408,SIRT5,https://ctdbase.org/detail.go?type=gene&acc=23408,,,23408.0,SIRT5,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in increased expression of SIRT5 mRNA,,,PMID:27281708,https://www.ncbi.nlm.nih.gov/pubmed/27281708,27281708,,
3387,232265,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,27240,SIT1,https://ctdbase.org/detail.go?type=gene&acc=27240,,,27240.0,SIT1,10090.0,Mus musculus (house mouse),Cyclophosphamide results in decreased expression of SIT1 mRNA,,,PMID:21041162,https://www.ncbi.nlm.nih.gov/pubmed/21041162,21041162,,
3388,232266,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6572,SLC18A3,https://ctdbase.org/detail.go?type=gene&acc=6572,,,6572.0,SLC18A3,10116.0,Rattus norvegicus (Norway rat),O-1602 compound inhibits the reaction [cyclophosphamide results in increased expression of SLC18A3 protein]|cyclophosphamide results in increased expression of SLC18A3 protein,,,PMID:32615180,https://www.ncbi.nlm.nih.gov/pubmed/32615180,32615180,,
3389,232267,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6581,SLC22A3,https://ctdbase.org/detail.go?type=gene&acc=6581,,,6581.0,SLC22A3,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in increased expression of SLC22A3 protein|o-1602 compound inhibits the reaction [cyclophosphamide results in increased expression of SLC22A3 protein],,,PMID:32615180,https://www.ncbi.nlm.nih.gov/pubmed/32615180,32615180,,
3390,232268,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6584,SLC22A5,https://ctdbase.org/detail.go?type=gene&acc=6584,,,6584.0,SLC22A5,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in decreased expression of SLC22A5 mrna|carnitine inhibits the reaction [cyclophosphamide results in decreased expression of SLC22A5 mrna]|carnitine inhibits the reaction [cyclophosphamide results in decreased expression of SLC22A5 protein]|cyclophosphamide results in decreased expression of SLC22A5 protein,,,PMID:22701146,https://www.ncbi.nlm.nih.gov/pubmed/22701146,22701146,,
3391,232269,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,10090.0,Mus musculus (house mouse),Cyclophosphamide results in decreased expression of SLC2A2 mRNA,,,PMID:15331540,https://www.ncbi.nlm.nih.gov/pubmed/15331540,15331540,,
3392,232954,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),[doxorubicin co-treated with cyclophosphamide] results in increased expression of SOD1 protein,,,PMID:29228376,https://www.ncbi.nlm.nih.gov/pubmed/29228376,29228376,,
3393,232955,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116.0,Rattus norvegicus (Norway rat),Allyl sulfide inhibits the reaction [cyclophosphamide results in decreased activity of SOD1 protein],,,PMID:31779506,https://www.ncbi.nlm.nih.gov/pubmed/31779506,31779506,,
3394,232956,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in decreased activity of SOD1 protein,,,PMID:31779506|PMID:35906875,https://www.ncbi.nlm.nih.gov/pubmed/31779506|https://www.ncbi.nlm.nih.gov/pubmed/35906875,31779506|35906875,,
3395,233363,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6767,ST13,https://ctdbase.org/detail.go?type=gene&acc=6767,,,6767.0,ST13,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in increased expression of ST13 mRNA,,,PMID:11599041,https://www.ncbi.nlm.nih.gov/pubmed/11599041,11599041,,
3396,233364,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6768,ST14,https://ctdbase.org/detail.go?type=gene&acc=6768,,,6768.0,ST14,9606.0,Homo sapiens (human),[doxorubicin co-treated with cyclophosphamide] affects the expression of ST14 mRNA,,,PMID:16322899,https://www.ncbi.nlm.nih.gov/pubmed/16322899,16322899,,
3397,233365,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,10090.0,Mus musculus (house mouse),Cyclophosphamide results in increased expression of STAT1 mRNA,,,PMID:21041162,https://www.ncbi.nlm.nih.gov/pubmed/21041162,21041162,,
3398,233366,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10090.0,Mus musculus (house mouse),Cyclophosphamide results in decreased phosphorylation of STAT3 protein,,,PMID:21880982,https://www.ncbi.nlm.nih.gov/pubmed/21880982,21880982,,
3399,233367,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10116.0,Rattus norvegicus (Norway rat),Chrysin inhibits the reaction [cyclophosphamide results in increased phosphorylation of STAT3 protein],,,PMID:37263553,https://www.ncbi.nlm.nih.gov/pubmed/37263553,37263553,,
3400,233368,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in increased phosphorylation of STAT3 protein,,,PMID:19625377|PMID:37263553,https://www.ncbi.nlm.nih.gov/pubmed/19625377|https://www.ncbi.nlm.nih.gov/pubmed/37263553,19625377|37263553,,
3401,233369,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6777,STAT5B,https://ctdbase.org/detail.go?type=gene&acc=6777,,,6777.0,STAT5B,10090.0,Mus musculus (house mouse),Cyclophosphamide results in decreased expression of STAT5B mRNA,,,PMID:21041162,https://www.ncbi.nlm.nih.gov/pubmed/21041162,21041162,,
3402,233370,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,10963,STIP1,https://ctdbase.org/detail.go?type=gene&acc=10963,,,10963.0,STIP1,10090.0,Mus musculus (house mouse),Cyclophosphamide results in decreased expression of STIP1 mRNA,,,PMID:15331540,https://www.ncbi.nlm.nih.gov/pubmed/15331540,15331540,,
3403,233797,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6869,TACR1,https://ctdbase.org/detail.go?type=gene&acc=6869,,,6869.0,TACR1,10116.0,Rattus norvegicus (Norway rat),Suramin inhibits the reaction [cyclophosphamide results in increased expression of TACR1 protein]|cyclophosphamide results in increased expression of TACR1 protein|gr 82334 inhibits the reaction [cyclophosphamide results in increased expression of TACR1 protein],,,PMID:23666265,https://www.ncbi.nlm.nih.gov/pubmed/23666265,23666265,,
3404,233798,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,25817,TAFA5,https://ctdbase.org/detail.go?type=gene&acc=25817,,,25817.0,TAFA5,10090.0,Mus musculus (house mouse),Cyclophosphamide results in increased expression of TAFA5 mRNA,,,PMID:21621594,https://www.ncbi.nlm.nih.gov/pubmed/21621594,21621594,,
3405,233799,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,6890,TAP1,https://ctdbase.org/detail.go?type=gene&acc=6890,,,6890.0,TAP1,9606.0,Homo sapiens (human),Cyclophosphamide results in increased expression of TAP1 mRNA,,,PMID:21527772,https://www.ncbi.nlm.nih.gov/pubmed/21527772,21527772,,
3406,234925,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),[cyclophosphamide co-treated with methylprednisolone] inhibits the reaction [paraquat results in increased expression of TNF protein],,,PMID:33737140,https://www.ncbi.nlm.nih.gov/pubmed/33737140,33737140,,
3407,234926,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Cyclophosphamide inhibits the reaction [paraquat results in increased expression of TNF mrna],,,PMID:36031164,https://www.ncbi.nlm.nih.gov/pubmed/36031164,36031164,,
3408,234927,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Fungal polysaccharides inhibits the reaction [cyclophosphamide results in decreased expression of TNF mrna]|cyclophosphamide results in decreased expression of TNF mRNA,,,PMID:32151603,https://www.ncbi.nlm.nih.gov/pubmed/32151603,32151603,,
3409,234928,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Cyclophosphamide results in increased expression of TNF protein,,,PMID:29753871|PMID:30506662,https://www.ncbi.nlm.nih.gov/pubmed/29753871|https://www.ncbi.nlm.nih.gov/pubmed/30506662,29753871|30506662,,
3410,234929,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Fungal polysaccharides inhibits the reaction [cyclophosphamide results in increased expression of TNF protein],,,PMID:29753871,https://www.ncbi.nlm.nih.gov/pubmed/29753871,29753871,,
3411,234930,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Ganoderic acid A inhibits the reaction [cyclophosphamide results in increased expression of TNF protein],,,PMID:30506662,https://www.ncbi.nlm.nih.gov/pubmed/30506662,30506662,,
3412,234931,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),TNF protein results in decreased susceptibility to cyclophosphamide,,,PMID:12797522,https://www.ncbi.nlm.nih.gov/pubmed/12797522,12797522,,
3413,234932,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),TNF protein results in increased susceptibility to cyclophosphamide,,,PMID:8634684,https://www.ncbi.nlm.nih.gov/pubmed/8634684,8634684,,
3414,234933,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Allyl sulfide inhibits the reaction [cyclophosphamide results in increased secretion of TNF protein]|cyclophosphamide results in increased secretion of TNF protein,,,PMID:31779506,https://www.ncbi.nlm.nih.gov/pubmed/31779506,31779506,,
3415,235841,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090.0,Mus musculus (house mouse),TRP53 affects the susceptibility to cyclophosphamide,,,PMID:10766175,https://www.ncbi.nlm.nih.gov/pubmed/10766175,10766175,,
3416,235842,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,8989,TRPA1,https://ctdbase.org/detail.go?type=gene&acc=8989,,,8989.0,TRPA1,10116.0,Rattus norvegicus (Norway rat),"[2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide binds to and results in decreased activity of TRPA1 protein] which results in decreased susceptibility to cyclophosphamide",,,PMID:23523557,https://www.ncbi.nlm.nih.gov/pubmed/23523557,23523557,,
3417,237400,2907,Comparative Toxicogenomics Database (CTD),Cyclophosphamide,D003520,Cyclophosphamide,https://ctdbase.org/detail.go?type=chem&acc=D003520,677,ZFP36L1,https://ctdbase.org/detail.go?type=gene&acc=677,,,677.0,ZFP36L1,10116.0,Rattus norvegicus (Norway rat),Cyclophosphamide results in decreased expression of ZFP36L1 mRNA,,,PMID:27281708,https://www.ncbi.nlm.nih.gov/pubmed/27281708,27281708,,
3418,235700,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,2,A2M,https://ctdbase.org/detail.go?type=gene&acc=2,,,2.0,A2M,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of A2M protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3419,235701,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,10157,AASS,https://ctdbase.org/detail.go?type=gene&acc=10157,,,10157.0,AASS,10090.0,Mus musculus (house mouse),Cypermethrin results in increased expression of AASS mRNA,,,PMID:21142847,https://www.ncbi.nlm.nih.gov/pubmed/21142847,21142847,,
3420,235702,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,18,ABAT,https://ctdbase.org/detail.go?type=gene&acc=18,,,18.0,ABAT,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased activity of ABAT protein,,,PMID:24220872,https://www.ncbi.nlm.nih.gov/pubmed/24220872,24220872,,
3421,235703,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,10029.0,Cricetulus griseus (Chinese hamster),Cypermethrin results in increased activity of ABCB1 protein|tetramethylrosamine inhibits the reaction [ABCB1 protein results in increased transport of cypermethrin],,,PMID:17490606,https://www.ncbi.nlm.nih.gov/pubmed/17490606,17490606,,
3422,235704,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,10058,ABCB6,https://ctdbase.org/detail.go?type=gene&acc=10058,,,10058.0,ABCB6,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of ABCB6 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3423,235705,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,9619,ABCG1,https://ctdbase.org/detail.go?type=gene&acc=9619,,,9619.0,ABCG1,9606.0,Homo sapiens (human),Cypermethrin results in decreased expression of ABCG1 mRNA,,,PMID:25424538,https://www.ncbi.nlm.nih.gov/pubmed/25424538,25424538,,
3424,235706,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of ABCG5 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3425,235707,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,340485,ACER2,https://ctdbase.org/detail.go?type=gene&acc=340485,,,340485.0,ACER2,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased expression of ACER2 mRNA,,,PMID:29020013,https://www.ncbi.nlm.nih.gov/pubmed/29020013,29020013,,
3426,235863,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9913.0,Bos taurus (cattle),Cypermethrin results in decreased activity of ACHE protein,,,PMID:2365420,https://www.ncbi.nlm.nih.gov/pubmed/2365420,2365420,,
3427,235864,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,84645.0,Labeo rohita (rohu),Cypermethrin results in decreased activity of ACHE protein,,,PMID:12524023,https://www.ncbi.nlm.nih.gov/pubmed/12524023,12524023,,
3428,235865,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,7370.0,Musca domestica (house fly),Cypermethrin promotes the reaction [triazophos results in decreased activity of ACHE protein]|cypermethrin promotes the reaction [monocrotophos results in decreased activity of ACHE protein]|cypermethrin promotes the reaction [malathion results in decreased activity of ACHE protein]|cypermethrin promotes the reaction [carbaryl results in decreased activity of ACHE protein]|cypermethrin promotes the reaction [chlorpyrifos results in decreased activity of ACHE protein],,,PMID:27988393,https://www.ncbi.nlm.nih.gov/pubmed/27988393,27988393,,
3429,235866,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,8022.0,Oncorhynchus mykiss (rainbow trout),Cypermethrin results in decreased activity of ACHE protein|acetylcysteine inhibits the reaction [cypermethrin results in decreased activity of ACHE protein],,,PMID:33412942,https://www.ncbi.nlm.nih.gov/pubmed/33412942,33412942,,
3430,235867,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116.0,Rattus norvegicus (Norway rat),Cypermethrin promotes the reaction [chlorpyrifos results in decreased activity of ACHE protein]|chlorpyrifos promotes the reaction [cypermethrin results in decreased activity of ACHE protein],,,PMID:32006337,https://www.ncbi.nlm.nih.gov/pubmed/32006337,32006337,,
3431,235868,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with fenvalerate] results in decreased activity of ACHE protein|cypermethrin affects the activity of ACHE protein,,,PMID:10355540,https://www.ncbi.nlm.nih.gov/pubmed/10355540,10355540,,
3432,235869,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in decreased activity of ACHE protein,,,PMID:32006337|PMID:8385837,https://www.ncbi.nlm.nih.gov/pubmed/32006337|https://www.ncbi.nlm.nih.gov/pubmed/8385837,32006337|8385837,,
3433,235870,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased activity of ACHE protein,,,PMID:7595515,https://www.ncbi.nlm.nih.gov/pubmed/7595515,7595515,,
3434,235871,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,57007,ACKR3,https://ctdbase.org/detail.go?type=gene&acc=57007,,,57007.0,ACKR3,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of ACKR3 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3435,235872,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,48,ACO1,https://ctdbase.org/detail.go?type=gene&acc=48,,,48.0,ACO1,42434.0,Culex pipiens pallens,ACO1 protein results in decreased susceptibility to cypermethrin,,,PMID:22075242,https://www.ncbi.nlm.nih.gov/pubmed/22075242,22075242,,
3436,236036,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,161823,ADAL,https://ctdbase.org/detail.go?type=gene&acc=161823,,,161823.0,ADAL,10090.0,Mus musculus (house mouse),Cypermethrin results in increased expression of ADAL mRNA,,,PMID:29020013,https://www.ncbi.nlm.nih.gov/pubmed/29020013,29020013,,
3437,236037,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,11173,ADAMTS7,https://ctdbase.org/detail.go?type=gene&acc=11173,,,11173.0,ADAMTS7,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in increased expression of ADAMTS7 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3438,236038,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,108,ADCY2,https://ctdbase.org/detail.go?type=gene&acc=108,,,108.0,ADCY2,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of ADCY2 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3439,236039,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,118,ADD1,https://ctdbase.org/detail.go?type=gene&acc=118,,,118.0,ADD1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of ADD1 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3440,236040,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,147,ADRA1B,https://ctdbase.org/detail.go?type=gene&acc=147,,,147.0,ADRA1B,10036.0,Mesocricetus auratus (golden hamster),Cypermethrin results in increased phosphorylation of ADRA1B protein,,,PMID:10683197,https://www.ncbi.nlm.nih.gov/pubmed/10683197,10683197,,
3441,236211,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),Cypermethrin affects the expression of agt|sesame oil affects the reaction [cypermethrin affects the expression of AGT],,,PMID:25816392,https://www.ncbi.nlm.nih.gov/pubmed/25816392,25816392,,
3442,236212,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),[prothioconazole co-treated with terbutylazine co-treated with bitertanol co-treated with cypermethrin co-treated with malathion] results in increased activity of AHR protein|cypermethrin inhibits the reaction [tetrachlorodibenzodioxin results in increased activity of AHR protein],,,PMID:25684042,https://www.ncbi.nlm.nih.gov/pubmed/25684042,25684042,,
3443,236213,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,7107.0,Spodoptera exigua (beet armyworm),AHR protein results in decreased susceptibility to cypermethrin,,,PMID:30610747,https://www.ncbi.nlm.nih.gov/pubmed/30610747,30610747,,
3444,236214,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of AKT1 mRNA,,,PMID:27704156,https://www.ncbi.nlm.nih.gov/pubmed/27704156,27704156,,
3445,236215,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased expression of AKT1 mRNA,,,PMID:34714723,https://www.ncbi.nlm.nih.gov/pubmed/34714723,34714723,,
3446,236216,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased phosphorylation of AKT1 protein,,,PMID:37011868,https://www.ncbi.nlm.nih.gov/pubmed/37011868,37011868,,
3447,236217,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in decreased expression of AKT1 mRNA,,,PMID:22528246,https://www.ncbi.nlm.nih.gov/pubmed/22528246,22528246,,
3448,236218,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in decreased expression of ALB mRNA,,,PMID:11428908|PMID:9650644,https://www.ncbi.nlm.nih.gov/pubmed/11428908|https://www.ncbi.nlm.nih.gov/pubmed/9650644,11428908|9650644,,
3449,236219,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10116.0,Rattus norvegicus (Norway rat),Sesame oil inhibits the reaction [cypermethrin results in increased expression of alb]|cypermethrin results in increased expression of ALB,,,PMID:25816392,https://www.ncbi.nlm.nih.gov/pubmed/25816392,25816392,,
3450,236543,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,268,AMH,https://ctdbase.org/detail.go?type=gene&acc=268,,,268.0,AMH,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of AMH protein|cypermethrin results in increased expression of AMH mRNA,,,PMID:35102696,https://www.ncbi.nlm.nih.gov/pubmed/35102696,35102696,,
3451,236544,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,268,AMH,https://ctdbase.org/detail.go?type=gene&acc=268,,,268.0,AMH,10116.0,Rattus norvegicus (Norway rat),[fenvalerate co-treated with allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of AMH mRNA,,,PMID:36053783,https://www.ncbi.nlm.nih.gov/pubmed/36053783,36053783,,
3452,236545,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,56172,ANKH,https://ctdbase.org/detail.go?type=gene&acc=56172,,,56172.0,ANKH,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of ANKH protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3453,236546,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,309,ANXA6,https://ctdbase.org/detail.go?type=gene&acc=309,,,309.0,ANXA6,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of ANXA6 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3454,236547,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,7955.0,Danio rerio (zebrafish),Cypermethrin results in increased expression of APAF1 mRNA,,,PMID:20965546|PMID:21316461,https://www.ncbi.nlm.nih.gov/pubmed/20965546|https://www.ncbi.nlm.nih.gov/pubmed/21316461,20965546|21316461,,
3455,236548,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of APAF1 mRNA,,,PMID:27704156,https://www.ncbi.nlm.nih.gov/pubmed/27704156,27704156,,
3456,236549,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of APAF1 protein,,,PMID:36063984,https://www.ncbi.nlm.nih.gov/pubmed/36063984,36063984,,
3457,236550,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,10090.0,Mus musculus (house mouse),Chlorpyrifos promotes the reaction [cypermethrin results in decreased expression of APAF1 mrna]|cypermethrin promotes the reaction [chlorpyrifos results in decreased expression of APAF1 mrna]|cypermethrin results in decreased expression of APAF1 protein|cypermethrin results in decreased expression of APAF1 mrna|[chlorpyrifos co-treated with cypermethrin] results in decreased expression of APAF1 protein,,,PMID:34559034,https://www.ncbi.nlm.nih.gov/pubmed/34559034,34559034,,
3458,236551,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,324,APC,https://ctdbase.org/detail.go?type=gene&acc=324,,,324.0,APC,10090.0,Mus musculus (house mouse),Cypermethrin results in increased expression of APC mRNA,,,PMID:21142847,https://www.ncbi.nlm.nih.gov/pubmed/21142847,21142847,,
3459,236552,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,324,APC,https://ctdbase.org/detail.go?type=gene&acc=324,,,324.0,APC,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of APC mRNA,,,PMID:22528246,https://www.ncbi.nlm.nih.gov/pubmed/22528246,22528246,,
3460,237100,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,399456,AR.L,https://ctdbase.org/detail.go?type=gene&acc=399456,,,399456.0,ar.L,8355.0,Xenopus laevis (African clawed frog),Cypermethrin inhibits the reaction [[6-fluorotestosterone co-treated with norgestrel] binds to and results in increased activity of AR.L protein],,,PMID:33049310,https://www.ncbi.nlm.nih.gov/pubmed/33049310,33049310,,
3461,237101,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,79798,ARMC5,https://ctdbase.org/detail.go?type=gene&acc=79798,,,79798.0,ARMC5,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of ARMC5 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3462,237102,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,64860,ARMCX5,https://ctdbase.org/detail.go?type=gene&acc=64860,,,64860.0,ARMCX5,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased expression of ARMCX5 mRNA,,,PMID:29020013,https://www.ncbi.nlm.nih.gov/pubmed/29020013,29020013,,
3463,237103,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,10095,ARPC1B,https://ctdbase.org/detail.go?type=gene&acc=10095,,,10095.0,ARPC1B,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of ARPC1B protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3464,237275,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,10116.0,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [cypermethrin results in increased expression of ATF6 mrna]|cypermethrin results in increased expression of ATF6 mRNA,,,PMID:35876585,https://www.ncbi.nlm.nih.gov/pubmed/35876585,35876585,,
3465,237276,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,9140,ATG12,https://ctdbase.org/detail.go?type=gene&acc=9140,,,9140.0,ATG12,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of ATG12 mRNA,,,PMID:27704156,https://www.ncbi.nlm.nih.gov/pubmed/27704156,27704156,,
3466,237277,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,64422,ATG3,https://ctdbase.org/detail.go?type=gene&acc=64422,,,64422.0,ATG3,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of ATG3 mRNA,,,PMID:27704156,https://www.ncbi.nlm.nih.gov/pubmed/27704156,27704156,,
3467,237278,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,9474,ATG5,https://ctdbase.org/detail.go?type=gene&acc=9474,,,9474.0,ATG5,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of ATG5 mRNA,,,PMID:27704156,https://www.ncbi.nlm.nih.gov/pubmed/27704156,27704156,,
3468,237279,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,10533,ATG7,https://ctdbase.org/detail.go?type=gene&acc=10533,,,10533.0,ATG7,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of ATG7 mRNA,,,PMID:27704156,https://www.ncbi.nlm.nih.gov/pubmed/27704156,27704156,,
3469,238828,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of CASP3 protein,,,PMID:25370934|PMID:35876585,https://www.ncbi.nlm.nih.gov/pubmed/25370934|https://www.ncbi.nlm.nih.gov/pubmed/35876585,25370934|35876585,,
3470,238829,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,140621,CASP3A,https://ctdbase.org/detail.go?type=gene&acc=140621,,,140621.0,casp3a,7955.0,Danio rerio (zebrafish),Cypermethrin results in increased expression of CASP3A mRNA,,,PMID:20965546,https://www.ncbi.nlm.nih.gov/pubmed/20965546,20965546,,
3471,238830,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,839,CASP6,https://ctdbase.org/detail.go?type=gene&acc=839,,,839.0,CASP6,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of CASP6 mRNA,,,PMID:22528246,https://www.ncbi.nlm.nih.gov/pubmed/22528246,22528246,,
3472,239757,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased expression of CCND3 mRNA,,,PMID:36116546,https://www.ncbi.nlm.nih.gov/pubmed/36116546,36116546,,
3473,239758,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,9973,CCS,https://ctdbase.org/detail.go?type=gene&acc=9973,,,9973.0,CCS,10090.0,Mus musculus (house mouse),Cypermethrin results in increased expression of CCS mRNA,,,PMID:21142847,https://www.ncbi.nlm.nih.gov/pubmed/21142847,21142847,,
3474,239955,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1025,CDK9,https://ctdbase.org/detail.go?type=gene&acc=1025,,,1025.0,CDK9,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in decreased expression of CDK9 mRNA,,,PMID:22528246,https://www.ncbi.nlm.nih.gov/pubmed/22528246,22528246,,
3475,239956,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of CDKN1A mRNA,,,PMID:36063984,https://www.ncbi.nlm.nih.gov/pubmed/36063984,36063984,,
3476,239957,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased expression of CDKN1A mRNA,,,PMID:36116546,https://www.ncbi.nlm.nih.gov/pubmed/36116546,36116546,,
3477,240133,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased expression of CDKN1A protein,,,PMID:37011868,https://www.ncbi.nlm.nih.gov/pubmed/37011868,37011868,,
3478,240134,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased expression of CDKN1B mRNA,,,PMID:35031408,https://www.ncbi.nlm.nih.gov/pubmed/35031408,35031408,,
3479,240135,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1028,CDKN1C,https://ctdbase.org/detail.go?type=gene&acc=1028,,,1028.0,CDKN1C,10090.0,Mus musculus (house mouse),Cypermethrin results in increased expression of CDKN1C protein|cypermethrin results in increased expression of CDKN1C mRNA,,,PMID:37011868,https://www.ncbi.nlm.nih.gov/pubmed/37011868,37011868,,
3480,240136,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029.0,CDKN2A,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of CDKN2A mRNA,,,PMID:36063984,https://www.ncbi.nlm.nih.gov/pubmed/36063984,36063984,,
3481,240137,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1030,CDKN2B,https://ctdbase.org/detail.go?type=gene&acc=1030,,,1030.0,CDKN2B,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of CDKN2B mRNA,,,PMID:22528246,https://www.ncbi.nlm.nih.gov/pubmed/22528246,22528246,,
3482,240666,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,81035,COLEC12,https://ctdbase.org/detail.go?type=gene&acc=81035,,,81035.0,COLEC12,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of COLEC12 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3483,240667,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,54939,COMMD4,https://ctdbase.org/detail.go?type=gene&acc=54939,,,54939.0,COMMD4,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of COMMD4 mRNA,,,PMID:27704156,https://www.ncbi.nlm.nih.gov/pubmed/27704156,27704156,,
3484,240668,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,26958,COPG2,https://ctdbase.org/detail.go?type=gene&acc=26958,,,26958.0,COPG2,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in decreased expression of COPG2 mRNA,,,PMID:22528246,https://www.ncbi.nlm.nih.gov/pubmed/22528246,22528246,,
3485,240669,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,9318,COPS2,https://ctdbase.org/detail.go?type=gene&acc=9318,,,9318.0,COPS2,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of COPS2 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3486,240670,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,84987,COX14,https://ctdbase.org/detail.go?type=gene&acc=84987,,,84987.0,COX14,10090.0,Mus musculus (house mouse),Cypermethrin results in increased expression of COX14 mRNA,,,PMID:29020013,https://www.ncbi.nlm.nih.gov/pubmed/29020013,29020013,,
3487,240671,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1350,COX7C,https://ctdbase.org/detail.go?type=gene&acc=1350,,,1350.0,COX7C,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased expression of COX7C mRNA,,,PMID:29020013,https://www.ncbi.nlm.nih.gov/pubmed/29020013,29020013,,
3488,240672,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,12869,COX8B,https://ctdbase.org/detail.go?type=gene&acc=12869,,,12869.0,Cox8b,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased expression of COX8B mRNA,,,PMID:29020013,https://www.ncbi.nlm.nih.gov/pubmed/29020013,29020013,,
3489,240673,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,10090.0,Mus musculus (house mouse),Cypermethrin promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of CPT1A mrna],,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
3490,240674,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1375,CPT1B,https://ctdbase.org/detail.go?type=gene&acc=1375,,,1375.0,CPT1B,7955.0,Danio rerio (zebrafish),Cypermethrin results in increased expression of CPT1B mRNA,,,PMID:20965546,https://www.ncbi.nlm.nih.gov/pubmed/20965546,20965546,,
3491,240675,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10090.0,Mus musculus (house mouse),[cypermethrin results in decreased susceptibility to dihydrotestosterone] which results in decreased phosphorylation of CREB1 protein,,,PMID:30974244,https://www.ncbi.nlm.nih.gov/pubmed/30974244,30974244,,
3492,242792,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1743,DLST,https://ctdbase.org/detail.go?type=gene&acc=1743,,,1743.0,DLST,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of DLST protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3493,242793,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,63951,DMRTA1,https://ctdbase.org/detail.go?type=gene&acc=63951,,,63951.0,DMRTA1,10090.0,Mus musculus (house mouse),Cypermethrin results in increased expression of DMRTA1 mRNA,,,PMID:29020013,https://www.ncbi.nlm.nih.gov/pubmed/29020013,29020013,,
3494,242794,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,10116.0,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT1 mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
3495,242795,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of DNMT1 mRNA,,,PMID:35605701,https://www.ncbi.nlm.nih.gov/pubmed/35605701,35605701,,
3496,242796,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,692480,DNMT2,https://ctdbase.org/detail.go?type=gene&acc=692480,,,692480.0,,10116.0,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT2 mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
3497,242797,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,692480,DNMT2,https://ctdbase.org/detail.go?type=gene&acc=692480,,,692480.0,,10116.0,Rattus norvegicus (Norway rat),[fenvalerate co-treated with allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT2 mRNA,,,PMID:36053783,https://www.ncbi.nlm.nih.gov/pubmed/36053783,36053783,,
3498,242798,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1788,DNMT3A,https://ctdbase.org/detail.go?type=gene&acc=1788,,,1788.0,DNMT3A,10116.0,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
3499,242799,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1977,EIF4E,https://ctdbase.org/detail.go?type=gene&acc=1977,,,1977.0,EIF4E,10090.0,Mus musculus (house mouse),Cypermethrin results in increased expression of EIF4E mRNA,,,PMID:29020013,https://www.ncbi.nlm.nih.gov/pubmed/29020013,29020013,,
3500,242800,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,10090.0,Mus musculus (house mouse),Cypermethrin results in increased phosphorylation of EIF4EBP1 protein|cypermethrin results in increased phosphorylation of EIF4EBP1 mRNA,,,PMID:37011868,https://www.ncbi.nlm.nih.gov/pubmed/37011868,37011868,,
3501,242801,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1788,DNMT3A,https://ctdbase.org/detail.go?type=gene&acc=1788,,,1788.0,DNMT3A,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in decreased expression of DNMT3A protein|diallyl tetrasulfide inhibits the reaction [cypermethrin results in decreased expression of DNMT3A protein]|cypermethrin results in decreased expression of and results in decreased activity of DNMT3A protein|cypermethrin results in decreased expression of DNMT3A mrna|[pyrazolanthrone co-treated with cypermethrin] results in decreased expression of DNMT3A protein|dnmt3a protein inhibits the reaction [cypermethrin results in increased expression of MIR140 mrna]|dnmt3a protein inhibits the reaction [cypermethrin results in increased expression of WWP2 mrna]|asiatic acid inhibits the reaction [cypermethrin results in decreased expression of DNMT3A protein],,,PMID:34794910,https://www.ncbi.nlm.nih.gov/pubmed/34794910,34794910,,
3502,242964,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1788,DNMT3A,https://ctdbase.org/detail.go?type=gene&acc=1788,,,1788.0,DNMT3A,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of DNMT3A mRNA,,,PMID:33396045,https://www.ncbi.nlm.nih.gov/pubmed/33396045,33396045,,
3503,242965,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1788,DNMT3A,https://ctdbase.org/detail.go?type=gene&acc=1788,,,1788.0,DNMT3A,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in increased expression of DNMT3A mRNA,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3504,242966,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1788,DNMT3A,https://ctdbase.org/detail.go?type=gene&acc=1788,,,1788.0,DNMT3A,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of DNMT3A mRNA,,,PMID:35605701,https://www.ncbi.nlm.nih.gov/pubmed/35605701,35605701,,
3505,242967,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,1788,DNMT3A,https://ctdbase.org/detail.go?type=gene&acc=1788,,,1788.0,DNMT3A,10116.0,Rattus norvegicus (Norway rat),[fenvalerate co-treated with allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of DNMT3A mRNA,,,PMID:36053783,https://www.ncbi.nlm.nih.gov/pubmed/36053783,36053783,,
3506,246242,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3065,HDAC1,https://ctdbase.org/detail.go?type=gene&acc=3065,,,3065.0,HDAC1,10116.0,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC1 mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
3507,246243,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3065,HDAC1,https://ctdbase.org/detail.go?type=gene&acc=3065,,,3065.0,HDAC1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of HDAC1 mRNA,,,PMID:33396045,https://www.ncbi.nlm.nih.gov/pubmed/33396045,33396045,,
3508,246244,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3065,HDAC1,https://ctdbase.org/detail.go?type=gene&acc=3065,,,3065.0,HDAC1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in increased expression of HDAC1 mRNA,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3509,246245,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,83933,HDAC10,https://ctdbase.org/detail.go?type=gene&acc=83933,,,83933.0,HDAC10,10116.0,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
3510,246246,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,83933,HDAC10,https://ctdbase.org/detail.go?type=gene&acc=83933,,,83933.0,HDAC10,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of HDAC10 mRNA,,,PMID:33396045|PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/33396045|https://www.ncbi.nlm.nih.gov/pubmed/34896426,33396045|34896426,,
3511,246247,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,9759,HDAC4,https://ctdbase.org/detail.go?type=gene&acc=9759,,,9759.0,HDAC4,10116.0,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC4 mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
3512,246248,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,9759,HDAC4,https://ctdbase.org/detail.go?type=gene&acc=9759,,,9759.0,HDAC4,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of HDAC4 mRNA,,,PMID:33396045|PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/33396045|https://www.ncbi.nlm.nih.gov/pubmed/34896426,33396045|34896426,,
3513,246249,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,9759,HDAC4,https://ctdbase.org/detail.go?type=gene&acc=9759,,,9759.0,HDAC4,10116.0,Rattus norvegicus (Norway rat),[fenvalerate co-treated with allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of HDAC4 mRNA,,,PMID:36053783,https://www.ncbi.nlm.nih.gov/pubmed/36053783,36053783,,
3514,246593,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3157,HMGCS1,https://ctdbase.org/detail.go?type=gene&acc=3157,,,3157.0,HMGCS1,10116.0,Rattus norvegicus (Norway rat),[fenvalerate co-treated with allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCS1 mRNA,,,PMID:36053783,https://www.ncbi.nlm.nih.gov/pubmed/36053783,36053783,,
3515,246594,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Cypermethrin results in decreased expression of HMOX1 protein|cypermethrin results in decreased expression of HMOX1 mRNA,,,PMID:31907151,https://www.ncbi.nlm.nih.gov/pubmed/31907151,31907151,,
3516,246595,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of HMOX1 mrna|acetylcysteine inhibits the reaction [cypermethrin results in increased expression of HMOX1 mrna],,,PMID:23900960,https://www.ncbi.nlm.nih.gov/pubmed/23900960,23900960,,
3517,246596,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Cypermethrin affects the expression of hmox1|sesame oil affects the reaction [cypermethrin affects the expression of HMOX1],,,PMID:25816392,https://www.ncbi.nlm.nih.gov/pubmed/25816392,25816392,,
3518,246597,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of HMOX1 mRNA,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3519,248578,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3741,KCNA5,https://ctdbase.org/detail.go?type=gene&acc=3741,,,3741.0,KCNA5,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of KCNA5 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3520,248579,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,9312,KCNB2,https://ctdbase.org/detail.go?type=gene&acc=9312,,,9312.0,KCNB2,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of KCNB2 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3521,248580,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,23416,KCNH3,https://ctdbase.org/detail.go?type=gene&acc=23416,,,23416.0,KCNH3,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of KCNH3 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3522,248581,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3765,KCNJ9,https://ctdbase.org/detail.go?type=gene&acc=3765,,,3765.0,KCNJ9,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in decreased expression of KCNJ9 mRNA,,,PMID:22528246,https://www.ncbi.nlm.nih.gov/pubmed/22528246,22528246,,
3523,248582,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,3785,KCNQ2,https://ctdbase.org/detail.go?type=gene&acc=3785,,,3785.0,KCNQ2,9606.0,Homo sapiens (human),Cypermethrin results in decreased expression of KCNQ2 protein,,,PMID:36063984,https://www.ncbi.nlm.nih.gov/pubmed/36063984,36063984,,
3524,248583,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,57582,KCNT1,https://ctdbase.org/detail.go?type=gene&acc=57582,,,57582.0,KCNT1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of KCNT1 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3525,248584,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,169522,KCNV2,https://ctdbase.org/detail.go?type=gene&acc=169522,,,169522.0,KCNV2,9606.0,Homo sapiens (human),Cypermethrin results in decreased expression of KCNV2 protein,,,PMID:36063984,https://www.ncbi.nlm.nih.gov/pubmed/36063984,36063984,,
3526,248585,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,55818,KDM3A,https://ctdbase.org/detail.go?type=gene&acc=55818,,,55818.0,KDM3A,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of KDM3A protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3527,249781,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,54627,MAP10,https://ctdbase.org/detail.go?type=gene&acc=54627,,,54627.0,MAP10,9606.0,Homo sapiens (human),Cypermethrin results in increased expression of MAP10 protein,,,PMID:36063984,https://www.ncbi.nlm.nih.gov/pubmed/36063984,36063984,,
3528,249782,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,84557,MAP1LC3A,https://ctdbase.org/detail.go?type=gene&acc=84557,,,84557.0,MAP1LC3A,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of MAP1LC3A mRNA,,,PMID:35876585,https://www.ncbi.nlm.nih.gov/pubmed/35876585,35876585,,
3529,249783,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of MAP1LC3B mRNA,,,PMID:35876585,https://www.ncbi.nlm.nih.gov/pubmed/35876585,35876585,,
3530,249784,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in decreased expression of MAP2 mRNA,,,PMID:22528246,https://www.ncbi.nlm.nih.gov/pubmed/22528246,22528246,,
3531,249785,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,6416,MAP2K4,https://ctdbase.org/detail.go?type=gene&acc=6416,,,6416.0,MAP2K4,10090.0,Mus musculus (house mouse),[[cypermethrin results in decreased expression of MIR155 mrna] which results in increased expression of BCL6 mrna] which results in decreased expression of MAP2K4 protein|[[[cypermethrin results in decreased expression of MIR155 mrna] which results in increased expression of BCL6 mrna] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein|[[[cypermethrin results in decreased expression of MIR155 mrna] which results in increased expression of BCL6 mrna] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein,,,PMID:29471534,https://www.ncbi.nlm.nih.gov/pubmed/29471534,29471534,,
3532,249786,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,4214,MAP3K1,https://ctdbase.org/detail.go?type=gene&acc=4214,,,4214.0,MAP3K1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of MAP3K1 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
3533,249787,2912,Comparative Toxicogenomics Database (CTD),Cypermethrin,C017160,cypermethrin,https://ctdbase.org/detail.go?type=chem&acc=C017160,4216,MAP3K4,https://ctdbase.org/detail.go?type=gene&acc=4216,,,4216.0,MAP3K4,10116.0,Rattus norvegicus (Norway rat),Cypermethrin results in increased expression of MAP3K4 mRNA,,,PMID:22528246,https://www.ncbi.nlm.nih.gov/pubmed/22528246,22528246,,
3534,295550,2973,Comparative Toxicogenomics Database (CTD),Deferoxamine,D003676,Deferoxamine,https://ctdbase.org/detail.go?type=chem&acc=D003676,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),"Deferoxamine inhibits the reaction [asbestos, crocidolite results in increased secretion of TNF protein]",,,PMID:10486238,https://www.ncbi.nlm.nih.gov/pubmed/10486238,10486238,,
3535,295551,2973,Comparative Toxicogenomics Database (CTD),Deferoxamine,D003676,Deferoxamine,https://ctdbase.org/detail.go?type=chem&acc=D003676,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),"Deferoxamine inhibits the reaction [asbestos, crocidolite results in increased secretion of TNF protein]",,,PMID:7539275,https://www.ncbi.nlm.nih.gov/pubmed/7539275,7539275,,
3536,295552,2973,Comparative Toxicogenomics Database (CTD),Deferoxamine,D003676,Deferoxamine,https://ctdbase.org/detail.go?type=chem&acc=D003676,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Deferoxamine inhibits the reaction [[copper sulfate results in increased abundance of copper] which results in increased expression of TNF protein],,,PMID:34577062,https://www.ncbi.nlm.nih.gov/pubmed/34577062,34577062,,
3537,295553,2973,Comparative Toxicogenomics Database (CTD),Deferoxamine,D003676,Deferoxamine,https://ctdbase.org/detail.go?type=chem&acc=D003676,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Nitrites inhibits the reaction [[TNF protein results in increased activity of NOS2 protein] which results in increased chemical synthesis of deferoxamine],,,PMID:7532384,https://www.ncbi.nlm.nih.gov/pubmed/7532384,7532384,,
3538,295554,2973,Comparative Toxicogenomics Database (CTD),Deferoxamine,D003676,Deferoxamine,https://ctdbase.org/detail.go?type=chem&acc=D003676,7130,TNFAIP6,https://ctdbase.org/detail.go?type=gene&acc=7130,,,7130.0,TNFAIP6,9606.0,Homo sapiens (human),Deferoxamine results in decreased expression of TNFAIP6 mRNA,,,PMID:32816093,https://www.ncbi.nlm.nih.gov/pubmed/32816093,32816093,,
3539,295752,2973,Comparative Toxicogenomics Database (CTD),Deferoxamine,D003676,Deferoxamine,https://ctdbase.org/detail.go?type=chem&acc=D003676,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Melatonin inhibits the reaction [[glucose co-treated with deferoxamine] results in increased expression of TP53 mrna]|[glucose co-treated with deferoxamine] results in increased expression of TP53 mRNA,,,PMID:33962019,https://www.ncbi.nlm.nih.gov/pubmed/33962019,33962019,,
3540,295753,2973,Comparative Toxicogenomics Database (CTD),Deferoxamine,D003676,Deferoxamine,https://ctdbase.org/detail.go?type=chem&acc=D003676,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),TP53 protein results in decreased susceptibility to deferoxamine|tp53 gene mutant form promotes the reaction [deferoxamine results in increased expression of PTGS2 protein]|tp53 gene mutant form promotes the reaction [deferoxamine results in increased expression of HIF1A protein],,,PMID:16527254,https://www.ncbi.nlm.nih.gov/pubmed/16527254,16527254,,
3541,299229,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,216,ALDH1A1,https://ctdbase.org/detail.go?type=gene&acc=216,,,216.0,ALDH1A1,10090.0,Mus musculus (house mouse),Amphetamine results in decreased expression of ALDH1A1 protein|mdk gene mutant form promotes the reaction [amphetamine results in decreased expression of ALDH1A1 protein],,,PMID:23459167,https://www.ncbi.nlm.nih.gov/pubmed/23459167,23459167,,
3542,299230,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,91801,ALKBH8,https://ctdbase.org/detail.go?type=gene&acc=91801,,,91801.0,ALKBH8,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of ALKBH8 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3543,299231,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,7840,ALMS1,https://ctdbase.org/detail.go?type=gene&acc=7840,,,7840.0,ALMS1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of ALMS1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3544,299232,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,11685,ALOX12E,https://ctdbase.org/detail.go?type=gene&acc=11685,,,11685.0,Alox12e,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of ALOX12E mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3545,299233,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,241,ALOX5AP,https://ctdbase.org/detail.go?type=gene&acc=241,,,241.0,ALOX5AP,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of ALOX5AP mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3546,300607,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,8623,ASMTL,https://ctdbase.org/detail.go?type=gene&acc=8623,,,8623.0,ASMTL,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of ASMTL mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3547,300608,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,440,ASNS,https://ctdbase.org/detail.go?type=gene&acc=440,,,440.0,ASNS,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of ASNS mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3548,300609,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,80150,ASRGL1,https://ctdbase.org/detail.go?type=gene&acc=80150,,,80150.0,ASRGL1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of ASRGL1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3549,300610,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,445,ASS1,https://ctdbase.org/detail.go?type=gene&acc=445,,,445.0,ASS1,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of ASS1 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3550,300611,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,79915,ATAD5,https://ctdbase.org/detail.go?type=gene&acc=79915,,,79915.0,ATAD5,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of ATAD5 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3551,300612,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,85300,ATCAY,https://ctdbase.org/detail.go?type=gene&acc=85300,,,85300.0,ATCAY,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of ATCAY mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3552,300613,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of ATF3 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3553,300614,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of ATF4 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3554,300615,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,11016,ATF7,https://ctdbase.org/detail.go?type=gene&acc=11016,,,11016.0,ATF7,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of ATF7 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3555,300616,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of ATM mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3556,301459,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,29994,BAZ2B,https://ctdbase.org/detail.go?type=gene&acc=29994,,,29994.0,BAZ2B,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of BAZ2B mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3557,303678,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,933,CD22,https://ctdbase.org/detail.go?type=gene&acc=933,,,933.0,CD22,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CD22 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3558,303679,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,919,CD247,https://ctdbase.org/detail.go?type=gene&acc=919,,,919.0,CD247,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CD247 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3559,303680,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,939,CD27,https://ctdbase.org/detail.go?type=gene&acc=939,,,939.0,CD27,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CD27 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3560,303681,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,940,CD28,https://ctdbase.org/detail.go?type=gene&acc=940,,,940.0,CD28,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CD28 mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3561,303682,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,23607,CD2AP,https://ctdbase.org/detail.go?type=gene&acc=23607,,,23607.0,CD2AP,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in decreased expression of CD2AP mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3562,303683,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,11314,CD300A,https://ctdbase.org/detail.go?type=gene&acc=11314,,,11314.0,CD300A,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of CD300A mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3563,303684,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,342510,CD300E,https://ctdbase.org/detail.go?type=gene&acc=342510,,,342510.0,CD300E,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of CD300E mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3564,305005,3007,Comparative Toxicogenomics Database (CTD),Amphetamine,D000661,Amphetamine,https://ctdbase.org/detail.go?type=chem&acc=D000661,51192,CKLF,https://ctdbase.org/detail.go?type=gene&acc=51192,,,51192.0,CKLF,10116.0,Rattus norvegicus (Norway rat),Amphetamine results in increased expression of CKLF mRNA,,,PMID:30779732,https://www.ncbi.nlm.nih.gov/pubmed/30779732,30779732,,
3565,343019,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,155,ADRB3,https://ctdbase.org/detail.go?type=gene&acc=155,,,155.0,ADRB3,10116.0,Rattus norvegicus (Norway rat),Diazinon affects the expression of ADRB3 mRNA,,,PMID:18812211,https://www.ncbi.nlm.nih.gov/pubmed/18812211,18812211,,
3566,343020,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,155,ADRB3,https://ctdbase.org/detail.go?type=gene&acc=155,,,155.0,ADRB3,10116.0,Rattus norvegicus (Norway rat),Diazinon results in decreased expression of ADRB3 mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
3567,343021,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,11047,ADRM1,https://ctdbase.org/detail.go?type=gene&acc=11047,,,11047.0,ADRM1,9606.0,Homo sapiens (human),Diazinon results in increased methylation of ADRM1 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3568,343022,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,158,ADSL,https://ctdbase.org/detail.go?type=gene&acc=158,,,158.0,ADSL,9606.0,Homo sapiens (human),Diazinon results in increased methylation of ADSL gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3569,343023,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,27161,AGO2,https://ctdbase.org/detail.go?type=gene&acc=27161,,,27161.0,AGO2,9606.0,Homo sapiens (human),Diazinon results in increased methylation of AGO2 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3570,343024,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,189,AGXT,https://ctdbase.org/detail.go?type=gene&acc=189,,,189.0,AGXT,9606.0,Homo sapiens (human),Diazinon results in increased methylation of AGXT gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3571,343025,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10116.0,Rattus norvegicus (Norway rat),Diazinon affects the expression of AHR mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
3572,344104,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,364,AQP7,https://ctdbase.org/detail.go?type=gene&acc=364,,,364.0,AQP7,9606.0,Homo sapiens (human),Diazinon results in decreased methylation of AQP7 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3573,344105,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),Diazinon inhibits the reaction [dihydrotestosterone results in increased activity of AR protein],,,PMID:28728110,https://www.ncbi.nlm.nih.gov/pubmed/28728110,28728110,,
3574,344106,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,369,ARAF,https://ctdbase.org/detail.go?type=gene&acc=369,,,369.0,ARAF,9606.0,Homo sapiens (human),Diazinon results in increased methylation of ARAF gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3575,344107,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,369,ARAF,https://ctdbase.org/detail.go?type=gene&acc=369,,,369.0,ARAF,10116.0,Rattus norvegicus (Norway rat),Diazinon affects the expression of ARAF mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
3576,344108,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,27236,ARFIP1,https://ctdbase.org/detail.go?type=gene&acc=27236,,,27236.0,ARFIP1,9606.0,Homo sapiens (human),Diazinon results in increased methylation of ARFIP1 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3577,344109,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,383,ARG1,https://ctdbase.org/detail.go?type=gene&acc=383,,,383.0,ARG1,10116.0,Rattus norvegicus (Norway rat),Diazinon affects the expression of ARG1 mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
3578,344110,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,23526,ARHGAP45,https://ctdbase.org/detail.go?type=gene&acc=23526,,,23526.0,ARHGAP45,9606.0,Homo sapiens (human),Diazinon results in increased methylation of ARHGAP45 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3579,345756,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,83596,BCL2L12,https://ctdbase.org/detail.go?type=gene&acc=83596,,,83596.0,BCL2L12,9606.0,Homo sapiens (human),Diazinon results in increased methylation of BCL2L12 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3580,345757,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,23786,BCL2L13,https://ctdbase.org/detail.go?type=gene&acc=23786,,,23786.0,BCL2L13,9606.0,Homo sapiens (human),Diazinon results in increased methylation of BCL2L13 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3581,345758,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,23786,BCL2L13,https://ctdbase.org/detail.go?type=gene&acc=23786,,,23786.0,BCL2L13,10116.0,Rattus norvegicus (Norway rat),Diazinon affects the expression of BCL2L13 mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
3582,345759,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,602,BCL3,https://ctdbase.org/detail.go?type=gene&acc=602,,,602.0,BCL3,9606.0,Homo sapiens (human),Diazinon results in increased methylation of BCL3 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3583,345760,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,604,BCL6,https://ctdbase.org/detail.go?type=gene&acc=604,,,604.0,BCL6,10116.0,Rattus norvegicus (Norway rat),Diazinon affects the expression of BCL6 mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
3584,345761,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,605,BCL7A,https://ctdbase.org/detail.go?type=gene&acc=605,,,605.0,BCL7A,9606.0,Homo sapiens (human),Diazinon results in increased methylation of BCL7A gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3585,347751,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,901,CCNG2,https://ctdbase.org/detail.go?type=gene&acc=901,,,901.0,CCNG2,9606.0,Homo sapiens (human),Diazinon results in increased expression of CCNG2 mRNA,,,PMID:24356939,https://www.ncbi.nlm.nih.gov/pubmed/24356939,24356939,,
3586,347752,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,902,CCNH,https://ctdbase.org/detail.go?type=gene&acc=902,,,902.0,CCNH,10116.0,Rattus norvegicus (Norway rat),Diazinon affects the expression of CCNH mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
3587,350264,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,7461,CLIP2,https://ctdbase.org/detail.go?type=gene&acc=7461,,,7461.0,CLIP2,9606.0,Homo sapiens (human),Diazinon results in decreased methylation of CLIP2 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3588,350265,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,57393,CLTRN,https://ctdbase.org/detail.go?type=gene&acc=57393,,,57393.0,CLTRN,10116.0,Rattus norvegicus (Norway rat),Diazinon results in decreased expression of CLTRN mRNA,,,PMID:29108742,https://www.ncbi.nlm.nih.gov/pubmed/29108742,29108742,,
3589,350266,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,23070,CMTR1,https://ctdbase.org/detail.go?type=gene&acc=23070,,,23070.0,CMTR1,9606.0,Homo sapiens (human),Diazinon results in increased methylation of CMTR1 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3590,350267,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,55748,CNDP2,https://ctdbase.org/detail.go?type=gene&acc=55748,,,55748.0,CNDP2,9606.0,Homo sapiens (human),Diazinon results in increased methylation of CNDP2 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3591,350268,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,84518,CNFN,https://ctdbase.org/detail.go?type=gene&acc=84518,,,84518.0,CNFN,9606.0,Homo sapiens (human),Diazinon results in increased methylation of CNFN gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3592,350269,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,22866,CNKSR2,https://ctdbase.org/detail.go?type=gene&acc=22866,,,22866.0,CNKSR2,9606.0,Homo sapiens (human),Diazinon results in decreased methylation of CNKSR2 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3593,355824,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2299,FOXI1,https://ctdbase.org/detail.go?type=gene&acc=2299,,,2299.0,FOXI1,9606.0,Homo sapiens (human),Diazinon results in increased methylation of FOXI1 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3594,355825,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2305,FOXM1,https://ctdbase.org/detail.go?type=gene&acc=2305,,,2305.0,FOXM1,9606.0,Homo sapiens (human),Diazinon results in increased methylation of FOXM1 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3595,355826,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,10116.0,Rattus norvegicus (Norway rat),Diazinon results in increased expression of FOXO1 mRNA,,,PMID:30359674|PMID:35403302,https://www.ncbi.nlm.nih.gov/pubmed/30359674|https://www.ncbi.nlm.nih.gov/pubmed/35403302,30359674|35403302,,
3596,355827,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,10116.0,Rattus norvegicus (Norway rat),[dietary fats co-treated with diazinon] results in increased expression of FOXO1 mRNA,,,PMID:30359674,https://www.ncbi.nlm.nih.gov/pubmed/30359674,30359674,,
3597,355828,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2308,FOXO1,https://ctdbase.org/detail.go?type=gene&acc=2308,,,2308.0,FOXO1,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [diazinon results in increased expression of FOXO1 mrna],,,PMID:35403302,https://www.ncbi.nlm.nih.gov/pubmed/35403302,35403302,,
3598,355829,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9606.0,Homo sapiens (human),Diazinon results in increased methylation of FOXO3 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3599,355830,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,93986,FOXP2,https://ctdbase.org/detail.go?type=gene&acc=93986,,,93986.0,FOXP2,10116.0,Rattus norvegicus (Norway rat),Diazinon results in increased expression of FOXP2 mRNA,,,PMID:29108742,https://www.ncbi.nlm.nih.gov/pubmed/29108742,29108742,,
3600,355831,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,50943,FOXP3,https://ctdbase.org/detail.go?type=gene&acc=50943,,,50943.0,FOXP3,10090.0,Mus musculus (house mouse),Diazinon results in decreased expression of FOXP3 mrna|chrysin inhibits the reaction [diazinon results in decreased expression of FOXP3 mrna],,,PMID:36114367,https://www.ncbi.nlm.nih.gov/pubmed/36114367,36114367,,
3601,355832,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,6624,FSCN1,https://ctdbase.org/detail.go?type=gene&acc=6624,,,6624.0,FSCN1,9606.0,Homo sapiens (human),Diazinon results in increased methylation of FSCN1 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3602,355833,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,282969,FUOM,https://ctdbase.org/detail.go?type=gene&acc=282969,,,282969.0,FUOM,9606.0,Homo sapiens (human),Diazinon results in increased methylation of FUOM gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3603,356466,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2588,GALNS,https://ctdbase.org/detail.go?type=gene&acc=2588,,,2588.0,GALNS,9606.0,Homo sapiens (human),Diazinon results in increased methylation of GALNS gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3604,356467,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,374378,GALNT18,https://ctdbase.org/detail.go?type=gene&acc=374378,,,374378.0,GALNT18,9606.0,Homo sapiens (human),Diazinon results in increased methylation of GALNT18 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3605,356468,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2592,GALT,https://ctdbase.org/detail.go?type=gene&acc=2592,,,2592.0,GALT,9606.0,Homo sapiens (human),Diazinon results in increased methylation of GALT gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3606,356469,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2596,GAP43,https://ctdbase.org/detail.go?type=gene&acc=2596,,,2596.0,GAP43,10116.0,Rattus norvegicus (Norway rat),Diazinon results in increased expression of GAP43 mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
3607,356470,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,10116.0,Rattus norvegicus (Norway rat),Diazinon affects the expression of GAPDH mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
3608,356471,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,84253,GARNL3,https://ctdbase.org/detail.go?type=gene&acc=84253,,,84253.0,GARNL3,10116.0,Rattus norvegicus (Norway rat),Diazinon results in increased expression of GARNL3 mRNA,,,PMID:29108742,https://www.ncbi.nlm.nih.gov/pubmed/29108742,29108742,,
3609,356472,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,10634,GAS2L1,https://ctdbase.org/detail.go?type=gene&acc=10634,,,10634.0,GAS2L1,9606.0,Homo sapiens (human),Diazinon results in increased methylation of GAS2L1 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3610,356747,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,9606.0,Homo sapiens (human),Diazinon results in increased expression of GCLM mRNA,,,PMID:26198647,https://www.ncbi.nlm.nih.gov/pubmed/26198647,26198647,,
3611,356748,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2651,GCNT2,https://ctdbase.org/detail.go?type=gene&acc=2651,,,2651.0,GCNT2,9606.0,Homo sapiens (human),Diazinon results in increased methylation of GCNT2 gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3612,356749,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,9245,GCNT3,https://ctdbase.org/detail.go?type=gene&acc=9245,,,9245.0,GCNT3,9606.0,Homo sapiens (human),Diazinon results in increased expression of GCNT3 mRNA,,,PMID:26198647,https://www.ncbi.nlm.nih.gov/pubmed/26198647,26198647,,
3613,356750,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,8200,GDF5,https://ctdbase.org/detail.go?type=gene&acc=8200,,,8200.0,GDF5,10116.0,Rattus norvegicus (Norway rat),Diazinon affects the expression of GDF5 mRNA,,,PMID:22546817,https://www.ncbi.nlm.nih.gov/pubmed/22546817,22546817,,
3614,358114,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2902,GRIN1,https://ctdbase.org/detail.go?type=gene&acc=2902,,,2902.0,GRIN1,10090.0,Mus musculus (house mouse),Diazinon results in decreased expression of GRIN1 mRNA,,,PMID:23212306,https://www.ncbi.nlm.nih.gov/pubmed/23212306,23212306,,
3615,358115,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,10116.0,Rattus norvegicus (Norway rat),Diazinon affects the expression of GRIN2A mRNA,,,PMID:19440498,https://www.ncbi.nlm.nih.gov/pubmed/19440498,19440498,,
3616,358116,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,10116.0,Rattus norvegicus (Norway rat),Diazinon results in increased expression of GRIN2A mRNA,,,PMID:17452286,https://www.ncbi.nlm.nih.gov/pubmed/17452286,17452286,,
3617,358117,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10090.0,Mus musculus (house mouse),Diazinon results in decreased expression of GRIN2B mRNA,,,PMID:23212306,https://www.ncbi.nlm.nih.gov/pubmed/23212306,23212306,,
3618,358118,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10116.0,Rattus norvegicus (Norway rat),Diazinon results in decreased expression of GRIN2B mRNA,,,PMID:19440498,https://www.ncbi.nlm.nih.gov/pubmed/19440498,19440498,,
3619,358119,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2905,GRIN2C,https://ctdbase.org/detail.go?type=gene&acc=2905,,,2905.0,GRIN2C,10116.0,Rattus norvegicus (Norway rat),Diazinon results in increased expression of GRIN2C mRNA,,,PMID:17452286|PMID:19440498,https://www.ncbi.nlm.nih.gov/pubmed/17452286|https://www.ncbi.nlm.nih.gov/pubmed/19440498,17452286|19440498,,
3620,358120,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2906,GRIN2D,https://ctdbase.org/detail.go?type=gene&acc=2906,,,2906.0,GRIN2D,10116.0,Rattus norvegicus (Norway rat),Diazinon results in decreased expression of GRIN2D mRNA,,,PMID:19440498,https://www.ncbi.nlm.nih.gov/pubmed/19440498,19440498,,
3621,358121,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,2907,GRINA,https://ctdbase.org/detail.go?type=gene&acc=2907,,,2907.0,GRINA,10116.0,Rattus norvegicus (Norway rat),Diazinon results in increased expression of GRINA mRNA,,,PMID:19440498,https://www.ncbi.nlm.nih.gov/pubmed/19440498,19440498,,
3622,359229,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,57467,HHATL,https://ctdbase.org/detail.go?type=gene&acc=57467,,,57467.0,HHATL,9606.0,Homo sapiens (human),Diazinon results in increased methylation of HHATL gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3623,359230,3017,Comparative Toxicogenomics Database (CTD),Diazinon,D003976,Diazinon,https://ctdbase.org/detail.go?type=chem&acc=D003976,3087,HHEX,https://ctdbase.org/detail.go?type=gene&acc=3087,,,3087.0,HHEX,9606.0,Homo sapiens (human),Diazinon results in increased methylation of HHEX gene,,,PMID:22964155,https://www.ncbi.nlm.nih.gov/pubmed/22964155,22964155,,
3624,247735,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5361,PLXNA1,https://ctdbase.org/detail.go?type=gene&acc=5361,,,5361.0,PLXNA1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PLXNA1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3625,247736,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,56937,PMEPA1,https://ctdbase.org/detail.go?type=gene&acc=56937,,,56937.0,PMEPA1,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of PMEPA1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3626,247737,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,11243,PMF1,https://ctdbase.org/detail.go?type=gene&acc=11243,,,11243.0,PMF1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PMF1 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3627,247738,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,11243,PMF1,https://ctdbase.org/detail.go?type=gene&acc=11243,,,11243.0,PMF1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of PMF1 mRNA,,,PMID:17361019,https://www.ncbi.nlm.nih.gov/pubmed/17361019,17361019,,
3628,247739,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5372,PMM1,https://ctdbase.org/detail.go?type=gene&acc=5372,,,5372.0,PMM1,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of PMM1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3629,247740,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376.0,PMP22,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate affects the expression of PMP22 mRNA,,,PMID:21745491,https://www.ncbi.nlm.nih.gov/pubmed/21745491,21745491,,
3630,247741,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5376,PMP22,https://ctdbase.org/detail.go?type=gene&acc=5376,,,5376.0,PMP22,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of PMP22 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3631,247742,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5378,PMS1,https://ctdbase.org/detail.go?type=gene&acc=5378,,,5378.0,PMS1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PMS1 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3632,249433,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10116.0,Rattus norvegicus (Norway rat),Taxifolin inhibits the reaction [dibutyl phthalate results in decreased expression of PPARGC1A protein]|dibutyl phthalate results in decreased expression of PPARGC1A protein,,,PMID:32525071,https://www.ncbi.nlm.nih.gov/pubmed/32525071,32525071,,
3633,249434,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,79717,PPCS,https://ctdbase.org/detail.go?type=gene&acc=79717,,,79717.0,PPCS,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PPCS mRNA,,,PMID:17361019,https://www.ncbi.nlm.nih.gov/pubmed/17361019,17361019,,
3634,249435,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,79144,PPDPF,https://ctdbase.org/detail.go?type=gene&acc=79144,,,79144.0,PPDPF,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PPDPF mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3635,249436,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,8496,PPFIBP1,https://ctdbase.org/detail.go?type=gene&acc=8496,,,8496.0,PPFIBP1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of PPFIBP1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3636,250488,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5565,PRKAB2,https://ctdbase.org/detail.go?type=gene&acc=5565,,,5565.0,PRKAB2,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of PRKAB2 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3637,250489,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5566,PRKACA,https://ctdbase.org/detail.go?type=gene&acc=5566,,,5566.0,PRKACA,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PRKACA protein,,,PMID:36602389,https://www.ncbi.nlm.nih.gov/pubmed/36602389,36602389,,
3638,250490,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5575,PRKAR1B,https://ctdbase.org/detail.go?type=gene&acc=5575,,,5575.0,PRKAR1B,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of PRKAR1B mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3639,250491,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5576,PRKAR2A,https://ctdbase.org/detail.go?type=gene&acc=5576,,,5576.0,PRKAR2A,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of PRKAR2A mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3640,250492,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5577,PRKAR2B,https://ctdbase.org/detail.go?type=gene&acc=5577,,,5577.0,PRKAR2B,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of PRKAR2B mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3641,250493,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of PRKCA mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3642,250494,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of PRKCD mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3643,250495,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5581,PRKCE,https://ctdbase.org/detail.go?type=gene&acc=5581,,,5581.0,PRKCE,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PRKCE mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3644,304499,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5050,PAFAH1B3,https://ctdbase.org/detail.go?type=gene&acc=5050,,,5050.0,PAFAH1B3,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PAFAH1B3 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3645,307041,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,5251,PHEX,https://ctdbase.org/detail.go?type=gene&acc=5251,,,5251.0,PHEX,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of PHEX mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3646,307042,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,148479,PHF13,https://ctdbase.org/detail.go?type=gene&acc=148479,,,148479.0,PHF13,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PHF13 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3647,307043,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,51105,PHF20L1,https://ctdbase.org/detail.go?type=gene&acc=51105,,,51105.0,PHF20L1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of PHF20L1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3648,307044,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,26227,PHGDH,https://ctdbase.org/detail.go?type=gene&acc=26227,,,26227.0,PHGDH,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of PHGDH mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3649,307045,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,26227,PHGDH,https://ctdbase.org/detail.go?type=gene&acc=26227,,,26227.0,PHGDH,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of PHGDH mRNA,,,PMID:17379624,https://www.ncbi.nlm.nih.gov/pubmed/17379624,17379624,,
3650,307046,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,55023,PHIP,https://ctdbase.org/detail.go?type=gene&acc=55023,,,55023.0,PHIP,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of PHIP mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3651,340510,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,6809,STX3,https://ctdbase.org/detail.go?type=gene&acc=6809,,,6809.0,STX3,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of STX3 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3652,340511,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,56389,STX5A,https://ctdbase.org/detail.go?type=gene&acc=56389,,,56389.0,Stx5a,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of STX5A mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3653,340655,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,3216,HOXB6,https://ctdbase.org/detail.go?type=gene&acc=3216,,,3216.0,HOXB6,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with diethylhexyl phthalate co-treated with dibutyl phthalate] affects the methylation of HOXB6 promoter,,,PMID:23359474,https://www.ncbi.nlm.nih.gov/pubmed/23359474,23359474,,
3654,340656,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,3218,HOXB8,https://ctdbase.org/detail.go?type=gene&acc=3218,,,3218.0,HOXB8,10116.0,Rattus norvegicus (Norway rat),[diethyl phthalate co-treated with diethylhexyl phthalate co-treated with dibutyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXB8 mRNA,,,PMID:31199487,https://www.ncbi.nlm.nih.gov/pubmed/31199487,31199487,,
3655,340657,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,3239,HOXD13,https://ctdbase.org/detail.go?type=gene&acc=3239,,,3239.0,HOXD13,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of HOXD13 mRNA,,,PMID:25213187|PMID:27079746,https://www.ncbi.nlm.nih.gov/pubmed/25213187|https://www.ncbi.nlm.nih.gov/pubmed/27079746,25213187|27079746,,
3656,340826,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,84343,HPS3,https://ctdbase.org/detail.go?type=gene&acc=84343,,,84343.0,HPS3,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of HPS3 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3657,340827,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,79803,HPS6,https://ctdbase.org/detail.go?type=gene&acc=79803,,,79803.0,HPS6,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of HPS6 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3658,340828,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,10855,HPSE,https://ctdbase.org/detail.go?type=gene&acc=10855,,,10855.0,HPSE,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of HPSE mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3659,340829,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,8739,HRK,https://ctdbase.org/detail.go?type=gene&acc=8739,,,8739.0,HRK,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of HRK mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3660,342861,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,3481,IGF2,https://ctdbase.org/detail.go?type=gene&acc=3481,,,3481.0,IGF2,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of IGF2 mRNA,,,PMID:15829613|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/15829613|https://www.ncbi.nlm.nih.gov/pubmed/21266533,15829613|21266533,,
3661,342862,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,10642,IGF2BP1,https://ctdbase.org/detail.go?type=gene&acc=10642,,,10642.0,IGF2BP1,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with diethylhexyl phthalate co-treated with dibutyl phthalate] affects the methylation of IGF2BP1 promoter,,,PMID:23359474,https://www.ncbi.nlm.nih.gov/pubmed/23359474,23359474,,
3662,342863,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,10643,IGF2BP3,https://ctdbase.org/detail.go?type=gene&acc=10643,,,10643.0,IGF2BP3,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of IGF2BP3 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3663,342864,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,3482,IGF2R,https://ctdbase.org/detail.go?type=gene&acc=3482,,,3482.0,IGF2R,10116.0,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of IGF2R mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
3664,342865,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,3485,IGFBP2,https://ctdbase.org/detail.go?type=gene&acc=3485,,,3485.0,IGFBP2,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of IGFBP2 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3665,342866,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,3488,IGFBP5,https://ctdbase.org/detail.go?type=gene&acc=3488,,,3488.0,IGFBP5,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of IGFBP5 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3666,342867,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,3488,IGFBP5,https://ctdbase.org/detail.go?type=gene&acc=3488,,,3488.0,IGFBP5,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of IGFBP5 mRNA,,,PMID:15829613,https://www.ncbi.nlm.nih.gov/pubmed/15829613,15829613,,
3667,342868,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,3490,IGFBP7,https://ctdbase.org/detail.go?type=gene&acc=3490,,,3490.0,IGFBP7,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of IGFBP7 mRNA,,,PMID:19560483,https://www.ncbi.nlm.nih.gov/pubmed/19560483,19560483,,
3668,345465,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,133746,JMY,https://ctdbase.org/detail.go?type=gene&acc=133746,,,133746.0,JMY,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of JMY mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3669,345466,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,9929,JOSD1,https://ctdbase.org/detail.go?type=gene&acc=9929,,,9929.0,JOSD1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of JOSD1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3670,345467,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,57158,JPH2,https://ctdbase.org/detail.go?type=gene&acc=57158,,,57158.0,JPH2,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of JPH2 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3671,345468,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,57338,JPH3,https://ctdbase.org/detail.go?type=gene&acc=57338,,,57338.0,JPH3,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of JPH3 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3672,345469,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,51155,JPT1,https://ctdbase.org/detail.go?type=gene&acc=51155,,,51155.0,JPT1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of JPT1 mRNA,,,PMID:17361019,https://www.ncbi.nlm.nih.gov/pubmed/17361019,17361019,,
3673,345470,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,51155,JPT1,https://ctdbase.org/detail.go?type=gene&acc=51155,,,51155.0,JPT1,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of JPT1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3674,345963,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,55365,TMEM176A,https://ctdbase.org/detail.go?type=gene&acc=55365,,,55365.0,TMEM176A,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of TMEM176A mrna|dibutyl phthalate results in increased expression of TMEM176A mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3675,345964,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,28959,TMEM176B,https://ctdbase.org/detail.go?type=gene&acc=28959,,,28959.0,TMEM176B,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of TMEM176B mrna|dibutyl phthalate results in increased expression of TMEM176B mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3676,345965,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,68027,TMEM178,https://ctdbase.org/detail.go?type=gene&acc=68027,,,68027.0,Tmem178,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of TMEM178 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3677,345966,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,202915,TMEM184A,https://ctdbase.org/detail.go?type=gene&acc=202915,,,202915.0,TMEM184A,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of TMEM184A mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3678,345967,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,84548,TMEM185A,https://ctdbase.org/detail.go?type=gene&acc=84548,,,84548.0,TMEM185A,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of TMEM185A mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3679,345968,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,79134,TMEM185B,https://ctdbase.org/detail.go?type=gene&acc=79134,,,79134.0,TMEM185B,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of TMEM185B mrna|dibutyl phthalate results in decreased expression of TMEM185B mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3680,345969,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,25880,TMEM186,https://ctdbase.org/detail.go?type=gene&acc=25880,,,25880.0,TMEM186,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of TMEM186 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3681,346601,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,57156,TMEM63C,https://ctdbase.org/detail.go?type=gene&acc=57156,,,57156.0,TMEM63C,10116.0,Rattus norvegicus (Norway rat),[diethyl phthalate co-treated with diethylhexyl phthalate co-treated with dibutyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM63C mRNA,,,PMID:31199487,https://www.ncbi.nlm.nih.gov/pubmed/31199487,31199487,,
3682,346602,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,157378,TMEM65,https://ctdbase.org/detail.go?type=gene&acc=157378,,,157378.0,TMEM65,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of TMEM65 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3683,346603,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,137835,TMEM71,https://ctdbase.org/detail.go?type=gene&acc=137835,,,137835.0,TMEM71,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of TMEM71 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3684,346604,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,144110,TMEM86A,https://ctdbase.org/detail.go?type=gene&acc=144110,,,144110.0,TMEM86A,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of TMEM86A mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3685,346605,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,252839,TMEM9,https://ctdbase.org/detail.go?type=gene&acc=252839,,,252839.0,TMEM9,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of TMEM9 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3686,346606,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,27346,TMEM97,https://ctdbase.org/detail.go?type=gene&acc=27346,,,27346.0,TMEM97,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of TMEM97 mRNA,,,PMID:17361019,https://www.ncbi.nlm.nih.gov/pubmed/17361019,17361019,,
3687,346607,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,27346,TMEM97,https://ctdbase.org/detail.go?type=gene&acc=27346,,,27346.0,TMEM97,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of TMEM97 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3688,346608,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,56674,TMEM9B,https://ctdbase.org/detail.go?type=gene&acc=56674,,,56674.0,TMEM9B,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of TMEM9B mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3689,346609,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,259236,TMIE,https://ctdbase.org/detail.go?type=gene&acc=259236,,,259236.0,TMIE,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of TMIE mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3690,346610,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,7111,TMOD1,https://ctdbase.org/detail.go?type=gene&acc=7111,,,7111.0,TMOD1,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of TMOD1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3691,347237,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,27242,TNFRSF21,https://ctdbase.org/detail.go?type=gene&acc=27242,,,27242.0,TNFRSF21,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of TNFRSF21 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3692,347238,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,8600,TNFSF11,https://ctdbase.org/detail.go?type=gene&acc=8600,,,8600.0,TNFSF11,9606.0,Homo sapiens (human),3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [dibutyl phthalate results in increased expression of TNFSF11 mrna]|dibutyl phthalate results in increased expression of TNFSF11 mrna|dibutyl phthalate results in increased expression of and results in increased secretion of TNFSF11 protein|3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [dibutyl phthalate results in increased expression of TNFSF11 protein]|dibutyl phthalate results in increased expression of TNFSF11 protein,,,PMID:35605887,https://www.ncbi.nlm.nih.gov/pubmed/35605887,35605887,,
3693,350440,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,7102,TSPAN7,https://ctdbase.org/detail.go?type=gene&acc=7102,,,7102.0,TSPAN7,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of TSPAN7 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3694,350441,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,10867,TSPAN9,https://ctdbase.org/detail.go?type=gene&acc=10867,,,10867.0,TSPAN9,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of TSPAN9 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3695,350442,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,706,TSPO,https://ctdbase.org/detail.go?type=gene&acc=706,,,706.0,TSPO,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of TSPO mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3696,350443,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,706,TSPO,https://ctdbase.org/detail.go?type=gene&acc=706,,,706.0,TSPO,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of TSPO mrna|dibutyl phthalate results in decreased expression of TSPO protein,,,PMID:15141095|PMID:21745491,https://www.ncbi.nlm.nih.gov/pubmed/15141095|https://www.ncbi.nlm.nih.gov/pubmed/21745491,15141095|21745491,,
3697,350444,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,241732,TSPYL3,https://ctdbase.org/detail.go?type=gene&acc=241732,,,241732.0,Tspyl3,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of TSPYL3 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3698,350445,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,22109,TSPY-PS,https://ctdbase.org/detail.go?type=gene&acc=22109,,,22109.0,Tspy-ps,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of TSPY-PS mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3699,350446,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,10078,TSSC4,https://ctdbase.org/detail.go?type=gene&acc=10078,,,10078.0,TSSC4,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of TSSC4 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3700,350447,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,73542,TSSK5,https://ctdbase.org/detail.go?type=gene&acc=73542,,,73542.0,Tssk5,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of TSSK5 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3701,351571,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,7298,TYMS,https://ctdbase.org/detail.go?type=gene&acc=7298,,,7298.0,TYMS,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of TYMS mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3702,351572,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,219743,TYSND1,https://ctdbase.org/detail.go?type=gene&acc=219743,,,219743.0,TYSND1,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of TYSND1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3703,351573,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,127253,TYW3,https://ctdbase.org/detail.go?type=gene&acc=127253,,,127253.0,TYW3,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of TYW3 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3704,351574,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,7307,U2AF1,https://ctdbase.org/detail.go?type=gene&acc=7307,,,7307.0,U2AF1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of U2AF1 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3705,351575,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,11338,U2AF2,https://ctdbase.org/detail.go?type=gene&acc=11338,,,11338.0,U2AF2,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of U2AF2 mRNA,,,PMID:17361019,https://www.ncbi.nlm.nih.gov/pubmed/17361019,17361019,,
3706,354656,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,7450,VWF,https://ctdbase.org/detail.go?type=gene&acc=7450,,,7450.0,VWF,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in decreased expression of VWF mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3707,354657,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,8936,WASF1,https://ctdbase.org/detail.go?type=gene&acc=8936,,,8936.0,WASF1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of WASF1 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3708,354658,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,100287171,WASHC1,https://ctdbase.org/detail.go?type=gene&acc=100287171,,,100287171.0,WASHC1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of WASHC1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3709,354659,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,8976,WASL,https://ctdbase.org/detail.go?type=gene&acc=8976,,,8976.0,WASL,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in increased expression of WASL mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3710,354660,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,23559,WBP1,https://ctdbase.org/detail.go?type=gene&acc=23559,,,23559.0,WBP1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of WBP1 mRNA,,,PMID:17361019|PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/17361019|https://www.ncbi.nlm.nih.gov/pubmed/21266533,17361019|21266533,,
3711,354661,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,11169,WDHD1,https://ctdbase.org/detail.go?type=gene&acc=11169,,,11169.0,WDHD1,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of WDHD1 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3712,357847,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,678,ZFP36L2,https://ctdbase.org/detail.go?type=gene&acc=678,,,678.0,ZFP36L2,10116.0,Rattus norvegicus (Norway rat),Dibutyl phthalate results in increased expression of ZFP36L2 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3713,357848,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,380912,ZFP395,https://ctdbase.org/detail.go?type=gene&acc=380912,,,380912.0,Zfp395,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of ZFP395 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3714,357849,3026,Comparative Toxicogenomics Database (CTD),Dibutyl Phthalate,D003993,Dibutyl Phthalate,https://ctdbase.org/detail.go?type=chem&acc=D003993,286128,ZFP41,https://ctdbase.org/detail.go?type=gene&acc=286128,,,286128.0,ZFP41,10090.0,Mus musculus (house mouse),Dibutyl phthalate results in decreased expression of ZFP41 mRNA,,,PMID:21266533,https://www.ncbi.nlm.nih.gov/pubmed/21266533,21266533,,
3715,297236,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090.0,Mus musculus (house mouse),Diclofenac affects the expression of CCND1 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3716,297237,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,9606.0,Homo sapiens (human),Diclofenac affects the expression of CCND3 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3717,297238,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),Diclofenac affects the expression of CCNE1 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3718,298879,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1491,CTH,https://ctdbase.org/detail.go?type=gene&acc=1491,,,1491.0,CTH,10090.0,Mus musculus (house mouse),Diclofenac results in decreased expression of CTH mRNA,,,PMID:35537566,https://www.ncbi.nlm.nih.gov/pubmed/35537566,35537566,,
3719,298880,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1493,CTLA4,https://ctdbase.org/detail.go?type=gene&acc=1493,,,1493.0,CTLA4,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of CTLA4 protein,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3720,298881,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Diclofenac affects the expression of CTNNB1 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3721,298882,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1503,CTPS1,https://ctdbase.org/detail.go?type=gene&acc=1503,,,1503.0,CTPS1,9606.0,Homo sapiens (human),Diclofenac affects the expression of CTPS1 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3722,298883,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,56474,CTPS2,https://ctdbase.org/detail.go?type=gene&acc=56474,,,56474.0,CTPS2,9606.0,Homo sapiens (human),Diclofenac affects the expression of CTPS2 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3723,298884,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1075,CTSC,https://ctdbase.org/detail.go?type=gene&acc=1075,,,1075.0,CTSC,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of CTSC mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3724,298885,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,1510,CTSE,https://ctdbase.org/detail.go?type=gene&acc=1510,,,1510.0,CTSE,10090.0,Mus musculus (house mouse),Diclofenac results in decreased expression of CTSE mRNA,,,PMID:35537566,https://www.ncbi.nlm.nih.gov/pubmed/35537566,35537566,,
3725,298886,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,26898,CTSJ,https://ctdbase.org/detail.go?type=gene&acc=26898,,,26898.0,Ctsj,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of CTSJ mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3726,298887,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,8452,CUL3,https://ctdbase.org/detail.go?type=gene&acc=8452,,,8452.0,CUL3,9606.0,Homo sapiens (human),Diclofenac affects the expression of CUL3 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3727,298888,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,9820,CUL7,https://ctdbase.org/detail.go?type=gene&acc=9820,,,9820.0,CUL7,10090.0,Mus musculus (house mouse),Diclofenac results in decreased expression of CUL7 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3728,301629,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,3337,DNAJB1,https://ctdbase.org/detail.go?type=gene&acc=3337,,,3337.0,DNAJB1,9606.0,Homo sapiens (human),Diclofenac affects the expression of DNAJB1 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3729,301630,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,79982,DNAJB14,https://ctdbase.org/detail.go?type=gene&acc=79982,,,79982.0,DNAJB14,9606.0,Homo sapiens (human),Diclofenac affects the expression of DNAJB14 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3730,301631,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,11080,DNAJB4,https://ctdbase.org/detail.go?type=gene&acc=11080,,,11080.0,DNAJB4,9606.0,Homo sapiens (human),Diclofenac affects the expression of DNAJB4 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3731,301632,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,10049,DNAJB6,https://ctdbase.org/detail.go?type=gene&acc=10049,,,10049.0,DNAJB6,9606.0,Homo sapiens (human),Diclofenac affects the expression of DNAJB6 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3732,301633,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,150353,DNAJB7,https://ctdbase.org/detail.go?type=gene&acc=150353,,,150353.0,DNAJB7,10116.0,Rattus norvegicus (Norway rat),Diclofenac results in increased expression of DNAJB7 mRNA,,,PMID:30723492,https://www.ncbi.nlm.nih.gov/pubmed/30723492,30723492,,
3733,301634,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,4189,DNAJB9,https://ctdbase.org/detail.go?type=gene&acc=4189,,,4189.0,DNAJB9,9606.0,Homo sapiens (human),Diclofenac affects the expression of DNAJB9 mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3734,301635,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,4189,DNAJB9,https://ctdbase.org/detail.go?type=gene&acc=4189,,,4189.0,DNAJB9,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of DNAJB9 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3735,303152,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,64850,ETNPPL,https://ctdbase.org/detail.go?type=gene&acc=64850,,,64850.0,ETNPPL,10090.0,Mus musculus (house mouse),Diclofenac results in decreased expression of ETNPPL mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3736,303153,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,7813,EVI5,https://ctdbase.org/detail.go?type=gene&acc=7813,,,7813.0,EVI5,10090.0,Mus musculus (house mouse),Diclofenac results in decreased expression of EVI5 mRNA,,,PMID:35537566,https://www.ncbi.nlm.nih.gov/pubmed/35537566,35537566,,
3737,303154,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,2134,EXTL1,https://ctdbase.org/detail.go?type=gene&acc=2134,,,2134.0,EXTL1,10090.0,Mus musculus (house mouse),Diclofenac results in decreased expression of EXTL1 mRNA,,,PMID:35537566,https://www.ncbi.nlm.nih.gov/pubmed/35537566,35537566,,
3738,303155,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,2070,EYA4,https://ctdbase.org/detail.go?type=gene&acc=2070,,,2070.0,EYA4,10090.0,Mus musculus (house mouse),Diclofenac results in decreased expression of EYA4 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3739,303156,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,2162,F13A1,https://ctdbase.org/detail.go?type=gene&acc=2162,,,2162.0,F13A1,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of F13A1 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3740,303157,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,91442,FAAP24,https://ctdbase.org/detail.go?type=gene&acc=91442,,,91442.0,FAAP24,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of FAAP24 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3741,303158,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,9606.0,Homo sapiens (human),Diclofenac results in decreased expression of FABP1 mRNA,,,PMID:19022234,https://www.ncbi.nlm.nih.gov/pubmed/19022234,19022234,,
3742,303159,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,10090.0,Mus musculus (house mouse),Diclofenac results in increased expression of FABP1 protein,,,PMID:23506792,https://www.ncbi.nlm.nih.gov/pubmed/23506792,23506792,,
3743,303160,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,171481,FABP10A,https://ctdbase.org/detail.go?type=gene&acc=171481,,,171481.0,fabp10a,7955.0,Danio rerio (zebrafish),Diclofenac results in decreased expression of FABP10A mRNA,,,PMID:25663337,https://www.ncbi.nlm.nih.gov/pubmed/25663337,25663337,,
3744,303161,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,2169,FABP2,https://ctdbase.org/detail.go?type=gene&acc=2169,,,2169.0,FABP2,10090.0,Mus musculus (house mouse),Diclofenac results in decreased expression of FABP2 mRNA,,,PMID:26934552,https://www.ncbi.nlm.nih.gov/pubmed/26934552,26934552,,
3745,303340,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,2189,FANCG,https://ctdbase.org/detail.go?type=gene&acc=2189,,,2189.0,FANCG,9606.0,Homo sapiens (human),Diclofenac affects the expression of FANCG mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3746,303341,3033,Comparative Toxicogenomics Database (CTD),Diclofenac,D004008,Diclofenac,https://ctdbase.org/detail.go?type=chem&acc=D004008,55120,FANCL,https://ctdbase.org/detail.go?type=gene&acc=55120,,,55120.0,FANCL,9606.0,Homo sapiens (human),Diclofenac affects the expression of FANCL mRNA,,,PMID:24752500,https://www.ncbi.nlm.nih.gov/pubmed/24752500,24752500,,
3747,341245,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,35587,CYP6A2,https://ctdbase.org/detail.go?type=gene&acc=35587,,,35587.0,Cyp6a2,7227.0,Drosophila melanogaster (fruit fly),DDT results in increased expression of CYP6A2 mRNA,,,PMID:20582327,https://www.ncbi.nlm.nih.gov/pubmed/20582327,20582327,,
3748,341246,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,36666,CYP6A8,https://ctdbase.org/detail.go?type=gene&acc=36666,,,36666.0,Cyp6a8,7227.0,Drosophila melanogaster (fruit fly),CYP6A8 protein affects the susceptibility to DDT,,,PMID:12826097,https://www.ncbi.nlm.nih.gov/pubmed/12826097,12826097,,
3749,344588,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,9446,GSTO1,https://ctdbase.org/detail.go?type=gene&acc=9446,,,9446.0,GSTO1,9606.0,Homo sapiens (human),DDT results in increased expression of GSTO1 mRNA,,,PMID:31521043,https://www.ncbi.nlm.nih.gov/pubmed/31521043,31521043,,
3750,344589,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,8338,H2AC20,https://ctdbase.org/detail.go?type=gene&acc=8338,,,8338.0,H2AC20,10116.0,Rattus norvegicus (Norway rat),DDT results in decreased expression of H2AC20 mRNA,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3751,344590,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,64224,HERPUD2,https://ctdbase.org/detail.go?type=gene&acc=64224,,,64224.0,HERPUD2,10116.0,Rattus norvegicus (Norway rat),DDT results in increased methylation of HERPUD2 gene,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3752,344591,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,3082,HGF,https://ctdbase.org/detail.go?type=gene&acc=3082,,,3082.0,HGF,9606.0,Homo sapiens (human),DDT results in decreased expression of HGF mRNA,,,PMID:25014179,https://www.ncbi.nlm.nih.gov/pubmed/25014179,25014179,,
3753,344592,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,10114,HIPK3,https://ctdbase.org/detail.go?type=gene&acc=10114,,,10114.0,HIPK3,10116.0,Rattus norvegicus (Norway rat),DDT results in increased methylation of HIPK3 gene,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3754,344593,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),DDT results in increased expression of HMOX1 mRNA,,,PMID:31521043,https://www.ncbi.nlm.nih.gov/pubmed/31521043,31521043,,
3755,344594,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,6927,HNF1A,https://ctdbase.org/detail.go?type=gene&acc=6927,,,6927.0,HNF1A,10116.0,Rattus norvegicus (Norway rat),[DDT co-treated with diethylnitrosamine] results in decreased expression of HNF1A mrna|[ddt co-treated with diethylnitrosamine] results in increased expression of HNF1A mRNA,,,PMID:15885732,https://www.ncbi.nlm.nih.gov/pubmed/15885732,15885732,,
3756,344595,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,84376,HOOK3,https://ctdbase.org/detail.go?type=gene&acc=84376,,,84376.0,HOOK3,10116.0,Rattus norvegicus (Norway rat),DDT results in decreased expression of HOOK3 mRNA,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3757,344596,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,42993,HR96,https://ctdbase.org/detail.go?type=gene&acc=42993,,,42993.0,Hr96,7227.0,Drosophila melanogaster (fruit fly),HR96 protein affects the susceptibility to DDT,,,PMID:16814731,https://www.ncbi.nlm.nih.gov/pubmed/16814731,16814731,,
3758,344597,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,9956,HS3ST2,https://ctdbase.org/detail.go?type=gene&acc=9956,,,9956.0,HS3ST2,10116.0,Rattus norvegicus (Norway rat),DDT results in decreased methylation of HS3ST2 gene,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3759,344990,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),DDT results in increased expression of IL6 mrna|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [DDT results in increased expression of and results in increased secretion of IL6 protein]|ddt results in increased expression of and results in increased secretion of IL6 protein,,,PMID:31542660,https://www.ncbi.nlm.nih.gov/pubmed/31542660,31542660,,
3760,346902,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,442909,MIR342,https://ctdbase.org/detail.go?type=gene&acc=442909,,,442909.0,MIR342,9606.0,Homo sapiens (human),DDT results in decreased expression of MIR342 mRNA,,,PMID:22403704,https://www.ncbi.nlm.nih.gov/pubmed/22403704,22403704,,
3761,346903,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,407041,MIR34B,https://ctdbase.org/detail.go?type=gene&acc=407041,,,407041.0,MIR34B,10116.0,Rattus norvegicus (Norway rat),DDT results in decreased expression of MIR34B mRNA,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3762,346904,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,407042,MIR34C,https://ctdbase.org/detail.go?type=gene&acc=407042,,,407042.0,MIR34C,10116.0,Rattus norvegicus (Norway rat),DDT results in decreased expression of MIR34C mRNA,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3763,346905,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,102466117,MIR374,https://ctdbase.org/detail.go?type=gene&acc=102466117,,,102466117.0,,10116.0,Rattus norvegicus (Norway rat),DDT results in increased expression of MIR374 mRNA,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3764,346906,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,619553,MIR484,https://ctdbase.org/detail.go?type=gene&acc=619553,,,619553.0,MIR484,10116.0,Rattus norvegicus (Norway rat),DDT results in decreased methylation of MIR484 gene,,,PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31682807,31682807,,
3765,347888,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,9606.0,Homo sapiens (human),DDT inhibits the reaction [hydrocortisone results in increased activity of NR3C1 protein],,,PMID:26647222,https://www.ncbi.nlm.nih.gov/pubmed/26647222,26647222,,
3766,347889,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,4306,NR3C2,https://ctdbase.org/detail.go?type=gene&acc=4306,,,4306.0,NR3C2,9606.0,Homo sapiens (human),DDT inhibits the reaction [aldosterone results in increased activity of NR3C2 protein]|ddt inhibits the reaction [aldosterone affects the localization of NR3C2 protein],,,PMID:29149346,https://www.ncbi.nlm.nih.gov/pubmed/29149346,29149346,,
3767,347890,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,9378,NRXN1,https://ctdbase.org/detail.go?type=gene&acc=9378,,,9378.0,NRXN1,10116.0,Rattus norvegicus (Norway rat),DDT results in increased methylation of NRXN1 gene,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3768,347891,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,9369,NRXN3,https://ctdbase.org/detail.go?type=gene&acc=9369,,,9369.0,NRXN3,10116.0,Rattus norvegicus (Norway rat),DDT results in increased methylation of NRXN3 gene,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3769,347892,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,9423,NTN1,https://ctdbase.org/detail.go?type=gene&acc=9423,,,9423.0,NTN1,10116.0,Rattus norvegicus (Norway rat),DDT results in increased methylation of NTN1 gene,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3770,347893,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,59277,NTN4,https://ctdbase.org/detail.go?type=gene&acc=59277,,,59277.0,NTN4,10116.0,Rattus norvegicus (Norway rat),DDT results in decreased expression of NTN4 mRNA,,,PMID:30207508,https://www.ncbi.nlm.nih.gov/pubmed/30207508,30207508,,
3771,349475,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,5876,RABGGTB,https://ctdbase.org/detail.go?type=gene&acc=5876,,,5876.0,RABGGTB,9606.0,Homo sapiens (human),DDT results in increased expression of RABGGTB mRNA,,,PMID:25014179,https://www.ncbi.nlm.nih.gov/pubmed/25014179,25014179,,
3772,352903,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,4569,TRNM,https://ctdbase.org/detail.go?type=gene&acc=4569,,,4569.0,TRNM,9606.0,Homo sapiens (human),DDT results in decreased expression of TRNM mRNA,,,PMID:25014179,https://www.ncbi.nlm.nih.gov/pubmed/25014179,25014179,,
3773,352904,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,4571,TRNP,https://ctdbase.org/detail.go?type=gene&acc=4571,,,4571.0,TRNP,9606.0,Homo sapiens (human),DDT results in decreased expression of TRNP mRNA,,,PMID:25014179,https://www.ncbi.nlm.nih.gov/pubmed/25014179,25014179,,
3774,353679,3036,Comparative Toxicogenomics Database (CTD),Clofenotane,D003634,DDT,https://ctdbase.org/detail.go?type=chem&acc=D003634,65249,ZSWIM4,https://ctdbase.org/detail.go?type=gene&acc=65249,,,65249.0,ZSWIM4,10116.0,Rattus norvegicus (Norway rat),DDT results in increased methylation of ZSWIM4 gene,,,PMID:31682807,https://www.ncbi.nlm.nih.gov/pubmed/31682807,31682807,,
3775,238971,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606.0,Homo sapiens (human),"3,3'-diindolylmethane promotes the reaction [ARNT protein binds to CYP1A1 promoter]",,,PMID:16972788,https://www.ncbi.nlm.nih.gov/pubmed/16972788,16972788,,
3776,238972,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in increased expression of ATF3",,,PMID:15670751,https://www.ncbi.nlm.nih.gov/pubmed/15670751,15670751,,
3777,238973,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,477,ATP1A2,https://ctdbase.org/detail.go?type=gene&acc=477,,,477.0,ATP1A2,8022.0,Oncorhynchus mykiss (rainbow trout),"3,3'-diindolylmethane results in increased expression of ATP1A2 mRNA",,,PMID:16192472,https://www.ncbi.nlm.nih.gov/pubmed/16192472,16192472,,
3778,238974,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,498,ATP5F1A,https://ctdbase.org/detail.go?type=gene&acc=498,,,498.0,ATP5F1A,9606.0,Homo sapiens (human),"3,3'-diindolylmethane inhibits the reaction [estradiol results in increased expression of ATP5F1A mrna]",,,PMID:11179685,https://www.ncbi.nlm.nih.gov/pubmed/11179685,11179685,,
3779,238975,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,572,BAD,https://ctdbase.org/detail.go?type=gene&acc=572,,,572.0,BAD,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased phosphorylation of BAD protein",,,PMID:22290291,https://www.ncbi.nlm.nih.gov/pubmed/22290291,22290291,,
3780,238976,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in increased expression of BAX protein",,,PMID:22290291,https://www.ncbi.nlm.nih.gov/pubmed/22290291,22290291,,
3781,238977,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,9606.0,Homo sapiens (human),"[3,3'-diindolylmethane results in increased phosphorylation of and results in increased activity of TP53 protein] which results in increased expression of BBC3",,,PMID:22290291,https://www.ncbi.nlm.nih.gov/pubmed/22290291,22290291,,
3782,238978,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),"3,3'-diindolylmethane analog results in decreased expression of BCL2 protein",,,PMID:16051428,https://www.ncbi.nlm.nih.gov/pubmed/16051428,16051428,,
3783,238979,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),"3,3'-diindolylmethane promotes the reaction [paclitaxel results in decreased expression of BCL2 protein]",,,PMID:16580691,https://www.ncbi.nlm.nih.gov/pubmed/16580691,16580691,,
3784,238980,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased expression of BCL2 protein",,,PMID:16580691|PMID:22290291,https://www.ncbi.nlm.nih.gov/pubmed/16580691|https://www.ncbi.nlm.nih.gov/pubmed/22290291,16580691|22290291,,
3785,239263,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),"3,3'-diindolylmethane analog results in decreased expression of BCL2 mRNA",,,PMID:26593444,https://www.ncbi.nlm.nih.gov/pubmed/26593444,26593444,,
3786,239264,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in increased expression of BCL2L1 mrna|3,3'-diindolylmethane results in increased expression of BCL2L1 protein",,,PMID:18025290,https://www.ncbi.nlm.nih.gov/pubmed/18025290,18025290,,
3787,239265,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,6046,BRD2,https://ctdbase.org/detail.go?type=gene&acc=6046,,,6046.0,BRD2,9606.0,Homo sapiens (human),"3,3'-diindolylmethane inhibits the reaction [estradiol results in increased expression of BRD2 mrna]",,,PMID:11179685,https://www.ncbi.nlm.nih.gov/pubmed/11179685,11179685,,
3788,239480,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896.0,CCND3,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased expression of CCND3 protein",,,PMID:22514694,https://www.ncbi.nlm.nih.gov/pubmed/22514694,22514694,,
3789,239481,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,1233,CCR4,https://ctdbase.org/detail.go?type=gene&acc=1233,,,1233.0,CCR4,9606.0,Homo sapiens (human),"3,3'-diindolylmethane affects the methylation of CCR4 promoter",,,PMID:24466240,https://www.ncbi.nlm.nih.gov/pubmed/24466240,24466240,,
3790,239482,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,959,CD40LG,https://ctdbase.org/detail.go?type=gene&acc=959,,,959.0,CD40LG,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in increased expression of CD40LG mRNA",,,PMID:22514694,https://www.ncbi.nlm.nih.gov/pubmed/22514694,22514694,,
3791,239483,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,969,CD69,https://ctdbase.org/detail.go?type=gene&acc=969,,,969.0,CD69,10090.0,Mus musculus (house mouse),"3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of CD69 protein]",,,PMID:24200994,https://www.ncbi.nlm.nih.gov/pubmed/24200994,24200994,,
3792,239484,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,995,CDC25C,https://ctdbase.org/detail.go?type=gene&acc=995,,,995.0,CDC25C,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased expression of CDC25C",,,PMID:22290291,https://www.ncbi.nlm.nih.gov/pubmed/22290291,22290291,,
3793,239485,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606.0,Homo sapiens (human),"3,3'-diindolylmethane inhibits the reaction [bisphenol A results in decreased expression of CDH1 protein]|3,3'-diindolylmethane inhibits the reaction [estradiol results in decreased expression of CDH1 protein]|3,3'-diindolylmethane inhibits the reaction [triclosan results in decreased expression of CDH1 protein]",,,PMID:28844962,https://www.ncbi.nlm.nih.gov/pubmed/28844962,28844962,,
3794,239486,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,1009,CDH11,https://ctdbase.org/detail.go?type=gene&acc=1009,,,1009.0,CDH11,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased expression of CDH11 protein",,,PMID:18025290,https://www.ncbi.nlm.nih.gov/pubmed/18025290,18025290,,
3795,239487,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,9606.0,Homo sapiens (human),"3,3'-diindolylmethane inhibits the reaction [triclosan results in increased expression of CDH2 protein]|3,3'-diindolylmethane inhibits the reaction [bisphenol A results in increased expression of CDH2 protein]|3,3'-diindolylmethane inhibits the reaction [estradiol results in increased expression of CDH2 protein]",,,PMID:28844962,https://www.ncbi.nlm.nih.gov/pubmed/28844962,28844962,,
3796,239488,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased activity of CDK2 protein|3,3'-diindolylmethane promotes the reaction [CDK2 protein binds to CDKN1A protein]",,,PMID:15611077,https://www.ncbi.nlm.nih.gov/pubmed/15611077,15611077,,
3797,239489,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased expression of CDK4 protein",,,PMID:22514694,https://www.ncbi.nlm.nih.gov/pubmed/22514694,22514694,,
3798,240603,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,5611,DNAJC3,https://ctdbase.org/detail.go?type=gene&acc=5611,,,5611.0,DNAJC3,8022.0,Oncorhynchus mykiss (rainbow trout),"3,3'-diindolylmethane results in increased expression of DNAJC3 mRNA",,,PMID:16192472,https://www.ncbi.nlm.nih.gov/pubmed/16192472,16192472,,
3799,240604,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased expression of DNMT1 mRNA",,,PMID:24466240,https://www.ncbi.nlm.nih.gov/pubmed/24466240,24466240,,
3800,240605,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,1789,DNMT3B,https://ctdbase.org/detail.go?type=gene&acc=1789,,,1789.0,DNMT3B,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased expression of DNMT3B mRNA",,,PMID:24466240,https://www.ncbi.nlm.nih.gov/pubmed/24466240,24466240,,
3801,241095,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased phosphorylation of GSK3B protein",,,PMID:22290291,https://www.ncbi.nlm.nih.gov/pubmed/22290291,22290291,,
3802,241096,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased expression of GSTM1 mrna|[3,3'-diindolylmethane results in decreased expression of GSTM1 mrna] which results in increased abundance of aflatoxin B1-DNA adduct",,,PMID:19770484,https://www.ncbi.nlm.nih.gov/pubmed/19770484,19770484,,
3803,241097,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,3020,H3-3A,https://ctdbase.org/detail.go?type=gene&acc=3020,,,3020.0,H3-3A,9606.0,Homo sapiens (human),"3,3'-diindolylmethane promotes the reaction [estradiol results in increased expression of H3-3A mrna]",,,PMID:11179685,https://www.ncbi.nlm.nih.gov/pubmed/11179685,11179685,,
3804,241098,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,3065,HDAC1,https://ctdbase.org/detail.go?type=gene&acc=3065,,,3065.0,HDAC1,10090.0,Mus musculus (house mouse),"3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC1 mrna]",,,PMID:24200994,https://www.ncbi.nlm.nih.gov/pubmed/24200994,24200994,,
3805,241099,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,83933,HDAC10,https://ctdbase.org/detail.go?type=gene&acc=83933,,,83933.0,HDAC10,10090.0,Mus musculus (house mouse),"3,3'-diindolylmethane promotes the reaction [enterotoxin B, staphylococcal results in decreased expression of HDAC10 mrna]",,,PMID:24200994,https://www.ncbi.nlm.nih.gov/pubmed/24200994,24200994,,
3806,241100,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,3066,HDAC2,https://ctdbase.org/detail.go?type=gene&acc=3066,,,3066.0,HDAC2,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in decreased expression of HDAC2 protein",,,PMID:22800507,https://www.ncbi.nlm.nih.gov/pubmed/22800507,22800507,,
3807,241101,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,3066,HDAC2,https://ctdbase.org/detail.go?type=gene&acc=3066,,,3066.0,HDAC2,10090.0,Mus musculus (house mouse),"3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC2 mrna]",,,PMID:24200994,https://www.ncbi.nlm.nih.gov/pubmed/24200994,24200994,,
3808,241298,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),"ESR1 mutant form promotes the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mrna]]|ahr mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mrna]]|3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mrna]",,,PMID:23583297,https://www.ncbi.nlm.nih.gov/pubmed/23583297,23583297,,
3809,241299,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,8739,HRK,https://ctdbase.org/detail.go?type=gene&acc=8739,,,8739.0,HRK,9606.0,Homo sapiens (human),"3,3'-diindolylmethane results in increased expression of HRK mRNA",,,PMID:22514694,https://www.ncbi.nlm.nih.gov/pubmed/22514694,22514694,,
3810,241300,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,7184,HSP90B1,https://ctdbase.org/detail.go?type=gene&acc=7184,,,7184.0,HSP90B1,8022.0,Oncorhynchus mykiss (rainbow trout),"3,3'-diindolylmethane results in increased expression of HSP90B1 mRNA",,,PMID:16192472,https://www.ncbi.nlm.nih.gov/pubmed/16192472,16192472,,
3811,241301,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,9606.0,Homo sapiens (human),"3,3'-diindolylmethane analog promotes the reaction [HSPA5 protein affects the expression of and affects the activity of MMP9 protein]|3,3'-diindolylmethane analog results in decreased expression of HSPA5 protein",,,PMID:25794856,https://www.ncbi.nlm.nih.gov/pubmed/25794856,25794856,,
3812,241302,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,9606.0,Homo sapiens (human),"3,3'-diindolylmethane inhibits the reaction [estradiol results in increased expression of HSPB1 mrna]",,,PMID:11179685,https://www.ncbi.nlm.nih.gov/pubmed/11179685,11179685,,
3813,241303,3071,Comparative Toxicogenomics Database (CTD),"3,3'-Diindolylmethane",C016392,"3,3'-diindolylmethane",https://ctdbase.org/detail.go?type=chem&acc=C016392,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090.0,Mus musculus (house mouse),"3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased secretion of IFNG protein]",,,PMID:24200994,https://www.ncbi.nlm.nih.gov/pubmed/24200994,24200994,,
3814,294729,3103,Comparative Toxicogenomics Database (CTD),Diphenylpyraline,D000485,Allergens,https://ctdbase.org/detail.go?type=chem&acc=D000485,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606.0,Homo sapiens (human),[allergens co-treated with vehicle emissions] results in increased expression of SRC mrna|allergens results in increased expression of SRC mRNA,,,PMID:27283384,https://www.ncbi.nlm.nih.gov/pubmed/27283384,27283384,,
3815,294730,3103,Comparative Toxicogenomics Database (CTD),Diphenylpyraline,D000485,Allergens,https://ctdbase.org/detail.go?type=chem&acc=D000485,6773,STAT2,https://ctdbase.org/detail.go?type=gene&acc=6773,,,6773.0,STAT2,9606.0,Homo sapiens (human),Allergens results in increased expression of STAT2 mrna|[allergens co-treated with vehicle emissions] results in increased expression of STAT2 mRNA,,,PMID:27283384,https://www.ncbi.nlm.nih.gov/pubmed/27283384,27283384,,
3816,294731,3103,Comparative Toxicogenomics Database (CTD),Diphenylpyraline,D000485,Allergens,https://ctdbase.org/detail.go?type=chem&acc=D000485,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),Allergens results in increased expression of STAT3 mrna|[allergens co-treated with vehicle emissions] results in increased expression of STAT3 mRNA,,,PMID:27283384,https://www.ncbi.nlm.nih.gov/pubmed/27283384,27283384,,
3817,294732,3103,Comparative Toxicogenomics Database (CTD),Diphenylpyraline,D000485,Allergens,https://ctdbase.org/detail.go?type=chem&acc=D000485,6775,STAT4,https://ctdbase.org/detail.go?type=gene&acc=6775,,,6775.0,STAT4,9606.0,Homo sapiens (human),Allergens results in increased expression of STAT4 mRNA,,,PMID:27283384,https://www.ncbi.nlm.nih.gov/pubmed/27283384,27283384,,
3818,294733,3103,Comparative Toxicogenomics Database (CTD),Diphenylpyraline,D000485,Allergens,https://ctdbase.org/detail.go?type=chem&acc=D000485,6776,STAT5A,https://ctdbase.org/detail.go?type=gene&acc=6776,,,6776.0,STAT5A,9606.0,Homo sapiens (human),Allergens results in increased expression of STAT5A mrna|[allergens co-treated with vehicle emissions] results in increased expression of STAT5A mRNA,,,PMID:27283384,https://www.ncbi.nlm.nih.gov/pubmed/27283384,27283384,,
3819,294734,3103,Comparative Toxicogenomics Database (CTD),Diphenylpyraline,D000485,Allergens,https://ctdbase.org/detail.go?type=chem&acc=D000485,6777,STAT5B,https://ctdbase.org/detail.go?type=gene&acc=6777,,,6777.0,STAT5B,9606.0,Homo sapiens (human),Allergens results in decreased expression of STAT5B mRNA,,,PMID:27283384,https://www.ncbi.nlm.nih.gov/pubmed/27283384,27283384,,
3820,294735,3103,Comparative Toxicogenomics Database (CTD),Diphenylpyraline,D000485,Allergens,https://ctdbase.org/detail.go?type=chem&acc=D000485,6778,STAT6,https://ctdbase.org/detail.go?type=gene&acc=6778,,,6778.0,STAT6,9606.0,Homo sapiens (human),[allergens co-treated with vehicle emissions] results in increased expression of STAT6 mrna|allergens results in increased expression of STAT6 mRNA,,,PMID:27283384,https://www.ncbi.nlm.nih.gov/pubmed/27283384,27283384,,
3821,294736,3103,Comparative Toxicogenomics Database (CTD),Diphenylpyraline,D000485,Allergens,https://ctdbase.org/detail.go?type=chem&acc=D000485,6850,SYK,https://ctdbase.org/detail.go?type=gene&acc=6850,,,6850.0,SYK,9606.0,Homo sapiens (human),Allergens results in decreased expression of SYK mRNA,,,PMID:27283384,https://www.ncbi.nlm.nih.gov/pubmed/27283384,27283384,,
3822,294737,3103,Comparative Toxicogenomics Database (CTD),Diphenylpyraline,D000485,Allergens,https://ctdbase.org/detail.go?type=chem&acc=D000485,117289,TAGAP,https://ctdbase.org/detail.go?type=gene&acc=117289,,,117289.0,TAGAP,9606.0,Homo sapiens (human),Allergens results in decreased expression of TAGAP mRNA,,,PMID:27283384,https://www.ncbi.nlm.nih.gov/pubmed/27283384,27283384,,
3823,221158,3120,Comparative Toxicogenomics Database (CTD),Diuron,D004237,Diuron,https://ctdbase.org/detail.go?type=chem&acc=D004237,57659,ZBTB4,https://ctdbase.org/detail.go?type=gene&acc=57659,,,57659.0,ZBTB4,10116.0,Rattus norvegicus (Norway rat),Diuron results in decreased expression of ZBTB4 mRNA,,,PMID:21551480,https://www.ncbi.nlm.nih.gov/pubmed/21551480,21551480,,
3824,221159,3120,Comparative Toxicogenomics Database (CTD),Diuron,D004237,Diuron,https://ctdbase.org/detail.go?type=chem&acc=D004237,29068,ZBTB44,https://ctdbase.org/detail.go?type=gene&acc=29068,,,29068.0,ZBTB44,10116.0,Rattus norvegicus (Norway rat),Diuron results in increased expression of ZBTB44 mRNA,,,PMID:21551480,https://www.ncbi.nlm.nih.gov/pubmed/21551480,21551480,,
3825,221160,3120,Comparative Toxicogenomics Database (CTD),Diuron,D004237,Diuron,https://ctdbase.org/detail.go?type=chem&acc=D004237,9877,ZC3H11A,https://ctdbase.org/detail.go?type=gene&acc=9877,,,9877.0,ZC3H11A,10116.0,Rattus norvegicus (Norway rat),Diuron results in decreased expression of ZC3H11A mRNA,,,PMID:25152437,https://www.ncbi.nlm.nih.gov/pubmed/25152437,25152437,,
3826,221161,3120,Comparative Toxicogenomics Database (CTD),Diuron,D004237,Diuron,https://ctdbase.org/detail.go?type=chem&acc=D004237,23091,ZC3H13,https://ctdbase.org/detail.go?type=gene&acc=23091,,,23091.0,ZC3H13,10116.0,Rattus norvegicus (Norway rat),Diuron results in decreased expression of ZC3H13 mRNA,,,PMID:25152437,https://www.ncbi.nlm.nih.gov/pubmed/25152437,25152437,,
3827,221162,3120,Comparative Toxicogenomics Database (CTD),Diuron,D004237,Diuron,https://ctdbase.org/detail.go?type=chem&acc=D004237,219654,ZCCHC24,https://ctdbase.org/detail.go?type=gene&acc=219654,,,219654.0,ZCCHC24,10116.0,Rattus norvegicus (Norway rat),Diuron results in increased expression of ZCCHC24 mRNA,,,PMID:21551480,https://www.ncbi.nlm.nih.gov/pubmed/21551480,21551480,,
3828,221163,3120,Comparative Toxicogenomics Database (CTD),Diuron,D004237,Diuron,https://ctdbase.org/detail.go?type=chem&acc=D004237,84186,ZCCHC7,https://ctdbase.org/detail.go?type=gene&acc=84186,,,84186.0,ZCCHC7,10116.0,Rattus norvegicus (Norway rat),Diuron results in decreased expression of ZCCHC7 mRNA,,,PMID:21551480,https://www.ncbi.nlm.nih.gov/pubmed/21551480,21551480,,
3829,221164,3120,Comparative Toxicogenomics Database (CTD),Diuron,D004237,Diuron,https://ctdbase.org/detail.go?type=chem&acc=D004237,55596,ZCCHC8,https://ctdbase.org/detail.go?type=gene&acc=55596,,,55596.0,ZCCHC8,9606.0,Homo sapiens (human),Diuron results in decreased expression of ZCCHC8 mRNA,,,PMID:35967413,https://www.ncbi.nlm.nih.gov/pubmed/35967413,35967413,,
3830,221165,3120,Comparative Toxicogenomics Database (CTD),Diuron,D004237,Diuron,https://ctdbase.org/detail.go?type=chem&acc=D004237,6935,ZEB1,https://ctdbase.org/detail.go?type=gene&acc=6935,,,6935.0,ZEB1,10116.0,Rattus norvegicus (Norway rat),Diuron results in decreased expression of ZEB1 mRNA,,,PMID:25152437,https://www.ncbi.nlm.nih.gov/pubmed/25152437,25152437,,
3831,221166,3120,Comparative Toxicogenomics Database (CTD),Diuron,D004237,Diuron,https://ctdbase.org/detail.go?type=chem&acc=D004237,6935,ZEB1,https://ctdbase.org/detail.go?type=gene&acc=6935,,,6935.0,ZEB1,10116.0,Rattus norvegicus (Norway rat),Diuron results in increased expression of ZEB1 mRNA,,,PMID:21551480,https://www.ncbi.nlm.nih.gov/pubmed/21551480,21551480,,
3832,221512,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57143,ADCK1,https://ctdbase.org/detail.go?type=gene&acc=57143,,,57143.0,ADCK1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ADCK1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3833,221513,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57143,ADCK1,https://ctdbase.org/detail.go?type=gene&acc=57143,,,57143.0,ADCK1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ADCK1 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3834,221514,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,90956,ADCK2,https://ctdbase.org/detail.go?type=gene&acc=90956,,,90956.0,ADCK2,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of ADCK2 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
3835,223539,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57211,ADGRG6,https://ctdbase.org/detail.go?type=gene&acc=57211,,,57211.0,ADGRG6,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of ADGRG6 mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
3836,223540,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84873,ADGRG7,https://ctdbase.org/detail.go?type=gene&acc=84873,,,84873.0,ADGRG7,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ADGRG7 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3837,223541,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22859,ADGRL1,https://ctdbase.org/detail.go?type=gene&acc=22859,,,22859.0,ADGRL1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ADGRL1 mRNA,,,PMID:19101580|PMID:23179753|PMID:24935251|PMID:27188386|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/29154799,19101580|23179753|24935251|27188386|29154799,,
3838,223976,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3796,KIF2A,https://ctdbase.org/detail.go?type=gene&acc=3796,,,3796.0,KIF2A,9606.0,Homo sapiens (human),Valproic acid affects the expression of KIF2A mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3839,223977,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3796,KIF2A,https://ctdbase.org/detail.go?type=gene&acc=3796,,,3796.0,KIF2A,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of KIF2A mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3840,223978,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3796,KIF2A,https://ctdbase.org/detail.go?type=gene&acc=3796,,,3796.0,KIF2A,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KIF2A mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3841,223979,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11004,KIF2C,https://ctdbase.org/detail.go?type=gene&acc=11004,,,11004.0,KIF2C,9606.0,Homo sapiens (human),Valproic acid affects the expression of KIF2C mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3842,223980,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11004,KIF2C,https://ctdbase.org/detail.go?type=gene&acc=11004,,,11004.0,KIF2C,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of KIF2C mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
3843,223981,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11004,KIF2C,https://ctdbase.org/detail.go?type=gene&acc=11004,,,11004.0,KIF2C,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of KIF2C mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
3844,223982,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11127,KIF3A,https://ctdbase.org/detail.go?type=gene&acc=11127,,,11127.0,KIF3A,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KIF3A mRNA,,,PMID:24935251|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/29154799,24935251|29154799,,
3845,223983,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9371,KIF3B,https://ctdbase.org/detail.go?type=gene&acc=9371,,,9371.0,KIF3B,9606.0,Homo sapiens (human),Valproic acid affects the expression of KIF3B mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3846,223984,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9371,KIF3B,https://ctdbase.org/detail.go?type=gene&acc=9371,,,9371.0,KIF3B,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KIF3B mRNA,,,PMID:23179753|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|28001369|29154799,,
3847,224148,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3797,KIF3C,https://ctdbase.org/detail.go?type=gene&acc=3797,,,3797.0,KIF3C,9606.0,Homo sapiens (human),Valproic acid affects the expression of KIF3C mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3848,224149,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3797,KIF3C,https://ctdbase.org/detail.go?type=gene&acc=3797,,,3797.0,KIF3C,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of KIF3C mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
3849,224150,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3797,KIF3C,https://ctdbase.org/detail.go?type=gene&acc=3797,,,3797.0,KIF3C,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KIF3C mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3850,224151,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3797,KIF3C,https://ctdbase.org/detail.go?type=gene&acc=3797,,,3797.0,KIF3C,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of KIF3C gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3851,224152,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3797,KIF3C,https://ctdbase.org/detail.go?type=gene&acc=3797,,,3797.0,KIF3C,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of KIF3C mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
3852,225080,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83440,ADPGK,https://ctdbase.org/detail.go?type=gene&acc=83440,,,83440.0,ADPGK,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ADPGK mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
3853,225330,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,141,ADPRH,https://ctdbase.org/detail.go?type=gene&acc=141,,,141.0,ADPRH,9606.0,Homo sapiens (human),Valproic acid affects the expression of ADPRH mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3854,225331,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,141,ADPRH,https://ctdbase.org/detail.go?type=gene&acc=141,,,141.0,ADPRH,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ADPRH mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
3855,225518,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8462,KLF11,https://ctdbase.org/detail.go?type=gene&acc=8462,,,8462.0,KLF11,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of KLF11 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
3856,225519,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8462,KLF11,https://ctdbase.org/detail.go?type=gene&acc=8462,,,8462.0,KLF11,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of KLF11 gene|valproic acid results in increased expression of KLF11 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3857,225520,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8462,KLF11,https://ctdbase.org/detail.go?type=gene&acc=8462,,,8462.0,KLF11,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of KLF11 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
3858,225952,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,122622,ADSS1,https://ctdbase.org/detail.go?type=gene&acc=122622,,,122622.0,ADSS1,7955.0,Danio rerio (zebrafish),Valproic acid results in decreased expression of ADSS1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
3859,225953,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,122622,ADSS1,https://ctdbase.org/detail.go?type=gene&acc=122622,,,122622.0,ADSS1,9606.0,Homo sapiens (human),Valproic acid affects the expression of ADSS1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3860,225954,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,122622,ADSS1,https://ctdbase.org/detail.go?type=gene&acc=122622,,,122622.0,ADSS1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ADSS1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3861,225955,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,122622,ADSS1,https://ctdbase.org/detail.go?type=gene&acc=122622,,,122622.0,ADSS1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ADSS1 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3862,225956,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,122622,ADSS1,https://ctdbase.org/detail.go?type=gene&acc=122622,,,122622.0,ADSS1,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of ADSS1 mRNA,,,PMID:35594946,https://www.ncbi.nlm.nih.gov/pubmed/35594946,35594946,,
3863,225957,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,159,ADSS2,https://ctdbase.org/detail.go?type=gene&acc=159,,,159.0,ADSS2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADSS2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3864,226133,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79667,KLF3-AS1,https://ctdbase.org/detail.go?type=gene&acc=79667,,,79667.0,KLF3-AS1,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of KLF3-AS1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3865,226134,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314.0,KLF4,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLF4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3866,226135,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314.0,KLF4,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KLF4 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24383497|26272509|27188386|28001369|29154799,,
3867,226136,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314.0,KLF4,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of KLF4 gene,,,PMID:28853863|PMID:29201983,https://www.ncbi.nlm.nih.gov/pubmed/28853863|https://www.ncbi.nlm.nih.gov/pubmed/29201983,28853863|29201983,,
3868,226137,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314.0,KLF4,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of KLF4 mRNA,,,PMID:19136453,https://www.ncbi.nlm.nih.gov/pubmed/19136453,19136453,,
3869,226138,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314.0,KLF4,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of KLF4 mRNA,,,PMID:35594946,https://www.ncbi.nlm.nih.gov/pubmed/35594946,35594946,,
3870,226139,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9314,KLF4,https://ctdbase.org/detail.go?type=gene&acc=9314,,,9314.0,KLF4,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of KLF4 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
3871,226357,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64782,AEN,https://ctdbase.org/detail.go?type=gene&acc=64782,,,64782.0,AEN,9606.0,Homo sapiens (human),Valproic acid affects the expression of AEN mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3872,226358,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64782,AEN,https://ctdbase.org/detail.go?type=gene&acc=64782,,,64782.0,AEN,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AEN mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3873,226359,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64782,AEN,https://ctdbase.org/detail.go?type=gene&acc=64782,,,64782.0,AEN,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of AEN mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3874,226360,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64782,AEN,https://ctdbase.org/detail.go?type=gene&acc=64782,,,64782.0,AEN,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of AEN mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
3875,226361,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,60312,AFAP1,https://ctdbase.org/detail.go?type=gene&acc=60312,,,60312.0,AFAP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AFAP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3876,226362,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,60312,AFAP1,https://ctdbase.org/detail.go?type=gene&acc=60312,,,60312.0,AFAP1,9606.0,Homo sapiens (human),Valproic acid affects the expression of AFAP1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3877,226363,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,60312,AFAP1,https://ctdbase.org/detail.go?type=gene&acc=60312,,,60312.0,AFAP1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AFAP1 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|24935251|26272509,,
3878,226364,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84740,AFAP1-AS1,https://ctdbase.org/detail.go?type=gene&acc=84740,,,84740.0,AFAP1-AS1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of AFAP1-AS1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3879,226986,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27125,AFF4,https://ctdbase.org/detail.go?type=gene&acc=27125,,,27125.0,AFF4,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of AFF4 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
3880,226987,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,166378,AFG2A,https://ctdbase.org/detail.go?type=gene&acc=166378,,,166378.0,AFG2A,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AFG2A mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3881,226988,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,172,AFG3L1P,https://ctdbase.org/detail.go?type=gene&acc=172,,,172.0,AFG3L1P,9606.0,Homo sapiens (human),Valproic acid affects the expression of AFG3L1P mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3882,226989,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,172,AFG3L1P,https://ctdbase.org/detail.go?type=gene&acc=172,,,172.0,AFG3L1P,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of AFG3L1P mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
3883,226990,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10939,AFG3L2,https://ctdbase.org/detail.go?type=gene&acc=10939,,,10939.0,AFG3L2,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of AFG3L2 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
3884,226991,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10939,AFG3L2,https://ctdbase.org/detail.go?type=gene&acc=10939,,,10939.0,AFG3L2,9606.0,Homo sapiens (human),Valproic acid affects the expression of AFG3L2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3885,227273,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27252,KLHL20,https://ctdbase.org/detail.go?type=gene&acc=27252,,,27252.0,KLHL20,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of KLHL20 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3886,227274,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9903,KLHL21,https://ctdbase.org/detail.go?type=gene&acc=9903,,,9903.0,KLHL21,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL21 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3887,228017,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,257240,KLHL34,https://ctdbase.org/detail.go?type=gene&acc=257240,,,257240.0,KLHL34,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of KLHL34 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3888,228018,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,283212,KLHL35,https://ctdbase.org/detail.go?type=gene&acc=283212,,,283212.0,KLHL35,9606.0,Homo sapiens (human),Valproic acid affects the expression of KLHL35 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3889,228019,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79786,KLHL36,https://ctdbase.org/detail.go?type=gene&acc=79786,,,79786.0,KLHL36,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KLHL36 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3890,228020,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79786,KLHL36,https://ctdbase.org/detail.go?type=gene&acc=79786,,,79786.0,KLHL36,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of KLHL36 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3891,228021,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,340359,KLHL38,https://ctdbase.org/detail.go?type=gene&acc=340359,,,340359.0,KLHL38,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of KLHL38 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3892,228022,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,563341,KLHL38B,https://ctdbase.org/detail.go?type=gene&acc=563341,,,563341.0,klhl38b,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of KLHL38B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
3893,228023,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56062,KLHL4,https://ctdbase.org/detail.go?type=gene&acc=56062,,,56062.0,KLHL4,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLHL4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3894,228812,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3818,KLKB1,https://ctdbase.org/detail.go?type=gene&acc=3818,,,3818.0,KLKB1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KLKB1 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
3895,228813,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,16633,KLRA2,https://ctdbase.org/detail.go?type=gene&acc=16633,,,16633.0,Klra2,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of KLRA2 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
3896,228814,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8302,KLRC4,https://ctdbase.org/detail.go?type=gene&acc=8302,,,8302.0,KLRC4,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of KLRC4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3897,228815,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,346689,KLRG2,https://ctdbase.org/detail.go?type=gene&acc=346689,,,346689.0,KLRG2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLRG2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3898,228816,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,346689,KLRG2,https://ctdbase.org/detail.go?type=gene&acc=346689,,,346689.0,KLRG2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KLRG2 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
3899,228817,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,346689,KLRG2,https://ctdbase.org/detail.go?type=gene&acc=346689,,,346689.0,KLRG2,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of KLRG2 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
3900,228818,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8564,KMO,https://ctdbase.org/detail.go?type=gene&acc=8564,,,8564.0,KMO,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of KMO gene|valproic acid results in decreased expression of KMO mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3901,228819,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4297,KMT2A,https://ctdbase.org/detail.go?type=gene&acc=4297,,,4297.0,KMT2A,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KMT2A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3902,229376,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57082,KNL1,https://ctdbase.org/detail.go?type=gene&acc=57082,,,57082.0,KNL1,9606.0,Homo sapiens (human),Valproic acid affects the expression of KNL1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3903,229377,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57082,KNL1,https://ctdbase.org/detail.go?type=gene&acc=57082,,,57082.0,KNL1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of KNL1 mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|27188386|28001369,,
3904,229378,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57082,KNL1,https://ctdbase.org/detail.go?type=gene&acc=57082,,,57082.0,KNL1,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of KNL1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3905,229379,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,400506,KNOP1,https://ctdbase.org/detail.go?type=gene&acc=400506,,,400506.0,KNOP1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of KNOP1 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3906,229380,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,90417,KNSTRN,https://ctdbase.org/detail.go?type=gene&acc=90417,,,90417.0,KNSTRN,9606.0,Homo sapiens (human),Valproic acid affects the expression of KNSTRN mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3907,229715,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,402569,KPNA7,https://ctdbase.org/detail.go?type=gene&acc=402569,,,402569.0,KPNA7,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of KPNA7 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
3908,229716,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3837,KPNB1,https://ctdbase.org/detail.go?type=gene&acc=3837,,,3837.0,KPNB1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of KPNB1 mRNA,,,PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,19101580|23179753|27188386|28001369,,
3909,229717,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3837,KPNB1,https://ctdbase.org/detail.go?type=gene&acc=3837,,,3837.0,KPNB1,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of KPNB1 mRNA,,,PMID:20546886,https://www.ncbi.nlm.nih.gov/pubmed/20546886,20546886,,
3910,229718,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,569455,KPNB3,https://ctdbase.org/detail.go?type=gene&acc=569455,,,569455.0,kpnb3,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of KPNB3 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3911,229719,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11133,KPTN,https://ctdbase.org/detail.go?type=gene&acc=11133,,,11133.0,KPTN,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of KPTN mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3912,229822,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,130872,AHSA2P,https://ctdbase.org/detail.go?type=gene&acc=130872,,,130872.0,AHSA2P,9606.0,Homo sapiens (human),Valproic acid affects the expression of AHSA2P mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3913,229823,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,130872,AHSA2P,https://ctdbase.org/detail.go?type=gene&acc=130872,,,130872.0,AHSA2P,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of AHSA2P mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|27188386|28001369,,
3914,229824,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,197,AHSG,https://ctdbase.org/detail.go?type=gene&acc=197,,,197.0,AHSG,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of AHSG mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3915,229825,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,197,AHSG,https://ctdbase.org/detail.go?type=gene&acc=197,,,197.0,AHSG,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of AHSG mRNA,,,PMID:35594946,https://www.ncbi.nlm.nih.gov/pubmed/35594946,35594946,,
3916,229826,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,398793,AIDA.L,https://ctdbase.org/detail.go?type=gene&acc=398793,,,398793.0,aida.L,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of AIDA.L mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
3917,229827,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,199,AIF1,https://ctdbase.org/detail.go?type=gene&acc=199,,,199.0,AIF1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of AIF1 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3918,229828,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,199,AIF1,https://ctdbase.org/detail.go?type=gene&acc=199,,,199.0,AIF1,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of AIF1 protein,,,PMID:31369746,https://www.ncbi.nlm.nih.gov/pubmed/31369746,31369746,,
3919,229829,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83543,AIF1L,https://ctdbase.org/detail.go?type=gene&acc=83543,,,83543.0,AIF1L,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIF1L mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3920,229830,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83543,AIF1L,https://ctdbase.org/detail.go?type=gene&acc=83543,,,83543.0,AIF1L,9606.0,Homo sapiens (human),Valproic acid affects the expression of AIF1L mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3921,230032,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83543,AIF1L,https://ctdbase.org/detail.go?type=gene&acc=83543,,,83543.0,AIF1L,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AIF1L mRNA,,,PMID:19101580|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/26272509,19101580|26272509,,
3922,230033,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83543,AIF1L,https://ctdbase.org/detail.go?type=gene&acc=83543,,,83543.0,AIF1L,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of AIF1L gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3923,230034,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AIFM1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3924,230035,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131.0,AIFM1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of AIFM1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3925,230036,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84883,AIFM2,https://ctdbase.org/detail.go?type=gene&acc=84883,,,84883.0,AIFM2,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of AIFM2 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3926,230104,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51315,KRCC1,https://ctdbase.org/detail.go?type=gene&acc=51315,,,51315.0,KRCC1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KRCC1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
3927,230105,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83999,KREMEN1,https://ctdbase.org/detail.go?type=gene&acc=83999,,,83999.0,KREMEN1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KREMEN1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3928,230106,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83999,KREMEN1,https://ctdbase.org/detail.go?type=gene&acc=83999,,,83999.0,KREMEN1,9606.0,Homo sapiens (human),Valproic acid affects the expression of KREMEN1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3929,230107,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83999,KREMEN1,https://ctdbase.org/detail.go?type=gene&acc=83999,,,83999.0,KREMEN1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KREMEN1 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|24383497|24935251|26272509|27188386,,
3930,230108,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83999,KREMEN1,https://ctdbase.org/detail.go?type=gene&acc=83999,,,83999.0,KREMEN1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of KREMEN1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3931,230252,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9255,AIMP1,https://ctdbase.org/detail.go?type=gene&acc=9255,,,9255.0,AIMP1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of AIMP1 mRNA,,,PMID:23179753|PMID:24935251|PMID:25192806|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24935251|25192806|26272509,,
3932,230253,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7965,AIMP2,https://ctdbase.org/detail.go?type=gene&acc=7965,,,7965.0,AIMP2,9606.0,Homo sapiens (human),Valproic acid affects the expression of AIMP2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3933,230254,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7965,AIMP2,https://ctdbase.org/detail.go?type=gene&acc=7965,,,7965.0,AIMP2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of AIMP2 mRNA,,,PMID:19101580,https://www.ncbi.nlm.nih.gov/pubmed/19101580,19101580,,
3934,230255,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9049,AIP,https://ctdbase.org/detail.go?type=gene&acc=9049,,,9049.0,AIP,9606.0,Homo sapiens (human),Valproic acid affects the expression of AIP mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3935,230451,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3875,KRT18,https://ctdbase.org/detail.go?type=gene&acc=3875,,,3875.0,KRT18,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of KRT18 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3936,230452,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3875,KRT18,https://ctdbase.org/detail.go?type=gene&acc=3875,,,3875.0,KRT18,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of KRT18 mRNA,,,PMID:15345369,https://www.ncbi.nlm.nih.gov/pubmed/15345369,15345369,,
3937,230600,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,125113,KRT222,https://ctdbase.org/detail.go?type=gene&acc=125113,,,125113.0,KRT222,9606.0,Homo sapiens (human),Valproic acid affects the expression of KRT222 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3938,230601,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,125113,KRT222,https://ctdbase.org/detail.go?type=gene&acc=125113,,,125113.0,KRT222,9606.0,Homo sapiens (human),Valproic acid results in increased expression of KRT222 mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24935251|26272509,,
3939,230602,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,25984,KRT23,https://ctdbase.org/detail.go?type=gene&acc=25984,,,25984.0,KRT23,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KRT23 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3940,230706,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84962,AJUBA,https://ctdbase.org/detail.go?type=gene&acc=84962,,,84962.0,AJUBA,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AJUBA mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3941,230707,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84962,AJUBA,https://ctdbase.org/detail.go?type=gene&acc=84962,,,84962.0,AJUBA,9606.0,Homo sapiens (human),Valproic acid affects the expression of AJUBA mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3942,230708,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84962,AJUBA,https://ctdbase.org/detail.go?type=gene&acc=84962,,,84962.0,AJUBA,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of AJUBA mRNA,,,PMID:24383497|PMID:26272509|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/29154799,24383497|26272509|29154799,,
3943,230709,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84962,AJUBA,https://ctdbase.org/detail.go?type=gene&acc=84962,,,84962.0,AJUBA,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AJUBA mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3944,230710,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,203,AK1,https://ctdbase.org/detail.go?type=gene&acc=203,,,203.0,AK1,9606.0,Homo sapiens (human),Valproic acid affects the expression of AK1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3945,230711,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,203,AK1,https://ctdbase.org/detail.go?type=gene&acc=203,,,203.0,AK1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AK1 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
3946,230712,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,203,AK1,https://ctdbase.org/detail.go?type=gene&acc=203,,,203.0,AK1,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of AK1 mRNA,,,PMID:19136453,https://www.ncbi.nlm.nih.gov/pubmed/19136453,19136453,,
3947,230713,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,447507,AK1.L,https://ctdbase.org/detail.go?type=gene&acc=447507,,,447507.0,ak1.L,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in decreased expression of AK1.L mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
3948,230714,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,443877,AK1.S,https://ctdbase.org/detail.go?type=gene&acc=443877,,,443877.0,ak1.S,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in decreased expression of AK1.S mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
3949,230715,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,204,AK2,https://ctdbase.org/detail.go?type=gene&acc=204,,,204.0,AK2,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of AK2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
3950,230765,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3885,KRT34,https://ctdbase.org/detail.go?type=gene&acc=3885,,,3885.0,KRT34,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of KRT34 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3951,232355,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26013,L3MBTL1,https://ctdbase.org/detail.go?type=gene&acc=26013,,,26013.0,L3MBTL1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of L3MBTL1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3952,232356,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51110,LACTB2,https://ctdbase.org/detail.go?type=gene&acc=51110,,,51110.0,LACTB2,9606.0,Homo sapiens (human),Valproic acid affects the expression of LACTB2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3953,232357,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26013,L3MBTL1,https://ctdbase.org/detail.go?type=gene&acc=26013,,,26013.0,L3MBTL1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of L3MBTL1 mRNA,,,PMID:24383497|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,24383497|26272509|28001369,,
3954,232358,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26013,L3MBTL1,https://ctdbase.org/detail.go?type=gene&acc=26013,,,26013.0,L3MBTL1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of L3MBTL1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3955,232359,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83746,L3MBTL2,https://ctdbase.org/detail.go?type=gene&acc=83746,,,83746.0,L3MBTL2,9606.0,Homo sapiens (human),Valproic acid affects the expression of L3MBTL2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3956,232360,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84456,L3MBTL3,https://ctdbase.org/detail.go?type=gene&acc=84456,,,84456.0,L3MBTL3,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of L3MBTL3 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
3957,232537,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84456,L3MBTL3,https://ctdbase.org/detail.go?type=gene&acc=84456,,,84456.0,L3MBTL3,9606.0,Homo sapiens (human),Valproic acid affects the expression of L3MBTL3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3958,232538,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84456,L3MBTL3,https://ctdbase.org/detail.go?type=gene&acc=84456,,,84456.0,L3MBTL3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of L3MBTL3 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3959,232539,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84456,L3MBTL3,https://ctdbase.org/detail.go?type=gene&acc=84456,,,84456.0,L3MBTL3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of L3MBTL3 mRNA,,,PMID:24935251|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/29154799,24935251|29154799,,
3960,232540,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84456,L3MBTL3,https://ctdbase.org/detail.go?type=gene&acc=84456,,,84456.0,L3MBTL3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of L3MBTL3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3961,232896,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3908,LAMA2,https://ctdbase.org/detail.go?type=gene&acc=3908,,,3908.0,LAMA2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LAMA2 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
3962,232897,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3909,LAMA3,https://ctdbase.org/detail.go?type=gene&acc=3909,,,3909.0,LAMA3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LAMA3 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
3963,232898,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3910,LAMA4,https://ctdbase.org/detail.go?type=gene&acc=3910,,,3910.0,LAMA4,9606.0,Homo sapiens (human),Valproic acid affects the expression of LAMA4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3964,232899,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3910,LAMA4,https://ctdbase.org/detail.go?type=gene&acc=3910,,,3910.0,LAMA4,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LAMA4 mRNA,,,PMID:24383497,https://www.ncbi.nlm.nih.gov/pubmed/24383497,24383497,,
3965,232900,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3910,LAMA4,https://ctdbase.org/detail.go?type=gene&acc=3910,,,3910.0,LAMA4,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of LAMA4 mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
3966,232901,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3911,LAMA5,https://ctdbase.org/detail.go?type=gene&acc=3911,,,3911.0,LAMA5,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LAMA5 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3967,232902,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3912,LAMB1,https://ctdbase.org/detail.go?type=gene&acc=3912,,,3912.0,LAMB1,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of LAMB1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
3968,232947,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6718,AKR1D1,https://ctdbase.org/detail.go?type=gene&acc=6718,,,6718.0,AKR1D1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AKR1D1 mrna|valproic acid results in decreased methylation of AKR1D1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3969,232948,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6718,AKR1D1,https://ctdbase.org/detail.go?type=gene&acc=6718,,,6718.0,AKR1D1,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of AKR1D1 mRNA,,,PMID:35594946,https://www.ncbi.nlm.nih.gov/pubmed/35594946,35594946,,
3970,232949,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83592,AKR1E2,https://ctdbase.org/detail.go?type=gene&acc=83592,,,83592.0,AKR1E2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AKR1E2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3971,232950,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83592,AKR1E2,https://ctdbase.org/detail.go?type=gene&acc=83592,,,83592.0,AKR1E2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AKR1E2 mRNA,,,PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,26272509|28001369,,
3972,232951,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83592,AKR1E2,https://ctdbase.org/detail.go?type=gene&acc=83592,,,83592.0,AKR1E2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of AKR1E2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3973,232952,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22977,AKR7A3,https://ctdbase.org/detail.go?type=gene&acc=22977,,,22977.0,AKR7A3,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of AKR7A3 mRNA,,,PMID:17381134|PMID:23665938,https://www.ncbi.nlm.nih.gov/pubmed/17381134|https://www.ncbi.nlm.nih.gov/pubmed/23665938,17381134|23665938,,
3974,232953,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,110198,AKR7A5,https://ctdbase.org/detail.go?type=gene&acc=110198,,,110198.0,Akr7a5,10090.0,Mus musculus (house mouse),Valproic acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein],,,PMID:12604212,https://www.ncbi.nlm.nih.gov/pubmed/12604212,12604212,,
3975,233147,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of AKT1 mRNA,,,PMID:29154799|PMID:29501571,https://www.ncbi.nlm.nih.gov/pubmed/29154799|https://www.ncbi.nlm.nih.gov/pubmed/29501571,29154799|29501571,,
3976,233148,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AKT1 mrna|valproic acid results in increased phosphorylation of AKT1 protein|valproic acid results in increased expression of AKT1 protein,,,PMID:19440698,https://www.ncbi.nlm.nih.gov/pubmed/19440698,19440698,,
3977,233149,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of AKT1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3978,233150,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of AKT1 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3979,233151,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of AKT1 mRNA,,,PMID:32445665,https://www.ncbi.nlm.nih.gov/pubmed/32445665,32445665,,
3980,233152,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84335,AKT1S1,https://ctdbase.org/detail.go?type=gene&acc=84335,,,84335.0,AKT1S1,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of AKT1S1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
3981,233361,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,210,ALAD,https://ctdbase.org/detail.go?type=gene&acc=210,,,210.0,ALAD,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ALAD mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3982,233362,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of ALAS1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
3983,233463,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3920,LAMP2,https://ctdbase.org/detail.go?type=gene&acc=3920,,,3920.0,LAMP2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3984,233464,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3920,LAMP2,https://ctdbase.org/detail.go?type=gene&acc=3920,,,3920.0,LAMP2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LAMP2 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|26272509|27188386|28001369,,
3985,233465,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27074,LAMP3,https://ctdbase.org/detail.go?type=gene&acc=27074,,,27074.0,LAMP3,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
3986,233466,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27074,LAMP3,https://ctdbase.org/detail.go?type=gene&acc=27074,,,27074.0,LAMP3,9606.0,Homo sapiens (human),Valproic acid affects the expression of LAMP3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3987,233467,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27074,LAMP3,https://ctdbase.org/detail.go?type=gene&acc=27074,,,27074.0,LAMP3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LAMP3 mRNA,,,PMID:19101580|PMID:23179753|PMID:23527032|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/23527032|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,19101580|23179753|23527032|24383497|26272509|27188386|28001369|29154799,,
3988,233646,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8649,LAMTOR3,https://ctdbase.org/detail.go?type=gene&acc=8649,,,8649.0,LAMTOR3,9606.0,Homo sapiens (human),Valproic acid affects the expression of LAMTOR3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3989,233647,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8649,LAMTOR3,https://ctdbase.org/detail.go?type=gene&acc=8649,,,8649.0,LAMTOR3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LAMTOR3 mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
3990,233648,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10314,LANCL1,https://ctdbase.org/detail.go?type=gene&acc=10314,,,10314.0,LANCL1,9606.0,Homo sapiens (human),Valproic acid affects the expression of LANCL1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3991,233649,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10314,LANCL1,https://ctdbase.org/detail.go?type=gene&acc=10314,,,10314.0,LANCL1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LANCL1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
3992,233650,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10314,LANCL1,https://ctdbase.org/detail.go?type=gene&acc=10314,,,10314.0,LANCL1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of LANCL1 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3993,233651,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55915,LANCL2,https://ctdbase.org/detail.go?type=gene&acc=55915,,,55915.0,LANCL2,9606.0,Homo sapiens (human),Valproic acid affects the expression of LANCL2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3994,233652,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55915,LANCL2,https://ctdbase.org/detail.go?type=gene&acc=55915,,,55915.0,LANCL2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LANCL2 mRNA,,,PMID:23179753|PMID:24935251|PMID:27188386|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24935251|27188386|29154799,,
3995,233653,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55915,LANCL2,https://ctdbase.org/detail.go?type=gene&acc=55915,,,55915.0,LANCL2,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of LANCL2 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
3996,234215,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,220,ALDH1A3,https://ctdbase.org/detail.go?type=gene&acc=220,,,220.0,ALDH1A3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ALDH1A3 mRNA,,,PMID:24383497|PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251,24383497|24935251,,
3997,234216,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26358,ALDH1A7,https://ctdbase.org/detail.go?type=gene&acc=26358,,,26358.0,Aldh1a7,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ALDH1A7 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
3998,234217,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,9606.0,Homo sapiens (human),Valproic acid affects the expression of ALDH1B1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
3999,234466,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ALDH1B1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4000,234467,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ALDH1B1 mRNA,,,PMID:23179753|PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251,23179753|24935251,,
4001,234468,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,219,ALDH1B1,https://ctdbase.org/detail.go?type=gene&acc=219,,,219.0,ALDH1B1,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of ALDH1B1 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
4002,234469,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10840,ALDH1L1,https://ctdbase.org/detail.go?type=gene&acc=10840,,,10840.0,ALDH1L1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ALDH1L1 gene|valproic acid results in decreased expression of ALDH1L1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4003,234470,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,160428,ALDH1L2,https://ctdbase.org/detail.go?type=gene&acc=160428,,,160428.0,ALDH1L2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH1L2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4004,234471,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,160428,ALDH1L2,https://ctdbase.org/detail.go?type=gene&acc=160428,,,160428.0,ALDH1L2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ALDH1L2 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
4005,234472,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,160428,ALDH1L2,https://ctdbase.org/detail.go?type=gene&acc=160428,,,160428.0,ALDH1L2,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ALDH1L2 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4006,234473,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALDH2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4007,234474,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,9606.0,Homo sapiens (human),Valproic acid affects the expression of ALDH2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4008,234475,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,217,ALDH2,https://ctdbase.org/detail.go?type=gene&acc=217,,,217.0,ALDH2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ALDH2 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
4009,234791,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3930,LBR,https://ctdbase.org/detail.go?type=gene&acc=3930,,,3930.0,LBR,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of LBR mRNA,,,PMID:17292431|PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17292431|https://www.ncbi.nlm.nih.gov/pubmed/17963808,17292431|17963808,,
4010,234792,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,167691,LCA5,https://ctdbase.org/detail.go?type=gene&acc=167691,,,167691.0,LCA5,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of LCA5 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4011,235114,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,501,ALDH7A1,https://ctdbase.org/detail.go?type=gene&acc=501,,,501.0,ALDH7A1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ALDH7A1 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
4012,235115,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,501,ALDH7A1,https://ctdbase.org/detail.go?type=gene&acc=501,,,501.0,ALDH7A1,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ALDH7A1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4013,235116,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64577,ALDH8A1,https://ctdbase.org/detail.go?type=gene&acc=64577,,,64577.0,ALDH8A1,7955.0,Danio rerio (zebrafish),Valproic acid results in decreased expression of ALDH8A1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4014,235117,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64577,ALDH8A1,https://ctdbase.org/detail.go?type=gene&acc=64577,,,64577.0,ALDH8A1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALDH8A1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4015,235163,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3932,LCK,https://ctdbase.org/detail.go?type=gene&acc=3932,,,3932.0,LCK,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LCK gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4016,235164,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3932,LCK,https://ctdbase.org/detail.go?type=gene&acc=3932,,,3932.0,LCK,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of LCK mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4017,235165,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51451,LCMT1,https://ctdbase.org/detail.go?type=gene&acc=51451,,,51451.0,LCMT1,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of LCMT1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4018,235166,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51451,LCMT1,https://ctdbase.org/detail.go?type=gene&acc=51451,,,51451.0,LCMT1,9606.0,Homo sapiens (human),Valproic acid affects the expression of LCMT1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4019,235167,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51451,LCMT1,https://ctdbase.org/detail.go?type=gene&acc=51451,,,51451.0,LCMT1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LCMT1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4020,235168,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9836,LCMT2,https://ctdbase.org/detail.go?type=gene&acc=9836,,,9836.0,LCMT2,9606.0,Homo sapiens (human),Valproic acid affects the expression of LCMT2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4021,235169,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9836,LCMT2,https://ctdbase.org/detail.go?type=gene&acc=9836,,,9836.0,LCMT2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LCMT2 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4022,235170,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9836,LCMT2,https://ctdbase.org/detail.go?type=gene&acc=9836,,,9836.0,LCMT2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LCMT2 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4023,235322,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,138307,LCN8,https://ctdbase.org/detail.go?type=gene&acc=138307,,,138307.0,LCN8,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LCN8 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4024,235323,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,392399,LCN9,https://ctdbase.org/detail.go?type=gene&acc=392399,,,392399.0,LCN9,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LCN9 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4025,235324,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,401562,LCNL1,https://ctdbase.org/detail.go?type=gene&acc=401562,,,401562.0,LCNL1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LCNL1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4026,235325,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84458,LCOR,https://ctdbase.org/detail.go?type=gene&acc=84458,,,84458.0,LCOR,9606.0,Homo sapiens (human),Valproic acid affects the expression of LCOR mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4027,235326,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84458,LCOR,https://ctdbase.org/detail.go?type=gene&acc=84458,,,84458.0,LCOR,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LCOR mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|27188386|28001369,,
4028,235512,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3936,LCP1,https://ctdbase.org/detail.go?type=gene&acc=3936,,,3936.0,LCP1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LCP1 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
4029,235513,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3937,LCP2,https://ctdbase.org/detail.go?type=gene&acc=3937,,,3937.0,LCP2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LCP2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4030,235514,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3937,LCP2,https://ctdbase.org/detail.go?type=gene&acc=3937,,,3937.0,LCP2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LCP2 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
4031,235515,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,197021,LCTL,https://ctdbase.org/detail.go?type=gene&acc=197021,,,197021.0,LCTL,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LCTL mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4032,235516,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,197021,LCTL,https://ctdbase.org/detail.go?type=gene&acc=197021,,,197021.0,LCTL,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LCTL mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|26272509|28001369,,
4033,235517,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,197021,LCTL,https://ctdbase.org/detail.go?type=gene&acc=197021,,,197021.0,LCTL,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LCTL gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4034,235518,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57146,LDAF1,https://ctdbase.org/detail.go?type=gene&acc=57146,,,57146.0,LDAF1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LDAF1 mRNA,,,PMID:19101580|PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,19101580|23179753|29154799,,
4035,235689,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57146,LDAF1,https://ctdbase.org/detail.go?type=gene&acc=57146,,,57146.0,LDAF1,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of LDAF1 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4036,235690,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,60526,LDAH,https://ctdbase.org/detail.go?type=gene&acc=60526,,,60526.0,LDAH,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of LDAH mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4037,235691,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,60526,LDAH,https://ctdbase.org/detail.go?type=gene&acc=60526,,,60526.0,LDAH,9606.0,Homo sapiens (human),Valproic acid affects the expression of LDAH mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4038,235692,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8861,LDB1,https://ctdbase.org/detail.go?type=gene&acc=8861,,,8861.0,LDB1,9606.0,Homo sapiens (human),Valproic acid affects the expression of LDB1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4039,235693,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8861,LDB1,https://ctdbase.org/detail.go?type=gene&acc=8861,,,8861.0,LDB1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LDB1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4040,235694,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9079,LDB2,https://ctdbase.org/detail.go?type=gene&acc=9079,,,9079.0,LDB2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LDB2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4041,235695,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9079,LDB2,https://ctdbase.org/detail.go?type=gene&acc=9079,,,9079.0,LDB2,9606.0,Homo sapiens (human),Valproic acid affects the expression of LDB2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4042,235696,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9079,LDB2,https://ctdbase.org/detail.go?type=gene&acc=9079,,,9079.0,LDB2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LDB2 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4043,235697,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9079,LDB2,https://ctdbase.org/detail.go?type=gene&acc=9079,,,9079.0,LDB2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LDB2 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|24935251|26272509,,
4044,235698,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11155,LDB3,https://ctdbase.org/detail.go?type=gene&acc=11155,,,11155.0,LDB3,9606.0,Homo sapiens (human),Valproic acid affects the expression of LDB3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4045,235861,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3939,LDHA,https://ctdbase.org/detail.go?type=gene&acc=3939,,,3939.0,LDHA,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in decreased expression of LDHA mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4046,235862,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3945,LDHB,https://ctdbase.org/detail.go?type=gene&acc=3945,,,3945.0,LDHB,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LDHB mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4047,236057,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79053,ALG8,https://ctdbase.org/detail.go?type=gene&acc=79053,,,79053.0,ALG8,9606.0,Homo sapiens (human),Valproic acid affects the expression of ALG8 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4048,236058,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79053,ALG8,https://ctdbase.org/detail.go?type=gene&acc=79053,,,79053.0,ALG8,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ALG8 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4049,236059,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79796,ALG9,https://ctdbase.org/detail.go?type=gene&acc=79796,,,79796.0,ALG9,9606.0,Homo sapiens (human),Valproic acid affects the expression of ALG9 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4050,236060,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79796,ALG9,https://ctdbase.org/detail.go?type=gene&acc=79796,,,79796.0,ALG9,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ALG9 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
4051,236061,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,285016,ALKAL2,https://ctdbase.org/detail.go?type=gene&acc=285016,,,285016.0,ALKAL2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALKAL2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4052,236062,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,285016,ALKAL2,https://ctdbase.org/detail.go?type=gene&acc=285016,,,285016.0,ALKAL2,9606.0,Homo sapiens (human),Valproic acid affects the expression of ALKAL2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4053,236063,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,285016,ALKAL2,https://ctdbase.org/detail.go?type=gene&acc=285016,,,285016.0,ALKAL2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ALKAL2 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4054,236064,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,285016,ALKAL2,https://ctdbase.org/detail.go?type=gene&acc=285016,,,285016.0,ALKAL2,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ALKAL2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4055,236065,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,285016,ALKAL2,https://ctdbase.org/detail.go?type=gene&acc=285016,,,285016.0,ALKAL2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ALKAL2 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|26272509,,
4056,236066,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,121642,ALKBH2,https://ctdbase.org/detail.go?type=gene&acc=121642,,,121642.0,ALKBH2,9606.0,Homo sapiens (human),Valproic acid affects the expression of ALKBH2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4057,236220,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,753,LDLRAD4,https://ctdbase.org/detail.go?type=gene&acc=753,,,753.0,LDLRAD4,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LDLRAD4 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4058,236221,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,753,LDLRAD4,https://ctdbase.org/detail.go?type=gene&acc=753,,,753.0,LDLRAD4,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LDLRAD4 mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|27188386|28001369,,
4059,236222,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26119,LDLRAP1,https://ctdbase.org/detail.go?type=gene&acc=26119,,,26119.0,LDLRAP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LDLRAP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4060,236223,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26119,LDLRAP1,https://ctdbase.org/detail.go?type=gene&acc=26119,,,26119.0,LDLRAP1,9606.0,Homo sapiens (human),Valproic acid affects the expression of LDLRAP1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4061,236224,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26119,LDLRAP1,https://ctdbase.org/detail.go?type=gene&acc=26119,,,26119.0,LDLRAP1,9606.0,Homo sapiens (human),Valproic acid affects the methylation of LDLRAP1 gene|valproic acid results in decreased expression of LDLRAP1 mRNA,,,PMID:29501571,https://www.ncbi.nlm.nih.gov/pubmed/29501571,29501571,,
4062,236225,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26119,LDLRAP1,https://ctdbase.org/detail.go?type=gene&acc=26119,,,26119.0,LDLRAP1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LDLRAP1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4063,236226,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26119,LDLRAP1,https://ctdbase.org/detail.go?type=gene&acc=26119,,,26119.0,LDLRAP1,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of LDLRAP1 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4064,236227,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26119,LDLRAP1,https://ctdbase.org/detail.go?type=gene&acc=26119,,,26119.0,LDLRAP1,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of LDLRAP1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4065,236228,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,368278,LDLRAP1A,https://ctdbase.org/detail.go?type=gene&acc=368278,,,368278.0,ldlrap1a,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of LDLRAP1A mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4066,236229,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,398568,LDLRAP1.S,https://ctdbase.org/detail.go?type=gene&acc=398568,,,398568.0,ldlrap1.S,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of LDLRAP1.S mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4067,236405,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23641,LDOC1,https://ctdbase.org/detail.go?type=gene&acc=23641,,,23641.0,LDOC1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LDOC1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4068,236570,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,221496,LEMD2,https://ctdbase.org/detail.go?type=gene&acc=221496,,,221496.0,LEMD2,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of LEMD2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4069,236571,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23592,LEMD3,https://ctdbase.org/detail.go?type=gene&acc=23592,,,23592.0,LEMD3,9606.0,Homo sapiens (human),Valproic acid affects the expression of LEMD3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4070,236572,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23592,LEMD3,https://ctdbase.org/detail.go?type=gene&acc=23592,,,23592.0,LEMD3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LEMD3 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4071,236938,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3954,LETM1,https://ctdbase.org/detail.go?type=gene&acc=3954,,,3954.0,LETM1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LETM1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4072,236939,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3954,LETM1,https://ctdbase.org/detail.go?type=gene&acc=3954,,,3954.0,LETM1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LETM1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4073,236940,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,25875,LETMD1,https://ctdbase.org/detail.go?type=gene&acc=25875,,,25875.0,LETMD1,9606.0,Homo sapiens (human),Valproic acid affects the expression of LETMD1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4074,236941,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,25875,LETMD1,https://ctdbase.org/detail.go?type=gene&acc=25875,,,25875.0,LETMD1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LETMD1 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
4075,236942,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,25875,LETMD1,https://ctdbase.org/detail.go?type=gene&acc=25875,,,25875.0,LETMD1,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of LETMD1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4076,236943,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3955,LFNG,https://ctdbase.org/detail.go?type=gene&acc=3955,,,3955.0,LFNG,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LFNG mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4077,236944,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3955,LFNG,https://ctdbase.org/detail.go?type=gene&acc=3955,,,3955.0,LFNG,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LFNG mRNA,,,PMID:23179753|PMID:23527032|PMID:24383497|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/23527032|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|23527032|24383497|26272509,,
4078,237581,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,144193,AMDHD1,https://ctdbase.org/detail.go?type=gene&acc=144193,,,144193.0,AMDHD1,9606.0,Homo sapiens (human),Valproic acid affects the expression of AMDHD1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4079,237582,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,144193,AMDHD1,https://ctdbase.org/detail.go?type=gene&acc=144193,,,144193.0,AMDHD1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of AMDHD1 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
4080,237583,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,144193,AMDHD1,https://ctdbase.org/detail.go?type=gene&acc=144193,,,144193.0,AMDHD1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AMDHD1 mRNA,,,PMID:23179753|PMID:25192806|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|25192806|28001369,,
4081,237584,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51005,AMDHD2,https://ctdbase.org/detail.go?type=gene&acc=51005,,,51005.0,AMDHD2,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of AMDHD2 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4082,237585,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51005,AMDHD2,https://ctdbase.org/detail.go?type=gene&acc=51005,,,51005.0,AMDHD2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AMDHD2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4083,237586,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51005,AMDHD2,https://ctdbase.org/detail.go?type=gene&acc=51005,,,51005.0,AMDHD2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of AMDHD2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4084,237587,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,265,AMELX,https://ctdbase.org/detail.go?type=gene&acc=265,,,265.0,AMELX,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of AMELX gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4085,237588,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,219287,AMER2,https://ctdbase.org/detail.go?type=gene&acc=219287,,,219287.0,AMER2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMER2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4086,237589,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,219287,AMER2,https://ctdbase.org/detail.go?type=gene&acc=219287,,,219287.0,AMER2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of AMER2 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4087,237590,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,219287,AMER2,https://ctdbase.org/detail.go?type=gene&acc=219287,,,219287.0,AMER2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of AMER2 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|26272509|28001369,,
4088,238077,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8549,LGR5,https://ctdbase.org/detail.go?type=gene&acc=8549,,,8549.0,LGR5,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of LGR5 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4089,238078,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,59352,LGR6,https://ctdbase.org/detail.go?type=gene&acc=59352,,,59352.0,LGR6,9606.0,Homo sapiens (human),Valproic acid affects the expression of LGR6 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4090,238079,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,59352,LGR6,https://ctdbase.org/detail.go?type=gene&acc=59352,,,59352.0,LGR6,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of LGR6 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4091,238080,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,9913.0,Bos taurus (cattle),Valproic acid inhibits the reaction [LHB protein results in increased abundance of androstenedione]|valproic acid inhibits the reaction [LHB protein results in increased abundance of progesterone],,,PMID:23152920,https://www.ncbi.nlm.nih.gov/pubmed/23152920,23152920,,
4092,238242,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10184,LHFPL2,https://ctdbase.org/detail.go?type=gene&acc=10184,,,10184.0,LHFPL2,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of LHFPL2 mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
4093,238243,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,375612,LHFPL3,https://ctdbase.org/detail.go?type=gene&acc=375612,,,375612.0,LHFPL3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LHFPL3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4094,238244,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,375323,LHFPL4,https://ctdbase.org/detail.go?type=gene&acc=375323,,,375323.0,LHFPL4,9606.0,Homo sapiens (human),Valproic acid affects the expression of LHFPL4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4095,238245,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,375323,LHFPL4,https://ctdbase.org/detail.go?type=gene&acc=375323,,,375323.0,LHFPL4,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LHFPL4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4096,238246,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,375323,LHFPL4,https://ctdbase.org/detail.go?type=gene&acc=375323,,,375323.0,LHFPL4,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LHFPL4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4097,238247,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,222662,LHFPL5,https://ctdbase.org/detail.go?type=gene&acc=222662,,,222662.0,LHFPL5,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of LHFPL5 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4098,238248,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10186,LHFPL6,https://ctdbase.org/detail.go?type=gene&acc=10186,,,10186.0,LHFPL6,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LHFPL6 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4099,238249,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10186,LHFPL6,https://ctdbase.org/detail.go?type=gene&acc=10186,,,10186.0,LHFPL6,9606.0,Homo sapiens (human),Valproic acid affects the expression of LHFPL6 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4100,238250,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10186,LHFPL6,https://ctdbase.org/detail.go?type=gene&acc=10186,,,10186.0,LHFPL6,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LHFPL6 mRNA,,,PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,19101580|23179753|24383497|24935251|26272509|27188386|28001369,,
4101,238251,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,255349,LHFPL7,https://ctdbase.org/detail.go?type=gene&acc=255349,,,255349.0,LHFPL7,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of LHFPL7 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4102,238821,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3977,LIFR,https://ctdbase.org/detail.go?type=gene&acc=3977,,,3977.0,LIFR,9606.0,Homo sapiens (human),Valproic acid affects the expression of LIFR mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4103,238822,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3977,LIFR,https://ctdbase.org/detail.go?type=gene&acc=3977,,,3977.0,LIFR,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LIFR mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4104,238823,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3977,LIFR,https://ctdbase.org/detail.go?type=gene&acc=3977,,,3977.0,LIFR,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LIFR mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|26272509|28001369|29154799,,
4105,238824,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3977,LIFR,https://ctdbase.org/detail.go?type=gene&acc=3977,,,3977.0,LIFR,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of LIFR mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
4106,238825,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3978,LIG1,https://ctdbase.org/detail.go?type=gene&acc=3978,,,3978.0,LIG1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LIG1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4107,238826,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3980,LIG3,https://ctdbase.org/detail.go?type=gene&acc=3980,,,3980.0,LIG3,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LIG3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4108,238827,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3980,LIG3,https://ctdbase.org/detail.go?type=gene&acc=3980,,,3980.0,LIG3,9606.0,Homo sapiens (human),Valproic acid affects the expression of LIG3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4109,238964,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,25906,ANAPC15,https://ctdbase.org/detail.go?type=gene&acc=25906,,,25906.0,ANAPC15,9606.0,Homo sapiens (human),Valproic acid affects the expression of ANAPC15 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4110,238965,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,25906,ANAPC15,https://ctdbase.org/detail.go?type=gene&acc=25906,,,25906.0,ANAPC15,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ANAPC15 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4111,238966,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,119504,ANAPC16,https://ctdbase.org/detail.go?type=gene&acc=119504,,,119504.0,ANAPC16,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANAPC16 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4112,238967,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,119504,ANAPC16,https://ctdbase.org/detail.go?type=gene&acc=119504,,,119504.0,ANAPC16,9606.0,Homo sapiens (human),Valproic acid affects the expression of ANAPC16 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4113,238968,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,119504,ANAPC16,https://ctdbase.org/detail.go?type=gene&acc=119504,,,119504.0,ANAPC16,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ANAPC16 mRNA,,,PMID:23179753|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24935251|25192806|26272509|27188386|28001369,,
4114,238969,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,29882,ANAPC2,https://ctdbase.org/detail.go?type=gene&acc=29882,,,29882.0,ANAPC2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ANAPC2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4115,238970,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,29945,ANAPC4,https://ctdbase.org/detail.go?type=gene&acc=29945,,,29945.0,ANAPC4,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ANAPC4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4116,239749,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8825,LIN7A,https://ctdbase.org/detail.go?type=gene&acc=8825,,,8825.0,LIN7A,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LIN7A mRNA,,,PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,26272509|28001369,,
4117,239750,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8825,LIN7A,https://ctdbase.org/detail.go?type=gene&acc=8825,,,8825.0,LIN7A,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of LIN7A mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4118,239751,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64130,LIN7B,https://ctdbase.org/detail.go?type=gene&acc=64130,,,64130.0,LIN7B,7955.0,Danio rerio (zebrafish),Valproic acid results in decreased expression of LIN7B mRNA,,,PMID:23774253,https://www.ncbi.nlm.nih.gov/pubmed/23774253,23774253,,
4119,239752,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64130,LIN7B,https://ctdbase.org/detail.go?type=gene&acc=64130,,,64130.0,LIN7B,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LIN7B mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4120,239753,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64130,LIN7B,https://ctdbase.org/detail.go?type=gene&acc=64130,,,64130.0,LIN7B,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of LIN7B mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4121,239754,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64130,LIN7B,https://ctdbase.org/detail.go?type=gene&acc=64130,,,64130.0,LIN7B,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of LIN7B mRNA,,,PMID:19136453|PMID:20546886|PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/19136453|https://www.ncbi.nlm.nih.gov/pubmed/20546886|https://www.ncbi.nlm.nih.gov/pubmed/21427059,19136453|20546886|21427059,,
4122,239755,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55327,LIN7C,https://ctdbase.org/detail.go?type=gene&acc=55327,,,55327.0,LIN7C,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LIN7C mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4123,239756,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,286826,LIN9,https://ctdbase.org/detail.go?type=gene&acc=286826,,,286826.0,LIN9,9606.0,Homo sapiens (human),Valproic acid affects the expression of LIN9 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4124,239927,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,286826,LIN9,https://ctdbase.org/detail.go?type=gene&acc=286826,,,286826.0,LIN9,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LIN9 mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|27188386|28001369,,
4125,239928,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,100144596,LINC00029,https://ctdbase.org/detail.go?type=gene&acc=100144596,,,100144596.0,LINC00029,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC00029 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4126,239929,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,158035,LINC00032,https://ctdbase.org/detail.go?type=gene&acc=158035,,,158035.0,LINC00032,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LINC00032 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4127,239930,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,158035,LINC00032,https://ctdbase.org/detail.go?type=gene&acc=158035,,,158035.0,LINC00032,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LINC00032 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|26272509,,
4128,239931,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,619434,LINC00051,https://ctdbase.org/detail.go?type=gene&acc=619434,,,619434.0,LINC00051,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC00051 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4129,239932,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,145978,LINC00052,https://ctdbase.org/detail.go?type=gene&acc=145978,,,145978.0,LINC00052,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of LINC00052 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4130,239933,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,145978,LINC00052,https://ctdbase.org/detail.go?type=gene&acc=145978,,,145978.0,LINC00052,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LINC00052 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4131,239934,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54090,LINC00111,https://ctdbase.org/detail.go?type=gene&acc=54090,,,54090.0,LINC00111,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC00111 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4132,240184,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83854,ANGPTL6,https://ctdbase.org/detail.go?type=gene&acc=83854,,,83854.0,ANGPTL6,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ANGPTL6 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4133,240185,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83854,ANGPTL6,https://ctdbase.org/detail.go?type=gene&acc=83854,,,83854.0,ANGPTL6,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ANGPTL6 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4134,240186,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10218,ANGPTL7,https://ctdbase.org/detail.go?type=gene&acc=10218,,,10218.0,ANGPTL7,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ANGPTL7 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4135,240187,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55908,ANGPTL8,https://ctdbase.org/detail.go?type=gene&acc=55908,,,55908.0,ANGPTL8,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ANGPTL8 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4136,240188,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11732,ANK,https://ctdbase.org/detail.go?type=gene&acc=11732,,,11732.0,Ank,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ANK mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4137,240189,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,286,ANK1,https://ctdbase.org/detail.go?type=gene&acc=286,,,286.0,ANK1,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of ANK1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4138,240277,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,140828,LINC00261,https://ctdbase.org/detail.go?type=gene&acc=140828,,,140828.0,LINC00261,9606.0,Homo sapiens (human),Valproic acid affects the expression of LINC00261 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4139,240278,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,140828,LINC00261,https://ctdbase.org/detail.go?type=gene&acc=140828,,,140828.0,LINC00261,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LINC00261 mRNA,,,PMID:23179753|PMID:27188386|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|27188386|29154799,,
4140,240279,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,349114,LINC00265,https://ctdbase.org/detail.go?type=gene&acc=349114,,,349114.0,LINC00265,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of LINC00265 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4141,240280,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,441426,LINC00268,https://ctdbase.org/detail.go?type=gene&acc=441426,,,441426.0,LINC00268,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC00268 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4142,240281,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,283267,LINC00294,https://ctdbase.org/detail.go?type=gene&acc=283267,,,283267.0,LINC00294,9606.0,Homo sapiens (human),Valproic acid affects the expression of LINC00294 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4143,240282,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,283860,LINC00304,https://ctdbase.org/detail.go?type=gene&acc=283860,,,283860.0,LINC00304,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC00304 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4144,240283,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,221241,LINC00305,https://ctdbase.org/detail.go?type=gene&acc=221241,,,221241.0,LINC00305,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LINC00305 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
4145,240284,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,150992,LINC00309,https://ctdbase.org/detail.go?type=gene&acc=150992,,,150992.0,LINC00309,9606.0,Homo sapiens (human),Valproic acid affects the expression of LINC00309 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4146,240285,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,114036,LINC00310,https://ctdbase.org/detail.go?type=gene&acc=114036,,,114036.0,LINC00310,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LINC00310 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
4147,240286,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,114036,LINC00310,https://ctdbase.org/detail.go?type=gene&acc=114036,,,114036.0,LINC00310,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LINC00310 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4148,240442,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,284836,LINC00319,https://ctdbase.org/detail.go?type=gene&acc=284836,,,284836.0,LINC00319,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC00319 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4149,240443,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,100506697,LINC00327,https://ctdbase.org/detail.go?type=gene&acc=100506697,,,100506697.0,LINC00327,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LINC00327 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4150,240444,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,401253,LINC00336,https://ctdbase.org/detail.go?type=gene&acc=401253,,,401253.0,LINC00336,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC00336 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4151,240445,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,29092,LINC00339,https://ctdbase.org/detail.go?type=gene&acc=29092,,,29092.0,LINC00339,9606.0,Homo sapiens (human),Valproic acid affects the expression of LINC00339 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4152,240446,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,150759,LINC00342,https://ctdbase.org/detail.go?type=gene&acc=150759,,,150759.0,LINC00342,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC00342 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4153,240447,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,150759,LINC00342,https://ctdbase.org/detail.go?type=gene&acc=150759,,,150759.0,LINC00342,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LINC00342 mRNA,,,PMID:24935251|PMID:26272509|PMID:37505509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/37505509,24935251|26272509|37505509,,
4154,240448,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,643365,LINC00452,https://ctdbase.org/detail.go?type=gene&acc=643365,,,643365.0,LINC00452,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC00452 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4155,240449,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,100507428,LINC00458,https://ctdbase.org/detail.go?type=gene&acc=100507428,,,100507428.0,LINC00458,9606.0,Homo sapiens (human),Valproic acid affects the expression of LINC00458 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4156,240593,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,63926,ANKEF1,https://ctdbase.org/detail.go?type=gene&acc=63926,,,63926.0,ANKEF1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4157,240594,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,63926,ANKEF1,https://ctdbase.org/detail.go?type=gene&acc=63926,,,63926.0,ANKEF1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ANKEF1 mRNA,,,PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,24935251|26272509|28001369,,
4158,240595,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,162282,ANKFN1,https://ctdbase.org/detail.go?type=gene&acc=162282,,,162282.0,ANKFN1,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of ANKFN1 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4159,240596,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51479,ANKFY1,https://ctdbase.org/detail.go?type=gene&acc=51479,,,51479.0,ANKFY1,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of ANKFY1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4160,240597,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51479,ANKFY1,https://ctdbase.org/detail.go?type=gene&acc=51479,,,51479.0,ANKFY1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ANKFY1 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4161,240598,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51479,ANKFY1,https://ctdbase.org/detail.go?type=gene&acc=51479,,,51479.0,ANKFY1,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of ANKFY1 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
4162,240599,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56172,ANKH,https://ctdbase.org/detail.go?type=gene&acc=56172,,,56172.0,ANKH,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKH mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4163,240600,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56172,ANKH,https://ctdbase.org/detail.go?type=gene&acc=56172,,,56172.0,ANKH,9606.0,Homo sapiens (human),Valproic acid affects the expression of ANKH mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4164,240601,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56172,ANKH,https://ctdbase.org/detail.go?type=gene&acc=56172,,,56172.0,ANKH,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ANKH gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4165,240602,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56172,ANKH,https://ctdbase.org/detail.go?type=gene&acc=56172,,,56172.0,ANKH,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ANKH mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
4166,241968,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84079,ANKRD27,https://ctdbase.org/detail.go?type=gene&acc=84079,,,84079.0,ANKRD27,9606.0,Homo sapiens (human),Valproic acid affects the expression of ANKRD27 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4167,241969,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84079,ANKRD27,https://ctdbase.org/detail.go?type=gene&acc=84079,,,84079.0,ANKRD27,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ANKRD27 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4168,241970,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23243,ANKRD28,https://ctdbase.org/detail.go?type=gene&acc=23243,,,23243.0,ANKRD28,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ANKRD28 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
4169,242958,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,283422,LINC01559,https://ctdbase.org/detail.go?type=gene&acc=283422,,,283422.0,LINC01559,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of LINC01559 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4170,242959,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,203414,LINC01560,https://ctdbase.org/detail.go?type=gene&acc=203414,,,203414.0,LINC01560,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of LINC01560 mRNA,,,PMID:23179753|PMID:24383497,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497,23179753|24383497,,
4171,242960,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23434,LINC01565,https://ctdbase.org/detail.go?type=gene&acc=23434,,,23434.0,LINC01565,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC01565 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4172,242961,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,154386,LINC01600,https://ctdbase.org/detail.go?type=gene&acc=154386,,,154386.0,LINC01600,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC01600 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4173,242962,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79160,LINC01711,https://ctdbase.org/detail.go?type=gene&acc=79160,,,79160.0,LINC01711,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of LINC01711 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4174,242963,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,284661,LINC01777,https://ctdbase.org/detail.go?type=gene&acc=284661,,,284661.0,LINC01777,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of LINC01777 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4175,243545,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,63982,ANO3,https://ctdbase.org/detail.go?type=gene&acc=63982,,,63982.0,ANO3,9606.0,Homo sapiens (human),Valproic acid affects the expression of ANO3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4176,243546,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,63982,ANO3,https://ctdbase.org/detail.go?type=gene&acc=63982,,,63982.0,ANO3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ANO3 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|27188386|28001369,,
4177,243547,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,121601,ANO4,https://ctdbase.org/detail.go?type=gene&acc=121601,,,121601.0,ANO4,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANO4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4178,243548,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,121601,ANO4,https://ctdbase.org/detail.go?type=gene&acc=121601,,,121601.0,ANO4,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ANO4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4179,243549,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,121601,ANO4,https://ctdbase.org/detail.go?type=gene&acc=121601,,,121601.0,ANO4,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ANO4 mRNA,,,PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|27188386|28001369,,
4180,243550,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,203859,ANO5,https://ctdbase.org/detail.go?type=gene&acc=203859,,,203859.0,ANO5,9606.0,Homo sapiens (human),Valproic acid affects the expression of ANO5 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4181,243551,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,203859,ANO5,https://ctdbase.org/detail.go?type=gene&acc=203859,,,203859.0,ANO5,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ANO5 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4182,243552,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,203859,ANO5,https://ctdbase.org/detail.go?type=gene&acc=203859,,,203859.0,ANO5,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ANO5 mRNA,,,PMID:19101580|PMID:23179753|PMID:24935251|PMID:27188386|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/29154799,19101580|23179753|24935251|27188386|29154799,,
4183,243706,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3988,LIPA,https://ctdbase.org/detail.go?type=gene&acc=3988,,,3988.0,LIPA,9606.0,Homo sapiens (human),Valproic acid affects the expression of LIPA mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4184,243707,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3988,LIPA,https://ctdbase.org/detail.go?type=gene&acc=3988,,,3988.0,LIPA,9606.0,Homo sapiens (human),Valproic acid results in increased expression of LIPA mRNA,,,PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:25716160|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/25716160|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,19101580|23179753|24383497|24935251|25192806|25716160|26272509|27188386|28001369|29154799,,
4185,243890,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,100874016,SYNPR-AS1,https://ctdbase.org/detail.go?type=gene&acc=100874016,,,100874016.0,SYNPR-AS1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of SYNPR-AS1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4186,243891,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11276,SYNRG,https://ctdbase.org/detail.go?type=gene&acc=11276,,,11276.0,SYNRG,9606.0,Homo sapiens (human),Valproic acid affects the expression of SYNRG mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4187,243892,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11276,SYNRG,https://ctdbase.org/detail.go?type=gene&acc=11276,,,11276.0,SYNRG,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of SYNRG mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
4188,243893,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6855,SYP,https://ctdbase.org/detail.go?type=gene&acc=6855,,,6855.0,SYP,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of SYP mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4189,243894,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6855,SYP,https://ctdbase.org/detail.go?type=gene&acc=6855,,,6855.0,SYP,9606.0,Homo sapiens (human),Valproic acid results in increased expression of SYP mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4190,244580,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6861,SYT5,https://ctdbase.org/detail.go?type=gene&acc=6861,,,6861.0,SYT5,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of SYT5 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4191,244581,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,148281,SYT6,https://ctdbase.org/detail.go?type=gene&acc=148281,,,148281.0,SYT6,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of SYT6 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4192,245074,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26099,SZRD1,https://ctdbase.org/detail.go?type=gene&acc=26099,,,26099.0,SZRD1,9606.0,Homo sapiens (human),Valproic acid affects the expression of SZRD1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4193,245075,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26099,SZRD1,https://ctdbase.org/detail.go?type=gene&acc=26099,,,26099.0,SZRD1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of SZRD1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4194,245076,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,20997,T,https://ctdbase.org/detail.go?type=gene&acc=20997,,,20997.0,T,10090.0,Mus musculus (house mouse),"4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [valproic acid results in increased expression of T mrna]",,,PMID:27693483,https://www.ncbi.nlm.nih.gov/pubmed/27693483,27693483,,
4195,245077,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,20997,T,https://ctdbase.org/detail.go?type=gene&acc=20997,,,20997.0,T,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of T mRNA,,,PMID:26072468|PMID:27693483,https://www.ncbi.nlm.nih.gov/pubmed/26072468|https://www.ncbi.nlm.nih.gov/pubmed/27693483,26072468|27693483,,
4196,245078,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,20997,T,https://ctdbase.org/detail.go?type=gene&acc=20997,,,20997.0,T,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of T mRNA,,,PMID:27237783,https://www.ncbi.nlm.nih.gov/pubmed/27237783,27237783,,
4197,245079,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,20997,T,https://ctdbase.org/detail.go?type=gene&acc=20997,,,20997.0,T,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of T mRNA,,,PMID:19136453|PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/19136453|https://www.ncbi.nlm.nih.gov/pubmed/24896083,19136453|24896083,,
4198,245574,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8416,ANXA9,https://ctdbase.org/detail.go?type=gene&acc=8416,,,8416.0,ANXA9,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANXA9 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4199,245575,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8416,ANXA9,https://ctdbase.org/detail.go?type=gene&acc=8416,,,8416.0,ANXA9,9606.0,Homo sapiens (human),Valproic acid affects the expression of ANXA9 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4200,245576,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8416,ANXA9,https://ctdbase.org/detail.go?type=gene&acc=8416,,,8416.0,ANXA9,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ANXA9 mRNA,,,PMID:29154799|PMID:29501571,https://www.ncbi.nlm.nih.gov/pubmed/29154799|https://www.ncbi.nlm.nih.gov/pubmed/29501571,29154799|29501571,,
4201,245577,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8416,ANXA9,https://ctdbase.org/detail.go?type=gene&acc=8416,,,8416.0,ANXA9,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ANXA9 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|26272509,,
4202,245578,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8416,ANXA9,https://ctdbase.org/detail.go?type=gene&acc=8416,,,8416.0,ANXA9,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ANXA9 gene,,,PMID:29501571,https://www.ncbi.nlm.nih.gov/pubmed/29501571,29501571,,
4203,245579,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,313,AOAH,https://ctdbase.org/detail.go?type=gene&acc=313,,,313.0,AOAH,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in decreased expression of AOAH mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4204,245580,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,313,AOAH,https://ctdbase.org/detail.go?type=gene&acc=313,,,313.0,AOAH,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AOAH mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4205,245581,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,313,AOAH,https://ctdbase.org/detail.go?type=gene&acc=313,,,313.0,AOAH,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of AOAH mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
4206,245582,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26,AOC1,https://ctdbase.org/detail.go?type=gene&acc=26,,,26.0,AOC1,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of AOC1 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4207,245583,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57597,BAHCC1,https://ctdbase.org/detail.go?type=gene&acc=57597,,,57597.0,BAHCC1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of BAHCC1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4208,247581,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79613,TANGO6,https://ctdbase.org/detail.go?type=gene&acc=79613,,,79613.0,TANGO6,9606.0,Homo sapiens (human),Valproic acid affects the expression of TANGO6 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4209,247743,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55973,BCAP29,https://ctdbase.org/detail.go?type=gene&acc=55973,,,55973.0,BCAP29,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of BCAP29 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4210,247744,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10134,BCAP31,https://ctdbase.org/detail.go?type=gene&acc=10134,,,10134.0,BCAP31,9606.0,Homo sapiens (human),Valproic acid results in increased expression of BCAP31 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
4211,248745,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83874,TBC1D10A,https://ctdbase.org/detail.go?type=gene&acc=83874,,,83874.0,TBC1D10A,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of TBC1D10A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4212,248746,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83874,TBC1D10A,https://ctdbase.org/detail.go?type=gene&acc=83874,,,83874.0,TBC1D10A,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of TBC1D10A mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4213,248747,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,374403,TBC1D10C,https://ctdbase.org/detail.go?type=gene&acc=374403,,,374403.0,TBC1D10C,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of TBC1D10C mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4214,249934,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54880,BCOR,https://ctdbase.org/detail.go?type=gene&acc=54880,,,54880.0,BCOR,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of BCOR mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4215,249935,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54880,BCOR,https://ctdbase.org/detail.go?type=gene&acc=54880,,,54880.0,BCOR,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of BCOR mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4216,249936,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,63035,BCORL1,https://ctdbase.org/detail.go?type=gene&acc=63035,,,63035.0,BCORL1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of BCORL1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4217,249937,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,63035,BCORL1,https://ctdbase.org/detail.go?type=gene&acc=63035,,,63035.0,BCORL1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of BCORL1 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4218,249938,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,613,BCR,https://ctdbase.org/detail.go?type=gene&acc=613,,,613.0,BCR,9606.0,Homo sapiens (human),Valproic acid results in increased expression of BCR mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
4219,249939,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,618,BCYRN1,https://ctdbase.org/detail.go?type=gene&acc=618,,,618.0,BCYRN1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of BCYRN1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4220,250827,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57673,BEND3,https://ctdbase.org/detail.go?type=gene&acc=57673,,,57673.0,BEND3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of BEND3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4221,250828,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,650623,BEND3P3,https://ctdbase.org/detail.go?type=gene&acc=650623,,,650623.0,BEND3P3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of BEND3P3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4222,250829,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,389206,BEND4,https://ctdbase.org/detail.go?type=gene&acc=389206,,,389206.0,BEND4,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEND4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4223,250830,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,389206,BEND4,https://ctdbase.org/detail.go?type=gene&acc=389206,,,389206.0,BEND4,9606.0,Homo sapiens (human),Valproic acid affects the expression of BEND4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4224,269777,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23474,ETHE1,https://ctdbase.org/detail.go?type=gene&acc=23474,,,23474.0,ETHE1,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of ETHE1 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4225,295086,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,81553,CYRIA,https://ctdbase.org/detail.go?type=gene&acc=81553,,,81553.0,CYRIA,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CYRIA mRNA,,,PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,19101580|23179753|24383497|24935251|26272509|27188386|28001369,,
4226,295087,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51571,CYRIB,https://ctdbase.org/detail.go?type=gene&acc=51571,,,51571.0,CYRIB,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CYRIB gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4227,295088,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51571,CYRIB,https://ctdbase.org/detail.go?type=gene&acc=51571,,,51571.0,CYRIB,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CYRIB mRNA,,,PMID:19101580,https://www.ncbi.nlm.nih.gov/pubmed/19101580,19101580,,
4228,295089,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,192668,CYS1,https://ctdbase.org/detail.go?type=gene&acc=192668,,,192668.0,CYS1,9606.0,Homo sapiens (human),Valproic acid affects the expression of CYS1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4229,295090,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,192668,CYS1,https://ctdbase.org/detail.go?type=gene&acc=192668,,,192668.0,CYS1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CYS1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4230,295234,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2971,GTF3A,https://ctdbase.org/detail.go?type=gene&acc=2971,,,2971.0,GTF3A,9606.0,Homo sapiens (human),Valproic acid results in increased expression of GTF3A mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
4231,295235,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2971,GTF3A,https://ctdbase.org/detail.go?type=gene&acc=2971,,,2971.0,GTF3A,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of GTF3A mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4232,295236,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2975,GTF3C1,https://ctdbase.org/detail.go?type=gene&acc=2975,,,2975.0,GTF3C1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of GTF3C1 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4233,295237,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9330,GTF3C3,https://ctdbase.org/detail.go?type=gene&acc=9330,,,9330.0,GTF3C3,9606.0,Homo sapiens (human),Valproic acid affects the expression of GTF3C3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4234,295238,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9330,GTF3C3,https://ctdbase.org/detail.go?type=gene&acc=9330,,,9330.0,GTF3C3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of GTF3C3 mRNA,,,PMID:23179753|PMID:25192806|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|25192806|27188386|28001369,,
4235,295409,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84705,GTPBP3,https://ctdbase.org/detail.go?type=gene&acc=84705,,,84705.0,GTPBP3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of GTPBP3 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4236,295410,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84705,GTPBP3,https://ctdbase.org/detail.go?type=gene&acc=84705,,,84705.0,GTPBP3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of GTPBP3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4237,295411,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23560,GTPBP4,https://ctdbase.org/detail.go?type=gene&acc=23560,,,23560.0,GTPBP4,9606.0,Homo sapiens (human),Valproic acid affects the expression of GTPBP4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4238,295412,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23560,GTPBP4,https://ctdbase.org/detail.go?type=gene&acc=23560,,,23560.0,GTPBP4,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of GTPBP4 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4239,295413,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23560,GTPBP4,https://ctdbase.org/detail.go?type=gene&acc=23560,,,23560.0,GTPBP4,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of GTPBP4 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4240,295754,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8996,NOL3,https://ctdbase.org/detail.go?type=gene&acc=8996,,,8996.0,NOL3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NOL3 mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
4241,295755,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8996,NOL3,https://ctdbase.org/detail.go?type=gene&acc=8996,,,8996.0,NOL3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NOL3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4242,295756,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8715,NOL4,https://ctdbase.org/detail.go?type=gene&acc=8715,,,8715.0,NOL4,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of NOL4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4243,295757,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8715,NOL4,https://ctdbase.org/detail.go?type=gene&acc=8715,,,8715.0,NOL4,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NOL4 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4244,295758,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,140688,NOL4L,https://ctdbase.org/detail.go?type=gene&acc=140688,,,140688.0,NOL4L,9606.0,Homo sapiens (human),Valproic acid affects the expression of NOL4L mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4245,295759,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,140688,NOL4L,https://ctdbase.org/detail.go?type=gene&acc=140688,,,140688.0,NOL4L,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NOL4L mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4246,295760,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,140688,NOL4L,https://ctdbase.org/detail.go?type=gene&acc=140688,,,140688.0,NOL4L,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NOL4L mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4247,295761,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,140688,NOL4L,https://ctdbase.org/detail.go?type=gene&acc=140688,,,140688.0,NOL4L,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NOL4L gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4248,295934,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55035,NOL8,https://ctdbase.org/detail.go?type=gene&acc=55035,,,55035.0,NOL8,9606.0,Homo sapiens (human),Valproic acid affects the expression of NOL8 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4249,295935,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79707,NOL9,https://ctdbase.org/detail.go?type=gene&acc=79707,,,79707.0,NOL9,9606.0,Homo sapiens (human),Valproic acid affects the expression of NOL9 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4250,295936,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79707,NOL9,https://ctdbase.org/detail.go?type=gene&acc=79707,,,79707.0,NOL9,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NOL9 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4251,295937,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79707,NOL9,https://ctdbase.org/detail.go?type=gene&acc=79707,,,79707.0,NOL9,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of NOL9 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4252,295938,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9221,NOLC1,https://ctdbase.org/detail.go?type=gene&acc=9221,,,9221.0,NOLC1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NOLC1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4253,295939,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9221,NOLC1,https://ctdbase.org/detail.go?type=gene&acc=9221,,,9221.0,NOLC1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NOLC1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4254,295940,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9221,NOLC1,https://ctdbase.org/detail.go?type=gene&acc=9221,,,9221.0,NOLC1,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of NOLC1 mRNA,,,PMID:19136453|PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/19136453|https://www.ncbi.nlm.nih.gov/pubmed/21427059,19136453|21427059,,
4255,295941,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64434,NOM1,https://ctdbase.org/detail.go?type=gene&acc=64434,,,64434.0,NOM1,9606.0,Homo sapiens (human),Valproic acid affects the expression of NOM1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4256,295942,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64434,NOM1,https://ctdbase.org/detail.go?type=gene&acc=64434,,,64434.0,NOM1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NOM1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4257,296118,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55505,NOP10,https://ctdbase.org/detail.go?type=gene&acc=55505,,,55505.0,NOP10,9606.0,Homo sapiens (human),Valproic acid affects the expression of NOP10 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4258,296119,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55505,NOP10,https://ctdbase.org/detail.go?type=gene&acc=55505,,,55505.0,NOP10,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NOP10 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4259,296120,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8602,NOP14,https://ctdbase.org/detail.go?type=gene&acc=8602,,,8602.0,NOP14,9606.0,Homo sapiens (human),Valproic acid affects the expression of NOP14 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4260,296121,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8602,NOP14,https://ctdbase.org/detail.go?type=gene&acc=8602,,,8602.0,NOP14,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NOP14 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4261,296122,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8602,NOP14,https://ctdbase.org/detail.go?type=gene&acc=8602,,,8602.0,NOP14,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of NOP14 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4262,296123,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,317648,NOP14-AS1,https://ctdbase.org/detail.go?type=gene&acc=317648,,,317648.0,NOP14-AS1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NOP14-AS1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4263,296124,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51491,NOP16,https://ctdbase.org/detail.go?type=gene&acc=51491,,,51491.0,NOP16,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NOP16 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4264,296125,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51491,NOP16,https://ctdbase.org/detail.go?type=gene&acc=51491,,,51491.0,NOP16,9606.0,Homo sapiens (human),Valproic acid affects the expression of NOP16 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4265,296126,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51491,NOP16,https://ctdbase.org/detail.go?type=gene&acc=51491,,,51491.0,NOP16,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NOP16 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
4266,296921,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2995,GYPC,https://ctdbase.org/detail.go?type=gene&acc=2995,,,2995.0,GYPC,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of GYPC mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
4267,296922,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2997,GYS1,https://ctdbase.org/detail.go?type=gene&acc=2997,,,2997.0,GYS1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of GYS1 gene|valproic acid results in decreased expression of GYS1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4268,296923,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2997,GYS1,https://ctdbase.org/detail.go?type=gene&acc=2997,,,2997.0,GYS1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of GYS1 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4269,296924,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64412,GZF1,https://ctdbase.org/detail.go?type=gene&acc=64412,,,64412.0,GZF1,9606.0,Homo sapiens (human),Valproic acid affects the expression of GZF1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4270,297239,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3006,H1-2,https://ctdbase.org/detail.go?type=gene&acc=3006,,,3006.0,H1-2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of H1-2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4271,297240,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3007,H1-3,https://ctdbase.org/detail.go?type=gene&acc=3007,,,3007.0,H1-3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of H1-3 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4272,297241,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3008,H1-4,https://ctdbase.org/detail.go?type=gene&acc=3008,,,3008.0,H1-4,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of H1-4 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
4273,297242,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,132243,H1-8,https://ctdbase.org/detail.go?type=gene&acc=132243,,,132243.0,H1-8,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of H1-8 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4274,297243,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,283120,H19,https://ctdbase.org/detail.go?type=gene&acc=283120,,,283120.0,H19,9606.0,Homo sapiens (human),Valproic acid affects the expression of H19 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4275,297244,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,283120,H19,https://ctdbase.org/detail.go?type=gene&acc=283120,,,283120.0,H19,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of H19 mrna|valproic acid results in increased methylation of H19 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4276,297245,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,283120,H19,https://ctdbase.org/detail.go?type=gene&acc=283120,,,283120.0,H19,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of H19 mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
4277,297420,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83740,H2AB3,https://ctdbase.org/detail.go?type=gene&acc=83740,,,83740.0,H2AB3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of H2AB3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4278,297421,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,221613,H2AC1,https://ctdbase.org/detail.go?type=gene&acc=221613,,,221613.0,H2AC1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of H2AC1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4279,297422,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,221613,H2AC1,https://ctdbase.org/detail.go?type=gene&acc=221613,,,221613.0,H2AC1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of H2AC1 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4280,297423,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8969,H2AC11,https://ctdbase.org/detail.go?type=gene&acc=8969,,,8969.0,H2AC11,9606.0,Homo sapiens (human),Valproic acid results in increased expression of H2AC11 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4281,297424,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,85235,H2AC12,https://ctdbase.org/detail.go?type=gene&acc=85235,,,85235.0,H2AC12,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of H2AC12 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
4282,297425,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8336,H2AC17,https://ctdbase.org/detail.go?type=gene&acc=8336,,,8336.0,H2AC17,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of H2AC17 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4283,297426,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8336,H2AC17,https://ctdbase.org/detail.go?type=gene&acc=8336,,,8336.0,H2AC17,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of H2AC17 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4284,297592,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,100131454,DBIL5P,https://ctdbase.org/detail.go?type=gene&acc=100131454,,,100131454.0,DBIL5P,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of DBIL5P gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4285,297593,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,444376,DBI.S,https://ctdbase.org/detail.go?type=gene&acc=444376,,,444376.0,dbi.S,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of DBI.S mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4286,297594,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1627,DBN1,https://ctdbase.org/detail.go?type=gene&acc=1627,,,1627.0,DBN1,9606.0,Homo sapiens (human),Valproic acid affects the expression of DBN1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4287,297595,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1627,DBN1,https://ctdbase.org/detail.go?type=gene&acc=1627,,,1627.0,DBN1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of DBN1 gene|valproic acid results in decreased expression of DBN1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4288,297596,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79007,DBNDD1,https://ctdbase.org/detail.go?type=gene&acc=79007,,,79007.0,DBNDD1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of DBNDD1 gene|valproic acid results in decreased expression of DBNDD1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4289,297597,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79007,DBNDD1,https://ctdbase.org/detail.go?type=gene&acc=79007,,,79007.0,DBNDD1,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of DBNDD1 mRNA,,,PMID:20546886,https://www.ncbi.nlm.nih.gov/pubmed/20546886,20546886,,
4290,297598,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,28988,DBNL,https://ctdbase.org/detail.go?type=gene&acc=28988,,,28988.0,DBNL,9606.0,Homo sapiens (human),Valproic acid affects the expression of DBNL mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4291,297599,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,553729,DBNLB,https://ctdbase.org/detail.go?type=gene&acc=553729,,,553729.0,dbnlb,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of DBNLB mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4292,297600,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1628,DBP,https://ctdbase.org/detail.go?type=gene&acc=1628,,,1628.0,DBP,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of DBP mRNA,,,PMID:17292431|PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17292431|https://www.ncbi.nlm.nih.gov/pubmed/17963808,17292431|17963808,,
4293,297601,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1628,DBP,https://ctdbase.org/detail.go?type=gene&acc=1628,,,1628.0,DBP,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of DBP mRNA,,,PMID:23665938|PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/23665938|https://www.ncbi.nlm.nih.gov/pubmed/29427782,23665938|29427782,,
4294,297743,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7103,TSPAN8,https://ctdbase.org/detail.go?type=gene&acc=7103,,,7103.0,TSPAN8,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of TSPAN8 gene|valproic acid results in decreased expression of TSPAN8 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4295,297744,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10867,TSPAN9,https://ctdbase.org/detail.go?type=gene&acc=10867,,,10867.0,TSPAN9,9606.0,Homo sapiens (human),Valproic acid results in increased expression of TSPAN9 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4296,297745,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10867,TSPAN9,https://ctdbase.org/detail.go?type=gene&acc=10867,,,10867.0,TSPAN9,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of TSPAN9 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4297,297746,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,114043,TSPEAR-AS2,https://ctdbase.org/detail.go?type=gene&acc=114043,,,114043.0,TSPEAR-AS2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of TSPEAR-AS2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4298,297747,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,114043,TSPEAR-AS2,https://ctdbase.org/detail.go?type=gene&acc=114043,,,114043.0,TSPEAR-AS2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of TSPEAR-AS2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4299,297948,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3015,H2AZ1,https://ctdbase.org/detail.go?type=gene&acc=3015,,,3015.0,H2AZ1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of H2AZ1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4300,297949,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,94239,H2AZ2,https://ctdbase.org/detail.go?type=gene&acc=94239,,,94239.0,H2AZ2,9606.0,Homo sapiens (human),Valproic acid affects the expression of H2AZ2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4301,297950,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,94239,H2AZ2,https://ctdbase.org/detail.go?type=gene&acc=94239,,,94239.0,H2AZ2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of H2AZ2 mRNA,,,PMID:23179753|PMID:27188386|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|27188386|29154799,,
4302,297951,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,255626,H2BC1,https://ctdbase.org/detail.go?type=gene&acc=255626,,,255626.0,H2BC1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of H2BC1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4303,297952,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8346,H2BC10,https://ctdbase.org/detail.go?type=gene&acc=8346,,,8346.0,H2BC10,9606.0,Homo sapiens (human),Valproic acid results in increased expression of H2BC10 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4304,297953,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,85236,H2BC12,https://ctdbase.org/detail.go?type=gene&acc=85236,,,85236.0,H2BC12,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of H2BC12 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4305,297954,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,85236,H2BC12,https://ctdbase.org/detail.go?type=gene&acc=85236,,,85236.0,H2BC12,9606.0,Homo sapiens (human),Valproic acid affects the expression of H2BC12 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4306,297955,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,85236,H2BC12,https://ctdbase.org/detail.go?type=gene&acc=85236,,,85236.0,H2BC12,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of H2BC12 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24383497|24935251|26272509|29154799,,
4307,298406,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,286436,H2BW2,https://ctdbase.org/detail.go?type=gene&acc=286436,,,286436.0,H2BW2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of H2BW2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4308,298407,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,767811,H2BW4P,https://ctdbase.org/detail.go?type=gene&acc=767811,,,767811.0,H2BW4P,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of H2BW4P mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4309,298408,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,767811,H2BW4P,https://ctdbase.org/detail.go?type=gene&acc=767811,,,767811.0,H2BW4P,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of H2BW4P mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|26272509|28001369,,
4310,298409,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,14998,H2-DMA,https://ctdbase.org/detail.go?type=gene&acc=14998,,,14998.0,H2-DMa,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of H2-DMA mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4311,298410,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,100504404,H2-EA,https://ctdbase.org/detail.go?type=gene&acc=100504404,,,100504404.0,H2-Ea,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of H2-EA mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4312,298724,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,121504,H4C16,https://ctdbase.org/detail.go?type=gene&acc=121504,,,121504.0,H4C16,9606.0,Homo sapiens (human),Valproic acid promotes the reaction [H4C16 protein modified form binds to SLC1A2 promoter],,,PMID:19924110,https://www.ncbi.nlm.nih.gov/pubmed/19924110,19924110,,
4313,298725,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,121504,H4C16,https://ctdbase.org/detail.go?type=gene&acc=121504,,,121504.0,H4C16,9606.0,Homo sapiens (human),Valproic acid results in increased acetylation of H4C16 protein,,,PMID:15103026|PMID:19924110,https://www.ncbi.nlm.nih.gov/pubmed/15103026|https://www.ncbi.nlm.nih.gov/pubmed/19924110,15103026|19924110,,
4314,299070,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22927,HABP4,https://ctdbase.org/detail.go?type=gene&acc=22927,,,22927.0,HABP4,9606.0,Homo sapiens (human),Valproic acid affects the expression of HABP4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4315,299071,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22927,HABP4,https://ctdbase.org/detail.go?type=gene&acc=22927,,,22927.0,HABP4,9606.0,Homo sapiens (human),Valproic acid results in increased expression of HABP4 mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|27188386|28001369|29154799,,
4316,299072,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22927,HABP4,https://ctdbase.org/detail.go?type=gene&acc=22927,,,22927.0,HABP4,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of HABP4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4317,299073,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9200,HACD1,https://ctdbase.org/detail.go?type=gene&acc=9200,,,9200.0,HACD1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HACD1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4318,299074,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9200,HACD1,https://ctdbase.org/detail.go?type=gene&acc=9200,,,9200.0,HACD1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of HACD1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4319,299075,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9200,HACD1,https://ctdbase.org/detail.go?type=gene&acc=9200,,,9200.0,HACD1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of HACD1 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
4320,299076,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9200,HACD1,https://ctdbase.org/detail.go?type=gene&acc=9200,,,9200.0,HACD1,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in decreased expression of HACD1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4321,299077,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,201562,HACD2,https://ctdbase.org/detail.go?type=gene&acc=201562,,,201562.0,HACD2,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of HACD2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4322,299696,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7181,NR2C1,https://ctdbase.org/detail.go?type=gene&acc=7181,,,7181.0,NR2C1,9606.0,Homo sapiens (human),Valproic acid affects the expression of NR2C1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4323,299697,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7181,NR2C1,https://ctdbase.org/detail.go?type=gene&acc=7181,,,7181.0,NR2C1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NR2C1 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
4324,299698,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7181,NR2C1,https://ctdbase.org/detail.go?type=gene&acc=7181,,,7181.0,NR2C1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NR2C1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4325,299699,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7182,NR2C2,https://ctdbase.org/detail.go?type=gene&acc=7182,,,7182.0,NR2C2,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of NR2C2 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4326,299700,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7182,NR2C2,https://ctdbase.org/detail.go?type=gene&acc=7182,,,7182.0,NR2C2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2C2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4327,299701,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7182,NR2C2,https://ctdbase.org/detail.go?type=gene&acc=7182,,,7182.0,NR2C2,9606.0,Homo sapiens (human),Valproic acid affects the expression of NR2C2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4328,299702,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7182,NR2C2,https://ctdbase.org/detail.go?type=gene&acc=7182,,,7182.0,NR2C2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NR2C2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4329,299703,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7182,NR2C2,https://ctdbase.org/detail.go?type=gene&acc=7182,,,7182.0,NR2C2,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of NR2C2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4330,299872,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7101,NR2E1,https://ctdbase.org/detail.go?type=gene&acc=7101,,,7101.0,NR2E1,7955.0,Danio rerio (zebrafish),Valproic acid results in decreased expression of NR2E1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4331,299873,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7101,NR2E1,https://ctdbase.org/detail.go?type=gene&acc=7101,,,7101.0,NR2E1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NR2E1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4332,299874,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7101,NR2E1,https://ctdbase.org/detail.go?type=gene&acc=7101,,,7101.0,NR2E1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NR2E1 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|26272509|28001369,,
4333,299875,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7101,NR2E1,https://ctdbase.org/detail.go?type=gene&acc=7101,,,7101.0,NR2E1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NR2E1 mRNA,,,PMID:19101580|PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753,19101580|23179753,,
4334,299876,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10002,NR2E3,https://ctdbase.org/detail.go?type=gene&acc=10002,,,10002.0,NR2E3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NR2E3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4335,299877,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7025,NR2F1,https://ctdbase.org/detail.go?type=gene&acc=7025,,,7025.0,NR2F1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NR2F1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4336,300963,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51084,CRYL1,https://ctdbase.org/detail.go?type=gene&acc=51084,,,51084.0,CRYL1,9606.0,Homo sapiens (human),Valproic acid affects the expression of CRYL1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4337,300964,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51084,CRYL1,https://ctdbase.org/detail.go?type=gene&acc=51084,,,51084.0,CRYL1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CRYL1 gene|valproic acid results in decreased expression of CRYL1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4338,300965,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51084,CRYL1,https://ctdbase.org/detail.go?type=gene&acc=51084,,,51084.0,CRYL1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CRYL1 mRNA,,,PMID:23179753|PMID:24383497,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497,23179753|24383497,,
4339,300966,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1428,CRYM,https://ctdbase.org/detail.go?type=gene&acc=1428,,,1428.0,CRYM,9606.0,Homo sapiens (human),Valproic acid affects the expression of CRYM mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4340,300967,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1428,CRYM,https://ctdbase.org/detail.go?type=gene&acc=1428,,,1428.0,CRYM,9606.0,Homo sapiens (human),Valproic acid affects the expression of CRYM protein|valproic acid results in decreased expression of CRYM mRNA,,,PMID:29501571,https://www.ncbi.nlm.nih.gov/pubmed/29501571,29501571,,
4341,301113,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4899,NRF1,https://ctdbase.org/detail.go?type=gene&acc=4899,,,4899.0,NRF1,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of NRF1 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4342,301114,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3084,NRG1,https://ctdbase.org/detail.go?type=gene&acc=3084,,,3084.0,NRG1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4343,301115,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3084,NRG1,https://ctdbase.org/detail.go?type=gene&acc=3084,,,3084.0,NRG1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NRG1 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
4344,301116,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3084,NRG1,https://ctdbase.org/detail.go?type=gene&acc=3084,,,3084.0,NRG1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NRG1 mRNA,,,PMID:19101580|PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753,19101580|23179753,,
4345,301117,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3084,NRG1,https://ctdbase.org/detail.go?type=gene&acc=3084,,,3084.0,NRG1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NRG1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4346,301307,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10718,NRG3,https://ctdbase.org/detail.go?type=gene&acc=10718,,,10718.0,NRG3,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRG3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4347,301308,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10718,NRG3,https://ctdbase.org/detail.go?type=gene&acc=10718,,,10718.0,NRG3,9606.0,Homo sapiens (human),Valproic acid affects the expression of NRG3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4348,301309,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10718,NRG3,https://ctdbase.org/detail.go?type=gene&acc=10718,,,10718.0,NRG3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NRG3 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
4349,301310,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,145957,NRG4,https://ctdbase.org/detail.go?type=gene&acc=145957,,,145957.0,NRG4,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of NRG4 mRNA,,,PMID:17292431|PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17292431|https://www.ncbi.nlm.nih.gov/pubmed/17963808,17292431|17963808,,
4350,301311,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,145957,NRG4,https://ctdbase.org/detail.go?type=gene&acc=145957,,,145957.0,NRG4,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of NRG4 mRNA,,,PMID:35594946,https://www.ncbi.nlm.nih.gov/pubmed/35594946,35594946,,
4351,301312,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4900,NRGN,https://ctdbase.org/detail.go?type=gene&acc=4900,,,4900.0,NRGN,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRGN mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4352,301313,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4900,NRGN,https://ctdbase.org/detail.go?type=gene&acc=4900,,,4900.0,NRGN,9606.0,Homo sapiens (human),Valproic acid affects the expression of NRGN mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4353,301810,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1453,CSNK1D,https://ctdbase.org/detail.go?type=gene&acc=1453,,,1453.0,CSNK1D,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of CSNK1D mRNA,,,PMID:20546886|PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/20546886|https://www.ncbi.nlm.nih.gov/pubmed/21427059,20546886|21427059,,
4354,301969,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7280,TUBB2A,https://ctdbase.org/detail.go?type=gene&acc=7280,,,7280.0,TUBB2A,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of TUBB2A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4355,301970,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7280,TUBB2A,https://ctdbase.org/detail.go?type=gene&acc=7280,,,7280.0,TUBB2A,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of TUBB2A mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4356,302148,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55308,DDX19A,https://ctdbase.org/detail.go?type=gene&acc=55308,,,55308.0,DDX19A,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of DDX19A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4357,302149,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55308,DDX19A,https://ctdbase.org/detail.go?type=gene&acc=55308,,,55308.0,DDX19A,9606.0,Homo sapiens (human),Valproic acid results in increased expression of DDX19A mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
4358,302150,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11269,DDX19B,https://ctdbase.org/detail.go?type=gene&acc=11269,,,11269.0,DDX19B,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of DDX19B mRNA,,,PMID:19136453,https://www.ncbi.nlm.nih.gov/pubmed/19136453,19136453,,
4359,302151,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11218,DDX20,https://ctdbase.org/detail.go?type=gene&acc=11218,,,11218.0,DDX20,9606.0,Homo sapiens (human),Valproic acid affects the expression of DDX20 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4360,302152,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11218,DDX20,https://ctdbase.org/detail.go?type=gene&acc=11218,,,11218.0,DDX20,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of DDX20 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
4361,302153,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9188,DDX21,https://ctdbase.org/detail.go?type=gene&acc=9188,,,9188.0,DDX21,9606.0,Homo sapiens (human),Valproic acid affects the expression of DDX21 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4362,302154,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9188,DDX21,https://ctdbase.org/detail.go?type=gene&acc=9188,,,9188.0,DDX21,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of DDX21 mRNA,,,PMID:19101580,https://www.ncbi.nlm.nih.gov/pubmed/19101580,19101580,,
4363,302155,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9188,DDX21,https://ctdbase.org/detail.go?type=gene&acc=9188,,,9188.0,DDX21,9606.0,Homo sapiens (human),Valproic acid results in increased expression of DDX21 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4364,302156,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9188,DDX21,https://ctdbase.org/detail.go?type=gene&acc=9188,,,9188.0,DDX21,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of DDX21 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4365,302157,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57062,DDX24,https://ctdbase.org/detail.go?type=gene&acc=57062,,,57062.0,DDX24,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of DDX24 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4366,302484,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10675,CSPG5,https://ctdbase.org/detail.go?type=gene&acc=10675,,,10675.0,CSPG5,9606.0,Homo sapiens (human),Valproic acid affects the expression of CSPG5 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4367,302485,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10675,CSPG5,https://ctdbase.org/detail.go?type=gene&acc=10675,,,10675.0,CSPG5,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CSPG5 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4368,302641,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55968,NSFL1C,https://ctdbase.org/detail.go?type=gene&acc=55968,,,55968.0,NSFL1C,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NSFL1C mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4369,302642,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27065,NSG1,https://ctdbase.org/detail.go?type=gene&acc=27065,,,27065.0,NSG1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NSG1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4370,302643,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27065,NSG1,https://ctdbase.org/detail.go?type=gene&acc=27065,,,27065.0,NSG1,9606.0,Homo sapiens (human),Valproic acid affects the expression of NSG1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4371,302644,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27065,NSG1,https://ctdbase.org/detail.go?type=gene&acc=27065,,,27065.0,NSG1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NSG1 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24383497|24935251|26272509|27188386|28001369|29154799,,
4372,302645,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51617,NSG2,https://ctdbase.org/detail.go?type=gene&acc=51617,,,51617.0,NSG2,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of NSG2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4373,302646,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of SLC29A1 mRNA,,,PMID:32437819,https://www.ncbi.nlm.nih.gov/pubmed/32437819,32437819,,
4374,302647,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3177,SLC29A2,https://ctdbase.org/detail.go?type=gene&acc=3177,,,3177.0,SLC29A2,9606.0,Homo sapiens (human),Valproic acid affects the expression of SLC29A2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4375,302648,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3177,SLC29A2,https://ctdbase.org/detail.go?type=gene&acc=3177,,,3177.0,SLC29A2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of SLC29A2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4376,302649,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55315,SLC29A3,https://ctdbase.org/detail.go?type=gene&acc=55315,,,55315.0,SLC29A3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of SLC29A3 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4377,303685,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9191,DEDD,https://ctdbase.org/detail.go?type=gene&acc=9191,,,9191.0,DEDD,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of DEDD gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4378,303686,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9191,DEDD,https://ctdbase.org/detail.go?type=gene&acc=9191,,,9191.0,DEDD,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of DEDD mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4379,304181,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,81567,TXNDC5,https://ctdbase.org/detail.go?type=gene&acc=81567,,,81567.0,TXNDC5,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of TXNDC5 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4380,304182,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10190,TXNDC9,https://ctdbase.org/detail.go?type=gene&acc=10190,,,10190.0,TXNDC9,9606.0,Homo sapiens (human),Valproic acid affects the expression of TXNDC9 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4381,304183,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),Valproic acid affects the expression of TXNIP mRNA,,,PMID:25979313|PMID:26072468,https://www.ncbi.nlm.nih.gov/pubmed/25979313|https://www.ncbi.nlm.nih.gov/pubmed/26072468,25979313|26072468,,
4382,304184,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of TXNIP mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4383,305012,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9909,DENND4B,https://ctdbase.org/detail.go?type=gene&acc=9909,,,9909.0,DENND4B,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of DENND4B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4384,305013,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55667,DENND4C,https://ctdbase.org/detail.go?type=gene&acc=55667,,,55667.0,DENND4C,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of DENND4C mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4385,305014,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55667,DENND4C,https://ctdbase.org/detail.go?type=gene&acc=55667,,,55667.0,DENND4C,9606.0,Homo sapiens (human),Valproic acid results in increased expression of DENND4C mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4386,305150,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11051,NUDT21,https://ctdbase.org/detail.go?type=gene&acc=11051,,,11051.0,NUDT21,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NUDT21 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4387,305151,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11051,NUDT21,https://ctdbase.org/detail.go?type=gene&acc=11051,,,11051.0,NUDT21,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of NUDT21 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4388,305152,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11051,NUDT21,https://ctdbase.org/detail.go?type=gene&acc=11051,,,11051.0,NUDT21,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NUDT21 gene|valproic acid results in increased expression of NUDT21 protein|valproic acid results in increased expression of NUDT21 mRNA,,,PMID:29501571,https://www.ncbi.nlm.nih.gov/pubmed/29501571,29501571,,
4389,305153,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84304,NUDT22,https://ctdbase.org/detail.go?type=gene&acc=84304,,,84304.0,NUDT22,9606.0,Homo sapiens (human),Valproic acid results in increased expression of NUDT22 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4390,305154,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84304,NUDT22,https://ctdbase.org/detail.go?type=gene&acc=84304,,,84304.0,NUDT22,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of NUDT22 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4391,305155,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84304,NUDT22,https://ctdbase.org/detail.go?type=gene&acc=84304,,,84304.0,NUDT22,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of NUDT22 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4392,305693,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51071,DERA,https://ctdbase.org/detail.go?type=gene&acc=51071,,,51071.0,DERA,9606.0,Homo sapiens (human),Valproic acid affects the expression of DERA mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4393,305694,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51071,DERA,https://ctdbase.org/detail.go?type=gene&acc=51071,,,51071.0,DERA,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of DERA gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4394,305695,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51009,DERL2,https://ctdbase.org/detail.go?type=gene&acc=51009,,,51009.0,DERL2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DERL2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4395,305696,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51009,DERL2,https://ctdbase.org/detail.go?type=gene&acc=51009,,,51009.0,DERL2,9606.0,Homo sapiens (human),Valproic acid affects the expression of DERL2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4396,305697,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51009,DERL2,https://ctdbase.org/detail.go?type=gene&acc=51009,,,51009.0,DERL2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of DERL2 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
4397,306385,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7319,UBE2A,https://ctdbase.org/detail.go?type=gene&acc=7319,,,7319.0,UBE2A,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of UBE2A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4398,306386,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7320,UBE2B,https://ctdbase.org/detail.go?type=gene&acc=7320,,,7320.0,UBE2B,9606.0,Homo sapiens (human),Valproic acid affects the expression of UBE2B mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4399,306387,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7320,UBE2B,https://ctdbase.org/detail.go?type=gene&acc=7320,,,7320.0,UBE2B,9606.0,Homo sapiens (human),Valproic acid results in increased expression of UBE2B mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
4400,306551,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51203,NUSAP1,https://ctdbase.org/detail.go?type=gene&acc=51203,,,51203.0,NUSAP1,9606.0,Homo sapiens (human),Valproic acid affects the expression of NUSAP1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4401,306552,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51203,NUSAP1,https://ctdbase.org/detail.go?type=gene&acc=51203,,,51203.0,NUSAP1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of NUSAP1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
4402,306696,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8029,CUBN,https://ctdbase.org/detail.go?type=gene&acc=8029,,,8029.0,CUBN,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CUBN gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4403,306697,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,404093,CUEDC1,https://ctdbase.org/detail.go?type=gene&acc=404093,,,404093.0,CUEDC1,9606.0,Homo sapiens (human),Valproic acid affects the expression of CUEDC1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4404,306698,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79004,CUEDC2,https://ctdbase.org/detail.go?type=gene&acc=79004,,,79004.0,CUEDC2,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of CUEDC2 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4405,306699,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79004,CUEDC2,https://ctdbase.org/detail.go?type=gene&acc=79004,,,79004.0,CUEDC2,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of CUEDC2 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4406,306700,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79004,CUEDC2,https://ctdbase.org/detail.go?type=gene&acc=79004,,,79004.0,CUEDC2,9606.0,Homo sapiens (human),Valproic acid affects the expression of CUEDC2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4407,306701,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8454,CUL1,https://ctdbase.org/detail.go?type=gene&acc=8454,,,8454.0,CUL1,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of CUL1 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4408,306702,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8454,CUL1,https://ctdbase.org/detail.go?type=gene&acc=8454,,,8454.0,CUL1,9606.0,Homo sapiens (human),Valproic acid affects the expression of CUL1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4409,306703,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8454,CUL1,https://ctdbase.org/detail.go?type=gene&acc=8454,,,8454.0,CUL1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CUL1 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
4410,306704,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8454,CUL1,https://ctdbase.org/detail.go?type=gene&acc=8454,,,8454.0,CUL1,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CUL1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4411,306705,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8454,CUL1,https://ctdbase.org/detail.go?type=gene&acc=8454,,,8454.0,CUL1,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of CUL1 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4412,340820,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84552,PARD6G,https://ctdbase.org/detail.go?type=gene&acc=84552,,,84552.0,PARD6G,9606.0,Homo sapiens (human),Valproic acid affects the expression of PARD6G mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4413,340821,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84552,PARD6G,https://ctdbase.org/detail.go?type=gene&acc=84552,,,84552.0,PARD6G,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PARD6G gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4414,340822,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,100130522,PARD6G-AS1,https://ctdbase.org/detail.go?type=gene&acc=100130522,,,100130522.0,PARD6G-AS1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PARD6G-AS1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4415,340823,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,100130522,PARD6G-AS1,https://ctdbase.org/detail.go?type=gene&acc=100130522,,,100130522.0,PARD6G-AS1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PARD6G-AS1 mRNA,,,PMID:24383497|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24383497|24935251|26272509,,
4416,340824,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,100130522,PARD6G-AS1,https://ctdbase.org/detail.go?type=gene&acc=100130522,,,100130522.0,PARD6G-AS1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PARD6G-AS1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4417,340825,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11315,PARK7,https://ctdbase.org/detail.go?type=gene&acc=11315,,,11315.0,PARK7,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of PARK7 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4418,341466,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,292,SLC25A5,https://ctdbase.org/detail.go?type=gene&acc=292,,,292.0,SLC25A5,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of SLC25A5 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4419,341467,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,292,SLC25A5,https://ctdbase.org/detail.go?type=gene&acc=292,,,292.0,SLC25A5,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of SLC25A5 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4420,341468,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,92014,SLC25A51,https://ctdbase.org/detail.go?type=gene&acc=92014,,,92014.0,SLC25A51,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A51 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4421,341469,3121,BindingDB,Valproic Acid,50003616,2-n-propyl-n-valeric acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50003616,8164,Aldo-keto reductase family 1 member A1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8164,Q3ZCJ2,Aldo-keto reductase family 1 member A1,618607.0,AKR1A1,9913.0,Bos taurus (cattle),,IC50 (nM),5.74e+4,PMID:27544072|DOI:10.1016/j.bioorg.2016.08.005,https://www.ncbi.nlm.nih.gov/pubmed/27544072|https://doi.org/10.1016/j.bioorg.2016.08.005,27544072,10.1016/j.bioorg.2016.08.005,
4422,341474,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,139411,PTCHD1,https://ctdbase.org/detail.go?type=gene&acc=139411,,,139411.0,PTCHD1,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of PTCHD1 mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
4423,341475,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,374308,PTCHD3,https://ctdbase.org/detail.go?type=gene&acc=374308,,,374308.0,PTCHD3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PTCHD3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4424,341641,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10362,HMG20B,https://ctdbase.org/detail.go?type=gene&acc=10362,,,10362.0,HMG20B,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of HMG20B mRNA,,,PMID:20546886,https://www.ncbi.nlm.nih.gov/pubmed/20546886,20546886,,
4425,341642,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3159,HMGA1,https://ctdbase.org/detail.go?type=gene&acc=3159,,,3159.0,HMGA1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of HMGA1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4426,341643,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8091,HMGA2,https://ctdbase.org/detail.go?type=gene&acc=8091,,,8091.0,HMGA2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMGA2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4427,341644,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8091,HMGA2,https://ctdbase.org/detail.go?type=gene&acc=8091,,,8091.0,HMGA2,9606.0,Homo sapiens (human),Valproic acid affects the expression of HMGA2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4428,341645,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8091,HMGA2,https://ctdbase.org/detail.go?type=gene&acc=8091,,,8091.0,HMGA2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of HMGA2 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
4429,341646,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8091,HMGA2,https://ctdbase.org/detail.go?type=gene&acc=8091,,,8091.0,HMGA2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of HMGA2 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
4430,341647,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8091,HMGA2,https://ctdbase.org/detail.go?type=gene&acc=8091,,,8091.0,HMGA2,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of HMGA2 mRNA,,,PMID:19136453|PMID:20546886,https://www.ncbi.nlm.nih.gov/pubmed/19136453|https://www.ncbi.nlm.nih.gov/pubmed/20546886,19136453|20546886,,
4431,341648,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8091,HMGA2,https://ctdbase.org/detail.go?type=gene&acc=8091,,,8091.0,HMGA2,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of HMGA2 mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
4432,341649,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,7955.0,Danio rerio (zebrafish),Valproic acid results in decreased expression of HMGB1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4433,342106,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,408,ARRB1,https://ctdbase.org/detail.go?type=gene&acc=408,,,408.0,ARRB1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARRB1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4434,342107,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,408,ARRB1,https://ctdbase.org/detail.go?type=gene&acc=408,,,408.0,ARRB1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ARRB1 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
4435,342108,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,409,ARRB2,https://ctdbase.org/detail.go?type=gene&acc=409,,,409.0,ARRB2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ARRB2 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4436,342109,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,92714,ARRDC1,https://ctdbase.org/detail.go?type=gene&acc=92714,,,92714.0,ARRDC1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ARRDC1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4437,342110,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,85026,ARRDC1-AS1,https://ctdbase.org/detail.go?type=gene&acc=85026,,,85026.0,ARRDC1-AS1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ARRDC1-AS1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4438,342111,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27106,ARRDC2,https://ctdbase.org/detail.go?type=gene&acc=27106,,,27106.0,ARRDC2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ARRDC2 gene|valproic acid results in decreased expression of ARRDC2 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4439,342112,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27106,ARRDC2,https://ctdbase.org/detail.go?type=gene&acc=27106,,,27106.0,ARRDC2,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of ARRDC2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4440,342113,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57561,ARRDC3,https://ctdbase.org/detail.go?type=gene&acc=57561,,,57561.0,ARRDC3,9606.0,Homo sapiens (human),Valproic acid affects the expression of ARRDC3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4441,342114,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57561,ARRDC3,https://ctdbase.org/detail.go?type=gene&acc=57561,,,57561.0,ARRDC3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ARRDC3 mRNA,,,PMID:23179753|PMID:27188386|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|27188386|29154799,,
4442,342115,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57561,ARRDC3,https://ctdbase.org/detail.go?type=gene&acc=57561,,,57561.0,ARRDC3,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ARRDC3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4443,342270,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAX6 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4444,342271,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PAX6 mRNA,,,PMID:22723015|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/22723015|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,22723015|23179753|24383497|24935251|26272509|28001369,,
4445,342272,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PAX6 mRNA,,,PMID:24849673|PMID:29775723|PMID:31711903|PMID:34742744,https://www.ncbi.nlm.nih.gov/pubmed/24849673|https://www.ncbi.nlm.nih.gov/pubmed/29775723|https://www.ncbi.nlm.nih.gov/pubmed/31711903|https://www.ncbi.nlm.nih.gov/pubmed/34742744,24849673|29775723|31711903|34742744,,
4446,342273,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5080,PAX6,https://ctdbase.org/detail.go?type=gene&acc=5080,,,5080.0,PAX6,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of PAX6 mRNA,,,PMID:17292431|PMID:22045034,https://www.ncbi.nlm.nih.gov/pubmed/17292431|https://www.ncbi.nlm.nih.gov/pubmed/22045034,17292431|22045034,,
4447,342274,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5081,PAX7,https://ctdbase.org/detail.go?type=gene&acc=5081,,,5081.0,PAX7,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX7 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4448,342275,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5081,PAX7,https://ctdbase.org/detail.go?type=gene&acc=5081,,,5081.0,PAX7,9606.0,Homo sapiens (human),Valproic acid affects the expression of PAX7 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4449,342276,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5081,PAX7,https://ctdbase.org/detail.go?type=gene&acc=5081,,,5081.0,PAX7,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PAX7 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
4450,342277,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5081,PAX7,https://ctdbase.org/detail.go?type=gene&acc=5081,,,5081.0,PAX7,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PAX7 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|26272509,,
4451,342278,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5081,PAX7,https://ctdbase.org/detail.go?type=gene&acc=5081,,,5081.0,PAX7,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of PAX7 mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
4452,342279,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of HMGCR gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4453,343184,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8853,ASAP2,https://ctdbase.org/detail.go?type=gene&acc=8853,,,8853.0,ASAP2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ASAP2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4454,343185,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8853,ASAP2,https://ctdbase.org/detail.go?type=gene&acc=8853,,,8853.0,ASAP2,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of ASAP2 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
4455,343186,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8853,ASAP2,https://ctdbase.org/detail.go?type=gene&acc=8853,,,8853.0,ASAP2,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of ASAP2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4456,343589,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54039,PCBP3,https://ctdbase.org/detail.go?type=gene&acc=54039,,,54039.0,PCBP3,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of PCBP3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4457,343590,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54039,PCBP3,https://ctdbase.org/detail.go?type=gene&acc=54039,,,54039.0,PCBP3,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of PCBP3 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4458,343591,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57060,PCBP4,https://ctdbase.org/detail.go?type=gene&acc=57060,,,57060.0,PCBP4,9606.0,Homo sapiens (human),Valproic acid affects the expression of PCBP4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4459,343592,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57060,PCBP4,https://ctdbase.org/detail.go?type=gene&acc=57060,,,57060.0,PCBP4,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PCBP4 mrna|valproic acid results in increased methylation of PCBP4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4460,343593,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57060,PCBP4,https://ctdbase.org/detail.go?type=gene&acc=57060,,,57060.0,PCBP4,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of PCBP4 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4461,343594,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57060,PCBP4,https://ctdbase.org/detail.go?type=gene&acc=57060,,,57060.0,PCBP4,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of PCBP4 mrna|valproic acid results in increased expression of PCBP4 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4462,343595,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5095,PCCA,https://ctdbase.org/detail.go?type=gene&acc=5095,,,5095.0,PCCA,9606.0,Homo sapiens (human),Valproic acid affects the expression of PCCA mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4463,343596,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5095,PCCA,https://ctdbase.org/detail.go?type=gene&acc=5095,,,5095.0,PCCA,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of PCCA gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4464,343597,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5096,PCCB,https://ctdbase.org/detail.go?type=gene&acc=5096,,,5096.0,PCCB,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of PCCB mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4465,343787,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57575,PCDH10,https://ctdbase.org/detail.go?type=gene&acc=57575,,,57575.0,PCDH10,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH10 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4466,343788,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57575,PCDH10,https://ctdbase.org/detail.go?type=gene&acc=57575,,,57575.0,PCDH10,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PCDH10 mRNA,,,PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/19101580|https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,19101580|23179753|24383497|24935251|26272509|28001369,,
4467,343789,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27328,PCDH11X,https://ctdbase.org/detail.go?type=gene&acc=27328,,,27328.0,PCDH11X,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of PCDH11X gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4468,343945,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26469,PTPN18,https://ctdbase.org/detail.go?type=gene&acc=26469,,,26469.0,PTPN18,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PTPN18 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4469,343946,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5771,PTPN2,https://ctdbase.org/detail.go?type=gene&acc=5771,,,5771.0,PTPN2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PTPN2 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
4470,343947,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5771,PTPN2,https://ctdbase.org/detail.go?type=gene&acc=5771,,,5771.0,PTPN2,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of PTPN2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4471,343948,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5771,PTPN2,https://ctdbase.org/detail.go?type=gene&acc=5771,,,5771.0,PTPN2,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of PTPN2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4472,343949,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11099,PTPN21,https://ctdbase.org/detail.go?type=gene&acc=11099,,,11099.0,PTPN21,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTPN21 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4473,343950,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11099,PTPN21,https://ctdbase.org/detail.go?type=gene&acc=11099,,,11099.0,PTPN21,9606.0,Homo sapiens (human),Valproic acid affects the expression of PTPN21 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4474,343951,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,64428,CIAO3,https://ctdbase.org/detail.go?type=gene&acc=64428,,,64428.0,CIAO3,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of CIAO3 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4475,343952,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57019,CIAPIN1,https://ctdbase.org/detail.go?type=gene&acc=57019,,,57019.0,CIAPIN1,7955.0,Danio rerio (zebrafish),Valproic acid results in decreased expression of CIAPIN1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4476,343953,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57019,CIAPIN1,https://ctdbase.org/detail.go?type=gene&acc=57019,,,57019.0,CIAPIN1,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CIAPIN1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4477,343954,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,148523,CIART,https://ctdbase.org/detail.go?type=gene&acc=148523,,,148523.0,CIART,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CIART mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4478,344434,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84867,PTPN5,https://ctdbase.org/detail.go?type=gene&acc=84867,,,84867.0,PTPN5,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PTPN5 mRNA,,,PMID:23179753|PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|26272509|27188386,,
4479,344435,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5777,PTPN6,https://ctdbase.org/detail.go?type=gene&acc=5777,,,5777.0,PTPN6,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PTPN6 mrna|valproic acid results in increased methylation of PTPN6 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4480,344436,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5777,PTPN6,https://ctdbase.org/detail.go?type=gene&acc=5777,,,5777.0,PTPN6,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PTPN6 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
4481,344437,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5778,PTPN7,https://ctdbase.org/detail.go?type=gene&acc=5778,,,5778.0,PTPN7,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PTPN7 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4482,344438,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5780,PTPN9,https://ctdbase.org/detail.go?type=gene&acc=5780,,,5780.0,PTPN9,9606.0,Homo sapiens (human),Valproic acid affects the expression of PTPN9 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4483,345151,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55847,CISD1,https://ctdbase.org/detail.go?type=gene&acc=55847,,,55847.0,CISD1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CISD1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4484,345152,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55847,CISD1,https://ctdbase.org/detail.go?type=gene&acc=55847,,,55847.0,CISD1,9606.0,Homo sapiens (human),Valproic acid affects the expression of CISD1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4485,345607,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,26586,CKAP2,https://ctdbase.org/detail.go?type=gene&acc=26586,,,26586.0,CKAP2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CKAP2 mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24935251|26272509|28001369,,
4486,345608,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10970,CKAP4,https://ctdbase.org/detail.go?type=gene&acc=10970,,,10970.0,CKAP4,9606.0,Homo sapiens (human),Valproic acid affects the expression of CKAP4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4487,345762,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3198,HOXA1,https://ctdbase.org/detail.go?type=gene&acc=3198,,,3198.0,HOXA1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of HOXA1 mRNA,,,PMID:17292431|PMID:26072468,https://www.ncbi.nlm.nih.gov/pubmed/17292431|https://www.ncbi.nlm.nih.gov/pubmed/26072468,17292431|26072468,,
4488,345763,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3198,HOXA1,https://ctdbase.org/detail.go?type=gene&acc=3198,,,3198.0,HOXA1,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of HOXA1 mRNA,,,PMID:21427059|PMID:27693483,https://www.ncbi.nlm.nih.gov/pubmed/21427059|https://www.ncbi.nlm.nih.gov/pubmed/27693483,21427059|27693483,,
4489,345764,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3198,HOXA1,https://ctdbase.org/detail.go?type=gene&acc=3198,,,3198.0,HOXA1,10116.0,Rattus norvegicus (Norway rat),Valproic acid analog results in increased expression of HOXA1 mrna|valproic acid results in increased expression of HOXA1 mRNA,,,PMID:16989981,https://www.ncbi.nlm.nih.gov/pubmed/16989981,16989981,,
4490,345765,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3206,HOXA10,https://ctdbase.org/detail.go?type=gene&acc=3206,,,3206.0,HOXA10,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of HOXA10 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4491,346439,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22809,ATF5,https://ctdbase.org/detail.go?type=gene&acc=22809,,,22809.0,ATF5,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ATF5 mRNA,,,PMID:22083351|PMID:24935251|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/22083351|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/29154799,22083351|24935251|29154799,,
4492,346440,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22809,ATF5,https://ctdbase.org/detail.go?type=gene&acc=22809,,,22809.0,ATF5,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ATF5 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4493,346441,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,446834,ATF5.2.S,https://ctdbase.org/detail.go?type=gene&acc=446834,,,446834.0,atf5.2.S,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of ATF5.2.S mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4494,346442,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,567253,ATF5B,https://ctdbase.org/detail.go?type=gene&acc=567253,,,567253.0,atf5b,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of ATF5B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4495,346443,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,9606.0,Homo sapiens (human),Valproic acid affects the expression of ATF6 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4496,346444,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ATF6 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4497,346445,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22926,ATF6,https://ctdbase.org/detail.go?type=gene&acc=22926,,,22926.0,ATF6,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ATF6 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4498,346446,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1388,ATF6B,https://ctdbase.org/detail.go?type=gene&acc=1388,,,1388.0,ATF6B,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ATF6B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4499,346447,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1388,ATF6B,https://ctdbase.org/detail.go?type=gene&acc=1388,,,1388.0,ATF6B,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ATF6B mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4500,346759,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,59285,CACNG6,https://ctdbase.org/detail.go?type=gene&acc=59285,,,59285.0,CACNG6,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of CACNG6 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4501,346760,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,59283,CACNG8,https://ctdbase.org/detail.go?type=gene&acc=59283,,,59283.0,CACNG8,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CACNG8 mRNA,,,PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,26272509|28001369,,
4502,346761,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,59283,CACNG8,https://ctdbase.org/detail.go?type=gene&acc=59283,,,59283.0,CACNG8,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CACNG8 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4503,347065,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,115201,ATG4A,https://ctdbase.org/detail.go?type=gene&acc=115201,,,115201.0,ATG4A,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATG4A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4504,347066,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,115201,ATG4A,https://ctdbase.org/detail.go?type=gene&acc=115201,,,115201.0,ATG4A,9606.0,Homo sapiens (human),Valproic acid affects the expression of ATG4A mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4505,347067,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,115201,ATG4A,https://ctdbase.org/detail.go?type=gene&acc=115201,,,115201.0,ATG4A,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ATG4A mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
4506,347068,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23192,ATG4B,https://ctdbase.org/detail.go?type=gene&acc=23192,,,23192.0,ATG4B,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of ATG4B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4507,347894,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,800,CALD1,https://ctdbase.org/detail.go?type=gene&acc=800,,,800.0,CALD1,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CALD1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4508,347895,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,800,CALD1,https://ctdbase.org/detail.go?type=gene&acc=800,,,800.0,CALD1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CALD1 mRNA,,,PMID:26272509|PMID:26705709|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/26705709|https://www.ncbi.nlm.nih.gov/pubmed/28001369,26272509|26705709|28001369,,
4509,347896,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,255022,CALHM1,https://ctdbase.org/detail.go?type=gene&acc=255022,,,255022.0,CALHM1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CALHM1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4510,347897,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,221301,CALHM4,https://ctdbase.org/detail.go?type=gene&acc=221301,,,221301.0,CALHM4,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CALHM4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4511,348056,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57130,ATP13A1,https://ctdbase.org/detail.go?type=gene&acc=57130,,,57130.0,ATP13A1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ATP13A1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4512,348057,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23400,ATP13A2,https://ctdbase.org/detail.go?type=gene&acc=23400,,,23400.0,ATP13A2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ATP13A2 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4513,348058,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23400,ATP13A2,https://ctdbase.org/detail.go?type=gene&acc=23400,,,23400.0,ATP13A2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ATP13A2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4514,348059,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79572,ATP13A3,https://ctdbase.org/detail.go?type=gene&acc=79572,,,79572.0,ATP13A3,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ATP13A3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4515,348060,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5133,PDCD1,https://ctdbase.org/detail.go?type=gene&acc=5133,,,5133.0,PDCD1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PDCD1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4516,348061,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11235,PDCD10,https://ctdbase.org/detail.go?type=gene&acc=11235,,,11235.0,PDCD10,9606.0,Homo sapiens (human),Valproic acid affects the expression of PDCD10 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4517,348062,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22984,PDCD11,https://ctdbase.org/detail.go?type=gene&acc=22984,,,22984.0,PDCD11,9606.0,Homo sapiens (human),Valproic acid affects the expression of PDCD11 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4518,348063,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5134,PDCD2,https://ctdbase.org/detail.go?type=gene&acc=5134,,,5134.0,PDCD2,9606.0,Homo sapiens (human),Valproic acid affects the expression of PDCD2 mRNA,,,PMID:23179753|PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/25979313,23179753|25979313,,
4519,348064,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5134,PDCD2,https://ctdbase.org/detail.go?type=gene&acc=5134,,,5134.0,PDCD2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PDCD2 mRNA,,,PMID:24383497,https://www.ncbi.nlm.nih.gov/pubmed/24383497,24383497,,
4520,348065,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84306,PDCD2L,https://ctdbase.org/detail.go?type=gene&acc=84306,,,84306.0,PDCD2L,9606.0,Homo sapiens (human),Valproic acid affects the expression of PDCD2L mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4521,348238,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27250,PDCD4,https://ctdbase.org/detail.go?type=gene&acc=27250,,,27250.0,PDCD4,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of PDCD4 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4522,348239,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,282997,PDCD4-AS1,https://ctdbase.org/detail.go?type=gene&acc=282997,,,282997.0,PDCD4-AS1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDCD4-AS1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4523,348240,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,282997,PDCD4-AS1,https://ctdbase.org/detail.go?type=gene&acc=282997,,,282997.0,PDCD4-AS1,9606.0,Homo sapiens (human),Valproic acid affects the expression of PDCD4-AS1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4524,348241,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,282997,PDCD4-AS1,https://ctdbase.org/detail.go?type=gene&acc=282997,,,282997.0,PDCD4-AS1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PDCD4-AS1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
4525,348242,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,282997,PDCD4-AS1,https://ctdbase.org/detail.go?type=gene&acc=282997,,,282997.0,PDCD4-AS1,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of PDCD4-AS1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4526,348243,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9141,PDCD5,https://ctdbase.org/detail.go?type=gene&acc=9141,,,9141.0,PDCD5,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PDCD5 mRNA,,,PMID:23179753|PMID:24383497|PMID:25192806|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|24383497|25192806|27188386,,
4527,348244,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10016,PDCD6,https://ctdbase.org/detail.go?type=gene&acc=10016,,,10016.0,PDCD6,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of PDCD6 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4528,348245,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10016,PDCD6,https://ctdbase.org/detail.go?type=gene&acc=10016,,,10016.0,PDCD6,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDCD6 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4529,348246,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10016,PDCD6,https://ctdbase.org/detail.go?type=gene&acc=10016,,,10016.0,PDCD6,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PDCD6 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|26272509,,
4530,348247,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84239,ATP13A4,https://ctdbase.org/detail.go?type=gene&acc=84239,,,84239.0,ATP13A4,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of ATP13A4 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4531,348407,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10846,PDE10A,https://ctdbase.org/detail.go?type=gene&acc=10846,,,10846.0,PDE10A,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PDE10A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4532,348408,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10846,PDE10A,https://ctdbase.org/detail.go?type=gene&acc=10846,,,10846.0,PDE10A,9606.0,Homo sapiens (human),Valproic acid affects the expression of PDE10A mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4533,348409,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10846,PDE10A,https://ctdbase.org/detail.go?type=gene&acc=10846,,,10846.0,PDE10A,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PDE10A mRNA,,,PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,24383497|24935251|26272509|27188386|28001369,,
4534,348410,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10846,PDE10A,https://ctdbase.org/detail.go?type=gene&acc=10846,,,10846.0,PDE10A,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PDE10A mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4535,348411,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10846,PDE10A,https://ctdbase.org/detail.go?type=gene&acc=10846,,,10846.0,PDE10A,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of PDE10A mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
4536,348412,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10846,PDE10A,https://ctdbase.org/detail.go?type=gene&acc=10846,,,10846.0,PDE10A,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of PDE10A mRNA,,,PMID:23665938,https://www.ncbi.nlm.nih.gov/pubmed/23665938,23665938,,
4537,348558,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9957,HS3ST1,https://ctdbase.org/detail.go?type=gene&acc=9957,,,9957.0,HS3ST1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4538,348559,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9957,HS3ST1,https://ctdbase.org/detail.go?type=gene&acc=9957,,,9957.0,HS3ST1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of HS3ST1 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
4539,348560,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9957,HS3ST1,https://ctdbase.org/detail.go?type=gene&acc=9957,,,9957.0,HS3ST1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of HS3ST1 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
4540,348561,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9957,HS3ST1,https://ctdbase.org/detail.go?type=gene&acc=9957,,,9957.0,HS3ST1,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of HS3ST1 mRNA,,,PMID:23665938,https://www.ncbi.nlm.nih.gov/pubmed/23665938,23665938,,
4541,348562,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9957,HS3ST1,https://ctdbase.org/detail.go?type=gene&acc=9957,,,9957.0,HS3ST1,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of HS3ST1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4542,348563,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9956,HS3ST2,https://ctdbase.org/detail.go?type=gene&acc=9956,,,9956.0,HS3ST2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of HS3ST2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4543,348720,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6249,CLIP1,https://ctdbase.org/detail.go?type=gene&acc=6249,,,6249.0,CLIP1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CLIP1 mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24935251|26272509|28001369,,
4544,348721,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6249,CLIP1,https://ctdbase.org/detail.go?type=gene&acc=6249,,,6249.0,CLIP1,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CLIP1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4545,348722,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,25999,CLIP3,https://ctdbase.org/detail.go?type=gene&acc=25999,,,25999.0,CLIP3,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CLIP3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4546,348854,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,818,CAMK2G,https://ctdbase.org/detail.go?type=gene&acc=818,,,818.0,CAMK2G,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CAMK2G gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4547,348855,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,818,CAMK2G,https://ctdbase.org/detail.go?type=gene&acc=818,,,818.0,CAMK2G,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of CAMK2G mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4548,348856,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55450,CAMK2N1,https://ctdbase.org/detail.go?type=gene&acc=55450,,,55450.0,CAMK2N1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAMK2N1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4549,349028,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55450,CAMK2N1,https://ctdbase.org/detail.go?type=gene&acc=55450,,,55450.0,CAMK2N1,9606.0,Homo sapiens (human),Valproic acid affects the expression of CAMK2N1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4550,349029,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55450,CAMK2N1,https://ctdbase.org/detail.go?type=gene&acc=55450,,,55450.0,CAMK2N1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CAMK2N1 mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24935251|26272509|28001369,,
4551,349030,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55450,CAMK2N1,https://ctdbase.org/detail.go?type=gene&acc=55450,,,55450.0,CAMK2N1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CAMK2N1 mRNA,,,PMID:19101580,https://www.ncbi.nlm.nih.gov/pubmed/19101580,19101580,,
4552,349031,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55450,CAMK2N1,https://ctdbase.org/detail.go?type=gene&acc=55450,,,55450.0,CAMK2N1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of CAMK2N1 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4553,349331,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9914,ATP2C2,https://ctdbase.org/detail.go?type=gene&acc=9914,,,9914.0,ATP2C2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ATP2C2 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|28001369,,
4554,349332,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,495,ATP4A,https://ctdbase.org/detail.go?type=gene&acc=495,,,495.0,ATP4A,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ATP4A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4555,349333,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,496,ATP4B,https://ctdbase.org/detail.go?type=gene&acc=496,,,496.0,ATP4B,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ATP4B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4556,349334,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,506,ATP5F1B,https://ctdbase.org/detail.go?type=gene&acc=506,,,506.0,ATP5F1B,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ATP5F1B gene|valproic acid results in decreased expression of ATP5F1B mRNA,,,PMID:29501571,https://www.ncbi.nlm.nih.gov/pubmed/29501571,29501571,,
4557,349335,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,506,ATP5F1B,https://ctdbase.org/detail.go?type=gene&acc=506,,,506.0,ATP5F1B,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of ATP5F1B mRNA,,,PMID:17292431|PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17292431|https://www.ncbi.nlm.nih.gov/pubmed/17963808,17292431|17963808,,
4558,349336,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,509,ATP5F1C,https://ctdbase.org/detail.go?type=gene&acc=509,,,509.0,ATP5F1C,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ATP5F1C gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4559,349337,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,509,ATP5F1C,https://ctdbase.org/detail.go?type=gene&acc=509,,,509.0,ATP5F1C,10116.0,Rattus norvegicus (Norway rat),Valproic acid affects the splicing of ATP5F1C mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
4560,349932,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of PDGFRB protein,,,PMID:29845424,https://www.ncbi.nlm.nih.gov/pubmed/29845424,29845424,,
4561,349933,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of PDGFRB mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
4562,349934,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5157,PDGFRL,https://ctdbase.org/detail.go?type=gene&acc=5157,,,5157.0,PDGFRL,9606.0,Homo sapiens (human),Valproic acid affects the expression of PDGFRL mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4563,349935,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5157,PDGFRL,https://ctdbase.org/detail.go?type=gene&acc=5157,,,5157.0,PDGFRL,9606.0,Homo sapiens (human),Valproic acid results in increased expression of PDGFRL mRNA,,,PMID:23179753|PMID:24935251|PMID:27188386|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24935251|27188386|29154799,,
4564,349936,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5157,PDGFRL,https://ctdbase.org/detail.go?type=gene&acc=5157,,,5157.0,PDGFRL,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of PDGFRL mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4565,349937,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5157,PDGFRL,https://ctdbase.org/detail.go?type=gene&acc=5157,,,5157.0,PDGFRL,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of PDGFRL mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
4566,349938,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10486,CAP2,https://ctdbase.org/detail.go?type=gene&acc=10486,,,10486.0,CAP2,9606.0,Homo sapiens (human),Valproic acid affects the expression of CAP2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4567,349939,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10486,CAP2,https://ctdbase.org/detail.go?type=gene&acc=10486,,,10486.0,CAP2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CAP2 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24383497|24935251|26272509|28001369|29154799,,
4568,349940,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,822,CAPG,https://ctdbase.org/detail.go?type=gene&acc=822,,,822.0,CAPG,9606.0,Homo sapiens (human),Valproic acid affects the expression of CAPG mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4569,349941,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,822,CAPG,https://ctdbase.org/detail.go?type=gene&acc=822,,,822.0,CAPG,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CAPG gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4570,350080,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,539,ATP5PO,https://ctdbase.org/detail.go?type=gene&acc=539,,,539.0,ATP5PO,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ATP5PO gene,,,PMID:29501571,https://www.ncbi.nlm.nih.gov/pubmed/29501571,29501571,,
4571,350081,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4508,ATP6,https://ctdbase.org/detail.go?type=gene&acc=4508,,,4508.0,ATP6,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ATP6 mrna|valproic acid results in decreased methylation of ATP6 gene,,,PMID:29501571,https://www.ncbi.nlm.nih.gov/pubmed/29501571,29501571,,
4572,350082,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4508,ATP6,https://ctdbase.org/detail.go?type=gene&acc=4508,,,4508.0,ATP6,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ATP6 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4573,350083,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,537,ATP6AP1,https://ctdbase.org/detail.go?type=gene&acc=537,,,537.0,ATP6AP1,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of ATP6AP1 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4574,350084,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,537,ATP6AP1,https://ctdbase.org/detail.go?type=gene&acc=537,,,537.0,ATP6AP1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ATP6AP1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4575,350085,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,92270,ATP6AP1L,https://ctdbase.org/detail.go?type=gene&acc=92270,,,92270.0,ATP6AP1L,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATP6AP1L mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4576,350438,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84263,HSDL2,https://ctdbase.org/detail.go?type=gene&acc=84263,,,84263.0,HSDL2,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of HSDL2 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4577,350439,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84263,HSDL2,https://ctdbase.org/detail.go?type=gene&acc=84263,,,84263.0,HSDL2,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of HSDL2 mrna|valproic acid results in decreased expression of HSDL2 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4578,351087,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,833,CARS1,https://ctdbase.org/detail.go?type=gene&acc=833,,,833.0,CARS1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CARS1 protein,,,PMID:29501571,https://www.ncbi.nlm.nih.gov/pubmed/29501571,29501571,,
4579,351088,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,22900,CARD8,https://ctdbase.org/detail.go?type=gene&acc=22900,,,22900.0,CARD8,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CARD8 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24383497|24935251|25192806|26272509|28001369|29154799,,
4580,351089,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,526,ATP6V1B2,https://ctdbase.org/detail.go?type=gene&acc=526,,,526.0,ATP6V1B2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ATP6V1B2 mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
4581,351090,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,526,ATP6V1B2,https://ctdbase.org/detail.go?type=gene&acc=526,,,526.0,ATP6V1B2,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of ATP6V1B2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4582,351091,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,359839,ATP6V1BA,https://ctdbase.org/detail.go?type=gene&acc=359839,,,359839.0,atp6v1ba,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of ATP6V1BA mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4583,351092,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,528,ATP6V1C1,https://ctdbase.org/detail.go?type=gene&acc=528,,,528.0,ATP6V1C1,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of ATP6V1C1 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4584,351093,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,528,ATP6V1C1,https://ctdbase.org/detail.go?type=gene&acc=528,,,528.0,ATP6V1C1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V1C1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4585,351094,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,528,ATP6V1C1,https://ctdbase.org/detail.go?type=gene&acc=528,,,528.0,ATP6V1C1,9606.0,Homo sapiens (human),Valproic acid affects the expression of ATP6V1C1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4586,351095,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,528,ATP6V1C1,https://ctdbase.org/detail.go?type=gene&acc=528,,,528.0,ATP6V1C1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ATP6V1C1 mRNA,,,PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|27188386|28001369,,
4587,351096,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,449655,ATP6V1C1B,https://ctdbase.org/detail.go?type=gene&acc=449655,,,449655.0,atp6v1c1b,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of ATP6V1C1B mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4588,351265,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51182,HSPA14,https://ctdbase.org/detail.go?type=gene&acc=51182,,,51182.0,HSPA14,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of HSPA14 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4589,351266,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51182,HSPA14,https://ctdbase.org/detail.go?type=gene&acc=51182,,,51182.0,HSPA14,9606.0,Homo sapiens (human),Valproic acid results in increased expression of HSPA14 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4590,351267,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309.0,HSPA5,9606.0,Homo sapiens (human),Valproic acid affects the expression of HSPA5 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4591,352301,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,375033,PEAR1,https://ctdbase.org/detail.go?type=gene&acc=375033,,,375033.0,PEAR1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEAR1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4592,352466,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,6310,ATXN1,https://ctdbase.org/detail.go?type=gene&acc=6310,,,6310.0,ATXN1,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of ATXN1 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
4593,353057,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54897,CASZ1,https://ctdbase.org/detail.go?type=gene&acc=54897,,,54897.0,CASZ1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CASZ1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4594,353058,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54897,CASZ1,https://ctdbase.org/detail.go?type=gene&acc=54897,,,54897.0,CASZ1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CASZ1 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|24935251|26272509,,
4595,353059,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54897,CASZ1,https://ctdbase.org/detail.go?type=gene&acc=54897,,,54897.0,CASZ1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CASZ1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4596,353060,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,7955.0,Danio rerio (zebrafish),[valproic acid co-treated with pentylenetetrazole] results in decreased activity of CAT protein,,,PMID:35866229,https://www.ncbi.nlm.nih.gov/pubmed/35866229,35866229,,
4597,353061,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of CAT mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4598,353062,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Cysteine inhibits the reaction [valproic acid results in decreased activity of CAT protein],,,PMID:28988495,https://www.ncbi.nlm.nih.gov/pubmed/28988495,28988495,,
4599,353199,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4848,CNOT2,https://ctdbase.org/detail.go?type=gene&acc=4848,,,4848.0,CNOT2,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of CNOT2 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4600,353200,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4849,CNOT3,https://ctdbase.org/detail.go?type=gene&acc=4849,,,4849.0,CNOT3,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4601,353201,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4849,CNOT3,https://ctdbase.org/detail.go?type=gene&acc=4849,,,4849.0,CNOT3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CNOT3 mRNA,,,PMID:24383497|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24383497|24935251|26272509,,
4602,353202,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4849,CNOT3,https://ctdbase.org/detail.go?type=gene&acc=4849,,,4849.0,CNOT3,10090.0,Mus musculus (house mouse),Valproic acid results in decreased expression of CNOT3 mRNA,,,PMID:19136453|PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/19136453|https://www.ncbi.nlm.nih.gov/pubmed/21427059,19136453|21427059,,
4603,353203,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4849,CNOT3,https://ctdbase.org/detail.go?type=gene&acc=4849,,,4849.0,CNOT3,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of CNOT3 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4604,353204,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,4850,CNOT4,https://ctdbase.org/detail.go?type=gene&acc=4850,,,4850.0,CNOT4,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4605,353356,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5654,HTRA1,https://ctdbase.org/detail.go?type=gene&acc=5654,,,5654.0,HTRA1,9606.0,Homo sapiens (human),Valproic acid affects the expression of HTRA1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4606,353357,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5654,HTRA1,https://ctdbase.org/detail.go?type=gene&acc=5654,,,5654.0,HTRA1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of HTRA1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4607,353358,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5654,HTRA1,https://ctdbase.org/detail.go?type=gene&acc=5654,,,5654.0,HTRA1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of HTRA1 mRNA,,,PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,27188386|28001369,,
4608,353359,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5654,HTRA1,https://ctdbase.org/detail.go?type=gene&acc=5654,,,5654.0,HTRA1,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of HTRA1 mRNA,,,PMID:19136453,https://www.ncbi.nlm.nih.gov/pubmed/19136453,19136453,,
4609,353360,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27429,HTRA2,https://ctdbase.org/detail.go?type=gene&acc=27429,,,27429.0,HTRA2,9606.0,Homo sapiens (human),Valproic acid affects the expression of HTRA2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4610,353361,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,27429,HTRA2,https://ctdbase.org/detail.go?type=gene&acc=27429,,,27429.0,HTRA2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of HTRA2 mRNA,,,PMID:23179753|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|28001369|29154799,,
4611,353362,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,94031,HTRA3,https://ctdbase.org/detail.go?type=gene&acc=94031,,,94031.0,HTRA3,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HTRA3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4612,353363,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,94031,HTRA3,https://ctdbase.org/detail.go?type=gene&acc=94031,,,94031.0,HTRA3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of HTRA3 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
4613,354154,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,863,CBFA2T3,https://ctdbase.org/detail.go?type=gene&acc=863,,,863.0,CBFA2T3,9606.0,Homo sapiens (human),Valproic acid affects the expression of CBFA2T3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4614,354155,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,865,CBFB,https://ctdbase.org/detail.go?type=gene&acc=865,,,865.0,CBFB,9606.0,Homo sapiens (human),Valproic acid affects the expression of CBFB mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4615,354315,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5697,PYY,https://ctdbase.org/detail.go?type=gene&acc=5697,,,5697.0,PYY,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of PYY mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4616,354316,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,23615,PYY2,https://ctdbase.org/detail.go?type=gene&acc=23615,,,23615.0,PYY2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of PYY2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4617,354317,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,30211,PYYA,https://ctdbase.org/detail.go?type=gene&acc=30211,,,30211.0,pyya,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of PYYA mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4618,354318,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5858,PZP,https://ctdbase.org/detail.go?type=gene&acc=5858,,,5858.0,PZP,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of PZP mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4619,354319,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5858,PZP,https://ctdbase.org/detail.go?type=gene&acc=5858,,,5858.0,PZP,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of PZP mRNA,,,PMID:35594946,https://www.ncbi.nlm.nih.gov/pubmed/35594946,35594946,,
4620,354320,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5859,QARS1,https://ctdbase.org/detail.go?type=gene&acc=5859,,,5859.0,QARS1,9606.0,Homo sapiens (human),Valproic acid affects the expression of QARS1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4621,354321,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5859,QARS1,https://ctdbase.org/detail.go?type=gene&acc=5859,,,5859.0,QARS1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of QARS1 mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
4622,354322,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5859,QARS1,https://ctdbase.org/detail.go?type=gene&acc=5859,,,5859.0,QARS1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of QARS1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4623,354323,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5859,QARS1,https://ctdbase.org/detail.go?type=gene&acc=5859,,,5859.0,QARS1,10116.0,Rattus norvegicus (Norway rat),Valproic acid inhibits the reaction [methamphetamine results in decreased expression of QARS1 mrna],,,PMID:19149911,https://www.ncbi.nlm.nih.gov/pubmed/19149911,19149911,,
4624,354324,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5860,QDPR,https://ctdbase.org/detail.go?type=gene&acc=5860,,,5860.0,QDPR,9606.0,Homo sapiens (human),Valproic acid affects the expression of QDPR mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4625,354502,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,192134,B3GNT6,https://ctdbase.org/detail.go?type=gene&acc=192134,,,192134.0,B3GNT6,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of B3GNT6 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4626,354503,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,93010,B3GNT7,https://ctdbase.org/detail.go?type=gene&acc=93010,,,93010.0,B3GNT7,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GNT7 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4627,354504,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,93010,B3GNT7,https://ctdbase.org/detail.go?type=gene&acc=93010,,,93010.0,B3GNT7,9606.0,Homo sapiens (human),Valproic acid affects the expression of B3GNT7 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4628,354505,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,93010,B3GNT7,https://ctdbase.org/detail.go?type=gene&acc=93010,,,93010.0,B3GNT7,9606.0,Homo sapiens (human),Valproic acid results in increased expression of B3GNT7 mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24935251|26272509,,
4629,354506,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,93010,B3GNT7,https://ctdbase.org/detail.go?type=gene&acc=93010,,,93010.0,B3GNT7,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of B3GNT7 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4630,354662,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3384,ICAM2,https://ctdbase.org/detail.go?type=gene&acc=3384,,,3384.0,ICAM2,9606.0,Homo sapiens (human),Valproic acid affects the expression of ICAM2 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4631,354663,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3385,ICAM3,https://ctdbase.org/detail.go?type=gene&acc=3385,,,3385.0,ICAM3,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ICAM3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4632,354664,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3385,ICAM3,https://ctdbase.org/detail.go?type=gene&acc=3385,,,3385.0,ICAM3,9606.0,Homo sapiens (human),Valproic acid affects the expression of ICAM3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4633,354665,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3385,ICAM3,https://ctdbase.org/detail.go?type=gene&acc=3385,,,3385.0,ICAM3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of ICAM3 gene|valproic acid results in decreased expression of ICAM3 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4634,355320,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7730,ZNF177,https://ctdbase.org/detail.go?type=gene&acc=7730,,,7730.0,ZNF177,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF177 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4635,355321,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7730,ZNF177,https://ctdbase.org/detail.go?type=gene&acc=7730,,,7730.0,ZNF177,9606.0,Homo sapiens (human),Valproic acid affects the expression of ZNF177 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4636,355322,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7730,ZNF177,https://ctdbase.org/detail.go?type=gene&acc=7730,,,7730.0,ZNF177,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ZNF177 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251,23179753|24383497|24935251,,
4637,355323,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7566,ZNF18,https://ctdbase.org/detail.go?type=gene&acc=7566,,,7566.0,ZNF18,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in decreased expression of ZNF18 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4638,355324,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7566,ZNF18,https://ctdbase.org/detail.go?type=gene&acc=7566,,,7566.0,ZNF18,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ZNF18 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4639,355325,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,7733,ZNF180,https://ctdbase.org/detail.go?type=gene&acc=7733,,,7733.0,ZNF180,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ZNF180 mRNA,,,PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,28001369|29154799,,
4640,355675,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,153733,CCDC112,https://ctdbase.org/detail.go?type=gene&acc=153733,,,153733.0,CCDC112,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CCDC112 gene|valproic acid results in increased expression of CCDC112 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4641,355676,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84317,CCDC115,https://ctdbase.org/detail.go?type=gene&acc=84317,,,84317.0,CCDC115,9606.0,Homo sapiens (human),Valproic acid affects the expression of CCDC115 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4642,355677,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84317,CCDC115,https://ctdbase.org/detail.go?type=gene&acc=84317,,,84317.0,CCDC115,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CCDC115 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4643,355678,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,164592,CCDC116,https://ctdbase.org/detail.go?type=gene&acc=164592,,,164592.0,CCDC116,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CCDC116 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4644,355679,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,150275,CCDC117,https://ctdbase.org/detail.go?type=gene&acc=150275,,,150275.0,CCDC117,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CCDC117 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4645,355680,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,151903,CCDC12,https://ctdbase.org/detail.go?type=gene&acc=151903,,,151903.0,CCDC12,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of CCDC12 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4646,355681,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79635,CCDC121,https://ctdbase.org/detail.go?type=gene&acc=79635,,,79635.0,CCDC121,9606.0,Homo sapiens (human),Valproic acid affects the expression of CCDC121 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4647,355682,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79635,CCDC121,https://ctdbase.org/detail.go?type=gene&acc=79635,,,79635.0,CCDC121,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CCDC121 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4648,355683,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,160857,CCDC122,https://ctdbase.org/detail.go?type=gene&acc=160857,,,160857.0,CCDC122,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of CCDC122 mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
4649,356152,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,54101,RIPK4,https://ctdbase.org/detail.go?type=gene&acc=54101,,,54101.0,RIPK4,9606.0,Homo sapiens (human),Valproic acid results in increased expression of RIPK4 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|24935251|26272509,,
4650,356153,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79567,RIPOR1,https://ctdbase.org/detail.go?type=gene&acc=79567,,,79567.0,RIPOR1,9606.0,Homo sapiens (human),Valproic acid affects the expression of RIPOR1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4651,356154,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79567,RIPOR1,https://ctdbase.org/detail.go?type=gene&acc=79567,,,79567.0,RIPOR1,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of RIPOR1 mRNA,,,PMID:19136453|PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/19136453|https://www.ncbi.nlm.nih.gov/pubmed/21427059,19136453|21427059,,
4652,356155,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9750,RIPOR2,https://ctdbase.org/detail.go?type=gene&acc=9750,,,9750.0,RIPOR2,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RIPOR2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4653,356156,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9750,RIPOR2,https://ctdbase.org/detail.go?type=gene&acc=9750,,,9750.0,RIPOR2,9606.0,Homo sapiens (human),Valproic acid results in increased expression of RIPOR2 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24383497|24935251|26272509|27188386|28001369,,
4654,356157,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,140876,RIPOR3,https://ctdbase.org/detail.go?type=gene&acc=140876,,,140876.0,RIPOR3,9606.0,Homo sapiens (human),Valproic acid affects the expression of RIPOR3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4655,356158,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,92129,RIPPLY1,https://ctdbase.org/detail.go?type=gene&acc=92129,,,92129.0,RIPPLY1,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of RIPPLY1 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4656,356159,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,92129,RIPPLY1,https://ctdbase.org/detail.go?type=gene&acc=92129,,,92129.0,RIPPLY1,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIPPLY1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4657,356160,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,92129,RIPPLY1,https://ctdbase.org/detail.go?type=gene&acc=92129,,,92129.0,RIPPLY1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of RIPPLY1 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
4658,356303,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57639,CCDC146,https://ctdbase.org/detail.go?type=gene&acc=57639,,,57639.0,CCDC146,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC146 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4659,356304,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57639,CCDC146,https://ctdbase.org/detail.go?type=gene&acc=57639,,,57639.0,CCDC146,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CCDC146 mRNA,,,PMID:26272509|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/29154799,26272509|29154799,,
4660,357242,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,129025,ZNF280A,https://ctdbase.org/detail.go?type=gene&acc=129025,,,129025.0,ZNF280A,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF280A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4661,357243,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,129025,ZNF280A,https://ctdbase.org/detail.go?type=gene&acc=129025,,,129025.0,ZNF280A,9606.0,Homo sapiens (human),Valproic acid affects the expression of ZNF280A mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4662,357244,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,129025,ZNF280A,https://ctdbase.org/detail.go?type=gene&acc=129025,,,129025.0,ZNF280A,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of ZNF280A mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24383497|26272509,,
4663,357245,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,129025,ZNF280A,https://ctdbase.org/detail.go?type=gene&acc=129025,,,129025.0,ZNF280A,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of ZNF280A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4664,357246,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,129025,ZNF280A,https://ctdbase.org/detail.go?type=gene&acc=129025,,,129025.0,ZNF280A,9606.0,Homo sapiens (human),Valproic acid results in increased expression of ZNF280A mRNA,,,PMID:23179753|PMID:24935251|PMID:25192806,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/25192806,23179753|24935251|25192806,,
4665,357392,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8519,IFITM1,https://ctdbase.org/detail.go?type=gene&acc=8519,,,8519.0,IFITM1,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of IFITM1 mRNA,,,PMID:35594946,https://www.ncbi.nlm.nih.gov/pubmed/35594946,35594946,,
4666,357393,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10581,IFITM2,https://ctdbase.org/detail.go?type=gene&acc=10581,,,10581.0,IFITM2,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of IFITM2 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4667,357394,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10581,IFITM2,https://ctdbase.org/detail.go?type=gene&acc=10581,,,10581.0,IFITM2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of IFITM2 mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
4668,357395,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10410,IFITM3,https://ctdbase.org/detail.go?type=gene&acc=10410,,,10410.0,IFITM3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of IFITM3 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4669,357532,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83643,CCDC3,https://ctdbase.org/detail.go?type=gene&acc=83643,,,83643.0,CCDC3,9606.0,Homo sapiens (human),Valproic acid affects the expression of CCDC3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4670,357533,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83643,CCDC3,https://ctdbase.org/detail.go?type=gene&acc=83643,,,83643.0,CCDC3,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CCDC3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4671,357534,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83643,CCDC3,https://ctdbase.org/detail.go?type=gene&acc=83643,,,83643.0,CCDC3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CCDC3 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24383497|24935251|26272509|28001369|29154799,,
4672,357535,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,728621,CCDC30,https://ctdbase.org/detail.go?type=gene&acc=728621,,,728621.0,CCDC30,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CCDC30 mRNA,,,PMID:37505509,https://www.ncbi.nlm.nih.gov/pubmed/37505509,37505509,,
4673,357536,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,90416,CCDC32,https://ctdbase.org/detail.go?type=gene&acc=90416,,,90416.0,CCDC32,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of CCDC32 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4674,357537,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,90416,CCDC32,https://ctdbase.org/detail.go?type=gene&acc=90416,,,90416.0,CCDC32,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CCDC32 mRNA,,,PMID:23179753|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|28001369,,
4675,357538,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,90416,CCDC32,https://ctdbase.org/detail.go?type=gene&acc=90416,,,90416.0,CCDC32,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of CCDC32 mRNA,,,PMID:19136453|PMID:20546886,https://www.ncbi.nlm.nih.gov/pubmed/19136453|https://www.ncbi.nlm.nih.gov/pubmed/20546886,19136453|20546886,,
4676,357539,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,100049764,CCDC32.L,https://ctdbase.org/detail.go?type=gene&acc=100049764,,,100049764.0,ccdc32.L,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of CCDC32.L mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4677,357540,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,80125,CCDC33,https://ctdbase.org/detail.go?type=gene&acc=80125,,,80125.0,CCDC33,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CCDC33 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4678,357541,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,105271287,CCDC37,https://ctdbase.org/detail.go?type=gene&acc=105271287,,,105271287.0,,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CCDC37 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4679,357695,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,115827,RAB3C,https://ctdbase.org/detail.go?type=gene&acc=115827,,,115827.0,RAB3C,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB3C mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4680,357850,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3460,IFNGR2,https://ctdbase.org/detail.go?type=gene&acc=3460,,,3460.0,IFNGR2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of IFNGR2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4681,357851,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56832,IFNK,https://ctdbase.org/detail.go?type=gene&acc=56832,,,56832.0,IFNK,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of IFNK gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4682,357852,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,282618,IFNL1,https://ctdbase.org/detail.go?type=gene&acc=282618,,,282618.0,IFNL1,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of IFNL1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4683,357853,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,282616,IFNL2,https://ctdbase.org/detail.go?type=gene&acc=282616,,,282616.0,IFNL2,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of IFNL2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4684,357854,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,282617,IFNL3,https://ctdbase.org/detail.go?type=gene&acc=282617,,,282617.0,IFNL3,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of IFNL3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4685,357855,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,282617,IFNL3,https://ctdbase.org/detail.go?type=gene&acc=282617,,,282617.0,IFNL3,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of IFNL3 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
4686,357856,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3475,IFRD1,https://ctdbase.org/detail.go?type=gene&acc=3475,,,3475.0,IFRD1,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of IFRD1 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4687,358299,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51668,IFT25,https://ctdbase.org/detail.go?type=gene&acc=51668,,,51668.0,IFT25,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of IFT25 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4688,358300,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,11020,IFT27,https://ctdbase.org/detail.go?type=gene&acc=11020,,,11020.0,IFT27,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of IFT27 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
4689,358301,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,112752,IFT43,https://ctdbase.org/detail.go?type=gene&acc=112752,,,112752.0,IFT43,9606.0,Homo sapiens (human),Valproic acid affects the expression of IFT43 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4690,358302,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,112752,IFT43,https://ctdbase.org/detail.go?type=gene&acc=112752,,,112752.0,IFT43,9606.0,Homo sapiens (human),Valproic acid results in increased expression of IFT43 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4691,358303,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56912,IFT46,https://ctdbase.org/detail.go?type=gene&acc=56912,,,56912.0,IFT46,9606.0,Homo sapiens (human),Valproic acid affects the expression of IFT46 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4692,358304,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,56912,IFT46,https://ctdbase.org/detail.go?type=gene&acc=56912,,,56912.0,IFT46,9606.0,Homo sapiens (human),Valproic acid results in increased expression of IFT46 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4693,358305,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79989,IFT56,https://ctdbase.org/detail.go?type=gene&acc=79989,,,79989.0,IFT56,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of IFT56 mRNA,,,PMID:19136453|PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/19136453|https://www.ncbi.nlm.nih.gov/pubmed/21427059,19136453|21427059,,
4694,358306,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55081,IFT57,https://ctdbase.org/detail.go?type=gene&acc=55081,,,55081.0,IFT57,7955.0,Danio rerio (zebrafish),Valproic acid results in increased expression of IFT57 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4695,358307,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55081,IFT57,https://ctdbase.org/detail.go?type=gene&acc=55081,,,55081.0,IFT57,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of IFT57 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4696,358441,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84318,CCDC77,https://ctdbase.org/detail.go?type=gene&acc=84318,,,84318.0,CCDC77,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of CCDC77 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4697,358442,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84318,CCDC77,https://ctdbase.org/detail.go?type=gene&acc=84318,,,84318.0,CCDC77,10116.0,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of CCDC77 mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
4698,358443,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84318,CCDC77,https://ctdbase.org/detail.go?type=gene&acc=84318,,,84318.0,CCDC77,8355.0,Xenopus laevis (African clawed frog),Valproic acid results in increased expression of CCDC77 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
4699,358444,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,124093,CCDC78,https://ctdbase.org/detail.go?type=gene&acc=124093,,,124093.0,CCDC78,9606.0,Homo sapiens (human),Valproic acid results in increased methylation of CCDC78 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4700,358445,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,83987,CCDC8,https://ctdbase.org/detail.go?type=gene&acc=83987,,,83987.0,CCDC8,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CCDC8 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4701,358446,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,151887,CCDC80,https://ctdbase.org/detail.go?type=gene&acc=151887,,,151887.0,CCDC80,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC80 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4702,358447,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,151887,CCDC80,https://ctdbase.org/detail.go?type=gene&acc=151887,,,151887.0,CCDC80,9606.0,Homo sapiens (human),Valproic acid affects the expression of CCDC80 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4703,358912,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8100,IFT88,https://ctdbase.org/detail.go?type=gene&acc=8100,,,8100.0,IFT88,9606.0,Homo sapiens (human),Valproic acid results in increased expression of IFT88 mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
4704,358913,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,119710,IFTAP,https://ctdbase.org/detail.go?type=gene&acc=119710,,,119710.0,IFTAP,9606.0,Homo sapiens (human),Valproic acid results in increased expression of IFTAP mrna|valproic acid results in decreased methylation of IFTAP gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4705,358914,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3476,IGBP1,https://ctdbase.org/detail.go?type=gene&acc=3476,,,3476.0,IGBP1,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of IGBP1 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4706,358915,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3476,IGBP1,https://ctdbase.org/detail.go?type=gene&acc=3476,,,3476.0,IGBP1,9606.0,Homo sapiens (human),Valproic acid affects the expression of IGBP1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4707,358916,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3476,IGBP1,https://ctdbase.org/detail.go?type=gene&acc=3476,,,3476.0,IGBP1,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of IGBP1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
4708,358917,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9543,IGDCC3,https://ctdbase.org/detail.go?type=gene&acc=9543,,,9543.0,IGDCC3,9606.0,Homo sapiens (human),Valproic acid affects the expression of IGDCC3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4709,358918,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9543,IGDCC3,https://ctdbase.org/detail.go?type=gene&acc=9543,,,9543.0,IGDCC3,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of IGDCC3 mRNA,,,PMID:23179753|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|27188386|28001369,,
4710,358919,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9543,IGDCC3,https://ctdbase.org/detail.go?type=gene&acc=9543,,,9543.0,IGDCC3,9606.0,Homo sapiens (human),Valproic acid results in increased expression of IGDCC3 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4711,358920,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57722,IGDCC4,https://ctdbase.org/detail.go?type=gene&acc=57722,,,57722.0,IGDCC4,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IGDCC4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4712,359063,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57484,RNF150,https://ctdbase.org/detail.go?type=gene&acc=57484,,,57484.0,RNF150,9606.0,Homo sapiens (human),Valproic acid results in increased expression of RNF150 mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|24935251|26272509,,
4713,359064,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,792211,RNF150B,https://ctdbase.org/detail.go?type=gene&acc=792211,,,792211.0,rnf150b,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of RNF150B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4714,359065,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,220441,RNF152,https://ctdbase.org/detail.go?type=gene&acc=220441,,,220441.0,RNF152,7955.0,Danio rerio (zebrafish),Valproic acid affects the expression of RNF152 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
4715,359066,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,220441,RNF152,https://ctdbase.org/detail.go?type=gene&acc=220441,,,220441.0,RNF152,9606.0,Homo sapiens (human),[hydralazine co-treated with valproic acid] results in increased expression of RNF152 mRNA,,,PMID:17183730,https://www.ncbi.nlm.nih.gov/pubmed/17183730,17183730,,
4716,359067,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,220441,RNF152,https://ctdbase.org/detail.go?type=gene&acc=220441,,,220441.0,RNF152,9606.0,Homo sapiens (human),Valproic acid results in decreased methylation of RNF152 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4717,359068,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,114804,RNF157,https://ctdbase.org/detail.go?type=gene&acc=114804,,,114804.0,RNF157,9606.0,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RNF157 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
4718,359069,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,114804,RNF157,https://ctdbase.org/detail.go?type=gene&acc=114804,,,114804.0,RNF157,9606.0,Homo sapiens (human),Valproic acid affects the expression of RNF157 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4719,359070,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,114804,RNF157,https://ctdbase.org/detail.go?type=gene&acc=114804,,,114804.0,RNF157,9606.0,Homo sapiens (human),Valproic acid results in increased expression of RNF157 mRNA,,,PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24383497|24935251|26272509|29154799,,
4720,360012,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,9606.0,Homo sapiens (human),Valproic acid affects the expression of CCN1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
4721,360013,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,9606.0,Homo sapiens (human),Valproic acid results in increased expression of CCN1 mRNA,,,PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24383497|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24383497|26272509|27188386|28001369|29154799,,
4722,360014,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,10090.0,Mus musculus (house mouse),Valproic acid affects the expression of CCN1 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
4723,360015,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,3491,CCN1,https://ctdbase.org/detail.go?type=gene&acc=3491,,,3491.0,CCN1,10090.0,Mus musculus (house mouse),Valproic acid results in increased expression of CCN1 mRNA,,,PMID:24896083,https://www.ncbi.nlm.nih.gov/pubmed/24896083,24896083,,
4724,360016,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,9606.0,Homo sapiens (human),Valproic acid affects the expression of CCN2 mRNA,,,PMID:25979313|PMID:26072468,https://www.ncbi.nlm.nih.gov/pubmed/25979313|https://www.ncbi.nlm.nih.gov/pubmed/26072468,25979313|26072468,,
4725,360017,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,1490,CCN2,https://ctdbase.org/detail.go?type=gene&acc=1490,,,1490.0,CCN2,9606.0,Homo sapiens (human),Valproic acid results in decreased expression of CCN2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
4726,341470,3132,BindingDB,Thiorphan,21641,2-(2-benzyl-3-sulfanylpropanamido)acetic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21641,9915,Endothelin-converting enzyme 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9915,P42892,Endothelin-converting enzyme 1,1889.0,ECE1,9606.0,Homo sapiens (human),,Ki (nM),>10000,PMID:11906289|DOI:10.1021/jm0005454,https://www.ncbi.nlm.nih.gov/pubmed/11906289|https://doi.org/10.1021/jm0005454,11906289,10.1021/jm0005454,
4727,341471,3134,Drug Gene Interaction database (DGIdb),6-Dimethylaminopurine,,DIMETHYLADENINE,https://www.dgidb.org/drugs/chembl:CHEMBL407391,,RPS6KA3,https://www.dgidb.org/genes/hgnc:10432,,,6197.0,RPS6KA3,9606.0,Homo sapiens (human),,,,,,,,
4728,341472,3134,Drug Gene Interaction database (DGIdb),6-Dimethylaminopurine,,DIMETHYLADENINE,https://www.dgidb.org/drugs/chembl:CHEMBL407391,,MARK3,https://www.dgidb.org/genes/hgnc:6897,,,4140.0,MARK3,9606.0,Homo sapiens (human),,,,,,,,
4729,341473,3152,Drug Gene Interaction database (DGIdb),Donepezil,,DONEPEZIL,https://www.dgidb.org/drugs/rxcui:135447,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,,,,,
4730,220389,3194,Comparative Toxicogenomics Database (CTD),Ebselen,C042986,ebselen,https://ctdbase.org/detail.go?type=chem&acc=C042986,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10116.0,Rattus norvegicus (Norway rat),Ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein],,,PMID:8147899,https://www.ncbi.nlm.nih.gov/pubmed/8147899,8147899,,
4731,220390,3194,Comparative Toxicogenomics Database (CTD),Ebselen,C042986,ebselen,https://ctdbase.org/detail.go?type=chem&acc=C042986,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116.0,Rattus norvegicus (Norway rat),Ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein],,,PMID:8147899,https://www.ncbi.nlm.nih.gov/pubmed/8147899,8147899,,
4732,220391,3194,Comparative Toxicogenomics Database (CTD),Ebselen,C042986,ebselen,https://ctdbase.org/detail.go?type=chem&acc=C042986,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,10116.0,Rattus norvegicus (Norway rat),Ebselen binds to and results in decreased activity of GSTP1 protein,,,PMID:8147899,https://www.ncbi.nlm.nih.gov/pubmed/8147899,8147899,,
4733,220392,3194,Comparative Toxicogenomics Database (CTD),Ebselen,C042986,ebselen,https://ctdbase.org/detail.go?type=chem&acc=C042986,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),Ebselen inhibits the reaction [lipopolysaccharides affects the localization of and affects the activity of RELA protein]|ebselen inhibits the reaction [peroxynitrous acid affects the localization of and affects the activity of RELA protein],,,PMID:14572605,https://www.ncbi.nlm.nih.gov/pubmed/14572605,14572605,,
4734,220393,3194,Comparative Toxicogenomics Database (CTD),Ebselen,C042986,ebselen,https://ctdbase.org/detail.go?type=chem&acc=C042986,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),Ebselen inhibits the reaction [acetylcysteine inhibits the reaction [oxygen deficiency results in increased activity of HIF1A protein]]|ebselen inhibits the reaction [acetylcysteine inhibits the reaction [oxygen deficiency results in increased expression of HIF1A mrna]]|ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [oxygen deficiency results in increased expression of HIF1A mrna]]|ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [oxygen deficiency results in increased activity of HIF1A protein]],,,PMID:19374849,https://www.ncbi.nlm.nih.gov/pubmed/19374849,19374849,,
4735,220394,3194,Comparative Toxicogenomics Database (CTD),Ebselen,C042986,ebselen,https://ctdbase.org/detail.go?type=chem&acc=C042986,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9913.0,Bos taurus (cattle),Ebselen affects the expression of HMOX1 protein,,,PMID:19131585,https://www.ncbi.nlm.nih.gov/pubmed/19131585,19131585,,
4736,220395,3194,Comparative Toxicogenomics Database (CTD),Ebselen,C042986,ebselen,https://ctdbase.org/detail.go?type=chem&acc=C042986,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),[ebselen affects the abundance of reactive oxygen species] which results in decreased expression of HMOX1 protein|[ebselen affects the abundance of reactive oxygen species] which results in increased activity of HMOX1 protein,,,PMID:16959961,https://www.ncbi.nlm.nih.gov/pubmed/16959961,16959961,,
4737,220396,3194,Comparative Toxicogenomics Database (CTD),Ebselen,C042986,ebselen,https://ctdbase.org/detail.go?type=chem&acc=C042986,27306,HPGDS,https://ctdbase.org/detail.go?type=gene&acc=27306,,,27306.0,HPGDS,10090.0,Mus musculus (house mouse),Ebselen results in increased expression of HPGDS mRNA,,,PMID:21669866,https://www.ncbi.nlm.nih.gov/pubmed/21669866,21669866,,
4738,220397,3194,Comparative Toxicogenomics Database (CTD),Ebselen,C042986,ebselen,https://ctdbase.org/detail.go?type=chem&acc=C042986,3297,HSF1,https://ctdbase.org/detail.go?type=gene&acc=3297,,,3297.0,HSF1,9606.0,Homo sapiens (human),Ebselen results in increased activity of HSF1 protein,,,PMID:34170685,https://www.ncbi.nlm.nih.gov/pubmed/34170685,34170685,,
4739,344429,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,1281,COL3A1,https://ctdbase.org/detail.go?type=gene&acc=1281,,,1281.0,COL3A1,10116.0,Rattus norvegicus (Norway rat),Emodin results in decreased expression of COL3A1 mRNA,,,PMID:15288473,https://www.ncbi.nlm.nih.gov/pubmed/15288473,15288473,,
4740,344430,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,10987,COPS5,https://ctdbase.org/detail.go?type=gene&acc=10987,,,10987.0,COPS5,9606.0,Homo sapiens (human),[arsenic trioxide co-treated with IFNA2 protein co-treated with docosahexaenoic acids co-treated with emodin] results in decreased expression of COPS5 protein,,,PMID:17077332,https://www.ncbi.nlm.nih.gov/pubmed/17077332,17077332,,
4741,344431,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,1457,CSNK2A1,https://ctdbase.org/detail.go?type=gene&acc=1457,,,1457.0,CSNK2A1,10090.0,Mus musculus (house mouse),Emodin results in increased expression of CSNK2A1 mRNA,,,PMID:21319176,https://www.ncbi.nlm.nih.gov/pubmed/21319176,21319176,,
4742,344432,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,1460,CSNK2B,https://ctdbase.org/detail.go?type=gene&acc=1460,,,1460.0,CSNK2B,10090.0,Mus musculus (house mouse),Emodin results in increased expression of CSNK2B mRNA,,,PMID:21319176,https://www.ncbi.nlm.nih.gov/pubmed/21319176,21319176,,
4743,344433,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509.0,CTSD,9606.0,Homo sapiens (human),Emodin results in decreased expression of CTSD mRNA,,,PMID:16045814,https://www.ncbi.nlm.nih.gov/pubmed/16045814,16045814,,
4744,345323,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,1638,DCT,https://ctdbase.org/detail.go?type=gene&acc=1638,,,1638.0,DCT,9606.0,Homo sapiens (human),Emodin results in decreased expression of DCT mrna|emodin results in decreased expression of DCT protein,,,PMID:26972667,https://www.ncbi.nlm.nih.gov/pubmed/26972667,26972667,,
4745,345324,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10116.0,Rattus norvegicus (Norway rat),Emodin results in increased expression of DDIT3 protein,,,PMID:19549930,https://www.ncbi.nlm.nih.gov/pubmed/19549930,19549930,,
4746,347059,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10116.0,Rattus norvegicus (Norway rat),Emodin affects the expression of MYC protein,,,PMID:19549930,https://www.ncbi.nlm.nih.gov/pubmed/19549930,19549930,,
4747,347060,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,10116.0,Rattus norvegicus (Norway rat),Emodin inhibits the reaction [AGT protein results in increased expression of MYC protein],,,PMID:17886230,https://www.ncbi.nlm.nih.gov/pubmed/17886230,17886230,,
4748,347061,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,4638,MYLK,https://ctdbase.org/detail.go?type=gene&acc=4638,,,4638.0,MYLK,10116.0,Rattus norvegicus (Norway rat),Emodin results in increased activity of MYLK protein,,,PMID:15133857,https://www.ncbi.nlm.nih.gov/pubmed/15133857,15133857,,
4749,347062,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,10499,NCOA2,https://ctdbase.org/detail.go?type=gene&acc=10499,,,10499.0,NCOA2,10090.0,Mus musculus (house mouse),Emodin results in increased expression of NCOA2 mRNA,,,PMID:21319176,https://www.ncbi.nlm.nih.gov/pubmed/21319176,21319176,,
4750,347063,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090.0,Mus musculus (house mouse),Emodin promotes the reaction [tobacco smoke pollution results in increased expression of NFE2L2 mrna]|emodin promotes the reaction [tobacco smoke pollution results in increased expression of and results in increased activity of NFE2L2 protein],,,PMID:26139382,https://www.ncbi.nlm.nih.gov/pubmed/26139382,26139382,,
4751,347064,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Emodin affects the localization of [PKM protein binds to NFE2L2 protein]|emodin affects the localization of NFE2L2 protein|[[emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]] results in increased abundance of [PKM protein binds to PKM protein]] which binds to NFE2L2 protein|emodin promotes the reaction [PKM protein binds to NFE2L2 protein],,,PMID:34971761,https://www.ncbi.nlm.nih.gov/pubmed/34971761,34971761,,
4752,347550,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,10090.0,Mus musculus (house mouse),Emodin results in decreased expression of NR1H4 mrna|emodin results in decreased expression of NR1H4 protein,,,PMID:30517764,https://www.ncbi.nlm.nih.gov/pubmed/30517764,30517764,,
4753,347551,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,115209,OMA1,https://ctdbase.org/detail.go?type=gene&acc=115209,,,115209.0,OMA1,10116.0,Rattus norvegicus (Norway rat),Emodin inhibits the reaction [hydrogen peroxide results in increased expression of OMA1 protein]|emodin inhibits the reaction [oxidopamine results in increased expression of OMA1 protein],,,PMID:34971761,https://www.ncbi.nlm.nih.gov/pubmed/34971761,34971761,,
4754,347552,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),U 0126 inhibits the reaction [emodin results in increased cleavage of PARP1 protein]|sb 203580 inhibits the reaction [emodin results in increased cleavage of PARP1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [emodin results in increased cleavage of PARP1 protein]|[u 0126 co-treated with emodin] results in increased cleavage of PARP1 protein,,,PMID:27032576,https://www.ncbi.nlm.nih.gov/pubmed/27032576,27032576,,
4755,347553,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Emodin results in increased activity of PARP1 protein,,,PMID:23848338,https://www.ncbi.nlm.nih.gov/pubmed/23848338,23848338,,
4756,347554,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Emodin results in increased cleavage of PARP1 protein,,,PMID:27032576|PMID:34492313|PMID:36893906,https://www.ncbi.nlm.nih.gov/pubmed/27032576|https://www.ncbi.nlm.nih.gov/pubmed/34492313|https://www.ncbi.nlm.nih.gov/pubmed/36893906,27032576|34492313|36893906,,
4757,347555,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10116.0,Rattus norvegicus (Norway rat),Emodin inhibits the reaction [AGT protein results in increased expression of PCNA protein],,,PMID:17886230,https://www.ncbi.nlm.nih.gov/pubmed/17886230,17886230,,
4758,347556,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5082,PDCL,https://ctdbase.org/detail.go?type=gene&acc=5082,,,5082.0,PDCL,9606.0,Homo sapiens (human),Emodin results in decreased expression of PDCL mRNA,,,PMID:16045814,https://www.ncbi.nlm.nih.gov/pubmed/16045814,16045814,,
4759,347557,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5894,RAF1,https://ctdbase.org/detail.go?type=gene&acc=5894,,,5894.0,RAF1,9606.0,Homo sapiens (human),Emodin results in decreased expression of RAF1 mRNA,,,PMID:16045814,https://www.ncbi.nlm.nih.gov/pubmed/16045814,16045814,,
4760,347558,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5894,RAF1,https://ctdbase.org/detail.go?type=gene&acc=5894,,,5894.0,RAF1,10116.0,Rattus norvegicus (Norway rat),Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of RAF1 protein],,,PMID:15288473,https://www.ncbi.nlm.nih.gov/pubmed/15288473,15288473,,
4761,347753,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5155,PDGFB,https://ctdbase.org/detail.go?type=gene&acc=5155,,,5155.0,PDGFB,10116.0,Rattus norvegicus (Norway rat),Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAP2K1 protein]|emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]|emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of RAF1 protein]|emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]|emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]|emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]|emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of MAP2K2 protein],,,PMID:15288473,https://www.ncbi.nlm.nih.gov/pubmed/15288473,15288473,,
4762,347754,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5159,PDGFRB,https://ctdbase.org/detail.go?type=gene&acc=5159,,,5159.0,PDGFRB,10116.0,Rattus norvegicus (Norway rat),Emodin inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]|emodin results in decreased expression of PDGFRB protein,,,PMID:15288473,https://www.ncbi.nlm.nih.gov/pubmed/15288473,15288473,,
4763,347755,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5175,PECAM1,https://ctdbase.org/detail.go?type=gene&acc=5175,,,5175.0,PECAM1,9606.0,Homo sapiens (human),Emodin results in decreased expression of PECAM1 protein,,,PMID:23848338,https://www.ncbi.nlm.nih.gov/pubmed/23848338,23848338,,
4764,347756,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5289,PIK3C3,https://ctdbase.org/detail.go?type=gene&acc=5289,,,5289.0,PIK3C3,9606.0,Homo sapiens (human),Emodin results in increased expression of PIK3C3 mRNA,,,PMID:16045814,https://www.ncbi.nlm.nih.gov/pubmed/16045814,16045814,,
4765,347757,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5295,PIK3R1,https://ctdbase.org/detail.go?type=gene&acc=5295,,,5295.0,PIK3R1,10116.0,Rattus norvegicus (Norway rat),Emodin affects the expression of PIK3R1 protein,,,PMID:19549930,https://www.ncbi.nlm.nih.gov/pubmed/19549930,19549930,,
4766,347758,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5315,PKM,https://ctdbase.org/detail.go?type=gene&acc=5315,,,5315.0,PKM,10116.0,Rattus norvegicus (Norway rat),Emodin results in decreased activity of PKM protein|emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]|[[emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]] results in increased abundance of [PKM protein binds to PKM protein]] which results in decreased activity of PKM protein|emodin affects the localization of PKM protein|emodin affects the localization of [PKM protein binds to NFE2L2 protein]|[[emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]] results in increased abundance of [PKM protein binds to PKM protein]] which binds to NFE2L2 protein|emodin promotes the reaction [PKM protein binds to NFE2L2 protein]|[emodin inhibits the reaction [PKM protein binds to PKM protein binds to PKM protein binds to PKM protein]] results in increased abundance of [PKM protein binds to PKM protein],,,PMID:34971761,https://www.ncbi.nlm.nih.gov/pubmed/34971761,34971761,,
4767,347759,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),Emodin results in increased expression of PPARG protein|emodin results in increased stability of and results in increased expression of PPARG mRNA,,,PMID:25448808,https://www.ncbi.nlm.nih.gov/pubmed/25448808,25448808,,
4768,347760,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,8493,PPM1D,https://ctdbase.org/detail.go?type=gene&acc=8493,,,8493.0,PPM1D,9606.0,Homo sapiens (human),Emodin results in increased expression of PPM1D mRNA,,,PMID:16045814,https://www.ncbi.nlm.nih.gov/pubmed/16045814,16045814,,
4769,349330,3220,Comparative Toxicogenomics Database (CTD),Emodin,D004642,Emodin,https://ctdbase.org/detail.go?type=chem&acc=D004642,54600,UGT1A9,https://ctdbase.org/detail.go?type=gene&acc=54600,,,54600.0,UGT1A9,9606.0,Homo sapiens (human),UGT1A9 protein results in increased glucuronidation of emodin,,,PMID:14557274|PMID:24854283,https://www.ncbi.nlm.nih.gov/pubmed/14557274|https://www.ncbi.nlm.nih.gov/pubmed/24854283,14557274|24854283,,
4770,249060,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,602,BCL3,https://ctdbase.org/detail.go?type=gene&acc=602,,,602.0,BCL3,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of BCL3 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4771,249061,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,607,BCL9,https://ctdbase.org/detail.go?type=gene&acc=607,,,607.0,BCL9,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of BCL9 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4772,250824,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,728,C5AR1,https://ctdbase.org/detail.go?type=gene&acc=728,,,728.0,C5AR1,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of C5AR1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4773,250825,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,27202,C5AR2,https://ctdbase.org/detail.go?type=gene&acc=27202,,,27202.0,C5AR2,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of C5AR2 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4774,250826,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,362592,C5H1ORF122,https://ctdbase.org/detail.go?type=gene&acc=362592,,,362592.0,C5h1orf122,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of C5H1ORF122 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4775,349783,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,34560,AB,https://ctdbase.org/detail.go?type=gene&acc=34560,,,34560.0,ab,7227.0,Drosophila melanogaster (fruit fly),Endosulfan results in increased expression of AB mRNA,,,PMID:21036383,https://www.ncbi.nlm.nih.gov/pubmed/21036383,21036383,,
4776,351576,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,55902,ACSS2,https://ctdbase.org/detail.go?type=gene&acc=55902,,,55902.0,ACSS2,10116.0,Rattus norvegicus (Norway rat),Endosulfan affects the expression of ACSS2 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4777,351577,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,79611,ACSS3,https://ctdbase.org/detail.go?type=gene&acc=79611,,,79611.0,ACSS3,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of ACSS3 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4778,351578,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,40444,ACT79B,https://ctdbase.org/detail.go?type=gene&acc=40444,,,40444.0,Act79B,7227.0,Drosophila melanogaster (fruit fly),Endosulfan results in increased expression of ACT79B mRNA,,,PMID:21036383,https://www.ncbi.nlm.nih.gov/pubmed/21036383,21036383,,
4779,351579,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,58,ACTA1,https://ctdbase.org/detail.go?type=gene&acc=58,,,58.0,ACTA1,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of ACTA1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4780,351580,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of ACTA2 protein,,,PMID:22198180,https://www.ncbi.nlm.nih.gov/pubmed/22198180,22198180,,
4781,353354,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of AGT mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4782,353355,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,11607,AGTR1A,https://ctdbase.org/detail.go?type=gene&acc=11607,,,11607.0,Agtr1a,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of AGTR1A mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4783,353999,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,80709,AKNA,https://ctdbase.org/detail.go?type=gene&acc=80709,,,80709.0,AKNA,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of AKNA mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4784,354000,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,254268,AKNAD1,https://ctdbase.org/detail.go?type=gene&acc=254268,,,254268.0,AKNAD1,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of AKNAD1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4785,354001,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,10327,AKR1A1,https://ctdbase.org/detail.go?type=gene&acc=10327,,,10327.0,AKR1A1,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of AKR1A1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4786,354002,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,231,AKR1B1,https://ctdbase.org/detail.go?type=gene&acc=231,,,231.0,AKR1B1,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of AKR1B1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4787,354003,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,27384,AKR1C13,https://ctdbase.org/detail.go?type=gene&acc=27384,,,27384.0,Akr1c13,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of AKR1C13 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4788,354004,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,105387,AKR1C14,https://ctdbase.org/detail.go?type=gene&acc=105387,,,105387.0,Akr1c14,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of AKR1C14 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4789,354005,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,432720,AKR1C19,https://ctdbase.org/detail.go?type=gene&acc=432720,,,432720.0,Akr1c19,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of AKR1C19 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4790,354006,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,498789,AKR1C3L1,https://ctdbase.org/detail.go?type=gene&acc=498789,,,498789.0,AKR1C3l1,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of AKR1C3L1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4791,355982,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,10053,AP1M2,https://ctdbase.org/detail.go?type=gene&acc=10053,,,10053.0,AP1M2,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of AP1M2 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4792,355983,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,8905,AP1S2,https://ctdbase.org/detail.go?type=gene&acc=8905,,,8905.0,AP1S2,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of AP1S2 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4793,355984,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,130340,AP1S3,https://ctdbase.org/detail.go?type=gene&acc=130340,,,130340.0,AP1S3,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in decreased expression of AP1S3 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4794,355985,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,91056,AP5B1,https://ctdbase.org/detail.go?type=gene&acc=91056,,,91056.0,AP5B1,10116.0,Rattus norvegicus (Norway rat),Endosulfan results in increased expression of AP5B1 mRNA,,,PMID:29391264,https://www.ncbi.nlm.nih.gov/pubmed/29391264,29391264,,
4795,355986,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606.0,Homo sapiens (human),Endosulfan results in decreased expression of APAF1 mRNA,,,PMID:30090376,https://www.ncbi.nlm.nih.gov/pubmed/30090376,30090376,,
4796,355987,3224,Comparative Toxicogenomics Database (CTD),Endosulfan,D004726,Endosulfan,https://ctdbase.org/detail.go?type=chem&acc=D004726,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606.0,Homo sapiens (human),Endosulfan results in increased expression of APAF1 protein,,,PMID:36513242,https://www.ncbi.nlm.nih.gov/pubmed/36513242,36513242,,
4797,222860,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0004902,Voltage-dependent L-type calcium channel subunit beta-3,https://www.drugbank.ca/bio_entities/BE0004902,P54284,Voltage-dependent L-type calcium channel subunit beta-3,784.0,CACNB3,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:8053596|PMID:1850580|PMID:7741301,https://www.ncbi.nlm.nih.gov/pubmed/8053596|https://www.ncbi.nlm.nih.gov/pubmed/1850580|https://www.ncbi.nlm.nih.gov/pubmed/7741301,8053596|1850580|7741301,,
4798,222861,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0004902,Voltage-dependent L-type calcium channel subunit beta-4,https://www.drugbank.ca/bio_entities/BE0004902,O00305,Voltage-dependent L-type calcium channel subunit beta-4,785.0,CACNB4,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:8053596|PMID:1850580|PMID:7741301,https://www.ncbi.nlm.nih.gov/pubmed/8053596|https://www.ncbi.nlm.nih.gov/pubmed/1850580|https://www.ncbi.nlm.nih.gov/pubmed/7741301,8053596|1850580|7741301,,
4799,223201,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0009847,Potassium voltage-gated channel subfamily A member 10,https://www.drugbank.ca/bio_entities/BE0009847,Q16322,Potassium voltage-gated channel subfamily A member 10,3744.0,KCNA10,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:19298752|PMID:11605938|PMID:10794813,https://www.ncbi.nlm.nih.gov/pubmed/19298752|https://www.ncbi.nlm.nih.gov/pubmed/11605938|https://www.ncbi.nlm.nih.gov/pubmed/10794813,19298752|11605938|10794813,,
4800,223873,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0009847,Potassium voltage-gated channel subfamily H member 8,https://www.drugbank.ca/bio_entities/BE0009847,Q96L42,Potassium voltage-gated channel subfamily H member 8,131096.0,KCNH8,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:19298752|PMID:11605938|PMID:10794813,https://www.ncbi.nlm.nih.gov/pubmed/19298752|https://www.ncbi.nlm.nih.gov/pubmed/11605938|https://www.ncbi.nlm.nih.gov/pubmed/10794813,19298752|11605938|10794813,,
4801,223874,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0009847,Potassium voltage-gated channel subfamily KQT member 1,https://www.drugbank.ca/bio_entities/BE0009847,P51787,Potassium voltage-gated channel subfamily KQT member 1,3784.0,KCNQ1,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:19298752|PMID:11605938|PMID:10794813,https://www.ncbi.nlm.nih.gov/pubmed/19298752|https://www.ncbi.nlm.nih.gov/pubmed/11605938|https://www.ncbi.nlm.nih.gov/pubmed/10794813,19298752|11605938|10794813,,
4802,223875,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0009847,Potassium voltage-gated channel subfamily KQT member 2,https://www.drugbank.ca/bio_entities/BE0009847,O43526,Potassium voltage-gated channel subfamily KQT member 2,3785.0,KCNQ2,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:19298752|PMID:11605938|PMID:10794813,https://www.ncbi.nlm.nih.gov/pubmed/19298752|https://www.ncbi.nlm.nih.gov/pubmed/11605938|https://www.ncbi.nlm.nih.gov/pubmed/10794813,19298752|11605938|10794813,,
4803,223876,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0009847,Potassium voltage-gated channel subfamily KQT member 3,https://www.drugbank.ca/bio_entities/BE0009847,O43525,Potassium voltage-gated channel subfamily KQT member 3,3786.0,KCNQ3,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:19298752|PMID:11605938|PMID:10794813,https://www.ncbi.nlm.nih.gov/pubmed/19298752|https://www.ncbi.nlm.nih.gov/pubmed/11605938|https://www.ncbi.nlm.nih.gov/pubmed/10794813,19298752|11605938|10794813,,
4804,223877,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0009847,Potassium voltage-gated channel subfamily KQT member 4,https://www.drugbank.ca/bio_entities/BE0009847,P56696,Potassium voltage-gated channel subfamily KQT member 4,9132.0,KCNQ4,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:19298752|PMID:11605938|PMID:10794813,https://www.ncbi.nlm.nih.gov/pubmed/19298752|https://www.ncbi.nlm.nih.gov/pubmed/11605938|https://www.ncbi.nlm.nih.gov/pubmed/10794813,19298752|11605938|10794813,,
4805,223878,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0009847,Potassium voltage-gated channel subfamily KQT member 5,https://www.drugbank.ca/bio_entities/BE0009847,Q9NR82,Potassium voltage-gated channel subfamily KQT member 5,56479.0,KCNQ5,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:19298752|PMID:11605938|PMID:10794813,https://www.ncbi.nlm.nih.gov/pubmed/19298752|https://www.ncbi.nlm.nih.gov/pubmed/11605938|https://www.ncbi.nlm.nih.gov/pubmed/10794813,19298752|11605938|10794813,,
4806,223879,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0009847,Potassium voltage-gated channel subfamily S member 1,https://www.drugbank.ca/bio_entities/BE0009847,Q96KK3,Potassium voltage-gated channel subfamily S member 1,3787.0,KCNS1,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:19298752|PMID:11605938|PMID:10794813,https://www.ncbi.nlm.nih.gov/pubmed/19298752|https://www.ncbi.nlm.nih.gov/pubmed/11605938|https://www.ncbi.nlm.nih.gov/pubmed/10794813,19298752|11605938|10794813,,
4807,223880,3226,DrugBank,Enflurane,DB00228,Enflurane,https://www.drugbank.ca/drugs/DB00228,BE0009847,Potassium voltage-gated channel subfamily S member 3,https://www.drugbank.ca/bio_entities/BE0009847,Q9BQ31,Potassium voltage-gated channel subfamily S member 3,3790.0,KCNS3,9606.0,Homo sapiens (human),Inhibitor|Activator,,,PMID:19298752|PMID:11605938|PMID:10794813,https://www.ncbi.nlm.nih.gov/pubmed/19298752|https://www.ncbi.nlm.nih.gov/pubmed/11605938|https://www.ncbi.nlm.nih.gov/pubmed/10794813,19298752|11605938|10794813,,
4808,224332,3226,ChEMBL,Enflurane,CHEMBL1257,ENFLURANE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1257/,CHEMBL2331041,Potassium channel subfamily K member 10,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2331041/,P57789,Potassium channel subfamily K member 10,54207.0,KCNK10,9606.0,Homo sapiens (human),Potassium channel subfamily K member 10 opener,,,PMID:16402123|PMID:16973644|PMID:17227289,https://www.ncbi.nlm.nih.gov/pubmed/16402123|https://www.ncbi.nlm.nih.gov/pubmed/16973644|https://www.ncbi.nlm.nih.gov/pubmed/17227289,16402123|16973644|17227289,,
4809,356904,3295,BindingDB,Ethoxzolamide,10882,"6-ethoxy-1,3-benzothiazole-2-sulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10882,4166,Carbonic anhydrase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4166,Q5AJ71,Carbonic anhydrase,3636621.0,NCE103,237561.0,Candida albicans SC5314,,Ki (nM),1070,PMID:19450983|DOI:10.1016/j.bmc.2009.05.002,https://www.ncbi.nlm.nih.gov/pubmed/19450983|https://doi.org/10.1016/j.bmc.2009.05.002,19450983,10.1016/j.bmc.2009.05.002,
4810,356905,3305,Drug Gene Interaction database (DGIdb),Etidronic Acid,,ETIDRONIC ACID,https://www.dgidb.org/drugs/rxcui:1356715,,BGLAP,https://www.dgidb.org/genes/hgnc:1043,,,632.0,BGLAP,9606.0,Homo sapiens (human),,,,,,,,
4811,356906,3331,Drug Gene Interaction database (DGIdb),Felbamate,,FELBAMATE,https://www.dgidb.org/drugs/rxcui:24812,,GRIN2A,https://www.dgidb.org/genes/hgnc:4585,,,2903.0,GRIN2A,9606.0,Homo sapiens (human),,,,,,,,
4812,356907,3331,ChEMBL,Felbamate,CHEMBL1094,FELBAMATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1094/,CHEMBL2094124,Glutamate [NMDA] receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094124/,O15399,"Glutamate receptor ionotropic, NMDA 2D",2906.0,GRIN2D,9606.0,Homo sapiens (human),Glutamate [NMDA] receptor antagonist,,,PMID:10215667,https://www.ncbi.nlm.nih.gov/pubmed/10215667,10215667,,
4813,356908,3331,ChEMBL,Felbamate,CHEMBL1094,FELBAMATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1094/,CHEMBL2094124,Glutamate [NMDA] receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094124/,O60391,"Glutamate receptor ionotropic, NMDA 3B",116444.0,GRIN3B,9606.0,Homo sapiens (human),Glutamate [NMDA] receptor antagonist,,,PMID:10215667,https://www.ncbi.nlm.nih.gov/pubmed/10215667,10215667,,
4814,356909,3331,ChEMBL,Felbamate,CHEMBL1094,FELBAMATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1094/,CHEMBL2094124,Glutamate [NMDA] receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094124/,Q05586,"Glutamate receptor ionotropic, NMDA 1",2902.0,GRIN1,9606.0,Homo sapiens (human),Glutamate [NMDA] receptor antagonist,,,PMID:10215667,https://www.ncbi.nlm.nih.gov/pubmed/10215667,10215667,,
4815,356910,3331,ChEMBL,Felbamate,CHEMBL1094,FELBAMATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1094/,CHEMBL2094124,Glutamate [NMDA] receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094124/,Q12879,"Glutamate receptor ionotropic, NMDA 2A",2903.0,GRIN2A,9606.0,Homo sapiens (human),Glutamate [NMDA] receptor antagonist,,,PMID:10215667,https://www.ncbi.nlm.nih.gov/pubmed/10215667,10215667,,
4816,356911,3331,ChEMBL,Felbamate,CHEMBL1094,FELBAMATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1094/,CHEMBL2094124,Glutamate [NMDA] receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2094124/,Q13224,"Glutamate receptor ionotropic, NMDA 2B",2904.0,GRIN2B,9606.0,Homo sapiens (human),Glutamate [NMDA] receptor antagonist,,,PMID:10215667,https://www.ncbi.nlm.nih.gov/pubmed/10215667,10215667,,
4817,340961,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,221692,PHACTR1,https://ctdbase.org/detail.go?type=gene&acc=221692,,,221692.0,PHACTR1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of PHACTR1 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
4818,340962,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,11331,PHB2,https://ctdbase.org/detail.go?type=gene&acc=11331,,,11331.0,PHB2,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of PHB2 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4819,340963,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,150368,PHETA2,https://ctdbase.org/detail.go?type=gene&acc=150368,,,150368.0,PHETA2,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of PHETA2 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4820,340964,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,5251,PHEX,https://ctdbase.org/detail.go?type=gene&acc=5251,,,5251.0,PHEX,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of PHEX mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4821,340965,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,9678,PHF14,https://ctdbase.org/detail.go?type=gene&acc=9678,,,9678.0,PHF14,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of PHF14 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4822,340966,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,51317,PHF21A,https://ctdbase.org/detail.go?type=gene&acc=51317,,,51317.0,PHF21A,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of PHF21A mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4823,340967,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of PHLDA1 protein|fenvalerate results in increased expression of PHLDA1 mRNA,,,PMID:31524104,https://www.ncbi.nlm.nih.gov/pubmed/31524104,31524104,,
4824,342579,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,5617,PRL,https://ctdbase.org/detail.go?type=gene&acc=5617,,,5617.0,PRL,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of PRL protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
4825,342580,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,13529,PRL8A2,https://ctdbase.org/detail.go?type=gene&acc=13529,,,13529.0,Prl8a2,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of PRL8A2 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4826,342581,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,100361884,PRL8A3,https://ctdbase.org/detail.go?type=gene&acc=100361884,,,100361884.0,Prl8a3,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of PRL8A3 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4827,342582,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,67310,PRL8A9,https://ctdbase.org/detail.go?type=gene&acc=67310,,,67310.0,Prl8a9,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of PRL8A9 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4828,342583,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,5619,PRM1,https://ctdbase.org/detail.go?type=gene&acc=5619,,,5619.0,PRM1,10116.0,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PRM1 mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
4829,342584,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,5619,PRM1,https://ctdbase.org/detail.go?type=gene&acc=5619,,,5619.0,PRM1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of PRM1 mRNA,,,PMID:33396045,https://www.ncbi.nlm.nih.gov/pubmed/33396045,33396045,,
4830,345315,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,55072,RNF31,https://ctdbase.org/detail.go?type=gene&acc=55072,,,55072.0,RNF31,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of RNF31 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4831,345316,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,9025,RNF8,https://ctdbase.org/detail.go?type=gene&acc=9025,,,9025.0,RNF8,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of RNF8 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
4832,345317,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,55599,RNPC3,https://ctdbase.org/detail.go?type=gene&acc=55599,,,55599.0,RNPC3,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of RNPC3 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4833,345318,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,54763,ROPN1,https://ctdbase.org/detail.go?type=gene&acc=54763,,,54763.0,ROPN1,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in decreased expression of ROPN1 protein,,,PMID:33656234,https://www.ncbi.nlm.nih.gov/pubmed/33656234,33656234,,
4834,345319,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,83853,ROPN1L,https://ctdbase.org/detail.go?type=gene&acc=83853,,,83853.0,ROPN1L,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of ROPN1L mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4835,345320,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,22934,RPIA,https://ctdbase.org/detail.go?type=gene&acc=22934,,,22934.0,RPIA,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of RPIA mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4836,345321,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,6170,RPL39,https://ctdbase.org/detail.go?type=gene&acc=6170,,,6170.0,RPL39,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of RPL39 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4837,345322,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,102548019,RPS4X-PS1,https://ctdbase.org/detail.go?type=gene&acc=102548019,,,102548019.0,Rps4x-ps1,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of RPS4X-PS1 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4838,345970,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,10116.0,Rattus norvegicus (Norway rat),[allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SCARB1 mRNA,,,PMID:33051911,https://www.ncbi.nlm.nih.gov/pubmed/33051911,33051911,,
4839,345971,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] affects the expression of SCARB1 mRNA,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
4840,345972,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,10116.0,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in increased expression of SCARB1 mRNA,,,PMID:33396045,https://www.ncbi.nlm.nih.gov/pubmed/33396045,33396045,,
4841,347239,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,9990,SLC12A6,https://ctdbase.org/detail.go?type=gene&acc=9990,,,9990.0,SLC12A6,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SLC12A6 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4842,347240,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,84561,SLC12A8,https://ctdbase.org/detail.go?type=gene&acc=84561,,,84561.0,SLC12A8,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SLC12A8 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4843,347241,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,8170,SLC14A2,https://ctdbase.org/detail.go?type=gene&acc=8170,,,8170.0,SLC14A2,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SLC14A2 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4844,347242,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SLC16A1 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4845,347243,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,201232,SLC16A13,https://ctdbase.org/detail.go?type=gene&acc=201232,,,201232.0,SLC16A13,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SLC16A13 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4846,347244,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,23539,SLC16A8,https://ctdbase.org/detail.go?type=gene&acc=23539,,,23539.0,SLC16A8,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SLC16A8 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4847,347245,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,57030,SLC17A7,https://ctdbase.org/detail.go?type=gene&acc=57030,,,57030.0,SLC17A7,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SLC17A7 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4848,347246,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,6511,SLC1A6,https://ctdbase.org/detail.go?type=gene&acc=6511,,,6511.0,SLC1A6,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SLC1A6 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4849,349784,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116.0,Rattus norvegicus (Norway rat),[fenvalerate co-treated with allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of STAR mRNA,,,PMID:36053783,https://www.ncbi.nlm.nih.gov/pubmed/36053783,36053783,,
4850,349785,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in decreased expression of STAR mRNA,,,PMID:19892000,https://www.ncbi.nlm.nih.gov/pubmed/19892000,19892000,,
4851,349786,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of STAR protein|fenvalerate results in increased expression of STAR mRNA,,,PMID:15907653,https://www.ncbi.nlm.nih.gov/pubmed/15907653,15907653,,
4852,349787,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,57519,STARD9,https://ctdbase.org/detail.go?type=gene&acc=57519,,,57519.0,STARD9,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of STARD9 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4853,349788,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,20863,STFA3,https://ctdbase.org/detail.go?type=gene&acc=20863,,,20863.0,Stfa3,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of STFA3 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4854,349789,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,282974,STK32C,https://ctdbase.org/detail.go?type=gene&acc=282974,,,282974.0,STK32C,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of STK32C mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4855,349790,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,27148,STK36,https://ctdbase.org/detail.go?type=gene&acc=27148,,,27148.0,STK36,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of STK36 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4856,349791,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,50861,STMN3,https://ctdbase.org/detail.go?type=gene&acc=50861,,,50861.0,STMN3,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of STMN3 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4857,349792,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,79991,STN1,https://ctdbase.org/detail.go?type=gene&acc=79991,,,79991.0,STN1,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of STN1 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4858,350260,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,284612,SYPL2,https://ctdbase.org/detail.go?type=gene&acc=284612,,,284612.0,SYPL2,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SYPL2 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4859,350261,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,57586,SYT13,https://ctdbase.org/detail.go?type=gene&acc=57586,,,57586.0,SYT13,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SYT13 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4860,350262,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,51760,SYT17,https://ctdbase.org/detail.go?type=gene&acc=51760,,,51760.0,SYT17,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SYT17 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4861,350263,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,127833,SYT2,https://ctdbase.org/detail.go?type=gene&acc=127833,,,127833.0,SYT2,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of SYT2 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4862,355316,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,51087,YBX2,https://ctdbase.org/detail.go?type=gene&acc=51087,,,51087.0,YBX2,10116.0,Rattus norvegicus (Norway rat),[fenvalerate co-treated with allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of YBX2 mRNA,,,PMID:36053783,https://www.ncbi.nlm.nih.gov/pubmed/36053783,36053783,,
4863,355317,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,150223,YDJC,https://ctdbase.org/detail.go?type=gene&acc=150223,,,150223.0,YDJC,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of YDJC mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4864,355318,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,25844,YIPF3,https://ctdbase.org/detail.go?type=gene&acc=25844,,,25844.0,YIPF3,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in decreased expression of YIPF3 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4865,355319,3347,Comparative Toxicogenomics Database (CTD),Fenvalerate,C017690,fenvalerate,https://ctdbase.org/detail.go?type=chem&acc=C017690,29799,YPEL1,https://ctdbase.org/detail.go?type=gene&acc=29799,,,29799.0,YPEL1,10116.0,Rattus norvegicus (Norway rat),Fenvalerate results in increased expression of YPEL1 mRNA,,,PMID:30307764,https://www.ncbi.nlm.nih.gov/pubmed/30307764,30307764,,
4866,350777,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,100005419,PPP4R2B,https://ctdbase.org/detail.go?type=gene&acc=100005419,,,100005419.0,ppp4r2b,7955.0,Danio rerio (zebrafish),Fipronil results in decreased expression of PPP4R2B mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4867,350778,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,55291,PPP6R3,https://ctdbase.org/detail.go?type=gene&acc=55291,,,55291.0,PPP6R3,10116.0,Rattus norvegicus (Norway rat),Fipronil results in decreased expression of PPP6R3 mRNA,,,PMID:34044035,https://www.ncbi.nlm.nih.gov/pubmed/34044035,34044035,,
4868,350779,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,405845,PPT2A.4,https://ctdbase.org/detail.go?type=gene&acc=405845,,,405845.0,ppt2a.4,7955.0,Danio rerio (zebrafish),Fipronil results in decreased expression of PPT2A.4 mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4869,350780,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,84279,PRADC1,https://ctdbase.org/detail.go?type=gene&acc=84279,,,84279.0,PRADC1,10116.0,Rattus norvegicus (Norway rat),Fipronil results in decreased expression of PRADC1 mRNA,,,PMID:34044035,https://www.ncbi.nlm.nih.gov/pubmed/34044035,34044035,,
4870,350781,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,391002,PRAMEF8,https://ctdbase.org/detail.go?type=gene&acc=391002,,,391002.0,PRAMEF8,9606.0,Homo sapiens (human),Fipronil results in increased expression of PRAMEF8 mrna|[fipronil co-treated with DEET] results in increased expression of PRAMEF8 mRNA,,,PMID:27091632,https://www.ncbi.nlm.nih.gov/pubmed/27091632,27091632,,
4871,350782,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,5547,PRCP,https://ctdbase.org/detail.go?type=gene&acc=5547,,,5547.0,PRCP,7955.0,Danio rerio (zebrafish),Fipronil results in decreased expression of PRCP mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4872,350783,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,56978,PRDM8,https://ctdbase.org/detail.go?type=gene&acc=56978,,,56978.0,PRDM8,7955.0,Danio rerio (zebrafish),Fipronil results in decreased expression of PRDM8 mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4873,350784,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,10116.0,Rattus norvegicus (Norway rat),Fipronil results in decreased expression of PRDX1 mRNA,,,PMID:34044035,https://www.ncbi.nlm.nih.gov/pubmed/34044035,34044035,,
4874,351421,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,69814,PRSS32,https://ctdbase.org/detail.go?type=gene&acc=69814,,,69814.0,Prss32,10116.0,Rattus norvegicus (Norway rat),Fipronil results in decreased expression of PRSS32 mRNA,,,PMID:23962444,https://www.ncbi.nlm.nih.gov/pubmed/23962444,23962444,,
4875,351422,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,56952,PRTFDC1,https://ctdbase.org/detail.go?type=gene&acc=56952,,,56952.0,PRTFDC1,10116.0,Rattus norvegicus (Norway rat),Fipronil results in increased expression of PRTFDC1 mRNA,,,PMID:23962444,https://www.ncbi.nlm.nih.gov/pubmed/23962444,23962444,,
4876,353839,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,39054,RDL,https://ctdbase.org/detail.go?type=gene&acc=39054,,,39054.0,Rdl,51655.0,Plutella xylostella (diamondback moth),RDL gene mutant form results in decreased susceptibility to fipronil,,,PMID:16813330,https://www.ncbi.nlm.nih.gov/pubmed/16813330,16813330,,
4877,353840,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,39054,RDL,https://ctdbase.org/detail.go?type=gene&acc=39054,,,39054.0,Rdl,7227.0,Drosophila melanogaster (fruit fly),Fipronil binds to and results in decreased activity of RDL protein,,,PMID:12770577,https://www.ncbi.nlm.nih.gov/pubmed/12770577,12770577,,
4878,353841,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,5966,REL,https://ctdbase.org/detail.go?type=gene&acc=5966,,,5966.0,REL,7955.0,Danio rerio (zebrafish),Fipronil results in increased expression of REL mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4879,353842,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,7955.0,Danio rerio (zebrafish),Fipronil results in increased expression of RELA mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4880,353843,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,5971,RELB,https://ctdbase.org/detail.go?type=gene&acc=5971,,,5971.0,RELB,7955.0,Danio rerio (zebrafish),Fipronil results in increased expression of RELB mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4881,353844,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,768211,RELL1,https://ctdbase.org/detail.go?type=gene&acc=768211,,,768211.0,RELL1,10116.0,Rattus norvegicus (Norway rat),Fipronil results in increased expression of RELL1 mRNA,,,PMID:31881178,https://www.ncbi.nlm.nih.gov/pubmed/31881178,31881178,,
4882,353845,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,285613,RELL2,https://ctdbase.org/detail.go?type=gene&acc=285613,,,285613.0,RELL2,10116.0,Rattus norvegicus (Norway rat),Fipronil results in increased expression of RELL2 mRNA,,,PMID:34044035,https://www.ncbi.nlm.nih.gov/pubmed/34044035,34044035,,
4883,353846,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,473,RERE,https://ctdbase.org/detail.go?type=gene&acc=473,,,473.0,RERE,10116.0,Rattus norvegicus (Norway rat),Fipronil results in increased expression of RERE mRNA,,,PMID:34044035,https://www.ncbi.nlm.nih.gov/pubmed/34044035,34044035,,
4884,354497,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,100861534,RN5-8S,https://ctdbase.org/detail.go?type=gene&acc=100861534,,,100861534.0,Rn5-8s,10116.0,Rattus norvegicus (Norway rat),Fipronil results in increased expression of RN5-8S mRNA,,,PMID:34044035,https://www.ncbi.nlm.nih.gov/pubmed/34044035,34044035,,
4885,354498,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,125050,RN7SK,https://ctdbase.org/detail.go?type=gene&acc=125050,,,125050.0,RN7SK,7955.0,Danio rerio (zebrafish),Fipronil results in increased expression of RN7SK mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4886,354499,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,405780,RND1A,https://ctdbase.org/detail.go?type=gene&acc=405780,,,405780.0,rnd1a,7955.0,Danio rerio (zebrafish),Fipronil results in increased expression of RND1A mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4887,354500,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,553414,RND1B,https://ctdbase.org/detail.go?type=gene&acc=553414,,,553414.0,rnd1b,7955.0,Danio rerio (zebrafish),Fipronil results in increased expression of RND1B mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4888,354501,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,7844,RNF103,https://ctdbase.org/detail.go?type=gene&acc=7844,,,7844.0,RNF103,10116.0,Rattus norvegicus (Norway rat),Fipronil results in increased expression of RNF103 mRNA,,,PMID:23962444,https://www.ncbi.nlm.nih.gov/pubmed/23962444,23962444,,
4889,356751,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,677769,SCARNA17,https://ctdbase.org/detail.go?type=gene&acc=677769,,,677769.0,SCARNA17,9606.0,Homo sapiens (human),[fipronil co-treated with DEET] results in decreased expression of SCARNA17 mrna|fipronil results in decreased expression of SCARNA17 mRNA,,,PMID:28991164,https://www.ncbi.nlm.nih.gov/pubmed/28991164,28991164,,
4890,356752,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,619207,SCART1,https://ctdbase.org/detail.go?type=gene&acc=619207,,,619207.0,SCART1,9606.0,Homo sapiens (human),[fipronil co-treated with DEET] results in decreased expression of SCART1 mrna|fipronil results in decreased expression of SCART1 mRNA,,,PMID:28991164,https://www.ncbi.nlm.nih.gov/pubmed/28991164,28991164,,
4891,356753,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,6319,SCD,https://ctdbase.org/detail.go?type=gene&acc=6319,,,6319.0,SCD,10116.0,Rattus norvegicus (Norway rat),Fipronil results in increased expression of SCD mRNA,,,PMID:23962444,https://www.ncbi.nlm.nih.gov/pubmed/23962444,23962444,,
4892,356754,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,100002334,SC:D189,https://ctdbase.org/detail.go?type=gene&acc=100002334,,,100002334.0,sc:d189,7955.0,Danio rerio (zebrafish),Fipronil affects the expression of SC:D189 mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4893,356755,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,23256,SCFD1,https://ctdbase.org/detail.go?type=gene&acc=23256,,,23256.0,SCFD1,7955.0,Danio rerio (zebrafish),Fipronil results in decreased expression of SCFD1 mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4894,359889,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,100093630,SNHG8,https://ctdbase.org/detail.go?type=gene&acc=100093630,,,100093630.0,SNHG8,9606.0,Homo sapiens (human),[fipronil co-treated with DEET] results in increased expression of SNHG8 mRNA,,,PMID:28991164,https://www.ncbi.nlm.nih.gov/pubmed/28991164,28991164,,
4895,359890,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,735301,SNHG9,https://ctdbase.org/detail.go?type=gene&acc=735301,,,735301.0,SNHG9,9606.0,Homo sapiens (human),[fipronil co-treated with DEET] results in increased expression of SNHG9 mRNA,,,PMID:28991164,https://www.ncbi.nlm.nih.gov/pubmed/28991164,28991164,,
4896,359891,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,6625,SNRNP70,https://ctdbase.org/detail.go?type=gene&acc=6625,,,6625.0,SNRNP70,7955.0,Danio rerio (zebrafish),Fipronil affects the expression of SNRNP70 mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
4897,226826,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),EGFR results in increased susceptibility to [cisplatin co-treated with docetaxel co-treated with fluorouracil],,,PMID:21947696,https://www.ncbi.nlm.nih.gov/pubmed/21947696,21947696,,
4898,226827,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),Fluorouracil promotes the reaction [curcumin results in decreased expression of EGFR protein]|fluorouracil promotes the reaction [curcumin results in decreased phosphorylation of and results in decreased activity of EGFR protein]|fluorouracil results in decreased phosphorylation of and results in decreased activity of EGFR protein,,,PMID:17918158,https://www.ncbi.nlm.nih.gov/pubmed/17918158,17918158,,
4899,226828,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of EGFR protein,,,PMID:17918158|PMID:17982676,https://www.ncbi.nlm.nih.gov/pubmed/17918158|https://www.ncbi.nlm.nih.gov/pubmed/17982676,17918158|17982676,,
4900,226829,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),Fluorouracil results in increased phosphorylation of EGFR protein,,,PMID:18794807,https://www.ncbi.nlm.nih.gov/pubmed/18794807,18794807,,
4901,226830,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of EGFR protein],,,PMID:17982676,https://www.ncbi.nlm.nih.gov/pubmed/17982676,17982676,,
4902,228168,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2067,ERCC1,https://ctdbase.org/detail.go?type=gene&acc=2067,,,2067.0,ERCC1,9606.0,Homo sapiens (human),ERCC1 mRNA affects the susceptibility to [cisplatin co-treated with fluorouracil],,,PMID:15173087,https://www.ncbi.nlm.nih.gov/pubmed/15173087,15173087,,
4903,228169,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2067,ERCC1,https://ctdbase.org/detail.go?type=gene&acc=2067,,,2067.0,ERCC1,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of ERCC1 mRNA,,,PMID:17016597,https://www.ncbi.nlm.nih.gov/pubmed/17016597,17016597,,
4904,228170,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2068,ERCC2,https://ctdbase.org/detail.go?type=gene&acc=2068,,,2068.0,ERCC2,9606.0,Homo sapiens (human),ERCC2 gene polymorphism affects the susceptibility to [fluorouracil co-treated with oxaliplatin],,,PMID:15213713,https://www.ncbi.nlm.nih.gov/pubmed/15213713,15213713,,
4905,228171,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2068,ERCC2,https://ctdbase.org/detail.go?type=gene&acc=2068,,,2068.0,ERCC2,9606.0,Homo sapiens (human),ERCC2 gene SNP affects the susceptibility to [fluorouracil co-treated with leucovorin co-treated with oxaliplatin],,,PMID:17401013,https://www.ncbi.nlm.nih.gov/pubmed/17401013,17401013,,
4906,228172,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2069,EREG,https://ctdbase.org/detail.go?type=gene&acc=2069,,,2069.0,EREG,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of EREG mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
4907,228173,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2081,ERN1,https://ctdbase.org/detail.go?type=gene&acc=2081,,,2081.0,ERN1,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of ERN1 mRNA,,,PMID:32535746,https://www.ncbi.nlm.nih.gov/pubmed/32535746,32535746,,
4908,228174,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10961,ERP29,https://ctdbase.org/detail.go?type=gene&acc=10961,,,10961.0,ERP29,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of ERP29 protein,,,PMID:15585135|PMID:16803524,https://www.ncbi.nlm.nih.gov/pubmed/15585135|https://www.ncbi.nlm.nih.gov/pubmed/16803524,15585135|16803524,,
4909,228175,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,9700,ESPL1,https://ctdbase.org/detail.go?type=gene&acc=9700,,,9700.0,ESPL1,9606.0,Homo sapiens (human),ESPL1 protein affects the susceptibility to fluorouracil,,,PMID:15548681,https://www.ncbi.nlm.nih.gov/pubmed/15548681,15548681,,
4910,228176,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2107,ETF1,https://ctdbase.org/detail.go?type=gene&acc=2107,,,2107.0,ETF1,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of ETF1 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
4911,228772,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),[docosahexaenoic acids co-treated with fluorouracil] results in decreased expression of FAS mRNA,,,PMID:19015929,https://www.ncbi.nlm.nih.gov/pubmed/19015929,19015929,,
4912,228773,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),FAS protein affects the reaction [fluorouracil results in increased activity of CASP3 protein]|fas protein affects the reaction [fluorouracil results in increased activity of CASP8 protein]|fas protein affects the reaction [fluorouracil results in increased activity of CASP9 protein],,,PMID:17056233,https://www.ncbi.nlm.nih.gov/pubmed/17056233,17056233,,
4913,228774,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),[fluorouracil co-treated with RNF34 protein] results in increased expression of FAS protein,,,PMID:16596200,https://www.ncbi.nlm.nih.gov/pubmed/16596200,16596200,,
4914,228775,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of FAS,,,PMID:11300326|PMID:15034078,https://www.ncbi.nlm.nih.gov/pubmed/11300326|https://www.ncbi.nlm.nih.gov/pubmed/15034078,11300326|15034078,,
4915,228776,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of FAS mRNA,,,PMID:15152939|PMID:15161716|PMID:16557594|PMID:16709241|PMID:16957513|PMID:17039268|PMID:22525470|PMID:33770205|PMID:34151400,https://www.ncbi.nlm.nih.gov/pubmed/15152939|https://www.ncbi.nlm.nih.gov/pubmed/15161716|https://www.ncbi.nlm.nih.gov/pubmed/16557594|https://www.ncbi.nlm.nih.gov/pubmed/16709241|https://www.ncbi.nlm.nih.gov/pubmed/16957513|https://www.ncbi.nlm.nih.gov/pubmed/17039268|https://www.ncbi.nlm.nih.gov/pubmed/22525470|https://www.ncbi.nlm.nih.gov/pubmed/33770205|https://www.ncbi.nlm.nih.gov/pubmed/34151400,15152939|15161716|16557594|16709241|16957513|17039268|22525470|33770205|34151400,,
4916,228777,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of FAS protein,,,PMID:14665630|PMID:15161716|PMID:15546879|PMID:15585135|PMID:16957513|PMID:17045692|PMID:17056233|PMID:17982676|PMID:18074150,https://www.ncbi.nlm.nih.gov/pubmed/14665630|https://www.ncbi.nlm.nih.gov/pubmed/15161716|https://www.ncbi.nlm.nih.gov/pubmed/15546879|https://www.ncbi.nlm.nih.gov/pubmed/15585135|https://www.ncbi.nlm.nih.gov/pubmed/16957513|https://www.ncbi.nlm.nih.gov/pubmed/17045692|https://www.ncbi.nlm.nih.gov/pubmed/17056233|https://www.ncbi.nlm.nih.gov/pubmed/17982676|https://www.ncbi.nlm.nih.gov/pubmed/18074150,14665630|15161716|15546879|15585135|16957513|17045692|17056233|17982676|18074150,,
4917,228778,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),"TP53 protein promotes the reaction [N(1),N(11)-diethylnorspermine promotes the reaction [fluorouracil results in increased expression of FAS protein]]|n(1),n(11)-diethylnorspermine promotes the reaction [fluorouracil results in increased expression of FAS protein]",,,PMID:15546879,https://www.ncbi.nlm.nih.gov/pubmed/15546879,15546879,,
4918,228965,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in increased expression of FAS mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
4919,228966,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in increased expression of FAS protein],,,PMID:15161716,https://www.ncbi.nlm.nih.gov/pubmed/15161716,15161716,,
4920,228967,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),TP53 protein promotes the reaction [fluorouracil results in increased expression of FAS protein],,,PMID:15546879|PMID:17982676,https://www.ncbi.nlm.nih.gov/pubmed/15546879|https://www.ncbi.nlm.nih.gov/pubmed/17982676,15546879|17982676,,
4921,228968,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,14103,FASL,https://ctdbase.org/detail.go?type=gene&acc=14103,,,14103.0,Fasl,10090.0,Mus musculus (house mouse),FASL results in increased susceptibility to fluorouracil|fluorouracil results in increased expression of FASL,,,PMID:11196169,https://www.ncbi.nlm.nih.gov/pubmed/11196169,11196169,,
4922,230099,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,10090.0,Mus musculus (house mouse),GADD45A protein affects the susceptibility to fluorouracil,,,PMID:16732331,https://www.ncbi.nlm.nih.gov/pubmed/16732331,16732331,,
4923,230100,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4616,GADD45B,https://ctdbase.org/detail.go?type=gene&acc=4616,,,4616.0,GADD45B,9606.0,Homo sapiens (human),GADD45B protein results in decreased susceptibility to fluorouracil|ifng protein inhibits the reaction [GADD45B protein results in decreased susceptibility to fluorouracil],,,PMID:17711513,https://www.ncbi.nlm.nih.gov/pubmed/17711513,17711513,,
4924,230101,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4616,GADD45B,https://ctdbase.org/detail.go?type=gene&acc=4616,,,4616.0,GADD45B,10090.0,Mus musculus (house mouse),GADD45B protein affects the susceptibility to fluorouracil,,,PMID:16732331,https://www.ncbi.nlm.nih.gov/pubmed/16732331,16732331,,
4925,230102,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10912,GADD45G,https://ctdbase.org/detail.go?type=gene&acc=10912,,,10912.0,GADD45G,10090.0,Mus musculus (house mouse),Fluorouracil results in increased expression of GADD45G mRNA,,,PMID:19272435,https://www.ncbi.nlm.nih.gov/pubmed/19272435,19272435,,
4926,230103,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,51083,GAL,https://ctdbase.org/detail.go?type=gene&acc=51083,,,51083.0,GAL,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of GAL protein,,,PMID:21296659,https://www.ncbi.nlm.nih.gov/pubmed/21296659,21296659,,
4927,230256,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2591,GALNT3,https://ctdbase.org/detail.go?type=gene&acc=2591,,,2591.0,GALNT3,9606.0,Homo sapiens (human),GALNT3 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
4928,230257,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2593,GAMT,https://ctdbase.org/detail.go?type=gene&acc=2593,,,2593.0,GAMT,9606.0,Homo sapiens (human),GAMT protein affects the susceptibility to fluorouracil|fluorouracil results in increased expression of GAMT protein,,,PMID:15352031,https://www.ncbi.nlm.nih.gov/pubmed/15352031,15352031,,
4929,230258,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2593,GAMT,https://ctdbase.org/detail.go?type=gene&acc=2593,,,2593.0,GAMT,9606.0,Homo sapiens (human),GAMT mRNA affects the susceptibility to [paclitaxel co-treated with fluorouracil co-treated with doxorubicin co-treated with cyclophosphamide],,,PMID:16896004,https://www.ncbi.nlm.nih.gov/pubmed/16896004,16896004,,
4930,230259,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2593,GAMT,https://ctdbase.org/detail.go?type=gene&acc=2593,,,2593.0,GAMT,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of GAMT mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
4931,230260,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,9606.0,Homo sapiens (human),Fluorouracil affects the splicing of GAPDH mRNA,,,PMID:17169984,https://www.ncbi.nlm.nih.gov/pubmed/17169984,17169984,,
4932,230261,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2597,GAPDH,https://ctdbase.org/detail.go?type=gene&acc=2597,,,2597.0,GAPDH,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of GAPDH protein,,,PMID:21296659,https://www.ncbi.nlm.nih.gov/pubmed/21296659,21296659,,
4933,231709,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,51564,HDAC7,https://ctdbase.org/detail.go?type=gene&acc=51564,,,51564.0,HDAC7,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of HDAC7 mRNA,,,PMID:26272751,https://www.ncbi.nlm.nih.gov/pubmed/26272751,26272751,,
4934,231710,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,9734,HDAC9,https://ctdbase.org/detail.go?type=gene&acc=9734,,,9734.0,HDAC9,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of HDAC9 mRNA,,,PMID:24737281,https://www.ncbi.nlm.nih.gov/pubmed/24737281,24737281,,
4935,231711,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,50810,HDGFL3,https://ctdbase.org/detail.go?type=gene&acc=50810,,,50810.0,HDGFL3,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of HDGFL3 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
4936,231712,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of HERPUD1 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
4937,231713,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3280,HES1,https://ctdbase.org/detail.go?type=gene&acc=3280,,,3280.0,HES1,9606.0,Homo sapiens (human),Fluorouracil results in increased activity of HES1 protein,,,PMID:19147571,https://www.ncbi.nlm.nih.gov/pubmed/19147571,19147571,,
4938,231714,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,38528,HEXO1,https://ctdbase.org/detail.go?type=gene&acc=38528,,,38528.0,Hexo1,9606.0,Homo sapiens (human),HEXO1 protein affects the susceptibility to fluorouracil,,,PMID:16477629,https://www.ncbi.nlm.nih.gov/pubmed/16477629,16477629,,
4939,231913,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3082,HGF,https://ctdbase.org/detail.go?type=gene&acc=3082,,,3082.0,HGF,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of HGF mRNA,,,PMID:24737281,https://www.ncbi.nlm.nih.gov/pubmed/24737281,24737281,,
4940,231914,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,23119,HIC2,https://ctdbase.org/detail.go?type=gene&acc=23119,,,23119.0,HIC2,9606.0,Homo sapiens (human),HIC2 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
4941,231915,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),Cyclosporine inhibits the reaction [HIF1A protein results in decreased uptake of fluorouracil]|fluorouracil affects the localization of HIF1A protein|hif1a protein results in decreased uptake of fluorouracil|acetylcysteine inhibits the reaction [fluorouracil affects the localization of HIF1A protein]|fluorouracil results in decreased susceptibility to HIF1A protein,,,PMID:17066447,https://www.ncbi.nlm.nih.gov/pubmed/17066447,17066447,,
4942,231916,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of HIF1A protein,,,PMID:27163855,https://www.ncbi.nlm.nih.gov/pubmed/27163855,27163855,,
4943,231917,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),HIF1A protein affects the susceptibility to fluorouracil,,,PMID:16628086,https://www.ncbi.nlm.nih.gov/pubmed/16628086,16628086,,
4944,231918,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,9606.0,Homo sapiens (human),HIF1A results in decreased susceptibility to fluorouracil,,,PMID:17219956,https://www.ncbi.nlm.nih.gov/pubmed/17219956,17219956,,
4945,232109,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3135,HLA-G,https://ctdbase.org/detail.go?type=gene&acc=3135,,,3135.0,HLA-G,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of HLA-G mRNA,,,PMID:16101138,https://www.ncbi.nlm.nih.gov/pubmed/16101138,16101138,,
4946,232110,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,81502,HM13,https://ctdbase.org/detail.go?type=gene&acc=81502,,,81502.0,HM13,9606.0,Homo sapiens (human),Fluorouracil affects the expression of HM13 mRNA,,,PMID:16584549,https://www.ncbi.nlm.nih.gov/pubmed/16584549,16584549,,
4947,232111,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,56941,HMCES,https://ctdbase.org/detail.go?type=gene&acc=56941,,,56941.0,HMCES,9606.0,Homo sapiens (human),HMCES protein affects the susceptibility to fluorouracil,,,PMID:15548681,https://www.ncbi.nlm.nih.gov/pubmed/15548681,15548681,,
4948,232112,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,373332,HMG1,https://ctdbase.org/detail.go?type=gene&acc=373332,,,373332.0,HMG1,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of HMG1 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
4949,232113,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10362,HMG20B,https://ctdbase.org/detail.go?type=gene&acc=10362,,,10362.0,HMG20B,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of HMG20B mRNA,,,PMID:16709241,https://www.ncbi.nlm.nih.gov/pubmed/16709241,16709241,,
4950,232114,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,79366,HMGN5,https://ctdbase.org/detail.go?type=gene&acc=79366,,,79366.0,HMGN5,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of HMGN5 mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
4951,232115,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3161,HMMR,https://ctdbase.org/detail.go?type=gene&acc=3161,,,3161.0,HMMR,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of HMMR mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
4952,232116,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),Fluorouracil results in increased expression of HMOX1,,,PMID:20722640,https://www.ncbi.nlm.nih.gov/pubmed/20722640,20722640,,
4953,232117,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Fluorouracil affects the expression of HMOX1 mRNA,,,PMID:22954530,https://www.ncbi.nlm.nih.gov/pubmed/22954530,22954530,,
4954,233969,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,9606.0,Homo sapiens (human),Fluorouracil results in increased cleavage of and results in increased secretion of IL18 protein|fluorouracil promotes the reaction [IL18 protein modified form results in increased expression of IFNG protein],,,PMID:15162350,https://www.ncbi.nlm.nih.gov/pubmed/15162350,15162350,,
4955,233970,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,10090.0,Mus musculus (house mouse),Fluorouracil affects the expression of IL18 mRNA,,,PMID:20421339,https://www.ncbi.nlm.nih.gov/pubmed/20421339,20421339,,
4956,233971,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,10090.0,Mus musculus (house mouse),[cyclophosphamide co-treated with methotrexate co-treated with fluorouracil] results in decreased expression of IL1A protein,,,PMID:31651976,https://www.ncbi.nlm.nih.gov/pubmed/31651976,31651976,,
4957,233972,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of IL1B mRNA,,,PMID:19528421,https://www.ncbi.nlm.nih.gov/pubmed/19528421,19528421,,
4958,233973,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),IL1B promoter polymorphism affects the susceptibility to [fluorouracil co-treated with cisplatin],,,PMID:16820919,https://www.ncbi.nlm.nih.gov/pubmed/16820919,16820919,,
4959,233974,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10036.0,Mesocricetus auratus (golden hamster),Fluorouracil results in increased expression of IL1B protein|olmesartan medoxomil inhibits the reaction [fluorouracil results in increased expression of IL1B mrna]|fluorouracil results in increased expression of IL1B mrna|olmesartan medoxomil inhibits the reaction [fluorouracil results in increased expression of IL1B protein],,,PMID:30125396,https://www.ncbi.nlm.nih.gov/pubmed/30125396,30125396,,
4960,233975,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),[cyclophosphamide co-treated with methotrexate co-treated with fluorouracil] results in decreased expression of IL1B protein,,,PMID:31651976,https://www.ncbi.nlm.nih.gov/pubmed/31651976,31651976,,
4961,233976,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Fluorouracil results in increased expression of IL1B mRNA,,,PMID:18523641|PMID:20844880,https://www.ncbi.nlm.nih.gov/pubmed/18523641|https://www.ncbi.nlm.nih.gov/pubmed/20844880,18523641|20844880,,
4962,233977,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Fluorouracil results in increased expression of IL1B protein,,,PMID:20844880,https://www.ncbi.nlm.nih.gov/pubmed/20844880,20844880,,
4963,233978,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Hydroxychloroquine inhibits the reaction [fluorouracil results in increased secretion of IL1B protein]|fluorouracil results in increased secretion of IL1B protein,,,PMID:32314717,https://www.ncbi.nlm.nih.gov/pubmed/32314717,32314717,,
4964,234156,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Fluorouracil results in increased expression of IL1B protein,,,PMID:18535404,https://www.ncbi.nlm.nih.gov/pubmed/18535404,18535404,,
4965,234157,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3557,IL1RN,https://ctdbase.org/detail.go?type=gene&acc=3557,,,3557.0,IL1RN,10090.0,Mus musculus (house mouse),IL1RN protein affects the reaction [fluorouracil results in increased expression of BAX protein]|il1rn protein inhibits the reaction [fluorouracil results in decreased expression of BCL2 protein]|il1rn protein affects the reaction [fluorouracil results in increased expression of CASP3 protein modified form]|il1rn protein inhibits the reaction [fluorouracil results in decreased expression of BCL2L1 protein],,,PMID:20844880,https://www.ncbi.nlm.nih.gov/pubmed/20844880,20844880,,
4966,234158,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,9466,IL27RA,https://ctdbase.org/detail.go?type=gene&acc=9466,,,9466.0,IL27RA,9606.0,Homo sapiens (human),IL27RA protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
4967,234159,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3562,IL3,https://ctdbase.org/detail.go?type=gene&acc=3562,,,3562.0,IL3,10090.0,Mus musculus (house mouse),[cyclophosphamide co-treated with methotrexate co-treated with fluorouracil] results in decreased expression of IL3 protein,,,PMID:31651976,https://www.ncbi.nlm.nih.gov/pubmed/31651976,31651976,,
4968,234160,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),"Alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [fluorouracil results in increased expression of IL6 mrna]|sb 203580 inhibits the reaction [fluorouracil results in increased expression of IL6 mrna]|3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fluorouracil results in increased secretion of IL6 protein]|3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [fluorouracil results in increased expression of IL6 mrna]|fluorouracil results in increased expression of IL6 mrna|pyrazolanthrone inhibits the reaction [fluorouracil results in increased expression of IL6 mrna]|fluorouracil results in increased secretion of IL6 protein",,,PMID:35147423,https://www.ncbi.nlm.nih.gov/pubmed/35147423,35147423,,
4969,234161,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,9817,KEAP1,https://ctdbase.org/detail.go?type=gene&acc=9817,,,9817.0,KEAP1,9606.0,Homo sapiens (human),KEAP1 protein affects the susceptibility to fluorouracil,,,PMID:18692501,https://www.ncbi.nlm.nih.gov/pubmed/18692501,18692501,,
4970,234162,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),IL6 protein inhibits the reaction [fluorouracil results in increased cleavage of PARP1 protein]|il6 protein inhibits the reaction [fluorouracil results in increased expression of XAF1 mrna]|il6 protein inhibits the reaction [fluorouracil results in decreased expression of MT2A protein]|il6 protein inhibits the reaction [fluorouracil results in increased expression of XAF1 protein]|[fluorouracil co-treated with IL6 protein] results in increased expression of MT2A mRNA,,,PMID:28507149,https://www.ncbi.nlm.nih.gov/pubmed/28507149,28507149,,
4971,234163,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),IL6 promoter polymorphism affects the susceptibility to [fluorouracil co-treated with cisplatin],,,PMID:16820919,https://www.ncbi.nlm.nih.gov/pubmed/16820919,16820919,,
4972,234476,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,445683,IPF1,https://ctdbase.org/detail.go?type=gene&acc=445683,,,445683.0,,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of IPF1 protein,,,PMID:21296659,https://www.ncbi.nlm.nih.gov/pubmed/21296659,21296659,,
4973,234477,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10788,IQGAP2,https://ctdbase.org/detail.go?type=gene&acc=10788,,,10788.0,IQGAP2,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of IQGAP2 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
4974,234478,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3654,IRAK1,https://ctdbase.org/detail.go?type=gene&acc=3654,,,3654.0,IRAK1,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of IRAK1 mRNA,,,PMID:15109396,https://www.ncbi.nlm.nih.gov/pubmed/15109396,15109396,,
4975,234479,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3654,IRAK1,https://ctdbase.org/detail.go?type=gene&acc=3654,,,3654.0,IRAK1,9606.0,Homo sapiens (human),IRAK1 affects the susceptibility to fluorouracil,,,PMID:15067352,https://www.ncbi.nlm.nih.gov/pubmed/15067352,15067352,,
4976,236695,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4133,MAP2,https://ctdbase.org/detail.go?type=gene&acc=4133,,,4133.0,MAP2,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of MAP2 mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
4977,236696,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,8930,MBD4,https://ctdbase.org/detail.go?type=gene&acc=8930,,,8930.0,MBD4,10090.0,Mus musculus (house mouse),MBD4 protein results in increased metabolism of fluorouracil,,,PMID:16885370,https://www.ncbi.nlm.nih.gov/pubmed/16885370,16885370,,
4978,236697,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5604,MAP2K1,https://ctdbase.org/detail.go?type=gene&acc=5604,,,5604.0,MAP2K1,9606.0,Homo sapiens (human),[U 0126 results in decreased activity of MAP2K1 protein] results in increased susceptibility to [fluorouracil co-treated with cisplatin]|map2k1 protein results in decreased susceptibility to [cisplatin co-treated with fluorouracil],,,PMID:21444628,https://www.ncbi.nlm.nih.gov/pubmed/21444628,21444628,,
4979,236698,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5605,MAP2K2,https://ctdbase.org/detail.go?type=gene&acc=5605,,,5605.0,MAP2K2,9606.0,Homo sapiens (human),MAP2K2 protein results in decreased susceptibility to [cisplatin co-treated with fluorouracil]|[u 0126 results in decreased activity of MAP2K2 protein] results in increased susceptibility to [fluorouracil co-treated with cisplatin],,,PMID:21444628,https://www.ncbi.nlm.nih.gov/pubmed/21444628,21444628,,
4980,236699,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4214,MAP3K1,https://ctdbase.org/detail.go?type=gene&acc=4214,,,4214.0,MAP3K1,9606.0,Homo sapiens (human),Fluorouracil affects the expression of MAP3K1 mRNA,,,PMID:34151400,https://www.ncbi.nlm.nih.gov/pubmed/34151400,34151400,,
4981,236700,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,51776,MAP3K20,https://ctdbase.org/detail.go?type=gene&acc=51776,,,51776.0,MAP3K20,9606.0,Homo sapiens (human),Fluorouracil affects the expression of MAP3K20 mRNA,,,PMID:16584549,https://www.ncbi.nlm.nih.gov/pubmed/16584549,16584549,,
4982,236701,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,11183,MAP4K5,https://ctdbase.org/detail.go?type=gene&acc=11183,,,11183.0,MAP4K5,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of MAP4K5 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
4983,236702,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Fluorouracil inhibits the reaction [cisplatin results in increased phosphorylation of MAPK1 protein],,,PMID:21444628,https://www.ncbi.nlm.nih.gov/pubmed/21444628,21444628,,
4984,236703,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Fluorouracil results in increased phosphorylation of MAPK1 protein|nicotine inhibits the reaction [fluorouracil results in increased phosphorylation of MAPK1 protein],,,PMID:24095863,https://www.ncbi.nlm.nih.gov/pubmed/24095863,24095863,,
4985,236704,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10036.0,Mesocricetus auratus (golden hamster),Olmesartan medoxomil inhibits the reaction [fluorouracil results in increased expression of MAPK1 protein]|fluorouracil results in increased expression of MAPK1 protein,,,PMID:30125396,https://www.ncbi.nlm.nih.gov/pubmed/30125396,30125396,,
4986,237084,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,375449,MAST4,https://ctdbase.org/detail.go?type=gene&acc=375449,,,375449.0,MAST4,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of MAST4 mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
4987,237085,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4154,MBNL1,https://ctdbase.org/detail.go?type=gene&acc=4154,,,4154.0,MBNL1,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of MBNL1 mRNA,,,PMID:16709241,https://www.ncbi.nlm.nih.gov/pubmed/16709241,16709241,,
4988,237086,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4155,MBP,https://ctdbase.org/detail.go?type=gene&acc=4155,,,4155.0,MBP,10090.0,Mus musculus (house mouse),[HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [fluorouracil results in decreased expression of MBP mrna]]|fluorouracil results in decreased expression of MBP mrna|fluorouracil results in decreased expression of MBP protein|tcf7l2 protein inhibits the reaction [fluorouracil results in decreased expression of MBP mrna],,,PMID:25178657,https://www.ncbi.nlm.nih.gov/pubmed/25178657,25178657,,
4989,237087,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,64087,MCCC2,https://ctdbase.org/detail.go?type=gene&acc=64087,,,64087.0,MCCC2,9606.0,Homo sapiens (human),MCCC2 protein affects the susceptibility to [fluorouracil co-treated with irinotecan analog],,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
4990,237088,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4168,MCF2,https://ctdbase.org/detail.go?type=gene&acc=4168,,,4168.0,MCF2,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of MCF2 mRNA,,,PMID:24737281,https://www.ncbi.nlm.nih.gov/pubmed/24737281,24737281,,
4991,239787,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,63973,NEUROG2,https://ctdbase.org/detail.go?type=gene&acc=63973,,,63973.0,NEUROG2,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of NEUROG2 mRNA,,,PMID:31711903,https://www.ncbi.nlm.nih.gov/pubmed/31711903,31711903,,
4992,239788,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Fluorouracil affects the expression of NFE2L2 mRNA,,,PMID:34151400,https://www.ncbi.nlm.nih.gov/pubmed/34151400,34151400,,
4993,239789,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),NFE2L2 protein affects the susceptibility to fluorouracil,,,PMID:18692501,https://www.ncbi.nlm.nih.gov/pubmed/18692501,18692501,,
4994,240510,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4869,NPM1,https://ctdbase.org/detail.go?type=gene&acc=4869,,,4869.0,NPM1,9606.0,Homo sapiens (human),NPM1 protein results in decreased susceptibility to fluorouracil,,,PMID:24736981,https://www.ncbi.nlm.nih.gov/pubmed/24736981,24736981,,
4995,240511,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10360,NPM3,https://ctdbase.org/detail.go?type=gene&acc=10360,,,10360.0,NPM3,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of NPM3 mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
4996,240512,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4878,NPPA,https://ctdbase.org/detail.go?type=gene&acc=4878,,,4878.0,NPPA,10090.0,Mus musculus (house mouse),Fluorouracil results in increased expression of NPPA protein,,,PMID:21296659,https://www.ncbi.nlm.nih.gov/pubmed/21296659,21296659,,
4997,240513,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of NQO1 protein,,,PMID:35101590,https://www.ncbi.nlm.nih.gov/pubmed/35101590,35101590,,
4998,240514,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,9975,NR1D2,https://ctdbase.org/detail.go?type=gene&acc=9975,,,9975.0,NR1D2,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of NR1D2 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
4999,240515,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,3164,NR4A1,https://ctdbase.org/detail.go?type=gene&acc=3164,,,3164.0,NR4A1,9606.0,Homo sapiens (human),Fluorouracil affects the expression of NR4A1 mRNA,,,PMID:15205334|PMID:16557594,https://www.ncbi.nlm.nih.gov/pubmed/15205334|https://www.ncbi.nlm.nih.gov/pubmed/16557594,15205334|16557594,,
5000,240516,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,2494,NR5A2,https://ctdbase.org/detail.go?type=gene&acc=2494,,,2494.0,NR5A2,10090.0,Mus musculus (house mouse),Fluorouracil affects the expression of NR5A2 protein,,,PMID:21296659,https://www.ncbi.nlm.nih.gov/pubmed/21296659,21296659,,
5001,241043,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5015,OTX2,https://ctdbase.org/detail.go?type=gene&acc=5015,,,5015.0,OTX2,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of OTX2 mRNA,,,PMID:30518710,https://www.ncbi.nlm.nih.gov/pubmed/30518710,30518710,,
5002,241044,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5019,OXCT1,https://ctdbase.org/detail.go?type=gene&acc=5019,,,5019.0,OXCT1,9606.0,Homo sapiens (human),OXCT1 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
5003,241045,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5019,OXCT1,https://ctdbase.org/detail.go?type=gene&acc=5019,,,5019.0,OXCT1,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of OXCT1 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
5004,241046,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5034,P4HB,https://ctdbase.org/detail.go?type=gene&acc=5034,,,5034.0,P4HB,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of P4HB mRNA,,,PMID:32535746,https://www.ncbi.nlm.nih.gov/pubmed/32535746,32535746,,
5005,241047,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5048,PAFAH1B1,https://ctdbase.org/detail.go?type=gene&acc=5048,,,5048.0,PAFAH1B1,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of PAFAH1B1 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
5006,241048,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10606,PAICS,https://ctdbase.org/detail.go?type=gene&acc=10606,,,10606.0,PAICS,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of PAICS mRNA,,,PMID:19219653,https://www.ncbi.nlm.nih.gov/pubmed/19219653,19219653,,
5007,242482,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10687,PNMA2,https://ctdbase.org/detail.go?type=gene&acc=10687,,,10687.0,PNMA2,9606.0,Homo sapiens (human),PNMA2 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
5008,242483,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,4860,PNP,https://ctdbase.org/detail.go?type=gene&acc=4860,,,4860.0,PNP,9606.0,Homo sapiens (human),PNP protein affects the susceptibility to fluorouracil,,,PMID:15548681,https://www.ncbi.nlm.nih.gov/pubmed/15548681,15548681,,
5009,242484,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10908,PNPLA6,https://ctdbase.org/detail.go?type=gene&acc=10908,,,10908.0,PNPLA6,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of PNPLA6 mRNA,,,PMID:26272751,https://www.ncbi.nlm.nih.gov/pubmed/26272751,26272751,,
5010,242485,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10957,PNRC1,https://ctdbase.org/detail.go?type=gene&acc=10957,,,10957.0,PNRC1,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of PNRC1 mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
5011,242486,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5420,PODXL,https://ctdbase.org/detail.go?type=gene&acc=5420,,,5420.0,PODXL,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of PODXL protein,,,PMID:21296659,https://www.ncbi.nlm.nih.gov/pubmed/21296659,21296659,,
5012,242632,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of POU5F1 protein,,,PMID:21296659,https://www.ncbi.nlm.nih.gov/pubmed/21296659,21296659,,
5013,242633,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,27068,PPA2,https://ctdbase.org/detail.go?type=gene&acc=27068,,,27068.0,PPA2,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of PPA2 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
5014,242634,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),PPARG protein affects the susceptibility to fluorouracil|fluorouracil results in decreased expression of PPARG protein,,,PMID:15352031,https://www.ncbi.nlm.nih.gov/pubmed/15352031,15352031,,
5015,242635,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,8496,PPFIBP1,https://ctdbase.org/detail.go?type=gene&acc=8496,,,8496.0,PPFIBP1,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of PPFIBP1 mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
5016,242636,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10450,PPIE,https://ctdbase.org/detail.go?type=gene&acc=10450,,,10450.0,PPIE,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of PPIE protein,,,PMID:16803524,https://www.ncbi.nlm.nih.gov/pubmed/16803524,16803524,,
5017,244772,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Bosentan inhibits the reaction [fluorouracil results in increased expression of RELA protein],,,PMID:34800596,https://www.ncbi.nlm.nih.gov/pubmed/34800596,34800596,,
5018,244773,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Fluorouracil affects the expression of RELA protein,,,PMID:18535404,https://www.ncbi.nlm.nih.gov/pubmed/18535404,18535404,,
5019,244774,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Fluorouracil results in increased expression of RELA protein,,,PMID:34665902|PMID:34800596,https://www.ncbi.nlm.nih.gov/pubmed/34665902|https://www.ncbi.nlm.nih.gov/pubmed/34800596,34665902|34800596,,
5020,244775,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),Thymol inhibits the reaction [fluorouracil results in increased expression of RELA protein],,,PMID:34665902,https://www.ncbi.nlm.nih.gov/pubmed/34665902,34665902,,
5021,244776,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,85021,REPS1,https://ctdbase.org/detail.go?type=gene&acc=85021,,,85021.0,REPS1,9606.0,Homo sapiens (human),REPS1 protein affects the susceptibility to [fluorouracil co-treated with irinotecan analog],,,PMID:18927307,https://www.ncbi.nlm.nih.gov/pubmed/18927307,18927307,,
5022,244777,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5978,REST,https://ctdbase.org/detail.go?type=gene&acc=5978,,,5978.0,REST,9606.0,Homo sapiens (human),Fluorouracil affects the expression of REST mRNA,,,PMID:16584549,https://www.ncbi.nlm.nih.gov/pubmed/16584549,16584549,,
5023,244778,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5978,REST,https://ctdbase.org/detail.go?type=gene&acc=5978,,,5978.0,REST,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of REST protein,,,PMID:21296659,https://www.ncbi.nlm.nih.gov/pubmed/21296659,21296659,,
5024,244779,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,51455,REV1,https://ctdbase.org/detail.go?type=gene&acc=51455,,,51455.0,REV1,9606.0,Homo sapiens (human),Fluorouracil affects the expression of REV1 mRNA,,,PMID:16584549,https://www.ncbi.nlm.nih.gov/pubmed/16584549,16584549,,
5025,244780,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5982,RFC2,https://ctdbase.org/detail.go?type=gene&acc=5982,,,5982.0,RFC2,9606.0,Homo sapiens (human),RFC2 protein affects the susceptibility to fluorouracil,,,PMID:15548681,https://www.ncbi.nlm.nih.gov/pubmed/15548681,15548681,,
5026,244781,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5983,RFC3,https://ctdbase.org/detail.go?type=gene&acc=5983,,,5983.0,RFC3,9606.0,Homo sapiens (human),RFC3 protein affects the susceptibility to fluorouracil,,,PMID:15548681,https://www.ncbi.nlm.nih.gov/pubmed/15548681,15548681,,
5027,244926,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5996,RGS1,https://ctdbase.org/detail.go?type=gene&acc=5996,,,5996.0,RGS1,9606.0,Homo sapiens (human),Fluorouracil affects the expression of RGS1 mRNA,,,PMID:15205334,https://www.ncbi.nlm.nih.gov/pubmed/15205334,15205334,,
5028,244927,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,6003,RGS13,https://ctdbase.org/detail.go?type=gene&acc=6003,,,6003.0,RGS13,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of RGS13 protein,,,PMID:16803524,https://www.ncbi.nlm.nih.gov/pubmed/16803524,16803524,,
5029,244928,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,6004,RGS16,https://ctdbase.org/detail.go?type=gene&acc=6004,,,6004.0,RGS16,9606.0,Homo sapiens (human),Fluorouracil affects the expression of RGS16 mRNA,,,PMID:15205334,https://www.ncbi.nlm.nih.gov/pubmed/15205334,15205334,,
5030,244929,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5997,RGS2,https://ctdbase.org/detail.go?type=gene&acc=5997,,,5997.0,RGS2,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of RGS2 mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
5031,244930,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5999,RGS4,https://ctdbase.org/detail.go?type=gene&acc=5999,,,5999.0,RGS4,9606.0,Homo sapiens (human),RGS4 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
5032,244931,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,8490,RGS5,https://ctdbase.org/detail.go?type=gene&acc=8490,,,8490.0,RGS5,10090.0,Mus musculus (house mouse),Fluorouracil results in decreased expression of RGS5 mrna|ifna1 protein promotes the reaction [fluorouracil results in decreased expression of RGS5 mrna],,,PMID:18157009,https://www.ncbi.nlm.nih.gov/pubmed/18157009,18157009,,
5033,244932,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,54933,RHBDL2,https://ctdbase.org/detail.go?type=gene&acc=54933,,,54933.0,RHBDL2,9606.0,Homo sapiens (human),RHBDL2 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
5034,244933,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,9606.0,Homo sapiens (human),RHOA protein results in decreased susceptibility to fluorouracil,,,PMID:15448013,https://www.ncbi.nlm.nih.gov/pubmed/15448013,15448013,,
5035,246398,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,22872,SEC31A,https://ctdbase.org/detail.go?type=gene&acc=22872,,,22872.0,SEC31A,9606.0,Homo sapiens (human),SEC31A protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
5036,246399,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,25956,SEC31B,https://ctdbase.org/detail.go?type=gene&acc=25956,,,25956.0,SEC31B,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of SEC31B mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
5037,246400,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,6414,SELENOP,https://ctdbase.org/detail.go?type=gene&acc=6414,,,6414.0,SELENOP,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of SELENOP mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
5038,246401,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10371,SEMA3A,https://ctdbase.org/detail.go?type=gene&acc=10371,,,10371.0,SEMA3A,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of SEMA3A mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
5039,246402,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,22929,SEPHS1,https://ctdbase.org/detail.go?type=gene&acc=22929,,,22929.0,SEPHS1,9606.0,Homo sapiens (human),SEPHS1 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
5040,246403,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,22928,SEPHS2,https://ctdbase.org/detail.go?type=gene&acc=22928,,,22928.0,SEPHS2,9606.0,Homo sapiens (human),SEPHS2 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
5041,246404,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10801,SEPTIN9,https://ctdbase.org/detail.go?type=gene&acc=10801,,,10801.0,SEPTIN9,10090.0,Mus musculus (house mouse),Fluorouracil affects the expression of SEPTIN9 mRNA,,,PMID:20421339,https://www.ncbi.nlm.nih.gov/pubmed/20421339,20421339,,
5042,246405,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,10169,SERF2,https://ctdbase.org/detail.go?type=gene&acc=10169,,,10169.0,SERF2,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of SERF2 mRNA,,,PMID:16510598,https://www.ncbi.nlm.nih.gov/pubmed/16510598,16510598,,
5043,246598,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5104,SERPINA5,https://ctdbase.org/detail.go?type=gene&acc=5104,,,5104.0,SERPINA5,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of SERPINA5 mRNA,,,PMID:17039268,https://www.ncbi.nlm.nih.gov/pubmed/17039268,17039268,,
5044,246599,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,6906,SERPINA7,https://ctdbase.org/detail.go?type=gene&acc=6906,,,6906.0,SERPINA7,9606.0,Homo sapiens (human),TP53 protein affects the reaction [fluorouracil results in decreased expression of SERPINA7 mrna],,,PMID:15016801,https://www.ncbi.nlm.nih.gov/pubmed/15016801,15016801,,
5045,246600,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5055,SERPINB2,https://ctdbase.org/detail.go?type=gene&acc=5055,,,5055.0,SERPINB2,9606.0,Homo sapiens (human),Fluorouracil results in increased expression of SERPINB2 mRNA,,,PMID:16709241,https://www.ncbi.nlm.nih.gov/pubmed/16709241,16709241,,
5046,246601,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,6318,SERPINB4,https://ctdbase.org/detail.go?type=gene&acc=6318,,,6318.0,SERPINB4,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of SERPINB4 protein,,,PMID:16803524,https://www.ncbi.nlm.nih.gov/pubmed/16803524,16803524,,
5047,246602,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,5268,SERPINB5,https://ctdbase.org/detail.go?type=gene&acc=5268,,,5268.0,SERPINB5,9606.0,Homo sapiens (human),[fluorouracil co-treated with irinotecan] results in decreased expression of SERPINB5 mRNA,,,PMID:16391804,https://www.ncbi.nlm.nih.gov/pubmed/16391804,16391804,,
5048,247572,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,144195,SLC2A14,https://ctdbase.org/detail.go?type=gene&acc=144195,,,144195.0,SLC2A14,9606.0,Homo sapiens (human),SLC2A14 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
5049,247573,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,10090.0,Mus musculus (house mouse),Fluorouracil promotes the reaction [SLC2A2 protein results in increased uptake of 3-O-methylglucose]|fluorouracil results in increased expression of SLC2A2 mrna|fluorouracil results in increased expression of SLC2A2 protein|phloretin inhibits the reaction [fluorouracil promotes the reaction [SLC2A2 protein results in increased uptake of 3-O-methylglucose]],,,PMID:15986457,https://www.ncbi.nlm.nih.gov/pubmed/15986457,15986457,,
5050,247574,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,6515,SLC2A3,https://ctdbase.org/detail.go?type=gene&acc=6515,,,6515.0,SLC2A3,9606.0,Homo sapiens (human),SLC2A3 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
5051,247575,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,80255,SLC35F5,https://ctdbase.org/detail.go?type=gene&acc=80255,,,80255.0,SLC35F5,9606.0,Homo sapiens (human),SLC35F5 protein affects the susceptibility to fluorouracil,,,PMID:16477629,https://www.ncbi.nlm.nih.gov/pubmed/16477629,16477629,,
5052,247576,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,6520,SLC3A2,https://ctdbase.org/detail.go?type=gene&acc=6520,,,6520.0,SLC3A2,9606.0,Homo sapiens (human),SLC3A2 protein affects the susceptibility to fluorouracil|fluorouracil results in increased expression of SLC3A2 mRNA,,,PMID:15331170,https://www.ncbi.nlm.nih.gov/pubmed/15331170,15331170,,
5053,247577,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244.0,SLC47A1,9606.0,Homo sapiens (human),SLC47A1 protein affects the susceptibility to fluorouracil,,,PMID:16217747,https://www.ncbi.nlm.nih.gov/pubmed/16217747,16217747,,
5054,247578,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,55652,SLC48A1,https://ctdbase.org/detail.go?type=gene&acc=55652,,,55652.0,SLC48A1,9606.0,Homo sapiens (human),Fluorouracil affects the expression of SLC48A1 mRNA,,,PMID:16584549,https://www.ncbi.nlm.nih.gov/pubmed/16584549,16584549,,
5055,247579,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,6523,SLC5A1,https://ctdbase.org/detail.go?type=gene&acc=6523,,,6523.0,SLC5A1,10090.0,Mus musculus (house mouse),Fluorouracil results in increased expression of SLC5A1 protein,,,PMID:15986457,https://www.ncbi.nlm.nih.gov/pubmed/15986457,15986457,,
5056,247580,3385,Comparative Toxicogenomics Database (CTD),Fluorouracil,D005472,Fluorouracil,https://ctdbase.org/detail.go?type=chem&acc=D005472,6550,SLC9A3,https://ctdbase.org/detail.go?type=gene&acc=6550,,,6550.0,SLC9A3,9606.0,Homo sapiens (human),Fluorouracil results in decreased expression of SLC9A3 mRNA,,,PMID:34151400,https://www.ncbi.nlm.nih.gov/pubmed/34151400,34151400,,
5057,356463,3393,DrugBank,Flurazepam,DB00690,Flurazepam,https://www.drugbank.ca/drugs/DB00690,BE0004797,Gamma-aminobutyric acid receptor subunit gamma-2,https://www.drugbank.ca/bio_entities/BE0004797,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
5058,356464,3393,DrugBank,Flurazepam,DB00690,Flurazepam,https://www.drugbank.ca/drugs/DB00690,BE0004797,Gamma-aminobutyric acid receptor subunit gamma-3,https://www.drugbank.ca/bio_entities/BE0004797,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,2567.0,GABRG3,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
5059,356465,3393,DrugBank,Flurazepam,DB00690,Flurazepam,https://www.drugbank.ca/drugs/DB00690,BE0004797,Gamma-aminobutyric acid receptor subunit pi,https://www.drugbank.ca/bio_entities/BE0004797,O00591,Gamma-aminobutyric acid receptor subunit pi,2568.0,GABRP,9606.0,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
5060,346276,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,10095,ARPC1B,https://ctdbase.org/detail.go?type=gene&acc=10095,,,10095.0,ARPC1B,7955.0,Danio rerio (zebrafish),Flutamide results in decreased expression of ARPC1B mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
5061,346277,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,81873,ARPC5L,https://ctdbase.org/detail.go?type=gene&acc=81873,,,81873.0,ARPC5L,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of ARPC5L mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5062,346278,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,348110,ARPIN,https://ctdbase.org/detail.go?type=gene&acc=348110,,,348110.0,ARPIN,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of ARPIN mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5063,346279,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,10776,ARPP19,https://ctdbase.org/detail.go?type=gene&acc=10776,,,10776.0,ARPP19,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of ARPP19 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5064,346280,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,92714,ARRDC1,https://ctdbase.org/detail.go?type=gene&acc=92714,,,92714.0,ARRDC1,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of ARRDC1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5065,346281,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,410,ARSA,https://ctdbase.org/detail.go?type=gene&acc=410,,,410.0,ARSA,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of ARSA mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5066,346897,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,9474,ATG5,https://ctdbase.org/detail.go?type=gene&acc=9474,,,9474.0,ATG5,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of ATG5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5067,346898,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,471,ATIC,https://ctdbase.org/detail.go?type=gene&acc=471,,,471.0,ATIC,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of ATIC mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5068,346899,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,471,ATIC,https://ctdbase.org/detail.go?type=gene&acc=471,,,471.0,ATIC,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of ATIC mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5069,346900,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,25923,ATL3,https://ctdbase.org/detail.go?type=gene&acc=25923,,,25923.0,ATL3,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of ATL3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5070,346901,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,84913,ATOH8,https://ctdbase.org/detail.go?type=gene&acc=84913,,,84913.0,ATOH8,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of ATOH8 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5071,348413,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,55973,BCAP29,https://ctdbase.org/detail.go?type=gene&acc=55973,,,55973.0,BCAP29,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of BCAP29 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5072,348414,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,10134,BCAP31,https://ctdbase.org/detail.go?type=gene&acc=10134,,,10134.0,BCAP31,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of BCAP31 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5073,348415,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,8412,BCAR3,https://ctdbase.org/detail.go?type=gene&acc=8412,,,8412.0,BCAR3,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of BCAR3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5074,348416,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,56647,BCCIP,https://ctdbase.org/detail.go?type=gene&acc=56647,,,56647.0,BCCIP,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of BCCIP mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5075,351722,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CD36 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5076,351723,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CD36 mRNA,,,PMID:21525395,https://www.ncbi.nlm.nih.gov/pubmed/21525395,21525395,,
5077,351724,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,952,CD38,https://ctdbase.org/detail.go?type=gene&acc=952,,,952.0,CD38,10090.0,Mus musculus (house mouse),Flutamide inhibits the reaction [CD38 gene mutant form results in increased expression of SLC8A1 mrna]|flutamide inhibits the reaction [CD38 gene mutant form results in increased expression of MYH6 mrna]|flutamide inhibits the reaction [CD38 gene mutant form results in decreased expression of MYH7 mrna]|flutamide inhibits the reaction [CD38 gene mutant form results in increased expression of RYR2 mrna]|flutamide inhibits the reaction [CD38 gene mutant form results in decreased expression of AR mrna],,,PMID:21840325,https://www.ncbi.nlm.nih.gov/pubmed/21840325,21840325,,
5078,351725,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,952,CD38,https://ctdbase.org/detail.go?type=gene&acc=952,,,952.0,CD38,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CD38 mRNA,,,PMID:15885261|PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/15885261|https://www.ncbi.nlm.nih.gov/pubmed/24136188,15885261|24136188,,
5079,351726,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,4179,CD46,https://ctdbase.org/detail.go?type=gene&acc=4179,,,4179.0,CD46,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CD46 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5080,351727,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,962,CD48,https://ctdbase.org/detail.go?type=gene&acc=962,,,962.0,CD48,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CD48 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5081,351728,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,1604,CD55,https://ctdbase.org/detail.go?type=gene&acc=1604,,,1604.0,CD55,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CD55 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5082,351729,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,966,CD59,https://ctdbase.org/detail.go?type=gene&acc=966,,,966.0,CD59,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CD59 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5083,351730,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,922,CD5L,https://ctdbase.org/detail.go?type=gene&acc=922,,,922.0,CD5L,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CD5L mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5084,351731,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,968,CD68,https://ctdbase.org/detail.go?type=gene&acc=968,,,968.0,CD68,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CD68 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5085,351900,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,968,CD68,https://ctdbase.org/detail.go?type=gene&acc=968,,,968.0,CD68,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CD68 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5086,351901,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,975,CD81,https://ctdbase.org/detail.go?type=gene&acc=975,,,975.0,CD81,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CD81 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5087,351902,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,3732,CD82,https://ctdbase.org/detail.go?type=gene&acc=3732,,,3732.0,CD82,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CD82 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5088,351903,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,942,CD86,https://ctdbase.org/detail.go?type=gene&acc=942,,,942.0,CD86,9606.0,Homo sapiens (human),Flutamide inhibits the reaction [[ethinyl estradiol co-treated with lipopolysaccharides] results in increased expression of CD86 protein],,,PMID:36113621,https://www.ncbi.nlm.nih.gov/pubmed/36113621,36113621,,
5089,351904,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,83692,CD99L2,https://ctdbase.org/detail.go?type=gene&acc=83692,,,83692.0,CD99L2,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CD99L2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5090,351905,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,81602,CDADC1,https://ctdbase.org/detail.go?type=gene&acc=81602,,,81602.0,CDADC1,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CDADC1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5091,351906,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,8872,CDC123,https://ctdbase.org/detail.go?type=gene&acc=8872,,,8872.0,CDC123,7955.0,Danio rerio (zebrafish),Flutamide results in increased expression of CDC123 mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
5092,351907,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,8872,CDC123,https://ctdbase.org/detail.go?type=gene&acc=8872,,,8872.0,CDC123,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CDC123 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5093,352096,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,79577,CDC73,https://ctdbase.org/detail.go?type=gene&acc=79577,,,79577.0,CDC73,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CDC73 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5094,352097,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,550236,CDCA7A,https://ctdbase.org/detail.go?type=gene&acc=550236,,,550236.0,cdca7a,7955.0,Danio rerio (zebrafish),Flutamide results in increased expression of CDCA7A mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
5095,352098,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,1012,CDH13,https://ctdbase.org/detail.go?type=gene&acc=1012,,,1012.0,CDH13,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CDH13 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5096,352457,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,91368,CDKN2AIPNL,https://ctdbase.org/detail.go?type=gene&acc=91368,,,91368.0,CDKN2AIPNL,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CDKN2AIPNL mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5097,352458,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,1031,CDKN2C,https://ctdbase.org/detail.go?type=gene&acc=1031,,,1031.0,CDKN2C,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CDKN2C mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5098,352459,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,1031,CDKN2C,https://ctdbase.org/detail.go?type=gene&acc=1031,,,1031.0,CDKN2C,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CDKN2C mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5099,352460,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,1036,CDO1,https://ctdbase.org/detail.go?type=gene&acc=1036,,,1036.0,CDO1,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CDO1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5100,352461,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,55573,CDV3,https://ctdbase.org/detail.go?type=gene&acc=55573,,,55573.0,CDV3,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CDV3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5101,352462,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,634,CEACAM1,https://ctdbase.org/detail.go?type=gene&acc=634,,,634.0,CEACAM1,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CEACAM1 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5102,352463,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,125931,CEACAM20,https://ctdbase.org/detail.go?type=gene&acc=125931,,,125931.0,CEACAM20,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CEACAM20 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5103,352464,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,10153,CEBPZ,https://ctdbase.org/detail.go?type=gene&acc=10153,,,10153.0,CEBPZ,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CEBPZ mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5104,352465,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,1990,CELA1,https://ctdbase.org/detail.go?type=gene&acc=1990,,,1990.0,CELA1,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CELA1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5105,353521,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,1182,CLCN3,https://ctdbase.org/detail.go?type=gene&acc=1182,,,1182.0,CLCN3,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of CLCN3 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5106,353522,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,1182,CLCN3,https://ctdbase.org/detail.go?type=gene&acc=1182,,,1182.0,CLCN3,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of CLCN3 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5107,354980,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,84274,COQ5,https://ctdbase.org/detail.go?type=gene&acc=84274,,,84274.0,COQ5,7955.0,Danio rerio (zebrafish),Flutamide results in decreased expression of COQ5 mRNA,,,PMID:21126777,https://www.ncbi.nlm.nih.gov/pubmed/21126777,21126777,,
5108,354981,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,84274,COQ5,https://ctdbase.org/detail.go?type=gene&acc=84274,,,84274.0,COQ5,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of COQ5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5109,354982,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,51004,COQ6,https://ctdbase.org/detail.go?type=gene&acc=51004,,,51004.0,COQ6,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of COQ6 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5110,354983,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,10229,COQ7,https://ctdbase.org/detail.go?type=gene&acc=10229,,,10229.0,COQ7,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of COQ7 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5111,354984,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,56997,COQ8A,https://ctdbase.org/detail.go?type=gene&acc=56997,,,56997.0,COQ8A,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of COQ8A mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5112,354985,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,79934,COQ8B,https://ctdbase.org/detail.go?type=gene&acc=79934,,,79934.0,COQ8B,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of COQ8B mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5113,354986,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,1355,COX15,https://ctdbase.org/detail.go?type=gene&acc=1355,,,1355.0,COX15,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of COX15 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5114,354987,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,10063,COX17,https://ctdbase.org/detail.go?type=gene&acc=10063,,,10063.0,COX17,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of COX17 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5115,354988,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,285521,COX18,https://ctdbase.org/detail.go?type=gene&acc=285521,,,285521.0,COX18,10090.0,Mus musculus (house mouse),Flutamide results in increased expression of COX18 mRNA,,,PMID:17702527,https://www.ncbi.nlm.nih.gov/pubmed/17702527,17702527,,
5116,358438,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,51164,DCTN4,https://ctdbase.org/detail.go?type=gene&acc=51164,,,51164.0,DCTN4,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of DCTN4 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5117,358439,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,84516,DCTN5,https://ctdbase.org/detail.go?type=gene&acc=84516,,,84516.0,DCTN5,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of DCTN5 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5118,358440,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,10671,DCTN6,https://ctdbase.org/detail.go?type=gene&acc=10671,,,10671.0,DCTN6,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of DCTN6 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5119,359385,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,51029,DESI2,https://ctdbase.org/detail.go?type=gene&acc=51029,,,51029.0,DESI2,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of DESI2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5120,359386,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,28955,DEXI,https://ctdbase.org/detail.go?type=gene&acc=28955,,,28955.0,DEXI,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of DEXI mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5121,359387,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,84649,DGAT2,https://ctdbase.org/detail.go?type=gene&acc=84649,,,84649.0,DGAT2,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of DGAT2 mRNA,,,PMID:21525395|PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/21525395|https://www.ncbi.nlm.nih.gov/pubmed/24793618,21525395|24793618,,
5122,359388,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,54487,DGCR8,https://ctdbase.org/detail.go?type=gene&acc=54487,,,54487.0,DGCR8,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of DGCR8 mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5123,359389,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,8525,DGKZ,https://ctdbase.org/detail.go?type=gene&acc=8525,,,8525.0,DGKZ,10116.0,Rattus norvegicus (Norway rat),Flutamide results in decreased expression of DGKZ mRNA,,,PMID:24793618,https://www.ncbi.nlm.nih.gov/pubmed/24793618,24793618,,
5124,359390,3397,Comparative Toxicogenomics Database (CTD),Flutamide,D005485,Flutamide,https://ctdbase.org/detail.go?type=chem&acc=D005485,1717,DHCR7,https://ctdbase.org/detail.go?type=gene&acc=1717,,,1717.0,DHCR7,10116.0,Rattus norvegicus (Norway rat),Flutamide results in increased expression of DHCR7 mRNA,,,PMID:19299419|PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/19299419|https://www.ncbi.nlm.nih.gov/pubmed/24136188,19299419|24136188,,
5125,359579,3446,Drug Gene Interaction database (DGIdb),Gabapentin,,GABAPENTIN,https://www.dgidb.org/drugs/rxcui:25480,,CACNA1H,https://www.dgidb.org/genes/hgnc:1395,,,8912.0,CACNA1H,9606.0,Homo sapiens (human),Modulator,,,,,,,
5126,359580,3446,Drug Gene Interaction database (DGIdb),Gabapentin,,GABAPENTIN,https://www.dgidb.org/drugs/rxcui:25480,,CACNA2D2,https://www.dgidb.org/genes/hgnc:1400,,,9254.0,CACNA2D2,9606.0,Homo sapiens (human),Modulator,,,,,,,
5127,340648,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,100996939,PYURF,https://ctdbase.org/detail.go?type=gene&acc=100996939,,,100996939.0,PYURF,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of PYURF mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5128,340649,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,5858,PZP,https://ctdbase.org/detail.go?type=gene&acc=5858,,,5858.0,PZP,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of PZP mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
5129,340650,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,5858,PZP,https://ctdbase.org/detail.go?type=gene&acc=5858,,,5858.0,PZP,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of PZP mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5130,340651,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,5860,QDPR,https://ctdbase.org/detail.go?type=gene&acc=5860,,,5860.0,QDPR,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of QDPR mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5131,340652,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,54814,QPCTL,https://ctdbase.org/detail.go?type=gene&acc=54814,,,54814.0,QPCTL,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of QPCTL mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5132,340653,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,79832,QSER1,https://ctdbase.org/detail.go?type=gene&acc=79832,,,79832.0,QSER1,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of QSER1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5133,340654,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,169714,QSOX2,https://ctdbase.org/detail.go?type=gene&acc=169714,,,169714.0,QSOX2,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of QSOX2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5134,341951,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,5892,RAD51D,https://ctdbase.org/detail.go?type=gene&acc=5892,,,5892.0,RAD51D,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of RAD51D mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5135,342860,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,10741,RBBP9,https://ctdbase.org/detail.go?type=gene&acc=10741,,,10741.0,RBBP9,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of RBBP9 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5136,344991,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,23221,RHOBTB2,https://ctdbase.org/detail.go?type=gene&acc=23221,,,23221.0,RHOBTB2,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of RHOBTB2 mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
5137,344992,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,22836,RHOBTB3,https://ctdbase.org/detail.go?type=gene&acc=22836,,,22836.0,RHOBTB3,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of RHOBTB3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5138,344993,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,54509,RHOF,https://ctdbase.org/detail.go?type=gene&acc=54509,,,54509.0,RHOF,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of RHOF mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5139,344994,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,391,RHOG,https://ctdbase.org/detail.go?type=gene&acc=391,,,391.0,RHOG,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of RHOG mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5140,344995,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,391,RHOG,https://ctdbase.org/detail.go?type=gene&acc=391,,,391.0,RHOG,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of RHOG mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
5141,344996,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,399,RHOH,https://ctdbase.org/detail.go?type=gene&acc=399,,,399.0,RHOH,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of RHOH mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
5142,344997,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,57381,RHOJ,https://ctdbase.org/detail.go?type=gene&acc=57381,,,57381.0,RHOJ,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of RHOJ mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5143,344998,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,23433,RHOQ,https://ctdbase.org/detail.go?type=gene&acc=23433,,,23433.0,RHOQ,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of RHOQ mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5144,344999,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,55288,RHOT1,https://ctdbase.org/detail.go?type=gene&acc=55288,,,55288.0,RHOT1,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of RHOT1 mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
5145,358743,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,7869,SEMA3B,https://ctdbase.org/detail.go?type=gene&acc=7869,,,7869.0,SEMA3B,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of SEMA3B mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5146,358744,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,10512,SEMA3C,https://ctdbase.org/detail.go?type=gene&acc=10512,,,10512.0,SEMA3C,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of SEMA3C mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5147,358745,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,9723,SEMA3E,https://ctdbase.org/detail.go?type=gene&acc=9723,,,9723.0,SEMA3E,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of SEMA3E mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5148,358746,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,6405,SEMA3F,https://ctdbase.org/detail.go?type=gene&acc=6405,,,6405.0,SEMA3F,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of SEMA3F mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5149,358747,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,56920,SEMA3G,https://ctdbase.org/detail.go?type=gene&acc=56920,,,56920.0,SEMA3G,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of SEMA3G mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5150,358748,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,64218,SEMA4A,https://ctdbase.org/detail.go?type=gene&acc=64218,,,64218.0,SEMA4A,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of SEMA4A mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5151,358749,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,64218,SEMA4A,https://ctdbase.org/detail.go?type=gene&acc=64218,,,64218.0,SEMA4A,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of SEMA4A mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
5152,358750,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,54910,SEMA4C,https://ctdbase.org/detail.go?type=gene&acc=54910,,,54910.0,SEMA4C,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of SEMA4C mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5153,358751,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,10507,SEMA4D,https://ctdbase.org/detail.go?type=gene&acc=10507,,,10507.0,SEMA4D,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of SEMA4D mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5154,358921,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,10507,SEMA4D,https://ctdbase.org/detail.go?type=gene&acc=10507,,,10507.0,SEMA4D,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of SEMA4D mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
5155,360018,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,9814,SFI1,https://ctdbase.org/detail.go?type=gene&acc=9814,,,9814.0,SFI1,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of SFI1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5156,360019,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,57713,SFMBT2,https://ctdbase.org/detail.go?type=gene&acc=57713,,,57713.0,SFMBT2,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of SFMBT2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5157,360020,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,6421,SFPQ,https://ctdbase.org/detail.go?type=gene&acc=6421,,,6421.0,SFPQ,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of SFPQ mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
5158,360021,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,119392,SFR1,https://ctdbase.org/detail.go?type=gene&acc=119392,,,119392.0,SFR1,10116.0,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of SFR1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5159,349635,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,23621,BACE1,https://ctdbase.org/detail.go?type=gene&acc=23621,,,23621.0,BACE1,9606.0,Homo sapiens (human),"Go 6976 inhibits the reaction [phorbol 12,13-dibutyrate affects the localization of BACE1 protein]",,,PMID:19476501,https://www.ncbi.nlm.nih.gov/pubmed/19476501,19476501,,
5160,349636,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,7832,BTG2,https://ctdbase.org/detail.go?type=gene&acc=7832,,,7832.0,BTG2,9606.0,Homo sapiens (human),[tetradecanoylphorbol acetate co-treated with go 6976] results in increased expression of BTG2 mRNA,,,PMID:15302583,https://www.ncbi.nlm.nih.gov/pubmed/15302583,15302583,,
5161,349637,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Go 6976 inhibits the reaction [ethanol results in increased cleavage of and results in increased activity of CASP3 protein],,,PMID:22497828,https://www.ncbi.nlm.nih.gov/pubmed/22497828,22497828,,
5162,349638,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,29158.0,Mytilus galloprovincialis (Mediterranean mussel),Go 6976 inhibits the reaction [cadmium chloride results in increased expression of CAT mrna],,,PMID:24316436,https://www.ncbi.nlm.nih.gov/pubmed/24316436,24316436,,
5163,349639,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606.0,Homo sapiens (human),Go 6976 inhibits the reaction [doxorubicin results in increased expression of CCNB1 protein],,,PMID:17320279,https://www.ncbi.nlm.nih.gov/pubmed/17320279,17320279,,
5164,349640,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,995,CDC25C,https://ctdbase.org/detail.go?type=gene&acc=995,,,995.0,CDC25C,9606.0,Homo sapiens (human),Go 6976 inhibits the reaction [xanthatin results in decreased stability of CDC25C protein],,,PMID:29074359,https://www.ncbi.nlm.nih.gov/pubmed/29074359,29074359,,
5165,349641,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,10116.0,Rattus norvegicus (Norway rat),Go 6976 inhibits the reaction [4-cresol affects the localization of CDH2 protein]|go 6976 inhibits the reaction [4-cresol inhibits the reaction [CTNND1 protein binds to CDH2 protein]],,,PMID:23466501,https://www.ncbi.nlm.nih.gov/pubmed/23466501,23466501,,
5166,349642,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),Go 6976 results in decreased phosphorylation of and results in increased activity of CDK1 protein|go 6976 inhibits the reaction [doxorubicin results in increased phosphorylation of and results in decreased activity of CDK1 protein],,,PMID:17320279,https://www.ncbi.nlm.nih.gov/pubmed/17320279,17320279,,
5167,350936,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116.0,Rattus norvegicus (Norway rat),Go 6976 inhibits the reaction [NGF protein results in increased expression of SERPINE1 protein]|go 6976 inhibits the reaction [NGF protein results in increased expression of SERPINE1 mrna],,,PMID:23825664,https://www.ncbi.nlm.nih.gov/pubmed/23825664,23825664,,
5168,350937,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,6464,SHC1,https://ctdbase.org/detail.go?type=gene&acc=6464,,,6464.0,SHC1,10116.0,Rattus norvegicus (Norway rat),Go 6976 inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of SHC1 protein alternative form],,,PMID:19168439,https://www.ncbi.nlm.nih.gov/pubmed/19168439,19168439,,
5169,350938,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606.0,Homo sapiens (human),Go 6976 inhibits the reaction [N-methylaspartate results in decreased expression of and results in decreased activity of SIRT1 protein]|go 6976 inhibits the reaction [N-methylaspartate results in decreased expression of SIRT1 mrna],,,PMID:31945382,https://www.ncbi.nlm.nih.gov/pubmed/31945382,31945382,,
5170,350939,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606.0,Homo sapiens (human),Go 6976 inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of SOD2 protein]|go 6976 inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of SOD2 mrna],,,PMID:21705328,https://www.ncbi.nlm.nih.gov/pubmed/21705328,21705328,,
5171,350940,3501,Comparative Toxicogenomics Database (CTD),Go-6976,C081021,Go 6976,https://ctdbase.org/detail.go?type=chem&acc=C081021,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606.0,Homo sapiens (human),Go 6976 inhibits the reaction [IL1B protein results in increased phosphorylation of SRC protein],,,PMID:19281832,https://www.ncbi.nlm.nih.gov/pubmed/19281832,19281832,,
5172,359231,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606.0,Homo sapiens (human),Heptachlor results in increased expression of ACTA2 protein|heptachlor results in increased expression of ACTA2 mRNA,,,PMID:30719927,https://www.ncbi.nlm.nih.gov/pubmed/30719927,30719927,,
5173,359232,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,211,ALAS1,https://ctdbase.org/detail.go?type=gene&acc=211,,,211.0,ALAS1,9031.0,Gallus gallus (chicken),Cycloheximide inhibits the reaction [heptachlor results in increased activity of ALAS1 protein]|hemin inhibits the reaction [heptachlor results in increased activity of ALAS1 protein]|heptachlor results in increased activity of ALAS1 protein|dactinomycin inhibits the reaction [heptachlor results in increased activity of ALAS1 protein],,,PMID:9879810,https://www.ncbi.nlm.nih.gov/pubmed/9879810,9879810,,
5174,359233,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,9606.0,Homo sapiens (human),Heptachlor results in decreased expression of ALB mRNA,,,PMID:22902829,https://www.ncbi.nlm.nih.gov/pubmed/22902829,22902829,,
5175,359234,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,214,ALCAM,https://ctdbase.org/detail.go?type=gene&acc=214,,,214.0,ALCAM,10116.0,Rattus norvegicus (Norway rat),Heptachlor results in decreased expression of ALCAM mRNA,,,PMID:23153324,https://www.ncbi.nlm.nih.gov/pubmed/23153324,23153324,,
5176,359235,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,282679,AQP11,https://ctdbase.org/detail.go?type=gene&acc=282679,,,282679.0,AQP11,10116.0,Rattus norvegicus (Norway rat),Heptachlor results in decreased expression of AQP11 mRNA,,,PMID:23153324,https://www.ncbi.nlm.nih.gov/pubmed/23153324,23153324,,
5177,359236,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,366,AQP9,https://ctdbase.org/detail.go?type=gene&acc=366,,,366.0,AQP9,10116.0,Rattus norvegicus (Norway rat),Heptachlor results in decreased expression of AQP9 mRNA,,,PMID:23153324,https://www.ncbi.nlm.nih.gov/pubmed/23153324,23153324,,
5178,359237,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),Heptachlor inhibits the reaction [dihydrotestosterone results in increased activity of AR protein],,,PMID:26022396,https://www.ncbi.nlm.nih.gov/pubmed/26022396,26022396,,
5179,359238,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,10116.0,Rattus norvegicus (Norway rat),Heptachlor binds to AR protein,,,PMID:14565775,https://www.ncbi.nlm.nih.gov/pubmed/14565775,14565775,,
5180,359882,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Heptachlor results in increased activity of ESR1 protein,,,PMID:26022396|PMID:26139245,https://www.ncbi.nlm.nih.gov/pubmed/26022396|https://www.ncbi.nlm.nih.gov/pubmed/26139245,26022396|26139245,,
5181,359883,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,8127.0,Oreochromis mossambicus (Mozambique tilapia),Heptachlor results in increased expression of ESR1 mRNA,,,PMID:19101654,https://www.ncbi.nlm.nih.gov/pubmed/19101654,19101654,,
5182,359884,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116.0,Rattus norvegicus (Norway rat),Heptachlor inhibits the reaction [estradiol results in increased activity of ESR1 protein],,,PMID:28531659,https://www.ncbi.nlm.nih.gov/pubmed/28531659,28531659,,
5183,359885,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10116.0,Rattus norvegicus (Norway rat),Heptachlor results in increased expression of ESR1,,,PMID:27240701,https://www.ncbi.nlm.nih.gov/pubmed/27240701,27240701,,
5184,359886,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Heptachlor results in increased activity of ESR2 protein,,,PMID:15064155|PMID:26139245,https://www.ncbi.nlm.nih.gov/pubmed/15064155|https://www.ncbi.nlm.nih.gov/pubmed/26139245,15064155|26139245,,
5185,359887,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,8127.0,Oreochromis mossambicus (Mozambique tilapia),Heptachlor results in increased expression of ESR2 mRNA,,,PMID:19101654,https://www.ncbi.nlm.nih.gov/pubmed/19101654,19101654,,
5186,359888,3589,Comparative Toxicogenomics Database (CTD),Heptachlor,D006533,Heptachlor,https://ctdbase.org/detail.go?type=chem&acc=D006533,10640,EXOC5,https://ctdbase.org/detail.go?type=gene&acc=10640,,,10640.0,EXOC5,9606.0,Homo sapiens (human),[insecticides results in increased abundance of heptachlor] which affects the methylation of EXOC5 gene,,,PMID:34516295,https://www.ncbi.nlm.nih.gov/pubmed/34516295,34516295,,
5187,294401,3608,Comparative Toxicogenomics Database (CTD),Hexobarbital,D006591,Hexobarbital,https://ctdbase.org/detail.go?type=chem&acc=D006591,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),CYP2C19 protein results in increased metabolism of hexobarbital,,,PMID:12464242,https://www.ncbi.nlm.nih.gov/pubmed/12464242,12464242,,
5188,294402,3608,Comparative Toxicogenomics Database (CTD),Hexobarbital,D006591,Hexobarbital,https://ctdbase.org/detail.go?type=chem&acc=D006591,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Hexobarbital inhibits the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin],,,PMID:19299527,https://www.ncbi.nlm.nih.gov/pubmed/19299527,19299527,,
5189,294403,3608,Comparative Toxicogenomics Database (CTD),Hexobarbital,D006591,Hexobarbital,https://ctdbase.org/detail.go?type=chem&acc=D006591,2566,GABRG2,https://ctdbase.org/detail.go?type=gene&acc=2566,,,2566.0,GABRG2,10116.0,Rattus norvegicus (Norway rat),Hexobarbital affects the expression of GABRG2 mRNA,,,PMID:9336343,https://www.ncbi.nlm.nih.gov/pubmed/9336343,9336343,,
5190,294404,3610,Comparative Toxicogenomics Database (CTD),Hexylresorcinol,D006604,Hexylresorcinol,https://ctdbase.org/detail.go?type=chem&acc=D006604,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),Hexylresorcinol inhibits the reaction [metribolone results in increased activity of AR protein],,,PMID:18324785,https://www.ncbi.nlm.nih.gov/pubmed/18324785,18324785,,
5191,294405,3610,Comparative Toxicogenomics Database (CTD),Hexylresorcinol,D006604,Hexylresorcinol,https://ctdbase.org/detail.go?type=chem&acc=D006604,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Hexylresorcinol results in decreased activity of CAT protein,,,PMID:12797471,https://www.ncbi.nlm.nih.gov/pubmed/12797471,12797471,,
5192,294406,3610,Comparative Toxicogenomics Database (CTD),Hexylresorcinol,D006604,Hexylresorcinol,https://ctdbase.org/detail.go?type=chem&acc=D006604,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Hexylresorcinol results in increased activity of ESR1 protein,,,PMID:19063592,https://www.ncbi.nlm.nih.gov/pubmed/19063592,19063592,,
5193,294407,3610,Comparative Toxicogenomics Database (CTD),Hexylresorcinol,D006604,Hexylresorcinol,https://ctdbase.org/detail.go?type=chem&acc=D006604,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),Hexylresorcinol results in increased activity of GSR protein,,,PMID:12797471,https://www.ncbi.nlm.nih.gov/pubmed/12797471,12797471,,
5194,294408,3610,Comparative Toxicogenomics Database (CTD),Hexylresorcinol,D006604,Hexylresorcinol,https://ctdbase.org/detail.go?type=chem&acc=D006604,7052,TGM2,https://ctdbase.org/detail.go?type=gene&acc=7052,,,7052.0,TGM2,9606.0,Homo sapiens (human),[hexylresorcinol results in decreased activity of TGM2 protein] which results in increased susceptibility to cisplatin|hexylresorcinol results in decreased activity of and affects the localization of TGM2 protein,,,PMID:21424127,https://www.ncbi.nlm.nih.gov/pubmed/21424127,21424127,,
5195,248576,3611,Drug Gene Interaction database (DGIdb),Hinokitiol,,HINOKITIOL,https://www.dgidb.org/drugs/chembl:CHEMBL48310,,HDAC11,https://www.dgidb.org/genes/hgnc:19086,,,79885.0,HDAC11,9606.0,Homo sapiens (human),,,,,,,,
5196,248577,3611,Drug Gene Interaction database (DGIdb),Hinokitiol,,HINOKITIOL,https://www.dgidb.org/drugs/chembl:CHEMBL48310,,HDAC5,https://www.dgidb.org/genes/hgnc:14068,,,10014.0,HDAC5,9606.0,Homo sapiens (human),,,,,,,,
5197,248748,3611,Drug Gene Interaction database (DGIdb),Hinokitiol,,HINOKITIOL,https://www.dgidb.org/drugs/chembl:CHEMBL48310,,BAZ2B,https://www.dgidb.org/genes/hgnc:963,,,29994.0,BAZ2B,9606.0,Homo sapiens (human),,,,,,,,
5198,248749,3634,Drug Gene Interaction database (DGIdb),Hycanthone,,HYCANTHONE,https://www.dgidb.org/drugs/ncit:C550,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606.0,Homo sapiens (human),,,,,,,,
5199,248750,3634,Drug Gene Interaction database (DGIdb),Hycanthone,,HYCANTHONE,https://www.dgidb.org/drugs/ncit:C550,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606.0,Homo sapiens (human),,,,,,,,
5200,248751,3655,Therapeutic Target Database (TTD),Velnacrine,D0L8QQ,VELNACRINE,https://idrblab.net/ttd/data/drug/details/D0L8QQ,T30082,Acetylcholinesterase (AChE),https://idrblab.net/ttd/data/target/details/T30082,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5201,248752,3676,DrugBank,Lidocaine,DB00281,Lidocaine,https://www.drugbank.ca/drugs/DB00281,BE0000177,Sodium channel protein type 10 subunit alpha,https://www.drugbank.ca/bio_entities/BE0000177,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,6336.0,SCN10A,9606.0,Homo sapiens (human),Inhibitor,,,PMID:17077153|PMID:19088384|PMID:20585544,https://www.ncbi.nlm.nih.gov/pubmed/17077153|https://www.ncbi.nlm.nih.gov/pubmed/19088384|https://www.ncbi.nlm.nih.gov/pubmed/20585544,17077153|19088384|20585544,,
5202,248753,3676,DrugBank,Lidocaine,DB00281,Lidocaine,https://www.drugbank.ca/drugs/DB00281,BE0001143,Sodium channel protein type 9 subunit alpha,https://www.drugbank.ca/bio_entities/BE0001143,Q15858,Sodium channel protein type 9 subunit alpha,6335.0,SCN9A,9606.0,Homo sapiens (human),Inhibitor,,,PMID:17430993|PMID:19088384|PMID:20585544,https://www.ncbi.nlm.nih.gov/pubmed/17430993|https://www.ncbi.nlm.nih.gov/pubmed/19088384|https://www.ncbi.nlm.nih.gov/pubmed/20585544,17430993|19088384|20585544,,
5203,248754,3676,DrugBank,Lidocaine,DB00281,Lidocaine,https://www.drugbank.ca/drugs/DB00281,BE0000197,Sodium channel protein type 5 subunit alpha,https://www.drugbank.ca/bio_entities/BE0000197,Q14524,Sodium channel protein type 5 subunit alpha,6331.0,SCN5A,9606.0,Homo sapiens (human),Inhibitor,,,PMID:17445919|PMID:16686685|PMID:17016511|PMID:16840798|PMID:19088384|PMID:20585544,https://www.ncbi.nlm.nih.gov/pubmed/17445919|https://www.ncbi.nlm.nih.gov/pubmed/16686685|https://www.ncbi.nlm.nih.gov/pubmed/17016511|https://www.ncbi.nlm.nih.gov/pubmed/16840798|https://www.ncbi.nlm.nih.gov/pubmed/19088384|https://www.ncbi.nlm.nih.gov/pubmed/20585544,17445919|16686685|17016511|16840798|19088384|20585544,,
5204,297079,3707,Comparative Toxicogenomics Database (CTD),Indirubin-3'-monoxime,C474021,indirubin-3'-monoxime,https://ctdbase.org/detail.go?type=chem&acc=C474021,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Indirubin-3'-monoxime results in decreased expression of BAX mRNA,,,PMID:18958680,https://www.ncbi.nlm.nih.gov/pubmed/18958680,18958680,,
5205,297080,3707,Comparative Toxicogenomics Database (CTD),Indirubin-3'-monoxime,C474021,indirubin-3'-monoxime,https://ctdbase.org/detail.go?type=chem&acc=C474021,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),[indirubin-3'-monoxime co-treated with tetradecanoylphorbol acetate] results in increased expression of BCL2L1 mRNA,,,PMID:18958680,https://www.ncbi.nlm.nih.gov/pubmed/18958680,18958680,,
5206,297427,3707,Comparative Toxicogenomics Database (CTD),Indirubin-3'-monoxime,C474021,indirubin-3'-monoxime,https://ctdbase.org/detail.go?type=chem&acc=C474021,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),Indirubin-3'-monoxime results in increased expression of CYP1A1 protein,,,PMID:21948866,https://www.ncbi.nlm.nih.gov/pubmed/21948866,21948866,,
5207,297428,3707,Comparative Toxicogenomics Database (CTD),Indirubin-3'-monoxime,C474021,indirubin-3'-monoxime,https://ctdbase.org/detail.go?type=chem&acc=C474021,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116.0,Rattus norvegicus (Norway rat),Indirubin-3'-monoxime results in increased expression of CYP1A1 mRNA,,,PMID:15001395,https://www.ncbi.nlm.nih.gov/pubmed/15001395,15001395,,
5208,297429,3707,Comparative Toxicogenomics Database (CTD),Indirubin-3'-monoxime,C474021,indirubin-3'-monoxime,https://ctdbase.org/detail.go?type=chem&acc=C474021,2053,EPHX2,https://ctdbase.org/detail.go?type=gene&acc=2053,,,2053.0,EPHX2,9606.0,Homo sapiens (human),Indirubin-3'-monoxime results in decreased expression of EPHX2 mRNA,,,PMID:18958680,https://www.ncbi.nlm.nih.gov/pubmed/18958680,18958680,,
5209,304490,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,1153,CIRBP,https://ctdbase.org/detail.go?type=gene&acc=1153,,,1153.0,CIRBP,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CIRBP mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
5210,304491,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,1154,CISH,https://ctdbase.org/detail.go?type=gene&acc=1154,,,1154.0,CISH,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of CISH mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
5211,304492,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,10970,CKAP4,https://ctdbase.org/detail.go?type=gene&acc=10970,,,10970.0,CKAP4,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of CKAP4 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
5212,304493,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,23155,CLCC1,https://ctdbase.org/detail.go?type=gene&acc=23155,,,23155.0,CLCC1,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CLCC1 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
5213,304494,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,9076,CLDN1,https://ctdbase.org/detail.go?type=gene&acc=9076,,,9076.0,CLDN1,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CLDN1 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
5214,304495,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,9076,CLDN1,https://ctdbase.org/detail.go?type=gene&acc=9076,,,9076.0,CLDN1,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of CLDN1 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
5215,304496,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,51208,CLDN18,https://ctdbase.org/detail.go?type=gene&acc=51208,,,51208.0,CLDN18,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol promotes the reaction [bisphenol A results in increased expression of CLDN18 mrna],,,PMID:27178563,https://www.ncbi.nlm.nih.gov/pubmed/27178563,27178563,,
5216,304497,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,10462,CLEC10A,https://ctdbase.org/detail.go?type=gene&acc=10462,,,10462.0,CLEC10A,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CLEC10A mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
5217,304498,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,70809,CLEC2G,https://ctdbase.org/detail.go?type=gene&acc=70809,,,70809.0,Clec2g,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol promotes the reaction [bisphenol A results in decreased expression of CLEC2G mrna],,,PMID:27178563,https://www.ncbi.nlm.nih.gov/pubmed/27178563,27178563,,
5218,304670,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,339390,CLEC4G,https://ctdbase.org/detail.go?type=gene&acc=339390,,,339390.0,CLEC4G,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CLEC4G mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
5219,304671,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,283420,CLEC9A,https://ctdbase.org/detail.go?type=gene&acc=283420,,,283420.0,CLEC9A,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of CLEC9A mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
5220,304672,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,171425,CLYBL,https://ctdbase.org/detail.go?type=gene&acc=171425,,,171425.0,CLYBL,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of CLYBL mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
5221,304673,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,1215,CMA1,https://ctdbase.org/detail.go?type=gene&acc=1215,,,1215.0,CMA1,10116.0,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of CMA1 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
5222,304674,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,7373,COL14A1,https://ctdbase.org/detail.go?type=gene&acc=7373,,,7373.0,COL14A1,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of COL14A1 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
5223,304675,3712,Comparative Toxicogenomics Database (CTD),Indole-3-carbinol,C016517,indole-3-carbinol,https://ctdbase.org/detail.go?type=chem&acc=C016517,1277,COL1A1,https://ctdbase.org/detail.go?type=gene&acc=1277,,,1277.0,COL1A1,10116.0,Rattus norvegicus (Norway rat),Indole-3-carbinol affects the expression of COL1A1 mRNA,,,PMID:21396975,https://www.ncbi.nlm.nih.gov/pubmed/21396975,21396975,,
5224,296271,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,147685,C19ORF18,https://ctdbase.org/detail.go?type=gene&acc=147685,,,147685.0,C19orf18,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of C19ORF18 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5225,298726,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Indomethacin results in increased expression of CASP3 protein|ranitidine inhibits the reaction [indomethacin results in increased expression of CASP3 protein]|silymarin inhibits the reaction [indomethacin results in increased expression of CASP3 protein],,,PMID:28648817,https://www.ncbi.nlm.nih.gov/pubmed/28648817,28648817,,
5226,298727,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Rebamipide inhibits the reaction [indomethacin results in increased activity of CASP3 protein],,,PMID:16184425,https://www.ncbi.nlm.nih.gov/pubmed/16184425,16184425,,
5227,298728,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Sulglicotide inhibits the reaction [indomethacin results in increased activity of CASP3 protein],,,PMID:17657623,https://www.ncbi.nlm.nih.gov/pubmed/17657623,17657623,,
5228,298729,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,140621,CASP3A,https://ctdbase.org/detail.go?type=gene&acc=140621,,,140621.0,casp3a,90988.0,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of CASP3A mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
5229,298730,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,839,CASP6,https://ctdbase.org/detail.go?type=gene&acc=839,,,839.0,CASP6,9606.0,Homo sapiens (human),"Pyrazolanthrone inhibits the reaction [indomethacin results in increased activity of CASP6 protein]|u 0126 inhibits the reaction [indomethacin results in increased activity of CASP6 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [indomethacin results in increased activity of CASP6 protein]|anisomycin promotes the reaction [indomethacin results in increased activity of CASP6 protein]|indomethacin results in increased activity of CASP6 protein|sb 203580 inhibits the reaction [indomethacin results in increased activity of CASP6 protein]|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [indomethacin results in increased activity of CASP6 protein]",,,PMID:17341418,https://www.ncbi.nlm.nih.gov/pubmed/17341418,17341418,,
5230,298731,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,839,CASP6,https://ctdbase.org/detail.go?type=gene&acc=839,,,839.0,CASP6,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of CASP6 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5231,298732,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of CASP7 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5232,298733,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,9606.0,Homo sapiens (human),Indomethacin results in increased cleavage of and results in increased activity of CASP8 protein|[indomethacin results in increased activity of CASP8 protein] which results in increased susceptibility to doxorubicin,,,PMID:15812552,https://www.ncbi.nlm.nih.gov/pubmed/15812552,15812552,,
5233,300958,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),Zinc protoporphyrin promotes the reaction [indomethacin results in increased expression of CCL2 mrna]|cobaltiprotoporphyrin inhibits the reaction [indomethacin results in increased expression of CCL2 mrna]|gallic acid analog inhibits the reaction [indomethacin results in increased expression of CCL2 mrna],,,PMID:23892052,https://www.ncbi.nlm.nih.gov/pubmed/23892052,23892052,,
5234,300959,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,793969,CCSER2A,https://ctdbase.org/detail.go?type=gene&acc=793969,,,793969.0,ccser2a,90988.0,Pimephales promelas (fathead minnow),Indomethacin results in decreased expression of CCSER2A mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
5235,300960,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,401541,CENPP,https://ctdbase.org/detail.go?type=gene&acc=401541,,,401541.0,CENPP,90988.0,Pimephales promelas (fathead minnow),Indomethacin results in decreased expression of CENPP mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
5236,300961,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),Indomethacin promotes the reaction [morin inhibits the reaction [freund's adjuvant results in increased expression of CCL2 protein]]|morin promotes the reaction [indomethacin inhibits the reaction [freund's adjuvant results in increased expression of CCL2 protein]]|[morin co-treated with indomethacin] inhibits the reaction [freund's adjuvant results in increased expression of CCL2 mrna]|indomethacin inhibits the reaction [freund's adjuvant results in increased expression of CCL2 mrna]|indomethacin inhibits the reaction [freund's adjuvant results in increased expression of CCL2 protein],,,PMID:25698669,https://www.ncbi.nlm.nih.gov/pubmed/25698669,25698669,,
5237,300962,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),Indomethacin results in increased expression of CCL2 mRNA,,,PMID:23892052|PMID:25051504,https://www.ncbi.nlm.nih.gov/pubmed/23892052|https://www.ncbi.nlm.nih.gov/pubmed/25051504,23892052|25051504,,
5238,306388,3715,Toxin and Toxin Target Database (T3DB),Indomethacin,T3D2753,Indomethacin,http://www.t3db.ca/toxins/T3D2753,BE0000438,Aldo-keto reductase family 1 member C4,http://www.t3db.ca/biodb/bio_entities/BE0000438,P17516,Aldo-keto reductase family 1 member C4,1109.0,AKR1C4,9606.0,Homo sapiens (human),,,,PMID:22877157|PMID:22506594,https://www.ncbi.nlm.nih.gov/pubmed/22877157|https://www.ncbi.nlm.nih.gov/pubmed/22506594,22877157|22506594,,
5239,306389,3715,Toxin and Toxin Target Database (T3DB),Indomethacin,T3D2753,Indomethacin,http://www.t3db.ca/toxins/T3D2753,BE0000368,Prostaglandin E2 receptor EP2 subtype,http://www.t3db.ca/biodb/bio_entities/BE0000368,P43116,Prostaglandin E2 receptor EP2 subtype,5732.0,PTGER2,9606.0,Homo sapiens (human),,,,PMID:10411562|PMID:11160644,https://www.ncbi.nlm.nih.gov/pubmed/10411562|https://www.ncbi.nlm.nih.gov/pubmed/11160644,10411562|11160644,,
5240,306390,3715,Toxin and Toxin Target Database (T3DB),Indomethacin,T3D2753,Indomethacin,http://www.t3db.ca/toxins/T3D2753,BE0001004,Solute carrier organic anion transporter family member 1B1,http://www.t3db.ca/biodb/bio_entities/BE0001004,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606.0,Homo sapiens (human),,,,PMID:22541068|PMID:11160644,https://www.ncbi.nlm.nih.gov/pubmed/22541068|https://www.ncbi.nlm.nih.gov/pubmed/11160644,22541068|11160644,,
5241,306391,3715,Toxin and Toxin Target Database (T3DB),Indomethacin,T3D2753,Indomethacin,http://www.t3db.ca/toxins/T3D2753,BE0000747,Aldose reductase,http://www.t3db.ca/biodb/bio_entities/BE0000747,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),,,,PMID:3097317,https://www.ncbi.nlm.nih.gov/pubmed/3097317,3097317,,
5242,306392,3715,Toxin and Toxin Target Database (T3DB),Indomethacin,T3D2753,Indomethacin,http://www.t3db.ca/toxins/T3D2753,BE0000248,Arachidonate 5-lipoxygenase,http://www.t3db.ca/biodb/bio_entities/BE0000248,P09917,Polyunsaturated fatty acid 5-lipoxygenase,240.0,ALOX5,9606.0,Homo sapiens (human),,,,PMID:9057869,https://www.ncbi.nlm.nih.gov/pubmed/9057869,9057869,,
5243,306393,3715,Toxin and Toxin Target Database (T3DB),Indomethacin,T3D2753,Indomethacin,http://www.t3db.ca/toxins/T3D2753,BE0000950,Bifunctional epoxide hydrolase 2,http://www.t3db.ca/biodb/bio_entities/BE0000950,P34913,Bifunctional epoxide hydrolase 2,2053.0,EPHX2,9606.0,Homo sapiens (human),,,,PMID:21434686,https://www.ncbi.nlm.nih.gov/pubmed/21434686,21434686,,
5244,306394,3715,Toxin and Toxin Target Database (T3DB),Indomethacin,T3D2753,Indomethacin,http://www.t3db.ca/toxins/T3D2753,BE0001069,Canalicular multispecific organic anion transporter 1,http://www.t3db.ca/biodb/bio_entities/BE0001069,Q92887,Canalicular multispecific organic anion transporter 1,1244.0,ABCC2,9606.0,Homo sapiens (human),,,,PMID:18707884,https://www.ncbi.nlm.nih.gov/pubmed/18707884,18707884,,
5245,352895,3749,DrugBank,Irbesartan,DB01029,Irbesartan,https://www.drugbank.ca/drugs/DB01029,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),Substrate,,,PMID:19515014|PMID:21949635,https://www.ncbi.nlm.nih.gov/pubmed/19515014|https://www.ncbi.nlm.nih.gov/pubmed/21949635,19515014|21949635,,
5246,352896,3749,DrugBank,Irbesartan,DB01029,Irbesartan,https://www.drugbank.ca/drugs/DB01029,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:15601807,https://www.ncbi.nlm.nih.gov/pubmed/15601807,15601807,,
5247,352897,3749,DrugBank,Irbesartan,DB01029,Irbesartan,https://www.drugbank.ca/drugs/DB01029,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),Binder,,,,,,,
5248,352898,3749,DrugBank,Irbesartan,DB01029,Irbesartan,https://www.drugbank.ca/drugs/DB01029,BE0004879,Alpha-1-acid glycoprotein 1,https://www.drugbank.ca/bio_entities/BE0004879,P02763,Alpha-1-acid glycoprotein 1,5004.0,ORM1,9606.0,Homo sapiens (human),Binder,,,,,,,
5249,352899,3749,DrugBank,Irbesartan,DB01029,Irbesartan,https://www.drugbank.ca/drugs/DB01029,BE0004879,Alpha-1-acid glycoprotein 2,https://www.drugbank.ca/bio_entities/BE0004879,P19652,Alpha-1-acid glycoprotein 2,5005.0,ORM2,9606.0,Homo sapiens (human),Binder,,,,,,,
5250,249427,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,513,ATP5F1D,https://ctdbase.org/detail.go?type=gene&acc=513,,,513.0,ATP5F1D,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of ATP5F1D mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5251,249428,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,390424,ATP5MC1P5,https://ctdbase.org/detail.go?type=gene&acc=390424,,,390424.0,ATP5MC1P5,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP5MC1P5 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5252,249429,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,9551,ATP5MF,https://ctdbase.org/detail.go?type=gene&acc=9551,,,9551.0,ATP5MF,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP5MF mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of ATP5MF mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5253,249430,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,537,ATP6AP1,https://ctdbase.org/detail.go?type=gene&acc=537,,,537.0,ATP6AP1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of ATP6AP1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5254,249431,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,92270,ATP6AP1L,https://ctdbase.org/detail.go?type=gene&acc=92270,,,92270.0,ATP6AP1L,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of ATP6AP1L mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of ATP6AP1L mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5255,249432,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,535,ATP6V0A1,https://ctdbase.org/detail.go?type=gene&acc=535,,,535.0,ATP6V0A1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ATP6V0A1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of ATP6V0A1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5256,249621,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,533,ATP6V0B,https://ctdbase.org/detail.go?type=gene&acc=533,,,533.0,ATP6V0B,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of ATP6V0B mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5257,249622,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,9114,ATP6V0D1,https://ctdbase.org/detail.go?type=gene&acc=9114,,,9114.0,ATP6V0D1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of ATP6V0D1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5258,249623,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,79992,AGPAT4-IT1,https://ctdbase.org/detail.go?type=gene&acc=79992,,,79992.0,AGPAT4-IT1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of AGPAT4-IT1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of AGPAT4-IT1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5259,249624,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,102843911,AGPAT9,https://ctdbase.org/detail.go?type=gene&acc=102843911,,,102843911.0,,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of AGPAT9 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5260,250127,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,9590,AKAP12,https://ctdbase.org/detail.go?type=gene&acc=9590,,,9590.0,AKAP12,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of AKAP12 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
5261,250128,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,9465,AKAP7,https://ctdbase.org/detail.go?type=gene&acc=9465,,,9465.0,AKAP7,9606.0,Homo sapiens (human),[dexamethasone co-treated with 8-bromo cyclic adenosine monophosphate co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of AKAP7 mRNA,,,PMID:16997883,https://www.ncbi.nlm.nih.gov/pubmed/16997883,16997883,,
5262,250129,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,79647,AKIRIN1,https://ctdbase.org/detail.go?type=gene&acc=79647,,,79647.0,AKIRIN1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of AKIRIN1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5263,250338,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,10327,AKR1A1,https://ctdbase.org/detail.go?type=gene&acc=10327,,,10327.0,AKR1A1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of AKR1A1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5264,250339,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,231,AKR1B1,https://ctdbase.org/detail.go?type=gene&acc=231,,,231.0,AKR1B1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of AKR1B1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5265,250340,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,231,AKR1B1,https://ctdbase.org/detail.go?type=gene&acc=231,,,231.0,AKR1B1,10090.0,Mus musculus (house mouse),[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of AKR1B1 mRNA,,,PMID:24848799,https://www.ncbi.nlm.nih.gov/pubmed/24848799,24848799,,
5266,250341,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in increased expression of AKR1C1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of AKR1C1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5267,250342,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in increased expression of AKR1C3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5268,250343,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in increased phosphorylation of AKT1 protein|silybin inhibits the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in increased phosphorylation of AKT1 protein],,,PMID:25559859,https://www.ncbi.nlm.nih.gov/pubmed/25559859,25559859,,
5269,250344,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),[bisphenol A co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased phosphorylation of AKT1 protein|[bisphenol A co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of AKT1 mRNA,,,PMID:30665118,https://www.ncbi.nlm.nih.gov/pubmed/30665118,30665118,,
5270,250345,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased phosphorylation of AKT1 protein,,,PMID:32017950,https://www.ncbi.nlm.nih.gov/pubmed/32017950,32017950,,
5271,296425,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,3077,HFE,https://ctdbase.org/detail.go?type=gene&acc=3077,,,3077.0,HFE,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of HFE mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5272,296426,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,3082,HGF,https://ctdbase.org/detail.go?type=gene&acc=3082,,,3082.0,HGF,10090.0,Mus musculus (house mouse),[BMP7 protein co-treated with INS1 protein co-treated with triiodothyronine co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with indomethacin co-treated with nicotine] affects the expression of HGF mRNA,,,PMID:33091441,https://www.ncbi.nlm.nih.gov/pubmed/33091441,33091441,,
5273,296427,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,54438,GFOD1,https://ctdbase.org/detail.go?type=gene&acc=54438,,,54438.0,GFOD1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of GFOD1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5274,298101,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,7485,GET1,https://ctdbase.org/detail.go?type=gene&acc=7485,,,7485.0,GET1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of GET1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5275,298102,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,8323,FZD6,https://ctdbase.org/detail.go?type=gene&acc=8323,,,8323.0,FZD6,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of FZD6 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
5276,298103,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,8324,FZD7,https://ctdbase.org/detail.go?type=gene&acc=8324,,,8324.0,FZD7,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of FZD7 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5277,299551,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2888,GRB14,https://ctdbase.org/detail.go?type=gene&acc=2888,,,2888.0,GRB14,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of GRB14 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5278,299552,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,26585,GREM1,https://ctdbase.org/detail.go?type=gene&acc=26585,,,26585.0,GREM1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in decreased expression of GREM1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5279,300437,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,387036,GUSBP2,https://ctdbase.org/detail.go?type=gene&acc=387036,,,387036.0,GUSBP2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of GUSBP2 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of GUSBP2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5280,300438,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,375513,GUSBP4,https://ctdbase.org/detail.go?type=gene&acc=375513,,,375513.0,GUSBP4,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of GUSBP4 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of GUSBP4 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of GUSBP4 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5281,300439,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,283464,GXYLT1,https://ctdbase.org/detail.go?type=gene&acc=283464,,,283464.0,GXYLT1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of GXYLT1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5282,300440,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2992,GYG1,https://ctdbase.org/detail.go?type=gene&acc=2992,,,2992.0,GYG1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of GYG1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5283,300441,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,8908,GYG2,https://ctdbase.org/detail.go?type=gene&acc=8908,,,8908.0,GYG2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in increased expression of GYG2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5284,300442,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,3005,H1-0,https://ctdbase.org/detail.go?type=gene&acc=3005,,,3005.0,H1-0,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of H1-0 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5285,300443,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,283120,H19,https://ctdbase.org/detail.go?type=gene&acc=283120,,,283120.0,H19,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of H19 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in increased expression of H19 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5286,301971,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,6619,SNAPC3,https://ctdbase.org/detail.go?type=gene&acc=6619,,,6619.0,SNAPC3,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of SNAPC3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5287,301972,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,6621,SNAPC4,https://ctdbase.org/detail.go?type=gene&acc=6621,,,6621.0,SNAPC4,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of SNAPC4 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5288,301973,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,6595,SMARCA2,https://ctdbase.org/detail.go?type=gene&acc=6595,,,6595.0,SMARCA2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SMARCA2 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of SMARCA2 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SMARCA2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5289,301974,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,6602,SMARCD1,https://ctdbase.org/detail.go?type=gene&acc=6602,,,6602.0,SMARCD1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of SMARCD1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5290,301975,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,140775,SMCR8,https://ctdbase.org/detail.go?type=gene&acc=140775,,,140775.0,SMCR8,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of SMCR8 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SMCR8 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5291,301976,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,23049,SMG1,https://ctdbase.org/detail.go?type=gene&acc=23049,,,23049.0,SMG1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of SMG1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SMG1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of SMG1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5292,301977,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,23049,SMG1,https://ctdbase.org/detail.go?type=gene&acc=23049,,,23049.0,SMG1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of SMG1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
5293,302300,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,1981,EIF4G1,https://ctdbase.org/detail.go?type=gene&acc=1981,,,1981.0,EIF4G1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of EIF4G1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of EIF4G1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5294,302301,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,1982,EIF4G2,https://ctdbase.org/detail.go?type=gene&acc=1982,,,1982.0,EIF4G2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5295,302302,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,7458,EIF4H,https://ctdbase.org/detail.go?type=gene&acc=7458,,,7458.0,EIF4H,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of EIF4H mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5296,304042,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2036,EPB41L1,https://ctdbase.org/detail.go?type=gene&acc=2036,,,2036.0,EPB41L1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of EPB41L1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5297,304043,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2036,EPB41L1,https://ctdbase.org/detail.go?type=gene&acc=2036,,,2036.0,EPB41L1,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of EPB41L1 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
5298,304044,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,63916,ELMO2,https://ctdbase.org/detail.go?type=gene&acc=63916,,,63916.0,ELMO2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of ELMO2 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ELMO2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5299,304045,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,255520,ELMOD2,https://ctdbase.org/detail.go?type=gene&acc=255520,,,255520.0,ELMOD2,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of ELMOD2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5300,304046,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,84173,ELMOD3,https://ctdbase.org/detail.go?type=gene&acc=84173,,,84173.0,ELMOD3,10090.0,Mus musculus (house mouse),[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of ELMOD3 mRNA,,,PMID:24848799,https://www.ncbi.nlm.nih.gov/pubmed/24848799,24848799,,
5301,304047,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2021,ENDOG,https://ctdbase.org/detail.go?type=gene&acc=2021,,,2021.0,ENDOG,10090.0,Mus musculus (house mouse),[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of ENDOG mRNA,,,PMID:24848799,https://www.ncbi.nlm.nih.gov/pubmed/24848799,24848799,,
5302,304336,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,8877,SPHK1,https://ctdbase.org/detail.go?type=gene&acc=8877,,,8877.0,SPHK1,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SPHK1 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
5303,304337,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,10927,SPIN1,https://ctdbase.org/detail.go?type=gene&acc=10927,,,10927.0,SPIN1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of SPIN1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5304,304338,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,84688,SPMIP6,https://ctdbase.org/detail.go?type=gene&acc=84688,,,84688.0,SPMIP6,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of SPMIP6 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SPMIP6 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SPMIP6 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5305,304339,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,83985,SPNS1,https://ctdbase.org/detail.go?type=gene&acc=83985,,,83985.0,SPNS1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of SPNS1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of SPNS1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5306,304340,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,124976,SPNS2,https://ctdbase.org/detail.go?type=gene&acc=124976,,,124976.0,SPNS2,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of SPNS2 mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
5307,304341,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,90853,SPOCD1,https://ctdbase.org/detail.go?type=gene&acc=90853,,,90853.0,SPOCD1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of SPOCD1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5308,304342,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,6695,SPOCK1,https://ctdbase.org/detail.go?type=gene&acc=6695,,,6695.0,SPOCK1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of SPOCK1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5309,304343,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,10418,SPON1,https://ctdbase.org/detail.go?type=gene&acc=10418,,,10418.0,SPON1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in increased expression of SPON1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5310,305006,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),Calcitriol inhibits the reaction [1-methyl-3-isobutylxanthine results in increased expression of FABP4 mrna]|1-methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA,,,PMID:9564879,https://www.ncbi.nlm.nih.gov/pubmed/9564879,9564879,,
5311,305007,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),"2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of FABP4 protein]|[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of FABP4 protein",,,PMID:29704545,https://www.ncbi.nlm.nih.gov/pubmed/29704545,29704545,,
5312,305008,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),"2,2',4,4',5-brominated diphenyl ether promotes the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mrna]",,,PMID:30903904,https://www.ncbi.nlm.nih.gov/pubmed/30903904,30903904,,
5313,305009,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mrna]|[bis(4-hydroxyphenyl)sulfone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein|2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mrna]|[bisphenol A co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein|[rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mrna|2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mrna]|[rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein|2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]|[bis(4-hydroxyphenyl)sulfone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mrna|[bisphenol A co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mrna|2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein],,,PMID:27273607,https://www.ncbi.nlm.nih.gov/pubmed/27273607,27273607,,
5314,305010,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of FABP4 mrna|rosiglitazone promotes the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of FABP4 mrna]|2-chloro-5-nitrobenzanilide inhibits the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of FABP4 mrna],,,PMID:29094436,https://www.ncbi.nlm.nih.gov/pubmed/29094436,29094436,,
5315,305011,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),MIR155 inhibits the reaction [[2-ethylhexyldiphenylphosphate co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mrna]|[2-ethylhexyldiphenylphosphate co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 protein|[2-ethylhexyldiphenylphosphate co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA,,,PMID:36764644,https://www.ncbi.nlm.nih.gov/pubmed/36764644,36764644,,
5316,305342,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA,,,PMID:32017950|PMID:34302803,https://www.ncbi.nlm.nih.gov/pubmed/32017950|https://www.ncbi.nlm.nih.gov/pubmed/34302803,32017950|34302803,,
5317,305343,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA,,,PMID:27273607|PMID:28031460|PMID:28285642|PMID:30903904,https://www.ncbi.nlm.nih.gov/pubmed/27273607|https://www.ncbi.nlm.nih.gov/pubmed/28031460|https://www.ncbi.nlm.nih.gov/pubmed/28285642|https://www.ncbi.nlm.nih.gov/pubmed/30903904,27273607|28031460|28285642|30903904,,
5318,305344,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,2167,FABP4,https://ctdbase.org/detail.go?type=gene&acc=2167,,,2167.0,FABP4,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein,,,PMID:27273607|PMID:28285642,https://www.ncbi.nlm.nih.gov/pubmed/27273607|https://www.ncbi.nlm.nih.gov/pubmed/28285642,27273607|28285642,,
5319,305534,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein co-treated with indomethacin] results in increased expression of PPARG protein|hispidulin inhibits the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein co-treated with indomethacin] results in increased expression of PPARG mrna]|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein co-treated with indomethacin] results in increased expression of PPARG mrna|hispidulin inhibits the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein co-treated with indomethacin] results in increased expression of PPARG protein],,,PMID:30055130,https://www.ncbi.nlm.nih.gov/pubmed/30055130,30055130,,
5320,305535,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Pentagalloylglucose inhibits the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG protein]|pentagalloylglucose inhibits the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna]|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPARG protein,,,PMID:30721698,https://www.ncbi.nlm.nih.gov/pubmed/30721698,30721698,,
5321,305536,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),"2,2',3',4,4',5-hexachlorobiphenyl promotes the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein",,,PMID:29704545,https://www.ncbi.nlm.nih.gov/pubmed/29704545,29704545,,
5322,305537,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),"2,2',4,4',5-brominated diphenyl ether promotes the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mrna]",,,PMID:30903904,https://www.ncbi.nlm.nih.gov/pubmed/30903904,30903904,,
5323,305538,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mrna|[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in decreased methylation of PPARG promoter|rosiglitazone promotes the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG mrna]|[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG protein|2-chloro-5-nitrobenzanilide inhibits the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of PPARG protein]|rosiglitazone promotes the reaction [[dexamethasone co-treated with INS1 protein co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG mrna],,,PMID:29094436,https://www.ncbi.nlm.nih.gov/pubmed/29094436,29094436,,
5324,305688,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),"3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]|3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mrna]",,,PMID:22298784,https://www.ncbi.nlm.nih.gov/pubmed/22298784,22298784,,
5325,305689,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA,,,PMID:28595985|PMID:30611848|PMID:31009676,https://www.ncbi.nlm.nih.gov/pubmed/28595985|https://www.ncbi.nlm.nih.gov/pubmed/30611848|https://www.ncbi.nlm.nih.gov/pubmed/31009676,28595985|30611848|31009676,,
5326,305690,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),"[chlorpyrifos co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein|[3,5,6-trichloro-2-pyridinol co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein|3,5,6-trichloro-2-pyridinol promotes the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mrna]|chlorpyrifos promotes the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mrna]",,,PMID:32017950,https://www.ncbi.nlm.nih.gov/pubmed/32017950,32017950,,
5327,305691,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Acrylamide promotes the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mrna]|acrylamide promotes the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],,,PMID:30409764,https://www.ncbi.nlm.nih.gov/pubmed/30409764,30409764,,
5328,305692,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),EGF protein inhibits the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|u 0126 inhibits the reaction [EGF protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|egf protein promotes the reaction [vanadates inhibits the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]|tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein]|egf protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]|ag 1879 inhibits the reaction [EGF protein promotes the reaction [tetrachlorodibenzodioxin inhibits the reaction [[dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]|[dexamethasone co-treated with 1-methyl-3-isobutylxanthine] results in increased expression of PPARG protein,,,PMID:16971554,https://www.ncbi.nlm.nih.gov/pubmed/16971554,16971554,,
5329,305862,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Andrographolide inhibits the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein],,,PMID:27475717,https://www.ncbi.nlm.nih.gov/pubmed/27475717,27475717,,
5330,352900,3759,Drug Gene Interaction database (DGIdb),Isocarboxazid,,ISOCARBOXAZID,https://www.dgidb.org/drugs/rxcui:6011,,CYP1A2,https://www.dgidb.org/genes/hgnc:2596,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,,,,,
5331,352901,3764,Therapeutic Target Database (TTD),Isoformononetin,D08MTZ,ISOFORMONENTIN,https://idrblab.net/ttd/data/drug/details/D08MTZ,T44282,Mitochondrial aldehyde dehydrogenase (ALDH2),https://idrblab.net/ttd/data/target/details/T44282,P05091,"Aldehyde dehydrogenase, mitochondrial",217.0,ALDH2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5332,352902,3779,Drug Gene Interaction database (DGIdb),Isoproterenol,,ISOPROTERENOL,https://www.dgidb.org/drugs/rxcui:6054,,VDR,https://www.dgidb.org/genes/hgnc:12679,,,7421.0,VDR,9606.0,Homo sapiens (human),,,,,,,,
5333,353670,3823,DrugBank,"1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",DB01026,Ketoconazole,https://www.drugbank.ca/drugs/DB01026,BE0003336,Cytochrome P450 2A6,https://www.drugbank.ca/bio_entities/BE0003336,P11509,Cytochrome P450 2A6,1548.0,CYP2A6,9606.0,Homo sapiens (human),Inhibitor,,,PMID:9143352|PMID:11996015,https://www.ncbi.nlm.nih.gov/pubmed/9143352|https://www.ncbi.nlm.nih.gov/pubmed/11996015,9143352|11996015,,
5334,353671,3823,DrugBank,"1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",DB01026,Ketoconazole,https://www.drugbank.ca/drugs/DB01026,BE0001111,Cytochrome P450 1B1,https://www.drugbank.ca/bio_entities/BE0001111,Q16678,Cytochrome P450 1B1,1545.0,CYP1B1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:14709627,https://www.ncbi.nlm.nih.gov/pubmed/14709627,14709627,,
5335,353672,3823,DrugBank,"1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",DB01026,Ketoconazole,https://www.drugbank.ca/drugs/DB01026,BE0003549,Cytochrome P450 2B6,https://www.drugbank.ca/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606.0,Homo sapiens (human),Inhibitor,,,PMID:14709627|PMID:17101742,https://www.ncbi.nlm.nih.gov/pubmed/14709627|https://www.ncbi.nlm.nih.gov/pubmed/17101742,14709627|17101742,,
5336,353673,3823,DrugBank,"1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",DB01026,Ketoconazole,https://www.drugbank.ca/drugs/DB01026,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15601807|PMID:14709627|PMID:15373932|PMID:11136296|PMID:26721703,https://www.ncbi.nlm.nih.gov/pubmed/15601807|https://www.ncbi.nlm.nih.gov/pubmed/14709627|https://www.ncbi.nlm.nih.gov/pubmed/15373932|https://www.ncbi.nlm.nih.gov/pubmed/11136296|https://www.ncbi.nlm.nih.gov/pubmed/26721703,15601807|14709627|15373932|11136296|26721703,,
5337,353674,3823,DrugBank,"1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",DB01026,Ketoconazole,https://www.drugbank.ca/drugs/DB01026,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15373932|PMID:14709627|PMID:9764927|PMID:11854151,https://www.ncbi.nlm.nih.gov/pubmed/15373932|https://www.ncbi.nlm.nih.gov/pubmed/14709627|https://www.ncbi.nlm.nih.gov/pubmed/9764927|https://www.ncbi.nlm.nih.gov/pubmed/11854151,15373932|14709627|9764927|11854151,,
5338,353675,3823,DrugBank,"1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",DB01026,Ketoconazole,https://www.drugbank.ca/drugs/DB01026,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565.0,CYP2D6,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15618748,https://www.ncbi.nlm.nih.gov/pubmed/15618748,15618748,,
5339,353676,3823,DrugBank,"1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",DB01026,Ketoconazole,https://www.drugbank.ca/drugs/DB01026,BE0000731,"Cytochrome P450 11B1, mitochondrial",https://www.drugbank.ca/bio_entities/BE0000731,P15538,"Cytochrome P450 11B1, mitochondrial",1584.0,CYP11B1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:7663533,https://www.ncbi.nlm.nih.gov/pubmed/7663533,7663533,,
5340,353677,3823,DrugBank,"1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",DB01026,Ketoconazole,https://www.drugbank.ca/drugs/DB01026,BE0003541,UDP-glucuronosyltransferase 1-1,https://www.drugbank.ca/bio_entities/BE0003541,P22309,UDP-glucuronosyltransferase 1A1 ,54658.0,UGT1A1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:16166450,https://www.ncbi.nlm.nih.gov/pubmed/16166450,16166450,,
5341,353678,3823,DrugBank,"1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",DB01026,Ketoconazole,https://www.drugbank.ca/drugs/DB01026,BE0004695,UDP-glucuronosyltransferase 1-7,https://www.drugbank.ca/bio_entities/BE0004695,Q9HAW7,UDP-glucuronosyltransferase 1A7,54577.0,UGT1A7,9606.0,Homo sapiens (human),Inhibitor,,,PMID:16166450,https://www.ncbi.nlm.nih.gov/pubmed/16166450,16166450,,
5342,354146,3825,DrugBank,Ketoprofen,DB01009,Ketoprofen,https://www.drugbank.ca/drugs/DB01009,BE0000879,Solute carrier family 22 member 11,https://www.drugbank.ca/bio_entities/BE0000879,Q9NSA0,Solute carrier family 22 member 11,55867.0,SLC22A11,9606.0,Homo sapiens (human),Inhibitor,,,PMID:12130730,https://www.ncbi.nlm.nih.gov/pubmed/12130730,12130730,,
5343,354147,3825,DrugBank,Ketoprofen,DB01009,Ketoprofen,https://www.drugbank.ca/drugs/DB01009,BE0003646,Solute carrier family 22 member 7,https://www.drugbank.ca/bio_entities/BE0003646,Q9Y694,Solute carrier family 22 member 7,10864.0,SLC22A7,9606.0,Homo sapiens (human),Inhibitor,,,PMID:9650585|PMID:11504818|PMID:10991954|PMID:12130730,https://www.ncbi.nlm.nih.gov/pubmed/9650585|https://www.ncbi.nlm.nih.gov/pubmed/11504818|https://www.ncbi.nlm.nih.gov/pubmed/10991954|https://www.ncbi.nlm.nih.gov/pubmed/12130730,9650585|11504818|10991954|12130730,,
5344,354148,3825,DrugBank,Ketoprofen,DB01009,Ketoprofen,https://www.drugbank.ca/drugs/DB01009,BE0000530,Serum albumin,https://www.drugbank.ca/bio_entities/BE0000530,P02768,Albumin,213.0,ALB,9606.0,Homo sapiens (human),,,,PMID:11400191|PMID:11022905|PMID:12725696|PMID:15807110,https://www.ncbi.nlm.nih.gov/pubmed/11400191|https://www.ncbi.nlm.nih.gov/pubmed/11022905|https://www.ncbi.nlm.nih.gov/pubmed/12725696|https://www.ncbi.nlm.nih.gov/pubmed/15807110,11400191|11022905|12725696|15807110,,
5345,354149,3825,BindingDB,Ketoprofen,50022271,2-(3-Benzoylphenyl)propionic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022271,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),>6.6e+4,PMID:28238723|DOI:10.1016/j.chembiol.2017.02.003,https://www.ncbi.nlm.nih.gov/pubmed/28238723|https://doi.org/10.1016/j.chembiol.2017.02.003,28238723,10.1016/j.chembiol.2017.02.003,
5346,354150,3825,BindingDB,Ketoprofen,50022271,2-(3-Benzoylphenyl)propionic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022271,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),5.0e+4,PMID:28238723|DOI:10.1016/j.chembiol.2017.02.003,https://www.ncbi.nlm.nih.gov/pubmed/28238723|https://doi.org/10.1016/j.chembiol.2017.02.003,28238723,10.1016/j.chembiol.2017.02.003,
5347,354151,3825,BindingDB,Ketoprofen,50022271,2-(3-Benzoylphenyl)propionic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022271,106,Caspase-4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=106,P49662,Caspase-4,837.0,CASP4,9606.0,Homo sapiens (human),,IC50 (nM),1.0e+4,PMID:28238723|DOI:10.1016/j.chembiol.2017.02.003,https://www.ncbi.nlm.nih.gov/pubmed/28238723|https://doi.org/10.1016/j.chembiol.2017.02.003,28238723,10.1016/j.chembiol.2017.02.003,
5348,354152,3825,BindingDB,Ketoprofen,50022271,2-(3-Benzoylphenyl)propionic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022271,122,Caspase-5,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=122,P51878,Caspase-5,838.0,CASP5,9606.0,Homo sapiens (human),,IC50 (nM),1.0e+4,PMID:28238723|DOI:10.1016/j.chembiol.2017.02.003,https://www.ncbi.nlm.nih.gov/pubmed/28238723|https://doi.org/10.1016/j.chembiol.2017.02.003,28238723,10.1016/j.chembiol.2017.02.003,
5349,354153,3825,BindingDB,Ketoprofen,50022271,2-(3-Benzoylphenyl)propionic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50022271,1120,Caspase-9,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1120,P55211,Caspase-9,842.0,CASP9,9606.0,Homo sapiens (human),,IC50 (nM),1.0e+4,PMID:28238723|DOI:10.1016/j.chembiol.2017.02.003,https://www.ncbi.nlm.nih.gov/pubmed/28238723|https://doi.org/10.1016/j.chembiol.2017.02.003,28238723,10.1016/j.chembiol.2017.02.003,
5350,356611,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [benzo(a)pyrene results in increased expression of BECN1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BECN1 protein,,,PMID:30726812,https://www.ncbi.nlm.nih.gov/pubmed/30726812,30726812,,
5351,356612,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,10090.0,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [calcitriol inhibits the reaction [glucose results in increased expression of BECN1 protein]],,,PMID:33450223,https://www.ncbi.nlm.nih.gov/pubmed/33450223,33450223,,
5352,356613,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,10090.0,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [melatonin inhibits the reaction [[nickel chloride results in increased abundance of nickel] which results in increased expression of BECN1 protein]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [melatonin inhibits the reaction [[nickel chloride results in increased abundance of nickel] which results in increased expression of BECN1 mrna]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of nickel] which results in increased expression of BECN1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of nickel] which results in increased expression of BECN1 mrna],,,PMID:35568058,https://www.ncbi.nlm.nih.gov/pubmed/35568058,35568058,,
5353,356614,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,10116.0,Rattus norvegicus (Norway rat),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium results in increased expression of BECN1 protein],,,PMID:25955216,https://www.ncbi.nlm.nih.gov/pubmed/25955216,25955216,,
5354,356615,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678.0,BECN1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LGALS3 protein results in decreased expression of BECN1 protein],,,PMID:32003113,https://www.ncbi.nlm.nih.gov/pubmed/32003113,32003113,,
5355,356616,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,632,BGLAP,https://ctdbase.org/detail.go?type=gene&acc=632,,,632.0,BGLAP,10090.0,Mus musculus (house mouse),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [calcitriol inhibits the reaction [glucose results in decreased expression of BGLAP protein]],,,PMID:33450223,https://www.ncbi.nlm.nih.gov/pubmed/33450223,33450223,,
5356,356617,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637.0,BID,9606.0,Homo sapiens (human),BCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [doxorubicin results in increased cleavage of and results in increased activity of and results in increased localization of BID protein]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [doxorubicin results in increased cleavage of and results in increased activity of and results in increased localization of BID protein],,,PMID:20856197,https://www.ncbi.nlm.nih.gov/pubmed/20856197,20856197,,
5357,356902,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of ABCB1 protein|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of ABCB1 mRNA,,,PMID:23466342,https://www.ncbi.nlm.nih.gov/pubmed/23466342,23466342,,
5358,356903,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,10116.0,Rattus norvegicus (Norway rat),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of ABCB1 protein,,,PMID:27888070,https://www.ncbi.nlm.nih.gov/pubmed/27888070,27888070,,
5359,358122,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [estradiol results in increased phosphorylation of AKT1 protein],,,PMID:23000059,https://www.ncbi.nlm.nih.gov/pubmed/23000059,23000059,,
5360,358123,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ethanol results in increased phosphorylation of AKT1 protein],,,PMID:33516933,https://www.ncbi.nlm.nih.gov/pubmed/33516933,33516933,,
5361,358308,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [hemistepsin results in decreased phosphorylation of AKT1 protein],,,PMID:31830547,https://www.ncbi.nlm.nih.gov/pubmed/31830547,31830547,,
5362,358599,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [phosphates results in increased phosphorylation of AKT1 protein],,,PMID:16763222,https://www.ncbi.nlm.nih.gov/pubmed/16763222,16763222,,
5363,358600,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [phosphocreatine inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of AKT1 protein]],,,PMID:37648050,https://www.ncbi.nlm.nih.gov/pubmed/37648050,37648050,,
5364,358601,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [polychlorinated biphenyls analog results in increased phosphorylation of AKT1 protein],,,PMID:24361488,https://www.ncbi.nlm.nih.gov/pubmed/24361488,24361488,,
5365,358602,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PTK2 protein promotes the reaction [doxorubicin results in increased phosphorylation of AKT1 protein]],,,PMID:16168102,https://www.ncbi.nlm.nih.gov/pubmed/16168102,16168102,,
5366,358603,3973,Comparative Toxicogenomics Database (CTD),2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,C085911,2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C085911,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of AKT1 protein]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [glucose results in decreased phosphorylation of AKT1 protein]]|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [hydrogen peroxide results in decreased phosphorylation of AKT1 protein]],,,PMID:27049278,https://www.ncbi.nlm.nih.gov/pubmed/27049278,27049278,,
5367,340508,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,6239,RREB1,https://ctdbase.org/detail.go?type=gene&acc=6239,,,6239.0,RREB1,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of RREB1 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5368,340509,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,23076,RRP1B,https://ctdbase.org/detail.go?type=gene&acc=23076,,,23076.0,RRP1B,9606.0,Homo sapiens (human),Methapyrilene results in decreased methylation of RRP1B intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5369,342437,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,205564,SENP5,https://ctdbase.org/detail.go?type=gene&acc=205564,,,205564.0,SENP5,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of SENP5 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5370,342438,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,22928,SEPHS2,https://ctdbase.org/detail.go?type=gene&acc=22928,,,22928.0,SEPHS2,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of SEPHS2 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
5371,342439,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,151011,SEPTIN10,https://ctdbase.org/detail.go?type=gene&acc=151011,,,151011.0,SEPTIN10,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of SEPTIN10 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
5372,342440,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,23176,SEPTIN8,https://ctdbase.org/detail.go?type=gene&acc=23176,,,23176.0,SEPTIN8,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of SEPTIN8 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5373,342441,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,10801,SEPTIN9,https://ctdbase.org/detail.go?type=gene&acc=10801,,,10801.0,SEPTIN9,9606.0,Homo sapiens (human),Methapyrilene results in decreased methylation of SEPTIN9 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5374,342442,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,10801,SEPTIN9,https://ctdbase.org/detail.go?type=gene&acc=10801,,,10801.0,SEPTIN9,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of SEPTIN9 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
5375,342443,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,256987,SERINC5,https://ctdbase.org/detail.go?type=gene&acc=256987,,,256987.0,SERINC5,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of SERINC5 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
5376,342444,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,27230,SERP1,https://ctdbase.org/detail.go?type=gene&acc=27230,,,27230.0,SERP1,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in increased expression of SERP1 mRNA,,,PMID:16393664,https://www.ncbi.nlm.nih.gov/pubmed/16393664,16393664,,
5377,342445,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,51156,SERPINA10,https://ctdbase.org/detail.go?type=gene&acc=51156,,,51156.0,SERPINA10,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of SERPINA10 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5378,342446,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,16625,SERPINA3C,https://ctdbase.org/detail.go?type=gene&acc=16625,,,16625.0,Serpina3c,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in increased expression of SERPINA3C mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
5379,342729,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,20716,SERPINA3N,https://ctdbase.org/detail.go?type=gene&acc=20716,,,20716.0,Serpina3n,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of SERPINA3N mRNA,,,PMID:28935588,https://www.ncbi.nlm.nih.gov/pubmed/28935588,28935588,,
5380,342730,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,866,SERPINA6,https://ctdbase.org/detail.go?type=gene&acc=866,,,866.0,SERPINA6,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in increased expression of SERPINA6 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
5381,342731,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,5272,SERPINB9,https://ctdbase.org/detail.go?type=gene&acc=5272,,,5272.0,SERPINB9,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in increased expression of SERPINB9 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
5382,342732,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,462,SERPINC1,https://ctdbase.org/detail.go?type=gene&acc=462,,,462.0,SERPINC1,9606.0,Homo sapiens (human),Methapyrilene results in increased methylation of SERPINC1 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5383,342733,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116.0,Rattus norvegicus (Norway rat),Methapyrilene results in increased expression of SERPINE1 mRNA,,,PMID:28935588,https://www.ncbi.nlm.nih.gov/pubmed/28935588,28935588,,
5384,345461,4205,Comparative Toxicogenomics Database (CTD),Mirtazapine,D000078785,Mirtazapine,https://ctdbase.org/detail.go?type=chem&acc=D000078785,3760,KCNJ3,https://ctdbase.org/detail.go?type=gene&acc=3760,,,3760.0,KCNJ3,10090.0,Mus musculus (house mouse),Mirtazapine affects the activity of [KCNJ3 mRNA co-treated with KCNJ5 mrna]|mirtazapine affects the activity of [KCNJ3 mRNA co-treated with KCNJ6 mrna],,,PMID:22164246,https://www.ncbi.nlm.nih.gov/pubmed/22164246,22164246,,
5385,345462,4205,Comparative Toxicogenomics Database (CTD),Mirtazapine,D000078785,Mirtazapine,https://ctdbase.org/detail.go?type=chem&acc=D000078785,3762,KCNJ5,https://ctdbase.org/detail.go?type=gene&acc=3762,,,3762.0,KCNJ5,10090.0,Mus musculus (house mouse),Mirtazapine affects the activity of [KCNJ3 mRNA co-treated with KCNJ5 mrna],,,PMID:22164246,https://www.ncbi.nlm.nih.gov/pubmed/22164246,22164246,,
5386,345463,4205,Comparative Toxicogenomics Database (CTD),Mirtazapine,D000078785,Mirtazapine,https://ctdbase.org/detail.go?type=chem&acc=D000078785,3763,KCNJ6,https://ctdbase.org/detail.go?type=gene&acc=3763,,,3763.0,KCNJ6,10090.0,Mus musculus (house mouse),Mirtazapine affects the activity of [KCNJ3 mRNA co-treated with KCNJ6 mrna],,,PMID:22164246,https://www.ncbi.nlm.nih.gov/pubmed/22164246,22164246,,
5387,345464,4205,Comparative Toxicogenomics Database (CTD),Mirtazapine,D000078785,Mirtazapine,https://ctdbase.org/detail.go?type=chem&acc=D000078785,3916,LAMP1,https://ctdbase.org/detail.go?type=gene&acc=3916,,,3916.0,LAMP1,10116.0,Rattus norvegicus (Norway rat),Ethanol promotes the reaction [mirtazapine results in decreased expression of LAMP1 protein]|hmgb1 protein affects the reaction [mirtazapine results in decreased expression of LAMP1 protein]|hmgb1 protein affects the reaction [ethanol promotes the reaction [mirtazapine results in decreased expression of LAMP1 protein]]|mirtazapine results in decreased expression of LAMP1 protein,,,PMID:35066094,https://www.ncbi.nlm.nih.gov/pubmed/35066094,35066094,,
5388,348554,4211,Comparative Toxicogenomics Database (CTD),Mitotane,D008939,Mitotane,https://ctdbase.org/detail.go?type=chem&acc=D008939,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),"[mitotane co-treated with NR1I3 protein alternative form] results in increased expression of CYP2B6 mrna|[mitotane co-treated with NR1I3 protein mutant form] results in increased expression of CYP2B6 mrna|mitotane binds to NR1I3 protein|mitotane inhibits the reaction [ethyl (5-(diethylglycyl)-10,11-dihydro-5H-dibenzo(b,f)azepin-3-yl)carbamate results in decreased activity of NR1I3 protein]|mitotane affects the localization of NR1I3 protein mutant form|mitotane binds to and results in increased activity of NR1I3 protein alternative form|mitotane promotes the reaction [NCOA3 protein binds to NR1I3 protein]|mitotane promotes the reaction [NCOA1 protein binds to NR1I3 protein]",,,PMID:31312845,https://www.ncbi.nlm.nih.gov/pubmed/31312845,31312845,,
5389,348555,4211,Comparative Toxicogenomics Database (CTD),Mitotane,D008939,Mitotane,https://ctdbase.org/detail.go?type=chem&acc=D008939,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),Mitotane results in increased activity of NR1I3 protein,,,PMID:28927721,https://www.ncbi.nlm.nih.gov/pubmed/28927721,28927721,,
5390,348556,4211,Comparative Toxicogenomics Database (CTD),Mitotane,D008939,Mitotane,https://ctdbase.org/detail.go?type=chem&acc=D008939,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,9606.0,Homo sapiens (human),Mitotane results in decreased expression of PCK1 mRNA,,,PMID:31312845,https://www.ncbi.nlm.nih.gov/pubmed/31312845,31312845,,
5391,348557,4211,Comparative Toxicogenomics Database (CTD),Mitotane,D008939,Mitotane,https://ctdbase.org/detail.go?type=chem&acc=D008939,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606.0,Homo sapiens (human),Mitotane inhibits the reaction [progesterone binds to PGR protein]|mitotane binds to PGR protein,,,PMID:14579009,https://www.ncbi.nlm.nih.gov/pubmed/14579009,14579009,,
5392,350607,4212,Comparative Toxicogenomics Database (CTD),Mitoxantrone,D008942,Mitoxantrone,https://ctdbase.org/detail.go?type=chem&acc=D008942,567,B2M,https://ctdbase.org/detail.go?type=gene&acc=567,,,567.0,B2M,7955.0,Danio rerio (zebrafish),Mitoxantrone results in increased expression of B2M mRNA,,,PMID:30413070,https://www.ncbi.nlm.nih.gov/pubmed/30413070,30413070,,
5393,340968,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,57664,PLEKHA4,https://ctdbase.org/detail.go?type=gene&acc=57664,,,57664.0,PLEKHA4,9606.0,Homo sapiens (human),Entinostat results in increased expression of PLEKHA4 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5394,340969,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,58473,PLEKHB1,https://ctdbase.org/detail.go?type=gene&acc=58473,,,58473.0,PLEKHB1,9606.0,Homo sapiens (human),Entinostat results in increased expression of PLEKHB1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5395,340970,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,57480,PLEKHG1,https://ctdbase.org/detail.go?type=gene&acc=57480,,,57480.0,PLEKHG1,9606.0,Homo sapiens (human),Entinostat results in decreased expression of PLEKHG1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5396,343187,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,11107,PRDM5,https://ctdbase.org/detail.go?type=gene&acc=11107,,,11107.0,PRDM5,9606.0,Homo sapiens (human),Entinostat results in decreased expression of PRDM5 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5397,343188,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5549,PRELP,https://ctdbase.org/detail.go?type=gene&acc=5549,,,5549.0,PRELP,9606.0,Homo sapiens (human),Entinostat results in increased expression of PRELP mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5398,343189,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,9581,PREPL,https://ctdbase.org/detail.go?type=gene&acc=9581,,,9581.0,PREPL,9606.0,Homo sapiens (human),Entinostat results in increased expression of PREPL mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5399,343190,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,144165,PRICKLE1,https://ctdbase.org/detail.go?type=gene&acc=144165,,,144165.0,PRICKLE1,9606.0,Homo sapiens (human),Entinostat results in decreased expression of PRICKLE1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5400,343191,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,144165,PRICKLE1,https://ctdbase.org/detail.go?type=gene&acc=144165,,,144165.0,PRICKLE1,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRICKLE1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5401,343192,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5563,PRKAA2,https://ctdbase.org/detail.go?type=gene&acc=5563,,,5563.0,PRKAA2,9606.0,Homo sapiens (human),Entinostat results in increased expression of PRKAA2 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5402,343381,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCA mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5403,343382,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,9606.0,Homo sapiens (human),Entinostat results in increased expression of PRKCB mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
5404,343383,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCB mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5405,343384,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Entinostat results in increased expression of PRKCD mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5406,343385,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5583,PRKCH,https://ctdbase.org/detail.go?type=gene&acc=5583,,,5583.0,PRKCH,9606.0,Homo sapiens (human),Entinostat results in increased expression of PRKCH mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5407,343386,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5583,PRKCH,https://ctdbase.org/detail.go?type=gene&acc=5583,,,5583.0,PRKCH,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKCH mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5408,343387,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5587,PRKD1,https://ctdbase.org/detail.go?type=gene&acc=5587,,,5587.0,PRKD1,9606.0,Homo sapiens (human),Entinostat results in decreased expression of PRKD1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5409,343388,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5587,PRKD1,https://ctdbase.org/detail.go?type=gene&acc=5587,,,5587.0,PRKD1,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKD1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5410,343389,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5618,PRLR,https://ctdbase.org/detail.go?type=gene&acc=5618,,,5618.0,PRLR,9606.0,Homo sapiens (human),Entinostat results in decreased expression of PRLR mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5411,343390,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,3275,PRMT2,https://ctdbase.org/detail.go?type=gene&acc=3275,,,3275.0,PRMT2,9606.0,Homo sapiens (human),Entinostat results in decreased expression of PRMT2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5412,343780,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,254427,PROSER2,https://ctdbase.org/detail.go?type=gene&acc=254427,,,254427.0,PROSER2,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROSER2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5413,343781,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,25766,PRPF40B,https://ctdbase.org/detail.go?type=gene&acc=25766,,,25766.0,PRPF40B,9606.0,Homo sapiens (human),Entinostat results in increased expression of PRPF40B mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5414,343782,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,222171,PRR15,https://ctdbase.org/detail.go?type=gene&acc=222171,,,222171.0,PRR15,9606.0,Homo sapiens (human),Entinostat results in increased expression of PRR15 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5415,343783,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,222171,PRR15,https://ctdbase.org/detail.go?type=gene&acc=222171,,,222171.0,PRR15,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5416,343784,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,51334,PRR16,https://ctdbase.org/detail.go?type=gene&acc=51334,,,51334.0,PRR16,9606.0,Homo sapiens (human),Entinostat results in increased expression of PRR16 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5417,343785,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,51334,PRR16,https://ctdbase.org/detail.go?type=gene&acc=51334,,,51334.0,PRR16,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR16 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5418,343786,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,284338,PRR19,https://ctdbase.org/detail.go?type=gene&acc=284338,,,284338.0,PRR19,9606.0,Homo sapiens (human),Entinostat results in decreased expression of PRR19 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5419,344288,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,5698,PSMB9,https://ctdbase.org/detail.go?type=gene&acc=5698,,,5698.0,PSMB9,9606.0,Homo sapiens (human),Entinostat results in increased expression of PSMB9 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5420,346282,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,116362,RBP7,https://ctdbase.org/detail.go?type=gene&acc=116362,,,116362.0,RBP7,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBP7 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5421,346283,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,11030,RBPMS,https://ctdbase.org/detail.go?type=gene&acc=11030,,,11030.0,RBPMS,9606.0,Homo sapiens (human),Entinostat results in increased expression of RBPMS mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5422,346284,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,11030,RBPMS,https://ctdbase.org/detail.go?type=gene&acc=11030,,,11030.0,RBPMS,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBPMS mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5423,346285,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,348093,RBPMS2,https://ctdbase.org/detail.go?type=gene&acc=348093,,,348093.0,RBPMS2,9606.0,Homo sapiens (human),Entinostat results in increased expression of RBPMS2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5424,349168,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,29106,SCG3,https://ctdbase.org/detail.go?type=gene&acc=29106,,,29106.0,SCG3,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCG3 mrna|entinostat results in decreased expression of SCG3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5425,349169,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,29106,SCG3,https://ctdbase.org/detail.go?type=gene&acc=29106,,,29106.0,SCG3,9606.0,Homo sapiens (human),Entinostat results in increased expression of SCG3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5426,349170,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,117156,SCGB3A2,https://ctdbase.org/detail.go?type=gene&acc=117156,,,117156.0,SCGB3A2,9606.0,Homo sapiens (human),Entinostat results in increased expression of SCGB3A2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5427,349171,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,117156,SCGB3A2,https://ctdbase.org/detail.go?type=gene&acc=117156,,,117156.0,SCGB3A2,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCGB3A2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5428,349172,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,29970,SCHIP1,https://ctdbase.org/detail.go?type=gene&acc=29970,,,29970.0,SCHIP1,9606.0,Homo sapiens (human),Entinostat results in decreased expression of SCHIP1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5429,349173,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6322,SCML1,https://ctdbase.org/detail.go?type=gene&acc=6322,,,6322.0,SCML1,9606.0,Homo sapiens (human),Entinostat results in increased expression of SCML1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5430,349174,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,256380,SCML4,https://ctdbase.org/detail.go?type=gene&acc=256380,,,256380.0,SCML4,9606.0,Homo sapiens (human),Entinostat results in decreased expression of SCML4 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5431,349175,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6323,SCN1A,https://ctdbase.org/detail.go?type=gene&acc=6323,,,6323.0,SCN1A,9606.0,Homo sapiens (human),Entinostat results in increased expression of SCN1A mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5432,349176,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6327,SCN2B,https://ctdbase.org/detail.go?type=gene&acc=6327,,,6327.0,SCN2B,9606.0,Homo sapiens (human),Entinostat results in increased expression of SCN2B mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5433,350931,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,55337,SHFL,https://ctdbase.org/detail.go?type=gene&acc=55337,,,55337.0,SHFL,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SHFL mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5434,350932,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,387914,SHISA2,https://ctdbase.org/detail.go?type=gene&acc=387914,,,387914.0,SHISA2,9606.0,Homo sapiens (human),Entinostat results in decreased expression of SHISA2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5435,350933,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,85352,SHISAL1,https://ctdbase.org/detail.go?type=gene&acc=85352,,,85352.0,SHISAL1,9606.0,Homo sapiens (human),Entinostat results in decreased expression of SHISAL1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5436,350934,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,85352,SHISAL1,https://ctdbase.org/detail.go?type=gene&acc=85352,,,85352.0,SHISAL1,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SHISAL1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5437,350935,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,57698,SHTN1,https://ctdbase.org/detail.go?type=gene&acc=57698,,,57698.0,SHTN1,9606.0,Homo sapiens (human),Entinostat results in increased expression of SHTN1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5438,352099,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,9906,SLC35E2A,https://ctdbase.org/detail.go?type=gene&acc=9906,,,9906.0,SLC35E2A,9606.0,Homo sapiens (human),Entinostat results in decreased expression of SLC35E2A mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
5439,352100,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,9906,SLC35E2A,https://ctdbase.org/detail.go?type=gene&acc=9906,,,9906.0,SLC35E2A,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC35E2A mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5440,352101,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,339665,SLC35E4,https://ctdbase.org/detail.go?type=gene&acc=339665,,,339665.0,SLC35E4,9606.0,Homo sapiens (human),Entinostat results in increased expression of SLC35E4 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5441,352102,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,80723,SLC35G2,https://ctdbase.org/detail.go?type=gene&acc=80723,,,80723.0,SLC35G2,9606.0,Homo sapiens (human),Entinostat results in increased expression of SLC35G2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5442,352103,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,80723,SLC35G2,https://ctdbase.org/detail.go?type=gene&acc=80723,,,80723.0,SLC35G2,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5443,352104,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,92745,SLC38A5,https://ctdbase.org/detail.go?type=gene&acc=92745,,,92745.0,SLC38A5,9606.0,Homo sapiens (human),Entinostat results in increased expression of SLC38A5 mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
5444,352105,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,92745,SLC38A5,https://ctdbase.org/detail.go?type=gene&acc=92745,,,92745.0,SLC38A5,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC38A5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5445,352292,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6520,SLC3A2,https://ctdbase.org/detail.go?type=gene&acc=6520,,,6520.0,SLC3A2,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC3A2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5446,352293,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,84102,SLC41A2,https://ctdbase.org/detail.go?type=gene&acc=84102,,,84102.0,SLC41A2,9606.0,Homo sapiens (human),Entinostat results in increased expression of SLC41A2 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5447,352294,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,8501,SLC43A1,https://ctdbase.org/detail.go?type=gene&acc=8501,,,8501.0,SLC43A1,9606.0,Homo sapiens (human),Entinostat results in increased expression of SLC43A1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5448,352295,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,8501,SLC43A1,https://ctdbase.org/detail.go?type=gene&acc=8501,,,8501.0,SLC43A1,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC43A1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5449,352296,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,29015,SLC43A3,https://ctdbase.org/detail.go?type=gene&acc=29015,,,29015.0,SLC43A3,9606.0,Homo sapiens (human),Entinostat results in increased expression of SLC43A3 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5450,352297,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,126969,SLC44A3,https://ctdbase.org/detail.go?type=gene&acc=126969,,,126969.0,SLC44A3,9606.0,Homo sapiens (human),Entinostat results in increased expression of SLC44A3 mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
5451,352298,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,126969,SLC44A3,https://ctdbase.org/detail.go?type=gene&acc=126969,,,126969.0,SLC44A3,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC44A3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5452,352299,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,283537,SLC46A3,https://ctdbase.org/detail.go?type=gene&acc=283537,,,283537.0,SLC46A3,9606.0,Homo sapiens (human),Entinostat results in increased expression of SLC46A3 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5453,352300,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,55244,SLC47A1,https://ctdbase.org/detail.go?type=gene&acc=55244,,,55244.0,SLC47A1,9606.0,Homo sapiens (human),Entinostat results in increased expression of SLC47A1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5454,354823,4261,BindingDB,Entinostat,19410,CHEMBL27759,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19410,3641,Histone deacetylase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3641,,,,,,,,IC50 (nM),940,PMID:19317450|DOI:10.1021/jm801654y,https://www.ncbi.nlm.nih.gov/pubmed/19317450|https://doi.org/10.1021/jm801654y,19317450,10.1021/jm801654y,
5455,354824,4261,Drug Gene Interaction database (DGIdb),Entinostat,,ENTINOSTAT,https://www.dgidb.org/drugs/ncit:C1863,,HDAC10,https://www.dgidb.org/genes/hgnc:18128,,,83933.0,HDAC10,9606.0,Homo sapiens (human),,,,,,,,
5456,354825,4261,Drug Gene Interaction database (DGIdb),Entinostat,,ENTINOSTAT,https://www.dgidb.org/drugs/ncit:C1863,,HDAC11,https://www.dgidb.org/genes/hgnc:19086,,,79885.0,HDAC11,9606.0,Homo sapiens (human),,,,,,,,
5457,354826,4261,Drug Gene Interaction database (DGIdb),Entinostat,,ENTINOSTAT,https://www.dgidb.org/drugs/ncit:C1863,,HDAC5,https://www.dgidb.org/genes/hgnc:14068,,,10014.0,HDAC5,9606.0,Homo sapiens (human),,,,,,,,
5458,354827,4261,Drug Gene Interaction database (DGIdb),Entinostat,,ENTINOSTAT,https://www.dgidb.org/drugs/ncit:C1863,,HDAC9,https://www.dgidb.org/genes/hgnc:14065,,,9734.0,HDAC9,9606.0,Homo sapiens (human),,,,,,,,
5459,354828,4261,Drug Gene Interaction database (DGIdb),Entinostat,,ENTINOSTAT,https://www.dgidb.org/drugs/ncit:C1863,,HDAC1,https://www.dgidb.org/genes/hgnc:4852,,,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,,,,,
5460,354829,4261,Drug Gene Interaction database (DGIdb),Entinostat,,ENTINOSTAT,https://www.dgidb.org/drugs/ncit:C1863,,HDAC2,https://www.dgidb.org/genes/hgnc:4853,,,3066.0,HDAC2,9606.0,Homo sapiens (human),,,,,,,,
5461,354830,4261,Drug Gene Interaction database (DGIdb),Entinostat,,ENTINOSTAT,https://www.dgidb.org/drugs/ncit:C1863,,HDAC1,https://www.dgidb.org/genes/hgnc:4852,,,3065.0,HDAC1,9606.0,Homo sapiens (human),,,,,,,,
5462,354831,4261,Drug Gene Interaction database (DGIdb),Entinostat,,ENTINOSTAT,https://www.dgidb.org/drugs/ncit:C1863,,HDAC9,https://www.dgidb.org/genes/hgnc:14065,,,9734.0,HDAC9,9606.0,Homo sapiens (human),,,,,,,,
5463,355143,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,285672,SREK1IP1,https://ctdbase.org/detail.go?type=gene&acc=285672,,,285672.0,SREK1IP1,9606.0,Homo sapiens (human),Entinostat results in decreased expression of SREK1IP1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5464,355144,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,285672,SREK1IP1,https://ctdbase.org/detail.go?type=gene&acc=285672,,,285672.0,SREK1IP1,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SREK1IP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5465,355145,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,8406,SRPX,https://ctdbase.org/detail.go?type=gene&acc=8406,,,8406.0,SRPX,9606.0,Homo sapiens (human),Entinostat results in increased expression of SRPX mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
5466,355146,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,8406,SRPX,https://ctdbase.org/detail.go?type=gene&acc=8406,,,8406.0,SRPX,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SRPX mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5467,355147,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,27286,SRPX2,https://ctdbase.org/detail.go?type=gene&acc=27286,,,27286.0,SRPX2,9606.0,Homo sapiens (human),Entinostat results in increased expression of SRPX2 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5468,355148,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,84530,SRRM4,https://ctdbase.org/detail.go?type=gene&acc=84530,,,84530.0,SRRM4,9606.0,Homo sapiens (human),Entinostat results in decreased expression of SRRM4 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5469,355513,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,8128,ST8SIA2,https://ctdbase.org/detail.go?type=gene&acc=8128,,,8128.0,ST8SIA2,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ST8SIA2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5470,355514,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,10274,STAG1,https://ctdbase.org/detail.go?type=gene&acc=10274,,,10274.0,STAG1,9606.0,Homo sapiens (human),Entinostat results in decreased expression of STAG1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5471,355515,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,57559,STAMBPL1,https://ctdbase.org/detail.go?type=gene&acc=57559,,,57559.0,STAMBPL1,9606.0,Homo sapiens (human),Entinostat results in decreased expression of STAMBPL1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5472,355516,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,9606.0,Homo sapiens (human),Entinostat results in increased expression of STAR mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
5473,355517,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STAR mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5474,355518,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),Entinostat results in increased expression of STAT3 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5475,355519,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6777,STAT5B,https://ctdbase.org/detail.go?type=gene&acc=6777,,,6777.0,STAT5B,9606.0,Homo sapiens (human),Entinostat results in decreased expression of STAT5B mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5476,355520,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6778,STAT6,https://ctdbase.org/detail.go?type=gene&acc=6778,,,6778.0,STAT6,9606.0,Homo sapiens (human),Entinostat results in increased expression of STAT6 mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
5477,356305,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6799,SULT1A2,https://ctdbase.org/detail.go?type=gene&acc=6799,,,6799.0,SULT1A2,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1A2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5478,356306,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6819,SULT1C2,https://ctdbase.org/detail.go?type=gene&acc=6819,,,6819.0,SULT1C2,9606.0,Homo sapiens (human),Entinostat results in increased expression of SULT1C2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5479,356307,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6819,SULT1C2,https://ctdbase.org/detail.go?type=gene&acc=6819,,,6819.0,SULT1C2,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5480,356308,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6820,SULT2B1,https://ctdbase.org/detail.go?type=gene&acc=6820,,,6820.0,SULT2B1,9606.0,Homo sapiens (human),Entinostat results in increased expression of SULT2B1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5481,356309,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,56241,SUSD2,https://ctdbase.org/detail.go?type=gene&acc=56241,,,56241.0,SUSD2,9606.0,Homo sapiens (human),Entinostat results in increased expression of SUSD2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
5482,356310,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,56241,SUSD2,https://ctdbase.org/detail.go?type=gene&acc=56241,,,56241.0,SUSD2,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SUSD2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5483,356311,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,203328,SUSD3,https://ctdbase.org/detail.go?type=gene&acc=203328,,,203328.0,SUSD3,9606.0,Homo sapiens (human),Entinostat results in increased expression of SUSD3 mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
5484,356312,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,203328,SUSD3,https://ctdbase.org/detail.go?type=gene&acc=203328,,,203328.0,SUSD3,9606.0,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SUSD3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5485,357063,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,85461,TANC1,https://ctdbase.org/detail.go?type=gene&acc=85461,,,85461.0,TANC1,9606.0,Homo sapiens (human),Entinostat results in increased expression of TANC1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5486,357064,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,6890,TAP1,https://ctdbase.org/detail.go?type=gene&acc=6890,,,6890.0,TAP1,9606.0,Homo sapiens (human),Entinostat results in increased expression of TAP1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
5487,354832,4266,BindingDB,Muscimol,23183,"5-(aminomethyl)-1,2-oxazol-3-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23183,2337,D-amino-acid oxidase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2337,P00371,D-amino-acid oxidase,397134.0,DAO,9823.0,Sus scrofa (pig),,IC50 (nM),>100000,PMID:18507366|DOI:10.1021/jm800200u,https://www.ncbi.nlm.nih.gov/pubmed/18507366|https://doi.org/10.1021/jm800200u,18507366,10.1021/jm800200u,
5488,358752,4449,Comparative Toxicogenomics Database (CTD),Nefazodone,C051752,nefazodone,https://ctdbase.org/detail.go?type=chem&acc=C051752,372,ARCN1,https://ctdbase.org/detail.go?type=gene&acc=372,,,372.0,ARCN1,10116.0,Rattus norvegicus (Norway rat),Nefazodone results in increased expression of ARCN1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5489,357966,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,129285,PPP1R21,https://ctdbase.org/detail.go?type=gene&acc=129285,,,129285.0,PPP1R21,10116.0,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of PPP1R21 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5490,357967,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,79660,PPP1R3B,https://ctdbase.org/detail.go?type=gene&acc=79660,,,79660.0,PPP1R3B,10116.0,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of PPP1R3B mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5491,357968,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,5507,PPP1R3C,https://ctdbase.org/detail.go?type=gene&acc=5507,,,5507.0,PPP1R3C,10116.0,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of PPP1R3C mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5492,357969,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,5525,PPP2R5A,https://ctdbase.org/detail.go?type=gene&acc=5525,,,5525.0,PPP2R5A,10116.0,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of PPP2R5A mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5493,357970,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,57223,PPP4R3B,https://ctdbase.org/detail.go?type=gene&acc=57223,,,57223.0,PPP4R3B,10116.0,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of PPP4R3B mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5494,357971,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,63977,PRDM15,https://ctdbase.org/detail.go?type=gene&acc=63977,,,63977.0,PRDM15,10116.0,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of PRDM15 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5495,359733,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Nimesulide inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 mrna],,,PMID:19931610,https://www.ncbi.nlm.nih.gov/pubmed/19931610,19931610,,
5496,359734,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),"Nimesulide inhibits the reaction [soluble tachyzoite antigen, toxoplasma gondii results in increased expression of PTGS2 mrna]|nimesulide inhibits the reaction [[soluble tachyzoite antigen, toxoplasma gondii results in increased expression of PTGS2 mrna] which results in increased abundance of dinoprostone]",,,PMID:18305957,https://www.ncbi.nlm.nih.gov/pubmed/18305957,18305957,,
5497,359735,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,23682,RAB38,https://ctdbase.org/detail.go?type=gene&acc=23682,,,23682.0,RAB38,10116.0,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of RAB38 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5498,359736,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,55969,RAB5IF,https://ctdbase.org/detail.go?type=gene&acc=55969,,,55969.0,RAB5IF,10116.0,Rattus norvegicus (Norway rat),Nimesulide results in increased expression of RAB5IF mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5499,359737,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,10567,RABAC1,https://ctdbase.org/detail.go?type=gene&acc=10567,,,10567.0,RABAC1,10116.0,Rattus norvegicus (Norway rat),Nimesulide results in increased expression of RABAC1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5500,359738,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,9135,RABEP1,https://ctdbase.org/detail.go?type=gene&acc=9135,,,9135.0,RABEP1,10116.0,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of RABEP1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
5501,360154,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10116.0,Rattus norvegicus (Norway rat),[nimesulide results in decreased activity of PTGS2 protein] which results in increased susceptibility to morphine,,,PMID:14511336,https://www.ncbi.nlm.nih.gov/pubmed/14511336,14511336,,
5502,341092,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,2904,GRIN2B,https://ctdbase.org/detail.go?type=gene&acc=2904,,,2904.0,GRIN2B,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [pilocarpine results in increased expression of GRIN2B protein],,,PMID:22824136,https://www.ncbi.nlm.nih.gov/pubmed/22824136,22824136,,
5503,341093,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,2896,GRN,https://ctdbase.org/detail.go?type=gene&acc=2896,,,2896.0,GRN,10116.0,Rattus norvegicus (Norway rat),"2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [wortmannin inhibits the reaction [GRN protein results in decreased susceptibility to 1-methyl-4-phenyl-2,3-dihydropyridinium]]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [GRN protein results in decreased susceptibility to 1-methyl-4-phenyl-2,3-dihydropyridinium]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [GRN protein results in increased phosphorylation of MAPK3 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [GRN protein results in increased phosphorylation of MAPK1 protein]",,,PMID:21820214,https://www.ncbi.nlm.nih.gov/pubmed/21820214,21820214,,
5504,341094,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,2896,GRN,https://ctdbase.org/detail.go?type=gene&acc=2896,,,2896.0,GRN,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [trimetazidine inhibits the reaction [paclitaxel results in decreased expression of GRN mrna]],,,PMID:35662665,https://www.ncbi.nlm.nih.gov/pubmed/35662665,35662665,,
5505,342585,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [troglitazone results in increased expression of EGR1 protein],,,PMID:12475986,https://www.ncbi.nlm.nih.gov/pubmed/12475986,12475986,,
5506,342586,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of EGR1 mRNA,,,PMID:12706485,https://www.ncbi.nlm.nih.gov/pubmed/12706485,12706485,,
5507,342587,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,10090.0,Mus musculus (house mouse),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hydrogen peroxide results in increased expression of EGR1 mrna],,,PMID:19786089,https://www.ncbi.nlm.nih.gov/pubmed/19786089,19786089,,
5508,342588,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,10090.0,Mus musculus (house mouse),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tobacco smoke pollution promotes the reaction [particulate matter results in increased expression of EGR1 mrna]]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [particulate matter promotes the reaction [tobacco smoke pollution results in increased expression of EGR1 mrna]]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tobacco smoke pollution results in increased expression of EGR1 mrna],,,PMID:22178768,https://www.ncbi.nlm.nih.gov/pubmed/22178768,22178768,,
5509,343016,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,2022,ENG,https://ctdbase.org/detail.go?type=gene&acc=2022,,,2022.0,ENG,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [AGT protein results in increased expression of ENG protein],,,PMID:15539634,https://www.ncbi.nlm.nih.gov/pubmed/15539634,15539634,,
5510,343017,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein]],,,PMID:16928824,https://www.ncbi.nlm.nih.gov/pubmed/16928824,16928824,,
5511,343018,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,2033,EP300,https://ctdbase.org/detail.go?type=gene&acc=2033,,,2033.0,EP300,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [phenylephrine results in increased expression of EP300 mrna],,,PMID:11705990,https://www.ncbi.nlm.nih.gov/pubmed/11705990,11705990,,
5512,344755,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [homocysteine results in increased phosphorylation of MAPK1 protein],,,PMID:16251475,https://www.ncbi.nlm.nih.gov/pubmed/16251475,16251475,,
5513,344756,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [humic substances results in increased phosphorylation of MAPK1 protein],,,PMID:19686714,https://www.ncbi.nlm.nih.gov/pubmed/19686714,19686714,,
5514,344757,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hydrogen peroxide results in increased phosphorylation of and results in increased activity of MAPK1 protein],,,PMID:10640773,https://www.ncbi.nlm.nih.gov/pubmed/10640773,10640773,,
5515,344758,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hydrogen peroxide results in increased phosphorylation of MAPK1 protein],,,PMID:19699794,https://www.ncbi.nlm.nih.gov/pubmed/19699794,19699794,,
5516,344759,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hydroquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein],,,PMID:15129224,https://www.ncbi.nlm.nih.gov/pubmed/15129224,15129224,,
5517,344760,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[IGF1 protein co-treated with estradiol] results in increased phosphorylation of MAPK1 protein],,,PMID:17458902,https://www.ncbi.nlm.nih.gov/pubmed/17458902,17458902,,
5518,344761,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein promotes the reaction [1-methyl-4-phenylpyridinium results in increased phosphorylation of MAPK1 protein]],,,PMID:20064577,https://www.ncbi.nlm.nih.gov/pubmed/20064577,20064577,,
5519,344762,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IL17A protein results in increased phosphorylation of and results in increased activity of MAPK1 protein],,,PMID:12016129,https://www.ncbi.nlm.nih.gov/pubmed/12016129,12016129,,
5520,345609,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [pentachlorophenol results in increased expression of and results in increased secretion of IL6 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [DDT results in increased expression of and results in increased secretion of IL6 protein],,,PMID:31542660,https://www.ncbi.nlm.nih.gov/pubmed/31542660,31542660,,
5521,345610,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hexabromocyclododecane results in increased expression of IL6 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tetrabromobisphenol A results in increased expression of IL6 protein],,,PMID:26718265,https://www.ncbi.nlm.nih.gov/pubmed/26718265,26718265,,
5522,345611,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IL17A protein results in increased expression of IL6 protein],,,PMID:12016129,https://www.ncbi.nlm.nih.gov/pubmed/12016129,12016129,,
5523,345612,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[IL1B protein co-treated with IL6 protein] results in increased expression of and results in increased secretion of CRP protein],,,PMID:17388968,https://www.ncbi.nlm.nih.gov/pubmed/17388968,17388968,,
5524,345613,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IL6 protein results in increased expression of KLK3 mrna],,,PMID:11410519,https://www.ncbi.nlm.nih.gov/pubmed/11410519,11410519,,
5525,345614,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lipopolysaccharides results in increased expression of IL6 mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lipopolysaccharides results in increased expression of IL6 protein],,,PMID:26862037,https://www.ncbi.nlm.nih.gov/pubmed/26862037,26862037,,
5526,345615,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [melamine results in increased expression of IL6 mrna],,,PMID:22915474,https://www.ncbi.nlm.nih.gov/pubmed/22915474,22915474,,
5527,345616,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[nickel sulfate co-treated with macrophage stimulatory lipopeptide 2] results in increased secretion of IL6 protein],,,PMID:20600219,https://www.ncbi.nlm.nih.gov/pubmed/20600219,20600219,,
5528,347559,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9685.0,Felis catus (domestic cat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hydrogen peroxide results in increased activity of MAPK1 protein],,,PMID:15328380,https://www.ncbi.nlm.nih.gov/pubmed/15328380,15328380,,
5529,349022,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3684,ITGAM,https://ctdbase.org/detail.go?type=gene&acc=3684,,,3684.0,ITGAM,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [dasatinib results in increased expression of ITGAM protein],,,PMID:23825585,https://www.ncbi.nlm.nih.gov/pubmed/23825585,23825585,,
5530,349023,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3684,ITGAM,https://ctdbase.org/detail.go?type=gene&acc=3684,,,3684.0,ITGAM,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [gefitinib promotes the reaction [arsenic trioxide results in increased expression of ITGAM protein]],,,PMID:20226526,https://www.ncbi.nlm.nih.gov/pubmed/20226526,20226526,,
5531,349024,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3684,ITGAM,https://ctdbase.org/detail.go?type=gene&acc=3684,,,3684.0,ITGAM,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tretinoin results in increased expression of ITGAM protein],,,PMID:16617325,https://www.ncbi.nlm.nih.gov/pubmed/16617325,16617325,,
5532,349025,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3689,ITGB2,https://ctdbase.org/detail.go?type=gene&acc=3689,,,3689.0,ITGB2,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tributyltin affects the localization of ITGB2 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tetradecanoylphorbol acetate affects the localization of ITGB2 protein],,,PMID:20883105,https://www.ncbi.nlm.nih.gov/pubmed/20883105,20883105,,
5533,349026,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3690,ITGB3,https://ctdbase.org/detail.go?type=gene&acc=3690,,,3690.0,ITGB3,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ITGB3 protein results in increased susceptibility to carmustine],,,PMID:21332719,https://www.ncbi.nlm.nih.gov/pubmed/21332719,21332719,,
5534,349027,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3690,ITGB3,https://ctdbase.org/detail.go?type=gene&acc=3690,,,3690.0,ITGB3,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [thyroxine promotes the reaction [SRC protein binds to ITGB3 protein]]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [triiodothyronine promotes the reaction [SRC protein binds to ITGB3 protein]],,,PMID:22227104,https://www.ncbi.nlm.nih.gov/pubmed/22227104,22227104,,
5535,350608,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [T-2 toxin results in increased expression of IL1B mrna],,,PMID:29079362,https://www.ncbi.nlm.nih.gov/pubmed/29079362,29079362,,
5536,350609,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IL2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IL2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IL2 protein results in increased expression of PRF1 protein],,,PMID:20082299,https://www.ncbi.nlm.nih.gov/pubmed/20082299,20082299,,
5537,350610,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [norcantharidin inhibits the reaction [[ionomycin co-treated with tetradecanoylphorbol acetate] results in increased secretion of IL2 protein]],,,PMID:21075198,https://www.ncbi.nlm.nih.gov/pubmed/21075198,21075198,,
5538,350611,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3558,IL2,https://ctdbase.org/detail.go?type=gene&acc=3558,,,3558.0,IL2,10090.0,Mus musculus (house mouse),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [zymosan results in increased expression of IL2 protein],,,PMID:17458858,https://www.ncbi.nlm.nih.gov/pubmed/17458858,17458858,,
5539,350612,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,50604,IL20,https://ctdbase.org/detail.go?type=gene&acc=50604,,,50604.0,IL20,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [trimetazidine inhibits the reaction [paclitaxel results in increased expression of IL20 protein]],,,PMID:35662665,https://www.ncbi.nlm.nih.gov/pubmed/35662665,35662665,,
5540,350613,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,11009,IL24,https://ctdbase.org/detail.go?type=gene&acc=11009,,,11009.0,IL24,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [IL24 protein results in increased expression of MMP1 protein],,,PMID:25168428,https://www.ncbi.nlm.nih.gov/pubmed/25168428,25168428,,
5541,350614,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [dinitrophenyl-human serum albumin conjugate results in increased secretion of IL4 protein],,,PMID:10611455,https://www.ncbi.nlm.nih.gov/pubmed/10611455,10611455,,
5542,350615,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9913.0,Bos taurus (cattle),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lipopolysaccharides results in increased secretion of IL6 protein],,,PMID:22053092,https://www.ncbi.nlm.nih.gov/pubmed/22053092,22053092,,
5543,353063,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3248,HPGD,https://ctdbase.org/detail.go?type=gene&acc=3248,,,3248.0,HPGD,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased activity of HPGD protein,,,PMID:19501039,https://www.ncbi.nlm.nih.gov/pubmed/19501039,19501039,,
5544,353064,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3265,HRAS,https://ctdbase.org/detail.go?type=gene&acc=3265,,,3265.0,HRAS,7955.0,Danio rerio (zebrafish),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [HRAS protein mutant form results in increased expression of MIR146A mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [HRAS protein mutant form results in increased expression of DRE-MIR-21-2 mrna],,,PMID:30619488,https://www.ncbi.nlm.nih.gov/pubmed/30619488,30619488,,
5545,353065,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3290,HSD11B1,https://ctdbase.org/detail.go?type=gene&acc=3290,,,3290.0,HSD11B1,10090.0,Mus musculus (house mouse),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[trimethyltin chloride results in increased abundance of trimethyltin] which results in increased expression of HSD11B1 mrna],,,PMID:30993381,https://www.ncbi.nlm.nih.gov/pubmed/30993381,30993381,,
5546,353066,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,3284,HSD3B2,https://ctdbase.org/detail.go?type=gene&acc=3284,,,3284.0,HSD3B2,9606.0,Homo sapiens (human),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of HSD3B2 mRNA,,,PMID:17138841,https://www.ncbi.nlm.nih.gov/pubmed/17138841,17138841,,
5547,357972,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of MAPK1 protein],,,PMID:12657697,https://www.ncbi.nlm.nih.gov/pubmed/12657697,12657697,,
5548,357973,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lysophosphatidylcholines results in increased phosphorylation of MAPK1 protein],,,PMID:20564508,https://www.ncbi.nlm.nih.gov/pubmed/20564508,20564508,,
5549,357974,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride results in increased phosphorylation of MAPK1 protein],,,PMID:23811825,https://www.ncbi.nlm.nih.gov/pubmed/23811825,23811825,,
5550,357975,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[methionine deficiency co-treated with cysteine deficiency] results in increased phosphorylation of and results in increased activity of MAPK1 protein],,,PMID:11709198,https://www.ncbi.nlm.nih.gov/pubmed/11709198,11709198,,
5551,359061,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of [MAPK1 protein co-treated with MAPK3 protein]] which results in decreased susceptibility to hydrogen peroxide,,,PMID:14975446,https://www.ncbi.nlm.nih.gov/pubmed/14975446,14975446,,
5552,359062,4713,Comparative Toxicogenomics Database (CTD),2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,C093973,2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one,https://ctdbase.org/detail.go?type=chem&acc=C093973,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in decreased activity of MAPK1 protein,,,PMID:12758056,https://www.ncbi.nlm.nih.gov/pubmed/12758056,12758056,,
5553,295555,4873,Comparative Toxicogenomics Database (CTD),Potassium Chloride,D011189,Potassium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D011189,729288,ZNF286B,https://ctdbase.org/detail.go?type=gene&acc=729288,,,729288.0,ZNF286B,9606.0,Homo sapiens (human),[dronabinol results in decreased susceptibility to potassium chloride] which results in increased expression of ZNF286B mRNA,,,PMID:29691375,https://www.ncbi.nlm.nih.gov/pubmed/29691375,29691375,,
5554,295556,4873,Comparative Toxicogenomics Database (CTD),Potassium Chloride,D011189,Potassium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D011189,57336,ZNF287,https://ctdbase.org/detail.go?type=gene&acc=57336,,,57336.0,ZNF287,9606.0,Homo sapiens (human),[dronabinol results in decreased susceptibility to potassium chloride] which results in decreased expression of ZNF287 mRNA,,,PMID:29691375,https://www.ncbi.nlm.nih.gov/pubmed/29691375,29691375,,
5555,295557,4873,Comparative Toxicogenomics Database (CTD),Potassium Chloride,D011189,Potassium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D011189,90075,ZNF30,https://ctdbase.org/detail.go?type=gene&acc=90075,,,90075.0,ZNF30,9606.0,Homo sapiens (human),[dronabinol results in decreased susceptibility to potassium chloride] which results in decreased expression of ZNF30 mRNA,,,PMID:29691375,https://www.ncbi.nlm.nih.gov/pubmed/29691375,29691375,,
5556,295558,4873,Comparative Toxicogenomics Database (CTD),Potassium Chloride,D011189,Potassium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D011189,252884,ZNF396,https://ctdbase.org/detail.go?type=gene&acc=252884,,,252884.0,ZNF396,9606.0,Homo sapiens (human),[dronabinol results in decreased susceptibility to potassium chloride] which results in decreased expression of ZNF396 mRNA,,,PMID:29691375,https://www.ncbi.nlm.nih.gov/pubmed/29691375,29691375,,
5557,295559,4873,Comparative Toxicogenomics Database (CTD),Potassium Chloride,D011189,Potassium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D011189,84307,ZNF397,https://ctdbase.org/detail.go?type=gene&acc=84307,,,84307.0,ZNF397,9606.0,Homo sapiens (human),[dronabinol results in decreased susceptibility to potassium chloride] which results in decreased expression of ZNF397 mRNA,,,PMID:29691375,https://www.ncbi.nlm.nih.gov/pubmed/29691375,29691375,,
5558,296117,4873,Comparative Toxicogenomics Database (CTD),Potassium Chloride,D011189,Potassium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D011189,775,CACNA1C,https://ctdbase.org/detail.go?type=gene&acc=775,,,775.0,CACNA1C,9606.0,Homo sapiens (human),Nifedipine inhibits the reaction [[potassium chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein]|[potassium chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein|peroxynitrous acid inhibits the reaction [[potassium chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein],,,PMID:20128810,https://www.ncbi.nlm.nih.gov/pubmed/20128810,20128810,,
5559,301626,5205,DrugBank,Setiptiline,DB09304,Setiptiline,https://www.drugbank.ca/drugs/DB09304,BE0004862,5-hydroxytryptamine receptor 3A,https://www.drugbank.ca/bio_entities/BE0004862,P46098,5-hydroxytryptamine receptor 3A,3359.0,HTR3A,9606.0,Homo sapiens (human),Antagonist,,,PMID:2806365,https://www.ncbi.nlm.nih.gov/pubmed/2806365,2806365,,
5560,301627,5205,DrugBank,Setiptiline,DB09304,Setiptiline,https://www.drugbank.ca/drugs/DB09304,BE0004862,5-hydroxytryptamine receptor 3B,https://www.drugbank.ca/bio_entities/BE0004862,O95264,5-hydroxytryptamine receptor 3B,9177.0,HTR3B,9606.0,Homo sapiens (human),Antagonist,,,PMID:2806365,https://www.ncbi.nlm.nih.gov/pubmed/2806365,2806365,,
5561,301628,5205,DrugBank,Setiptiline,DB09304,Setiptiline,https://www.drugbank.ca/drugs/DB09304,BE0004862,5-hydroxytryptamine receptor 3C,https://www.drugbank.ca/bio_entities/BE0004862,Q8WXA8,5-hydroxytryptamine receptor 3C,170572.0,HTR3C,9606.0,Homo sapiens (human),Antagonist,,,PMID:2806365,https://www.ncbi.nlm.nih.gov/pubmed/2806365,2806365,,
5562,302811,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,1052,CEBPD,https://ctdbase.org/detail.go?type=gene&acc=1052,,,1052.0,CEBPD,9606.0,Homo sapiens (human),Sulforaphane results in decreased expression of CEBPD mRNA,,,PMID:31838189,https://www.ncbi.nlm.nih.gov/pubmed/31838189,31838189,,
5563,302812,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,1053,CEBPE,https://ctdbase.org/detail.go?type=gene&acc=1053,,,1053.0,CEBPE,9606.0,Homo sapiens (human),Sulforaphane results in increased expression of CEBPE mRNA,,,PMID:26833863,https://www.ncbi.nlm.nih.gov/pubmed/26833863,26833863,,
5564,302813,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,338657,CENATAC,https://ctdbase.org/detail.go?type=gene&acc=338657,,,338657.0,CENATAC,10090.0,Mus musculus (house mouse),[sulforaphane affects the susceptibility to oxygen] which affects the expression of CENATAC mrna|sulforaphane results in decreased expression of CENATAC mRNA,,,PMID:30529165,https://www.ncbi.nlm.nih.gov/pubmed/30529165,30529165,,
5565,303342,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,1140,CHRNB1,https://ctdbase.org/detail.go?type=gene&acc=1140,,,1140.0,CHRNB1,9606.0,Homo sapiens (human),Sulforaphane results in decreased expression of CHRNB1 mRNA,,,PMID:31838189,https://www.ncbi.nlm.nih.gov/pubmed/31838189,31838189,,
5566,303343,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,166012,CHST13,https://ctdbase.org/detail.go?type=gene&acc=166012,,,166012.0,CHST13,9606.0,Homo sapiens (human),Sulforaphane results in decreased expression of CHST13 mRNA,,,PMID:31838189,https://www.ncbi.nlm.nih.gov/pubmed/31838189,31838189,,
5567,303344,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,51363,CHST15,https://ctdbase.org/detail.go?type=gene&acc=51363,,,51363.0,CHST15,9606.0,Homo sapiens (human),Sulforaphane results in increased expression of CHST15 mRNA,,,PMID:31838189,https://www.ncbi.nlm.nih.gov/pubmed/31838189,31838189,,
5568,303345,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,9435,CHST2,https://ctdbase.org/detail.go?type=gene&acc=9435,,,9435.0,CHST2,9606.0,Homo sapiens (human),Sulforaphane results in decreased expression of CHST2 mRNA,,,PMID:31838189,https://www.ncbi.nlm.nih.gov/pubmed/31838189,31838189,,
5569,303346,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,1149,CIDEA,https://ctdbase.org/detail.go?type=gene&acc=1149,,,1149.0,CIDEA,10090.0,Mus musculus (house mouse),Sulforaphane results in increased expression of CIDEA mRNA,,,PMID:30529165,https://www.ncbi.nlm.nih.gov/pubmed/30529165,30529165,,
5570,303347,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,148113,CILP2,https://ctdbase.org/detail.go?type=gene&acc=148113,,,148113.0,CILP2,9606.0,Homo sapiens (human),Sulforaphane results in increased expression of CILP2 mRNA,,,PMID:31838189,https://www.ncbi.nlm.nih.gov/pubmed/31838189,31838189,,
5571,303348,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,148113,CILP2,https://ctdbase.org/detail.go?type=gene&acc=148113,,,148113.0,CILP2,10090.0,Mus musculus (house mouse),Sulforaphane results in increased expression of CILP2 mRNA,,,PMID:30529165,https://www.ncbi.nlm.nih.gov/pubmed/30529165,30529165,,
5572,303349,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,10370,CITED2,https://ctdbase.org/detail.go?type=gene&acc=10370,,,10370.0,CITED2,9606.0,Homo sapiens (human),Sulforaphane results in decreased expression of CITED2 mRNA,,,PMID:31838189,https://www.ncbi.nlm.nih.gov/pubmed/31838189,31838189,,
5573,303523,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,9022,CLIC3,https://ctdbase.org/detail.go?type=gene&acc=9022,,,9022.0,CLIC3,9606.0,Homo sapiens (human),Sulforaphane results in decreased expression of CLIC3 mRNA,,,PMID:31838189,https://www.ncbi.nlm.nih.gov/pubmed/31838189,31838189,,
5574,303524,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,54102,CLIC6,https://ctdbase.org/detail.go?type=gene&acc=54102,,,54102.0,CLIC6,10090.0,Mus musculus (house mouse),Sulforaphane results in increased expression of CLIC6 mRNA,,,PMID:30529165,https://www.ncbi.nlm.nih.gov/pubmed/30529165,30529165,,
5575,303525,5350,Comparative Toxicogenomics Database (CTD),Sulforaphane,C016766,sulforaphane,https://ctdbase.org/detail.go?type=chem&acc=C016766,1209,CLPTM1,https://ctdbase.org/detail.go?type=gene&acc=1209,,,1209.0,CLPTM1,10090.0,Mus musculus (house mouse),[sulforaphane affects the susceptibility to oxygen] which affects the expression of CLPTM1 mRNA,,,PMID:30529165,https://www.ncbi.nlm.nih.gov/pubmed/30529165,30529165,,
5576,341237,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,2781,GNAZ,https://ctdbase.org/detail.go?type=gene&acc=2781,,,2781.0,GNAZ,9606.0,Homo sapiens (human),Urethane results in decreased expression of GNAZ mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5577,341238,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,54584,GNB1L,https://ctdbase.org/detail.go?type=gene&acc=54584,,,54584.0,GNB1L,9606.0,Homo sapiens (human),Urethane results in decreased expression of GNB1L mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5578,341239,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,2784,GNB3,https://ctdbase.org/detail.go?type=gene&acc=2784,,,2784.0,GNB3,9606.0,Homo sapiens (human),Urethane results in decreased expression of GNB3 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5579,341240,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,2786,GNG4,https://ctdbase.org/detail.go?type=gene&acc=2786,,,2786.0,GNG4,9606.0,Homo sapiens (human),Urethane results in decreased expression of GNG4 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5580,341241,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,2787,GNG5,https://ctdbase.org/detail.go?type=gene&acc=2787,,,2787.0,GNG5,9606.0,Homo sapiens (human),Urethane results in decreased expression of GNG5 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5581,341242,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,26354,GNL3,https://ctdbase.org/detail.go?type=gene&acc=26354,,,26354.0,GNL3,9606.0,Homo sapiens (human),Urethane results in decreased expression of GNL3 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5582,341243,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,27232,GNMT,https://ctdbase.org/detail.go?type=gene&acc=27232,,,27232.0,GNMT,9606.0,Homo sapiens (human),Urethane results in decreased expression of GNMT mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5583,341244,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,10007,GNPDA1,https://ctdbase.org/detail.go?type=gene&acc=10007,,,10007.0,GNPDA1,9606.0,Homo sapiens (human),Urethane results in decreased expression of GNPDA1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5584,341784,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,56834,GPR137,https://ctdbase.org/detail.go?type=gene&acc=56834,,,56834.0,GPR137,9606.0,Homo sapiens (human),Urethane results in increased expression of GPR137 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5585,341785,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,7107,GPR137B,https://ctdbase.org/detail.go?type=gene&acc=7107,,,7107.0,GPR137B,9606.0,Homo sapiens (human),Urethane results in increased expression of GPR137B mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5586,341786,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,27239,GPR162,https://ctdbase.org/detail.go?type=gene&acc=27239,,,27239.0,GPR162,9606.0,Homo sapiens (human),Urethane results in decreased expression of GPR162 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5587,341943,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,114787,GPRIN1,https://ctdbase.org/detail.go?type=gene&acc=114787,,,114787.0,GPRIN1,9606.0,Homo sapiens (human),Urethane results in increased expression of GPRIN1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5588,341944,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,29899,GPSM2,https://ctdbase.org/detail.go?type=gene&acc=29899,,,29899.0,GPSM2,9606.0,Homo sapiens (human),Urethane results in increased expression of GPSM2 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5589,341945,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,9606.0,Homo sapiens (human),Urethane results in decreased expression of GPT mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5590,341946,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,2882,GPX7,https://ctdbase.org/detail.go?type=gene&acc=2882,,,2882.0,GPX7,9606.0,Homo sapiens (human),Urethane results in decreased expression of GPX7 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5591,341947,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,65983,GRAMD2B,https://ctdbase.org/detail.go?type=gene&acc=65983,,,65983.0,GRAMD2B,9606.0,Homo sapiens (human),Urethane results in increased expression of GRAMD2B mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5592,341948,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,10750,GRAP,https://ctdbase.org/detail.go?type=gene&acc=10750,,,10750.0,GRAP,9606.0,Homo sapiens (human),Urethane results in decreased expression of GRAP mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5593,341949,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,400581,GRAPL,https://ctdbase.org/detail.go?type=gene&acc=400581,,,400581.0,GRAPL,9606.0,Homo sapiens (human),Urethane results in decreased expression of GRAPL mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5594,341950,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,80000,GREB1L,https://ctdbase.org/detail.go?type=gene&acc=80000,,,80000.0,GREB1L,9606.0,Homo sapiens (human),Urethane results in decreased expression of GREB1L mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5595,344905,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,30811,HUNK,https://ctdbase.org/detail.go?type=gene&acc=30811,,,30811.0,HUNK,9606.0,Homo sapiens (human),Urethane results in decreased expression of HUNK mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5596,344906,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,3364,HUS1,https://ctdbase.org/detail.go?type=gene&acc=3364,,,3364.0,HUS1,9606.0,Homo sapiens (human),Urethane results in increased expression of HUS1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5597,344907,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,135458,HUS1B,https://ctdbase.org/detail.go?type=gene&acc=135458,,,135458.0,HUS1B,9606.0,Homo sapiens (human),Urethane results in increased expression of HUS1B mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5598,344908,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,84668,HYCC1,https://ctdbase.org/detail.go?type=gene&acc=84668,,,84668.0,HYCC1,9606.0,Homo sapiens (human),Urethane results in increased expression of HYCC1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5599,344909,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,285172,HYCC2,https://ctdbase.org/detail.go?type=gene&acc=285172,,,285172.0,HYCC2,9606.0,Homo sapiens (human),Urethane results in increased expression of HYCC2 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5600,346448,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,3565,IL4,https://ctdbase.org/detail.go?type=gene&acc=3565,,,3565.0,IL4,10090.0,Mus musculus (house mouse),Freund's adjuvant inhibits the reaction [urethane results in decreased expression of IL4 mrna]|urethane results in decreased expression of IL4 mrna|ifng protein inhibits the reaction [urethane results in decreased expression of IL4 mrna],,,PMID:12810352,https://www.ncbi.nlm.nih.gov/pubmed/12810352,12810352,,
5601,348857,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,10656,KHDRBS3,https://ctdbase.org/detail.go?type=gene&acc=10656,,,10656.0,KHDRBS3,9606.0,Homo sapiens (human),Urethane results in increased expression of KHDRBS3 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5602,348858,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,3795,KHK,https://ctdbase.org/detail.go?type=gene&acc=3795,,,3795.0,KHK,9606.0,Homo sapiens (human),Urethane results in decreased expression of KHK mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5603,348859,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,9786,KIAA0586,https://ctdbase.org/detail.go?type=gene&acc=9786,,,9786.0,KIAA0586,9606.0,Homo sapiens (human),Urethane results in increased expression of KIAA0586 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5604,348860,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,57670,KIAA1549,https://ctdbase.org/detail.go?type=gene&acc=57670,,,57670.0,KIAA1549,9606.0,Homo sapiens (human),Urethane results in increased expression of KIAA1549 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5605,348861,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,57691,KIAA1586,https://ctdbase.org/detail.go?type=gene&acc=57691,,,57691.0,KIAA1586,9606.0,Homo sapiens (human),Urethane results in decreased expression of KIAA1586 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5606,348862,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,85379,KIAA1671,https://ctdbase.org/detail.go?type=gene&acc=85379,,,85379.0,KIAA1671,9606.0,Homo sapiens (human),Urethane results in decreased expression of KIAA1671 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5607,348863,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,158405,KIAA1958,https://ctdbase.org/detail.go?type=gene&acc=158405,,,158405.0,KIAA1958,9606.0,Homo sapiens (human),Urethane results in increased expression of KIAA1958 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5608,351898,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,26175,LYSET,https://ctdbase.org/detail.go?type=gene&acc=26175,,,26175.0,LYSET,9606.0,Homo sapiens (human),Urethane results in decreased expression of LYSET mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5609,351899,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,388695,LYSMD1,https://ctdbase.org/detail.go?type=gene&acc=388695,,,388695.0,LYSMD1,9606.0,Homo sapiens (human),Urethane affects the expression of LYSMD1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5610,352760,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,9064,MAP3K6,https://ctdbase.org/detail.go?type=gene&acc=9064,,,9064.0,MAP3K6,9606.0,Homo sapiens (human),Urethane results in increased expression of MAP3K6 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5611,355149,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,100126308,MIR541,https://ctdbase.org/detail.go?type=gene&acc=100126308,,,100126308.0,MIR541,10090.0,Mus musculus (house mouse),Urethane results in increased expression of MIR541 mRNA,,,PMID:23761296,https://www.ncbi.nlm.nih.gov/pubmed/23761296,23761296,,
5612,355150,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,126353,MISP,https://ctdbase.org/detail.go?type=gene&acc=126353,,,126353.0,MISP,9606.0,Homo sapiens (human),Urethane results in decreased expression of MISP mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5613,355151,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,129531,MITD1,https://ctdbase.org/detail.go?type=gene&acc=129531,,,129531.0,MITD1,9606.0,Homo sapiens (human),Urethane results in decreased expression of MITD1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5614,355152,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4286,MITF,https://ctdbase.org/detail.go?type=gene&acc=4286,,,4286.0,MITF,9606.0,Homo sapiens (human),Urethane results in increased expression of MITF mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5615,355521,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),Urethane results in increased expression of MMP2 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5616,355522,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,10893,MMP24,https://ctdbase.org/detail.go?type=gene&acc=10893,,,10893.0,MMP24,9606.0,Homo sapiens (human),Urethane results in decreased expression of MMP24 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5617,355684,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,22879,MON1B,https://ctdbase.org/detail.go?type=gene&acc=22879,,,22879.0,MON1B,9606.0,Homo sapiens (human),Urethane results in increased expression of MON1B mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5618,357065,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,89853,MVB12B,https://ctdbase.org/detail.go?type=gene&acc=89853,,,89853.0,MVB12B,9606.0,Homo sapiens (human),Urethane results in decreased expression of MVB12B mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5619,357066,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4600,MX2,https://ctdbase.org/detail.go?type=gene&acc=4600,,,4600.0,MX2,9606.0,Homo sapiens (human),Urethane results in decreased expression of MX2 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5620,357067,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4084,MXD1,https://ctdbase.org/detail.go?type=gene&acc=4084,,,4084.0,MXD1,9606.0,Homo sapiens (human),Urethane results in increased expression of MXD1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5621,357068,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,10608,MXD4,https://ctdbase.org/detail.go?type=gene&acc=10608,,,10608.0,MXD4,9606.0,Homo sapiens (human),Urethane results in increased expression of MXD4 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5622,357069,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4601,MXI1,https://ctdbase.org/detail.go?type=gene&acc=4601,,,4601.0,MXI1,9606.0,Homo sapiens (human),Urethane results in increased expression of MXI1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5623,357070,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,91663,MYADM,https://ctdbase.org/detail.go?type=gene&acc=91663,,,91663.0,MYADM,9606.0,Homo sapiens (human),Urethane results in increased expression of MYADM mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5624,357071,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,10514,MYBBP1A,https://ctdbase.org/detail.go?type=gene&acc=10514,,,10514.0,MYBBP1A,9606.0,Homo sapiens (human),Urethane results in decreased expression of MYBBP1A mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5625,357072,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4603,MYBL1,https://ctdbase.org/detail.go?type=gene&acc=4603,,,4603.0,MYBL1,9606.0,Homo sapiens (human),Urethane results in increased expression of MYBL1 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5626,357237,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,22989,MYH15,https://ctdbase.org/detail.go?type=gene&acc=22989,,,22989.0,MYH15,9606.0,Homo sapiens (human),Urethane results in decreased expression of MYH15 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5627,357238,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4621,MYH3,https://ctdbase.org/detail.go?type=gene&acc=4621,,,4621.0,MYH3,9606.0,Homo sapiens (human),Urethane results in decreased expression of MYH3 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5628,357239,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4625,MYH7,https://ctdbase.org/detail.go?type=gene&acc=4625,,,4625.0,MYH7,9606.0,Homo sapiens (human),Urethane results in increased expression of MYH7 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5629,357240,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4627,MYH9,https://ctdbase.org/detail.go?type=gene&acc=4627,,,4627.0,MYH9,9606.0,Homo sapiens (human),Urethane results in increased expression of MYH9 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5630,357241,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4636,MYL5,https://ctdbase.org/detail.go?type=gene&acc=4636,,,4636.0,MYL5,9606.0,Homo sapiens (human),Urethane results in decreased expression of MYL5 mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5631,357386,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4430,MYO1B,https://ctdbase.org/detail.go?type=gene&acc=4430,,,4430.0,MYO1B,10090.0,Mus musculus (house mouse),Urethane results in decreased expression of MYO1B mRNA,,,PMID:16289808,https://www.ncbi.nlm.nih.gov/pubmed/16289808,16289808,,
5632,357387,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4642,MYO1D,https://ctdbase.org/detail.go?type=gene&acc=4642,,,4642.0,MYO1D,9606.0,Homo sapiens (human),Urethane results in increased expression of MYO1D mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5633,357388,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4643,MYO1E,https://ctdbase.org/detail.go?type=gene&acc=4643,,,4643.0,MYO1E,9606.0,Homo sapiens (human),Urethane results in increased expression of MYO1E mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5634,357389,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,64005,MYO1G,https://ctdbase.org/detail.go?type=gene&acc=64005,,,64005.0,MYO1G,9606.0,Homo sapiens (human),Urethane results in decreased expression of MYO1G mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5635,357390,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,4644,MYO5A,https://ctdbase.org/detail.go?type=gene&acc=4644,,,4644.0,MYO5A,9606.0,Homo sapiens (human),Urethane results in increased expression of MYO5A mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5636,357391,5641,Comparative Toxicogenomics Database (CTD),Urethane,D014520,Urethane,https://ctdbase.org/detail.go?type=chem&acc=D014520,55930,MYO5C,https://ctdbase.org/detail.go?type=gene&acc=55930,,,55930.0,MYO5C,9606.0,Homo sapiens (human),Urethane results in decreased expression of MYO5C mRNA,,,PMID:28818685,https://www.ncbi.nlm.nih.gov/pubmed/28818685,28818685,,
5637,357696,5656,DrugBank,Venlafaxine,DB00285,Venlafaxine,https://www.drugbank.ca/drugs/DB00285,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606.0,Homo sapiens (human),Substrate|Inhibitor,,,PMID:12649369|PMID:14550684|PMID:20466523|PMID:21446053|PMID:25567760,https://www.ncbi.nlm.nih.gov/pubmed/12649369|https://www.ncbi.nlm.nih.gov/pubmed/14550684|https://www.ncbi.nlm.nih.gov/pubmed/20466523|https://www.ncbi.nlm.nih.gov/pubmed/21446053|https://www.ncbi.nlm.nih.gov/pubmed/25567760,12649369|14550684|20466523|21446053|25567760,,
5638,357697,5656,DrugBank,Venlafaxine,DB00285,Venlafaxine,https://www.drugbank.ca/drugs/DB00285,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),Inducer,,,PMID:21446053,https://www.ncbi.nlm.nih.gov/pubmed/21446053,21446053,,
5639,357698,5656,DrugBank,Venlafaxine,DB00285,Venlafaxine,https://www.drugbank.ca/drugs/DB00285,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606.0,Homo sapiens (human),Substrate,,,PMID:10192828,https://www.ncbi.nlm.nih.gov/pubmed/10192828,10192828,,
5640,357699,5665,Drug Gene Interaction database (DGIdb),Vigabatrin,,VIGABATRIN,https://www.dgidb.org/drugs/rxcui:14851,,ABAT,https://www.dgidb.org/genes/hgnc:23,,,18.0,ABAT,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
5641,357700,5697,Drug Gene Interaction database (DGIdb),Xanthine amine congener,,PP2,https://www.dgidb.org/drugs/iuphar.ligand:9404,,TNK2,https://www.dgidb.org/genes/hgnc:19297,,,10188.0,TNK2,9606.0,Homo sapiens (human),,,,,,,,
5642,357701,5697,Drug Gene Interaction database (DGIdb),Xanthine amine congener,,PP2,https://www.dgidb.org/drugs/iuphar.ligand:9404,,CSNK1A1,https://www.dgidb.org/genes/hgnc:2451,,,1452.0,CSNK1A1,9606.0,Homo sapiens (human),,,,,,,,
5643,357702,5697,Drug Gene Interaction database (DGIdb),Xanthine amine congener,,PP2,https://www.dgidb.org/drugs/iuphar.ligand:9404,,MAP2K2,https://www.dgidb.org/genes/hgnc:6842,,,5605.0,MAP2K2,9606.0,Homo sapiens (human),,,,,,,,
5644,357703,5697,Drug Gene Interaction database (DGIdb),Xanthine amine congener,,PP2,https://www.dgidb.org/drugs/iuphar.ligand:9404,,CYP1A2,https://www.dgidb.org/genes/hgnc:2596,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,,,,,
5645,357704,5697,Drug Gene Interaction database (DGIdb),Xanthine amine congener,,PP2,https://www.dgidb.org/drugs/iuphar.ligand:9404,,LCK,https://www.dgidb.org/genes/hgnc:6524,,,3932.0,LCK,9606.0,Homo sapiens (human),,,,,,,,
5646,358594,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,14961,H2-AB1,https://ctdbase.org/detail.go?type=gene&acc=14961,,,14961.0,H2-Ab1,10090.0,Mus musculus (house mouse),Dexamethasone results in increased expression of H2-AB1 mRNA,,,PMID:21041162,https://www.ncbi.nlm.nih.gov/pubmed/21041162,21041162,,
5647,358595,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,14961,H2-AB1,https://ctdbase.org/detail.go?type=gene&acc=14961,,,14961.0,H2-Ab1,10116.0,Rattus norvegicus (Norway rat),Dexamethasone results in decreased expression of H2-AB1 mRNA,,,PMID:14618091,https://www.ncbi.nlm.nih.gov/pubmed/14618091,14618091,,
5648,358596,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,221613,H2AC1,https://ctdbase.org/detail.go?type=gene&acc=221613,,,221613.0,H2AC1,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of H2AC1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5649,358597,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,8331,H2AC14,https://ctdbase.org/detail.go?type=gene&acc=8331,,,8331.0,H2AC14,9606.0,Homo sapiens (human),Dexamethasone results in increased expression of H2AC14 mRNA,,,PMID:25047013,https://www.ncbi.nlm.nih.gov/pubmed/25047013,25047013,,
5650,358598,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,8338,H2AC20,https://ctdbase.org/detail.go?type=gene&acc=8338,,,8338.0,H2AC20,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of H2AC20 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of H2AC20 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5651,359381,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,9563,H6PD,https://ctdbase.org/detail.go?type=gene&acc=9563,,,9563.0,H6PD,10090.0,Mus musculus (house mouse),Dexamethasone results in increased expression of H6PD mRNA,,,PMID:22733784|PMID:23946490,https://www.ncbi.nlm.nih.gov/pubmed/22733784|https://www.ncbi.nlm.nih.gov/pubmed/23946490,22733784|23946490,,
5652,359382,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,9563,H6PD,https://ctdbase.org/detail.go?type=gene&acc=9563,,,9563.0,H6PD,9940.0,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of H6PD mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
5653,359383,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,23498,HAAO,https://ctdbase.org/detail.go?type=gene&acc=23498,,,23498.0,HAAO,7955.0,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of HAAO mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
5654,359384,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,23498,HAAO,https://ctdbase.org/detail.go?type=gene&acc=23498,,,23498.0,HAAO,9031.0,Gallus gallus (chicken),Dexamethasone results in decreased expression of HAAO mRNA,,,PMID:34464682,https://www.ncbi.nlm.nih.gov/pubmed/34464682,34464682,,
5655,359581,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,9200,HACD1,https://ctdbase.org/detail.go?type=gene&acc=9200,,,9200.0,HACD1,7955.0,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of HACD1 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
5656,359582,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,9200,HACD1,https://ctdbase.org/detail.go?type=gene&acc=9200,,,9200.0,HACD1,9606.0,Homo sapiens (human),Dexamethasone results in increased expression of HACD1 mRNA,,,PMID:25047013,https://www.ncbi.nlm.nih.gov/pubmed/25047013,25047013,,
5657,359583,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,201562,HACD2,https://ctdbase.org/detail.go?type=gene&acc=201562,,,201562.0,HACD2,9606.0,Homo sapiens (human),Dexamethasone results in increased expression of HACD2 mRNA,,,PMID:25047013,https://www.ncbi.nlm.nih.gov/pubmed/25047013,25047013,,
5658,359584,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,51495,HACD3,https://ctdbase.org/detail.go?type=gene&acc=51495,,,51495.0,HACD3,7955.0,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of HACD3 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
5659,359585,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,401494,HACD4,https://ctdbase.org/detail.go?type=gene&acc=401494,,,401494.0,HACD4,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of HACD4 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5660,359586,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,3033,HADH,https://ctdbase.org/detail.go?type=gene&acc=3033,,,3033.0,HADH,9606.0,Homo sapiens (human),Dexamethasone results in increased expression of HADH mRNA,,,PMID:25047013,https://www.ncbi.nlm.nih.gov/pubmed/25047013,25047013,,
5661,359587,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,3033,HADH,https://ctdbase.org/detail.go?type=gene&acc=3033,,,3033.0,HADH,9606.0,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in increased expression of HADH mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
5662,359588,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,3033,HADH,https://ctdbase.org/detail.go?type=gene&acc=3033,,,3033.0,HADH,10090.0,Mus musculus (house mouse),[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS1 protein] results in increased expression of HADH mRNA,,,PMID:23428407,https://www.ncbi.nlm.nih.gov/pubmed/23428407,23428407,,
5663,717253,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7051,TGM1,https://ctdbase.org/detail.go?type=gene&acc=7051,,,7051.0,TGM1,7955.0,Danio rerio (zebrafish),Bisphenol A results in increased expression of TGM1 mRNA,,,PMID:30826544,https://www.ncbi.nlm.nih.gov/pubmed/30826544,30826544,,
5664,717446,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,566581,TGM1L1,https://ctdbase.org/detail.go?type=gene&acc=566581,,,566581.0,tgm1l1,8090.0,Oryzias latipes (Japanese medaka),Bisphenol A results in increased expression of TGM1L1 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
5665,717447,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,793448,TGM1L3,https://ctdbase.org/detail.go?type=gene&acc=793448,,,793448.0,tgm1l3,7955.0,Danio rerio (zebrafish),Bisphenol A affects the methylation of TGM1L3 intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
5666,717448,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7052,TGM2,https://ctdbase.org/detail.go?type=gene&acc=7052,,,7052.0,TGM2,9606.0,Homo sapiens (human),Bisphenol A results in decreased expression of TGM2 mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
5667,717449,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7052,TGM2,https://ctdbase.org/detail.go?type=gene&acc=7052,,,7052.0,TGM2,10090.0,Mus musculus (house mouse),Bisphenol A results in decreased methylation of TGM2 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
5668,717450,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7052,TGM2,https://ctdbase.org/detail.go?type=gene&acc=7052,,,7052.0,TGM2,10090.0,Mus musculus (house mouse),Bisphenol A results in increased expression of TGM2 mRNA,,,PMID:30951980|PMID:32156529|PMID:34585602,https://www.ncbi.nlm.nih.gov/pubmed/30951980|https://www.ncbi.nlm.nih.gov/pubmed/32156529|https://www.ncbi.nlm.nih.gov/pubmed/34585602,30951980|32156529|34585602,,
5669,717451,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7052,TGM2,https://ctdbase.org/detail.go?type=gene&acc=7052,,,7052.0,TGM2,10116.0,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in decreased expression of TGM2 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
5670,717452,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7052,TGM2,https://ctdbase.org/detail.go?type=gene&acc=7052,,,7052.0,TGM2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of TGM2 mRNA,,,PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/30816183,30816183,,
5671,717453,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7052,TGM2,https://ctdbase.org/detail.go?type=gene&acc=7052,,,7052.0,TGM2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of TGM2 protein,,,PMID:22649256,https://www.ncbi.nlm.nih.gov/pubmed/22649256,22649256,,
5672,717454,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,7052,TGM2,https://ctdbase.org/detail.go?type=gene&acc=7052,,,7052.0,TGM2,10116.0,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of TGM2 mRNA,,,PMID:25181051|PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/32145629,25181051|32145629,,
5673,717804,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,80339,PNPLA3,https://ctdbase.org/detail.go?type=gene&acc=80339,,,80339.0,PNPLA3,10116.0,Rattus norvegicus (Norway rat),Rotenone results in decreased expression of PNPLA3 mRNA,,,PMID:28374803,https://www.ncbi.nlm.nih.gov/pubmed/28374803,28374803,,
5674,717805,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,375775,PNPLA7,https://ctdbase.org/detail.go?type=gene&acc=375775,,,375775.0,PNPLA7,10116.0,Rattus norvegicus (Norway rat),Rotenone results in increased expression of PNPLA7 mRNA,,,PMID:28374803,https://www.ncbi.nlm.nih.gov/pubmed/28374803,28374803,,
5675,717806,6758,Comparative Toxicogenomics Database (CTD),Rotenone,D012402,Rotenone,https://ctdbase.org/detail.go?type=chem&acc=D012402,10957,PNRC1,https://ctdbase.org/detail.go?type=gene&acc=10957,,,10957.0,PNRC1,9606.0,Homo sapiens (human),Rotenone results in decreased expression of PNRC1 mRNA,,,PMID:29955902,https://www.ncbi.nlm.nih.gov/pubmed/29955902,29955902,,
5676,717807,9049,BindingDB,Cycloguanil,18792,"1-(4-chlorophenyl)-6,6-dimethyl-1,6-dihydro-1,3,5-triazine-2,4-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18792,1940,Bifunctional dihydrofolate reductase-thymidylate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1940,P13922,Bifunctional dihydrofolate reductase-thymidylate synthase,,,5839.0,Plasmodium falciparum K1,,Ki (nM),6.2,PMID:12704428|DOI:10.1038/nsb921,https://www.ncbi.nlm.nih.gov/pubmed/12704428|https://doi.org/10.1038/nsb921,12704428,10.1038/nsb921,
5677,717808,9049,BindingDB,Cycloguanil,18792,"1-(4-chlorophenyl)-6,6-dimethyl-1,6-dihydro-1,3,5-triazine-2,4-diamine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18792,1939,Bifunctional dihydrofolate reductase-thymidylate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1939,,,,,,,,Ki (nM),0.3,PMID:12704428|DOI:10.1038/nsb921,https://www.ncbi.nlm.nih.gov/pubmed/12704428|https://doi.org/10.1038/nsb921,12704428,10.1038/nsb921,
5678,717809,9064,BindingDB,Cianidanol,23416,"&#945;-CA inhibitor, 3",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23416,10332,Carbonic anhydrase 3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10332,Q3SZX4,Carbonic anhydrase 3,513212.0,CA3,9913.0,Bos taurus (cattle),,Ki (nM),9.71e+3,PMID:22299585|DOI:10.3109/14756366.2011.651464,https://www.ncbi.nlm.nih.gov/pubmed/22299585|https://doi.org/10.3109/14756366.2011.651464,22299585,10.3109/14756366.2011.651464,
5679,717810,9128,Drug Gene Interaction database (DGIdb),Benzo[e]pyrene,,BENZO[E]PYRENE,https://www.dgidb.org/drugs/chembl:CHEMBL1371125,,HSD17B10,https://www.dgidb.org/genes/hgnc:4800,,,3028.0,HSD17B10,9606.0,Homo sapiens (human),,,,,,,,
5680,717811,9131,Comparative Toxicogenomics Database (CTD),"Indeno[1,2,3-cd]pyrene",C041508,"indeno(1,2,3-cd)pyrene",https://ctdbase.org/detail.go?type=chem&acc=C041508,6296,ACSM3,https://ctdbase.org/detail.go?type=gene&acc=6296,,,6296.0,ACSM3,10090.0,Mus musculus (house mouse),"Indeno(1,2,3-cd)pyrene results in decreased expression of ACSM3 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
5681,717812,9131,Comparative Toxicogenomics Database (CTD),"Indeno[1,2,3-cd]pyrene",C041508,"indeno(1,2,3-cd)pyrene",https://ctdbase.org/detail.go?type=chem&acc=C041508,170689,ADAMTS15,https://ctdbase.org/detail.go?type=gene&acc=170689,,,170689.0,ADAMTS15,10090.0,Mus musculus (house mouse),"Indeno(1,2,3-cd)pyrene results in decreased expression of ADAMTS15 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
5682,718289,9131,Comparative Toxicogenomics Database (CTD),"Indeno[1,2,3-cd]pyrene",C041508,"indeno(1,2,3-cd)pyrene",https://ctdbase.org/detail.go?type=chem&acc=C041508,51129,ANGPTL4,https://ctdbase.org/detail.go?type=gene&acc=51129,,,51129.0,ANGPTL4,10090.0,Mus musculus (house mouse),"Indeno(1,2,3-cd)pyrene results in decreased expression of ANGPTL4 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
5683,718290,9131,Comparative Toxicogenomics Database (CTD),"Indeno[1,2,3-cd]pyrene",C041508,"indeno(1,2,3-cd)pyrene",https://ctdbase.org/detail.go?type=chem&acc=C041508,374,AREG,https://ctdbase.org/detail.go?type=gene&acc=374,,,374.0,AREG,10090.0,Mus musculus (house mouse),"Indeno(1,2,3-cd)pyrene results in decreased expression of AREG mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
5684,718291,9131,Comparative Toxicogenomics Database (CTD),"Indeno[1,2,3-cd]pyrene",C041508,"indeno(1,2,3-cd)pyrene",https://ctdbase.org/detail.go?type=chem&acc=C041508,379,ARL4D,https://ctdbase.org/detail.go?type=gene&acc=379,,,379.0,ARL4D,10090.0,Mus musculus (house mouse),"Indeno(1,2,3-cd)pyrene results in decreased expression of ARL4D mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
5685,717445,12479,BindingDB,Catechol diacetate,178051,"1,2-phenylene diacetate (15)",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=178051,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),1537,PMID:26642829|DOI:10.1111/cbdd.12695,https://www.ncbi.nlm.nih.gov/pubmed/26642829|https://doi.org/10.1111/cbdd.12695,26642829,10.1111/cbdd.12695,
5686,718287,12560,ChEMBL,Erythromycin,CHEMBL532,ERYTHROMYCIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL532/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60624,50S ribosomal protein L24,944759.0,rpsT,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:20876130,https://www.ncbi.nlm.nih.gov/pubmed/20876130,20876130,,
5687,718288,12560,ChEMBL,Erythromycin,CHEMBL532,ERYTHROMYCIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL532/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P60723,50S ribosomal protein L4,83578037.0,,2.0,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:20876130,https://www.ncbi.nlm.nih.gov/pubmed/20876130,20876130,,
5688,1218278,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,10943,MSL3,https://ctdbase.org/detail.go?type=gene&acc=10943,,,10943.0,MSL3,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of MSL3 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
5689,1220815,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,23347,SMCHD1,https://ctdbase.org/detail.go?type=gene&acc=23347,,,23347.0,SMCHD1,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in decreased expression of SMCHD1 mRNA,,,PMID:32109520|PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/32109520|https://www.ncbi.nlm.nih.gov/pubmed/33387578,32109520|33387578,,
5690,1220816,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,23347,SMCHD1,https://ctdbase.org/detail.go?type=gene&acc=23347,,,23347.0,SMCHD1,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in increased expression of SMCHD1 mRNA,,,PMID:34747641,https://www.ncbi.nlm.nih.gov/pubmed/34747641,34747641,,
5691,1220817,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,255798,SMCO1,https://ctdbase.org/detail.go?type=gene&acc=255798,,,255798.0,SMCO1,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in decreased expression of SMCO1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5692,1220818,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,341346,SMCO2,https://ctdbase.org/detail.go?type=gene&acc=341346,,,341346.0,SMCO2,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in increased expression of SMCO2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5693,1220819,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,56935,SMCO4,https://ctdbase.org/detail.go?type=gene&acc=56935,,,56935.0,SMCO4,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in decreased expression of SMCO4 mRNA,,,PMID:34747641,https://www.ncbi.nlm.nih.gov/pubmed/34747641,34747641,,
5694,1220820,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4184,SMCP,https://ctdbase.org/detail.go?type=gene&acc=4184,,,4184.0,SMCP,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin affects the expression of SMCP mRNA,,,PMID:26377647,https://www.ncbi.nlm.nih.gov/pubmed/26377647,26377647,,
5695,1220821,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4184,SMCP,https://ctdbase.org/detail.go?type=gene&acc=4184,,,4184.0,SMCP,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin results in increased expression of SMCP mRNA,,,PMID:25975270|PMID:26290441|PMID:31511937,https://www.ncbi.nlm.nih.gov/pubmed/25975270|https://www.ncbi.nlm.nih.gov/pubmed/26290441|https://www.ncbi.nlm.nih.gov/pubmed/31511937,25975270|26290441|31511937,,
5696,1220822,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4184,SMCP,https://ctdbase.org/detail.go?type=gene&acc=4184,,,4184.0,SMCP,10090.0,Mus musculus (house mouse),[TIPARP gene mutant form results in increased susceptibility to tetrachlorodibenzodioxin] which results in increased expression of SMCP mRNA,,,PMID:25975270,https://www.ncbi.nlm.nih.gov/pubmed/25975270,25975270,,
5697,1220823,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,140775,SMCR8,https://ctdbase.org/detail.go?type=gene&acc=140775,,,140775.0,SMCR8,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in decreased expression of SMCR8 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5698,1221571,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,57509,MTUS1,https://ctdbase.org/detail.go?type=gene&acc=57509,,,57509.0,MTUS1,9606.0,Homo sapiens (human),Tetrachlorodibenzodioxin results in decreased expression of MTUS1 mRNA,,,PMID:21296121|PMID:29704546,https://www.ncbi.nlm.nih.gov/pubmed/21296121|https://www.ncbi.nlm.nih.gov/pubmed/29704546,21296121|29704546,,
5699,1221572,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,57509,MTUS1,https://ctdbase.org/detail.go?type=gene&acc=57509,,,57509.0,MTUS1,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin affects the expression of MTUS1 mRNA,,,PMID:21570461,https://www.ncbi.nlm.nih.gov/pubmed/21570461,21570461,,
5700,1221573,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,57509,MTUS1,https://ctdbase.org/detail.go?type=gene&acc=57509,,,57509.0,MTUS1,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in decreased expression of MTUS1 mRNA,,,PMID:19490992|PMID:21215274,https://www.ncbi.nlm.nih.gov/pubmed/19490992|https://www.ncbi.nlm.nih.gov/pubmed/21215274,19490992|21215274,,
5701,1221574,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,57509,MTUS1,https://ctdbase.org/detail.go?type=gene&acc=57509,,,57509.0,MTUS1,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in increased expression of MTUS1 mRNA,,,PMID:34747641,https://www.ncbi.nlm.nih.gov/pubmed/34747641,34747641,,
5702,1221575,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,246754,MTVR2,https://ctdbase.org/detail.go?type=gene&acc=246754,,,246754.0,MTVR2,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin affects the expression of MTVR2 mRNA,,,PMID:21570461,https://www.ncbi.nlm.nih.gov/pubmed/21570461,21570461,,
5703,1221576,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4580,MTX1,https://ctdbase.org/detail.go?type=gene&acc=4580,,,4580.0,MTX1,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin affects the expression of MTX1 mRNA,,,PMID:21570461,https://www.ncbi.nlm.nih.gov/pubmed/21570461,21570461,,
5704,1224002,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4615,MYD88,https://ctdbase.org/detail.go?type=gene&acc=4615,,,4615.0,MYD88,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin affects the expression of MYD88 mRNA,,,PMID:22298810,https://www.ncbi.nlm.nih.gov/pubmed/22298810,22298810,,
5705,1224003,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4615,MYD88,https://ctdbase.org/detail.go?type=gene&acc=4615,,,4615.0,MYD88,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in increased expression of MYD88 mRNA,,,PMID:32109520|PMID:34747641,https://www.ncbi.nlm.nih.gov/pubmed/32109520|https://www.ncbi.nlm.nih.gov/pubmed/34747641,32109520|34747641,,
5706,1224004,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,56005,MYDGF,https://ctdbase.org/detail.go?type=gene&acc=56005,,,56005.0,MYDGF,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in increased expression of MYDGF mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
5707,1224005,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,50804,MYEF2,https://ctdbase.org/detail.go?type=gene&acc=50804,,,50804.0,MYEF2,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin affects the expression of MYEF2 mRNA,,,PMID:21570461,https://www.ncbi.nlm.nih.gov/pubmed/21570461,21570461,,
5708,1224006,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,50804,MYEF2,https://ctdbase.org/detail.go?type=gene&acc=50804,,,50804.0,MYEF2,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of MYEF2 mRNA,,,PMID:19465110,https://www.ncbi.nlm.nih.gov/pubmed/19465110,19465110,,
5709,1224256,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4624,MYH6,https://ctdbase.org/detail.go?type=gene&acc=4624,,,4624.0,MYH6,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of MYH6 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
5710,1224257,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4624,MYH6,https://ctdbase.org/detail.go?type=gene&acc=4624,,,4624.0,MYH6,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin results in decreased expression of MYH6 mRNA,,,PMID:20130022,https://www.ncbi.nlm.nih.gov/pubmed/20130022,20130022,,
5711,1224258,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4624,MYH6,https://ctdbase.org/detail.go?type=gene&acc=4624,,,4624.0,MYH6,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin results in increased expression of MYH6 mRNA,,,PMID:15328365|PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/15328365|https://www.ncbi.nlm.nih.gov/pubmed/17942748,15328365|17942748,,
5712,1224259,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4624,MYH6,https://ctdbase.org/detail.go?type=gene&acc=4624,,,4624.0,MYH6,10116.0,Rattus norvegicus (Norway rat),Tetrachlorodibenzodioxin results in increased expression of MYH6 mRNA,,,PMID:32109520,https://www.ncbi.nlm.nih.gov/pubmed/32109520,32109520,,
5713,1224260,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,4625,MYH7,https://ctdbase.org/detail.go?type=gene&acc=4625,,,4625.0,MYH7,7955.0,Danio rerio (zebrafish),Tetrachlorodibenzodioxin results in increased expression of MYH7 mRNA,,,PMID:15716485,https://www.ncbi.nlm.nih.gov/pubmed/15716485,15716485,,
5714,1224604,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,64089,SNX16,https://ctdbase.org/detail.go?type=gene&acc=64089,,,64089.0,SNX16,9606.0,Homo sapiens (human),Tetrachlorodibenzodioxin affects the expression of SNX16 mRNA,,,PMID:22298810,https://www.ncbi.nlm.nih.gov/pubmed/22298810,22298810,,
5715,1224605,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,64089,SNX16,https://ctdbase.org/detail.go?type=gene&acc=64089,,,64089.0,SNX16,10090.0,Mus musculus (house mouse),Tetrachlorodibenzodioxin affects the expression of SNX16 mRNA,,,PMID:21570461,https://www.ncbi.nlm.nih.gov/pubmed/21570461,21570461,,
5716,1224606,15625,Comparative Toxicogenomics Database (CTD),"2,3,7,8-Tetrachlorodibenzo-P-dioxin",D013749,Tetrachlorodibenzodioxin,https://ctdbase.org/detail.go?type=chem&acc=D013749,64089,SNX16,https://ctdbase.org/detail.go?type=gene&acc=64089,,,64089.0,SNX16,10090.0,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of SNX16 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
5717,1229833,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4761,NEUROD2,https://ctdbase.org/detail.go?type=gene&acc=4761,,,4761.0,NEUROD2,10090.0,Mus musculus (house mouse),Paraquat results in decreased expression of NEUROD2 mRNA,,,PMID:22563483,https://www.ncbi.nlm.nih.gov/pubmed/22563483,22563483,,
5718,1229834,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4762,NEUROG1,https://ctdbase.org/detail.go?type=gene&acc=4762,,,4762.0,NEUROG1,9606.0,Homo sapiens (human),Paraquat affects the reaction [bucladesine affects the expression of NEUROG1 protein]|paraquat affects the reaction [bucladesine affects the expression of NEUROG1 mrna],,,PMID:31400064,https://www.ncbi.nlm.nih.gov/pubmed/31400064,31400064,,
5719,1229835,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4762,NEUROG1,https://ctdbase.org/detail.go?type=gene&acc=4762,,,4762.0,NEUROG1,9606.0,Homo sapiens (human),Paraquat results in decreased expression of NEUROG1 mRNA,,,PMID:25314302|PMID:30698896,https://www.ncbi.nlm.nih.gov/pubmed/25314302|https://www.ncbi.nlm.nih.gov/pubmed/30698896,25314302|30698896,,
5720,1229836,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4762,NEUROG1,https://ctdbase.org/detail.go?type=gene&acc=4762,,,4762.0,NEUROG1,9606.0,Homo sapiens (human),Paraquat results in decreased expression of NEUROG1 protein,,,PMID:30698896,https://www.ncbi.nlm.nih.gov/pubmed/30698896,30698896,,
5721,1229837,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,340533,NEXMIF,https://ctdbase.org/detail.go?type=gene&acc=340533,,,340533.0,NEXMIF,10116.0,Rattus norvegicus (Norway rat),Paraquat results in decreased expression of NEXMIF mRNA,,,PMID:32680482,https://www.ncbi.nlm.nih.gov/pubmed/32680482,32680482,,
5722,1229838,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4763,NF1,https://ctdbase.org/detail.go?type=gene&acc=4763,,,4763.0,NF1,10116.0,Rattus norvegicus (Norway rat),Paraquat affects the expression of NF1 mRNA,,,PMID:15206577,https://www.ncbi.nlm.nih.gov/pubmed/15206577,15206577,,
5723,1229839,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,10725,NFAT5,https://ctdbase.org/detail.go?type=gene&acc=10725,,,10725.0,NFAT5,10090.0,Mus musculus (house mouse),Paraquat results in increased expression of NFAT5 mrna|[paraquat co-treated with maneb] affects the expression of NFAT5 mRNA,,,PMID:22563483,https://www.ncbi.nlm.nih.gov/pubmed/22563483,22563483,,
5724,1229840,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,405781,NFE2L1A,https://ctdbase.org/detail.go?type=gene&acc=405781,,,405781.0,nfe2l1a,7955.0,Danio rerio (zebrafish),Paraquat affects the expression of NFE2L1A mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
5725,1229841,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [paraquat results in decreased expression of NFE2L2 protein]|meloxicam inhibits the reaction [paraquat results in decreased expression of NFE2L2 protein],,,PMID:20851755,https://www.ncbi.nlm.nih.gov/pubmed/20851755,20851755,,
5726,1230069,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),[paraquat co-treated with ellagic acid] results in increased expression of and affects the localization of NFE2L2 protein|[paraquat co-treated with ellagic acid] results in increased expression of NFE2L2 mRNA,,,PMID:23546295,https://www.ncbi.nlm.nih.gov/pubmed/23546295,23546295,,
5727,1230070,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),[paraquat co-treated with quercetin] results in increased expression of NFE2L2 mrna|[paraquat co-treated with quercetin] results in increased localization of NFE2L2 protein,,,PMID:22996356,https://www.ncbi.nlm.nih.gov/pubmed/22996356,22996356,,
5728,1230665,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,360149,NFE2L2A,https://ctdbase.org/detail.go?type=gene&acc=360149,,,360149.0,nfe2l2a,7955.0,Danio rerio (zebrafish),Paraquat results in increased expression of NFE2L2A mRNA,,,PMID:27288846,https://www.ncbi.nlm.nih.gov/pubmed/27288846,27288846,,
5729,1230666,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4781,NFIB,https://ctdbase.org/detail.go?type=gene&acc=4781,,,4781.0,NFIB,10090.0,Mus musculus (house mouse),Paraquat results in increased expression of NFIB mrna|[paraquat co-treated with maneb] affects the expression of NFIB mRNA,,,PMID:22563483,https://www.ncbi.nlm.nih.gov/pubmed/22563483,22563483,,
5730,1230667,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4783,NFIL3,https://ctdbase.org/detail.go?type=gene&acc=4783,,,4783.0,NFIL3,10116.0,Rattus norvegicus (Norway rat),Paraquat results in increased expression of NFIL3 mRNA,,,PMID:32680482,https://www.ncbi.nlm.nih.gov/pubmed/32680482,32680482,,
5731,1230668,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,431765,NFIL3-6,https://ctdbase.org/detail.go?type=gene&acc=431765,,,431765.0,nfil3-6,7955.0,Danio rerio (zebrafish),Paraquat affects the expression of NFIL3-6 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
5732,1230669,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),Paraquat promotes the reaction [RELA protein binds to NFKB1 promoter],,,PMID:22043816,https://www.ncbi.nlm.nih.gov/pubmed/22043816,22043816,,
5733,1230670,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),Paraquat results in increased expression of NFKB1 mRNA,,,PMID:20883675|PMID:35641671,https://www.ncbi.nlm.nih.gov/pubmed/20883675|https://www.ncbi.nlm.nih.gov/pubmed/35641671,20883675|35641671,,
5734,1230671,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090.0,Mus musculus (house mouse),Melatonin inhibits the reaction [[maneb co-treated with paraquat] results in increased expression of NFKB1 mrna]|silymarin inhibits the reaction [[maneb co-treated with paraquat] results in increased expression of NFKB1 mrna]|[maneb co-treated with paraquat] results in increased expression of NFKB1 mRNA,,,PMID:23963992,https://www.ncbi.nlm.nih.gov/pubmed/23963992,23963992,,
5735,1230672,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090.0,Mus musculus (house mouse),Paraquat promotes the reaction [NFKB1 protein binds to RELB protein]|paraquat promotes the reaction [NFKB1 protein binds to NFKB1 protein]|nfkb1 protein mutant form inhibits the reaction [paraquat results in increased expression of CAT mrna]|paraquat promotes the reaction [NFKB1 protein binds to RELA protein],,,PMID:11728812,https://www.ncbi.nlm.nih.gov/pubmed/11728812,11728812,,
5736,1230673,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090.0,Mus musculus (house mouse),"Paraquat promotes the reaction [endotoxin, escherichia coli affects the localization of [NFKB1 protein binds to RELA protein]]|paraquat affects the localization of [NFKB1 protein binds to RELA protein]|sb 203580 inhibits the reaction [paraquat affects the localization of [NFKB1 protein binds to RELA protein]]|sb 203580 inhibits the reaction [paraquat promotes the reaction [endotoxin, escherichia coli affects the localization of [NFKB1 protein binds to RELA protein]]]",,,PMID:16919916,https://www.ncbi.nlm.nih.gov/pubmed/16919916,16919916,,
5737,1232058,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),BAX protein affects the susceptibility to [paraquat co-treated with maneb],,,PMID:18266926,https://www.ncbi.nlm.nih.gov/pubmed/18266926,18266926,,
5738,1232803,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Salvin inhibits the reaction [paraquat results in decreased expression of BCL2 protein],,,PMID:26686574,https://www.ncbi.nlm.nih.gov/pubmed/26686574,26686574,,
5739,1232804,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Lithium chloride inhibits the reaction [paraquat results in decreased expression of BCL2 protein]|wnt1 protein inhibits the reaction [paraquat results in decreased expression of BCL2 protein],,,PMID:30171970,https://www.ncbi.nlm.nih.gov/pubmed/30171970,30171970,,
5740,1232805,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [paraquat results in decreased expression of BCL2 protein],,,PMID:31368586,https://www.ncbi.nlm.nih.gov/pubmed/31368586,31368586,,
5741,1232806,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),AKT1 protein affects the reaction [paraquat results in decreased expression of BCL2 protein],,,PMID:28115273,https://www.ncbi.nlm.nih.gov/pubmed/28115273,28115273,,
5742,1232807,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),[crocin co-treated with paraquat] results in decreased expression of BCL2 mRNA,,,PMID:31911963,https://www.ncbi.nlm.nih.gov/pubmed/31911963,31911963,,
5743,1232808,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),GPX1 protein affects the reaction [paraquat affects the expression of BCL2 mrna],,,PMID:12654481,https://www.ncbi.nlm.nih.gov/pubmed/12654481,12654481,,
5744,1233901,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,274,BIN1,https://ctdbase.org/detail.go?type=gene&acc=274,,,274.0,BIN1,9606.0,Homo sapiens (human),Paraquat affects the splicing of BIN1 mRNA,,,PMID:23613995,https://www.ncbi.nlm.nih.gov/pubmed/23613995,23613995,,
5745,1233902,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,329,BIRC2,https://ctdbase.org/detail.go?type=gene&acc=329,,,329.0,BIRC2,9606.0,Homo sapiens (human),Paraquat results in decreased expression of BIRC2 mRNA,,,PMID:18836921,https://www.ncbi.nlm.nih.gov/pubmed/18836921,18836921,,
5746,1233903,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,330,BIRC3,https://ctdbase.org/detail.go?type=gene&acc=330,,,330.0,BIRC3,9606.0,Homo sapiens (human),Paraquat results in decreased expression of BIRC3 mRNA,,,PMID:18836921,https://www.ncbi.nlm.nih.gov/pubmed/18836921,18836921,,
5747,1233904,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,330,BIRC3,https://ctdbase.org/detail.go?type=gene&acc=330,,,330.0,BIRC3,10116.0,Rattus norvegicus (Norway rat),Paraquat results in increased expression of BIRC3 mRNA,,,PMID:32680482,https://www.ncbi.nlm.nih.gov/pubmed/32680482,32680482,,
5748,1233905,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,10090.0,Mus musculus (house mouse),Paraquat results in increased expression of BIRC5 mRNA,,,PMID:26345256,https://www.ncbi.nlm.nih.gov/pubmed/26345256,26345256,,
5749,1233906,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,10116.0,Rattus norvegicus (Norway rat),Paraquat results in decreased expression of BIRC5 mRNA,,,PMID:26887261,https://www.ncbi.nlm.nih.gov/pubmed/26887261,26887261,,
5750,1233907,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,112401,BIRC8,https://ctdbase.org/detail.go?type=gene&acc=112401,,,112401.0,BIRC8,9606.0,Homo sapiens (human),Paraquat results in decreased expression of BIRC8 mRNA,,,PMID:18836921,https://www.ncbi.nlm.nih.gov/pubmed/18836921,18836921,,
5751,1233908,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,503516,BLF,https://ctdbase.org/detail.go?type=gene&acc=503516,,,503516.0,blf,7955.0,Danio rerio (zebrafish),Paraquat affects the expression of BLF mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
5752,1233909,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,640,BLK,https://ctdbase.org/detail.go?type=gene&acc=640,,,640.0,BLK,10116.0,Rattus norvegicus (Norway rat),Paraquat results in decreased expression of BLK mRNA,,,PMID:32680482,https://www.ncbi.nlm.nih.gov/pubmed/32680482,32680482,,
5753,1234567,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,55643,BTBD2,https://ctdbase.org/detail.go?type=gene&acc=55643,,,55643.0,BTBD2,7955.0,Danio rerio (zebrafish),Paraquat affects the expression of BTBD2 mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
5754,1234568,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,55643,BTBD2,https://ctdbase.org/detail.go?type=gene&acc=55643,,,55643.0,BTBD2,10116.0,Rattus norvegicus (Norway rat),Paraquat results in decreased expression of BTBD2 mRNA,,,PMID:32680482,https://www.ncbi.nlm.nih.gov/pubmed/32680482,32680482,,
5755,1234569,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,22903,BTBD3,https://ctdbase.org/detail.go?type=gene&acc=22903,,,22903.0,BTBD3,10090.0,Mus musculus (house mouse),[maneb co-treated with paraquat] results in increased expression of BTBD3 mrna|[maneb co-treated with paraquat] results in decreased expression of BTBD3 mRNA,,,PMID:36117858,https://www.ncbi.nlm.nih.gov/pubmed/36117858,36117858,,
5756,1234570,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,7832,BTG2,https://ctdbase.org/detail.go?type=gene&acc=7832,,,7832.0,BTG2,10090.0,Mus musculus (house mouse),Paraquat results in increased expression of BTG2 mRNA,,,PMID:12595580,https://www.ncbi.nlm.nih.gov/pubmed/12595580,12595580,,
5757,1234571,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,695,BTK,https://ctdbase.org/detail.go?type=gene&acc=695,,,695.0,BTK,7227.0,Drosophila melanogaster (fruit fly),Paraquat results in decreased expression of BTK mRNA,,,PMID:15458575,https://www.ncbi.nlm.nih.gov/pubmed/15458575,15458575,,
5758,1234572,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,151888,BTLA,https://ctdbase.org/detail.go?type=gene&acc=151888,,,151888.0,BTLA,10116.0,Rattus norvegicus (Norway rat),Paraquat results in decreased expression of BTLA mRNA,,,PMID:32680482,https://www.ncbi.nlm.nih.gov/pubmed/32680482,32680482,,
5759,1234573,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,8945,BTRC,https://ctdbase.org/detail.go?type=gene&acc=8945,,,8945.0,BTRC,10116.0,Rattus norvegicus (Norway rat),Paraquat results in increased expression of BTRC mRNA,,,PMID:32680482,https://www.ncbi.nlm.nih.gov/pubmed/32680482,32680482,,
5760,1234574,15939,Comparative Toxicogenomics Database (CTD),Paraquat,D010269,Paraquat,https://ctdbase.org/detail.go?type=chem&acc=D010269,699,BUB1,https://ctdbase.org/detail.go?type=gene&acc=699,,,699.0,BUB1,10090.0,Mus musculus (house mouse),[ATG7 protein affects the susceptibility to paraquat] which affects the expression of BUB1 mRNA,,,PMID:28012437,https://www.ncbi.nlm.nih.gov/pubmed/28012437,28012437,,
5761,1219922,18529,Comparative Toxicogenomics Database (CTD),"1,2,5,6,9,10-Hexabromocyclododecane",C089796,hexabromocyclododecane,https://ctdbase.org/detail.go?type=chem&acc=C089796,5723,PSPH,https://ctdbase.org/detail.go?type=gene&acc=5723,,,5723.0,PSPH,10090.0,Mus musculus (house mouse),Hexabromocyclododecane results in decreased expression of PSPH mRNA,,,PMID:29177809,https://www.ncbi.nlm.nih.gov/pubmed/29177809,29177809,,
5762,1219923,18529,Comparative Toxicogenomics Database (CTD),"1,2,5,6,9,10-Hexabromocyclododecane",C089796,hexabromocyclododecane,https://ctdbase.org/detail.go?type=chem&acc=C089796,9050,PSTPIP2,https://ctdbase.org/detail.go?type=gene&acc=9050,,,9050.0,PSTPIP2,10116.0,Rattus norvegicus (Norway rat),[flame retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of PSTPIP2 mRNA,,,PMID:32207525,https://www.ncbi.nlm.nih.gov/pubmed/32207525,32207525,,
5763,1219924,18529,Comparative Toxicogenomics Database (CTD),"1,2,5,6,9,10-Hexabromocyclododecane",C089796,hexabromocyclododecane,https://ctdbase.org/detail.go?type=chem&acc=C089796,55037,PTCD3,https://ctdbase.org/detail.go?type=gene&acc=55037,,,55037.0,PTCD3,10090.0,Mus musculus (house mouse),Hexabromocyclododecane results in increased expression of PTCD3 mRNA,,,PMID:29177809,https://www.ncbi.nlm.nih.gov/pubmed/29177809,29177809,,
5764,1219925,18529,Comparative Toxicogenomics Database (CTD),"1,2,5,6,9,10-Hexabromocyclododecane",C089796,hexabromocyclododecane,https://ctdbase.org/detail.go?type=chem&acc=C089796,139411,PTCHD1,https://ctdbase.org/detail.go?type=gene&acc=139411,,,139411.0,PTCHD1,10116.0,Rattus norvegicus (Norway rat),[flame retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of PTCHD1 mRNA,,,PMID:32207525,https://www.ncbi.nlm.nih.gov/pubmed/32207525,32207525,,
5765,1219926,18529,Comparative Toxicogenomics Database (CTD),"1,2,5,6,9,10-Hexabromocyclododecane",C089796,hexabromocyclododecane,https://ctdbase.org/detail.go?type=chem&acc=C089796,5728,PTEN,https://ctdbase.org/detail.go?type=gene&acc=5728,,,5728.0,PTEN,10090.0,Mus musculus (house mouse),Hexabromocyclododecane results in increased expression of PTEN mRNA,,,PMID:29177809,https://www.ncbi.nlm.nih.gov/pubmed/29177809,29177809,,
5766,1221032,18529,Comparative Toxicogenomics Database (CTD),"1,2,5,6,9,10-Hexabromocyclododecane",C089796,hexabromocyclododecane,https://ctdbase.org/detail.go?type=chem&acc=C089796,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,10090.0,Mus musculus (house mouse),Hexabromocyclododecane results in decreased expression of RB1 mRNA,,,PMID:29177809,https://www.ncbi.nlm.nih.gov/pubmed/29177809,29177809,,
5767,1221033,18529,Comparative Toxicogenomics Database (CTD),"1,2,5,6,9,10-Hexabromocyclododecane",C089796,hexabromocyclododecane,https://ctdbase.org/detail.go?type=chem&acc=C089796,9821,RB1CC1,https://ctdbase.org/detail.go?type=gene&acc=9821,,,9821.0,RB1CC1,10090.0,Mus musculus (house mouse),Hexabromocyclododecane results in decreased expression of RB1CC1 mRNA,,,PMID:29177809,https://www.ncbi.nlm.nih.gov/pubmed/29177809,29177809,,
5768,1217572,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,4010,LMX1B,https://ctdbase.org/detail.go?type=gene&acc=4010,,,4010.0,LMX1B,9606.0,Homo sapiens (human),Aflatoxin B2 affects the methylation of LMX1B intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5769,1217573,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,100996645,LNCBRM,https://ctdbase.org/detail.go?type=gene&acc=100996645,,,100996645.0,LNCBRM,9606.0,Homo sapiens (human),Aflatoxin B2 results in increased methylation of LNCBRM intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5770,1217574,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,105369848,LNCOG,https://ctdbase.org/detail.go?type=gene&acc=105369848,,,105369848.0,LNCOG,9606.0,Homo sapiens (human),Aflatoxin B2 results in increased methylation of LNCOG intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5771,1225700,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,1903,S1PR3,https://ctdbase.org/detail.go?type=gene&acc=1903,,,1903.0,S1PR3,9606.0,Homo sapiens (human),Aflatoxin B2 results in decreased methylation of S1PR3 3' UTR,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5772,1225701,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,6295,SAG,https://ctdbase.org/detail.go?type=gene&acc=6295,,,6295.0,SAG,9606.0,Homo sapiens (human),Aflatoxin B2 results in decreased methylation of SAG intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5773,1226216,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,10801,SEPTIN9,https://ctdbase.org/detail.go?type=gene&acc=10801,,,10801.0,SEPTIN9,9606.0,Homo sapiens (human),Aflatoxin B2 affects the methylation of SEPTIN9 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5774,1226217,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,256987,SERINC5,https://ctdbase.org/detail.go?type=gene&acc=256987,,,256987.0,SERINC5,9606.0,Homo sapiens (human),Aflatoxin B2 affects the methylation of SERINC5 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5775,1226218,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,5269,SERPINB6,https://ctdbase.org/detail.go?type=gene&acc=5269,,,5269.0,SERPINB6,9606.0,Homo sapiens (human),Aflatoxin B2 results in decreased methylation of SERPINB6 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5776,1226219,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270.0,SERPINE2,9606.0,Homo sapiens (human),Aflatoxin B2 results in increased methylation of SERPINE2 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5777,1226220,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,83667,SESN2,https://ctdbase.org/detail.go?type=gene&acc=83667,,,83667.0,SESN2,9606.0,Homo sapiens (human),Aflatoxin B2 results in increased methylation of SESN2 3' UTR,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5778,1226221,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,51460,SFMBT1,https://ctdbase.org/detail.go?type=gene&acc=51460,,,51460.0,SFMBT1,9606.0,Homo sapiens (human),Aflatoxin B2 results in decreased methylation of SFMBT1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5779,1226222,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,57713,SFMBT2,https://ctdbase.org/detail.go?type=gene&acc=57713,,,57713.0,SFMBT2,9606.0,Homo sapiens (human),Aflatoxin B2 results in decreased methylation of SFMBT2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5780,1226223,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,6422,SFRP1,https://ctdbase.org/detail.go?type=gene&acc=6422,,,6422.0,SFRP1,9606.0,Homo sapiens (human),Aflatoxin B2 results in increased methylation of SFRP1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5781,1226707,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,8631,SKAP1,https://ctdbase.org/detail.go?type=gene&acc=8631,,,8631.0,SKAP1,9606.0,Homo sapiens (human),Aflatoxin B2 results in decreased methylation of SKAP1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5782,1226708,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,8935,SKAP2,https://ctdbase.org/detail.go?type=gene&acc=8935,,,8935.0,SKAP2,9606.0,Homo sapiens (human),Aflatoxin B2 results in increased methylation of SKAP2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5783,1226709,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,6559,SLC12A3,https://ctdbase.org/detail.go?type=gene&acc=6559,,,6559.0,SLC12A3,9606.0,Homo sapiens (human),Aflatoxin B2 results in increased methylation of SLC12A3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5784,1226710,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,6563,SLC14A1,https://ctdbase.org/detail.go?type=gene&acc=6563,,,6563.0,SLC14A1,9606.0,Homo sapiens (human),Aflatoxin B2 results in increased methylation of SLC14A1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5785,1226711,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,8170,SLC14A2,https://ctdbase.org/detail.go?type=gene&acc=8170,,,8170.0,SLC14A2,9606.0,Homo sapiens (human),Aflatoxin B2 results in increased methylation of SLC14A2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5786,1226712,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,6571,SLC18A2,https://ctdbase.org/detail.go?type=gene&acc=6571,,,6571.0,SLC18A2,9606.0,Homo sapiens (human),Aflatoxin B2 results in increased methylation of SLC18A2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5787,1226713,23648,Comparative Toxicogenomics Database (CTD),Aflatoxin B2 alpha,C029753,aflatoxin B2,https://ctdbase.org/detail.go?type=chem&acc=C029753,80704,SLC19A3,https://ctdbase.org/detail.go?type=gene&acc=80704,,,80704.0,SLC19A3,9606.0,Homo sapiens (human),Aflatoxin B2 results in decreased methylation of SLC19A3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
5788,1220824,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,8436,CAVIN2,https://ctdbase.org/detail.go?type=gene&acc=8436,,,8436.0,CAVIN2,10090.0,Mus musculus (house mouse),Silver results in increased expression of CAVIN2 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5789,1223255,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,666168,CYP4A31,https://ctdbase.org/detail.go?type=gene&acc=666168,,,666168.0,Cyp4a31,10090.0,Mus musculus (house mouse),Silver results in increased expression of CYP4A31 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5790,1223256,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,13121,CYP51,https://ctdbase.org/detail.go?type=gene&acc=13121,,,13121.0,Cyp51,10090.0,Mus musculus (house mouse),Silver results in decreased expression of CYP51 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5791,1223257,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,1601,DAB2,https://ctdbase.org/detail.go?type=gene&acc=1601,,,1601.0,DAB2,10090.0,Mus musculus (house mouse),Silver results in decreased expression of DAB2 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5792,1223258,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,1603,DAD1,https://ctdbase.org/detail.go?type=gene&acc=1603,,,1603.0,DAD1,10116.0,Rattus norvegicus (Norway rat),[silver analog co-treated with povidone] results in decreased expression of DAD1 mRNA,,,PMID:25194297,https://www.ncbi.nlm.nih.gov/pubmed/25194297,25194297,,
5793,1223997,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,1814,DRD3,https://ctdbase.org/detail.go?type=gene&acc=1814,,,1814.0,DRD3,10116.0,Rattus norvegicus (Norway rat),Silver inhibits the reaction [3-N-methylspiperone binds to DRD3 protein],,,PMID:10215675,https://www.ncbi.nlm.nih.gov/pubmed/10215675,10215675,,
5794,1223998,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,1815,DRD4,https://ctdbase.org/detail.go?type=gene&acc=1815,,,1815.0,DRD4,10116.0,Rattus norvegicus (Norway rat),Silver inhibits the reaction [3-N-methylspiperone binds to DRD4 protein],,,PMID:10215675,https://www.ncbi.nlm.nih.gov/pubmed/10215675,10215675,,
5795,1223999,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,57453,DSCAML1,https://ctdbase.org/detail.go?type=gene&acc=57453,,,57453.0,DSCAML1,9606.0,Homo sapiens (human),Silver results in increased expression of DSCAML1 mRNA,,,PMID:26551752,https://www.ncbi.nlm.nih.gov/pubmed/26551752,26551752,,
5796,1224000,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,56986,DTWD1,https://ctdbase.org/detail.go?type=gene&acc=56986,,,56986.0,DTWD1,10090.0,Mus musculus (house mouse),Silver results in decreased expression of DTWD1 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5797,1224001,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,151636,DTX3L,https://ctdbase.org/detail.go?type=gene&acc=151636,,,151636.0,DTX3L,10090.0,Mus musculus (house mouse),Silver results in decreased expression of DTX3L mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5798,1227542,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Silver results in increased expression of NFE2L2 protein,,,PMID:22036727|PMID:28109747,https://www.ncbi.nlm.nih.gov/pubmed/22036727|https://www.ncbi.nlm.nih.gov/pubmed/28109747,22036727|28109747,,
5799,1227543,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,360149,NFE2L2A,https://ctdbase.org/detail.go?type=gene&acc=360149,,,360149.0,nfe2l2a,7955.0,Danio rerio (zebrafish),[silver nitrate results in increased abundance of silver] which results in increased expression of NFE2L2A mRNA,,,PMID:31617658,https://www.ncbi.nlm.nih.gov/pubmed/31617658,31617658,,
5800,1227544,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4784,NFIX,https://ctdbase.org/detail.go?type=gene&acc=4784,,,4784.0,NFIX,10116.0,Rattus norvegicus (Norway rat),[silver analog co-treated with povidone] results in increased expression of NFIX mRNA,,,PMID:25194297,https://www.ncbi.nlm.nih.gov/pubmed/25194297,25194297,,
5801,1227545,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),Silver results in increased expression of NFKB1 mRNA,,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
5802,1227546,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10116.0,Rattus norvegicus (Norway rat),Silver analog results in increased expression of NFKB1 mRNA,,,PMID:27417253,https://www.ncbi.nlm.nih.gov/pubmed/27417253,27417253,,
5803,1227547,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4791,NFKB2,https://ctdbase.org/detail.go?type=gene&acc=4791,,,4791.0,NFKB2,9606.0,Homo sapiens (human),Silver results in decreased expression of NFKB2 mRNA,,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
5804,1227548,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),NFKBIA protein inhibits the reaction [silver results in increased expression of HMOX1 protein]|silver results in increased phosphorylation of NFKBIA protein|nfkbia protein inhibits the reaction [silver results in increased phosphorylation of MAPK14 protein],,,PMID:22342292,https://www.ncbi.nlm.nih.gov/pubmed/22342292,22342292,,
5805,1227549,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),Silver results in decreased expression of NFKBIA mRNA,,,PMID:26014281,https://www.ncbi.nlm.nih.gov/pubmed/26014281,26014281,,
5806,1227550,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,64332,NFKBIZ,https://ctdbase.org/detail.go?type=gene&acc=64332,,,64332.0,NFKBIZ,10090.0,Mus musculus (house mouse),Silver results in increased expression of NFKBIZ mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5807,1228422,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4969,OGN,https://ctdbase.org/detail.go?type=gene&acc=4969,,,4969.0,OGN,10090.0,Mus musculus (house mouse),Silver results in decreased expression of OGN mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5808,1228423,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,116448,OLIG1,https://ctdbase.org/detail.go?type=gene&acc=116448,,,116448.0,OLIG1,9606.0,Homo sapiens (human),Silver results in decreased expression of OLIG1 mRNA,,,PMID:26551752,https://www.ncbi.nlm.nih.gov/pubmed/26551752,26551752,,
5809,1228424,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4973,OLR1,https://ctdbase.org/detail.go?type=gene&acc=4973,,,4973.0,OLR1,9606.0,Homo sapiens (human),Silver results in increased expression of OLR1 mRNA,,,PMID:28959546,https://www.ncbi.nlm.nih.gov/pubmed/28959546,28959546,,
5810,1228425,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4958,OMD,https://ctdbase.org/detail.go?type=gene&acc=4958,,,4958.0,OMD,10090.0,Mus musculus (house mouse),Silver results in decreased expression of OMD mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5811,1228426,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,2652,OPN1MW,https://ctdbase.org/detail.go?type=gene&acc=2652,,,2652.0,OPN1MW,10090.0,Mus musculus (house mouse),Silver results in increased expression of OPN1MW mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5812,1228427,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,26254,OPTC,https://ctdbase.org/detail.go?type=gene&acc=26254,,,26254.0,OPTC,10090.0,Mus musculus (house mouse),Silver results in decreased expression of OPTC mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5813,1228428,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,258224,OR10B1,https://ctdbase.org/detail.go?type=gene&acc=258224,,,258224.0,Or10b1,10090.0,Mus musculus (house mouse),Silver results in increased expression of OR10B1 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5814,1229300,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,654790,PCP4L1,https://ctdbase.org/detail.go?type=gene&acc=654790,,,654790.0,PCP4L1,10090.0,Mus musculus (house mouse),Silver affects the expression of PCP4L1 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5815,1229301,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,255738,PCSK9,https://ctdbase.org/detail.go?type=gene&acc=255738,,,255738.0,PCSK9,9606.0,Homo sapiens (human),Silver results in decreased expression of PCSK9 mRNA,,,PMID:26014281,https://www.ncbi.nlm.nih.gov/pubmed/26014281,26014281,,
5816,1229302,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,58488,PCTP,https://ctdbase.org/detail.go?type=gene&acc=58488,,,58488.0,PCTP,10090.0,Mus musculus (house mouse),Silver results in increased expression of PCTP mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5817,1229303,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,10081,PDCD7,https://ctdbase.org/detail.go?type=gene&acc=10081,,,10081.0,PDCD7,9606.0,Homo sapiens (human),Silver results in decreased expression of PDCD7 mRNA,,,PMID:26014281,https://www.ncbi.nlm.nih.gov/pubmed/26014281,26014281,,
5818,1229304,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,5082,PDCL,https://ctdbase.org/detail.go?type=gene&acc=5082,,,5082.0,PDCL,10090.0,Mus musculus (house mouse),Silver results in decreased expression of PDCL mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5819,1229305,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,5136,PDE1A,https://ctdbase.org/detail.go?type=gene&acc=5136,,,5136.0,PDE1A,9606.0,Homo sapiens (human),Silver results in decreased expression of PDE1A mRNA,,,PMID:26551752,https://www.ncbi.nlm.nih.gov/pubmed/26551752,26551752,,
5820,1229306,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,5136,PDE1A,https://ctdbase.org/detail.go?type=gene&acc=5136,,,5136.0,PDE1A,10090.0,Mus musculus (house mouse),Silver results in decreased expression of PDE1A mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5821,1229307,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,5137,PDE1C,https://ctdbase.org/detail.go?type=gene&acc=5137,,,5137.0,PDE1C,10090.0,Mus musculus (house mouse),Silver affects the expression of PDE1C mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5822,1229308,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,5138,PDE2A,https://ctdbase.org/detail.go?type=gene&acc=5138,,,5138.0,PDE2A,10090.0,Mus musculus (house mouse),Silver results in decreased expression of PDE2A mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5823,1229309,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,5141,PDE4A,https://ctdbase.org/detail.go?type=gene&acc=5141,,,5141.0,PDE4A,10090.0,Mus musculus (house mouse),Silver results in increased expression of PDE4A mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5824,1229842,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),Silver results in increased secretion of IL1B protein,,,PMID:20064793|PMID:26968431,https://www.ncbi.nlm.nih.gov/pubmed/20064793|https://www.ncbi.nlm.nih.gov/pubmed/26968431,20064793|26968431,,
5825,1230454,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,10265,IRX5,https://ctdbase.org/detail.go?type=gene&acc=10265,,,10265.0,IRX5,10090.0,Mus musculus (house mouse),Silver results in decreased expression of IRX5 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5826,1230455,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,81689,ISCA1,https://ctdbase.org/detail.go?type=gene&acc=81689,,,81689.0,ISCA1,9606.0,Homo sapiens (human),Silver results in increased expression of ISCA1 mRNA,,,PMID:26014281,https://www.ncbi.nlm.nih.gov/pubmed/26014281,26014281,,
5827,1230456,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,9636,ISG15,https://ctdbase.org/detail.go?type=gene&acc=9636,,,9636.0,ISG15,10090.0,Mus musculus (house mouse),Silver results in decreased expression of ISG15 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5828,1230457,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,3669,ISG20,https://ctdbase.org/detail.go?type=gene&acc=3669,,,3669.0,ISG20,10090.0,Mus musculus (house mouse),Silver affects the expression of ISG20 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5829,1230458,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,3670,ISL1,https://ctdbase.org/detail.go?type=gene&acc=3670,,,3670.0,ISL1,10090.0,Mus musculus (house mouse),Silver results in decreased expression of ISL1 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5830,1230459,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,64843,ISL2,https://ctdbase.org/detail.go?type=gene&acc=64843,,,64843.0,ISL2,9606.0,Homo sapiens (human),Silver results in increased expression of ISL2 mRNA,,,PMID:26014281|PMID:26551752,https://www.ncbi.nlm.nih.gov/pubmed/26014281|https://www.ncbi.nlm.nih.gov/pubmed/26551752,26014281|26551752,,
5831,1230460,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,3672,ITGA1,https://ctdbase.org/detail.go?type=gene&acc=3672,,,3672.0,ITGA1,10090.0,Mus musculus (house mouse),Silver results in decreased expression of ITGA1 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5832,1230461,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,22801,ITGA11,https://ctdbase.org/detail.go?type=gene&acc=22801,,,22801.0,ITGA11,10090.0,Mus musculus (house mouse),Silver results in decreased expression of ITGA11 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5833,1230462,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,3673,ITGA2,https://ctdbase.org/detail.go?type=gene&acc=3673,,,3673.0,ITGA2,9606.0,Homo sapiens (human),Silver results in increased expression of ITGA2 mRNA,,,PMID:28959546,https://www.ncbi.nlm.nih.gov/pubmed/28959546,28959546,,
5834,1230463,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,3682,ITGAE,https://ctdbase.org/detail.go?type=gene&acc=3682,,,3682.0,ITGAE,10090.0,Mus musculus (house mouse),Silver results in increased expression of ITGAE mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5835,1231395,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,139221,PWWP3B,https://ctdbase.org/detail.go?type=gene&acc=139221,,,139221.0,PWWP3B,10090.0,Mus musculus (house mouse),Silver results in decreased expression of PWWP3B mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5836,1231396,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,149628,PYHIN1,https://ctdbase.org/detail.go?type=gene&acc=149628,,,149628.0,PYHIN1,10090.0,Mus musculus (house mouse),Silver affects the expression of PYHIN1 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5837,1231397,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,5697,PYY,https://ctdbase.org/detail.go?type=gene&acc=5697,,,5697.0,PYY,10090.0,Mus musculus (house mouse),Silver results in decreased expression of PYY mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5838,1231398,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,25797,QPCT,https://ctdbase.org/detail.go?type=gene&acc=25797,,,25797.0,QPCT,10090.0,Mus musculus (house mouse),Silver results in increased expression of QPCT mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5839,1231399,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,54870,QRICH1,https://ctdbase.org/detail.go?type=gene&acc=54870,,,54870.0,QRICH1,10090.0,Mus musculus (house mouse),Silver results in decreased expression of QRICH1 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5840,1231400,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,51552,RAB14,https://ctdbase.org/detail.go?type=gene&acc=51552,,,51552.0,RAB14,10116.0,Rattus norvegicus (Norway rat),[silver analog co-treated with povidone] results in increased expression of RAB14 mRNA,,,PMID:25194297,https://www.ncbi.nlm.nih.gov/pubmed/25194297,25194297,,
5841,1231401,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,376267,RAB15,https://ctdbase.org/detail.go?type=gene&acc=376267,,,376267.0,RAB15,10090.0,Mus musculus (house mouse),Silver results in decreased expression of RAB15 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5842,1234775,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,20556,SLFN2,https://ctdbase.org/detail.go?type=gene&acc=20556,,,20556.0,Slfn2,10090.0,Mus musculus (house mouse),Silver results in decreased expression of SLFN2 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5843,1234776,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,20558,SLFN4,https://ctdbase.org/detail.go?type=gene&acc=20558,,,20558.0,Slfn4,10090.0,Mus musculus (house mouse),Silver results in decreased expression of SLFN4 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5844,1234777,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,9353,SLIT2,https://ctdbase.org/detail.go?type=gene&acc=9353,,,9353.0,SLIT2,10090.0,Mus musculus (house mouse),Silver results in decreased expression of SLIT2 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5845,1234778,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,26050,SLITRK5,https://ctdbase.org/detail.go?type=gene&acc=26050,,,26050.0,SLITRK5,10090.0,Mus musculus (house mouse),Silver results in increased expression of SLITRK5 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5846,1234779,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,128710,SLX4IP,https://ctdbase.org/detail.go?type=gene&acc=128710,,,128710.0,SLX4IP,10090.0,Mus musculus (house mouse),Silver results in decreased expression of SLX4IP mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5847,1234780,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,9606.0,Homo sapiens (human),Silver results in increased expression of SMAD3 mRNA,,,PMID:28959546,https://www.ncbi.nlm.nih.gov/pubmed/28959546,28959546,,
5848,1234781,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4092,SMAD7,https://ctdbase.org/detail.go?type=gene&acc=4092,,,4092.0,SMAD7,9606.0,Homo sapiens (human),Silver results in increased expression of SMAD7 mRNA,,,PMID:26014281|PMID:28959546,https://www.ncbi.nlm.nih.gov/pubmed/26014281|https://www.ncbi.nlm.nih.gov/pubmed/28959546,26014281|28959546,,
5849,1234782,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,4092,SMAD7,https://ctdbase.org/detail.go?type=gene&acc=4092,,,4092.0,SMAD7,10090.0,Mus musculus (house mouse),Silver results in decreased expression of SMAD7 mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5850,1234783,23954,Comparative Toxicogenomics Database (CTD),Silver,D012834,Silver,https://ctdbase.org/detail.go?type=chem&acc=D012834,223809,SMGC,https://ctdbase.org/detail.go?type=gene&acc=223809,,,223809.0,Smgc,10090.0,Mus musculus (house mouse),Silver results in increased expression of SMGC mRNA,,,PMID:27131904,https://www.ncbi.nlm.nih.gov/pubmed/27131904,27131904,,
5851,1234575,23964,Comparative Toxicogenomics Database (CTD),Tungsten,D014414,Tungsten,https://ctdbase.org/detail.go?type=chem&acc=D014414,1105,CHD1,https://ctdbase.org/detail.go?type=gene&acc=1105,,,1105.0,CHD1,10090.0,Mus musculus (house mouse),Tungsten results in decreased expression of CHD1 mRNA,,,PMID:30912803,https://www.ncbi.nlm.nih.gov/pubmed/30912803,30912803,,
5852,1234576,23964,Comparative Toxicogenomics Database (CTD),Tungsten,D014414,Tungsten,https://ctdbase.org/detail.go?type=chem&acc=D014414,1106,CHD2,https://ctdbase.org/detail.go?type=gene&acc=1106,,,1106.0,CHD2,10090.0,Mus musculus (house mouse),Tungsten results in decreased expression of CHD2 mRNA,,,PMID:30912803,https://www.ncbi.nlm.nih.gov/pubmed/30912803,30912803,,
5853,1218813,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,5663,PSEN1,https://ctdbase.org/detail.go?type=gene&acc=5663,,,5663.0,PSEN1,9606.0,Homo sapiens (human),PSEN1 protein mutant form inhibits the reaction [TRPM7 protein affects the transport of zinc],,,PMID:22102510,https://www.ncbi.nlm.nih.gov/pubmed/22102510,22102510,,
5854,1218814,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,5669,PSG1,https://ctdbase.org/detail.go?type=gene&acc=5669,,,5669.0,PSG1,9606.0,Homo sapiens (human),Zinc deficiency results in decreased expression of PSG1 mRNA,,,PMID:18356318,https://www.ncbi.nlm.nih.gov/pubmed/18356318,18356318,,
5855,1218815,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,171585,PSMA6A,https://ctdbase.org/detail.go?type=gene&acc=171585,,,171585.0,psma6a,7955.0,Danio rerio (zebrafish),Zinc deficiency results in increased expression of PSMA6A mRNA,,,PMID:20932299,https://www.ncbi.nlm.nih.gov/pubmed/20932299,20932299,,
5856,1218816,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,5702,PSMC3,https://ctdbase.org/detail.go?type=gene&acc=5702,,,5702.0,PSMC3,10116.0,Rattus norvegicus (Norway rat),Zinc deficiency results in decreased expression of PSMC3 mRNA,,,PMID:11717422,https://www.ncbi.nlm.nih.gov/pubmed/11717422,11717422,,
5857,1218817,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,5710,PSMD4,https://ctdbase.org/detail.go?type=gene&acc=5710,,,5710.0,PSMD4,10116.0,Rattus norvegicus (Norway rat),Zinc affects the expression of PSMD4 mRNA,,,PMID:16413754,https://www.ncbi.nlm.nih.gov/pubmed/16413754,16413754,,
5858,1218818,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,5715,PSMD9,https://ctdbase.org/detail.go?type=gene&acc=5715,,,5715.0,PSMD9,7955.0,Danio rerio (zebrafish),Zinc deficiency results in increased expression of PSMD9 mRNA,,,PMID:20932299,https://www.ncbi.nlm.nih.gov/pubmed/20932299,20932299,,
5859,1218819,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,10197,PSME3,https://ctdbase.org/detail.go?type=gene&acc=10197,,,10197.0,PSME3,10116.0,Rattus norvegicus (Norway rat),Zinc deficiency results in decreased expression of PSME3 mRNA,,,PMID:12672911,https://www.ncbi.nlm.nih.gov/pubmed/12672911,12672911,,
5860,1218820,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,5723,PSPH,https://ctdbase.org/detail.go?type=gene&acc=5723,,,5723.0,PSPH,9606.0,Homo sapiens (human),PSPH protein binds to zinc,,,PMID:14534351,https://www.ncbi.nlm.nih.gov/pubmed/14534351,14534351,,
5861,1218821,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,396818,PSP-I,https://ctdbase.org/detail.go?type=gene&acc=396818,,,396818.0,PSP-I,9823.0,Sus scrofa (pig),Zinc promotes the reaction [PSP-I protein binds to heparin]|zinc affects the folding of PSP-I protein,,,PMID:16819821,https://www.ncbi.nlm.nih.gov/pubmed/16819821,16819821,,
5862,1221378,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,1757,SARDH,https://ctdbase.org/detail.go?type=gene&acc=1757,,,1757.0,SARDH,9606.0,Homo sapiens (human),Zinc deficiency results in decreased expression of SARDH mRNA,,,PMID:18356318,https://www.ncbi.nlm.nih.gov/pubmed/18356318,18356318,,
5863,1221379,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,55206,SBNO1,https://ctdbase.org/detail.go?type=gene&acc=55206,,,55206.0,SBNO1,9606.0,Homo sapiens (human),Zinc results in increased expression of SBNO1 mRNA,,,PMID:16870260,https://www.ncbi.nlm.nih.gov/pubmed/16870260,16870260,,
5864,1221995,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of SERPINE1 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
5865,1221996,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116.0,Rattus norvegicus (Norway rat),Zinc inhibits the reaction [streptozocin results in increased expression of SERPINE1 protein],,,PMID:19369054,https://www.ncbi.nlm.nih.gov/pubmed/19369054,19369054,,
5866,1221997,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270.0,SERPINE2,9606.0,Homo sapiens (human),Zinc deficiency results in decreased expression of SERPINE2 mRNA,,,PMID:22171008,https://www.ncbi.nlm.nih.gov/pubmed/22171008,22171008,,
5867,1221998,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,871,SERPINH1,https://ctdbase.org/detail.go?type=gene&acc=871,,,871.0,SERPINH1,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of SERPINH1 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
5868,1221999,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,871,SERPINH1,https://ctdbase.org/detail.go?type=gene&acc=871,,,871.0,SERPINH1,9606.0,Homo sapiens (human),Zinc results in decreased expression of SERPINH1 protein,,,PMID:15984569,https://www.ncbi.nlm.nih.gov/pubmed/15984569,15984569,,
5869,1222000,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,29950,SERTAD1,https://ctdbase.org/detail.go?type=gene&acc=29950,,,29950.0,SERTAD1,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of SERTAD1 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
5870,1222001,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,29946,SERTAD3,https://ctdbase.org/detail.go?type=gene&acc=29946,,,29946.0,SERTAD3,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of SERTAD3 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
5871,1222002,23994,Comparative Toxicogenomics Database (CTD),Zinc,D015032,Zinc,https://ctdbase.org/detail.go?type=chem&acc=D015032,83667,SESN2,https://ctdbase.org/detail.go?type=gene&acc=83667,,,83667.0,SESN2,9606.0,Homo sapiens (human),[PCI 5002 co-treated with zinc] results in increased expression of SESN2 mRNA,,,PMID:18593933,https://www.ncbi.nlm.nih.gov/pubmed/18593933,18593933,,
5872,1223445,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,88,ACTN2,https://ctdbase.org/detail.go?type=gene&acc=88,,,88.0,ACTN2,10116.0,Rattus norvegicus (Norway rat),Mercuric chloride results in increased expression of ACTN2 mRNA,,,PMID:16507785,https://www.ncbi.nlm.nih.gov/pubmed/16507785,16507785,,
5873,1223446,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,91,ACVR1B,https://ctdbase.org/detail.go?type=gene&acc=91,,,91.0,ACVR1B,7955.0,Danio rerio (zebrafish),Mercuric chloride affects the expression of ACVR1B mRNA,,,PMID:20353558,https://www.ncbi.nlm.nih.gov/pubmed/20353558,20353558,,
5874,1223447,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,100,ADA,https://ctdbase.org/detail.go?type=gene&acc=100,,,100.0,ADA,7955.0,Danio rerio (zebrafish),Mercuric chloride results in decreased activity of ADA protein|dithiothreitol inhibits the reaction [mercuric chloride results in decreased activity of ADA protein],,,PMID:20226812,https://www.ncbi.nlm.nih.gov/pubmed/20226812,20226812,,
5875,1223448,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,373884,ADA2A,https://ctdbase.org/detail.go?type=gene&acc=373884,,,373884.0,ada2a,7955.0,Danio rerio (zebrafish),Mercuric chloride affects the expression of ADA2A mRNA,,,PMID:20353558,https://www.ncbi.nlm.nih.gov/pubmed/20353558,20353558,,
5876,1223449,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,9510,ADAMTS1,https://ctdbase.org/detail.go?type=gene&acc=9510,,,9510.0,ADAMTS1,10116.0,Rattus norvegicus (Norway rat),Mercuric chloride results in increased expression of ADAMTS1 mRNA,,,PMID:16507785,https://www.ncbi.nlm.nih.gov/pubmed/16507785,16507785,,
5877,1223450,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,117,ADCYAP1R1,https://ctdbase.org/detail.go?type=gene&acc=117,,,117.0,ADCYAP1R1,10116.0,Rattus norvegicus (Norway rat),Mercuric chloride results in increased expression of ADCYAP1R1 mRNA,,,PMID:32599119,https://www.ncbi.nlm.nih.gov/pubmed/32599119,32599119,,
5878,1223451,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,118,ADD1,https://ctdbase.org/detail.go?type=gene&acc=118,,,118.0,ADD1,7955.0,Danio rerio (zebrafish),Mercuric chloride affects the expression of ADD1 mRNA,,,PMID:20353558,https://www.ncbi.nlm.nih.gov/pubmed/20353558,20353558,,
5879,1227551,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Mercuric chloride results in decreased expression of CAT protein,,,PMID:24970117,https://www.ncbi.nlm.nih.gov/pubmed/24970117,24970117,,
5880,1227207,24197,Comparative Toxicogenomics Database (CTD),Diethyl malate,C058705,diethyl malate,https://ctdbase.org/detail.go?type=chem&acc=C058705,9249,DHRS3,https://ctdbase.org/detail.go?type=gene&acc=9249,,,9249.0,DHRS3,10090.0,Mus musculus (house mouse),Diethyl malate affects the expression of DHRS3 mRNA,,,PMID:24814887,https://www.ncbi.nlm.nih.gov/pubmed/24814887,24814887,,
5881,1227208,24197,Comparative Toxicogenomics Database (CTD),Diethyl malate,C058705,diethyl malate,https://ctdbase.org/detail.go?type=chem&acc=C058705,79132,DHX58,https://ctdbase.org/detail.go?type=gene&acc=79132,,,79132.0,DHX58,10090.0,Mus musculus (house mouse),Diethyl malate affects the expression of DHX58 mRNA,,,PMID:24814887,https://www.ncbi.nlm.nih.gov/pubmed/24814887,24814887,,
5882,1227209,24197,Comparative Toxicogenomics Database (CTD),Diethyl malate,C058705,diethyl malate,https://ctdbase.org/detail.go?type=chem&acc=C058705,10913,EDAR,https://ctdbase.org/detail.go?type=gene&acc=10913,,,10913.0,EDAR,10090.0,Mus musculus (house mouse),Diethyl malate affects the expression of EDAR mRNA,,,PMID:24814887,https://www.ncbi.nlm.nih.gov/pubmed/24814887,24814887,,
5883,1227210,24197,Comparative Toxicogenomics Database (CTD),Diethyl malate,C058705,diethyl malate,https://ctdbase.org/detail.go?type=chem&acc=C058705,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,10090.0,Mus musculus (house mouse),Diethyl malate affects the expression of EDNRA mRNA,,,PMID:24814887,https://www.ncbi.nlm.nih.gov/pubmed/24814887,24814887,,
5884,1227211,24197,Comparative Toxicogenomics Database (CTD),Diethyl malate,C058705,diethyl malate,https://ctdbase.org/detail.go?type=chem&acc=C058705,2034,EPAS1,https://ctdbase.org/detail.go?type=gene&acc=2034,,,2034.0,EPAS1,10090.0,Mus musculus (house mouse),Diethyl malate affects the expression of EPAS1 mRNA,,,PMID:24814887,https://www.ncbi.nlm.nih.gov/pubmed/24814887,24814887,,
5885,1227212,24197,Comparative Toxicogenomics Database (CTD),Diethyl malate,C058705,diethyl malate,https://ctdbase.org/detail.go?type=chem&acc=C058705,2045,EPHA7,https://ctdbase.org/detail.go?type=gene&acc=2045,,,2045.0,EPHA7,10090.0,Mus musculus (house mouse),Diethyl malate affects the expression of EPHA7 mRNA,,,PMID:24814887,https://www.ncbi.nlm.nih.gov/pubmed/24814887,24814887,,
5886,1227213,24197,Comparative Toxicogenomics Database (CTD),Diethyl malate,C058705,diethyl malate,https://ctdbase.org/detail.go?type=chem&acc=C058705,2048,EPHB2,https://ctdbase.org/detail.go?type=gene&acc=2048,,,2048.0,EPHB2,10090.0,Mus musculus (house mouse),Diethyl malate affects the expression of EPHB2 mRNA,,,PMID:24814887,https://www.ncbi.nlm.nih.gov/pubmed/24814887,24814887,,
5887,1227214,24197,Comparative Toxicogenomics Database (CTD),Diethyl malate,C058705,diethyl malate,https://ctdbase.org/detail.go?type=chem&acc=C058705,2051,EPHB6,https://ctdbase.org/detail.go?type=gene&acc=2051,,,2051.0,EPHB6,10090.0,Mus musculus (house mouse),Diethyl malate affects the expression of EPHB6 mRNA,,,PMID:24814887,https://www.ncbi.nlm.nih.gov/pubmed/24814887,24814887,,
5888,1227215,24197,Comparative Toxicogenomics Database (CTD),Diethyl malate,C058705,diethyl malate,https://ctdbase.org/detail.go?type=chem&acc=C058705,2255,FGF10,https://ctdbase.org/detail.go?type=gene&acc=2255,,,2255.0,FGF10,10090.0,Mus musculus (house mouse),Diethyl malate affects the expression of FGF10 mRNA,,,PMID:24814887,https://www.ncbi.nlm.nih.gov/pubmed/24814887,24814887,,
5889,1229299,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,184616,F17C11.6,https://ctdbase.org/detail.go?type=gene&acc=184616,,,184616.0,F17C11.6,6239.0,Caenorhabditis elegans,Silicon dioxide results in decreased expression of F17C11.6 mRNA,,,PMID:31369748,https://www.ncbi.nlm.nih.gov/pubmed/31369748,31369748,,
5890,1229530,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,180319,F19B2.5,https://ctdbase.org/detail.go?type=gene&acc=180319,,,180319.0,F19B2.5,6239.0,Caenorhabditis elegans,Silicon dioxide results in decreased expression of F19B2.5 mRNA,,,PMID:31369748,https://www.ncbi.nlm.nih.gov/pubmed/31369748,31369748,,
5891,1229531,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,178181,F19B6.1,https://ctdbase.org/detail.go?type=gene&acc=178181,,,178181.0,F19B6.1,6239.0,Caenorhabditis elegans,Silicon dioxide results in increased expression of F19B6.1 mRNA,,,PMID:31369748,https://www.ncbi.nlm.nih.gov/pubmed/31369748,31369748,,
5892,1229532,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,181213,F19C6.2,https://ctdbase.org/detail.go?type=gene&acc=181213,,,181213.0,F19C6.2,6239.0,Caenorhabditis elegans,Silicon dioxide results in increased expression of F19C6.2 mRNA,,,PMID:31369748,https://www.ncbi.nlm.nih.gov/pubmed/31369748,31369748,,
5893,1229533,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,177226,F19C7.8,https://ctdbase.org/detail.go?type=gene&acc=177226,,,177226.0,F19C7.8,6239.0,Caenorhabditis elegans,Silicon dioxide results in increased expression of F19C7.8 mRNA,,,PMID:31369748,https://www.ncbi.nlm.nih.gov/pubmed/31369748,31369748,,
5894,1229534,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,184685,F19F10.3,https://ctdbase.org/detail.go?type=gene&acc=184685,,,184685.0,F19F10.3,6239.0,Caenorhabditis elegans,Silicon dioxide results in increased expression of F19F10.3 mRNA,,,PMID:31369748,https://www.ncbi.nlm.nih.gov/pubmed/31369748,31369748,,
5895,1229535,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,2147,F2,https://ctdbase.org/detail.go?type=gene&acc=2147,,,2147.0,F2,9606.0,Homo sapiens (human),Silicon dioxide analog results in decreased expression of F2 mRNA,,,PMID:25895662,https://www.ncbi.nlm.nih.gov/pubmed/25895662,25895662,,
5896,1229536,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,184715,F20B10.3,https://ctdbase.org/detail.go?type=gene&acc=184715,,,184715.0,F20B10.3,6239.0,Caenorhabditis elegans,Silicon dioxide results in increased expression of F20B10.3 mRNA,,,PMID:31369748,https://www.ncbi.nlm.nih.gov/pubmed/31369748,31369748,,
5897,1232799,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,399726,MIR1915HG,https://ctdbase.org/detail.go?type=gene&acc=399726,,,399726.0,MIR1915HG,9606.0,Homo sapiens (human),Silicon dioxide analog results in increased expression of MIR1915HG mRNA,,,PMID:25895662,https://www.ncbi.nlm.nih.gov/pubmed/25895662,25895662,,
5898,1232800,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,406985,MIR200C,https://ctdbase.org/detail.go?type=gene&acc=406985,,,406985.0,MIR200C,9606.0,Homo sapiens (human),MIR200C mRNA inhibits the reaction [silicon dioxide results in increased expression of ZEB1 protein]|mir200c mRNA inhibits the reaction [silicon dioxide results in decreased expression of CDH1 protein]|mir200c mRNA inhibits the reaction [silicon dioxide results in increased expression of FN1 protein]|silicon dioxide results in decreased expression of MIR200C mrna|mir200c mRNA inhibits the reaction [silicon dioxide results in increased expression of ACTA2 protein]|mir200c mRNA inhibits the reaction [silicon dioxide results in increased expression of VIM protein],,,PMID:29113749,https://www.ncbi.nlm.nih.gov/pubmed/29113749,29113749,,
5899,1232801,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,642587,MIR205HG,https://ctdbase.org/detail.go?type=gene&acc=642587,,,642587.0,MIR205HG,9606.0,Homo sapiens (human),Silicon dioxide results in increased expression of MIR205HG mRNA,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
5900,1232802,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,100500809,MIR23C,https://ctdbase.org/detail.go?type=gene&acc=100500809,,,100500809.0,MIR23C,10090.0,Mus musculus (house mouse),MIR23C mRNA inhibits the reaction [silicon dioxide results in increased expression of CTNNB1 protein]|mir23c mRNA inhibits the reaction [silicon dioxide results in increased expression of MMP2 protein]|mir23c mRNA inhibits the reaction [silicon dioxide results in increased expression of MMP9 mrna]|silicon dioxide results in decreased expression of MIR23C mrna|mir23c mRNA inhibits the reaction [silicon dioxide results in increased expression of TGFB1 protein]|mir23c mRNA inhibits the reaction [silicon dioxide results in increased expression of IL6 protein]|mir23c mRNA inhibits the reaction [silicon dioxide results in increased expression of MMP9 protein]|mir23c mRNA inhibits the reaction [silicon dioxide results in increased expression of MMP2 mrna]|mir23c mRNA inhibits the reaction [silicon dioxide results in increased expression of CTNNB1 mrna],,,PMID:29216763,https://www.ncbi.nlm.nih.gov/pubmed/29216763,29216763,,
5901,1233910,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,171957,MPC-2,https://ctdbase.org/detail.go?type=gene&acc=171957,,,171957.0,mpc-2,6239.0,Caenorhabditis elegans,Silicon dioxide results in decreased expression of MPC-2 mRNA,,,PMID:31369748,https://www.ncbi.nlm.nih.gov/pubmed/31369748,31369748,,
5902,1226704,24287,Toxin and Toxin Target Database (T3DB),Tin tetrachloride,T3D1275,Tin chloride,http://www.t3db.ca/toxins/T3D1275,BE0000227,Alcohol dehydrogenase 1A,http://www.t3db.ca/biodb/bio_entities/BE0000227,P07327,Alcohol dehydrogenase 1A,124.0,ADH1A,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
5903,1226705,24287,Toxin and Toxin Target Database (T3DB),Tin tetrachloride,T3D1275,Tin chloride,http://www.t3db.ca/toxins/T3D1275,BE0000400,Alcohol dehydrogenase 1B,http://www.t3db.ca/biodb/bio_entities/BE0000400,P00325,All-trans-retinol dehydrogenase [NAD(+)] ADH1B,125.0,ADH1B,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
5904,1226706,24287,Toxin and Toxin Target Database (T3DB),Tin tetrachloride,T3D1275,Tin chloride,http://www.t3db.ca/toxins/T3D1275,BE0000465,Alcohol dehydrogenase 1C,http://www.t3db.ca/biodb/bio_entities/BE0000465,P00326,Alcohol dehydrogenase 1C,126.0,ADH1C,9606.0,Homo sapiens (human),Inorganic and organic tin compounds are weak inhibitors of alcohol dehydrogenase. (A183),,,PMID:18365099,https://www.ncbi.nlm.nih.gov/pubmed/18365099,18365099,,
5905,1221370,24459,Comparative Toxicogenomics Database (CTD),Lead chloride,C029891,lead chloride,https://ctdbase.org/detail.go?type=chem&acc=C029891,6649,SOD3,https://ctdbase.org/detail.go?type=gene&acc=6649,,,6649.0,SOD3,157728.0,Saccostrea glomerata,Lead chloride results in increased expression of SOD3 protein,,,PMID:22030410,https://www.ncbi.nlm.nih.gov/pubmed/22030410,22030410,,
5906,1221371,24459,Comparative Toxicogenomics Database (CTD),Lead chloride,C029891,lead chloride,https://ctdbase.org/detail.go?type=chem&acc=C029891,6667,SP1,https://ctdbase.org/detail.go?type=gene&acc=6667,,,6667.0,SP1,10090.0,Mus musculus (house mouse),[[lead chloride results in increased abundance of lead] co-treated with [sodium arsenite results in increased abundance of arsenic]] results in increased expression of SP1 protein|[[lead chloride results in increased abundance of lead] which co-treated with methylmercuric chloride] results in increased expression of SP1 protein,,,PMID:32179164,https://www.ncbi.nlm.nih.gov/pubmed/32179164,32179164,,
5907,1221372,24459,Comparative Toxicogenomics Database (CTD),Lead chloride,C029891,lead chloride,https://ctdbase.org/detail.go?type=chem&acc=C029891,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,9606.0,Homo sapiens (human),[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of SQLE mRNA,,,PMID:18654764,https://www.ncbi.nlm.nih.gov/pubmed/18654764,18654764,,
5908,1221373,24459,Comparative Toxicogenomics Database (CTD),Lead chloride,C029891,lead chloride,https://ctdbase.org/detail.go?type=chem&acc=C029891,6722,SRF,https://ctdbase.org/detail.go?type=gene&acc=6722,,,6722.0,SRF,9606.0,Homo sapiens (human),[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] affects the expression of SRF mRNA,,,PMID:18654764,https://www.ncbi.nlm.nih.gov/pubmed/18654764,18654764,,
5909,1221374,24459,Comparative Toxicogenomics Database (CTD),Lead chloride,C029891,lead chloride,https://ctdbase.org/detail.go?type=chem&acc=C029891,6736,SRY,https://ctdbase.org/detail.go?type=gene&acc=6736,,,6736.0,SRY,9606.0,Homo sapiens (human),[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] affects the expression of SRY mRNA,,,PMID:18654764,https://www.ncbi.nlm.nih.gov/pubmed/18654764,18654764,,
5910,1221375,24459,Comparative Toxicogenomics Database (CTD),Lead chloride,C029891,lead chloride,https://ctdbase.org/detail.go?type=chem&acc=C029891,8128,ST8SIA2,https://ctdbase.org/detail.go?type=gene&acc=8128,,,8128.0,ST8SIA2,10116.0,Rattus norvegicus (Norway rat),Lead chloride results in decreased expression of ST8SIA2 mRNA,,,PMID:18499259,https://www.ncbi.nlm.nih.gov/pubmed/18499259,18499259,,
5911,1221376,24459,Comparative Toxicogenomics Database (CTD),Lead chloride,C029891,lead chloride,https://ctdbase.org/detail.go?type=chem&acc=C029891,7903,ST8SIA4,https://ctdbase.org/detail.go?type=gene&acc=7903,,,7903.0,ST8SIA4,10116.0,Rattus norvegicus (Norway rat),Lead chloride results in decreased expression of ST8SIA4 mRNA,,,PMID:18499259,https://www.ncbi.nlm.nih.gov/pubmed/18499259,18499259,,
5912,1221377,24459,Comparative Toxicogenomics Database (CTD),Lead chloride,C029891,lead chloride,https://ctdbase.org/detail.go?type=chem&acc=C029891,51765,STK26,https://ctdbase.org/detail.go?type=gene&acc=51765,,,51765.0,STK26,9606.0,Homo sapiens (human),[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of STK26 mRNA,,,PMID:18654764,https://www.ncbi.nlm.nih.gov/pubmed/18654764,18654764,,
5913,1221993,24460,Comparative Toxicogenomics Database (CTD),Lead chromate,C031895,lead chromate,https://ctdbase.org/detail.go?type=chem&acc=C031895,3897,L1CAM,https://ctdbase.org/detail.go?type=gene&acc=3897,,,3897.0,L1CAM,9750.0,Physeteridae (sperm whales),Lead chromate results in decreased expression of L1CAM mRNA,,,PMID:23584427,https://www.ncbi.nlm.nih.gov/pubmed/23584427,23584427,,
5914,1221994,24460,Comparative Toxicogenomics Database (CTD),Lead chromate,C031895,lead chromate,https://ctdbase.org/detail.go?type=chem&acc=C031895,3938,LCT,https://ctdbase.org/detail.go?type=gene&acc=3938,,,3938.0,LCT,9750.0,Physeteridae (sperm whales),Lead chromate results in decreased expression of LCT mRNA,,,PMID:23584427,https://www.ncbi.nlm.nih.gov/pubmed/23584427,23584427,,
5915,1230876,24480,Comparative Toxicogenomics Database (CTD),Manganese dichloride,C025340,manganese chloride,https://ctdbase.org/detail.go?type=chem&acc=C025340,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606.0,Homo sapiens (human),[N-((3-(aminomethyl)phenyl)methyl)ethanimidamide co-treated with manganese chloride] results in decreased expression of SQSTM1 protein,,,PMID:28856835,https://www.ncbi.nlm.nih.gov/pubmed/28856835,28856835,,
5916,1230877,24480,Comparative Toxicogenomics Database (CTD),Manganese dichloride,C025340,manganese chloride,https://ctdbase.org/detail.go?type=chem&acc=C025340,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10090.0,Mus musculus (house mouse),SQSTM1 protein inhibits the reaction [[manganese chloride results in increased abundance of manganese] which results in increased expression of SQSTM1 protein]|sirolimus inhibits the reaction [[manganese chloride results in increased abundance of manganese] which results in increased expression of SQSTM1 protein]|[manganese chloride results in increased abundance of manganese] which results in increased expression of SQSTM1 protein,,,PMID:31690173,https://www.ncbi.nlm.nih.gov/pubmed/31690173,31690173,,
5917,1230878,24480,Comparative Toxicogenomics Database (CTD),Manganese dichloride,C025340,manganese chloride,https://ctdbase.org/detail.go?type=chem&acc=C025340,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10116.0,Rattus norvegicus (Norway rat),Resveratrol promotes the reaction [manganese chloride results in increased expression of SQSTM1 protein]|manganese chloride results in increased expression of SQSTM1 protein|chloroquine promotes the reaction [manganese chloride results in increased expression of SQSTM1 protein]|sirolimus inhibits the reaction [manganese chloride results in increased expression of SQSTM1 protein]|acetylcysteine promotes the reaction [manganese chloride results in increased expression of SQSTM1 protein],,,PMID:29222055,https://www.ncbi.nlm.nih.gov/pubmed/29222055,29222055,,
5918,1230879,24480,Comparative Toxicogenomics Database (CTD),Manganese dichloride,C025340,manganese chloride,https://ctdbase.org/detail.go?type=chem&acc=C025340,174709,SRAP-1,https://ctdbase.org/detail.go?type=gene&acc=174709,,,174709.0,srap-1,6239.0,Caenorhabditis elegans,Manganese chloride results in increased expression of SRAP-1 mRNA,,,PMID:26418576,https://www.ncbi.nlm.nih.gov/pubmed/26418576,26418576,,
5919,1230880,24480,Comparative Toxicogenomics Database (CTD),Manganese dichloride,C025340,manganese chloride,https://ctdbase.org/detail.go?type=chem&acc=C025340,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606.0,Homo sapiens (human),[AG 1879 results in decreased activity of SRC protein] promotes the reaction [manganese chloride affects the localization of and affects the activity of [ITGB3 protein binds to ITGAV protein]]|[cgp 77675 results in decreased activity of SRC protein] promotes the reaction [manganese chloride affects the localization of and affects the activity of [ITGB3 protein binds to ITGAV protein]],,,PMID:15213856,https://www.ncbi.nlm.nih.gov/pubmed/15213856,15213856,,
5920,1216910,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,77117,ZFP934,https://ctdbase.org/detail.go?type=gene&acc=77117,,,77117.0,Zfp934,10090.0,Mus musculus (house mouse),Potassium dichromate results in decreased expression of ZFP934 mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
5921,1216911,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,240041,ZFP945,https://ctdbase.org/detail.go?type=gene&acc=240041,,,240041.0,Zfp945,10090.0,Mus musculus (house mouse),Potassium dichromate results in decreased expression of ZFP945 mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
5922,1216912,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,414758,ZFP950,https://ctdbase.org/detail.go?type=gene&acc=414758,,,414758.0,Zfp950,10090.0,Mus musculus (house mouse),Potassium dichromate results in decreased expression of ZFP950 mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
5923,1216913,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,234413,ZFP961,https://ctdbase.org/detail.go?type=gene&acc=234413,,,234413.0,Zfp961,10090.0,Mus musculus (house mouse),Potassium dichromate results in decreased expression of ZFP961 mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
5924,1223442,24592,Toxin and Toxin Target Database (T3DB),Cesium bromide,T3D1726,Cesium bromide,http://www.t3db.ca/toxins/T3D1726,BE0005283,Chloride channel protein ClC-Kb,http://www.t3db.ca/biodb/bio_entities/BE0005283,P51801,Chloride channel protein ClC-Kb ,1188.0,CLCNKB,9606.0,Homo sapiens (human),,,,PMID:3047312|PMID:10050002,https://www.ncbi.nlm.nih.gov/pubmed/3047312|https://www.ncbi.nlm.nih.gov/pubmed/10050002,3047312|10050002,,
5925,1223443,24592,Toxin and Toxin Target Database (T3DB),Cesium bromide,T3D1726,Cesium bromide,http://www.t3db.ca/toxins/T3D1726,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000795,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606.0,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
5926,1223444,24592,Toxin and Toxin Target Database (T3DB),Cesium bromide,T3D1726,Cesium bromide,http://www.t3db.ca/toxins/T3D1726,BE0002345,Gamma-aminobutyric acid receptor subunit beta-3,http://www.t3db.ca/biodb/bio_entities/BE0002345,P28472,Gamma-aminobutyric acid receptor subunit beta-3,2562.0,GABRB3,9606.0,Homo sapiens (human),,,,PMID:7843172,https://www.ncbi.nlm.nih.gov/pubmed/7843172,7843172,,
5927,1217575,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,10090.0,Mus musculus (house mouse),Ozone results in decreased expression of UCP1 mRNA,,,PMID:31626304,https://www.ncbi.nlm.nih.gov/pubmed/31626304,31626304,,
5928,1217576,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,10116.0,Rattus norvegicus (Norway rat),Ozone results in decreased expression of UCP1 mrna|fructose promotes the reaction [ozone results in decreased expression of UCP1 mrna]|fructose promotes the reaction [[ozone co-treated with particulate matter] results in decreased expression of UCP1 mrna]|[ozone co-treated with particulate matter] results in decreased expression of UCP1 mRNA,,,PMID:23968387,https://www.ncbi.nlm.nih.gov/pubmed/23968387,23968387,,
5929,1217577,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7352,UCP3,https://ctdbase.org/detail.go?type=gene&acc=7352,,,7352.0,UCP3,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of UCP3 mrna|[air pollutants results in increased abundance of ozone] which results in decreased expression of UCP3 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5930,1217578,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7360,UGP2,https://ctdbase.org/detail.go?type=gene&acc=7360,,,7360.0,UGP2,9606.0,Homo sapiens (human),[volatile organic compounds co-treated with ozone] results in increased expression of UGP2 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of UGP2 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of UGP2 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5931,1217579,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7360,UGP2,https://ctdbase.org/detail.go?type=gene&acc=7360,,,7360.0,UGP2,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of UGP2 mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
5932,1217580,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,394435,UGT1A6B,https://ctdbase.org/detail.go?type=gene&acc=394435,,,394435.0,Ugt1a6b,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of UGT1A6B mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5933,1217581,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,100384899,UGT1B5,https://ctdbase.org/detail.go?type=gene&acc=100384899,,,100384899.0,ugt1b5,90988.0,Pimephales promelas (fathead minnow),"[water pollutants, chemical co-treated with ozone] results in decreased expression of UGT1B5 mRNA",,,PMID:23246600,https://www.ncbi.nlm.nih.gov/pubmed/23246600,23246600,,
5934,1219307,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5236,PGM1,https://ctdbase.org/detail.go?type=gene&acc=5236,,,5236.0,PGM1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of PGM1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5935,1219308,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5238,PGM3,https://ctdbase.org/detail.go?type=gene&acc=5238,,,5238.0,PGM3,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of PGM3 mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of PGM3 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5936,1219309,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5239,PGM5,https://ctdbase.org/detail.go?type=gene&acc=5239,,,5239.0,PGM5,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of PGM5 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5937,1219310,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5239,PGM5,https://ctdbase.org/detail.go?type=gene&acc=5239,,,5239.0,PGM5,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of PGM5 mRNA,,,PMID:27106289,https://www.ncbi.nlm.nih.gov/pubmed/27106289,27106289,,
5938,1221034,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,8502,PKP4,https://ctdbase.org/detail.go?type=gene&acc=8502,,,8502.0,PKP4,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with ozone] results in increased expression of PKP4 mRNA,,,PMID:32845096,https://www.ncbi.nlm.nih.gov/pubmed/32845096,32845096,,
5939,1221035,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,51365,PLA1A,https://ctdbase.org/detail.go?type=gene&acc=51365,,,51365.0,PLA1A,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of PLA1A mRNA,,,PMID:27106289|PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/27106289|https://www.ncbi.nlm.nih.gov/pubmed/34911549,27106289|34911549,,
5940,1221036,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,8399,PLA2G10,https://ctdbase.org/detail.go?type=gene&acc=8399,,,8399.0,PLA2G10,10090.0,Mus musculus (house mouse),Ozone results in increased expression of PLA2G10 mRNA,,,PMID:33026818,https://www.ncbi.nlm.nih.gov/pubmed/33026818,33026818,,
5941,1221037,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,81579,PLA2G12A,https://ctdbase.org/detail.go?type=gene&acc=81579,,,81579.0,PLA2G12A,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of PLA2G12A mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5942,1221038,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,81579,PLA2G12A,https://ctdbase.org/detail.go?type=gene&acc=81579,,,81579.0,PLA2G12A,10116.0,Rattus norvegicus (Norway rat),Ozone results in increased expression of PLA2G12A mRNA,,,PMID:35737395,https://www.ncbi.nlm.nih.gov/pubmed/35737395,35737395,,
5943,1221039,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5319,PLA2G1B,https://ctdbase.org/detail.go?type=gene&acc=5319,,,5319.0,PLA2G1B,10116.0,Rattus norvegicus (Norway rat),Ozone results in decreased expression of PLA2G1B mRNA,,,PMID:16716893,https://www.ncbi.nlm.nih.gov/pubmed/16716893,16716893,,
5944,1221040,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,391013,PLA2G2C,https://ctdbase.org/detail.go?type=gene&acc=391013,,,391013.0,PLA2G2C,10116.0,Rattus norvegicus (Norway rat),[ozone co-treated with chlorine] results in increased expression of PLA2G2C mRNA,,,PMID:18636392,https://www.ncbi.nlm.nih.gov/pubmed/18636392,18636392,,
5945,1221041,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,26279,PLA2G2D,https://ctdbase.org/detail.go?type=gene&acc=26279,,,26279.0,PLA2G2D,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of PLA2G2D mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of PLA2G2D mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5946,1222503,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,9512,PMPCB,https://ctdbase.org/detail.go?type=gene&acc=9512,,,9512.0,PMPCB,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of PMPCB mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
5947,1222504,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,9512,PMPCB,https://ctdbase.org/detail.go?type=gene&acc=9512,,,9512.0,PMPCB,10116.0,Rattus norvegicus (Norway rat),Ozone results in increased expression of PMPCB protein,,,PMID:33146391,https://www.ncbi.nlm.nih.gov/pubmed/33146391,33146391,,
5948,1222505,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5378,PMS1,https://ctdbase.org/detail.go?type=gene&acc=5378,,,5378.0,PMS1,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of PMS1 mrna|[volatile organic compounds co-treated with ozone] results in increased expression of PMS1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of PMS1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5949,1225098,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,63977,PRDM15,https://ctdbase.org/detail.go?type=gene&acc=63977,,,63977.0,PRDM15,9606.0,Homo sapiens (human),[volatile organic compounds co-treated with ozone] results in increased expression of PRDM15 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of PRDM15 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of PRDM15 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5950,1225099,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,63977,PRDM15,https://ctdbase.org/detail.go?type=gene&acc=63977,,,63977.0,PRDM15,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with ozone] results in increased expression of PRDM15 mRNA,,,PMID:32845096,https://www.ncbi.nlm.nih.gov/pubmed/32845096,32845096,,
5951,1225100,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7799,PRDM2,https://ctdbase.org/detail.go?type=gene&acc=7799,,,7799.0,PRDM2,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of PRDM2 mrna|[volatile organic compounds co-treated with ozone] results in increased expression of PRDM2 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of PRDM2 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5952,1225101,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7799,PRDM2,https://ctdbase.org/detail.go?type=gene&acc=7799,,,7799.0,PRDM2,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with ozone] results in increased expression of PRDM2 mRNA,,,PMID:32845096,https://www.ncbi.nlm.nih.gov/pubmed/32845096,32845096,,
5953,1225102,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7799,PRDM2,https://ctdbase.org/detail.go?type=gene&acc=7799,,,7799.0,PRDM2,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of PRDM2 mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
5954,1225103,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7799,PRDM2,https://ctdbase.org/detail.go?type=gene&acc=7799,,,7799.0,PRDM2,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of PRDM2 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5955,1225394,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,148206,ZNF714,https://ctdbase.org/detail.go?type=gene&acc=148206,,,148206.0,ZNF714,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of ZNF714 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of ZNF714 mrna|[volatile organic compounds co-treated with ozone] results in decreased expression of ZNF714 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5956,1225395,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,100131827,ZNF717,https://ctdbase.org/detail.go?type=gene&acc=100131827,,,100131827.0,ZNF717,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of ZNF717 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of ZNF717 mrna|[volatile organic compounds co-treated with ozone] results in increased expression of ZNF717 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5957,1225396,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,170960,ZNF721,https://ctdbase.org/detail.go?type=gene&acc=170960,,,170960.0,ZNF721,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of ZNF721 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of ZNF721 mrna|[volatile organic compounds co-treated with ozone] results in decreased expression of ZNF721 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5958,1225397,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,100129842,ZNF737,https://ctdbase.org/detail.go?type=gene&acc=100129842,,,100129842.0,ZNF737,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of ZNF737 mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
5959,1225398,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7625,ZNF74,https://ctdbase.org/detail.go?type=gene&acc=7625,,,7625.0,ZNF74,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of ZNF74 mrna|[volatile organic compounds co-treated with ozone] results in decreased expression of ZNF74 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of ZNF74 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5960,1225399,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,155061,ZNF746,https://ctdbase.org/detail.go?type=gene&acc=155061,,,155061.0,ZNF746,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of ZNF746 mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
5961,1225400,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,388567,ZNF749,https://ctdbase.org/detail.go?type=gene&acc=388567,,,388567.0,ZNF749,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of ZNF749 mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
5962,1225401,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,388561,ZNF761,https://ctdbase.org/detail.go?type=gene&acc=388561,,,388561.0,ZNF761,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of ZNF761 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of ZNF761 mrna|[volatile organic compounds co-treated with ozone] results in decreased expression of ZNF761 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5963,1225702,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5571,PRKAG1,https://ctdbase.org/detail.go?type=gene&acc=5571,,,5571.0,PRKAG1,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of PRKAG1 mrna|[volatile organic compounds co-treated with ozone] results in increased expression of PRKAG1 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of PRKAG1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5964,1225703,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,51422,PRKAG2,https://ctdbase.org/detail.go?type=gene&acc=51422,,,51422.0,PRKAG2,10116.0,Rattus norvegicus (Norway rat),Ozone results in decreased expression of PRKAG2 mRNA,,,PMID:35737395,https://www.ncbi.nlm.nih.gov/pubmed/35737395,35737395,,
5965,1225704,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,53632,PRKAG3,https://ctdbase.org/detail.go?type=gene&acc=53632,,,53632.0,PRKAG3,9606.0,Homo sapiens (human),[ozone results in increased abundance of soot metabolite] which results in increased expression of PRKAG3 mRNA,,,PMID:28410501,https://www.ncbi.nlm.nih.gov/pubmed/28410501,28410501,,
5966,1225705,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5573,PRKAR1A,https://ctdbase.org/detail.go?type=gene&acc=5573,,,5573.0,PRKAR1A,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of and results in increased oxidation of PRKAR1A mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of and results in increased oxidation of PRKAR1A mrna|[volatile organic compounds co-treated with ozone] results in decreased expression of and results in increased oxidation of PRKAR1A mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5967,1225706,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5573,PRKAR1A,https://ctdbase.org/detail.go?type=gene&acc=5573,,,5573.0,PRKAR1A,10116.0,Rattus norvegicus (Norway rat),Ozone results in increased phosphorylation of PRKAR1A protein,,,PMID:33146391,https://www.ncbi.nlm.nih.gov/pubmed/33146391,33146391,,
5968,1225707,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5576,PRKAR2A,https://ctdbase.org/detail.go?type=gene&acc=5576,,,5576.0,PRKAR2A,9606.0,Homo sapiens (human),[volatile organic compounds co-treated with ozone] results in increased oxidation of PRKAR2A mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of PRKAR2A mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of PRKAR2A mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5969,1225708,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5577,PRKAR2B,https://ctdbase.org/detail.go?type=gene&acc=5577,,,5577.0,PRKAR2B,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of PRKAR2B mrna|[air pollutants results in increased abundance of ozone] which results in decreased expression of PRKAR2B mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5970,1225709,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of PRKCB mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
5971,1226224,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,10544,PROCR,https://ctdbase.org/detail.go?type=gene&acc=10544,,,10544.0,PROCR,9606.0,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of PROCR mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of PROCR mrna|[volatile organic compounds co-treated with ozone] results in increased oxidation of PROCR mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
5972,1226225,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5625,PRODH,https://ctdbase.org/detail.go?type=gene&acc=5625,,,5625.0,PRODH,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of PRODH mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5973,1227206,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,5701,PSMC2,https://ctdbase.org/detail.go?type=gene&acc=5701,,,5701.0,PSMC2,10116.0,Rattus norvegicus (Norway rat),[ozone co-treated with chlorine] results in decreased expression of PSMC2 mRNA,,,PMID:18636392,https://www.ncbi.nlm.nih.gov/pubmed/18636392,18636392,,
5974,1230664,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,54922,RASIP1,https://ctdbase.org/detail.go?type=gene&acc=54922,,,54922.0,RASIP1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of RASIP1 mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of RASIP1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
5975,1228905,24924,Comparative Toxicogenomics Database (CTD),Lead nitrate,C017461,lead nitrate,https://ctdbase.org/detail.go?type=chem&acc=C017461,6670,SP3,https://ctdbase.org/detail.go?type=gene&acc=6670,,,6670.0,SP3,10090.0,Mus musculus (house mouse),Lead nitrate affects the reaction [SP3 affects the expression of MT2 mrna]|lead nitrate affects the reaction [SP3 affects the expression of MT1 mrna]|lead nitrate results in decreased expression of SP3 mRNA,,,PMID:11891201,https://www.ncbi.nlm.nih.gov/pubmed/11891201,11891201,,
5976,1228906,24924,Comparative Toxicogenomics Database (CTD),Lead nitrate,C017461,lead nitrate,https://ctdbase.org/detail.go?type=chem&acc=C017461,6678,SPARC,https://ctdbase.org/detail.go?type=gene&acc=6678,,,6678.0,SPARC,35525.0,Daphnia magna,[nickel chloride co-treated with lead nitrate] results in decreased expression of SPARC mRNA,,,PMID:19187980,https://www.ncbi.nlm.nih.gov/pubmed/19187980,19187980,,
5977,1228907,24924,Comparative Toxicogenomics Database (CTD),Lead nitrate,C017461,lead nitrate,https://ctdbase.org/detail.go?type=chem&acc=C017461,132671,SPATA18,https://ctdbase.org/detail.go?type=gene&acc=132671,,,132671.0,SPATA18,10116.0,Rattus norvegicus (Norway rat),Lead nitrate results in decreased expression of SPATA18 mRNA,,,PMID:21628963,https://www.ncbi.nlm.nih.gov/pubmed/21628963,21628963,,
5978,1228908,24924,Comparative Toxicogenomics Database (CTD),Lead nitrate,C017461,lead nitrate,https://ctdbase.org/detail.go?type=chem&acc=C017461,64847,SPATA20,https://ctdbase.org/detail.go?type=gene&acc=64847,,,64847.0,SPATA20,10116.0,Rattus norvegicus (Norway rat),Lead nitrate results in decreased expression of SPATA20 mRNA,,,PMID:21628963,https://www.ncbi.nlm.nih.gov/pubmed/21628963,21628963,,
5979,1227026,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2200,FBN1,https://ctdbase.org/detail.go?type=gene&acc=2200,,,2200.0,FBN1,9606.0,Homo sapiens (human),[cadmium chloride results in increased abundance of cadmium] which results in decreased expression of FBN1 mRNA,,,PMID:29741670,https://www.ncbi.nlm.nih.gov/pubmed/29741670,29741670,,
5980,1227027,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2201,FBN2,https://ctdbase.org/detail.go?type=gene&acc=2201,,,2201.0,FBN2,10116.0,Rattus norvegicus (Norway rat),Cadmium chloride results in increased methylation of FBN2 promoter,,,PMID:22457795,https://www.ncbi.nlm.nih.gov/pubmed/22457795,22457795,,
5981,1227028,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2203,FBP1,https://ctdbase.org/detail.go?type=gene&acc=2203,,,2203.0,FBP1,8260.0,Platichthys flesus (European flounder),Cadmium chloride results in decreased expression of FBP1 mRNA,,,PMID:18804290,https://www.ncbi.nlm.nih.gov/pubmed/18804290,18804290,,
5982,1227029,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,64319,FBRS,https://ctdbase.org/detail.go?type=gene&acc=64319,,,64319.0,FBRS,9606.0,Homo sapiens (human),[cadmium chloride results in increased abundance of cadmium] which results in decreased expression of FBRS mRNA,,,PMID:35301059,https://www.ncbi.nlm.nih.gov/pubmed/35301059,35301059,,
5983,1228909,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,80308,FLAD1,https://ctdbase.org/detail.go?type=gene&acc=80308,,,80308.0,FLAD1,8260.0,Platichthys flesus (European flounder),Cadmium chloride results in decreased expression of FLAD1 mRNA,,,PMID:18804290,https://www.ncbi.nlm.nih.gov/pubmed/18804290,18804290,,
5984,1228910,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2312,FLG,https://ctdbase.org/detail.go?type=gene&acc=2312,,,2312.0,FLG,9606.0,Homo sapiens (human),[cadmium chloride results in increased abundance of cadmium] which results in decreased expression of FLG mRNA,,,PMID:35301059,https://www.ncbi.nlm.nih.gov/pubmed/35301059,35301059,,
5985,1228911,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2313,FLI1,https://ctdbase.org/detail.go?type=gene&acc=2313,,,2313.0,FLI1,10116.0,Rattus norvegicus (Norway rat),Cadmium chloride results in decreased expression of FLI1 mRNA,,,PMID:33453195,https://www.ncbi.nlm.nih.gov/pubmed/33453195,33453195,,
5986,1228912,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2316,FLNA,https://ctdbase.org/detail.go?type=gene&acc=2316,,,2316.0,FLNA,35525.0,Daphnia magna,Cadmium chloride results in increased expression of FLNA mRNA,,,PMID:17582521,https://www.ncbi.nlm.nih.gov/pubmed/17582521,17582521,,
5987,1228913,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2316,FLNA,https://ctdbase.org/detail.go?type=gene&acc=2316,,,2316.0,FLNA,158441.0,Folsomia candida,Cadmium chloride results in decreased expression of FLNA mRNA,,,PMID:19031917,https://www.ncbi.nlm.nih.gov/pubmed/19031917,19031917,,
5988,1228914,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2316,FLNA,https://ctdbase.org/detail.go?type=gene&acc=2316,,,2316.0,FLNA,9606.0,Homo sapiens (human),[cadmium chloride results in increased abundance of cadmium] which results in decreased expression of FLNA mRNA,,,PMID:29741670,https://www.ncbi.nlm.nih.gov/pubmed/29741670,29741670,,
5989,1229527,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090.0,Mus musculus (house mouse),[tetradecanoylphorbol acetate co-treated with [cadmium chloride results in increased abundance of cadmium]] affects the expression of FOS mRNA,,,PMID:31904401,https://www.ncbi.nlm.nih.gov/pubmed/31904401,31904401,,
5990,1229528,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,8260.0,Platichthys flesus (European flounder),Cadmium chloride results in increased expression of FOS mRNA,,,PMID:16624402,https://www.ncbi.nlm.nih.gov/pubmed/16624402,16624402,,
5991,1229529,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10116.0,Rattus norvegicus (Norway rat),2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [cadmium chloride results in increased expression of FOS mrna],,,PMID:10637132|PMID:9417049|PMID:9650640,https://www.ncbi.nlm.nih.gov/pubmed/10637132|https://www.ncbi.nlm.nih.gov/pubmed/9417049|https://www.ncbi.nlm.nih.gov/pubmed/9650640,10637132|9417049|9650640,,
5992,1230871,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,8727,CTNNAL1,https://ctdbase.org/detail.go?type=gene&acc=8727,,,8727.0,CTNNAL1,10090.0,Mus musculus (house mouse),[cadmium chloride results in increased abundance of cadmium] which results in increased expression of CTNNAL1 mRNA,,,PMID:37325564,https://www.ncbi.nlm.nih.gov/pubmed/37325564,37325564,,
5993,1230872,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,8727,CTNNAL1,https://ctdbase.org/detail.go?type=gene&acc=8727,,,8727.0,CTNNAL1,10116.0,Rattus norvegicus (Norway rat),Cadmium chloride results in decreased expression of CTNNAL1 mRNA,,,PMID:33453195,https://www.ncbi.nlm.nih.gov/pubmed/33453195,33453195,,
5994,1230873,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),ARL6 protein inhibits the reaction [[cadmium chloride results in increased abundance of cadmium] which results in decreased expression of CTNNB1 protein]|[cadmium chloride results in increased abundance of cadmium] which results in decreased expression of CTNNB1 protein,,,PMID:32522577,https://www.ncbi.nlm.nih.gov/pubmed/32522577,32522577,,
5995,1230874,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Cadmium chloride affects the localization of CTNNB1 protein,,,PMID:24532171,https://www.ncbi.nlm.nih.gov/pubmed/24532171,24532171,,
5996,1230875,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606.0,Homo sapiens (human),Cadmium chloride results in increased expression of CTNNB1 mRNA,,,PMID:26472689,https://www.ncbi.nlm.nih.gov/pubmed/26472689,26472689,,
5997,1234784,24947,Comparative Toxicogenomics Database (CTD),Cadmium Chloride,D019256,Cadmium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D019256,3837,KPNB1,https://ctdbase.org/detail.go?type=gene&acc=3837,,,3837.0,KPNB1,6573.0,Mizuhopecten yessoensis (Yesso scallop),Cadmium chloride results in increased expression of KPNB1 mRNA,,,PMID:23741332,https://www.ncbi.nlm.nih.gov/pubmed/23741332,23741332,,
5998,1218822,25408,Comparative Toxicogenomics Database (CTD),Sodium Dichromate,C016104,sodium bichromate,https://ctdbase.org/detail.go?type=chem&acc=C016104,6142,RPL18A,https://ctdbase.org/detail.go?type=gene&acc=6142,,,6142.0,RPL18A,10116.0,Rattus norvegicus (Norway rat),Sodium bichromate results in increased expression of RPL18A mRNA,,,PMID:22561333,https://www.ncbi.nlm.nih.gov/pubmed/22561333,22561333,,
5999,1219302,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,51224,ELOA2,https://ctdbase.org/detail.go?type=gene&acc=51224,,,51224.0,ELOA2,9606.0,Homo sapiens (human),Terbufos results in increased methylation of ELOA2 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6000,1219303,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,64834,ELOVL1,https://ctdbase.org/detail.go?type=gene&acc=64834,,,64834.0,ELOVL1,9606.0,Homo sapiens (human),Terbufos results in increased methylation of ELOVL1 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6001,1219304,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,10712,ENTREP3,https://ctdbase.org/detail.go?type=gene&acc=10712,,,10712.0,ENTREP3,9606.0,Homo sapiens (human),Terbufos results in increased methylation of ENTREP3 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6002,1219305,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,2036,EPB41L1,https://ctdbase.org/detail.go?type=gene&acc=2036,,,2036.0,EPB41L1,9606.0,Homo sapiens (human),Terbufos results in increased methylation of EPB41L1 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6003,1219306,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,2043,EPHA4,https://ctdbase.org/detail.go?type=gene&acc=2043,,,2043.0,EPHA4,9606.0,Homo sapiens (human),Terbufos results in increased methylation of EPHA4 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6004,1219917,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,2587,GALR1,https://ctdbase.org/detail.go?type=gene&acc=2587,,,2587.0,GALR1,9606.0,Homo sapiens (human),Terbufos results in increased methylation of GALR1 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6005,1219918,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,64762,GAREM1,https://ctdbase.org/detail.go?type=gene&acc=64762,,,64762.0,GAREM1,9606.0,Homo sapiens (human),Terbufos results in increased methylation of GAREM1 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6006,1219919,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,246176,GAS2L2,https://ctdbase.org/detail.go?type=gene&acc=246176,,,246176.0,GAS2L2,9606.0,Homo sapiens (human),Terbufos results in increased methylation of GAS2L2 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6007,1219920,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,2626,GATA4,https://ctdbase.org/detail.go?type=gene&acc=2626,,,2626.0,GATA4,9606.0,Homo sapiens (human),Terbufos results in increased methylation of GATA4 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6008,1219921,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,140628,GATA5,https://ctdbase.org/detail.go?type=gene&acc=140628,,,140628.0,GATA5,9606.0,Homo sapiens (human),Terbufos results in increased methylation of GATA5 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6009,1222506,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,5081,PAX7,https://ctdbase.org/detail.go?type=gene&acc=5081,,,5081.0,PAX7,9606.0,Homo sapiens (human),Terbufos results in increased methylation of PAX7 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6010,1222507,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,56099,PCDHGB7,https://ctdbase.org/detail.go?type=gene&acc=56099,,,56099.0,PCDHGB7,9606.0,Homo sapiens (human),Terbufos results in increased methylation of PCDHGB7 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6011,1222508,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,91523,PCED1B,https://ctdbase.org/detail.go?type=gene&acc=91523,,,91523.0,PCED1B,9606.0,Homo sapiens (human),Terbufos results in decreased methylation of PCED1B promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6012,1222509,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,5152,PDE9A,https://ctdbase.org/detail.go?type=gene&acc=5152,,,5152.0,PDE9A,9606.0,Homo sapiens (human),Terbufos results in increased methylation of PDE9A promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6013,1222510,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,3651,PDX1,https://ctdbase.org/detail.go?type=gene&acc=3651,,,3651.0,PDX1,9606.0,Homo sapiens (human),Terbufos results in increased methylation of PDX1 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6014,1222511,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,5179,PENK,https://ctdbase.org/detail.go?type=gene&acc=5179,,,5179.0,PENK,9606.0,Homo sapiens (human),Terbufos results in increased methylation of PENK promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6015,1222512,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,84302,PGAP4,https://ctdbase.org/detail.go?type=gene&acc=84302,,,84302.0,PGAP4,9606.0,Homo sapiens (human),Terbufos results in increased methylation of PGAP4 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6016,1223249,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,5909,RAP1GAP,https://ctdbase.org/detail.go?type=gene&acc=5909,,,5909.0,RAP1GAP,9606.0,Homo sapiens (human),Terbufos results in decreased methylation of RAP1GAP promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6017,1223250,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,5914,RARA,https://ctdbase.org/detail.go?type=gene&acc=5914,,,5914.0,RARA,9606.0,Homo sapiens (human),Terbufos results in increased methylation of RARA promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6018,1223251,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,158158,RASEF,https://ctdbase.org/detail.go?type=gene&acc=158158,,,158158.0,RASEF,9606.0,Homo sapiens (human),Terbufos results in increased methylation of RASEF promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6019,1223252,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,5923,RASGRF1,https://ctdbase.org/detail.go?type=gene&acc=5923,,,5923.0,RASGRF1,9606.0,Homo sapiens (human),Terbufos results in increased methylation of RASGRF1 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6020,1223253,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,5947,RBP1,https://ctdbase.org/detail.go?type=gene&acc=5947,,,5947.0,RBP1,9606.0,Homo sapiens (human),Terbufos results in increased methylation of RBP1 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6021,1223254,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,5950,RBP4,https://ctdbase.org/detail.go?type=gene&acc=5950,,,5950.0,RBP4,9606.0,Homo sapiens (human),Terbufos results in increased methylation of RBP4 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6022,1224597,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,7024,TFCP2,https://ctdbase.org/detail.go?type=gene&acc=7024,,,7024.0,TFCP2,9606.0,Homo sapiens (human),Terbufos results in increased methylation of TFCP2 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6023,1224598,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,7030,TFE3,https://ctdbase.org/detail.go?type=gene&acc=7030,,,7030.0,TFE3,9606.0,Homo sapiens (human),Terbufos results in increased methylation of TFE3 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6024,1224599,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,7980,TFPI2,https://ctdbase.org/detail.go?type=gene&acc=7980,,,7980.0,TFPI2,9606.0,Homo sapiens (human),Terbufos results in increased methylation of TFPI2 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6025,1224600,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,7075,TIE1,https://ctdbase.org/detail.go?type=gene&acc=7075,,,7075.0,TIE1,9606.0,Homo sapiens (human),Terbufos results in increased methylation of TIE1 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6026,1224601,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,26517,TIMM13,https://ctdbase.org/detail.go?type=gene&acc=26517,,,26517.0,TIMM13,9606.0,Homo sapiens (human),Terbufos results in increased methylation of TIMM13 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6027,1224602,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,7079,TIMP4,https://ctdbase.org/detail.go?type=gene&acc=7079,,,7079.0,TIMP4,9606.0,Homo sapiens (human),Terbufos results in increased methylation of TIMP4 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6028,1224603,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,7091,TLE4,https://ctdbase.org/detail.go?type=gene&acc=7091,,,7091.0,TLE4,9606.0,Homo sapiens (human),Terbufos results in increased methylation of TLE4 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6029,1225104,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,158880,USP51,https://ctdbase.org/detail.go?type=gene&acc=158880,,,158880.0,USP51,9606.0,Homo sapiens (human),Terbufos results in increased methylation of USP51 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6030,1225105,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,8433,UTF1,https://ctdbase.org/detail.go?type=gene&acc=8433,,,8433.0,UTF1,9606.0,Homo sapiens (human),Terbufos results in increased methylation of UTF1 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6031,1225106,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,22846,VASH1,https://ctdbase.org/detail.go?type=gene&acc=22846,,,22846.0,VASH1,9606.0,Homo sapiens (human),Terbufos results in increased methylation of VASH1 promoter,,,PMID:22847954,https://www.ncbi.nlm.nih.gov/pubmed/22847954,22847954,,
6032,1225107,25670,Comparative Toxicogenomics Database (CTD),Terbufos,C012568,terbufos,https://ctdbase.org/detail.go?type=chem&acc=C012568,7421,VDR,https://ctdbase.org/detail.go?type=gene&acc=7421,,,7421.0,VDR,9606.0,Homo sapiens (human),VDR gene SNP affects the susceptibility to terbufos,,,PMID:23833127,https://www.ncbi.nlm.nih.gov/pubmed/23833127,23833127,,
6033,1230061,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,116150,NUS1,https://ctdbase.org/detail.go?type=gene&acc=116150,,,116150.0,NUS1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of NUS1 mRNA,,,PMID:23409001|PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/23409001|https://www.ncbi.nlm.nih.gov/pubmed/27760801,23409001|27760801,,
6034,1230062,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,51203,NUSAP1,https://ctdbase.org/detail.go?type=gene&acc=51203,,,51203.0,NUSAP1,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of NUSAP1 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
6035,1230063,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,51203,NUSAP1,https://ctdbase.org/detail.go?type=gene&acc=51203,,,51203.0,NUSAP1,10116.0,Rattus norvegicus (Norway rat),Titanium dioxide results in increased expression of NUSAP1 mRNA,,,PMID:30012374,https://www.ncbi.nlm.nih.gov/pubmed/30012374,30012374,,
6036,1230064,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,56001,NXF2,https://ctdbase.org/detail.go?type=gene&acc=56001,,,56001.0,NXF2,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of NXF2 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
6037,1230065,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,158046,NXNL2,https://ctdbase.org/detail.go?type=gene&acc=158046,,,158046.0,NXNL2,9606.0,Homo sapiens (human),Titanium dioxide results in decreased methylation of NXNL2 gene,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
6038,1230066,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,11248,NXPH3,https://ctdbase.org/detail.go?type=gene&acc=11248,,,11248.0,NXPH3,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of NXPH3 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
6039,1230067,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,319888,OACYL,https://ctdbase.org/detail.go?type=gene&acc=319888,,,319888.0,Oacyl,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of OACYL mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
6040,1230068,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,220323,OAF,https://ctdbase.org/detail.go?type=gene&acc=220323,,,220323.0,OAF,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of OAF mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
6041,1232049,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,258784,OR4A72,https://ctdbase.org/detail.go?type=gene&acc=258784,,,258784.0,Or4a72,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of OR4A72 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
6042,1232050,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,259145,OR4A78,https://ctdbase.org/detail.go?type=gene&acc=259145,,,259145.0,Or4a78,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of OR4A78 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
6043,1232051,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,258982,OR4B1B,https://ctdbase.org/detail.go?type=gene&acc=258982,,,258982.0,Or4b1b,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of OR4B1B mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
6044,1232052,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,18331,OR4B1D,https://ctdbase.org/detail.go?type=gene&acc=18331,,,18331.0,Or4b1d,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of OR4B1D mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
6045,1232053,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,18331,OR4B1D,https://ctdbase.org/detail.go?type=gene&acc=18331,,,18331.0,Or4b1d,10090.0,Mus musculus (house mouse),Titanium dioxide results in decreased expression of OR4B1D mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
6046,1232054,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,18331,OR4B1D,https://ctdbase.org/detail.go?type=gene&acc=18331,,,18331.0,Or4b1d,10090.0,Mus musculus (house mouse),Titanium dioxide results in increased expression of OR4B1D mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
6047,1232055,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,258984,OR4C10B,https://ctdbase.org/detail.go?type=gene&acc=258984,,,258984.0,Or4c10b,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of OR4C10B mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
6048,1232056,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,258903,OR4C112,https://ctdbase.org/detail.go?type=gene&acc=258903,,,258903.0,Or4c112,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of OR4C112 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
6049,1232057,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,258815,OR4C113,https://ctdbase.org/detail.go?type=gene&acc=258815,,,258815.0,Or4c113,10090.0,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of OR4C113 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
6050,1218269,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,51310,SLC22A17,https://ctdbase.org/detail.go?type=gene&acc=51310,,,51310.0,SLC22A17,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of SLC22A17 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6051,1218270,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,63027,SLC22A23,https://ctdbase.org/detail.go?type=gene&acc=63027,,,63027.0,SLC22A23,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of SLC22A23 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6052,1218271,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,6584,SLC22A5,https://ctdbase.org/detail.go?type=gene&acc=6584,,,6584.0,SLC22A5,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of SLC22A5 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6053,1218272,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,9356,SLC22A6,https://ctdbase.org/detail.go?type=gene&acc=9356,,,9356.0,SLC22A6,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of SLC22A6 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6054,1218273,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,9376,SLC22A8,https://ctdbase.org/detail.go?type=gene&acc=9376,,,9376.0,SLC22A8,9986.0,Oryctolagus cuniculus (rabbit),Tetradecanoylphorbol acetate inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]|bisindolylmaleimide I inhibits the reaction [tetradecanoylphorbol acetate inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]],,,PMID:15238352,https://www.ncbi.nlm.nih.gov/pubmed/15238352,15238352,,
6055,1218274,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,9962,SLC23A2,https://ctdbase.org/detail.go?type=gene&acc=9962,,,9962.0,SLC23A2,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] affects the expression of SLC23A2 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6056,1218275,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,57419,SLC24A3,https://ctdbase.org/detail.go?type=gene&acc=57419,,,57419.0,SLC24A3,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of SLC24A3 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6057,1218276,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,8402,SLC25A11,https://ctdbase.org/detail.go?type=gene&acc=8402,,,8402.0,SLC25A11,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of SLC25A11 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6058,1218277,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,8604,SLC25A12,https://ctdbase.org/detail.go?type=gene&acc=8604,,,8604.0,SLC25A12,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] affects the expression of SLC25A12 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6059,1221567,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),Tetradecanoylphorbol acetate results in increased expression of RB1 protein modified form,,,PMID:9348195,https://www.ncbi.nlm.nih.gov/pubmed/9348195,9348195,,
6060,1221568,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),Tetradecanoylphorbol acetate results in increased phosphorylation of RB1 protein,,,PMID:12421932|PMID:8927716,https://www.ncbi.nlm.nih.gov/pubmed/12421932|https://www.ncbi.nlm.nih.gov/pubmed/8927716,12421932|8927716,,
6061,1221569,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),[zinc co-treated with tetradecanoylphorbol acetate] affects the expression of RB1 mRNA,,,PMID:16979875,https://www.ncbi.nlm.nih.gov/pubmed/16979875,16979875,,
6062,1221570,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of RB1 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6063,1224261,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,6191,RPS4X,https://ctdbase.org/detail.go?type=gene&acc=6191,,,6191.0,RPS4X,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of RPS4X mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6064,1224262,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,9606.0,Homo sapiens (human),[tetradecanoylphorbol acetate results in increased activity of PRKCH protein] inhibits the reaction [sirolimus results in decreased phosphorylation of RPS6 protein],,,PMID:16832347,https://www.ncbi.nlm.nih.gov/pubmed/16832347,16832347,,
6065,1224263,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,10090.0,Mus musculus (house mouse),Plant extracts inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of RPS6 protein]|tetradecanoylphorbol acetate results in increased phosphorylation of RPS6 protein|quercetin inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of RPS6 protein],,,PMID:18245498,https://www.ncbi.nlm.nih.gov/pubmed/18245498,18245498,,
6066,1224264,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,6195,RPS6KA1,https://ctdbase.org/detail.go?type=gene&acc=6195,,,6195.0,RPS6KA1,10090.0,Mus musculus (house mouse),Tetradecanoylphorbol acetate results in increased phosphorylation of RPS6KA1 protein|myricetin inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of RPS6KA1 protein],,,PMID:17693661,https://www.ncbi.nlm.nih.gov/pubmed/17693661,17693661,,
6067,1224265,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,6195,RPS6KA1,https://ctdbase.org/detail.go?type=gene&acc=6195,,,6195.0,RPS6KA1,9986.0,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of RPS6KA1 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
6068,1225392,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606.0,Homo sapiens (human),Tetradecanoylphorbol acetate inhibits the reaction [oxygen deficiency results in increased activity of and results in increased localization of PRKCD protein],,,PMID:11424089,https://www.ncbi.nlm.nih.gov/pubmed/11424089,11424089,,
6069,1225393,27959,Comparative Toxicogenomics Database (CTD),"2,3-Dichlorobiphenyl",C030375,"2,3-dichlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C030375,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606.0,Homo sapiens (human),"2,3-dichlorobiphenyl inhibits the reaction [metribolone results in increased activity of AR protein]",,,PMID:18324785,https://www.ncbi.nlm.nih.gov/pubmed/18324785,18324785,,
6070,1227020,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,444,ASPH,https://ctdbase.org/detail.go?type=gene&acc=444,,,444.0,ASPH,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of ASPH mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
6071,1227021,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,29028,ATAD2,https://ctdbase.org/detail.go?type=gene&acc=29028,,,29028.0,ATAD2,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of ATAD2 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
6072,1227022,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,55210,ATAD3A,https://ctdbase.org/detail.go?type=gene&acc=55210,,,55210.0,ATAD3A,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of ATAD3A mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
6073,1227023,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,10090.0,Mus musculus (house mouse),Chromium hexavalent ion results in increased phosphorylation of ATF2 protein|acetylcysteine inhibits the reaction [chromium hexavalent ion results in increased phosphorylation of ATF2 protein]|map2k4 protein promotes the reaction [chromium hexavalent ion results in increased phosphorylation of ATF2 protein],,,PMID:19654923,https://www.ncbi.nlm.nih.gov/pubmed/19654923,19654923,,
6074,1227024,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606.0,Homo sapiens (human),Chromium hexavalent ion results in increased expression of ATF3 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
6075,1227025,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,468,ATF4,https://ctdbase.org/detail.go?type=gene&acc=468,,,468.0,ATF4,9606.0,Homo sapiens (human),Chromium hexavalent ion results in increased expression of ATF4 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
6076,1231080,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,1359,CPA3,https://ctdbase.org/detail.go?type=gene&acc=1359,,,1359.0,CPA3,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of CPA3 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
6077,1231081,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,1360,CPB1,https://ctdbase.org/detail.go?type=gene&acc=1360,,,1360.0,CPB1,8265.0,Pseudopleuronectes americanus (winter flounder),Chromium hexavalent ion affects the expression of CPB1 mRNA,,,PMID:15003702,https://www.ncbi.nlm.nih.gov/pubmed/15003702,15003702,,
6078,1231082,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,132864,CPEB2,https://ctdbase.org/detail.go?type=gene&acc=132864,,,132864.0,CPEB2,9606.0,Homo sapiens (human),Chromium hexavalent ion results in decreased expression of CPEB2 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
6079,1231083,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,22849,CPEB3,https://ctdbase.org/detail.go?type=gene&acc=22849,,,22849.0,CPEB3,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of CPEB3 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
6080,1231084,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,144402,CPNE8,https://ctdbase.org/detail.go?type=gene&acc=144402,,,144402.0,CPNE8,9606.0,Homo sapiens (human),Chromium hexavalent ion results in decreased expression of CPNE8 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
6081,1231085,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,1387,CREBBP,https://ctdbase.org/detail.go?type=gene&acc=1387,,,1387.0,CREBBP,10116.0,Rattus norvegicus (Norway rat),Chromium hexavalent ion results in decreased expression of CREBBP protein,,,PMID:32679048,https://www.ncbi.nlm.nih.gov/pubmed/32679048,32679048,,
6082,1231086,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,1389,CREBL2,https://ctdbase.org/detail.go?type=gene&acc=1389,,,1389.0,CREBL2,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of CREBL2 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
6083,1231087,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,9606.0,Homo sapiens (human),Chromium hexavalent ion results in increased expression of CRP protein,,,PMID:28596144,https://www.ncbi.nlm.nih.gov/pubmed/28596144,28596144,,
6084,1231088,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,1415,CRYBB2,https://ctdbase.org/detail.go?type=gene&acc=1415,,,1415.0,CRYBB2,9606.0,Homo sapiens (human),Chromium hexavalent ion results in increased expression of CRYBB2 mRNA,,,PMID:30690063,https://www.ncbi.nlm.nih.gov/pubmed/30690063,30690063,,
6085,1231089,29131,Comparative Toxicogenomics Database (CTD),Chromium(6+),C074702,chromium hexavalent ion,https://ctdbase.org/detail.go?type=chem&acc=C074702,1417,CRYBB3,https://ctdbase.org/detail.go?type=gene&acc=1417,,,1417.0,CRYBB3,10090.0,Mus musculus (house mouse),Chromium hexavalent ion affects the expression of CRYBB3 mRNA,,,PMID:28472532,https://www.ncbi.nlm.nih.gov/pubmed/28472532,28472532,,
6086,1228429,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),Aflatoxin B1 affects the expression of TXNIP protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
6087,1228430,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),[aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in increased expression of TXNIP mRNA,,,PMID:31904472,https://www.ncbi.nlm.nih.gov/pubmed/31904472,31904472,,
6088,1228431,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10628,TXNIP,https://ctdbase.org/detail.go?type=gene&acc=10628,,,10628.0,TXNIP,9606.0,Homo sapiens (human),Aflatoxin B1 results in increased expression of TXNIP mRNA,,,PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/21632981,21632981,,
6089,1231392,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1006,CDH8,https://ctdbase.org/detail.go?type=gene&acc=1006,,,1006.0,CDH8,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CDH8 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
6090,1231393,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1006,CDH8,https://ctdbase.org/detail.go?type=gene&acc=1006,,,1006.0,CDH8,9606.0,Homo sapiens (human),Methylmercuric chloride results in increased expression of CDH8 mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
6091,1231394,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1007,CDH9,https://ctdbase.org/detail.go?type=gene&acc=1007,,,1007.0,CDH9,9606.0,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CDH9 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
6092,1235295,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5251,PHEX,https://ctdbase.org/detail.go?type=gene&acc=5251,,,5251.0,PHEX,9606.0,Homo sapiens (human),Sodium arsenite results in increased expression of PHEX mRNA,,,PMID:29301061|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/29301061|https://www.ncbi.nlm.nih.gov/pubmed/34032870,29301061|34032870,,
6093,1235296,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5251,PHEX,https://ctdbase.org/detail.go?type=gene&acc=5251,,,5251.0,PHEX,10090.0,Mus musculus (house mouse),Sodium arsenite results in increased expression of PHEX mRNA,,,PMID:19000923,https://www.ncbi.nlm.nih.gov/pubmed/19000923,19000923,,
6094,1235297,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5252,PHF1,https://ctdbase.org/detail.go?type=gene&acc=5252,,,5252.0,PHF1,9606.0,Homo sapiens (human),Sodium arsenite affects the expression of PHF1 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
